1_2_4_trichlorobenzene
  SciTegic08102311032D

  9  9  0  0  0  0            999 V2000
    7.5197   -0.4751    0.0000 Cl  0  0
    6.2207    0.2748    0.0000 C   0  0
    6.2206    1.7748    0.0000 C   0  0
    4.9215    2.5248    0.0000 C   0  0
    3.6225    1.7747    0.0000 C   0  0
    3.6226    0.2747    0.0000 C   0  0
    4.9217   -0.4752    0.0000 C   0  0
    2.3234    2.5246    0.0000 Cl  0  0
    2.3236   -0.4754    0.0000 Cl  0  0
  1  2  1  0
  2  3  1  0
  2  7  2  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  8  1  0
  6  7  1  0
  6  9  1  0
M  END
> <Name>
1_2_4_trichlorobenzene

> <ID>
1_2_4_trichlorobenzene

> <PRIMARY_SOM>
3

> <SECONDARY_SOM>
7

> <Citation>
Bogaards et al.,Toxicol. Appl. Pharmacol.,132,44,1995

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
1_nitropyrene
  SciTegic08102311032D

 19 22  0  0  0  0            999 V2000
    4.9216   -2.5245    0.0000 C   0  0
    4.9216   -1.0245    0.0000 C   0  0
    3.6226   -3.2745    0.0000 C   0  0
    6.2207   -3.2745    0.0000 C   0  0
    6.2207   -0.2745    0.0000 C   0  0
    3.6226   -0.2745    0.0000 C   0  0
    2.3236   -2.5245    0.0000 C   0  0
    3.6226   -4.7745    0.0000 C   0  0
    7.5197   -2.5245    0.0000 C   0  0
    6.2207   -4.7745    0.0000 C   0  0
    7.5197   -1.0245    0.0000 C   0  0
    6.2207    1.2255    0.0000 C   0  0
    2.3236   -1.0245    0.0000 C   0  0
    3.6226    1.2255    0.0000 C   0  0
    4.9217   -5.5245    0.0000 C   0  0
    4.9216    1.9755    0.0000 C   0  0
    7.5197   -5.5245    0.0000 N   0  3
    8.8188   -4.7745    0.0000 O   0  5
    7.5197   -7.0245    0.0000 O   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  4 10  2  0
  5 11  1  0
  5 12  1  0
  6 13  1  0
  6 14  2  0
  7 13  2  0
  8 15  2  0
  9 11  2  0
 10 15  1  0
 10 17  1  0
 12 16  2  0
 14 16  1  0
 17 18  1  0
 17 19  2  0
M  CHG  2  17   1  18  -1
M  END
> <Name>
1_nitropyrene

> <ID>
1_nitropyrene

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
14

> <Citation>
Chae et al.,Cancer Res.,59,1473,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
3_hpph
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -5.985 1.9016 0 0
M  V30 2 C -6.8638 3.1172 0 0
M  V30 3 C -8.3559 2.9639 0 0
M  V30 4 C -8.9693 1.595 0 0
M  V30 5 C -8.0905 0.3794 0 0
M  V30 6 C -6.5983 0.5327 0 0
M  V30 7 C -7.0203 -1.4298 0 0
M  V30 8 C -7.0238 -2.9298 0 0
M  V30 9 C -8.3246 -3.6767 0 0
M  V30 10 C -9.6219 -2.9237 0 0
M  V30 11 C -9.6184 -1.4237 0 0
M  V30 12 C -8.3176 -0.6768 0 0
M  V30 13 C -5.7195 -0.6829 0 0 CFG=2
M  V30 14 N -5.1126 -2.0546 0 0
M  V30 15 C -3.6205 -1.9013 0 0
M  V30 16 N -3.3051 -0.4349 0 0
M  V30 17 C -4.6024 0.3182 0 0
M  V30 18 O -4.7557 1.8103 0 0
M  V30 19 O -2.6194 -3.0184 0 0
M  V30 20 O -10.4614 1.4418 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 4 20
M  V30 7 1 5 6
M  V30 8 1 13 6 CFG=1
M  V30 9 1 7 8
M  V30 10 2 7 12
M  V30 11 1 7 13
M  V30 12 2 8 9
M  V30 13 1 9 10
M  V30 14 2 10 11
M  V30 15 1 11 12
M  V30 16 1 13 14
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 15 16
M  V30 20 2 15 19
M  V30 21 1 16 17
M  V30 22 2 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
3_hpph

> <ID>
3_hpph

> <PRIMARY_SOM>
3

> <Citation>
Komatsu et al.,Drug Metab. Disp.,28,1361,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
4_hpph
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -1.2004 6.8556 0 0
M  V30 2 C -1.2004 8.3556 0 0
M  V30 3 C -2.4995 9.1056 0 0
M  V30 4 C -3.7985 8.3556 0 0
M  V30 5 C -3.7985 6.8556 0 0
M  V30 6 C -2.4995 6.1056 0 0
M  V30 7 C -3.9913 4.7624 0 0
M  V30 8 C -4.873 3.5489 0 0
M  V30 9 C -6.3647 3.7057 0 0
M  V30 10 C -6.9748 5.076 0 0
M  V30 11 C -6.0932 6.2895 0 0
M  V30 12 C -4.6014 6.1327 0 0
M  V30 13 C -2.4995 4.6056 0 0 CFG=2
M  V30 14 N -2.8114 3.1384 0 0
M  V30 15 C -1.5123 2.3884 0 0
M  V30 16 N -0.3976 3.3921 0 0
M  V30 17 C -1.0077 4.7624 0 0
M  V30 18 O -0.2577 6.0614 0 0
M  V30 19 O -1.3555 0.8966 0 0
M  V30 20 O -2.4995 10.6056 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 20
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 1 13 6 CFG=1
M  V30 9 1 7 8
M  V30 10 2 7 12
M  V30 11 1 7 13
M  V30 12 2 8 9
M  V30 13 1 9 10
M  V30 14 2 10 11
M  V30 15 1 11 12
M  V30 16 1 13 14
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 15 16
M  V30 20 2 15 19
M  V30 21 1 16 17
M  V30 22 2 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
4_hpph

> <ID>
4_hpph

> <PRIMARY_SOM>
4 2

> <Citation>
Komatsu et al.,Drug Metab. Disp.,28,1361,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
4_hydroxytamoxifen
  SciTegic08102311032D

 29 31  0  0  0  0            999 V2000
   -5.9462   -3.7500    0.0000 C   0  0
   -5.9462   -5.2500    0.0000 C   0  0
   -7.2452   -3.0000    0.0000 C   0  0
   -4.6471   -3.0000    0.0000 C   0  0
   -7.2452   -6.0000    0.0000 C   0  0
   -4.6471   -6.0000    0.0000 C   0  0
   -7.2452   -1.5000    0.0000 C   0  0
   -8.5442   -3.7500    0.0000 C   0  0
   -3.3481   -3.7500    0.0000 C   0  0
   -4.6471   -1.5000    0.0000 C   0  0
   -7.2452   -7.5000    0.0000 C   0  0
   -8.5442   -5.2500    0.0000 C   0  0
   -3.3481   -5.2500    0.0000 C   0  0
   -8.5442   -0.7500    0.0000 C   0  0
   -9.8433   -3.0000    0.0000 C   0  0
   -2.0490   -3.0000    0.0000 C   0  0
   -3.3481   -0.7500    0.0000 C   0  0
   -8.5442   -8.2500    0.0000 C   0  0
   -9.8433   -6.0000    0.0000 C   0  0
   -9.8433   -1.5000    0.0000 C   0  0
   -2.0490   -1.5000    0.0000 C   0  0
   -9.8433   -7.5000    0.0000 C   0  0
  -11.1423   -0.7500    0.0000 O   0  0
  -12.4413   -1.5000    0.0000 C   0  0
  -13.7404   -0.7500    0.0000 C   0  0
  -15.0394   -1.5000    0.0000 N   0  0
  -16.3385   -0.7500    0.0000 C   0  0
  -15.0394   -3.0000    0.0000 C   0  0
   -0.7500   -0.7500    0.0000 O   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  2  0
  5 12  1  0
  6 13  1  0
  7 14  1  0
  8 15  2  0
  9 16  1  0
 10 17  2  0
 11 18  1  0
 12 19  2  0
 14 20  2  0
 15 20  1  0
 16 21  2  0
 17 21  1  0
 18 22  2  0
 19 22  1  0
 20 23  1  0
 21 29  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
M  END
> <Name>
4_hydroxytamoxifen

> <ID>
4_hydroxytamoxifen

> <PRIMARY_SOM>
17 16

> <Citation>
Dehal and Kupfer,Drug Metab. Disp.,27,681,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
4_nitropyrene
  SciTegic08102311032D

 19 22  0  0  0  0            999 V2000
    3.4514    5.8587    0.0000 C   0  0
    3.4514    7.3587    0.0000 C   0  0
    2.1524    5.1087    0.0000 C   0  0
    4.7504    5.1087    0.0000 C   0  0
    4.7504    8.1087    0.0000 C   0  0
    2.1524    8.1087    0.0000 C   0  0
    0.8533    5.8587    0.0000 C   0  0
    2.1524    3.6087    0.0000 C   0  0
    6.0495    5.8587    0.0000 C   0  0
    4.7504    3.6087    0.0000 C   0  0
    6.0495    7.3587    0.0000 C   0  0
    4.7504    9.6087    0.0000 C   0  0
    0.8533    7.3587    0.0000 C   0  0
    2.1524    9.6087    0.0000 C   0  0
    3.4514    2.8587    0.0000 C   0  0
    3.4514   10.3587    0.0000 C   0  0
   -0.4457    5.1087    0.0000 N   0  3
   -0.4457    3.6087    0.0000 O   0  5
   -1.7447    5.8587    0.0000 O   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  4 10  2  0
  5 11  1  0
  5 12  1  0
  6 13  1  0
  6 14  2  0
  7 13  2  0
  7 17  1  0
  8 15  2  0
  9 11  2  0
 10 15  1  0
 12 16  2  0
 14 16  1  0
 17 18  1  0
 17 19  2  0
M  CHG  2  17   1  18  -1
M  END
> <Name>
4_nitropyrene

> <ID>
4_nitropyrene

> <PRIMARY_SOM>
11 9

> <Citation>
Chae et al.,Cancer Res.,59,1473,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
5_methylchrysene
  SciTegic08102311032D

 19 22  0  0  0  0            999 V2000
    3.5219    4.3997    0.0000 C   0  0
    3.5218    5.8997    0.0000 C   0  0
    2.2229    3.6496    0.0000 C   0  0
    4.8210    3.6498    0.0000 C   0  0
    4.8208    6.6498    0.0000 C   0  0
    2.2227    6.6496    0.0000 C   0  0
    0.9238    4.3996    0.0000 C   0  0
    2.2230    2.1496    0.0000 C   0  0
    6.1200    4.3998    0.0000 C   0  0
    6.1199    5.8998    0.0000 C   0  0
    4.8207    8.1498    0.0000 C   0  0
    0.9237    5.8996    0.0000 C   0  0
   -0.3752    3.6495    0.0000 C   0  0
    0.9240    1.3996    0.0000 C   0  0
    7.4189    6.6499    0.0000 C   0  0
    6.1197    8.8998    0.0000 C   0  0
   -0.3751    2.1495    0.0000 C   0  0
    7.4188    8.1499    0.0000 C   0  0
    2.2227    8.1496    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  2  0
  5 11  1  0
  6 12  2  0
  6 19  1  0
  7 12  1  0
  7 13  1  0
  8 14  2  0
  9 10  1  0
 10 15  1  0
 11 16  2  0
 13 17  2  0
 14 17  1  0
 15 18  2  0
 16 18  1  0
M  END
> <Name>
5_methylchrysene

> <ID>
5_methylchrysene

> <PRIMARY_SOM>
19

> <SECONDARY_SOM>
18 15

> <TERTIARY_SOM>
17 13 14

> <Citation>
Koehl et al.,Cancer Res.,56,316,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
9_anthraldehyde
  SciTegic08102311032D

 16 18  0  0  0  0            999 V2000
    5.9462    1.5000    0.0000 C   0  0
    5.9462    3.0000    0.0000 C   0  0
    4.6471    0.7500    0.0000 C   0  0
    7.2452    0.7500    0.0000 C   0  0
    4.6471    3.7500    0.0000 C   0  0
    7.2452    3.7500    0.0000 C   0  0
    3.3481    1.5000    0.0000 C   0  0
    8.5442    1.5000    0.0000 C   0  0
    3.3481    3.0000    0.0000 C   0  0
    8.5442    3.0000    0.0000 C   0  0
    2.0490    0.7500    0.0000 C   0  0
    2.0490    3.7500    0.0000 C   0  0
    0.7500    1.5000    0.0000 C   0  0
    0.7500    3.0000    0.0000 C   0  0
    4.6471    5.2500    0.0000 C   0  0
    3.3481    6.0000    0.0000 O   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  4  8  2  0
  5  9  2  0
  5 15  1  0
  6 10  2  0
  7  9  1  0
  7 11  1  0
  8 10  1  0
  9 12  1  0
 11 13  2  0
 12 14  2  0
 13 14  1  0
 15 16  2  0
M  END
> <Name>
9_anthraldehyde

> <ID>
9_anthraldehyde

> <PRIMARY_SOM>
15 16

> <Citation>
Watanabe et al.,Drug Metab. Pharmacokin.,17,516,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
9_cis_retinoic_acid
  SciTegic08102311032D

 22 22  0  0  0  0            999 V2000
    0.8457    5.8543    0.0000 C   0  0
    2.1447    5.1043    0.0000 C   0  0
    0.8457    7.3543    0.0000 C   0  0
   -0.4533    5.1043    0.0000 C   0  0
    3.4438    5.8543    0.0000 C   0  0
    8.6399   10.3543    0.0000 C   0  0
    8.6399   11.8543    0.0000 C   0  0
    6.0418    7.3543    0.0000 C   0  0
    7.3409    9.6043    0.0000 C   0  0
    4.7428    5.1043    0.0000 C   0  0
    7.3409    8.1043    0.0000 C   0  0
    6.0418    5.8543    0.0000 C   0  0
    9.9390   12.6043    0.0000 O   0  0
    7.3409   12.6043    0.0000 O   0  0
   -0.4533    8.1043    0.0000 C   0  0
   -1.7524    5.8543    0.0000 C   0  0
    2.1447    8.1043    0.0000 C   0  0
    0.5108    3.9552    0.0000 C   0  0
   -1.4175    3.9552    0.0000 C   0  0
   -1.7524    7.3543    0.0000 C   0  0
    6.0418   10.3543    0.0000 C   0  0
    4.7428    3.6043    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  3 15  1  0
  3 17  1  0
  4 16  1  0
  4 18  1  0
  4 19  1  0
  5 10  1  0
  6  7  1  0
  6  9  2  0
  7 13  2  0
  7 14  1  0
  8 11  2  0
  8 12  1  0
  9 11  1  0
  9 21  1  0
 10 12  2  0
 10 22  1  0
 15 20  1  0
 16 20  1  0
M  END
> <Name>
9_cis_retinoic_acid

> <ID>
9_cis_retinoic_acid

> <PRIMARY_SOM>
15

> <Citation>
Marill et al.,Biochem. Pharmacol.,63,933,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
BFBFC
  SciTegic08102311032D

 31 33  0  0  0  0            999 V2000
    6.2207    0.2745    0.0000 C   0  0
    6.2207    1.7745    0.0000 C   0  0
    4.9216   -0.4755    0.0000 O   0  0
    7.5197   -0.4755    0.0000 C   0  0
    4.9216    2.5245    0.0000 C   0  0
    7.5197    2.5245    0.0000 C   0  0
    3.6226    0.2745    0.0000 C   0  0
    8.8188    0.2745    0.0000 C   0  0
    3.6226    1.7745    0.0000 C   0  0
    8.8187    1.7745    0.0000 C   0  0
    2.3236   -0.4755    0.0000 O   0  0
    4.9216    4.0245    0.0000 C   0  0
    6.2207    4.7745    0.0000 F   0  0
    3.6226    4.7745    0.0000 F   0  0
    4.9216    5.5245    0.0000 F   0  0
   10.1178   -0.4755    0.0000 O   0  0
   11.4168    0.2746    0.0000 C   0  0
   12.7159   -0.4754    0.0000 C   0  0
   12.7159   -1.9754    0.0000 C   0  0
   14.0149   -2.7254    0.0000 C   0  0
   15.3140   -1.9754    0.0000 C   0  0
   15.3140   -0.4754    0.0000 C   0  0
   14.0149    0.2746    0.0000 C   0  0
   14.0149    1.7746    0.0000 C   0  0
   12.7159    2.5246    0.0000 F   0  0
   15.3140    2.5246    0.0000 F   0  0
   14.0149    3.2746    0.0000 F   0  0
   14.0149   -4.2254    0.0000 C   0  0
   12.7159   -4.9754    0.0000 F   0  0
   15.3139   -4.9754    0.0000 F   0  0
   14.0149   -5.7254    0.0000 F   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  5 12  1  0
  6 10  2  0
  7  9  1  0
  7 11  2  0
  8 10  1  0
  8 16  1  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 23  2  0
 19 20  2  0
 20 21  1  0
 20 28  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
 28 29  1  0
 28 30  1  0
 28 31  1  0
M  END
> <Name>
BFBFC

> <ID>
BFBFC

> <PRIMARY_SOM>
17

> <Citation>
Renwick et al.,Xenobiotica,31,187,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
BFC
  SciTegic08102311032D

 23 25  0  0  0  0            999 V2000
    6.2207    0.2745    0.0000 C   0  0
    6.2207    1.7745    0.0000 C   0  0
    4.9216   -0.4755    0.0000 O   0  0
    7.5197   -0.4755    0.0000 C   0  0
    4.9216    2.5245    0.0000 C   0  0
    7.5197    2.5245    0.0000 C   0  0
    3.6226    0.2745    0.0000 C   0  0
    8.8188    0.2746    0.0000 C   0  0
    3.6226    1.7745    0.0000 C   0  0
    8.8187    1.7746    0.0000 C   0  0
    2.3236   -0.4755    0.0000 O   0  0
    4.9216    4.0245    0.0000 C   0  0
    6.2207    4.7745    0.0000 F   0  0
    3.6226    4.7745    0.0000 F   0  0
    4.9216    5.5245    0.0000 F   0  0
   10.1178   -0.4754    0.0000 O   0  0
   11.4168    0.2746    0.0000 C   0  0
   12.7159   -0.4754    0.0000 C   0  0
   14.0149    0.2746    0.0000 C   0  0
   15.3140   -0.4754    0.0000 C   0  0
   15.3140   -1.9754    0.0000 C   0  0
   14.0149   -2.7254    0.0000 C   0  0
   12.7159   -1.9754    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  5 12  1  0
  6 10  2  0
  7  9  1  0
  7 11  2  0
  8 10  1  0
  8 16  1  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 23  2  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
M  END
> <Name>
BFC

> <ID>
BFC

> <PRIMARY_SOM>
17

> <Citation>
Renwick et al.,Xenobiotica,30,955,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
BPU
  SciTegic08102311032D

 30 32  0  0  0  0            999 V2000
    6.8702   -1.3995    0.0000 C   0  0
    6.8702    0.1005    0.0000 N   0  0
    5.5712    0.8505    0.0000 C   0  0
    4.2721    0.1005    0.0000 C   0  0
    4.2721   -1.3995    0.0000 C   0  0
    5.5712   -2.1495    0.0000 N   0  0
    2.9731    0.8505    0.0000 Br  0  0
    8.1692   -2.1495    0.0000 O   0  0
    8.1692   -3.6495    0.0000 C   0  0
    6.8702   -4.3995    0.0000 C   0  0
    6.8702   -5.8995    0.0000 C   0  0
    8.1692   -6.6495    0.0000 C   0  0
    9.4683   -5.8995    0.0000 C   0  0
    9.4683   -4.3995    0.0000 C   0  0
   10.7673   -3.6495    0.0000 C   0  0
    8.1693   -8.1495    0.0000 N   0  0
    9.4683   -8.8995    0.0000 C   0  0
   10.7673   -8.1495    0.0000 O   0  0
    9.4683  -10.3995    0.0000 N   0  0
   10.7673  -11.1495    0.0000 C   0  0
   12.0664  -10.3995    0.0000 O   0  0
   10.7673  -12.6495    0.0000 C   0  0
    9.4683  -13.3995    0.0000 C   0  0
    9.4683  -14.8995    0.0000 C   0  0
   10.7673  -15.6495    0.0000 C   0  0
   12.0664  -14.8995    0.0000 C   0  0
   12.0664  -13.3995    0.0000 C   0  0
   13.3654  -12.6495    0.0000 N   0  0
   14.6645  -13.3995    0.0000 C   0  0
   13.3654  -11.1495    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  1  8  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  7  1  0
  5  6  1  0
  8  9  1  0
  9 10  1  0
  9 14  2  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 16  1  0
 13 14  1  0
 14 15  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 22 27  2  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  1  0
M  END
> <Name>
BPU

> <ID>
BPU

> <PRIMARY_SOM>
30 29

> <Citation>
Rudek et al.,Clin. Cancer Res.,11,8503,2005

> <DOI>
10.1158/1078-0432-CCR-05-1037

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
CARBAMAZEPINE
  SciTegic08102311032D

 18 20  0  0  0  0            999 V2000
   -0.6546    6.0912    0.0000 N   0  0
   -0.9884    7.5536    0.0000 C   0  0
   -1.5898    4.9185    0.0000 C   0  0
    0.8078    5.7575    0.0000 C   0  0
   -2.3399    8.2045    0.0000 C   0  0
    0.2510    8.3986    0.0000 C   0  0
   -3.0898    4.9185    0.0000 C   0  0
   -0.8398    3.6195    0.0000 C   0  0
    1.8280    6.8571    0.0000 N   0  0
    1.2499    4.3241    0.0000 O   0  0
   -2.4520    9.7003    0.0000 C   0  0
   -3.6913    7.5536    0.0000 C   0  0
    0.1389    9.8944    0.0000 C   0  0
   -3.8398    3.6194    0.0000 C   0  0
   -4.0251    6.0912    0.0000 C   0  0
   -1.5898    2.3204    0.0000 C   0  0
   -1.2126   10.5452    0.0000 C   0  0
   -3.0898    2.3204    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  2  0
  5 11  1  0
  5 12  1  0
  6 13  2  0
  7 14  1  0
  7 15  1  0
  8 16  2  0
 11 17  2  0
 12 15  2  0
 13 17  1  0
 14 18  2  0
 16 18  1  0
M  END
> <Name>
CARBAMAZEPINE

> <ID>
CARBAMAZEPINE

> <PRIMARY_SOM>
15 12

> <SECONDARY_SOM>
18 17

> <TERTIARY_SOM>
16 13

> <Citation>
Parkinson, A.,Biotransformation of xenobiotics. In C. D. Klaassen (ed.), Casarett and Doull's Toxicology: The Basic Science of Poinsons,172,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
CLARITHROMYCIN
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 52 54 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -11.5455 2.2014 0 0 CFG=1
M  V30 2 C -12.0577 0.7916 0 0 CFG=2
M  V30 3 C -10.0684 2.4627 0 0 CFG=2
M  V30 4 O -12.5103 3.35 0 0
M  V30 5 C -11.0929 -0.3569 0 0
M  V30 6 O -13.3572 1.5409 0 0
M  V30 7 C -13.0213 -0.358 0 0
M  V30 8 C -9.1036 1.3142 0 0 CFG=2
M  V30 9 C -9.5561 3.8725 0 0
M  V30 10 C -11.998 4.7598 0 0 CFG=2
M  V30 11 C -9.6158 -0.0956 0 0 CFG=2
M  V30 12 C -13.358 3.0409 0 0
M  V30 13 O -9.532 -1.1235 0 0
M  V30 14 C -7.6265 1.5755 0 0 CFG=2
M  V30 15 C -12.9628 5.9083 0 0 CFG=1
M  V30 16 O -10.5209 5.0211 0 0
M  V30 17 C -8.651 -1.2442 0 0
M  V30 18 C -9.1036 1.3142 0 0
M  V30 19 C -10.9413 -1.6373 0 0 CFG=2
M  V30 20 C -6.6617 0.4269 0 0
M  V30 21 C -7.1142 2.9853 0 0
M  V30 22 C -12.4506 7.3182 0 0 CFG=2
M  V30 23 O -14.4399 5.6471 0 0
M  V30 24 C -10.0087 6.4309 0 0 CFG=1
M  V30 25 C -7.174 -0.9829 0 0 CFG=1
M  V30 26 O -9.1633 -2.654 0 0
M  V30 27 C -11.2009 -3.1146 0 0
M  V30 28 O -12.0909 -0.6737 0 0
M  V30 29 O -5.1846 0.6882 0 0
M  V30 30 O -6.9214 -1.0504 0 0
M  V30 31 C -10.9735 7.5794 0 0
M  V30 32 N -13.4154 8.4667 0 0
M  V30 33 C -8.5316 6.6922 0 0
M  V30 34 C -6.2091 -2.1314 0 0 CFG=2
M  V30 35 C -6.6617 0.4269 0 0
M  V30 36 C -12.6102 -3.6284 0 0 CFG=2
M  V30 37 C -13.5001 -1.1875 0 0 CFG=2
M  V30 38 C -4.2198 -0.4603 0 0 CFG=1
M  V30 39 C -14.8924 8.2054 0 0
M  V30 40 C -12.9031 9.8765 0 0
M  V30 41 C -4.7321 -1.8702 0 0 CFG=1
M  V30 42 O -6.7214 -3.5413 0 0
M  V30 43 C -13.7598 -2.6649 0 0 CFG=2
M  V30 44 O -13.7587 -4.5933 0 0
M  V30 45 C -11.8595 -4.9271 0 0
M  V30 46 C -14.6497 -0.224 0 0
M  V30 47 C -2.7427 -0.1991 0 0
M  V30 48 C -3.2547 -2.1298 0 0
M  V30 49 O -4.7313 -3.3702 0 0
M  V30 50 O -15.169 -3.1787 0 0
M  V30 51 C -13.4974 -6.0703 0 0
M  V30 52 C -2.2305 1.2108 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7 CFG=1
M  V30 7 1 3 8
M  V30 8 1 3 9 CFG=1
M  V30 9 1 10 4 CFG=3
M  V30 10 1 5 11
M  V30 11 1 6 12
M  V30 12 1 8 13 CFG=1
M  V30 13 1 8 14
M  V30 14 1 10 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 11 18 CFG=1
M  V30 18 1 19 13 CFG=3
M  V30 19 1 14 20
M  V30 20 1 14 21 CFG=1
M  V30 21 1 15 22
M  V30 22 1 15 23 CFG=3
M  V30 23 1 16 24
M  V30 24 1 17 25
M  V30 25 2 17 26
M  V30 26 1 19 27
M  V30 27 1 19 28
M  V30 28 1 20 29
M  V30 29 2 20 30
M  V30 30 1 22 31
M  V30 31 1 22 32 CFG=1
M  V30 32 1 24 31
M  V30 33 1 24 33 CFG=1
M  V30 34 1 25 34
M  V30 35 1 25 35 CFG=3
M  V30 36 1 27 36
M  V30 37 1 28 37
M  V30 38 1 29 38
M  V30 39 1 32 39
M  V30 40 1 32 40
M  V30 41 1 34 41
M  V30 42 1 34 42 CFG=3
M  V30 43 1 36 43
M  V30 44 1 36 44
M  V30 45 1 36 45 CFG=3
M  V30 46 1 37 43
M  V30 47 1 37 46 CFG=3
M  V30 48 1 38 41
M  V30 49 1 38 47 CFG=3
M  V30 50 1 41 48 CFG=1
M  V30 51 1 41 49
M  V30 52 1 43 50 CFG=1
M  V30 53 1 44 51
M  V30 54 1 47 52
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(18 1 2 3 8 10 11 14 15 19 22 24 25 34 36 37  -
M  V30 38 41 43) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
CLARITHROMYCIN

> <ID>
CLARITHROMYCIN

> <PRIMARY_SOM>
40 39

> <SECONDARY_SOM>
47

> <Citation>
Rodrigues et al.,Drug Metab. Disp.,25,623,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
CMV423
  SciTegic08102311032D

 19 21  0  0  0  0            999 V2000
    6.5922   -4.0344    0.0000 C   0  0
    5.5885   -5.1491    0.0000 C   0  0
    6.0521   -6.5757    0.0000 N   0  0
    7.5193   -6.8876    0.0000 C   0  0
    8.5230   -5.7729    0.0000 C   0  0
    8.0595   -4.3463    0.0000 C   0  0
    6.1287   -2.6078    0.0000 C   0  0
    4.7021   -2.1443    0.0000 N   0  0
    4.7021   -0.6443    0.0000 C   0  0
    6.1287   -0.1808    0.0000 C   0  0
    7.0104   -1.3943    0.0000 C   0  0
    8.5104   -1.3943    0.0000 Cl  0  0
    3.4031    0.1057    0.0000 C   0  0
    3.4031   -2.8943    0.0000 C   0  0
    2.1040   -0.6443    0.0000 C   0  0
    2.1040   -2.1443    0.0000 C   0  0
    6.5922    1.2458    0.0000 C   0  0
    8.0595    1.5577    0.0000 O   0  0
    5.5885    2.3605    0.0000 N   0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  7  8  1  0
  7 11  2  0
  8  9  1  0
  8 14  1  0
  9 10  2  0
  9 13  1  0
 10 11  1  0
 10 17  1  0
 11 12  1  0
 13 15  1  0
 14 16  1  0
 15 16  1  0
 17 18  2  0
 17 19  1  0
M  END
> <Name>
CMV423

> <ID>
CMV423

> <PRIMARY_SOM>
13

> <Citation>
Bournique et al.,Br. J. Clin. Pharm.,52,53,2001

> <DOI>
10.1046/j.0306-5251.2001.01413.x

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
CORTISOL
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6471 -9 0 0 CFG=2
M  V30 2 C 4.6471 -7.5 0 0 CFG=2
M  V30 3 C 3.3481 -9.75 0 0 CFG=1
M  V30 4 C 5.7619 -10.0037 0 0
M  V30 5 C 3.3481 -6.75 0 0 CFG=2
M  V30 6 C 5.9462 -6.75 0 0
M  V30 7 C 3.66 -11.2172 0 0 CFG=2
M  V30 8 C 2.0491 -9 0 0
M  V30 9 C 1.9999 -10.4075 0 0
M  V30 10 C 5.1517 -11.374 0 0
M  V30 11 C 3.3481 -5.25 0 0 CFG=2
M  V30 12 C 2.0491 -7.5 0 0 CFG=2
M  V30 13 C 5.9462 -5.25 0 0
M  V30 14 C 3.66 -12.7172 0 0
M  V30 15 O 2.1682 -11.374 0 0
M  V30 16 C 4.6471 -4.5 0 0
M  V30 17 C 2.049 -4.5 0 0
M  V30 18 C 2.049 -6 0 0
M  V30 19 O 0.75 -6.75 0 0
M  V30 20 C 4.959 -13.4672 0 0
M  V30 21 O 2.3609 -13.4672 0 0
M  V30 22 C 4.6471 -3 0 0
M  V30 23 C 2.049 -3 0 0
M  V30 24 O 4.959 -14.9672 0 0
M  V30 25 C 3.3481 -2.25 0 0
M  V30 26 O 3.3481 -0.75 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 5 2 CFG=1
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 9 CFG=3
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 12 1 6 13
M  V30 13 1 7 10
M  V30 14 1 7 14
M  V30 15 1 7 15 CFG=1
M  V30 16 1 8 12
M  V30 17 1 11 16
M  V30 18 1 11 17
M  V30 19 1 11 18 CFG=3
M  V30 20 1 12 19 CFG=3
M  V30 21 1 13 16
M  V30 22 1 14 20
M  V30 23 2 14 21
M  V30 24 2 16 22
M  V30 25 1 17 23
M  V30 26 1 20 24
M  V30 27 1 22 25
M  V30 28 1 23 25
M  V30 29 2 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 1 2 3 5 7 11 12) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
CORTISOL

> <ID>
CORTISOL

> <PRIMARY_SOM>
13

> <Citation>
Tran et al.,J. Clin. Pharmacol.,39,487,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
DETC_Me
  SciTegic08102311032D

  9  8  0  0  0  0            999 V2000
    1.5803    3.2713    0.0000 N   0  0
    0.2828    4.0239    0.0000 C   0  0
    1.5772    1.7713    0.0000 C   0  0
    0.2766    1.0240    0.0000 C   0  0
   -1.0178    3.2766    0.0000 C   0  0
    2.8808    4.0186    0.0000 C   0  0
    2.8839    5.5186    0.0000 O   0  0
    4.1783    3.2660    0.0000 S   0  0
    5.4789    4.0133    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  6  1  0
  2  5  1  0
  3  4  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
M  END
> <Name>
DETC_Me

> <ID>
DETC_Me

> <PRIMARY_SOM>
8

> <Citation>
Madan et al.,Drug Metab. Disp.,23,1153,1995

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
FELODIPINE
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -4.6471 5.25 0 0 CFG=2
M  V30 2 C -2.5037 4.0125 0 0
M  V30 3 C -4.6471 6.75 0 0
M  V30 4 C -5.9462 4.5 0 0
M  V30 5 C -2.5037 2.5125 0 0
M  V30 6 C -1.2047 4.7625 0 0
M  V30 7 C -5.9462 7.5 0 0
M  V30 8 C -3.3481 7.5 0 0
M  V30 9 C -7.2452 5.25 0 0
M  V30 10 C -5.9462 3 0 0
M  V30 11 C -1.2047 1.7625 0 0
M  V30 12 Cl -3.8027 1.7625 0 0
M  V30 13 C 0.0944 4.0125 0 0
M  V30 14 N -7.2452 6.75 0 0
M  V30 15 C -5.9462 9 0 0
M  V30 16 O -3.3481 9 0 0
M  V30 17 O -2.049 6.75 0 0
M  V30 18 C -8.5442 4.5 0 0
M  V30 19 O -7.2452 2.25 0 0
M  V30 20 O -4.6471 2.25 0 0
M  V30 21 C 0.0944 2.5125 0 0
M  V30 22 Cl -1.2047 0.2625 0 0
M  V30 23 C -2.049 9.75 0 0
M  V30 24 C -7.2452 0.75 0 0
M  V30 25 C -2.049 11.25 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 12 2 6 13
M  V30 13 1 7 14
M  V30 14 1 7 15
M  V30 15 1 8 16
M  V30 16 2 8 17
M  V30 17 1 9 14
M  V30 18 1 9 18
M  V30 19 1 10 19
M  V30 20 2 10 20
M  V30 21 2 11 21
M  V30 22 1 11 22
M  V30 23 1 13 21
M  V30 24 1 16 23
M  V30 25 1 19 24
M  V30 26 1 23 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
FELODIPINE

> <ID>
FELODIPINE

> <PRIMARY_SOM>
14 1

> <Citation>
Walsky et al.,Drug Metab. Disp.,32,647,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
FLU-1
  SciTegic08102311032D

 14 14  0  0  0  0            999 V2000
    5.7215    3.0000    0.0000 C   0  0
    7.0205    5.2500    0.0000 N   0  3
    7.0205    2.2500    0.0000 C   0  0
    5.7215    4.5000    0.0000 C   0  0
    1.8243    2.2500    0.0000 N   0  0
    4.4224    2.2500    0.0000 C   0  0
    4.4224    5.2500    0.0000 C   0  0
    7.0205    6.7500    0.0000 O   0  0
    8.3195    4.5000    0.0000 O   0  5
    3.1234    3.0000    0.0000 C   0  0
    8.3195    3.0000    0.0000 F   0  0
    7.0205    0.7500    0.0000 F   0  0
    8.3195    1.5000    0.0000 F   0  0
    3.1234    4.5000    0.0000 C   0  0
  1  3  1  0
  1  4  2  0
  1  6  1  0
  2  4  1  0
  2  8  2  0
  2  9  1  0
  3 11  1  0
  3 12  1  0
  3 13  1  0
  4  7  1  0
  5 10  1  0
  6 10  2  0
  7 14  2  0
 10 14  1  0
M  CHG  2   2   1   9  -1
M  END
> <Name>
FLU-1

> <ID>
FLU-1

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
5

> <Citation>
Goda et al.,Drug Metab. Disp.,34,828,2006

> <DOI>
10.1124/dmd.105.008623

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
M17055
  SciTegic08102311032D

 26 28  0  0  0  0            999 V2000
   -6.2371   -4.7530    0.0000 C   0  0
   -4.9407   -5.5075    0.0000 C   0  0
   -4.9458   -7.0075    0.0000 C   0  0
   -6.2474   -7.7530    0.0000 C   0  0
   -7.5439   -6.9986    0.0000 C   0  0
   -7.5387   -5.4986    0.0000 C   0  0
   -3.6390   -4.7620    0.0000 C   0  0
   -6.2319   -3.2530    0.0000 C   0  0
   -4.9303   -2.5075    0.0000 O   0  0
   -7.5284   -2.4986    0.0000 N   0  0
   -7.5232   -0.9986    0.0000 C   0  0
   -8.8196   -0.2441    0.0000 C   0  0
   -8.8145    1.2559    0.0000 C   0  0
   -7.5129    2.0014    0.0000 C   0  0
   -6.2164    1.2469    0.0000 C   0  0
   -6.2216   -0.2531    0.0000 C   0  0
   -8.8300   -3.2441    0.0000 C   0  0
  -10.1264   -2.4896    0.0000 C   0  0
  -10.1213   -0.9896    0.0000 C   0  0
  -11.4177   -0.2352    0.0000 N   0  0
  -12.7193   -0.9807    0.0000 O   0  0
  -14.0158   -0.2262    0.0000 S   0  0
  -13.2613    1.0703    0.0000 O   0  0
  -14.7702   -1.5226    0.0000 O   0  0
  -15.3122    0.5283    0.0000 O   0  0
   -4.9148    1.9924    0.0000 Cl  0  0
  1  2  1  0
  1  6  2  0
  1  8  1  0
  2  3  2  0
  2  7  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 10 17  1  0
 11 12  1  0
 11 16  2  0
 12 13  2  0
 12 19  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 26  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 22 25  2  0
M  END
> <Name>
M17055

> <ID>
M17055

> <PRIMARY_SOM>
7

> <Citation>
Nakajima et al.,Drug Metab. Pharmacokin.,17,60,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
MK_0767
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8702 -2.8995 0 0
M  V30 2 C 6.8702 -1.3995 0 0
M  V30 3 C 5.5712 -0.6495 0 0
M  V30 4 C 4.2721 -1.3995 0 0
M  V30 5 C 4.2721 -2.8995 0 0
M  V30 6 C 5.5712 -3.6495 0 0
M  V30 7 C 2.9731 -0.6495 0 0
M  V30 8 F 2.9731 0.8505 0 0
M  V30 9 F 1.674 -1.3995 0 0
M  V30 10 F 1.674 0.1005 0 0
M  V30 11 C 8.1692 -3.6495 0 0
M  V30 12 N 8.1692 -5.1495 0 0
M  V30 13 C 9.4683 -5.8995 0 0
M  V30 14 O 10.7673 -5.1495 0 0
M  V30 15 C 9.4683 -7.3995 0 0
M  V30 16 C 8.1692 -8.1495 0 0
M  V30 17 C 8.1692 -9.6495 0 0
M  V30 18 C 9.4683 -10.3995 0 0
M  V30 19 C 10.7673 -9.6495 0 0
M  V30 20 C 10.7673 -8.1495 0 0
M  V30 21 O 12.0664 -7.3995 0 0
M  V30 22 C 13.3654 -8.1495 0 0
M  V30 23 C 9.4683 -11.8995 0 0
M  V30 24 C 10.7673 -12.6495 0 0 CFG=2
M  V30 25 S 12.1376 -12.0394 0 0
M  V30 26 C 13.1413 -13.1541 0 0
M  V30 27 N 12.3913 -14.4532 0 0
M  V30 28 C 10.9241 -14.1413 0 0
M  V30 29 O 9.8094 -15.145 0 0
M  V30 30 O 14.6331 -12.9973 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 11
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 4 7
M  V30 8 1 5 6
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 2 15 20
M  V30 18 2 16 17
M  V30 19 1 17 18
M  V30 20 2 18 19
M  V30 21 1 18 23
M  V30 22 1 19 20
M  V30 23 1 20 21
M  V30 24 1 21 22
M  V30 25 1 24 23 CFG=3
M  V30 26 1 24 25
M  V30 27 1 24 28
M  V30 28 1 25 26
M  V30 29 1 26 27
M  V30 30 2 26 30
M  V30 31 1 27 28
M  V30 32 2 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 24) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
MK_0767

> <ID>
MK_0767

> <PRIMARY_SOM>
25

> <SECONDARY_SOM>
24

> <Citation>
Liu et al.,Drug Metab. Disp.,32,1023,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
NNK
  SciTegic08102311032D

 15 15  0  0  0  0            999 V2000
    4.2721   -1.3995    0.0000 C   0  0
    4.2721    0.1005    0.0000 C   0  0
    2.9731    0.8505    0.0000 N   0  0
    1.6740    0.1005    0.0000 C   0  0
    1.6740   -1.3995    0.0000 C   0  0
    2.9731   -2.1495    0.0000 C   0  0
    5.5712   -2.1495    0.0000 C   0  0
    6.8702   -1.3995    0.0000 O   0  0
    5.5712   -3.6495    0.0000 C   0  0
    6.8702   -4.3995    0.0000 C   0  0
    6.8702   -5.8995    0.0000 C   0  0
    8.1692   -6.6495    0.0000 N   0  0
    9.4683   -5.8995    0.0000 C   0  0
    8.1692   -8.1495    0.0000 N   0  0
    9.4683   -8.8995    0.0000 O   0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
M  END
> <Name>
NNK

> <ID>
NNK

> <PRIMARY_SOM>
11

> <SECONDARY_SOM>
3

> <Citation>
Staretz et al.,Drug Metab. Disp.,25,154,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
NN_diethylformamide
  SciTegic08102311032D

  7  6  0  0  0  0            999 V2000
   -3.3512   -1.4931    0.0000 N   0  0
   -4.6487   -0.7404    0.0000 C   0  0
   -5.9492   -1.4877    0.0000 O   0  0
   -2.0506   -0.7458    0.0000 C   0  0
   -3.3543   -2.9931    0.0000 C   0  0
   -0.7531   -1.4984    0.0000 C   0  0
   -2.0568   -3.7458    0.0000 C   0  0
  1  2  1  0
  1  4  1  0
  1  5  1  0
  2  3  2  0
  4  6  1  0
  5  7  1  0
M  END
> <Name>
NN_diethylformamide

> <ID>
NN_diethylformamide

> <PRIMARY_SOM>
5 4

> <Citation>
Amato et al.,Toxicology Lett.,124,11,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
NN_dimethyl_M_toluamide
  SciTegic08102311032D

 14 14  0  0  0  0            999 V2000
    4.9216   -2.5245    0.0000 C   0  0
    4.9216   -1.0245    0.0000 C   0  0
    3.6226   -0.2745    0.0000 C   0  0
    2.3236   -1.0245    0.0000 C   0  0
    2.3236   -2.5245    0.0000 C   0  0
    3.6226   -3.2745    0.0000 C   0  0
    6.2207   -3.2745    0.0000 C   0  0
    7.5197   -2.5245    0.0000 O   0  0
    6.2207   -4.7745    0.0000 N   0  0
    7.5197   -5.5245    0.0000 C   0  0
    4.9216   -5.5245    0.0000 C   0  0
    4.9217   -7.0245    0.0000 C   0  0
    7.5197   -7.0245    0.0000 C   0  0
    3.6226    1.2255    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  3  4  1  0
  3 14  1  0
  4  5  2  0
  5  6  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  9 11  1  0
 10 13  1  0
 11 12  1  0
M  END
> <Name>
NN_dimethyl_M_toluamide

> <ID>
NN_dimethyl_M_toluamide

> <PRIMARY_SOM>
11 10

> <Citation>
Usmani et al.,Drug Metab. Disp.,30,289,2002

> <DOI>
10.1124/dmd.30.3.289

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
N_ac_DFEC
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -0.3614 6.6503 0 0
M  V30 2 C 0.9392 7.3976 0 0 CFG=2
M  V30 3 C 0.9423 8.8976 0 0
M  V30 4 O 2.2429 9.6449 0 0
M  V30 5 C 2.2367 6.6449 0 0
M  V30 6 S 3.5373 7.3923 0 0
M  V30 7 O -0.3552 9.6503 0 0
M  V30 8 C -1.6589 7.4029 0 0
M  V30 9 O -2.9594 6.6556 0 0
M  V30 10 C 4.8348 6.6396 0 0
M  V30 11 F 4.0821 5.3421 0 0
M  V30 12 F 5.5821 5.339 0 0
M  V30 13 C 6.1354 7.387 0 0 CFG=2
M  V30 14 C 6.1384 8.8869 0 0
M  V30 15 F 7.439 9.6343 0 0
M  V30 16 F 4.8409 9.6396 0 0
M  V30 17 O 7.4329 6.6343 0 0
M  V30 18 C 8.7334 7.3816 0 0
M  V30 19 F 10.0309 6.629 0 0
M  V30 20 C -1.6558 8.9029 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 5
M  V30 5 2 3 4
M  V30 6 1 3 7
M  V30 7 1 5 6
M  V30 8 1 6 10
M  V30 9 2 8 9
M  V30 10 1 8 20
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 13 14
M  V30 15 1 13 17 CFG=3
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 13) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
N_ac_DFEC

> <ID>
N_ac_DFEC

> <PRIMARY_SOM>
6

> <Citation>
Altuntas et al.,Chem. Res. Tox.,17,435,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
N_ac_FFVC
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 19 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -11.15 -3.7269 0 0
M  V30 2 C -9.8495 -2.9796 0 0 CFG=2
M  V30 3 C -9.8464 -1.4796 0 0
M  V30 4 O -8.5458 -0.7323 0 0
M  V30 5 C -8.552 -3.7323 0 0
M  V30 6 S -7.2514 -2.985 0 0
M  V30 7 O -11.1438 -0.7269 0 0
M  V30 8 C -12.4475 -2.9742 0 0
M  V30 9 O -13.7481 -3.7216 0 0
M  V30 10 C -5.9539 -3.7377 0 0
M  V30 11 F -5.957 -5.2377 0 0
M  V30 12 C -4.6533 -2.9904 0 0
M  V30 13 C -4.6502 -1.4904 0 0
M  V30 14 F -3.3496 -0.7431 0 0
M  V30 15 F -5.9477 -0.7377 0 0
M  V30 16 O -3.3558 -3.7431 0 0
M  V30 17 C -2.0552 -2.9957 0 0
M  V30 18 F -0.7578 -3.7484 0 0
M  V30 19 C -12.4444 -1.4742 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 5
M  V30 5 2 3 4
M  V30 6 1 3 7
M  V30 7 1 5 6
M  V30 8 1 6 10
M  V30 9 2 8 9
M  V30 10 1 8 19
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 12 13
M  V30 14 1 12 16
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
N_ac_FFVC

> <ID>
N_ac_FFVC

> <PRIMARY_SOM>
6

> <Citation>
Altuntas et al.,Chem. Res. Tox.,17,435,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
N_ac_PCBC
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -9.4683 -1.3995 0 0
M  V30 2 C -9.4683 0.1005 0 0 CFG=2
M  V30 3 C -10.7673 0.8505 0 0
M  V30 4 O -12.0664 0.1005 0 0
M  V30 5 C -8.1692 0.8505 0 0
M  V30 6 S -6.8702 0.1005 0 0
M  V30 7 O -10.7673 2.3505 0 0
M  V30 8 C -5.5712 0.8505 0 0
M  V30 9 Cl -5.5712 2.3505 0 0
M  V30 10 C -4.2721 0.1005 0 0
M  V30 11 Cl -2.9731 0.8505 0 0
M  V30 12 C -4.2721 -1.3995 0 0
M  V30 13 Cl -5.5712 -2.1495 0 0
M  V30 14 C -2.9731 -2.1495 0 0
M  V30 15 Cl -2.9731 -3.6495 0 0
M  V30 16 Cl -1.674 -1.3995 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 5
M  V30 4 2 3 4
M  V30 5 1 3 7
M  V30 6 1 5 6
M  V30 7 1 6 8
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
N_ac_PCBC

> <ID>
N_ac_PCBC

> <PRIMARY_SOM>
6

> <Citation>
Werner et al.,Chem. Res. Toxicol.,8,917,1995

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
N_nitrosodiamylamine
  SciTegic08102311032D

 13 12  0  0  0  0            999 V2000
    7.2422    1.5146    0.0000 N   0  0
    7.2391    3.0146    0.0000 N   0  0
    8.5367    3.7672    0.0000 O   0  0
    5.9446    0.7620    0.0000 C   0  0
    8.5427    0.7672    0.0000 C   0  0
    4.6441    1.5094    0.0000 C   0  0
    9.8402    1.5198    0.0000 C   0  0
    3.3466    0.7567    0.0000 C   0  0
   11.1408    0.7724    0.0000 C   0  0
    2.0460    1.5041    0.0000 C   0  0
   12.4383    1.5251    0.0000 C   0  0
    0.7485    0.7515    0.0000 C   0  0
   13.7388    0.7777    0.0000 C   0  0
  1  2  1  0
  1  4  1  0
  1  5  1  0
  2  3  2  0
  4  6  1  0
  5  7  1  0
  6  8  1  0
  7  9  1  0
  8 10  1  0
  9 11  1  0
 10 12  1  0
 11 13  1  0
M  END
> <Name>
N_nitrosodiamylamine

> <ID>
N_nitrosodiamylamine

> <PRIMARY_SOM>
9 8

> <SECONDARY_SOM>
10 11

> <TERTIARY_SOM>
6 7

> <Citation>
Bellec et al.,Mutation Res.,377,199,1997

> <DOI>
10.1016/S0027-5107(97)00073-0

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
N_nitrosonornicotine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5712 -0.8505 0 0 CFG=2
M  V30 2 C 4.2721 -0.1005 0 0
M  V30 3 C 5.7279 -2.3423 0 0
M  V30 4 N 6.9415 -0.2404 0 0
M  V30 5 C 4.2721 1.3995 0 0
M  V30 6 C 2.9731 -0.8505 0 0
M  V30 7 C 7.1952 -2.6541 0 0
M  V30 8 C 7.9452 -1.3551 0 0
M  V30 9 C 2.9731 2.1495 0 0
M  V30 10 N 1.674 -0.1005 0 0
M  V30 11 C 1.674 1.3995 0 0
M  V30 12 N 7.2533 1.2269 0 0
M  V30 13 O 8.6799 1.6904 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 12
M  V30 9 1 5 9
M  V30 10 2 6 10
M  V30 11 1 7 8
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
N_nitrosonornicotine

> <ID>
N_nitrosonornicotine

> <PRIMARY_SOM>
1

> <Citation>
Patten et al.,Carcinogenesis,18,1623,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
R_95913
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1763 -4.6976 0 0
M  V30 2 C 6.1763 -3.1976 0 0
M  V30 3 C 4.8772 -2.4476 0 0
M  V30 4 C 3.5782 -3.1976 0 0 CFG=1
M  V30 5 C 3.5782 -4.6976 0 0
M  V30 6 C 4.8772 -5.4476 0 0
M  V30 7 C 7.4753 -5.4476 0 0 CFG=2
M  V30 8 C 7.4753 -6.9476 0 0
M  V30 9 C 8.7743 -7.6976 0 0
M  V30 10 C 8.7743 -9.1976 0 0
M  V30 11 C 7.4753 -9.9476 0 0
M  V30 12 C 6.1763 -9.1976 0 0
M  V30 13 C 6.1763 -7.6976 0 0
M  V30 14 C 8.7743 -4.6976 0 0
M  V30 15 O 10.0734 -5.4475 0 0
M  V30 16 C 8.7743 -3.1976 0 0
M  V30 17 C 9.5243 -1.8985 0 0
M  V30 18 C 8.0243 -1.8985 0 0
M  V30 19 F 10.0734 -6.9476 0 0
M  V30 20 C 4.5654 -0.9803 0 0
M  V30 21 S 2.4635 -2.1939 0 0
M  V30 22 C 3.0736 -0.8235 0 0
M  V30 23 O 2.3236 0.4755 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 7 1 CFG=1
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 2 3 20
M  V30 7 1 4 5 CFG=1
M  V30 8 1 4 21
M  V30 9 1 5 6
M  V30 10 1 7 8
M  V30 11 1 7 14
M  V30 12 1 8 9
M  V30 13 2 8 13
M  V30 14 2 9 10
M  V30 15 1 9 19
M  V30 16 1 10 11
M  V30 17 2 11 12
M  V30 18 1 12 13
M  V30 19 2 14 15
M  V30 20 1 14 16
M  V30 21 1 16 17
M  V30 22 1 16 18
M  V30 23 1 17 18
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 7) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
R_95913

> <ID>
R_95913

> <PRIMARY_SOM>
21

> <Citation>
Rehmel et al.,Drug Metab. Dispos.,34,600,2006

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
SENECIONINE
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -6.5207 -4.8275 0 0 CFG=2
M  V30 2 C -6.5207 -6.3275 0 0 CFG=1
M  V30 3 N -7.8197 -4.0775 0 0 CFG=1
M  V30 4 C -5.2216 -4.0775 0 0
M  V30 5 C -7.9696 -6.7158 0 0
M  V30 6 O -5.2216 -7.0775 0 0
M  V30 7 C -8.7196 -5.4167 0 0
M  V30 8 C -7.1099 -5.5264 0 0
M  V30 9 C -5.6099 -5.5264 0 0
M  V30 10 C -5.2216 -2.5775 0 0
M  V30 11 C -3.9226 -6.3275 0 0
M  V30 12 O -3.9226 -1.8275 0 0
M  V30 13 C -2.6236 -7.0775 0 0
M  V30 14 O -3.9226 -4.8275 0 0
M  V30 15 C -2.6236 -2.5775 0 0
M  V30 16 C -1.3245 -6.3275 0 0
M  V30 17 C -2.6236 -8.5775 0 0
M  V30 18 C -2.6236 -4.0775 0 0 CFG=2
M  V30 19 O -1.3245 -1.8275 0 0
M  V30 20 C -1.3245 -4.8275 0 0 CFG=1
M  V30 21 C -3.9226 -9.3275 0 0
M  V30 22 C -3.1366 -5.4871 0 0
M  V30 23 O -4.1008 -3.817 0 0
M  V30 24 C -0.0255 -4.0775 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 3 7 CFG=3
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 4 10
M  V30 10 1 5 7
M  V30 11 1 6 11
M  V30 12 1 8 9
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 15 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 20
M  V30 24 1 18 22 CFG=3
M  V30 25 1 18 23
M  V30 26 1 20 24 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 2 3 18 20) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
SENECIONINE

> <ID>
SENECIONINE

> <PRIMARY_SOM>
1 8

> <SECONDARY_SOM>
3

> <Citation>
Reed et al.,Carciniogenesis,12,515,1991

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
TAXOL
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 62 68 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.41 -7.0053 0 0 CFG=2
M  V30 2 C 8.8972 -6.8095 0 0 CFG=1
M  V30 3 C 6.836 -5.6195 0 0 CFG=1
M  V30 4 C 6.836 -8.3912 0 0 CFG=2
M  V30 5 C 9.8104 -7.9996 0 0 CFG=2
M  V30 6 C 10.0872 -5.8964 0 0
M  V30 7 O 8.8089 -8.8326 0 0
M  V30 8 C 5.4502 -5.0455 0 0 CFG=1
M  V30 9 O 7.8967 -4.5589 0 0
M  V30 10 C 5.4502 -8.9652 0 0
M  V30 11 C 7.7492 -9.5812 0 0 CFG=2
M  V30 12 C 6.4478 -9.8401 0 0
M  V30 13 O 11.0004 -7.0864 0 0
M  V30 14 C 9.2363 -9.3854 0 0
M  V30 15 C 10.2733 -9.1573 0 0
M  V30 16 C 4.0643 -5.6195 0 0
M  V30 17 C 6.5908 -6.0197 0 0
M  V30 18 O 6.7291 -5.8292 0 0
M  V30 19 C 7.5084 -3.11 0 0
M  V30 20 C 4.0644 -8.3912 0 0 CFG=1
M  V30 21 O 5.4502 -10.4652 0 0
M  V30 22 O 7.1752 -10.967 0 0
M  V30 23 C 11.2867 -8.0514 0 0
M  V30 24 O 10.7244 -10.5878 0 0
M  V30 25 C 3.4903 -7.0054 0 0
M  V30 26 C 3.8686 -4.1324 0 0
M  V30 27 C 2.5772 -5.4237 0 0
M  V30 28 C 6.2406 -7.4782 0 0 CFG=1
M  V30 29 C 8.5691 -2.0493 0 0
M  V30 30 O 6.0595 -2.7217 0 0
M  V30 31 O 3.0037 -9.4519 0 0
M  V30 32 C 4.7821 -7.8284 0 0
M  V30 33 O 8.6033 -9.8408 0 0
M  V30 34 C 10.018 -2.4375 0 0
M  V30 35 C 8.1808 -0.6004 0 0
M  V30 36 C 1.6442 -8.8179 0 0
M  V30 37 C 4.5345 -9.3078 0 0
M  V30 38 C 7.9694 -11.2003 0 0
M  V30 39 C 11.0786 -1.3768 0 0
M  V30 40 C 9.2415 0.4603 0 0
M  V30 41 C 0.4155 -9.6783 0 0
M  V30 42 O 1.5135 -7.3236 0 0
M  V30 43 C 8.6033 -12.5598 0 0 CFG=1
M  V30 44 O 6.4751 -11.3311 0 0
M  V30 45 C 10.6904 0.0721 0 0
M  V30 46 C 7.7429 -13.7885 0 0 CFG=2
M  V30 47 O 10.0976 -12.6905 0 0
M  V30 48 C 6.2486 -13.6578 0 0
M  V30 49 N 8.3769 -15.148 0 0
M  V30 50 C 5.3883 -14.8865 0 0
M  V30 51 C 5.6147 -12.2983 0 0
M  V30 52 C 7.5165 -16.3767 0 0
M  V30 53 C 3.894 -14.7558 0 0
M  V30 54 C 4.1204 -12.1676 0 0
M  V30 55 C 8.1505 -17.7362 0 0
M  V30 56 O 6.0222 -16.246 0 0
M  V30 57 C 3.26 -13.3964 0 0
M  V30 58 C 7.2901 -18.9649 0 0
M  V30 59 C 9.6448 -17.8669 0 0
M  V30 60 C 7.9241 -20.3244 0 0
M  V30 61 C 10.2787 -19.2263 0 0
M  V30 62 C 9.4184 -20.4551 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7 CFG=1
M  V30 7 1 3 8
M  V30 8 1 3 9 CFG=1
M  V30 9 1 4 10
M  V30 10 1 4 11
M  V30 11 1 4 12 CFG=3
M  V30 12 1 5 13 CFG=3
M  V30 13 1 5 14
M  V30 14 1 6 13
M  V30 15 1 7 15
M  V30 16 1 8 16
M  V30 17 1 8 17
M  V30 18 1 8 18 CFG=1
M  V30 19 1 9 19
M  V30 20 1 10 20
M  V30 21 2 10 21
M  V30 22 1 11 14
M  V30 23 1 11 22 CFG=3
M  V30 24 1 15 23
M  V30 25 2 15 24
M  V30 26 1 16 25
M  V30 27 1 16 26
M  V30 28 1 16 27
M  V30 29 1 17 28
M  V30 30 1 19 29
M  V30 31 2 19 30
M  V30 32 1 20 25
M  V30 33 1 20 31 CFG=3
M  V30 34 2 25 32
M  V30 35 1 28 32
M  V30 36 1 28 33 CFG=3
M  V30 37 2 29 34
M  V30 38 1 29 35
M  V30 39 1 31 36
M  V30 40 1 32 37
M  V30 41 1 33 38
M  V30 42 1 34 39
M  V30 43 2 35 40
M  V30 44 1 36 41
M  V30 45 2 36 42
M  V30 46 1 38 43
M  V30 47 2 38 44
M  V30 48 2 39 45
M  V30 49 1 40 45
M  V30 50 1 43 46
M  V30 51 1 43 47 CFG=3
M  V30 52 1 46 48
M  V30 53 1 46 49 CFG=1
M  V30 54 2 48 50
M  V30 55 1 48 51
M  V30 56 1 49 52
M  V30 57 1 50 53
M  V30 58 2 51 54
M  V30 59 1 52 55
M  V30 60 2 52 56
M  V30 61 2 53 57
M  V30 62 1 54 57
M  V30 63 2 55 58
M  V30 64 1 55 59
M  V30 65 1 58 60
M  V30 66 2 59 61
M  V30 67 2 60 62
M  V30 68 1 61 62
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 1 2 3 4 5 8 11 20 28 43 46) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
TAXOL

> <ID>
TAXOL

> <PRIMARY_SOM>
57

> <Citation>
Harris et al.,Cancer Res.,54,4026,1994

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
V11294
  SciTegic08102311032D

 30 33  0  0  0  0            999 V2000
    6.1027    5.7221    0.0000 N   0  0
    6.1027    7.2221    0.0000 C   0  0
    4.8037    7.9721    0.0000 N   0  0
    3.5046    7.2221    0.0000 C   0  0
    3.5046    5.7221    0.0000 C   0  0
    4.8037    4.9721    0.0000 C   0  0
    2.3899    4.7184    0.0000 N   0  0
    4.4918    3.5049    0.0000 N   0  0
    7.4017    4.9721    0.0000 C   0  0
    8.7008    5.7221    0.0000 C   0  0
    9.9998    4.9721    0.0000 C   0  0
   11.2989    5.7221    0.0000 C   0  0
   11.2989    7.2221    0.0000 C   0  0
    9.9998    7.9721    0.0000 C   0  0
    8.7008    7.2221    0.0000 C   0  0
   12.5979    7.9721    0.0000 O   0  0
   12.5979    4.9721    0.0000 O   0  0
   12.5979    9.4721    0.0000 C   0  0
   12.5979    3.4721    0.0000 C   0  0
   13.8114    2.5904    0.0000 C   0  0
   13.3479    1.1638    0.0000 C   0  0
   11.8479    1.1638    0.0000 C   0  0
   11.3844    2.5904    0.0000 C   0  0
    3.0000    3.3481    0.0000 C   0  0
    2.2500    2.0490    0.0000 C   0  0
    3.0000    0.7500    0.0000 C   0  0
    0.7500    2.0490    0.0000 C   0  0
    2.2056    7.9721    0.0000 N   0  0
    2.2056    9.4721    0.0000 C   0  0
    0.9066   10.2221    0.0000 C   0  0
  1  2  1  0
  1  6  1  0
  1  9  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4 28  1  0
  5  6  1  0
  5  7  1  0
  6  8  2  0
  7 24  2  0
  8 24  1  0
  9 10  1  0
 10 11  1  0
 10 15  2  0
 11 12  2  0
 12 13  1  0
 12 17  1  0
 13 14  2  0
 13 16  1  0
 14 15  1  0
 16 18  1  0
 17 19  1  0
 19 20  1  0
 19 23  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 28 29  1  0
 29 30  1  0
M  END
> <Name>
V11294

> <ID>
V11294

> <PRIMARY_SOM>
29

> <SECONDARY_SOM>
22 21

> <TERTIARY_SOM>
25

> <Citation>
Subrahmanyam et al.,Xenobiotica,32,521,2002

> <DOI>
10.1080/00498250210128684

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
abt_378
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 46 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -15.9357 6.7158 0 0
M  V30 2 C -14.6398 5.9604 0 0 CFG=1
M  V30 3 C -17.2379 5.9712 0 0
M  V30 4 C -15.9295 8.2158 0 0
M  V30 5 C -13.3377 6.705 0 0
M  V30 6 C -14.646 4.4604 0 0
M  V30 7 N -18.5338 6.7266 0 0
M  V30 8 O -17.2441 4.4712 0 0
M  V30 9 C -17.2254 8.9711 0 0
M  V30 10 N -12.0418 5.9496 0 0
M  V30 11 O -13.3314 8.205 0 0
M  V30 12 C -15.9482 3.7158 0 0
M  V30 13 C -13.3501 3.705 0 0
M  V30 14 C -18.5275 8.2265 0 0
M  V30 15 C -10.7396 6.6942 0 0 CFG=1
M  V30 16 C -10.7334 8.1942 0 0
M  V30 17 C -9.4437 5.9388 0 0
M  V30 18 C -9.4312 8.9388 0 0
M  V30 19 C -9.4499 4.4388 0 0 CFG=1
M  V30 20 C -9.425 10.4388 0 0
M  V30 21 C -8.1353 8.1834 0 0
M  V30 22 C -8.154 3.6834 0 0 CFG=2
M  V30 23 O -10.7521 3.6942 0 0
M  V30 24 C -8.1229 11.1834 0 0
M  V30 25 C -6.8332 8.928 0 0
M  V30 26 C -6.8519 4.428 0 0
M  V30 27 N -8.1602 2.1834 0 0
M  V30 28 C -6.827 10.428 0 0
M  V30 29 C -5.556 3.6726 0 0
M  V30 30 C -9.4624 1.4388 0 0
M  V30 31 C -4.2538 4.4172 0 0
M  V30 32 C -5.5622 2.1727 0 0
M  V30 33 C -9.4686 -0.0611 0 0
M  V30 34 O -10.7583 2.1942 0 0
M  V30 35 C -2.9579 3.6619 0 0
M  V30 36 C -4.2663 1.4173 0 0
M  V30 37 O -10.7707 -0.8057 0 0
M  V30 38 C -2.9641 2.1619 0 0
M  V30 39 C -10.777 -2.3057 0 0
M  V30 40 C -12.0791 -3.0503 0 0
M  V30 41 C -9.4811 -3.0611 0 0
M  V30 42 C -12.0853 -4.5503 0 0
M  V30 43 C -13.375 -2.2949 0 0
M  V30 44 C -9.4873 -4.5611 0 0
M  V30 45 C -8.1789 -2.3165 0 0
M  V30 46 C -10.7894 -5.3057 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 7 14
M  V30 14 1 9 14
M  V30 15 1 15 10 CFG=1
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23 CFG=1
M  V30 24 1 20 24
M  V30 25 2 21 25
M  V30 26 1 22 26 CFG=3
M  V30 27 1 22 27
M  V30 28 2 24 28
M  V30 29 1 25 28
M  V30 30 1 26 29
M  V30 31 1 27 30
M  V30 32 2 29 31
M  V30 33 1 29 32
M  V30 34 1 30 33
M  V30 35 2 30 34
M  V30 36 1 31 35
M  V30 37 2 32 36
M  V30 38 1 33 37
M  V30 39 2 35 38
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 39 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 1 40 43
M  V30 46 2 41 44
M  V30 47 1 41 45
M  V30 48 2 42 46
M  V30 49 1 44 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 15 19 22) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
abt_378

> <ID>
abt_378

> <PRIMARY_SOM>
14

> <Citation>
Kumar et al.,Drug Metab. Disp.,27,902,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
abt_438
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2721 -1.3995 0 0
M  V30 2 C 4.2721 0.1005 0 0
M  V30 3 C 2.9731 0.8505 0 0
M  V30 4 C 1.674 0.1005 0 0
M  V30 5 C 1.674 -1.3995 0 0
M  V30 6 C 2.9731 -2.1495 0 0
M  V30 7 C 5.5712 -2.1495 0 0
M  V30 8 C 5.5712 -3.6495 0 0
M  V30 9 S 6.7847 -4.5312 0 0
M  V30 10 C 6.3212 -5.9578 0 0
M  V30 11 C 4.8212 -5.9578 0 0
M  V30 12 C 4.3576 -4.5312 0 0
M  V30 13 C 7.2028 -7.1713 0 0
M  V30 14 C 8.0845 -8.3848 0 0
M  V30 15 C 8.9662 -9.5983 0 0 CFG=2
M  V30 16 C 8.3561 -10.9687 0 0
M  V30 17 N 10.458 -9.4415 0 0
M  V30 18 C 11.3397 -10.6551 0 0
M  V30 19 O 12.8315 -10.4983 0 0
M  V30 20 N 10.7296 -12.0254 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 7
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 12
M  V30 11 1 9 10
M  V30 12 2 10 11
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 15 3 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16 CFG=1
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
abt_438

> <ID>
abt_438

> <PRIMARY_SOM>
7

> <Citation>
Machinist et al.,Drug Metab. Disp.,26,970,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
acetochlor
  SciTegic08102311032D

 18 18  0  0  0  0            999 V2000
    4.2721   -1.3995    0.0000 C   0  0
    5.5712   -2.1495    0.0000 N   0  0
    4.2721    0.1005    0.0000 C   0  0
    2.9731   -2.1495    0.0000 C   0  0
    6.8702   -1.3995    0.0000 C   0  0
    5.5712   -3.6495    0.0000 C   0  0
    2.9731    0.8505    0.0000 C   0  0
    5.5712    0.8505    0.0000 C   0  0
    1.6740   -1.3995    0.0000 C   0  0
    2.9731   -3.6495    0.0000 C   0  0
    8.1692   -2.1495    0.0000 C   0  0
    6.8702    0.1005    0.0000 O   0  0
    6.8702   -4.3995    0.0000 O   0  0
    1.6740    0.1005    0.0000 C   0  0
    5.5712    2.3505    0.0000 C   0  0
    9.4683   -1.3995    0.0000 Cl  0  0
    6.8702   -5.8995    0.0000 C   0  0
    8.1692   -6.6495    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  5 12  2  0
  6 13  1  0
  7 14  2  0
  8 15  1  0
  9 14  1  0
 11 16  1  0
 13 17  1  0
 17 18  1  0
M  END
> <Name>
acetochlor

> <ID>
acetochlor

> <PRIMARY_SOM>
17

> <Citation>
Coleman et al.,Env. Health Perspec.,108,1151,2000
Coleman et al.,Chem. Biol. Inter.,122,27,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
aflatoxin_b1
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -3.6684 6.3319 0 0
M  V30 2 C -3.6684 7.8319 0 0
M  V30 3 C -4.9674 8.5819 0 0
M  V30 4 C -6.2665 7.8319 0 0
M  V30 5 C -6.2665 6.3319 0 0
M  V30 6 C -4.9674 5.5819 0 0
M  V30 7 C -4.9674 4.0819 0 0
M  V30 8 C -3.6684 3.3319 0 0
M  V30 9 C -2.3693 4.0819 0 0
M  V30 10 O -2.3693 5.5819 0 0
M  V30 11 C -6.0821 3.0782 0 0
M  V30 12 C -5.472 1.7079 0 0
M  V30 13 C -3.9803 1.8647 0 0
M  V30 14 C -2.5537 8.8356 0 0 CFG=1
M  V30 15 C -3.1638 10.206 0 0 CFG=1
M  V30 16 O -4.6556 10.0492 0 0
M  V30 17 C -1.0619 8.9924 0 0
M  V30 18 C -0.75 10.4596 0 0
M  V30 19 O -2.0491 11.2096 0 0
M  V30 20 O -2.9766 0.75 0 0
M  V30 21 O -1.0703 3.3319 0 0
M  V30 22 O -7.5655 5.5819 0 0
M  V30 23 C -8.8645 6.3319 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 10
M  V30 4 2 2 3
M  V30 5 1 2 14
M  V30 6 1 3 4
M  V30 7 1 3 16
M  V30 8 2 4 5
M  V30 9 1 5 6
M  V30 10 1 5 22
M  V30 11 1 6 7
M  V30 12 2 7 8
M  V30 13 1 7 11
M  V30 14 1 8 9
M  V30 15 1 8 13
M  V30 16 1 9 10
M  V30 17 2 9 21
M  V30 18 1 11 12
M  V30 19 1 12 13
M  V30 20 2 13 20
M  V30 21 1 14 15
M  V30 22 1 14 17 CFG=1
M  V30 23 1 15 16 CFG=1
M  V30 24 1 15 19
M  V30 25 2 17 18
M  V30 26 1 18 19
M  V30 27 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 15) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
aflatoxin_b1

> <ID>
aflatoxin_b1

> <PRIMARY_SOM>
11

> <SECONDARY_SOM>
17 18

> <Citation>
Gallagher et al.,Toxicol. App. Pharm.,141,595,1996
X. Y. He, L. L. Tang, S. L. Wang, Q. S. Cai, J. S. Wang, J. Y. Hong, Int. J. Cancer 2006, 118, 2665-2671

> <DOI>
0041-008X/96
10.1002/ijc.21665

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
alachlor
  SciTegic08102311032D

 18 18  0  0  0  0            999 V2000
    7.5104    1.0299    0.0000 C   0  0
    8.8094    0.2799    0.0000 N   0  0
    7.5104    2.5299    0.0000 C   0  0
    6.2113    0.2799    0.0000 C   0  0
    8.8094   -1.2201    0.0000 C   0  0
   10.1085    1.0299    0.0000 C   0  0
    6.2113    3.2799    0.0000 C   0  0
    8.8094    3.2799    0.0000 C   0  0
    4.9123    1.0299    0.0000 C   0  0
    6.2114   -1.2201    0.0000 C   0  0
   10.1085   -1.9701    0.0000 C   0  0
    7.5104   -1.9701    0.0000 O   0  0
   11.4075    0.2799    0.0000 O   0  0
    4.9123    2.5299    0.0000 C   0  0
    8.8094    4.7799    0.0000 C   0  0
    4.9123   -1.9701    0.0000 C   0  0
   10.1085   -3.4701    0.0000 Cl  0  0
   12.7065    1.0299    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  5 12  2  0
  6 13  1  0
  7 14  2  0
  8 15  1  0
  9 14  1  0
 10 16  1  0
 11 17  1  0
 13 18  1  0
M  END
> <Name>
alachlor

> <ID>
alachlor

> <PRIMARY_SOM>
18

> <Citation>
Coleman et al.,Chem. Biol. Inter.,122,27,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
albendazole
  SciTegic08102311032D

 18 19  0  0  0  0            999 V2000
   10.8525    2.2500    0.0000 C   0  0
    9.9708    1.0365    0.0000 N   0  0
    9.9708    3.4635    0.0000 N   0  0
   12.3525    2.2500    0.0000 N   0  0
    8.5442    1.5000    0.0000 C   0  0
   13.1025    3.5490    0.0000 C   0  0
    8.5442    3.0000    0.0000 C   0  0
    7.2452    0.7500    0.0000 C   0  0
   12.3525    4.8481    0.0000 O   0  0
    7.2452    3.7500    0.0000 C   0  0
    5.9462    1.5000    0.0000 C   0  0
   14.6025    3.5490    0.0000 O   0  0
    4.6471    0.7500    0.0000 S   0  0
    5.9462    3.0000    0.0000 C   0  0
    3.3481    1.5000    0.0000 C   0  0
   15.3525    4.8481    0.0000 C   0  0
    2.0490    0.7500    0.0000 C   0  0
    0.7500    1.5000    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  7  1  0
  4  6  1  0
  5  7  2  0
  5  8  1  0
  6  9  2  0
  6 12  1  0
  7 10  1  0
  8 11  2  0
 10 14  2  0
 11 13  1  0
 11 14  1  0
 12 16  1  0
 13 15  1  0
 15 17  1  0
 17 18  1  0
M  END
> <Name>
albendazole

> <ID>
albendazole

> <PRIMARY_SOM>
13

> <Citation>
Rawden et al.,Br. J. Clin. Pharm.,49,313,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
alfentanil
  SciTegic08102311032D

 30 32  0  0  0  0            999 V2000
    5.5436   -1.8761    0.0000 N   0  0
    6.6252   -2.9154    0.0000 N   0  0
    5.9710   -4.2652    0.0000 N   0  0
    4.4851   -4.0601    0.0000 C   0  0
    4.2209   -2.5836    0.0000 N   0  0
    2.8711   -1.9294    0.0000 C   0  0
    3.4458   -5.1417    0.0000 O   0  0
    6.6785   -5.5879    0.0000 C   0  0
    8.1777   -5.6365    0.0000 C   0  0
    2.7628   -0.4333    0.0000 C   0  0
    1.4129    0.2209    0.0000 N   0  0
    1.3046    1.7170    0.0000 C   0  0
   -0.0452    2.3712    0.0000 C   0  0
   -1.2867    1.5293    0.0000 C   0  0
   -1.1784    0.0332    0.0000 C   0  0
    0.1715   -0.6210    0.0000 C   0  0
   -1.9002    2.8981    0.0000 C   0  0
   -2.7412    1.1628    0.0000 N   0  0
   -1.0216    4.1138    0.0000 O   0  0
   -1.6351    5.4826    0.0000 C   0  0
   -3.1511   -0.2801    0.0000 C   0  0
   -3.7859    2.2392    0.0000 C   0  0
   -4.6057   -0.6466    0.0000 C   0  0
   -5.0155   -2.0895    0.0000 C   0  0
   -3.3761    3.6821    0.0000 C   0  0
   -4.4207    4.7586    0.0000 C   0  0
   -5.8753    4.3920    0.0000 C   0  0
   -6.2851    2.9491    0.0000 C   0  0
   -5.2405    1.8727    0.0000 C   0  0
   -2.1064   -1.3565    0.0000 O   0  0
  1  2  2  0
  1  5  1  0
  2  3  1  0
  3  4  1  0
  3  8  1  0
  4  5  1  0
  4  7  2  0
  5  6  1  0
  6 10  1  0
  8  9  1  0
 10 11  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 17  1  0
 14 18  1  0
 15 16  1  0
 17 19  1  0
 18 21  1  0
 18 22  1  0
 19 20  1  0
 21 23  1  0
 21 30  2  0
 22 25  1  0
 22 29  2  0
 23 24  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
M  END
> <Name>
alfentanil

> <ID>
alfentanil

> <PRIMARY_SOM>
10

> <SECONDARY_SOM>
18

> <Citation>
Klees et al.,Drug Metab. Dispos.,33,303,2005

> <DOI>
10.1124/dmb.104.0020790

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
all_trans_retinol
  SciTegic08102311032D

 21 21  0  0  0  0            999 V2000
    6.8702   -1.3995    0.0000 C   0  0
    5.5712   -0.6495    0.0000 C   0  0
    5.5712    0.8505    0.0000 C   0  0
    4.2721    1.6005    0.0000 C   0  0
    2.9731    0.8505    0.0000 C   0  0
    2.9731   -0.6495    0.0000 C   0  0
    2.4601   -2.0590    0.0000 C   0  0
    1.4959   -0.3890    0.0000 C   0  0
    4.2721   -1.3995    0.0000 C   0  0
    4.2721   -2.8995    0.0000 C   0  0
    5.5712   -3.6495    0.0000 C   0  0
    5.5712   -5.1495    0.0000 C   0  0
    6.8702   -5.8995    0.0000 C   0  0
    4.2721   -5.8995    0.0000 C   0  0
    6.8702   -7.3995    0.0000 C   0  0
    8.1693   -8.1495    0.0000 C   0  0
    8.1693   -9.6495    0.0000 C   0  0
    9.4683  -10.3995    0.0000 C   0  0
    6.8702  -10.3995    0.0000 C   0  0
    9.4683  -11.8995    0.0000 C   0  0
   10.7673  -12.6495    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  9  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 18 20  1  0
 20 21  1  0
M  END
> <Name>
all_trans_retinol

> <ID>
all_trans_retinol

> <PRIMARY_SOM>
20

> <Citation>
Chen et al.,Drug Metab. Disp.,28,315,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
almotriptan
  SciTegic08102311032D

 23 25  0  0  0  0            999 V2000
    8.4998    5.4933    0.0000 C   0  0
    8.4998    6.9933    0.0000 C   0  0
    9.9264    5.0298    0.0000 C   0  0
    7.2008    4.7433    0.0000 C   0  0
    9.9264    7.4568    0.0000 N   0  0
    7.2008    7.7433    0.0000 C   0  0
   10.8081    6.2433    0.0000 C   0  0
   10.3899    3.6032    0.0000 C   0  0
    5.9017    5.4933    0.0000 C   0  0
    5.9017    6.9933    0.0000 C   0  0
   11.8571    3.2913    0.0000 C   0  0
    4.6027    4.7433    0.0000 C   0  0
   12.3207    1.8647    0.0000 N   0  0
    3.3036    5.4933    0.0000 S   0  0
   13.7879    1.5529    0.0000 C   0  0
   11.3170    0.7500    0.0000 C   0  0
    2.5536    4.1942    0.0000 N   0  0
    2.0046    6.2433    0.0000 O   0  0
    4.0536    6.7923    0.0000 O   0  0
    3.1638    2.8239    0.0000 C   0  0
    1.0619    4.0375    0.0000 C   0  0
    2.0490    1.8202    0.0000 C   0  0
    0.7500    2.5702    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5  7  1  0
  6 10  2  0
  8 11  1  0
  9 10  1  0
  9 12  1  0
 11 13  1  0
 12 14  1  0
 13 15  1  0
 13 16  1  0
 14 17  1  0
 14 18  2  0
 14 19  2  0
 17 20  1  0
 17 21  1  0
 20 22  1  0
 21 23  1  0
 22 23  1  0
M  END
> <Name>
almotriptan

> <ID>
almotriptan

> <PRIMARY_SOM>
16 15

> <SECONDARY_SOM>
21 20

> <Citation>
Salva et al.,Drug Metab. Disp.,31,404,2003

> <DOI>
10.1124/dmd.31.4.404

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
alpha_dihydroergocryptine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 38 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.1046 -3.3819 0 0 CFG=2
M  V30 2 O 13.2194 -4.3856 0 0
M  V30 3 C 12.7147 -2.0116 0 0
M  V30 4 N 9.9612 -2.1444 0 0
M  V30 5 C 11.223 -4.5955 0 0
M  V30 6 C 14.5184 -3.6356 0 0 CFG=2
M  V30 7 N 14.2065 -2.1684 0 0
M  V30 8 O 11.9647 -0.7126 0 0
M  V30 9 C 9.9612 -0.6444 0 0
M  V30 10 C 9.7312 -4.4387 0 0
M  V30 11 C 11.8331 -5.9658 0 0
M  V30 12 C 15.945 -4.0992 0 0 CFG=1
M  V30 13 O 14.6752 -5.1274 0 0
M  V30 14 C 15.3212 -1.1647 0 0
M  V30 15 C 8.6622 0.1056 0 0 CFG=2
M  V30 16 O 11.2603 0.1056 0 0
M  V30 17 N 17.0597 -3.0955 0 0
M  V30 18 C 16.5551 -5.4695 0 0
M  V30 19 C 16.7478 -1.6282 0 0
M  V30 20 C 8.6622 1.6056 0 0
M  V30 21 C 7.3631 -0.6444 0 0
M  V30 22 C 18.3587 -3.8455 0 0
M  V30 23 C 18.0469 -5.3127 0 0
M  V30 24 O 17.8625 -0.6245 0 0
M  V30 25 C 7.3631 2.3556 0 0 CFG=1
M  V30 26 N 6.0641 0.1055 0 0
M  V30 27 C 7.3631 3.8556 0 0
M  V30 28 C 6.0641 1.6055 0 0 CFG=1
M  V30 29 C 4.7651 -0.6445 0 0
M  V30 30 C 6.0641 4.6056 0 0
M  V30 31 C 8.6622 4.6056 0 0
M  V30 32 C 4.7651 2.3555 0 0
M  V30 33 C 4.7651 3.8556 0 0
M  V30 34 C 6.0641 6.1056 0 0
M  V30 35 C 8.6622 6.1056 0 0
M  V30 36 C 3.7044 4.9162 0 0
M  V30 37 N 4.4544 6.2152 0 0
M  V30 38 C 7.3631 6.8556 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 6 7
M  V30 12 1 6 12
M  V30 13 1 6 13 CFG=1
M  V30 14 1 7 14
M  V30 15 1 15 9 CFG=1
M  V30 16 2 9 16
M  V30 17 1 12 17
M  V30 18 1 12 18 CFG=1
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 1 15 21
M  V30 22 1 17 19
M  V30 23 1 17 22
M  V30 24 1 18 23
M  V30 25 2 19 24
M  V30 26 1 25 20 CFG=3
M  V30 27 1 21 26
M  V30 28 1 22 23
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 1 26 28
M  V30 32 1 26 29
M  V30 33 2 27 30
M  V30 34 1 27 31
M  V30 35 1 28 32 CFG=1
M  V30 36 1 30 33
M  V30 37 1 30 34
M  V30 38 2 31 35
M  V30 39 1 32 33
M  V30 40 2 33 36
M  V30 41 1 34 37
M  V30 42 2 34 38
M  V30 43 1 35 38
M  V30 44 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 1 6 12 15 25 28) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
alpha_dihydroergocryptine

> <ID>
alpha_dihydroergocryptine

> <PRIMARY_SOM>
23

> <SECONDARY_SOM>
22

> <Citation>
Althaus et al.,Xenobiotica,30,1033,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
alpha_thujone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.75 -5.6563 0 0 CFG=2
M  V30 2 C 4.2135 -4.2297 0 0 CFG=1
M  V30 3 C 4.3703 -2.738 0 0
M  V30 4 C 3 -3.3481 0 0 CFG=1
M  V30 5 C 1.7865 -4.2297 0 0
M  V30 6 C 2.25 -5.6563 0 0
M  V30 7 C 4.6317 -6.8699 0 0
M  V30 8 O 1.3683 -6.8699 0 0
M  V30 9 C 2.25 -2.049 0 0
M  V30 10 C 3 -0.75 0 0
M  V30 11 C 0.75 -2.049 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 7 CFG=1
M  V30 4 1 2 3 CFG=3
M  V30 5 1 2 4
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 4 9 CFG=1
M  V30 9 1 5 6
M  V30 10 2 6 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 4) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
alpha_thujone

> <ID>
alpha_thujone

> <PRIMARY_SOM>
9

> <SECONDARY_SOM>
1

> <TERTIARY_SOM>
10 11

> <Citation>
Hold et al.,Chem. Res. Toxicol.,14,589,2001

> <DOI>
10.1021/tx000242c

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ametryne
  SciTegic08102311032D

 15 15  0  0  0  0            999 V2000
    2.3236    5.5245    0.0000 N   0  0
    2.3236    7.0245    0.0000 C   0  0
    1.0245    7.7745    0.0000 N   0  0
   -0.2745    7.0245    0.0000 C   0  0
   -0.2745    5.5245    0.0000 N   0  0
    1.0245    4.7745    0.0000 C   0  0
    1.0245    3.2745    0.0000 N   0  0
   -0.2745    2.5245    0.0000 C   0  0
   -0.2745    1.0245    0.0000 C   0  0
    3.6226    7.7745    0.0000 N   0  0
    3.6226    9.2745    0.0000 C   0  0
    4.9216   10.0245    0.0000 C   0  0
    2.3236   10.0245    0.0000 C   0  0
   -1.5736    7.7745    0.0000 S   0  0
   -2.8726    7.0245    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  2 10  1  0
  3  4  1  0
  4  5  2  0
  4 14  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 14 15  1  0
M  END
> <Name>
ametryne

> <ID>
ametryne

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
11

> <TERTIARY_SOM>
8

> <Citation>
Lang et al.,Chem. Res. Tox.,10,1037,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
amiodarone
  SciTegic08102311032D

 31 33  0  0  0  0            999 V2000
    6.2763   14.5670    0.0000 C   0  0
    6.2763   16.0670    0.0000 C   0  0
    4.9773   16.8170    0.0000 C   0  0
    3.6782   16.0670    0.0000 C   0  0
    3.6782   14.5670    0.0000 C   0  0
    4.9773   13.8170    0.0000 C   0  0
    4.6654   12.3498    0.0000 O   0  0
    2.5635   13.5633    0.0000 C   0  0
    3.1736   12.1930    0.0000 C   0  0
    2.4236   10.8940    0.0000 C   0  0
    3.1736    9.5949    0.0000 C   0  0
    2.4236    8.2959    0.0000 C   0  0
    3.1736    6.9969    0.0000 C   0  0
    1.0963   13.8752    0.0000 C   0  0
    0.0926   12.7605    0.0000 C   0  0
   -1.3746   13.0723    0.0000 C   0  0
   -2.3783   11.9576    0.0000 C   0  0
   -1.9148   10.5310    0.0000 C   0  0
   -0.4476   10.2192    0.0000 C   0  0
    0.5561   11.3339    0.0000 C   0  0
    0.6328   15.3018    0.0000 O   0  0
   -3.8455   12.2695    0.0000 I   0  0
    0.0160    8.7926    0.0000 I   0  0
   -2.9185    9.4163    0.0000 O   0  0
   -2.4550    7.9897    0.0000 C   0  0
   -3.4587    6.8750    0.0000 C   0  0
   -2.9951    5.4484    0.0000 N   0  0
   -3.9988    4.3337    0.0000 C   0  0
   -3.5353    2.9071    0.0000 C   0  0
   -1.5279    5.1366    0.0000 C   0  0
   -1.0644    3.7100    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  8  1  0
  6  7  1  0
  7  9  1  0
  8  9  2  0
  8 14  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 14 15  1  0
 14 21  2  0
 15 16  1  0
 15 20  2  0
 16 17  2  0
 17 18  1  0
 17 22  1  0
 18 19  2  0
 18 24  1  0
 19 20  1  0
 19 23  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 30  1  0
 28 29  1  0
 30 31  1  0
M  END
> <Name>
amiodarone

> <ID>
amiodarone

> <PRIMARY_SOM>
30 28

> <Citation>
Fabre et al.,Drug Metab. Disp.,21,978,1993

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
amitriptyline
  SciTegic08102311032D

 21 23  0  0  0  0            999 V2000
    6.3992   -2.4734    0.0000 C   0  0
    6.0654   -1.0110    0.0000 C   0  0
    5.4640   -3.6462    0.0000 C   0  0
    7.8616   -2.8072    0.0000 C   0  0
    4.7140   -0.3602    0.0000 C   0  0
    7.3048   -0.1660    0.0000 C   0  0
    3.9640   -3.6462    0.0000 C   0  0
    6.2140   -4.9452    0.0000 C   0  0
    8.3037   -4.2405    0.0000 C   0  0
    3.3625   -1.0110    0.0000 C   0  0
    4.6019    1.1356    0.0000 C   0  0
    7.1927    1.3298    0.0000 C   0  0
    3.0287   -2.4734    0.0000 C   0  0
    3.2140   -4.9452    0.0000 C   0  0
    5.4640   -6.2443    0.0000 C   0  0
    9.7661   -4.5743    0.0000 C   0  0
    5.8412    1.9806    0.0000 C   0  0
    3.9640   -6.2443    0.0000 C   0  0
   10.2083   -6.0077    0.0000 N   0  0
   11.6707   -6.3414    0.0000 C   0  0
    9.1880   -7.1073    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  7 14  1  0
  8 15  2  0
  9 16  1  0
 10 13  1  0
 11 17  2  0
 12 17  1  0
 14 18  2  0
 15 18  1  0
 16 19  1  0
 19 20  1  0
 19 21  1  0
M  END
> <Name>
amitriptyline

> <ID>
amitriptyline

> <PRIMARY_SOM>
21 20

> <SECONDARY_SOM>
13 10

> <Citation>
Breyer-Pfaff, Drug Metab. Rev.,36,723,2004

> <DOI>
10.1081/DMR-200033482

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
amodiaquine
  SciTegic08102311032D

 25 27  0  0  0  0            999 V2000
    6.2207   -1.7745    0.0000 C   0  0
    6.2207   -0.2745    0.0000 C   0  0
    4.9216    0.4755    0.0000 C   0  0
    3.6226   -0.2745    0.0000 C   0  0
    2.3235    0.4755    0.0000 Cl  0  0
    3.6226   -1.7745    0.0000 C   0  0
    4.9216   -2.5245    0.0000 C   0  0
    7.5197   -2.5245    0.0000 C   0  0
    7.5197   -4.0245    0.0000 N   0  0
    8.8188   -4.7745    0.0000 C   0  0
    8.8188   -1.7745    0.0000 C   0  0
    8.8187   -0.2745    0.0000 C   0  0
    7.5197    0.4755    0.0000 N   0  0
    8.8188   -6.2745    0.0000 C   0  0
   10.1178   -7.0245    0.0000 C   0  0
   10.1178   -8.5245    0.0000 C   0  0
    8.8188   -9.2745    0.0000 N   0  0
    8.8188  -10.7745    0.0000 C   0  0
    7.5197  -11.5245    0.0000 C   0  0
    7.5197   -8.5245    0.0000 C   0  0
    6.2207   -9.2745    0.0000 C   0  0
   11.4168   -6.2745    0.0000 C   0  0
   12.7159   -7.0245    0.0000 O   0  0
   11.4168   -4.7745    0.0000 C   0  0
   10.1178   -4.0245    0.0000 C   0  0
  1  2  1  0
  1  7  1  0
  1  8  2  0
  2  3  1  0
  2 13  2  0
  3  4  2  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 10 14  1  0
 10 25  2  0
 11 12  2  0
 12 13  1  0
 14 15  2  0
 15 16  1  0
 15 22  1  0
 16 17  1  0
 17 18  1  0
 17 20  1  0
 18 19  1  0
 20 21  1  0
 22 23  1  0
 22 24  2  0
 24 25  1  0
M  END
> <Name>
amodiaquine

> <ID>
amodiaquine

> <PRIMARY_SOM>
20 18

> <Citation>
Li et al.,J. Pharm. Exp. Therap.,300,399,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
androstenedione
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -0.75 6 0 0
M  V30 2 C -2.049 5.25 0 0 CFG=1
M  V30 3 C -2.049 6.75 0 0 CFG=1
M  V30 4 C -3.3481 4.5 0 0
M  V30 5 C -0.75 4.5 0 0
M  V30 6 C -3.3481 7.5 0 0 CFG=1
M  V30 7 C -0.75 7.5 0 0
M  V30 8 C -4.6471 5.25 0 0
M  V30 9 C -3.3481 3 0 0
M  V30 10 C -0.75 3 0 0
M  V30 11 C -3.3481 9 0 0 CFG=1
M  V30 12 C -4.6471 6.75 0 0
M  V30 13 C -0.75 9 0 0
M  V30 14 C -2.049 2.25 0 0
M  V30 15 C -2.049 9.75 0 0 CFG=1
M  V30 16 C -4.4628 10.0037 0 0
M  V30 17 O -2.049 0.75 0 0
M  V30 18 C -0.8355 10.6317 0 0
M  V30 19 C -2.3609 11.2172 0 0
M  V30 20 C -3.8527 11.374 0 0
M  V30 21 O -1.3572 12.3319 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7 CFG=1
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12 CFG=3
M  V30 12 1 7 13
M  V30 13 1 8 12
M  V30 14 1 9 14
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 11 16 CFG=3
M  V30 18 1 13 15
M  V30 19 2 14 17
M  V30 20 1 15 18 CFG=3
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 1 19 20
M  V30 24 2 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 2 3 6 11 15) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
androstenedione

> <ID>
androstenedione

> <PRIMARY_SOM>
8

> <Citation>
Waxman et al.,Arch. Biochem. Biophys.,290,160,1991

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
aprepitant
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -7.5896 -0.6343 0 0
M  V30 2 N -10.1021 2.4974 0 0
M  V30 3 C -8.8031 0.2474 0 0
M  V30 4 C -11.4012 4.7474 0 0 CFG=1
M  V30 5 C -8.0531 -2.0609 0 0
M  V30 6 N -10.0166 -0.6343 0 0
M  V30 7 C -10.1021 11.4974 0 0
M  V30 8 C -15.2983 11.4974 0 0
M  V30 9 C -10.1021 3.9974 0 0 CFG=2
M  V30 10 N -9.5531 -2.0609 0 0
M  V30 11 C -11.4012 10.7474 0 0
M  V30 12 C -13.9992 10.7474 0 0
M  V30 13 O -11.4012 6.2474 0 0
M  V30 14 C -12.7002 8.4974 0 0
M  V30 15 C -8.8031 1.7474 0 0
M  V30 16 C -12.7002 11.4974 0 0
M  V30 17 C -13.9992 9.2474 0 0
M  V30 18 C -11.4012 9.2474 0 0
M  V30 19 O -12.7002 3.9974 0 0
M  V30 20 C -12.7002 6.9974 0 0 CFG=1
M  V30 21 C -8.8031 4.7474 0 0
M  V30 22 O -7.1714 -3.2744 0 0
M  V30 23 F -10.1021 12.9974 0 0
M  V30 24 F -8.8031 10.7474 0 0
M  V30 25 F -8.8031 12.2474 0 0
M  V30 26 F -15.2983 12.9974 0 0
M  V30 27 F -16.5973 10.7474 0 0
M  V30 28 F -16.5973 12.2474 0 0
M  V30 29 C -8.8031 6.2474 0 0
M  V30 30 C -7.504 3.9974 0 0
M  V30 31 C -11.4012 1.7474 0 0
M  V30 32 C -6.205 6.2474 0 0
M  V30 33 C -12.7002 2.4974 0 0
M  V30 34 C -6.205 4.7474 0 0
M  V30 35 C -7.504 6.9974 0 0
M  V30 36 F -4.906 6.9974 0 0
M  V30 37 C -13.9992 6.2474 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 5
M  V30 3 1 2 9
M  V30 4 1 2 15
M  V30 5 1 2 31
M  V30 6 2 3 6
M  V30 7 1 3 15
M  V30 8 1 4 9
M  V30 9 1 4 13 CFG=3
M  V30 10 1 4 19
M  V30 11 1 5 10
M  V30 12 2 5 22
M  V30 13 1 6 10
M  V30 14 1 7 11
M  V30 15 1 7 23
M  V30 16 1 7 24
M  V30 17 1 7 25
M  V30 18 1 8 12
M  V30 19 1 8 26
M  V30 20 1 8 27
M  V30 21 1 8 28
M  V30 22 1 9 21 CFG=3
M  V30 23 2 11 16
M  V30 24 1 11 18
M  V30 25 1 12 16
M  V30 26 2 12 17
M  V30 27 1 13 20
M  V30 28 1 14 17
M  V30 29 2 14 18
M  V30 30 1 14 20
M  V30 31 1 19 33
M  V30 32 1 20 37 CFG=3
M  V30 33 2 21 29
M  V30 34 1 21 30
M  V30 35 1 29 35
M  V30 36 2 30 34
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 32 35
M  V30 40 1 32 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 9 20) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
aprepitant

> <ID>
aprepitant

> <PRIMARY_SOM>
4 33 31

> <SECONDARY_SOM>
20

> <Citation>
Sanchez et al.,Drug Metab. Disp.,32,1287,2004

> <DOI>
10.1124/dmd.104.000216

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
aripiprazole
  SciTegic08102311032D

 30 33  0  0  0  0            999 V2000
   18.9365    1.5000    0.0000 C   0  0
   18.9365    3.0000    0.0000 C   0  0
   17.6375    0.7500    0.0000 C   0  0
   20.2356    0.7500    0.0000 N   0  0
   17.6375    3.7500    0.0000 C   0  0
   20.2356    3.7500    0.0000 C   0  0
   16.3385    1.5000    0.0000 C   0  0
   21.5346    1.5000    0.0000 C   0  0
   16.3385    3.0000    0.0000 C   0  0
   21.5346    3.0000    0.0000 C   0  0
   15.0394    0.7500    0.0000 O   0  0
   22.8337    0.7500    0.0000 O   0  0
   13.7404    1.5000    0.0000 C   0  0
   12.4414    0.7500    0.0000 C   0  0
   11.1423    1.5000    0.0000 C   0  0
    9.8433    0.7500    0.0000 C   0  0
    8.5442    1.5000    0.0000 N   0  0
    7.2452    0.7500    0.0000 C   0  0
    8.5442    3.0000    0.0000 C   0  0
    5.9462    1.5000    0.0000 C   0  0
    7.2452    3.7500    0.0000 C   0  0
    5.9462    3.0000    0.0000 N   0  0
    4.6471    3.7500    0.0000 C   0  0
    3.3481    3.0000    0.0000 C   0  0
    4.6471    5.2500    0.0000 C   0  0
    2.0490    3.7500    0.0000 C   0  0
    3.3481    1.5000    0.0000 Cl  0  0
    3.3481    6.0000    0.0000 C   0  0
    2.0490    5.2500    0.0000 C   0  0
    0.7500    3.0000    0.0000 Cl  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  4  8  1  0
  5  9  2  0
  6 10  1  0
  7  9  1  0
  7 11  1  0
  8 10  1  0
  8 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 18 20  1  0
 19 21  1  0
 20 22  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 24 26  1  0
 24 27  1  0
 25 28  2  0
 26 29  2  0
 26 30  1  0
 28 29  1  0
M  END
> <Name>
aripiprazole

> <ID>
aripiprazole

> <PRIMARY_SOM>
10 6

> <Citation>
Kubo et al.,J. Chromatogr. B.,822,294,2005

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
artelinic_acid
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.5951 5.5553 0 0 CFG=2
M  V30 2 C 0.0821 6.9649 0 0 CFG=2
M  V30 3 C 2.0724 5.2949 0 0 CFG=2
M  V30 4 C -0.369 4.4063 0 0 CFG=1
M  V30 5 O -0.0642 7.3628 0 0
M  V30 6 O 1.0463 8.114 0 0
M  V30 7 O -1.2737 7.7826 0 0
M  V30 8 C 3.0365 6.4439 0 0 CFG=2
M  V30 9 C 2.5854 3.8853 0 0
M  V30 10 C -1.869 4.4063 0 0
M  V30 11 C 0.144 2.9967 0 0 CFG=1
M  V30 12 O -1.4237 7.9967 0 0
M  V30 13 C 2.5235 7.8535 0 0 CFG=1
M  V30 14 C -2.5727 7.0326 0 0 CFG=2
M  V30 15 C 4.5138 6.1835 0 0
M  V30 16 C 1.6212 2.7363 0 0
M  V30 17 C -2.8332 5.5553 0 0
M  V30 18 C -0.8202 1.8477 0 0
M  V30 19 O 3.4877 9.0026 0 0
M  V30 20 C -3.8718 7.7826 0 0
M  V30 21 C 2.9747 10.4121 0 0
M  V30 22 C 3.9388 11.5612 0 0
M  V30 23 C 3.4258 12.9707 0 0
M  V30 24 C 5.4161 11.3007 0 0
M  V30 25 C 4.39 14.1198 0 0
M  V30 26 C 6.3802 12.4498 0 0
M  V30 27 C 5.8672 13.8593 0 0
M  V30 28 C 6.8314 15.0084 0 0
M  V30 29 O 6.3184 16.4179 0 0
M  V30 30 O 8.3086 14.7479 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5 CFG=1
M  V30 5 1 2 6 CFG=1
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 3 9 CFG=3
M  V30 9 1 4 10 CFG=3
M  V30 10 1 4 11
M  V30 11 1 5 12
M  V30 12 1 6 13
M  V30 13 1 7 14
M  V30 14 1 8 13
M  V30 15 1 8 15 CFG=3
M  V30 16 1 9 16
M  V30 17 1 10 17
M  V30 18 1 11 16
M  V30 19 1 11 18 CFG=1
M  V30 20 1 12 14
M  V30 21 1 13 19 CFG=3
M  V30 22 1 14 17
M  V30 23 1 14 20 CFG=3
M  V30 24 1 19 21
M  V30 25 1 21 22
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 1 27 28
M  V30 33 1 28 29
M  V30 34 2 28 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 1 2 3 4 8 11 13 14) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
artelinic_acid

> <ID>
artelinic_acid

> <PRIMARY_SOM>
21

> <Citation>
Grace et al.,Xenobiotica,29,703,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
astemizole
  SciTegic08102311032D

 34 38  0  0  0  0            999 V2000
   -5.3970    5.8110    0.0000 N   0  0
   -6.8252    6.2695    0.0000 C   0  0
   -4.5196    7.0276    0.0000 C   0  0
   -4.9284    4.3861    0.0000 C   0  0
   -6.8305    7.7694    0.0000 C   0  0
   -8.1215    5.5149    0.0000 C   0  0
   -5.4056    8.2380    0.0000 N   0  0
   -3.0196    7.0330    0.0000 N   0  0
   -3.4600    4.0794    0.0000 C   0  0
   -8.1322    8.5148    0.0000 C   0  0
   -9.4232    6.2602    0.0000 C   0  0
   -2.2742    8.3347    0.0000 C   0  0
   -2.9915    2.6545    0.0000 C   0  0
   -2.4603    5.1977    0.0000 C   0  0
   -9.4286    7.7602    0.0000 C   0  0
   -0.7742    8.3400    0.0000 C   0  0
   -3.0288    9.6310    0.0000 C   0  0
   -1.5231    2.3478    0.0000 C   0  0
   -0.9920    4.8910    0.0000 C   0  0
   -0.0288    9.6417    0.0000 C   0  0
   -2.2834   10.9327    0.0000 C   0  0
   -0.5234    3.4661    0.0000 C   0  0
   -0.7834   10.9381    0.0000 N   0  0
    0.9449    3.1594    0.0000 F   0  0
   -0.0381   12.2397    0.0000 C   0  0
   -0.7927   13.5361    0.0000 C   0  0
   -0.0473   14.8378    0.0000 C   0  0
   -0.8019   16.1342    0.0000 C   0  0
    1.4527   14.8431    0.0000 C   0  0
   -0.0565   17.4359    0.0000 C   0  0
    2.1981   16.1448    0.0000 C   0  0
    1.4435   17.4412    0.0000 C   0  0
    2.1889   18.7429    0.0000 O   0  0
    3.6889   18.7482    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5  7  1  0
  5 10  1  0
  6 11  2  0
  8 12  1  0
  9 13  2  0
  9 14  1  0
 10 15  2  0
 11 15  1  0
 12 16  1  0
 12 17  1  0
 13 18  1  0
 14 19  2  0
 16 20  1  0
 17 21  1  0
 18 22  2  0
 19 22  1  0
 20 23  1  0
 21 23  1  0
 22 24  1  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 28 30  1  0
 29 31  2  0
 30 32  2  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
M  END
> <Name>
astemizole

> <ID>
astemizole

> <PRIMARY_SOM>
25

> <SECONDARY_SOM>
11

> <Citation>
Matsumoto and Yamazoe,Br. J. Clin. Pharm.,51,133,2001

> <DOI>
10.111/j.1365-2125.2001.01292.x.

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
atorvastatin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 41 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0246 8.1873 0 0
M  V30 2 C 7.395 8.7974 0 0
M  V30 3 C 6.1814 6.6955 0 0
M  V30 4 C 4.7256 8.9373 0 0
M  V30 5 N 8.3987 7.6827 0 0
M  V30 6 C 7.7068 10.2646 0 0
M  V30 7 C 7.6487 6.3837 0 0
M  V30 8 C 5.0667 5.6918 0 0
M  V30 9 C 4.7256 10.4373 0 0
M  V30 10 C 3.4266 8.1873 0 0
M  V30 11 C 9.8904 7.8395 0 0
M  V30 12 C 6.5921 11.2683 0 0
M  V30 13 C 9.1334 10.7282 0 0
M  V30 14 C 8.2588 5.0133 0 0
M  V30 15 N 5.3786 4.2246 0 0
M  V30 16 O 3.6401 6.1554 0 0
M  V30 17 C 3.4266 11.1873 0 0
M  V30 18 C 2.1275 8.9373 0 0
M  V30 19 C 10.7721 6.626 0 0
M  V30 20 C 6.904 12.7356 0 0
M  V30 21 C 9.4453 12.1954 0 0
M  V30 22 C 9.7505 4.8566 0 0
M  V30 23 C 7.3771 3.7998 0 0
M  V30 24 C 4.2639 3.2209 0 0
M  V30 25 C 2.1275 10.4373 0 0
M  V30 26 C 12.2639 6.7828 0 0 CFG=2
M  V30 27 C 8.3306 13.1991 0 0
M  V30 28 C 4.5757 1.7537 0 0
M  V30 29 C 2.8373 3.6844 0 0
M  V30 30 C 13.1456 5.5692 0 0
M  V30 31 O 12.874 8.1531 0 0
M  V30 32 F 8.6424 14.6663 0 0
M  V30 33 C 3.461 0.75 0 0
M  V30 34 C 1.7226 2.6807 0 0
M  V30 35 C 14.6374 5.726 0 0 CFG=2
M  V30 36 C 2.0344 1.2135 0 0
M  V30 37 C 15.519 4.5125 0 0
M  V30 38 O 15.2475 7.0963 0 0
M  V30 39 C 17.0108 4.6693 0 0
M  V30 40 O 17.6209 6.0396 0 0
M  V30 41 O 17.8925 3.4558 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 4 10
M  V30 10 1 5 7
M  V30 11 1 5 11
M  V30 12 2 6 12
M  V30 13 1 6 13
M  V30 14 1 7 14
M  V30 15 1 8 15
M  V30 16 2 8 16
M  V30 17 1 9 17
M  V30 18 2 10 18
M  V30 19 1 11 19
M  V30 20 1 12 20
M  V30 21 2 13 21
M  V30 22 1 14 22
M  V30 23 1 14 23
M  V30 24 1 15 24
M  V30 25 2 17 25
M  V30 26 1 18 25
M  V30 27 1 19 26
M  V30 28 2 20 27
M  V30 29 1 21 27
M  V30 30 2 24 28
M  V30 31 1 24 29
M  V30 32 1 26 30
M  V30 33 1 26 31 CFG=1
M  V30 34 1 27 32
M  V30 35 1 28 33
M  V30 36 2 29 34
M  V30 37 1 30 35
M  V30 38 2 33 36
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 35 38 CFG=1
M  V30 42 1 37 39
M  V30 43 1 39 40
M  V30 44 2 39 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 26 35) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
atorvastatin

> <ID>
atorvastatin

> <PRIMARY_SOM>
36

> <SECONDARY_SOM>
29 28

> <Citation>
Jacobsen et al.,Drug Metab. Disp.,28,1369,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
atrazine
  SciTegic08102311032D

 14 14  0  0  0  0            999 V2000
    2.3236    5.5245    0.0000 N   0  0
    2.3236    7.0245    0.0000 C   0  0
    1.0245    7.7745    0.0000 N   0  0
   -0.2745    7.0245    0.0000 C   0  0
   -0.2745    5.5245    0.0000 N   0  0
    1.0245    4.7745    0.0000 C   0  0
    1.0245    3.2745    0.0000 N   0  0
   -0.2745    2.5245    0.0000 C   0  0
   -0.2745    1.0245    0.0000 C   0  0
    3.6226    7.7745    0.0000 N   0  0
    3.6226    9.2745    0.0000 C   0  0
    4.9216   10.0245    0.0000 C   0  0
    2.3236   10.0245    0.0000 C   0  0
   -1.5736    7.7745    0.0000 Cl  0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  2 10  1  0
  3  4  1  0
  4  5  2  0
  4 14  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
M  END
> <Name>
atrazine

> <ID>
atrazine

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
11

> <Citation>
Lang et al.,Chem. Res. Toxicol.,10,1037,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
azelastine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9753 -6.0815 0 0
M  V30 2 C 6.9753 -4.5815 0 0
M  V30 3 C 5.6763 -3.8316 0 0
M  V30 4 C 5.6763 -6.8315 0 0
M  V30 5 C 4.3772 -4.5816 0 0
M  V30 6 C 4.3772 -6.0816 0 0
M  V30 7 C 8.2743 -3.8315 0 0
M  V30 8 C 8.2743 -6.8315 0 0
M  V30 9 N 9.5734 -4.5815 0 0
M  V30 10 N 9.5734 -6.0815 0 0
M  V30 11 O 8.2744 -8.3315 0 0
M  V30 12 C 8.2743 -2.3315 0 0
M  V30 13 C 9.5734 -1.5815 0 0
M  V30 14 C 9.5734 -0.0815 0 0
M  V30 15 C 10.8724 -2.3315 0 0
M  V30 16 C 10.8724 0.6685 0 0
M  V30 17 C 12.1714 -0.0815 0 0
M  V30 18 C 12.1714 -1.5815 0 0
M  V30 19 Cl 13.4705 0.6685 0 0
M  V30 20 C 10.8724 -6.8315 0 0 CFG=1
M  V30 21 C 12.1118 -5.9866 0 0
M  V30 22 C 13.5451 -6.4287 0 0
M  V30 23 N 14.0932 -7.825 0 0
M  V30 24 C 13.3432 -9.124 0 0
M  V30 25 C 11.8599 -9.3476 0 0
M  V30 26 C 10.7603 -8.3273 0 0
M  V30 27 C 15.589 -7.9371 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 8
M  V30 4 1 2 3
M  V30 5 1 2 7
M  V30 6 2 3 5
M  V30 7 2 4 6
M  V30 8 1 5 6
M  V30 9 2 7 9
M  V30 10 1 7 12
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 10
M  V30 14 1 20 10 CFG=1
M  V30 15 1 12 13
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 18
M  V30 20 2 16 17
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 1 20 21
M  V30 24 1 20 26
M  V30 25 1 21 22
M  V30 26 1 22 23
M  V30 27 1 23 24
M  V30 28 1 23 27
M  V30 29 1 24 25
M  V30 30 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
azelastine

> <ID>
azelastine

> <PRIMARY_SOM>
27

> <Citation>
Imai et al.,Drug Metab. Disp.,27,942,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
barnidipine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -2.8726 8.5245 0 0 CFG=1
M  V30 2 C -2.8726 10.0245 0 0
M  V30 3 C -1.5736 7.7745 0 0
M  V30 4 C -4.1716 7.7745 0 0
M  V30 5 C -1.5736 10.7745 0 0
M  V30 6 C -4.1716 10.7745 0 0
M  V30 7 C -1.5736 6.2745 0 0
M  V30 8 C -0.2745 8.5245 0 0
M  V30 9 C -5.4707 8.5245 0 0
M  V30 10 C -4.1716 6.2745 0 0
M  V30 11 O -1.5736 12.2745 0 0
M  V30 12 O -0.2745 10.0245 0 0
M  V30 13 N -5.4707 10.0245 0 0
M  V30 14 C -4.1716 12.2745 0 0
M  V30 15 C -0.2745 5.5245 0 0
M  V30 16 C 1.0245 7.7745 0 0
M  V30 17 C -6.7697 7.7745 0 0
M  V30 18 O -5.4707 5.5245 0 0
M  V30 19 O -2.8726 5.5245 0 0
M  V30 20 C -0.2745 13.0245 0 0 CFG=2
M  V30 21 C 1.0245 6.2745 0 0
M  V30 22 N -0.2745 4.0245 0 0 CHG=1
M  V30 23 C -5.4707 4.0245 0 0
M  V30 24 C -0.1177 14.5163 0 0
M  V30 25 C 1.0958 12.4144 0 0
M  V30 26 O -1.5736 3.2745 0 0 CHG=-1
M  V30 27 O 1.0245 3.2745 0 0
M  V30 28 N 1.3495 14.8282 0 0
M  V30 29 C 2.0995 13.5291 0 0
M  V30 30 C 1.9596 16.1985 0 0
M  V30 31 C 3.4514 16.3553 0 0
M  V30 32 C 4.0615 17.7256 0 0
M  V30 33 C 4.3331 15.1418 0 0
M  V30 34 C 5.5533 17.8824 0 0
M  V30 35 C 5.8248 15.2986 0 0
M  V30 36 C 6.4349 16.6689 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 2 5 12
M  V30 12 1 6 13
M  V30 13 1 6 14
M  V30 14 1 7 15
M  V30 15 2 8 16
M  V30 16 1 9 13
M  V30 17 1 9 17
M  V30 18 1 10 18
M  V30 19 2 10 19
M  V30 20 1 20 11 CFG=3
M  V30 21 2 15 21
M  V30 22 1 15 22
M  V30 23 1 16 21
M  V30 24 1 18 23
M  V30 25 1 20 24
M  V30 26 1 20 25
M  V30 27 1 22 26
M  V30 28 2 22 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 30 31
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 20) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
barnidipine

> <ID>
barnidipine

> <PRIMARY_SOM>
30

> <SECONDARY_SOM>
1 13

> <TERTIARY_SOM>
20

> <Citation>
Teramura et al.,Xenobiotica,27,885,1997

> <DOI>
0049-8254/97

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
beta_arteether
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.9183 11.1469 0 0
M  V30 2 C 4.045 9.9273 0 0
M  V30 3 O 2.5522 10.0738 0 0
M  V30 4 C 1.6789 8.8542 0 0 CFG=1
M  V30 5 O 2.2984 7.4882 0 0
M  V30 6 C 0.1861 9.0007 0 0 CFG=1
M  V30 7 C -0.6872 7.7811 0 0 CFG=1
M  V30 8 C -0.4335 10.3668 0 0
M  V30 9 C 1.4252 6.2686 0 0 CFG=1
M  V30 10 C -0.0677 6.4151 0 0 CFG=2
M  V30 11 C -2.18 7.9276 0 0
M  V30 12 O 2.4199 5.1458 0 0
M  V30 13 C -0.9409 5.1955 0 0 CFG=2
M  V30 14 O 1.3409 6.9308 0 0
M  V30 15 C -3.0533 6.708 0 0
M  V30 16 C -2.4338 5.342 0 0 CFG=1
M  V30 17 O 2.3356 5.808 0 0
M  V30 18 C -3.307 4.1224 0 0
M  V30 19 C -1.3089 3.4547 0 0
M  V30 20 C 2.3853 3.6462 0 0 CFG=1
M  V30 21 C 1.3401 2.5704 0 0
M  V30 22 C -0.1579 2.4928 0 0
M  V30 23 C 2.3853 5.1462 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 4 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 9 5 CFG=3
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 10
M  V30 10 1 7 11 CFG=1
M  V30 11 1 9 10
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14 CFG=1
M  V30 15 1 11 15
M  V30 16 1 12 20
M  V30 17 1 13 16
M  V30 18 1 13 19 CFG=1
M  V30 19 1 14 17
M  V30 20 1 15 16
M  V30 21 1 16 18 CFG=3
M  V30 22 1 17 20
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 1 20 23 CFG=1
M  V30 26 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 4 6 7 9 10 13 16 20) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
beta_arteether

> <ID>
beta_arteether

> <PRIMARY_SOM>
2

> <Citation>
Grace et al.,Drug Metab. Dispos.,26,313,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
beta_thujone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.75 -5.6563 0 0 CFG=1
M  V30 2 C 4.2135 -4.2297 0 0 CFG=1
M  V30 3 C 4.3703 -2.738 0 0
M  V30 4 C 3 -3.3481 0 0 CFG=1
M  V30 5 C 1.7865 -4.2297 0 0
M  V30 6 C 2.25 -5.6563 0 0
M  V30 7 C 4.6317 -6.8699 0 0
M  V30 8 O 1.3683 -6.8699 0 0
M  V30 9 C 2.25 -2.049 0 0
M  V30 10 C 3 -0.75 0 0
M  V30 11 C 0.75 -2.049 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 7 CFG=3
M  V30 4 1 2 3 CFG=3
M  V30 5 1 2 4
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 4 9 CFG=1
M  V30 9 1 5 6
M  V30 10 2 6 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 4) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
beta_thujone

> <ID>
beta_thujone

> <PRIMARY_SOM>
1

> <SECONDARY_SOM>
9

> <TERTIARY_SOM>
10 11

> <Citation>
Hold et al.,Chem. Res. Toxicol.,14,589,2001

> <DOI>
10.1021/tx000242c

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
bisoprolol
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3654 -0.8498 0 0
M  V30 2 C 13.3654 0.6502 0 0
M  V30 3 C 12.0664 -1.5998 0 0
M  V30 4 O 14.6645 -1.5997 0 0
M  V30 5 C 12.0663 1.4002 0 0
M  V30 6 C 10.7674 -0.8499 0 0
M  V30 7 C 14.6646 -3.0997 0 0
M  V30 8 C 10.7673 0.6501 0 0
M  V30 9 C 15.9637 -3.8496 0 0 CFG=1
M  V30 10 C 9.4682 1.4 0 0
M  V30 11 C 15.9638 -5.3496 0 0
M  V30 12 O 17.2627 -3.0996 0 0
M  V30 13 O 8.1692 0.65 0 0
M  V30 14 N 17.2628 -6.0996 0 0
M  V30 15 C 6.8701 1.3999 0 0
M  V30 16 C 17.2629 -7.5996 0 0
M  V30 17 C 5.5711 0.6498 0 0
M  V30 18 C 18.562 -8.3495 0 0
M  V30 19 C 15.9639 -8.3496 0 0
M  V30 20 O 4.2721 1.3998 0 0
M  V30 21 C 2.9731 0.6497 0 0
M  V30 22 C 1.674 1.3996 0 0
M  V30 23 C 2.9731 -0.8503 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12 CFG=3
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
bisoprolol

> <ID>
bisoprolol

> <PRIMARY_SOM>
21

> <Citation>
Horikiri et al.,Life Sciences,63,1097,1998

> <DOI>
10.1016/S0024-3205(98)0037-3

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
bortezomib
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -6.8702 -1.3996 0 0
M  V30 2 C -8.1692 -0.6496 0 0
M  V30 3 C -10.7673 0.8504 0 0
M  V30 4 C -5.5711 -0.6495 0 0 CFG=2
M  V30 5 N -10.7673 -0.6496 0 0
M  V30 6 C -12.0664 1.6004 0 0
M  V30 7 B -5.5712 0.8505 0 0
M  V30 8 C -9.4683 -1.3996 0 0 CFG=1
M  V30 9 N -12.0664 3.1004 0 0
M  V30 10 O -9.4683 1.6004 0 0
M  V30 11 O -8.1692 0.8504 0 0
M  V30 12 C -4.2721 -1.3995 0 0
M  V30 13 C -9.4683 -2.8996 0 0
M  V30 14 N -14.6644 1.6004 0 0
M  V30 15 O -4.2721 1.6005 0 0
M  V30 16 O -6.8702 1.6004 0 0
M  V30 17 C -13.3654 0.8504 0 0
M  V30 18 C -8.1692 -3.6496 0 0
M  V30 19 C -2.9731 -0.6495 0 0
M  V30 20 C -13.3654 3.8504 0 0
M  V30 21 C -14.6644 3.1004 0 0
M  V30 22 C -8.1692 -5.1496 0 0
M  V30 23 C -6.8702 -2.8996 0 0
M  V30 24 C -1.674 -1.3995 0 0
M  V30 25 C -2.9731 0.8505 0 0
M  V30 26 C -5.5711 -3.6496 0 0
M  V30 27 C -6.8702 -5.8996 0 0
M  V30 28 C -5.5711 -5.1496 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 4 1 CFG=3
M  V30 3 1 2 8
M  V30 4 2 2 11
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 2 3 10
M  V30 8 1 4 7
M  V30 9 1 4 12
M  V30 10 1 8 5 CFG=3
M  V30 11 2 6 9
M  V30 12 1 6 17
M  V30 13 1 7 15
M  V30 14 1 7 16
M  V30 15 1 8 13
M  V30 16 1 9 20
M  V30 17 1 12 19
M  V30 18 1 13 18
M  V30 19 2 14 17
M  V30 20 1 14 21
M  V30 21 2 18 22
M  V30 22 1 18 23
M  V30 23 1 19 24
M  V30 24 1 19 25
M  V30 25 2 20 21
M  V30 26 1 22 27
M  V30 27 2 23 26
M  V30 28 1 26 28
M  V30 29 2 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 8) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
bortezomib

> <ID>
bortezomib

> <PRIMARY_SOM>
4

> <Citation>
Pekol et al.,Drug Metab. Disp.,33,771,2005

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
bosentan
  SciTegic08102311032D

 39 42  0  0  0  0            999 V2000
  -11.0127    4.6231    0.0000 C   0  0
  -10.2600    5.9206    0.0000 C   0  0
  -11.0073    7.2211    0.0000 C   0  0
  -12.5073    7.2242    0.0000 N   0  0
  -13.2600    5.9267    0.0000 C   0  0
  -12.5127    4.6261    0.0000 N   0  0
  -14.7600    5.9298    0.0000 C   0  0
  -15.5073    7.2304    0.0000 N   0  0
  -17.0073    7.2334    0.0000 C   0  0
  -17.7600    5.9359    0.0000 C   0  0
  -17.0127    4.6354    0.0000 C   0  0
  -15.5127    4.6323    0.0000 N   0  0
   -8.7600    5.9175    0.0000 O   0  0
   -8.0073    7.2150    0.0000 C   0  0
   -6.5074    7.2119    0.0000 C   0  0
   -5.7547    8.5094    0.0000 C   0  0
   -6.5020    9.8100    0.0000 C   0  0
   -8.0020    9.8131    0.0000 C   0  0
   -8.7547    8.5156    0.0000 C   0  0
   -5.7600    5.9113    0.0000 O   0  0
   -4.2600    5.9083    0.0000 C   0  0
  -10.2547    8.5186    0.0000 O   0  0
  -11.0020    9.8192    0.0000 C   0  0
  -10.2494   11.1167    0.0000 C   0  0
  -10.9967   12.4173    0.0000 O   0  0
  -10.2653    3.3225    0.0000 N   0  0
  -11.0180    2.0250    0.0000 S   0  0
  -11.7707    0.7275    0.0000 O   0  0
  -12.3155    2.7777    0.0000 O   0  0
   -9.7205    1.2723    0.0000 C   0  0
   -9.7236   -0.2277    0.0000 C   0  0
   -8.4261   -0.9803    0.0000 C   0  0
   -7.1255   -0.2330    0.0000 C   0  0
   -7.1224    1.2670    0.0000 C   0  0
   -8.4199    2.0197    0.0000 C   0  0
   -5.8280   -0.9857    0.0000 C   0  0
   -5.8311   -2.4857    0.0000 C   0  0
   -4.5274   -0.2383    0.0000 C   0  0
   -4.5305   -1.7383    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  1 26  1  0
  2  3  2  0
  2 13  1  0
  3  4  1  0
  3 22  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7 12  2  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 13 14  1  0
 14 15  1  0
 14 19  2  0
 15 16  2  0
 15 20  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 20 21  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 26 27  1  0
 27 28  2  0
 27 29  2  0
 27 30  1  0
 30 31  1  0
 30 35  2  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 33 36  1  0
 34 35  1  0
 36 37  1  0
 36 38  1  0
 36 39  1  0
M  END
> <Name>
bosentan

> <ID>
bosentan

> <PRIMARY_SOM>
39 38 37

> <SECONDARY_SOM>
21

> <Citation>
van Giersbergen et al.,J. Clin. Pharmacol.,43,15,2003

> <DOI>
10.1067/mcp.2002.122473

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
bromocriptine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 43 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 14.3927 -2.2759 0 0
M  V30 2 C 14.7046 -3.7432 0 0 CFG=2
M  V30 3 C 12.901 -2.1191 0 0
M  V30 4 C 15.5075 -1.2722 0 0 CFG=2
M  V30 5 C 16.1312 -4.2067 0 0 CFG=1
M  V30 6 O 13.4056 -4.4932 0 0
M  V30 7 O 14.8614 -5.2349 0 0
M  V30 8 C 12.2909 -3.4895 0 0 CFG=1
M  V30 9 O 12.151 -0.8201 0 0
M  V30 10 C 16.934 -1.7358 0 0
M  V30 11 C 15.1956 0.195 0 0
M  V30 12 N 17.2459 -3.203 0 0
M  V30 13 C 16.7413 -5.577 0 0
M  V30 14 N 10.1474 -2.252 0 0
M  V30 15 C 11.4092 -4.703 0 0
M  V30 16 O 18.0488 -0.7321 0 0
M  V30 17 C 16.3103 1.1987 0 0
M  V30 18 C 18.545 -3.953 0 0
M  V30 19 C 18.2331 -5.4202 0 0
M  V30 20 C 10.1474 -0.752 0 0
M  V30 21 C 9.9174 -4.5462 0 0
M  V30 22 C 12.0193 -6.0733 0 0
M  V30 23 C 15.9984 2.6659 0 0
M  V30 24 C 17.7369 0.7352 0 0
M  V30 25 C 8.8484 -0.002 0 0 CFG=2
M  V30 26 O 11.4465 -0.002 0 0
M  V30 27 C 8.8484 1.498 0 0
M  V30 28 C 7.5494 -0.752 0 0
M  V30 29 C 7.5494 2.248 0 0
M  V30 30 N 6.2503 -0.002 0 0
M  V30 31 C 7.5494 3.748 0 0
M  V30 32 C 6.2503 1.498 0 0 CFG=2
M  V30 33 C 4.9513 -0.752 0 0
M  V30 34 C 6.2503 4.498 0 0
M  V30 35 C 8.8484 4.498 0 0
M  V30 36 C 4.9513 2.248 0 0
M  V30 37 C 4.9513 3.748 0 0
M  V30 38 C 6.2503 5.998 0 0
M  V30 39 C 8.8484 5.998 0 0
M  V30 40 C 3.8906 4.8087 0 0
M  V30 41 N 4.6406 6.1077 0 0
M  V30 42 C 7.5494 6.748 0 0
M  V30 43 Br 2.4035 4.6129 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7 CFG=1
M  V30 7 1 3 8
M  V30 8 2 3 9
M  V30 9 1 4 10
M  V30 10 1 4 11 CFG=1
M  V30 11 1 5 12
M  V30 12 1 5 13 CFG=1
M  V30 13 1 6 8
M  V30 14 1 8 14 CFG=1
M  V30 15 1 8 15
M  V30 16 1 10 12
M  V30 17 2 10 16
M  V30 18 1 11 17
M  V30 19 1 12 18
M  V30 20 1 13 19
M  V30 21 1 14 20
M  V30 22 1 15 21
M  V30 23 1 15 22
M  V30 24 1 17 23
M  V30 25 1 17 24
M  V30 26 1 18 19
M  V30 27 1 25 20 CFG=1
M  V30 28 2 20 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 29 32
M  V30 35 1 30 32
M  V30 36 1 30 33
M  V30 37 2 31 34
M  V30 38 1 31 35
M  V30 39 1 32 36 CFG=3
M  V30 40 1 34 37
M  V30 41 1 34 38
M  V30 42 2 35 39
M  V30 43 1 36 37
M  V30 44 2 37 40
M  V30 45 1 38 41
M  V30 46 2 38 42
M  V30 47 1 39 42
M  V30 48 1 40 41
M  V30 49 1 40 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 2 4 5 8 25 32) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
bromocriptine

> <ID>
bromocriptine

> <PRIMARY_SOM>
19 18

> <Citation>
Althaus et al.,Xenobiotica,30,1033,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
brotizolam
  SciTegic08102311032D

 22 25  0  0  0  0            999 V2000
   10.2345   -3.8884    0.0000 C   0  0
   10.7616   -2.4840    0.0000 C   0  0
   12.2076   -2.0850    0.0000 N   0  0
   12.2748   -0.5865    0.0000 N   0  0
   10.8705   -0.0594    0.0000 C   0  0
   10.5367    1.4030    0.0000 C   0  0
    9.1852    2.0538    0.0000 N   0  0
    7.8338    1.4030    0.0000 C   0  0
    6.6610    2.3382    0.0000 C   0  0
    5.2647    1.7902    0.0000 C   0  0
    4.0920    2.7254    0.0000 C   0  0
    4.3155    4.2087    0.0000 C   0  0
    5.7118    4.7567    0.0000 C   0  0
    6.8846    3.8214    0.0000 C   0  0
    8.2809    4.3695    0.0000 Cl  0  0
    7.5000   -0.0594    0.0000 C   0  0
    6.0957   -0.5865    0.0000 C   0  0
    6.1630   -2.0850    0.0000 C   0  0
    4.9902   -3.0202    0.0000 Br  0  0
    7.6089   -2.4840    0.0000 S   0  0
    8.4352   -1.2322    0.0000 C   0  0
    9.9352   -1.2322    0.0000 N   0  0
  1  2  1  0
  2  3  2  0
  2 22  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 22  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 16  1  0
  9 10  1  0
  9 14  2  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 16 17  1  0
 16 21  2  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
M  END
> <Name>
brotizolam

> <ID>
brotizolam

> <PRIMARY_SOM>
1

> <SECONDARY_SOM>
6

> <Citation>
Senda et al.,Xenobiotica,27,913,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
budesonide
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3609 -4.5 0 0
M  V30 2 C 5.3609 -3 0 0
M  V30 3 C 4.0619 -5.25 0 0 CFG=1
M  V30 4 C 2.7628 -4.5 0 0
M  V30 5 C 2.7628 -3 0 0
M  V30 6 C 4.0619 -2.25 0 0
M  V30 7 O 4.0619 -0.75 0 0
M  V30 8 C 1.4638 -5.25 0 0
M  V30 9 C 1.4638 -6.75 0 0
M  V30 10 C 2.7628 -7.5 0 0 CFG=2
M  V30 11 C 4.0619 -6.75 0 0 CFG=2
M  V30 12 C 5.3609 -6 0 0
M  V30 13 C 2.7629 -9 0 0 CFG=1
M  V30 14 C 5.3609 -7.5 0 0 CFG=1
M  V30 15 C 5.3609 -9 0 0
M  V30 16 C 4.0619 -9.75 0 0 CFG=2
M  V30 17 C 1.6481 -10.0037 0 0
M  V30 18 O 6.66 -6.75 0 0
M  V30 19 C 3.75 -11.2172 0 0 CFG=2
M  V30 20 C 5.2754 -10.6317 0 0
M  V30 21 C 2.2582 -11.374 0 0 CFG=2
M  V30 22 C 3 -12.5163 0 0
M  V30 23 O 4.3601 -12.5875 0 0
M  V30 24 O 1.9464 -12.8412 0 0
M  V30 25 O 3.75 -13.8153 0 0
M  V30 26 C 0.525 -12.5163 0 0
M  V30 27 O -0.225 -13.8153 0 0
M  V30 28 C 3.2454 -13.5912 0 0 CFG=1
M  V30 29 C 3.4022 -15.083 0 0
M  V30 30 C 4.7725 -15.6931 0 0
M  V30 31 C 4.9293 -17.1849 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 2 6
M  V30 4 1 3 4
M  V30 5 1 11 3 CFG=1
M  V30 6 1 3 12 CFG=1
M  V30 7 2 4 5
M  V30 8 1 4 8
M  V30 9 1 5 6
M  V30 10 2 6 7
M  V30 11 1 8 9
M  V30 12 1 10 9 CFG=3
M  V30 13 1 10 11
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 16
M  V30 17 1 13 17 CFG=1
M  V30 18 1 14 15
M  V30 19 1 14 18 CFG=3
M  V30 20 1 15 16
M  V30 21 1 16 19
M  V30 22 1 16 20 CFG=1
M  V30 23 1 21 17 CFG=3
M  V30 24 1 19 21
M  V30 25 1 19 22 CFG=1
M  V30 26 1 19 23
M  V30 27 1 21 24
M  V30 28 2 22 25
M  V30 29 1 22 26
M  V30 30 1 23 28
M  V30 31 1 24 28
M  V30 32 1 26 27
M  V30 33 1 28 29 CFG=3
M  V30 34 1 29 30
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 3 10 11 13 14 16 19 21 28) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
budesonide

> <ID>
budesonide

> <PRIMARY_SOM>
28

> <SECONDARY_SOM>
8

> <Citation>
Jonsson et al.,Drug Metab. Disp.,23,137,1995

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
bufuralol
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1445 5.2852 0 0
M  V30 2 C 2.1445 6.7852 0 0
M  V30 3 C 0.8455 4.5351 0 0
M  V30 4 O 3.5712 4.8217 0 0
M  V30 5 C 3.571 7.2488 0 0
M  V30 6 C 0.8454 7.5351 0 0
M  V30 7 C -0.4535 5.2851 0 0
M  V30 8 C 0.8456 3.0351 0 0
M  V30 9 C 4.4528 6.0353 0 0
M  V30 10 C -0.4536 6.7851 0 0
M  V30 11 C -0.4534 2.2851 0 0
M  V30 12 C 5.9528 6.0354 0 0 CFG=1
M  V30 13 C 6.7027 7.3345 0 0
M  V30 14 O 6.7028 4.7364 0 0
M  V30 15 N 8.2027 7.3345 0 0
M  V30 16 C 8.9526 8.6336 0 0
M  V30 17 C 10.4526 8.6337 0 0
M  V30 18 C 9.7026 9.9327 0 0
M  V30 19 C 8.2026 9.9326 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 5 9
M  V30 10 2 6 10
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 12 13
M  V30 15 1 12 14 CFG=1
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
bufuralol

> <ID>
bufuralol

> <PRIMARY_SOM>
8

> <Citation>
Narimatsu et al.,Chirality,15,333,2003

> <DOI>
10.1002/chir.10212

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
bupivacaine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -0.75 8.25 0 0
M  V30 2 C -2.049 7.5 0 0
M  V30 3 C -3.3481 8.25 0 0
M  V30 4 C -4.6471 7.5 0 0
M  V30 5 N -5.9462 8.25 0 0
M  V30 6 C -5.9462 9.75 0 0
M  V30 7 C -7.2452 10.5 0 0
M  V30 8 C -8.5442 9.75 0 0
M  V30 9 C -8.5442 8.25 0 0
M  V30 10 C -7.2452 7.5 0 0 CFG=1
M  V30 11 C -7.2452 6 0 0
M  V30 12 O -8.5442 5.25 0 0
M  V30 13 N -5.9462 5.25 0 0
M  V30 14 C -5.9462 3.75 0 0
M  V30 15 C -4.6471 3 0 0
M  V30 16 C -3.3481 3.75 0 0
M  V30 17 C -4.6471 1.5 0 0
M  V30 18 C -5.9462 0.75 0 0
M  V30 19 C -7.2452 1.5 0 0
M  V30 20 C -7.2452 3 0 0
M  V30 21 C -8.5442 3.75 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 3 4
M  V30 4 1 4 5
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11 CFG=3
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 14 20
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 17 18
M  V30 20 2 18 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
bupivacaine

> <ID>
bupivacaine

> <PRIMARY_SOM>
4

> <Citation>
Gantenbein et al.,Drug Metab. Dispos.,28,383,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
buprenorphine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 34 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -2.3881 -4.776 0 0
M  V30 2 C -2.3881 -3.276 0 0
M  V30 3 C -3.6871 -2.526 0 0
M  V30 4 C -4.9861 -3.276 0 0
M  V30 5 C -4.9862 -4.776 0 0
M  V30 6 C -3.6871 -5.526 0 0
M  V30 7 O -1.089 -2.526 0 0
M  V30 8 O -4.397 -1.0771 0 0
M  V30 9 C -6.2852 -2.526 0 0 CFG=2
M  V30 10 C -6.2852 -5.526 0 0
M  V30 11 C -7.5842 -4.776 0 0 CFG=2
M  V30 12 C -6.2852 -4.026 0 0 CFG=1
M  V30 13 C -5.897 -1.0771 0 0 CFG=2
M  V30 14 C -7.4543 -1.7316 0 0 CFG=2
M  V30 15 C -7.777 -4.1828 0 0
M  V30 16 C -8.458 -2.8463 0 0 CFG=2
M  V30 17 C -9.9451 -2.6505 0 0 CFG=2
M  V30 18 O -10.1409 -4.1377 0 0
M  V30 19 C -9.7493 -1.1634 0 0
M  V30 20 C -11.4323 -2.4547 0 0
M  V30 21 C -12.3454 -3.6448 0 0
M  V30 22 C -12.0063 -1.0689 0 0
M  V30 23 C -12.9195 -2.2589 0 0
M  V30 24 C -5.9546 -1.763 0 0
M  V30 25 O -5.5806 -0.1144 0 0
M  V30 26 C -5.8617 1.359 0 0
M  V30 27 C -5.2736 -3.0995 0 0
M  V30 28 C -7.5842 -1.776 0 0
M  V30 29 N -8.8833 -4.026 0 0
M  V30 30 C -8.8833 -2.526 0 0
M  V30 31 C -9.8475 -5.1751 0 0
M  V30 32 C -9.3344 -6.5846 0 0
M  V30 33 C -9.5949 -8.0618 0 0
M  V30 34 C -8.1854 -7.5488 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 2 2 3
M  V30 4 1 2 7
M  V30 5 1 3 4
M  V30 6 1 3 8
M  V30 7 2 4 5
M  V30 8 1 4 9
M  V30 9 1 5 6
M  V30 10 1 5 10
M  V30 11 1 13 8 CFG=3
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 28 CFG=1
M  V30 15 1 11 10 CFG=1
M  V30 16 1 11 12
M  V30 17 1 11 29
M  V30 18 1 12 15 CFG=3
M  V30 19 1 12 27
M  V30 20 1 13 14
M  V30 21 1 14 16
M  V30 22 1 14 24
M  V30 23 1 14 25 CFG=3
M  V30 24 1 16 15 CFG=3
M  V30 25 1 16 17
M  V30 26 1 17 18 CFG=3
M  V30 27 1 17 19
M  V30 28 1 17 20
M  V30 29 1 20 21
M  V30 30 1 20 22
M  V30 31 1 20 23
M  V30 32 1 24 27
M  V30 33 1 25 26
M  V30 34 1 28 30
M  V30 35 1 29 30
M  V30 36 1 29 31
M  V30 37 1 31 32
M  V30 38 1 32 33
M  V30 39 1 32 34
M  V30 40 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 9 11 12 13 14 16 17) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
buprenorphine

> <ID>
buprenorphine

> <PRIMARY_SOM>
31

> <SECONDARY_SOM>
1 6

> <Citation>
Picard et al.,Drug Metab. Disp.,33,689,2005

> <DOI>
10.1124/dmd.105.003681

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
bupropion
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3236 8.5245 0 0
M  V30 2 C 2.3236 10.0245 0 0
M  V30 3 C 1.0245 10.7745 0 0
M  V30 4 C -0.2745 10.0245 0 0
M  V30 5 C -0.2745 8.5245 0 0
M  V30 6 C 1.0245 7.7745 0 0
M  V30 7 C -1.5736 7.7745 0 0
M  V30 8 C -1.5736 6.2745 0 0 CFG=1
M  V30 9 C -0.2745 5.5245 0 0
M  V30 10 N -2.8726 5.5245 0 0
M  V30 11 C -2.8726 4.0245 0 0
M  V30 12 C -4.1716 3.2745 0 0
M  V30 13 C -1.5736 3.2745 0 0
M  V30 14 C -2.8726 2.5245 0 0
M  V30 15 Cl 3.6226 7.7745 0 0
M  V30 16 O -2.8726 8.5245 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 15
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 2 7 16
M  V30 11 1 8 9 CFG=1
M  V30 12 1 8 10
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
bupropion

> <ID>
bupropion

> <PRIMARY_SOM>
14 13 12

> <Citation>
Faucette et al.,Drug Metab. Disp.,29,1123,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
capsaicin
  SciTegic08102311032D

 22 22  0  0  0  0            999 V2000
    4.9216   -2.5245    0.0000 C   0  0
    4.9216   -1.0245    0.0000 C   0  0
    3.6226   -3.2745    0.0000 C   0  0
    6.2207   -3.2745    0.0000 C   0  0
    3.6226   -0.2745    0.0000 C   0  0
    2.3236   -2.5245    0.0000 C   0  0
    6.2207   -4.7745    0.0000 N   0  0
    2.3236   -1.0245    0.0000 C   0  0
    3.6226    1.2255    0.0000 O   0  0
    7.5197   -5.5245    0.0000 C   0  0
    1.0245   -0.2745    0.0000 O   0  0
    4.9216    1.9755    0.0000 C   0  0
    7.5197   -7.0245    0.0000 C   0  0
    8.8188   -4.7745    0.0000 O   0  0
    8.8188   -7.7745    0.0000 C   0  0
    8.8188   -9.2745    0.0000 C   0  0
   10.1178  -10.0245    0.0000 C   0  0
   10.1178  -11.5245    0.0000 C   0  0
   11.4169  -12.2745    0.0000 C   0  0
   11.4169  -13.7745    0.0000 C   0  0
   12.7159  -14.5245    0.0000 C   0  0
   10.1178  -14.5245    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  6  2  0
  4  7  1  0
  5  8  2  0
  5  9  1  0
  6  8  1  0
  7 10  1  0
  8 11  1  0
  9 12  1  0
 10 13  1  0
 10 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
M  END
> <Name>
capsaicin

> <ID>
capsaicin

> <PRIMARY_SOM>
4 7 20

> <Citation>
Reilly et al.,Chem. Res. Toxicol.,16,336,2003

> <DOI>
10.1021/tx025599q

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
carbaryl
  SciTegic08102311032D

 15 16  0  0  0  0            999 V2000
   -0.9240    4.3995    0.0000 C   0  0
   -0.9240    5.8995    0.0000 C   0  0
   -2.2231    3.6495    0.0000 C   0  0
    0.3750    3.6495    0.0000 C   0  0
    0.3750    6.6495    0.0000 O   0  0
   -2.2231    6.6495    0.0000 C   0  0
   -3.5221    4.3995    0.0000 C   0  0
   -2.2231    2.1495    0.0000 C   0  0
    0.3750    2.1495    0.0000 C   0  0
    0.3750    8.1495    0.0000 C   0  0
   -3.5221    5.8995    0.0000 C   0  0
   -0.9240    1.3995    0.0000 C   0  0
    1.6740    8.8995    0.0000 N   0  0
   -0.9240    8.8995    0.0000 O   0  0
    1.6740   10.3995    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5 10  1  0
  6 11  1  0
  7 11  2  0
  8 12  1  0
  9 12  2  0
 10 13  1  0
 10 14  2  0
 13 15  1  0
M  END
> <Name>
carbaryl

> <ID>
carbaryl

> <PRIMARY_SOM>
7

> <SECONDARY_SOM>
8

> <TERTIARY_SOM>
15

> <Citation>
Tang et al,Chem. Biol. Inter.,141,229,2002

> <DOI>
10.1016/S0009-2797(02)00074-1

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
carbofuran
  SciTegic08102311032D

 16 17  0  0  0  0            999 V2000
    4.1716    6.2745    0.0000 C   0  0
    4.1716    7.7745    0.0000 C   0  0
    2.8726    5.5245    0.0000 C   0  0
    5.5982    5.8110    0.0000 O   0  0
    5.5982    8.2380    0.0000 C   0  0
    2.8726    8.5245    0.0000 C   0  0
    2.8726    4.0245    0.0000 O   0  0
    1.5736    6.2745    0.0000 C   0  0
    6.4799    7.0245    0.0000 C   0  0
    1.5736    7.7745    0.0000 C   0  0
    1.5736    3.2745    0.0000 C   0  0
    7.5946    8.0282    0.0000 C   0  0
    7.5946    6.0208    0.0000 C   0  0
    1.5736    1.7745    0.0000 N   0  0
    0.2745    4.0245    0.0000 O   0  0
    0.2745    1.0245    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5  9  1  0
  6 10  2  0
  7 11  1  0
  8 10  1  0
  9 12  1  0
  9 13  1  0
 11 14  1  0
 11 15  2  0
 14 16  1  0
M  END
> <Name>
carbofuran

> <ID>
carbofuran

> <PRIMARY_SOM>
5

> <Citation>
Usmani et al.,Chem. Biol. Inter.,150,221,2004

> <DOI>
10.1016/j.cbi.2004.09.015

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
carvedilol
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -0.54 -5.3347 0 0
M  V30 2 C 0.8866 -5.7983 0 0
M  V30 3 C -0.54 -3.8347 0 0
M  V30 4 C -1.839 -6.0848 0 0
M  V30 5 C 1.7683 -4.5847 0 0
M  V30 6 C 1.4967 -7.1686 0 0
M  V30 7 N 0.8866 -3.3712 0 0
M  V30 8 C -1.839 -3.0847 0 0
M  V30 9 C -3.138 -5.3348 0 0
M  V30 10 O -1.839 -7.5848 0 0
M  V30 11 C 3.2601 -4.7415 0 0
M  V30 12 C 2.9885 -7.3254 0 0
M  V30 13 C -3.138 -3.8347 0 0
M  V30 14 C -3.138 -8.3348 0 0
M  V30 15 C 3.8702 -6.1119 0 0
M  V30 16 C -3.138 -9.8348 0 0 CFG=2
M  V30 17 C -4.4371 -10.5848 0 0
M  V30 18 O -1.839 -10.5848 0 0
M  V30 19 N -4.4371 -12.0848 0 0
M  V30 20 C -5.7361 -12.8348 0 0
M  V30 21 C -5.7361 -14.3348 0 0
M  V30 22 O -7.0351 -15.0848 0 0
M  V30 23 C -7.0351 -16.5848 0 0
M  V30 24 C -8.3342 -17.3348 0 0
M  V30 25 C -5.7361 -17.3348 0 0
M  V30 26 C -8.3342 -18.8348 0 0
M  V30 27 O -9.6332 -16.5848 0 0
M  V30 28 C -5.7361 -18.8348 0 0
M  V30 29 C -7.0351 -19.5848 0 0
M  V30 30 C -10.9322 -17.3348 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 4 10
M  V30 10 1 5 7
M  V30 11 1 5 11
M  V30 12 2 6 12
M  V30 13 2 8 13
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 2 11 15
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 1 16 17
M  V30 20 1 16 18 CFG=1
M  V30 21 1 17 19
M  V30 22 1 19 20
M  V30 23 1 20 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 24 27
M  V30 30 2 25 28
M  V30 31 2 26 29
M  V30 32 1 27 30
M  V30 33 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
carvedilol

> <ID>
carvedilol

> <PRIMARY_SOM>
11

> <SECONDARY_SOM>
29

> <Citation>
Oldham and Clarke,Drug Metab. Disp.,25,970,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
cerivastatin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 33 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -2.8726 8.5245 0 0
M  V30 2 C -1.5736 7.7745 0 0
M  V30 3 C -2.8726 10.0245 0 0
M  V30 4 C -4.1716 10.7745 0 0
M  V30 5 C -5.4707 10.0245 0 0
M  V30 6 C -5.4707 8.5245 0 0
M  V30 7 C -4.1716 7.7745 0 0
M  V30 8 F -6.7697 10.7745 0 0
M  V30 9 C -0.2745 8.5245 0 0
M  V30 10 C 1.0245 7.7745 0 0
M  V30 11 N 1.0245 6.2745 0 0
M  V30 12 C -0.2745 5.5245 0 0
M  V30 13 C -1.5736 6.2745 0 0
M  V30 14 C -0.2745 10.0245 0 0
M  V30 15 C 2.3235 8.5245 0 0
M  V30 16 C 1.0245 3.2745 0 0
M  V30 17 C -0.2745 4.0245 0 0
M  V30 18 C -2.8726 5.5245 0 0
M  V30 19 C -1.5736 3.2745 0 0
M  V30 20 C 3.6226 7.7745 0 0
M  V30 21 C 2.3235 10.0245 0 0
M  V30 22 C 1.0245 10.7745 0 0
M  V30 23 C 1.0245 12.2745 0 0 CFG=2
M  V30 24 C 2.3235 13.0245 0 0
M  V30 25 C 2.3235 14.5245 0 0 CFG=2
M  V30 26 C 3.6226 15.2745 0 0
M  V30 27 C 3.6226 16.7745 0 0
M  V30 28 O 2.3235 17.5245 0 0
M  V30 29 O 4.9216 17.5245 0 0
M  V30 30 O -0.2745 13.0245 0 0
M  V30 31 O 1.0245 15.2745 0 0
M  V30 32 O -2.8726 4.0245 0 0
M  V30 33 C -4.1716 3.2745 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 7
M  V30 4 1 2 9
M  V30 5 2 2 13
M  V30 6 2 3 4
M  V30 7 1 4 5
M  V30 8 2 5 6
M  V30 9 1 5 8
M  V30 10 1 6 7
M  V30 11 2 9 10
M  V30 12 1 9 14
M  V30 13 1 10 11
M  V30 14 1 10 15
M  V30 15 2 11 12
M  V30 16 1 12 13
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 2 14 22
M  V30 20 1 15 20
M  V30 21 1 15 21
M  V30 22 1 16 17
M  V30 23 1 17 19
M  V30 24 1 18 32
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 1 23 30 CFG=1
M  V30 28 1 24 25
M  V30 29 1 25 26
M  V30 30 1 25 31 CFG=1
M  V30 31 1 26 27
M  V30 32 1 27 28
M  V30 33 2 27 29
M  V30 34 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 23 25) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
cerivastatin

> <ID>
cerivastatin

> <PRIMARY_SOM>
33

> <Citation>
Boberg et al.,Drug Metab. Disp.,25,321,1977

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
chloroquine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6226 12.2745 0 0
M  V30 2 C 3.6226 13.7745 0 0
M  V30 3 C 2.3236 11.5245 0 0
M  V30 4 C 4.9216 11.5245 0 0
M  V30 5 N 2.3235 14.5245 0 0
M  V30 6 C 4.9216 14.5245 0 0
M  V30 7 C 1.0245 12.2745 0 0
M  V30 8 N 2.3236 10.0245 0 0
M  V30 9 C 6.2207 12.2745 0 0
M  V30 10 C 1.0245 13.7745 0 0
M  V30 11 C 6.2207 13.7745 0 0
M  V30 12 C 1.0245 9.2745 0 0 CFG=1
M  V30 13 Cl 7.5197 14.5245 0 0
M  V30 14 C 1.0245 7.7745 0 0
M  V30 15 C -0.2745 10.0245 0 0
M  V30 16 C -0.2745 7.0245 0 0
M  V30 17 C -0.2745 5.5245 0 0
M  V30 18 N -1.5736 4.7745 0 0
M  V30 19 C -1.5736 3.2745 0 0
M  V30 20 C -2.8726 5.5245 0 0
M  V30 21 C -2.8726 2.5245 0 0
M  V30 22 C -4.1716 4.7745 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 2 5 10
M  V30 10 2 6 11
M  V30 11 1 7 10
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 12 15 CFG=1
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
chloroquine

> <ID>
chloroquine

> <PRIMARY_SOM>
20 19

> <Citation>
Projean et al.,Drug Metab. Disp.,31,748,2003

> <DOI>
10.1124/dmd.31.6.748

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
chlorpyrifos
  SciTegic08102311032D

 18 18  0  0  0  0            999 V2000
    0.8978   -1.2876    0.0000 P   0  0
    1.1328    0.1939    0.0000 O   0  0
    0.6628   -2.7691    0.0000 O   0  0
    2.3793   -1.5226    0.0000 O   0  0
   -0.5836   -1.0526    0.0000 S   0  0
   -0.1789    0.9214    0.0000 C   0  0
    1.8283   -3.7133    0.0000 C   0  0
    3.3236   -0.3571    0.0000 C   0  0
   -0.2047    2.4212    0.0000 C   0  0
   -1.4648    0.1492    0.0000 N   0  0
    1.5933   -5.1948    0.0000 C   0  0
    4.8051   -0.5921    0.0000 C   0  0
   -1.5165    3.1487    0.0000 C   0  0
    1.0812    3.1934    0.0000 Cl  0  0
   -2.7766    0.8767    0.0000 C   0  0
   -2.8024    2.3765    0.0000 C   0  0
   -4.0625    0.1044    0.0000 Cl  0  0
   -4.1142    3.1040    0.0000 Cl  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  1  0
  6  9  2  0
  6 10  1  0
  7 11  1  0
  8 12  1  0
  9 13  1  0
  9 14  1  0
 10 15  2  0
 13 16  2  0
 15 16  1  0
 15 17  1  0
 16 18  1  0
M  END
> <Name>
chlorpyrifos

> <ID>
chlorpyrifos

> <PRIMARY_SOM>
1 5

> <Citation>
Tang et al.,Drug Metab. Disp.,29,1201,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
chlorzoxazone
  SciTegic08102311032D

 11 12  0  0  0  0            999 V2000
    4.9216   -2.5245    0.0000 C   0  0
    4.9216   -1.0245    0.0000 C   0  0
    3.6226   -0.2745    0.0000 C   0  0
    1.0245   -0.2745    0.0000 Cl  0  0
    2.3236   -1.0245    0.0000 C   0  0
    2.3236   -2.5245    0.0000 C   0  0
    3.6226   -3.2745    0.0000 C   0  0
    3.9345   -4.7417    0.0000 N   0  0
    5.4263   -4.8985    0.0000 C   0  0
    6.1763   -6.1976    0.0000 O   0  0
    6.0364   -3.5282    0.0000 O   0  0
  1  2  1  0
  1  7  2  0
  1 11  1  0
  2  3  2  0
  3  5  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
M  END
> <Name>
chlorzoxazone

> <ID>
chlorzoxazone

> <PRIMARY_SOM>
3

> <Citation>
T. Shimada, F. Tsumura, H. Yamazaki, Drug Metab. Dispos. 1999, 27, 1274-1280.

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
cilostazol
  SciTegic08102311032D

 27 30  0  0  0  0            999 V2000
    5.0784   16.0163    0.0000 N   0  0
    7.2956   15.0292    0.0000 N   0  0
    6.5456   16.3282    0.0000 N   0  0
    6.2919   13.9144    0.0000 N   0  0
    4.9216   14.5245    0.0000 C   0  0
    1.0245    3.2745    0.0000 N   0  0
    1.0245    4.7745    0.0000 C   0  0
   -0.2745    2.5245    0.0000 C   0  0
   -0.2745    5.5245    0.0000 C   0  0
    3.9637   17.0200    0.0000 C   0  0
   -0.2745    7.0245    0.0000 C   0  0
   -0.2745    1.0245    0.0000 O   0  0
    2.3236    5.5245    0.0000 C   0  0
   -1.5736    4.7745    0.0000 C   0  0
   -1.5736    3.2745    0.0000 C   0  0
    1.0245    7.7745    0.0000 C   0  0
    2.3236    7.0245    0.0000 C   0  0
    3.6226   13.7745    0.0000 C   0  0
    1.0245    9.2745    0.0000 O   0  0
    2.5371   16.5565    0.0000 C   0  0
    4.2756   18.4872    0.0000 C   0  0
    2.3235   10.0245    0.0000 C   0  0
    3.6226   12.2745    0.0000 C   0  0
    2.3235   11.5245    0.0000 C   0  0
    3.1608   19.4909    0.0000 C   0  0
    1.4224   17.5602    0.0000 C   0  0
    1.7343   19.0274    0.0000 C   0  0
  1  3  1  0
  1  5  1  0
  1 10  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5 18  1  0
  6  7  1  0
  6  8  1  0
  7  9  2  0
  7 13  1  0
  8 12  2  0
  8 15  1  0
  9 11  1  0
  9 14  1  0
 10 20  1  0
 10 21  1  0
 11 16  2  0
 13 17  2  0
 14 15  1  0
 16 17  1  0
 16 19  1  0
 18 23  1  0
 19 22  1  0
 20 26  1  0
 21 25  1  0
 22 24  1  0
 23 24  1  0
 25 27  1  0
 26 27  1  0
M  END
> <Name>
cilostazol

> <ID>
cilostazol

> <PRIMARY_SOM>
27

> <SECONDARY_SOM>
14

> <Citation>
Suri et al.,Clin. Pharmacokin.,37 sup2,61,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
cisapride
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.8187 4.7745 0 0
M  V30 2 C 8.8187 6.2745 0 0
M  V30 3 C 7.5197 7.0245 0 0
M  V30 4 C 6.2207 6.2745 0 0
M  V30 5 C 6.2207 4.7745 0 0
M  V30 6 C 7.5197 4.0245 0 0
M  V30 7 F 4.9216 7.0245 0 0
M  V30 8 O 10.1178 4.0245 0 0
M  V30 9 C 10.1178 2.5245 0 0
M  V30 10 C 11.4168 1.7745 0 0
M  V30 11 C 11.4168 0.2745 0 0
M  V30 12 N 12.7159 -0.4754 0 0
M  V30 13 C 12.7159 -1.9754 0 0
M  V30 14 C 14.0149 -2.7254 0 0
M  V30 15 C 15.3139 -1.9754 0 0 CFG=1
M  V30 16 C 15.3139 -0.4754 0 0 CFG=1
M  V30 17 C 14.0149 0.2746 0 0
M  V30 18 O 16.613 0.2746 0 0
M  V30 19 C 17.912 -0.4754 0 0
M  V30 20 N 16.613 -2.7254 0 0
M  V30 21 C 16.613 -4.2254 0 0
M  V30 22 O 15.314 -4.9754 0 0
M  V30 23 C 17.912 -4.9754 0 0
M  V30 24 C 17.912 -6.4754 0 0
M  V30 25 C 19.2111 -7.2254 0 0
M  V30 26 C 20.5101 -6.4754 0 0
M  V30 27 C 20.5101 -4.9754 0 0
M  V30 28 C 19.2111 -4.2254 0 0
M  V30 29 Cl 21.8091 -4.2254 0 0
M  V30 30 N 21.8091 -7.2254 0 0
M  V30 31 O 16.613 -7.2254 0 0
M  V30 32 C 16.613 -8.7254 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 8
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 4 7
M  V30 8 1 5 6
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 12 17
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 15 20 CFG=1
M  V30 19 1 16 17
M  V30 20 1 16 18 CFG=1
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 23 24
M  V30 26 2 23 28
M  V30 27 2 24 25
M  V30 28 1 24 31
M  V30 29 1 25 26
M  V30 30 2 26 27
M  V30 31 1 26 30
M  V30 32 1 27 28
M  V30 33 1 27 29
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 16) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
cisapride

> <ID>
cisapride

> <PRIMARY_SOM>
11

> <SECONDARY_SOM>
2 6

> <TERTIARY_SOM>
3 4 5

> <Citation>
Desta et al.,Drug Metab. Disp.,28,789,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
citalopram
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2699 2.25 0 0
M  V30 2 C 11.2699 3.75 0 0
M  V30 3 C 9.9708 4.5 0 0
M  V30 4 C 9.9708 1.5 0 0
M  V30 5 C 8.6718 2.25 0 0
M  V30 6 C 8.6718 3.75 0 0
M  V30 7 C 12.5689 1.5 0 0
M  V30 8 N 13.8679 0.75 0 0
M  V30 9 C 7.2452 1.7865 0 0
M  V30 10 O 6.3635 3 0 0
M  V30 11 C 7.2452 4.2135 0 0 CFG=2
M  V30 12 C 5.9462 4.9635 0 0
M  V30 13 C 7.8553 5.5839 0 0
M  V30 14 C 9.3471 5.7406 0 0
M  V30 15 C 6.9736 6.7974 0 0
M  V30 16 C 9.9572 7.111 0 0
M  V30 17 C 7.5837 8.1677 0 0
M  V30 18 C 9.0755 8.3245 0 0
M  V30 19 C 4.6471 4.2135 0 0
M  V30 20 C 3.3481 4.9635 0 0
M  V30 21 N 2.049 4.2135 0 0
M  V30 22 C 0.75 4.9635 0 0
M  V30 23 C 2.049 2.7135 0 0
M  V30 24 F 9.6856 9.6948 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 7
M  V30 4 1 2 3
M  V30 5 2 3 6
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 1 5 9
M  V30 9 1 6 11
M  V30 10 3 7 8
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12 CFG=3
M  V30 14 1 11 13
M  V30 15 1 12 19
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 1 18 24
M  V30 23 1 19 20
M  V30 24 1 20 21
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
citalopram

> <ID>
citalopram

> <PRIMARY_SOM>
23 22

> <Citation>
Olesen et al.,Pharma.,59,298,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
clindamycin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0443 -1.299 0 0 CFG=1
M  V30 2 O 7.0443 0.201 0 0
M  V30 3 C 5.7453 -2.049 0 0 CFG=1
M  V30 4 C 4.4463 0.201 0 0 CFG=2
M  V30 5 C 4.4463 -1.299 0 0 CFG=1
M  V30 6 C 8.3434 -2.049 0 0 CFG=2
M  V30 7 C 9.6424 -4.299 0 0
M  V30 8 N 8.3434 -3.549 0 0
M  V30 9 C 5.7453 0.951 0 0 CFG=1
M  V30 10 N 10.856 -6.6806 0 0
M  V30 11 C 9.6424 -5.799 0 0 CFG=1
M  V30 12 C 10.3924 -8.1072 0 0
M  V30 13 O 10.9415 -3.549 0 0
M  V30 14 C 8.4289 -6.6806 0 0
M  V30 15 C 9.6424 -1.299 0 0 CFG=1
M  V30 16 S 5.7453 2.451 0 0
M  V30 17 C 8.8924 -8.1072 0 0 CFG=1
M  V30 18 O 3.1472 0.951 0 0
M  V30 19 O 5.7453 -3.549 0 0
M  V30 20 O 3.1472 -2.049 0 0
M  V30 21 C 12.2825 -6.2171 0 0
M  V30 22 Cl 9.6424 0.201 0 0
M  V30 23 C 8.0108 -9.3207 0 0
M  V30 24 C 7.0443 3.201 0 0
M  V30 25 C 10.9415 -2.049 0 0
M  V30 26 C 8.6209 -10.6911 0 0
M  V30 27 C 7.7392 -11.9046 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 9
M  V30 5 1 3 5
M  V30 6 1 3 19 CFG=3
M  V30 7 1 4 5
M  V30 8 1 4 9
M  V30 9 1 4 18 CFG=1
M  V30 10 1 5 20 CFG=3
M  V30 11 1 6 8 CFG=1
M  V30 12 1 6 15
M  V30 13 1 7 8
M  V30 14 1 11 7 CFG=1
M  V30 15 2 7 13
M  V30 16 1 9 16 CFG=1
M  V30 17 1 10 11
M  V30 18 1 10 12
M  V30 19 1 10 21
M  V30 20 1 11 14
M  V30 21 1 12 17
M  V30 22 1 14 17
M  V30 23 1 15 22 CFG=1
M  V30 24 1 15 25
M  V30 25 1 16 24
M  V30 26 1 17 23 CFG=3
M  V30 27 1 23 26
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 1 3 4 5 6 9 11 15 17) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
clindamycin

> <ID>
clindamycin

> <PRIMARY_SOM>
16

> <SECONDARY_SOM>
21

> <Citation>
Wynalda et al.,Drug Metab. Disp.,31,878,2003

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
clobazam
  SciTegic08102311032D

 21 23  0  0  0  0            999 V2000
   -1.9294   -7.4551    0.0000 C   0  0
   -2.2632   -5.9928    0.0000 N   0  0
   -2.8647   -8.6279    0.0000 C   0  0
   -0.4462   -7.6787    0.0000 C   0  0
   -1.0905   -5.0575    0.0000 C   0  0
   -3.6147   -5.3419    0.0000 C   0  0
   -4.3647   -8.6279    0.0000 N   0  0
   -2.3167  -10.0242    0.0000 C   0  0
    0.1018   -9.0750    0.0000 C   0  0
    0.3058   -5.6055    0.0000 C   0  0
   -1.3141   -3.5743    0.0000 C   0  0
   -4.9661   -5.9928    0.0000 C   0  0
   -3.6147   -3.8419    0.0000 O   0  0
   -5.2999   -7.4551    0.0000 C   0  0
   -5.0155   -9.9793    0.0000 C   0  0
   -0.8334  -10.2478    0.0000 C   0  0
    1.5851   -9.2986    0.0000 Cl  0  0
    1.4786   -4.6703    0.0000 C   0  0
   -0.1413   -2.6390    0.0000 C   0  0
   -6.7623   -7.7889    0.0000 O   0  0
    1.2550   -3.1870    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  5 10  2  0
  5 11  1  0
  6 12  1  0
  6 13  2  0
  7 14  1  0
  7 15  1  0
  8 16  2  0
  9 16  1  0
  9 17  1  0
 10 18  1  0
 11 19  2  0
 12 14  1  0
 14 20  2  0
 18 21  2  0
 19 21  1  0
M  END
> <Name>
clobazam

> <ID>
clobazam

> <PRIMARY_SOM>
15

> <Citation>
Giraud et al.,Drug Metab. Disp.,32,1279,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
clomipramine
  SciTegic08102311032D

 22 24  0  0  0  0            999 V2000
    1.0882   11.1896    0.0000 C   0  0
    2.5215   10.7475    0.0000 C   0  0
    2.8553    9.2851    0.0000 C   0  0
    1.7557    8.2648    0.0000 C   0  0
    0.3224    8.7070    0.0000 C   0  0
   -0.0114   10.1694    0.0000 C   0  0
   -1.3629   10.8202    0.0000 C   0  0
   -2.7143   10.1694    0.0000 C   0  0
   -3.0481    8.7070    0.0000 C   0  0
   -4.5313    8.4834    0.0000 C   0  0
   -5.0793    7.0871    0.0000 C   0  0
   -4.1441    5.9143    0.0000 C   0  0
   -2.6609    6.1379    0.0000 C   0  0
   -2.1128    7.5342    0.0000 C   0  0
   -0.6128    7.5342    0.0000 N   0  0
    0.0380    6.1828    0.0000 C   0  0
   -0.8070    4.9434    0.0000 C   0  0
   -0.1562    3.5919    0.0000 C   0  0
   -1.0011    2.3526    0.0000 N   0  0
   -0.3503    1.0011    0.0000 C   0  0
   -2.4970    2.4647    0.0000 C   0  0
   -4.6921    4.5180    0.0000 Cl  0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 15  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 14  2  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 22  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
M  END
> <Name>
clomipramine

> <ID>
clomipramine

> <PRIMARY_SOM>
21 20

> <Citation>
Nielsen et al.,J. Pharm. Exp. Ther.,277,1659,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
clozapine
  SciTegic08102311032D

 23 26  0  0  0  0            999 V2000
    4.9298    7.9178    0.0000 C   0  0
    6.3632    7.4757    0.0000 C   0  0
    7.4628    8.4959    0.0000 C   0  0
    7.1290    9.9583    0.0000 C   0  0
    5.6956   10.4004    0.0000 C   0  0
    4.5960    9.3802    0.0000 C   0  0
    3.2446   10.0310    0.0000 N   0  0
    1.8931    9.3802    0.0000 C   0  0
    0.7936   10.4004    0.0000 C   0  0
   -0.6398    9.9583    0.0000 C   0  0
   -0.9736    8.4959    0.0000 C   0  0
    0.1260    7.4756    0.0000 C   0  0
    1.5594    7.9178    0.0000 C   0  0
    2.4946    6.7450    0.0000 C   0  0
    3.9946    6.7450    0.0000 N   0  0
    1.8438    5.3936    0.0000 N   0  0
    0.3480    5.2815    0.0000 C   0  0
   -0.3029    3.9300    0.0000 C   0  0
    0.5421    2.6907    0.0000 N   0  0
    2.0379    2.8028    0.0000 C   0  0
    2.6888    4.1542    0.0000 C   0  0
   -0.1087    1.3392    0.0000 C   0  0
    8.8961    8.0538    0.0000 Cl  0  0
  1  2  1  0
  1  6  2  0
  1 15  1  0
  2  3  2  0
  3  4  1  0
  3 23  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 13  2  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 22  1  0
 20 21  1  0
M  END
> <Name>
clozapine

> <ID>
clozapine

> <PRIMARY_SOM>
22

> <SECONDARY_SOM>
19

> <Citation>
Fang et al.,Naunyn-Schm. Arch. Pharma.,358,592,1998

> <DOI>
10.1007/PL00005298

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
cocaine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.7673 -5.1495 0 0
M  V30 2 C 8.1692 -3.6495 0 0 CFG=1
M  V30 3 C 8.1692 -5.1495 0 0 CFG=2
M  V30 4 C 12.0663 -5.8995 0 0
M  V30 5 C 9.4683 -3.6495 0 0
M  V30 6 C 10.7673 -3.6495 0 0 CFG=2
M  V30 7 C 9.4683 -2.8995 0 0
M  V30 8 C 6.8702 -5.8995 0 0
M  V30 9 O 6.8702 -7.3995 0 0
M  V30 10 O 5.5712 -5.1495 0 0
M  V30 11 C 4.2721 -5.8995 0 0
M  V30 12 O 6.8702 -2.8995 0 0
M  V30 13 C 6.8702 -1.3995 0 0
M  V30 14 C 5.5711 -0.6495 0 0
M  V30 15 O 8.1692 -0.6495 0 0
M  V30 16 C 5.5711 0.8505 0 0
M  V30 17 C 4.2721 1.6005 0 0
M  V30 18 C 2.9731 0.8505 0 0
M  V30 19 C 2.9731 -0.6495 0 0
M  V30 20 C 4.2721 -1.3995 0 0
M  V30 21 C 9.4683 -5.8995 0 0 CFG=2
M  V30 22 C 8.8187 -4.7745 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 6
M  V30 3 1 1 21
M  V30 4 1 2 3
M  V30 5 1 2 7
M  V30 6 1 2 12 CFG=3
M  V30 7 1 3 8 CFG=1
M  V30 8 1 3 21
M  V30 9 1 6 5 CFG=1
M  V30 10 1 5 22
M  V30 11 1 6 7
M  V30 12 2 8 9
M  V30 13 1 8 10
M  V30 14 1 10 11
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 2 14 20
M  V30 20 2 16 17
M  V30 21 1 17 18
M  V30 22 2 18 19
M  V30 23 1 19 20
M  V30 24 1 21 22 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 3 6 21) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
cocaine

> <ID>
cocaine

> <PRIMARY_SOM>
4

> <Citation>
LeDuc et al.,Pharmacology,46,293,1993

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
codeine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9462 3.5172 0 0
M  V30 2 C 5.9462 5.0172 0 0
M  V30 3 C 4.6471 5.7672 0 0
M  V30 4 C 3.3481 5.0172 0 0
M  V30 5 C 3.3481 3.5172 0 0
M  V30 6 C 4.6471 2.7672 0 0
M  V30 7 C 7.2452 2.7672 0 0 CFG=2
M  V30 8 C 7.2452 4.2672 0 0 CFG=2
M  V30 9 C 8.5442 5.0172 0 0 CFG=1
M  V30 10 C 7.2452 5.7672 0 0
M  V30 11 C 6.857 1.3183 0 0 CFG=2
M  V30 12 C 8.4143 1.9727 0 0 CFG=2
M  V30 13 C 9.418 3.0875 0 0
M  V30 14 C 8.737 4.424 0 0
M  V30 15 O 2.049 2.7672 0 0
M  V30 16 O 9.2831 0.75 0 0
M  V30 17 O 5.357 1.3183 0 0
M  V30 18 N 9.8433 4.2672 0 0
M  V30 19 C 8.5442 2.0172 0 0
M  V30 20 C 9.8433 2.7672 0 0
M  V30 21 C 11.1423 5.0172 0 0
M  V30 22 C 0.75 3.5172 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 7
M  V30 4 2 2 3
M  V30 5 1 2 10
M  V30 6 1 3 4
M  V30 7 2 4 5
M  V30 8 1 5 6
M  V30 9 1 5 15
M  V30 10 1 6 17
M  V30 11 1 7 8
M  V30 12 1 7 11
M  V30 13 1 7 19 CFG=1
M  V30 14 1 8 9
M  V30 15 1 8 14 CFG=1
M  V30 16 1 9 10 CFG=1
M  V30 17 1 9 18
M  V30 18 1 11 12
M  V30 19 1 11 17 CFG=3
M  V30 20 1 12 13
M  V30 21 1 12 16 CFG=3
M  V30 22 2 13 14
M  V30 23 1 15 22
M  V30 24 1 18 20
M  V30 25 1 18 21
M  V30 26 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 7 8 9 11 12) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
codeine

> <ID>
codeine

> <PRIMARY_SOM>
21

> <Citation>
Tateishi et al.,Drug Metab. Disp.,24,761,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
colchicine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4311 11.6221 0 0
M  V30 2 C 9.8645 11.18 0 0
M  V30 3 C 10.1982 9.7176 0 0
M  V30 4 C 9.0987 8.6973 0 0
M  V30 5 C 7.6653 9.1394 0 0
M  V30 6 C 7.3315 10.6018 0 0
M  V30 7 O 10.964 12.2002 0 0
M  V30 8 C 10.6302 13.6626 0 0
M  V30 9 O 11.6316 9.2754 0 0
M  V30 10 C 11.9654 7.8131 0 0
M  V30 11 O 9.4325 7.2349 0 0
M  V30 12 C 10.8658 6.7928 0 0
M  V30 13 C 5.9801 11.2527 0 0
M  V30 14 C 4.6286 10.6018 0 0
M  V30 15 C 4.2948 9.1394 0 0 CFG=2
M  V30 16 C 5.2301 7.9667 0 0
M  V30 17 C 6.7301 7.9667 0 0
M  V30 18 C 4.2948 6.7939 0 0
M  V30 19 C 7.6653 6.7939 0 0
M  V30 20 C 7.3315 5.3316 0 0
M  V30 21 C 4.6286 5.3315 0 0
M  V30 22 C 5.9801 4.6807 0 0
M  V30 23 O 3.4559 4.3963 0 0
M  V30 24 O 5.9801 3.1807 0 0
M  V30 25 C 7.2791 2.4307 0 0
M  V30 26 N 2.8324 8.8057 0 0
M  V30 27 C 1.8122 9.9052 0 0
M  V30 28 C 2.2543 11.3386 0 0
M  V30 29 O 0.3498 9.5714 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 2 2 3
M  V30 4 1 2 7
M  V30 5 1 3 4
M  V30 6 1 3 9
M  V30 7 2 4 5
M  V30 8 1 4 11
M  V30 9 1 5 6
M  V30 10 1 5 17
M  V30 11 1 6 13
M  V30 12 1 7 8
M  V30 13 1 9 10
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 15 26 CFG=3
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 21
M  V30 23 1 19 20
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 21 23
M  V30 27 1 22 24
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
colchicine

> <ID>
colchicine

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
10

> <Citation>
Soucek et al.,Biochem. Phamacol.,53,111,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
compound_1
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -0.75 -6 0 0
M  V30 2 C -0.75 -4.5 0 0
M  V30 3 C -2.049 -3.75 0 0
M  V30 4 C -3.3481 -4.5 0 0
M  V30 5 C -3.3481 -6 0 0
M  V30 6 C -2.049 -6.75 0 0
M  V30 7 C -4.6471 -6.75 0 0 CFG=1
M  V30 8 O -4.6471 -8.25 0 0
M  V30 9 C -5.9461 -6 0 0
M  V30 10 N -7.2452 -6.75 0 0
M  V30 11 C -8.5442 -6 0 0
M  V30 12 C -9.8433 -6.75 0 0
M  V30 13 C -11.1423 -6 0 0
M  V30 14 C -12.4413 -6.75 0 0
M  V30 15 C -13.7404 -6 0 0
M  V30 16 C -13.7404 -4.5 0 0
M  V30 17 C -12.4413 -3.75 0 0
M  V30 18 C -11.1423 -4.5 0 0
M  V30 19 N -15.0394 -3.75 0 0
M  V30 20 S -15.0394 -2.25 0 0
M  V30 21 O -15.0394 -0.75 0 0
M  V30 22 O -13.5394 -2.25 0 0
M  V30 23 C -16.5394 -2.25 0 0
M  V30 24 C -17.2894 -3.5491 0 0
M  V30 25 C -18.7894 -3.5491 0 0
M  V30 26 C -19.5394 -2.25 0 0
M  V30 27 C -18.7894 -0.951 0 0
M  V30 28 C -17.2894 -0.951 0 0
M  V30 29 C -21.0394 -2.25 0 0
M  V30 30 N -21.9211 -3.4636 0 0
M  V30 31 C -23.3477 -3 0 0
M  V30 32 C -23.3477 -1.5 0 0
M  V30 33 C -21.9211 -1.0365 0 0
M  V30 34 C -24.5612 -3.8817 0 0
M  V30 35 C -24.4044 -5.3735 0 0
M  V30 36 C -25.6179 -6.2552 0 0
M  V30 37 C -26.9883 -5.6451 0 0
M  V30 38 C -27.1451 -4.1533 0 0
M  V30 39 C -25.9315 -3.2716 0 0
M  V30 40 C -28.2018 -6.5268 0 0
M  V30 41 F -28.045 -8.0186 0 0
M  V30 42 F -29.5721 -5.9167 0 0
M  V30 43 F -29.4153 -7.4085 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 7 8 CFG=1
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 18
M  V30 16 2 14 15
M  V30 17 1 15 16
M  V30 18 2 16 17
M  V30 19 1 16 19
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 2 20 21
M  V30 23 2 20 22
M  V30 24 1 20 23
M  V30 25 1 23 24
M  V30 26 2 23 28
M  V30 27 2 24 25
M  V30 28 1 25 26
M  V30 29 2 26 27
M  V30 30 1 26 29
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 33
M  V30 34 1 30 31
M  V30 35 2 31 32
M  V30 36 1 31 34
M  V30 37 1 32 33
M  V30 38 1 34 35
M  V30 39 2 34 39
M  V30 40 2 35 36
M  V30 41 1 36 37
M  V30 42 2 37 38
M  V30 43 1 37 40
M  V30 44 1 38 39
M  V30 45 1 40 41
M  V30 46 1 40 42
M  V30 47 1 40 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
compound_1

> <ID>
compound_1

> <PRIMARY_SOM>
1

> <SECONDARY_SOM>
9

> <Citation>
Tang et al.,Drug Metab. Disp.,30,778,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
compound_A
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -13.0106 10.8905 0 0
M  V30 2 C -13.0106 12.3905 0 0
M  V30 3 C -14.3096 13.1405 0 0
M  V30 4 C -15.6087 12.3905 0 0
M  V30 5 N -15.6087 10.8905 0 0
M  V30 6 C -14.3096 10.1405 0 0
M  V30 7 C -11.7115 10.1405 0 0
M  V30 8 N -14.3096 8.6405 0 0
M  V30 9 C -11.7115 8.6405 0 0
M  V30 10 C -13.0106 7.8905 0 0
M  V30 11 C -13.0106 6.3905 0 0
M  V30 12 C -11.7115 5.6405 0 0
M  V30 13 C -11.7115 4.1405 0 0
M  V30 14 N -10.4125 3.3905 0 0
M  V30 15 C -9.0422 4.0006 0 0
M  V30 16 C -8.0385 2.8859 0 0
M  V30 17 N -8.7885 1.5868 0 0
M  V30 18 C -10.2557 1.8987 0 0
M  V30 19 O -11.3704 0.895 0 0
M  V30 20 C -8.1784 0.2165 0 0 CFG=2
M  V30 21 C -9.0601 -0.997 0 0
M  V30 22 C -8.45 -2.3673 0 0
M  V30 23 N -9.3316 -3.5809 0 0
M  V30 24 C -10.8234 -3.4241 0 0
M  V30 25 C -11.4335 -2.0537 0 0
M  V30 26 C -10.5518 -0.8402 0 0
M  V30 27 C -6.6866 0.0597 0 0
M  V30 28 C -5.8049 1.2732 0 0
M  V30 29 O -4.3131 1.1164 0 0
M  V30 30 O -6.415 2.6436 0 0
M  V30 31 O -11.7051 -4.6376 0 0
M  V30 32 C -13.1969 -4.4808 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 7
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 1 20 21
M  V30 24 1 20 27 CFG=1
M  V30 25 1 21 22
M  V30 26 2 21 26
M  V30 27 2 22 23
M  V30 28 1 23 24
M  V30 29 2 24 25
M  V30 30 1 24 31
M  V30 31 1 25 26
M  V30 32 1 27 28
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
compound_A

> <ID>
compound_A

> <PRIMARY_SOM>
4

> <SECONDARY_SOM>
2

> <Citation>
Cui et al.,Drug Metab. Disp.,32,848,2004

> <DOI>
10.1124/dmd.32.8.848

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
cp_195543
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0853 10.0112 0 0
M  V30 2 C 4.1845 7.7676 0 0
M  V30 3 C 11.9812 9.2548 0 0
M  V30 4 C 8.0878 11.5112 0 0
M  V30 5 C 4.1869 9.2676 0 0
M  V30 6 C 2.8842 7.0198 0 0 CFG=1
M  V30 7 C 1.5864 7.7719 0 0 CFG=2
M  V30 8 C 6.785 9.2633 0 0
M  V30 9 C 9.3831 9.2591 0 0
M  V30 10 C 10.6834 10.0069 0 0
M  V30 11 O 2.8891 10.0198 0 0
M  V30 12 C 6.79 12.2633 0 0
M  V30 13 C 5.4872 10.0155 0 0
M  V30 14 C 5.4823 7.0155 0 0
M  V30 15 C 9.388 12.259 0 0
M  V30 16 C 1.5889 9.2719 0 0
M  V30 17 C 0.2861 7.024 0 0
M  V30 18 C 6.7825 7.7633 0 0
M  V30 19 C 10.6858 11.5069 0 0
M  V30 20 O 6.7924 13.7633 0 0
M  V30 21 F 11.9787 7.7548 0 0
M  V30 22 F 13.2814 10.0026 0 0
M  V30 23 F 13.279 8.5026 0 0
M  V30 24 O 2.8817 5.5198 0 0
M  V30 25 O 5.4897 11.5155 0 0
M  V30 26 C 0.2836 5.524 0 0
M  V30 27 C -1.0166 4.7762 0 0
M  V30 28 C 1.5814 4.7719 0 0
M  V30 29 C -1.0191 3.2762 0 0
M  V30 30 C 1.579 3.2719 0 0
M  V30 31 C 0.2787 2.5241 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 1 1 8
M  V30 3 1 1 9
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 2 14
M  V30 7 1 3 10
M  V30 8 1 3 21
M  V30 9 1 3 22
M  V30 10 1 3 23
M  V30 11 1 4 12
M  V30 12 1 4 15
M  V30 13 1 5 11
M  V30 14 2 5 13
M  V30 15 1 6 7
M  V30 16 1 6 24 CFG=3
M  V30 17 1 7 16
M  V30 18 1 7 17 CFG=1
M  V30 19 1 8 13
M  V30 20 2 8 18
M  V30 21 2 9 10
M  V30 22 1 10 19
M  V30 23 1 11 16
M  V30 24 2 12 20
M  V30 25 1 12 25
M  V30 26 1 14 18
M  V30 27 2 15 19
M  V30 28 1 17 26
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 7) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
cp_195543

> <ID>
cp_195543

> <PRIMARY_SOM>
17

> <SECONDARY_SOM>
31

> <Citation>
Khojasteh-Bakht et al.,Xenobiotica,33,1201,2003

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
cp_199331
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -13.3692 -3 0 0
M  V30 2 C -13.3692 -1.5 0 0
M  V30 3 C -14.6682 -3.75 0 0 CFG=1
M  V30 4 C -12.0702 -3.75 0 0
M  V30 5 O -14.6682 -0.75 0 0
M  V30 6 C -12.0702 -0.75 0 0
M  V30 7 C -15.9673 -3 0 0 CFG=1
M  V30 8 O -14.6682 -5.25 0 0
M  V30 9 C -10.7711 -3 0 0
M  V30 10 C -15.9673 -1.5 0 0
M  V30 11 C -10.7711 -1.5 0 0
M  V30 12 C -17.2663 -3.75 0 0
M  V30 13 O -9.4721 -3.75 0 0
M  V30 14 C -17.2663 -5.25 0 0
M  V30 15 C -8.1731 -3 0 0
M  V30 16 C -18.5654 -6 0 0
M  V30 17 C -15.9673 -6 0 0
M  V30 18 C -6.874 -3.75 0 0
M  V30 19 C -18.5654 -7.5 0 0
M  V30 20 O -19.8644 -5.25 0 0
M  V30 21 C -15.9673 -7.5 0 0
M  V30 22 N -5.5037 -3.1399 0 0
M  V30 23 S -6.7172 -5.2418 0 0
M  V30 24 C -17.2663 -8.25 0 0
M  V30 25 C -21.1634 -6 0 0
M  V30 26 N -14.6682 -8.25 0 0
M  V30 27 C -4.5 -4.2546 0 0
M  V30 28 C -5.25 -5.5537 0 0
M  V30 29 S -14.6682 -9.75 0 0
M  V30 30 C -3 -4.2546 0 0
M  V30 31 C -4.5 -6.8527 0 0
M  V30 32 C -13.1682 -9.75 0 0
M  V30 33 O -14.6682 -11.25 0 0
M  V30 34 O -16.1682 -9.75 0 0
M  V30 35 C -2.25 -5.5537 0 0
M  V30 36 C -3 -6.8527 0 0
M  V30 37 F -12.4182 -11.0491 0 0
M  V30 38 F -12.4182 -8.451 0 0
M  V30 39 F -11.6682 -9.75 0 0
M  V30 40 F -0.75 -5.5537 0 0
M  V30 41 F -2.25 -8.1517 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=3
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 2 6 11
M  V30 11 1 7 10
M  V30 12 1 7 12 CFG=3
M  V30 13 1 9 11
M  V30 14 1 9 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 2 18 22
M  V30 24 1 18 23
M  V30 25 2 19 24
M  V30 26 1 20 25
M  V30 27 1 21 24
M  V30 28 1 21 26
M  V30 29 1 22 27
M  V30 30 1 23 28
M  V30 31 1 26 29
M  V30 32 2 27 28
M  V30 33 1 27 30
M  V30 34 1 28 31
M  V30 35 1 29 32
M  V30 36 2 29 33
M  V30 37 2 29 34
M  V30 38 2 30 35
M  V30 39 2 31 36
M  V30 40 1 32 37
M  V30 41 1 32 38
M  V30 42 1 32 39
M  V30 43 1 35 36
M  V30 44 1 35 40
M  V30 45 1 36 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 3 7) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
cp_199331

> <ID>
cp_199331

> <PRIMARY_SOM>
25

> <Citation>
Kuperman et al.,Drug Metab. Disp.,29,1403,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
cqa_206_291
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -0.3015 -11.0221 0 0
M  V30 2 C -0.3015 -9.5221 0 0 CFG=2
M  V30 3 C -1.6005 -11.7721 0 0
M  V30 4 C -1.6005 -13.2721 0 0
M  V30 5 C -0.3015 -14.0221 0 0
M  V30 6 C 0.9976 -13.2721 0 0
M  V30 7 C 0.9976 -11.7721 0 0
M  V30 8 C -2.8995 -11.0221 0 0
M  V30 9 N -3.0494 -13.6603 0 0
M  V30 10 C -3.7994 -12.3613 0 0
M  V30 11 C -3.6234 -15.0462 0 0
M  V30 12 C -5.1106 -15.242 0 0
M  V30 13 C -2.8995 -9.5221 0 0
M  V30 14 C -1.6005 -8.7721 0 0 CFG=1
M  V30 15 C 0.9976 -8.7721 0 0
M  V30 16 N -1.6005 -7.2721 0 0
M  V30 17 C -0.3015 -6.5221 0 0
M  V30 18 C 0.9976 -7.2721 0 0 CFG=1
M  V30 19 C -2.8995 -6.5221 0 0
M  V30 20 N 2.2966 -6.5221 0 0
M  V30 21 S 3.5957 -7.2721 0 0
M  V30 22 N 4.3457 -5.9731 0 0
M  V30 23 O 4.8947 -8.0221 0 0
M  V30 24 O 2.8457 -8.5712 0 0
M  V30 25 C 5.8457 -5.9731 0 0
M  V30 26 C 3.5957 -4.674 0 0
M  V30 27 C 6.5957 -4.674 0 0
M  V30 28 C 4.3457 -3.375 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 7
M  V30 4 1 2 14
M  V30 5 1 2 15 CFG=3
M  V30 6 2 3 4
M  V30 7 1 3 8
M  V30 8 1 4 5
M  V30 9 1 4 9
M  V30 10 2 5 6
M  V30 11 1 6 7
M  V30 12 2 8 10
M  V30 13 1 8 13
M  V30 14 1 9 10
M  V30 15 1 9 11
M  V30 16 1 11 12
M  V30 17 1 14 13 CFG=1
M  V30 18 1 14 16
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 1 16 19
M  V30 22 1 17 18
M  V30 23 1 18 20 CFG=1
M  V30 24 1 20 21
M  V30 25 1 21 22
M  V30 26 2 21 23
M  V30 27 2 21 24
M  V30 28 1 22 25
M  V30 29 1 22 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 14 18) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
cqa_206_291

> <ID>
cqa_206_291

> <PRIMARY_SOM>
26 25

> <Citation>
Ball et al.,Drug Metab. Disp.,20,56,1992

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
cyclobenzaprine
  SciTegic08102311032D

 21 23  0  0  0  0            999 V2000
    2.8553    9.2851    0.0000 C   0  0
    2.5215   10.7475    0.0000 C   0  0
    1.7557    8.2648    0.0000 C   0  0
    1.0882   11.1896    0.0000 C   0  0
    0.3224    8.7070    0.0000 C   0  0
   -0.0114   10.1694    0.0000 C   0  0
   -0.6129    7.5342    0.0000 C   0  0
   -2.1129    7.5342    0.0000 C   0  0
   -1.3629   10.8202    0.0000 C   0  0
   -2.7143   10.1694    0.0000 C   0  0
   -3.0481    8.7070    0.0000 C   0  0
   -2.6609    6.1379    0.0000 C   0  0
   -4.5313    8.4834    0.0000 C   0  0
    0.0380    6.1828    0.0000 C   0  0
   -4.1441    5.9143    0.0000 C   0  0
   -5.0793    7.0871    0.0000 C   0  0
   -0.8070    4.9434    0.0000 C   0  0
   -0.1562    3.5919    0.0000 C   0  0
   -1.0011    2.3526    0.0000 N   0  0
   -0.3503    1.0011    0.0000 C   0  0
   -2.4970    2.4647    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  2  4  2  0
  3  5  1  0
  4  6  1  0
  5  6  2  0
  5  7  1  0
  6  9  1  0
  7  8  1  0
  7 14  2  0
  8 11  2  0
  8 12  1  0
  9 10  2  0
 10 11  1  0
 11 13  1  0
 12 15  2  0
 13 16  2  0
 14 17  1  0
 15 16  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
M  END
> <Name>
cyclobenzaprine

> <ID>
cyclobenzaprine

> <PRIMARY_SOM>
21 20

> <Citation>
Wang et al.,Drug Metab. Disp.,24,786,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
cyclophosphamide
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3481 2.5272 0 0 CFG=2
M  V30 2 N 3.3481 4.0272 0 0
M  V30 3 N 4.8253 2.7877 0 0
M  V30 4 O 2.049 1.7772 0 0
M  V30 5 O 3.8611 1.1177 0 0
M  V30 6 C 5.3383 4.1972 0 0
M  V30 7 C 5.7895 1.6386 0 0
M  V30 8 Cl 7.3286 5.8672 0 0
M  V30 9 Cl 8.2309 0.75 0 0
M  V30 10 C 2.049 4.7772 0 0
M  V30 11 C 0.75 4.0272 0 0
M  V30 12 C 0.75 2.5272 0 0
M  V30 13 C 7.2667 1.8991 0 0
M  V30 14 C 6.8155 4.4577 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 10
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 4 12
M  V30 9 1 6 14
M  V30 10 1 7 13
M  V30 11 1 8 14
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
cyclophosphamide

> <ID>
cyclophosphamide

> <PRIMARY_SOM>
10

> <SECONDARY_SOM>
7 6

> <Citation>
Roy et al.,Drug Metab. Disp.,27,655,1999
Bohnenstengel et al.,Eur. J. Clin. Pharmacol.,51,297,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
cyclosporine_a
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 85 85 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -7.0881 -14.9767 0 0
M  V30 2 C -5.9956 -16.0045 0 0
M  V30 3 N -4.5653 -17.9566 0 0
M  V30 4 C -6.4385 -13.618 0 0 CFG=1
M  V30 5 C -4.8272 -19.4336 0 0
M  V30 6 N -2.4234 -19.0981 0 0
M  V30 7 C -1.2507 -20.0334 0 0
M  V30 8 N 1.4569 -19.5308 0 0
M  V30 9 C -6.9768 -12.2179 0 0
M  V30 10 N 3.9969 -11.6812 0 0
M  V30 11 C 3.997 -10.1812 0 0
M  V30 12 C -3.5034 -20.1391 0 0 CFG=1
M  V30 13 C -0.0055 -19.197 0 0 CFG=1
M  V30 14 N 2.8286 -8.2522 0 0
M  V30 15 N -0.7479 -7.6523 0 0
M  V30 16 C 2.2159 -18.237 0 0
M  V30 17 C 1.5049 -7.5466 0 0
M  V30 18 C -5.9956 -17.5045 0 0 CFG=1
M  V30 19 C 5.7579 -13.3514 0 0
M  V30 20 C -1.9931 -8.4887 0 0
M  V30 21 N -5.804 -11.2827 0 0
M  V30 22 N -4.2145 -9.4486 0 0
M  V30 23 C 5.4842 -11.8766 0 0 CFG=1
M  V30 24 C 2.5667 -9.7291 0 0 CFG=1
M  V30 25 C 0.4249 -8.5876 0 0 CFG=1
M  V30 26 C -5.5961 -8.8646 0 0
M  V30 27 N 4.4399 -14.0675 0 0
M  V30 28 N 4.5799 -17.6874 0 0
M  V30 29 C 3.8054 -16.4028 0 0
M  V30 30 C 3.5975 -18.821 0 0 CFG=1
M  V30 31 C -6.5785 -9.9981 0 0 CFG=1
M  V30 32 C -3.4555 -8.1548 0 0
M  V30 33 C -4.9397 -13.6772 0 0 CFG=1
M  V30 34 C 4.9782 -15.4676 0 0 CFG=1
M  V30 35 O -4.6186 -15.4095 0 0
M  V30 36 O -6.176 -20.0898 0 0
M  V30 37 O -1.312 -21.5321 0 0
M  V30 38 O 5.207 -9.2947 0 0
M  V30 39 O -8.4243 -11.8246 0 0
M  V30 40 C -0.98 -18.0566 0 0
M  V30 41 O 1.7438 -16.8132 0 0
M  V30 42 C -3.2961 -21.6247 0 0
M  V30 43 O 1.2976 -6.061 0 0
M  V30 44 O 7.112 -13.9968 0 0
M  V30 45 O -1.7193 -9.9635 0 0
M  V30 46 O -5.9357 -7.4035 0 0
M  V30 47 C 6.5164 -10.7883 0 0
M  V30 48 C 0.2339 -10.0754 0 0
M  V30 49 O 2.329 -16.1379 0 0
M  V30 50 C -7.2056 -18.3911 0 0
M  V30 51 C 1.4381 -10.7172 0 0
M  V30 52 C -8.5625 -15.2526 0 0
M  V30 53 C -1.942 -13.7955 0 0
M  V30 54 C -3.2823 -17.1795 0 0
M  V30 55 C -2.7426 -15.064 0 0
M  V30 56 C -2.4937 -17.5998 0 0
M  V30 57 C 2.052 -20.9077 0 0
M  V30 58 C 2.8693 -12.6704 0 0
M  V30 59 C -4.139 -12.4088 0 0 CFG=1
M  V30 60 C -0.6866 -6.1535 0 0
M  V30 61 O -4.2415 -15.0048 0 0
M  V30 62 C -3.7424 -10.8724 0 0
M  V30 63 C -8.073 -9.8696 0 0
M  V30 64 C 3.9372 -20.282 0 0
M  V30 65 C -2.6402 -12.4679 0 0
M  V30 66 C -4.4791 -22.547 0 0
M  V30 67 C -0.4797 -16.6425 0 0
M  V30 68 C -1.1501 -10.6539 0 0
M  V30 69 C 7.9751 -11.1381 0 0
M  V30 70 C 6.4257 -15.8609 0 0
M  V30 71 C -2.0444 -16.3916 0 0
M  V30 72 C 1.7295 -12.1886 0 0
M  V30 73 C 0.0181 -10.2338 0 0
M  V30 74 C -8.5783 -17.7865 0 0
M  V30 75 C -7.0428 -19.8823 0 0
M  V30 76 C -4.8372 -11.0811 0 0
M  V30 77 C -1.4541 -15.5022 0 0
M  V30 78 C 0.9952 -16.3688 0 0
M  V30 79 C -5.8693 -21.9838 0 0
M  V30 80 C -1.3411 -12.1417 0 0
M  V30 81 C -2.3431 -9.7446 0 0
M  V30 82 C -4.2718 -24.0326 0 0
M  V30 83 C 9.0073 -10.0497 0 0
M  V30 84 C 8.4015 -12.5762 0 0
M  V30 85 C -8.9315 -11.0997 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 4 1 CFG=1
M  V30 3 1 1 52
M  V30 4 1 2 18
M  V30 5 2 2 35
M  V30 6 1 3 5
M  V30 7 1 3 18
M  V30 8 1 3 54
M  V30 9 1 4 9
M  V30 10 1 4 33
M  V30 11 1 5 12
M  V30 12 2 5 36
M  V30 13 1 6 7
M  V30 14 1 6 12
M  V30 15 1 6 56
M  V30 16 1 7 13
M  V30 17 2 7 37
M  V30 18 1 8 13
M  V30 19 1 8 16
M  V30 20 1 8 57
M  V30 21 1 9 21
M  V30 22 2 9 39
M  V30 23 1 10 11
M  V30 24 1 10 23
M  V30 25 1 10 58
M  V30 26 1 11 24
M  V30 27 2 11 38
M  V30 28 1 12 42 CFG=1
M  V30 29 1 13 40 CFG=3
M  V30 30 1 14 17
M  V30 31 1 14 24
M  V30 32 1 15 20
M  V30 33 1 15 25
M  V30 34 1 15 60
M  V30 35 1 16 30
M  V30 36 2 16 41
M  V30 37 1 17 25
M  V30 38 2 17 43
M  V30 39 1 18 50 CFG=1
M  V30 40 1 19 23
M  V30 41 1 19 27
M  V30 42 2 19 44
M  V30 43 1 20 32
M  V30 44 2 20 45
M  V30 45 1 21 31
M  V30 46 1 22 26
M  V30 47 1 22 32
M  V30 48 1 22 62
M  V30 49 1 23 47 CFG=3
M  V30 50 1 24 51 CFG=3
M  V30 51 1 25 48 CFG=1
M  V30 52 1 26 31
M  V30 53 2 26 46
M  V30 54 1 27 34
M  V30 55 1 28 29
M  V30 56 1 28 30
M  V30 57 1 29 34
M  V30 58 2 29 49
M  V30 59 1 30 64 CFG=1
M  V30 60 1 31 63 CFG=3
M  V30 61 1 33 59
M  V30 62 1 33 61 CFG=1
M  V30 63 1 34 70 CFG=3
M  V30 64 1 40 67
M  V30 65 1 42 66
M  V30 66 1 47 69
M  V30 67 1 48 68
M  V30 68 1 50 74
M  V30 69 1 50 75
M  V30 70 1 51 72
M  V30 71 1 51 73
M  V30 72 2 53 55
M  V30 73 1 53 65
M  V30 74 1 55 71
M  V30 75 1 59 65
M  V30 76 1 59 76 CFG=3
M  V30 77 1 63 85
M  V30 78 1 66 79
M  V30 79 1 66 82
M  V30 80 1 67 77
M  V30 81 1 67 78
M  V30 82 1 68 80
M  V30 83 1 68 81
M  V30 84 1 69 83
M  V30 85 1 69 84
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(12 4 12 13 18 23 24 25 30 31 33 34 59) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
cyclosporine_a

> <ID>
cyclosporine_a

> <PRIMARY_SOM>
71

> <SECONDARY_SOM>
66

> <Citation>
Dai et al.,Biochem. Pharmacol.,68,1889,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
da_8159
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.8923 -3 0 0
M  V30 2 C 11.8923 -1.5 0 0
M  V30 3 C 13.3189 -3.4635 0 0
M  V30 4 N 10.5933 -3.75 0 0
M  V30 5 C 10.5933 -0.75 0 0
M  V30 6 N 13.3189 -1.0364 0 0
M  V30 7 N 14.2006 -2.25 0 0
M  V30 8 C 13.7824 -4.8901 0 0
M  V30 9 C 9.2942 -3 0 0
M  V30 10 N 9.2942 -1.5 0 0
M  V30 11 O 10.5933 0.75 0 0
M  V30 12 C 13.7824 0.3901 0 0
M  V30 13 C 15.2497 -5.2019 0 0
M  V30 14 C 7.9952 -3.75 0 0
M  V30 15 C 15.7132 -6.6285 0 0
M  V30 16 C 6.6962 -3 0 0
M  V30 17 C 7.9952 -5.25 0 0
M  V30 18 C 5.3971 -3.75 0 0
M  V30 19 O 6.6962 -1.5 0 0
M  V30 20 C 6.6962 -6 0 0
M  V30 21 C 5.3971 -5.25 0 0
M  V30 22 C 5.3971 -0.75 0 0
M  V30 23 S 6.6962 -7.5 0 0
M  V30 24 C 5.3971 0.75 0 0
M  V30 25 N 8.1962 -7.5 0 0
M  V30 26 O 5.1962 -7.5 0 0
M  V30 27 O 6.6962 -9 0 0
M  V30 28 C 4.0981 1.5 0 0
M  V30 29 C 8.9462 -8.799 0 0
M  V30 30 C 10.4462 -8.799 0 0
M  V30 31 C 11.1962 -10.098 0 0 CFG=1
M  V30 32 N 12.688 -10.2548 0 0
M  V30 33 C 10.5861 -11.4684 0 0
M  V30 34 C 12.9998 -11.722 0 0
M  V30 35 C 13.6917 -9.1401 0 0
M  V30 36 C 11.7008 -12.4721 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 6 7
M  V30 12 1 6 12
M  V30 13 1 8 13
M  V30 14 1 9 10
M  V30 15 1 9 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 2 17 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 1 20 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 23 26
M  V30 29 2 23 27
M  V30 30 1 24 28
M  V30 31 1 25 29
M  V30 32 1 29 30
M  V30 33 1 31 30 CFG=1
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 32 35
M  V30 38 1 33 36
M  V30 39 1 34 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 31) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
da_8159

> <ID>
da_8159

> <PRIMARY_SOM>
12

> <SECONDARY_SOM>
29

> <TERTIARY_SOM>
8 13 15 22 24 28

> <Citation>
Ji et al.,Xenobiotica,34,973,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
dehydropranidipine
  SciTegic08102311032D

 33 35  0  0  0  0            999 V2000
   -2.8726    8.5245    0.0000 C   0  0
   -1.5736    7.7745    0.0000 C   0  0
   -2.8726   10.0245    0.0000 C   0  0
   -4.1716    7.7745    0.0000 C   0  0
   -0.2745    8.5245    0.0000 C   0  0
   -1.5736    6.2745    0.0000 C   0  0
   -4.1716   10.7745    0.0000 C   0  0
   -1.5736   10.7745    0.0000 C   0  0
   -5.4707    8.5245    0.0000 C   0  0
   -4.1717    6.2745    0.0000 C   0  0
    1.0245    7.7745    0.0000 C   0  0
   -0.2745    5.5245    0.0000 C   0  0
   -5.4707   10.0245    0.0000 N   0  0
   -4.1716   12.2745    0.0000 C   0  0
   -1.5736   12.2745    0.0000 O   0  0
   -0.2745   10.0245    0.0000 O   0  0
   -6.7697    7.7745    0.0000 C   0  0
   -5.4707    5.5245    0.0000 O   0  0
   -2.8726    5.5245    0.0000 O   0  0
    1.0245    6.2745    0.0000 C   0  0
    2.3235    8.5245    0.0000 N   0  3
   -0.2745   13.0245    0.0000 C   0  0
   -5.4707    4.0245    0.0000 C   0  0
    2.3235   10.0245    0.0000 O   0  5
    3.6226    7.7745    0.0000 O   0  0
   -0.2745   14.5245    0.0000 C   0  0
    1.0245   15.2745    0.0000 C   0  0
    1.0245   16.7745    0.0000 C   0  0
    2.3235   17.5245    0.0000 C   0  0
   -0.2745   17.5245    0.0000 C   0  0
    2.3235   19.0245    0.0000 C   0  0
   -0.2745   19.0245    0.0000 C   0  0
    1.0245   19.7745    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  6 12  2  0
  7 13  2  0
  7 14  1  0
  8 15  1  0
  8 16  2  0
  9 13  1  0
  9 17  1  0
 10 18  1  0
 10 19  2  0
 11 20  2  0
 11 21  1  0
 12 20  1  0
 15 22  1  0
 18 23  1  0
 21 24  1  0
 21 25  2  0
 22 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 29 31  1  0
 30 32  2  0
 31 33  2  0
 32 33  1  0
M  CHG  2  21   1  24  -1
M  END
> <Name>
dehydropranidipine

> <ID>
dehydropranidipine

> <PRIMARY_SOM>
22

> <Citation>
Kudo et al.,Drug Metab. Disp.,27,303,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
delavirdine
  SciTegic08102311032D

 32 35  0  0  0  0            999 V2000
   15.2012   -7.0953    0.0000 C   0  0
   16.7012   -7.0901    0.0000 S   0  0
   18.2012   -7.0848    0.0000 O   0  0
   16.7064   -8.5901    0.0000 O   0  0
   16.6959   -5.5901    0.0000 N   0  0
   15.3943   -4.8446    0.0000 C   0  0
   15.3890   -3.3446    0.0000 C   0  0
   14.0979   -5.5992    0.0000 C   0  0
   12.7962   -4.8537    0.0000 C   0  0
   14.0874   -2.5992    0.0000 C   0  0
   12.7910   -3.3537    0.0000 C   0  0
   13.7704   -1.1331    0.0000 C   0  0
   11.6727   -2.3540    0.0000 N   0  0
   12.2780   -0.9815    0.0000 C   0  0
   11.5235    0.3149    0.0000 C   0  0
   10.0235    0.3096    0.0000 N   0  0
   12.2689    1.6165    0.0000 O   0  0
    9.2689    1.6060    0.0000 C   0  0
    9.2780   -0.9920    0.0000 C   0  0
    7.7690    1.6008    0.0000 C   0  0
    7.7781   -0.9973    0.0000 C   0  0
    7.0235    0.2991    0.0000 N   0  0
    5.5235    0.2939    0.0000 C   0  0
    4.7690    1.5903    0.0000 C   0  0
    3.2690    1.5850    0.0000 C   0  0
    2.5235    0.2834    0.0000 C   0  0
    3.2781   -1.0130    0.0000 C   0  0
    4.7781   -1.0078    0.0000 N   0  0
    5.5144    2.8919    0.0000 N   0  0
    4.7599    4.1883    0.0000 C   0  0
    5.5053    5.4900    0.0000 C   0  0
    3.2599    4.1831    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  7 10  1  0
  8  9  2  0
  9 11  1  0
 10 11  2  0
 10 12  1  0
 11 13  1  0
 12 14  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 16 19  1  0
 18 20  1  0
 19 21  1  0
 20 22  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 28  2  0
 24 25  2  0
 24 29  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
M  END
> <Name>
delavirdine

> <ID>
delavirdine

> <PRIMARY_SOM>
30

> <SECONDARY_SOM>
27

> <Citation>
Voorman et al.,Drug Metab. Disp.,26,631,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
deoxycholic_acid
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.2748 -3.4667 0 0
M  V30 2 C 10.1179 -1.975 0 0 CFG=2
M  V30 3 C 10.1178 -0.475 0 0 CFG=2
M  V30 4 C 11.5445 -2.4384 0 0 CFG=1
M  V30 5 C 8.8189 -2.725 0 0 CFG=2
M  V30 6 C 8.8187 0.275 0 0 CFG=1
M  V30 7 C 11.5444 -0.0114 0 0
M  V30 8 C 12.0081 -3.865 0 0 CFG=1
M  V30 9 C 12.4261 -1.2248 0 0
M  V30 10 O 8.819 -4.225 0 0
M  V30 11 C 7.5198 -1.9751 0 0
M  V30 12 C 7.5197 -0.4751 0 0 CFG=2
M  V30 13 C 8.8187 1.775 0 0
M  V30 14 C 13.4753 -4.1768 0 0
M  V30 15 C 11.0045 -4.9797 0 0
M  V30 16 C 6.2207 0.2748 0 0 CFG=2
M  V30 17 C 7.5196 2.5249 0 0
M  V30 18 C 13.9389 -5.6033 0 0
M  V30 19 C 6.2207 -1.2252 0 0
M  V30 20 C 6.2206 1.7748 0 0 CFG=1
M  V30 21 C 4.9217 -0.4752 0 0
M  V30 22 C 15.4062 -5.9151 0 0
M  V30 23 C 4.9215 2.5248 0 0
M  V30 24 C 3.6226 0.2747 0 0
M  V30 25 O 15.8698 -7.3417 0 0
M  V30 26 O 16.4098 -4.8003 0 0
M  V30 27 C 3.6225 1.7747 0 0 CFG=1
M  V30 28 O 2.3234 2.5246 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7 CFG=3
M  V30 7 1 4 8
M  V30 8 1 4 9 CFG=3
M  V30 9 1 5 10 CFG=3
M  V30 10 1 5 11
M  V30 11 1 6 12
M  V30 12 1 6 13 CFG=1
M  V30 13 1 7 9
M  V30 14 1 8 14
M  V30 15 1 8 15 CFG=1
M  V30 16 1 12 11 CFG=3
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 16 19 CFG=3
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 1 20 17 CFG=3
M  V30 24 1 18 22
M  V30 25 1 20 23
M  V30 26 1 21 24
M  V30 27 2 22 25
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 24 27
M  V30 31 1 27 28 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 2 3 4 5 6 8 12 16 20 27) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
deoxycholic_acid

> <ID>
deoxycholic_acid

> <PRIMARY_SOM>
27

> <Citation>
Bodin et al.,Biochim. Biophys. Acta.,1687,84,2005

> <DOI>
10.1016/j.bbalip.2004.11.003

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
deramciclane
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3505 -7.2933 0 0 CFG=1
M  V30 2 C 5.8141 -5.8667 0 0 CFG=2
M  V30 3 C 3.8505 -7.2933 0 0
M  V30 4 C 4.6005 -4.985 0 0
M  V30 5 C 3.387 -5.8667 0 0 CFG=1
M  V30 6 C 4.137 -8.175 0 0
M  V30 7 C 7.1844 -6.4768 0 0
M  V30 8 C 2.9235 -7.2933 0 0
M  V30 9 O 6.5641 -4.5677 0 0
M  V30 10 C 6.5641 -8.175 0 0
M  V30 11 N 5.814 -0.6705 0 0
M  V30 12 C 4.0073 -8.7851 0 0
M  V30 13 C 2.3833 -7.6052 0 0
M  V30 14 C 5.8141 -3.2686 0 0
M  V30 15 C 6.564 -1.9696 0 0
M  V30 16 C 7.3412 -7.9686 0 0
M  V30 17 C 8.3979 -5.5951 0 0
M  V30 18 C 6.564 0.6285 0 0
M  V30 19 C 4.314 -0.6705 0 0
M  V30 20 C 9.7682 -6.2052 0 0
M  V30 21 C 8.7115 -8.5787 0 0
M  V30 22 C 9.925 -7.697 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 1 10 CFG=1
M  V30 5 1 2 4
M  V30 6 1 2 7
M  V30 7 1 2 9 CFG=1
M  V30 8 1 3 5
M  V30 9 1 3 12
M  V30 10 1 3 13
M  V30 11 1 5 4 CFG=3
M  V30 12 1 5 8
M  V30 13 1 6 8
M  V30 14 2 7 16
M  V30 15 1 7 17
M  V30 16 1 9 14
M  V30 17 1 11 15
M  V30 18 1 11 18
M  V30 19 1 11 19
M  V30 20 1 14 15
M  V30 21 1 16 21
M  V30 22 2 17 20
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 5) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
deramciclane

> <ID>
deramciclane

> <PRIMARY_SOM>
19 18

> <Citation>
Laine et al.,Eur. J. Clin. Pharm.,59,761,2003

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
dexamethasone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.2746 -3.4672 0 0
M  V30 2 C 10.1178 -1.9755 0 0 CFG=2
M  V30 3 C 10.1178 -0.4755 0 0 CFG=2
M  V30 4 C 11.5444 -2.439 0 0 CFG=2
M  V30 5 C 8.8188 -2.7255 0 0
M  V30 6 C 8.8187 0.2745 0 0 CFG=1
M  V30 7 C 11.5444 -0.0119 0 0
M  V30 8 C 12.8434 -3.189 0 0
M  V30 9 O 10.9343 -3.8093 0 0
M  V30 10 C 12.4261 -1.2255 0 0 CFG=1
M  V30 11 C 7.5197 -1.9755 0 0 CFG=1
M  V30 12 C 7.5197 -0.4755 0 0 CFG=1
M  V30 13 C 8.8188 1.7745 0 0
M  V30 14 C 14.1425 -2.439 0 0
M  V30 15 O 12.8434 -4.689 0 0
M  V30 16 C 13.9261 -1.2255 0 0
M  V30 17 O 6.2207 -2.7255 0 0
M  V30 18 F 6.2207 -1.2255 0 0
M  V30 19 C 6.2207 0.2745 0 0 CFG=2
M  V30 20 C 7.5197 2.5245 0 0
M  V30 21 O 15.4415 -3.189 0 0
M  V30 22 C 5.9602 -1.2027 0 0
M  V30 23 C 6.2207 1.7745 0 0
M  V30 24 C 4.9216 -0.4755 0 0
M  V30 25 C 4.9216 2.5245 0 0
M  V30 26 C 3.6226 0.2745 0 0
M  V30 27 C 3.6226 1.7745 0 0
M  V30 28 O 2.3235 2.5245 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7 CFG=3
M  V30 7 1 4 8
M  V30 8 1 4 9 CFG=1
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 1 6 12
M  V30 12 1 6 13 CFG=1
M  V30 13 1 7 10
M  V30 14 1 8 14
M  V30 15 2 8 15
M  V30 16 1 10 16 CFG=1
M  V30 17 1 11 12
M  V30 18 1 11 17 CFG=3
M  V30 19 1 12 18 CFG=1
M  V30 20 1 12 19
M  V30 21 1 13 20
M  V30 22 1 14 21
M  V30 23 1 19 22 CFG=3
M  V30 24 1 19 23
M  V30 25 1 19 24
M  V30 26 1 20 23
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 2 3 4 6 10 11 12 19) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
dexamethasone

> <ID>
dexamethasone

> <PRIMARY_SOM>
20

> <Citation>
Gentile et al.,J. Pharmacol. Exp. Ther.,277,105,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
dexloxiglumide
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 30 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7673 0.6495 0 0 CFG=2
M  V30 2 C 10.7673 -0.8505 0 0
M  V30 3 N 9.4683 1.3995 0 0
M  V30 4 C 12.0663 1.3995 0 0
M  V30 5 N 12.0663 -1.6005 0 0
M  V30 6 O 9.4683 -1.6005 0 0
M  V30 7 C 9.4683 2.8995 0 0
M  V30 8 C 13.3654 0.6495 0 0
M  V30 9 C 12.0664 -3.1005 0 0
M  V30 10 C 13.3654 -0.8504 0 0
M  V30 11 C 8.1692 3.6495 0 0
M  V30 12 O 10.7673 3.6495 0 0
M  V30 13 C 14.6644 1.3995 0 0
M  V30 14 C 13.3654 -3.8505 0 0
M  V30 15 C 14.6644 -1.6004 0 0
M  V30 16 C 8.1692 5.1495 0 0
M  V30 17 C 6.8702 2.8995 0 0
M  V30 18 O 14.6644 2.8995 0 0
M  V30 19 O 15.9635 0.6496 0 0
M  V30 20 C 13.3654 -5.3505 0 0
M  V30 21 C 15.9635 -0.8504 0 0
M  V30 22 C 6.8702 5.8995 0 0
M  V30 23 C 5.5711 3.6495 0 0
M  V30 24 C 14.6644 -6.1005 0 0
M  V30 25 O 17.2625 -1.6004 0 0
M  V30 26 C 5.5711 5.1495 0 0
M  V30 27 Cl 6.8702 7.3995 0 0
M  V30 28 C 14.6644 -7.6004 0 0
M  V30 29 C 18.5615 -0.8504 0 0
M  V30 30 Cl 4.2721 5.8995 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 2 11 16
M  V30 16 1 11 17
M  V30 17 1 13 18
M  V30 18 2 13 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 1 16 22
M  V30 22 2 17 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 22 26
M  V30 26 1 22 27
M  V30 27 1 23 26
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
dexloxiglumide

> <ID>
dexloxiglumide

> <PRIMARY_SOM>
29

> <Citation>
Hall et al.,Biopharm. Drug Disp.,25,163,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
dextromethorphan
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8906 -5.9349 0 0
M  V30 2 C 6.8906 -4.4349 0 0
M  V30 3 C 5.5916 -6.6849 0 0
M  V30 4 C 4.2926 -5.9349 0 0
M  V30 5 C 4.2926 -4.4349 0 0
M  V30 6 C 5.5916 -3.6849 0 0
M  V30 7 C 5.5916 -2.1849 0 0 CFG=1
M  V30 8 C 6.8906 -1.4349 0 0
M  V30 9 C 6.8906 0.0651 0 0
M  V30 10 C 5.5916 0.8151 0 0
M  V30 11 C 4.2925 0.0651 0 0
M  V30 12 C 4.2925 -1.4349 0 0 CFG=2
M  V30 13 C 2.9935 -2.1849 0 0 CFG=2
M  V30 14 C 2.9935 -3.6849 0 0
M  V30 15 N 2.6053 -0.736 0 0
M  V30 16 C 5.5916 -0.6849 0 0
M  V30 17 C 3.9043 0.014 0 0
M  V30 18 C 1.2195 -0.162 0 0
M  V30 19 O 8.1897 -6.6849 0 0
M  V30 20 C 8.1897 -8.1849 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 2 2 6
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 1 5 14
M  V30 9 1 6 7
M  V30 10 1 7 8 CFG=3
M  V30 11 1 7 12
M  V30 12 1 7 16
M  V30 13 1 8 9
M  V30 14 1 9 10
M  V30 15 1 10 11
M  V30 16 1 12 11 CFG=1
M  V30 17 1 12 13
M  V30 18 1 13 14 CFG=3
M  V30 19 1 13 15
M  V30 20 1 15 17
M  V30 21 1 15 18
M  V30 22 1 16 17
M  V30 23 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 12 13) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
dextromethorphan

> <ID>
dextromethorphan

> <PRIMARY_SOM>
18

> <Citation>
Wang and Unadkat,Biopharm. Drug Disp.,20,341,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
dextropropoxyphene
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6471 -5.9683 0 0 CFG=2
M  V30 2 C 3.3481 -5.2183 0 0
M  V30 3 C 6.1243 -6.2287 0 0
M  V30 4 C 3.8971 -7.2673 0 0 CFG=1
M  V30 5 O 5.3971 -4.6692 0 0
M  V30 6 C 3.3481 -3.7183 0 0
M  V30 7 C 2.0491 -5.9683 0 0
M  V30 8 C 6.6374 -7.6383 0 0
M  V30 9 C 2.3971 -7.2673 0 0
M  V30 10 C 4.6471 -8.5664 0 0
M  V30 11 C 6.8971 -4.6692 0 0
M  V30 12 C 2.049 -2.9683 0 0
M  V30 13 C 0.75 -5.2183 0 0
M  V30 14 C 8.1146 -7.8988 0 0
M  V30 15 C 5.6732 -8.7874 0 0
M  V30 16 N 1.6471 -8.5664 0 0
M  V30 17 C 7.6471 -3.3702 0 0
M  V30 18 O 7.6471 -5.9683 0 0
M  V30 19 C 0.75 -3.7183 0 0
M  V30 20 C 8.6276 -9.3083 0 0
M  V30 21 C 6.1862 -10.1969 0 0
M  V30 22 C 0.1471 -8.5664 0 0
M  V30 23 C 2.3971 -9.8654 0 0
M  V30 24 C 9.1471 -3.3702 0 0
M  V30 25 C 7.6635 -10.4574 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 2 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 4 10 CFG=3
M  V30 10 1 5 11
M  V30 11 1 6 12
M  V30 12 2 7 13
M  V30 13 2 8 14
M  V30 14 1 8 15
M  V30 15 1 9 16
M  V30 16 1 11 17
M  V30 17 2 11 18
M  V30 18 2 12 19
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 2 15 21
M  V30 22 1 16 22
M  V30 23 1 16 23
M  V30 24 1 17 24
M  V30 25 2 20 25
M  V30 26 1 21 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
dextropropoxyphene

> <ID>
dextropropoxyphene

> <PRIMARY_SOM>
23 22

> <Citation>
Somogyi et al.,Xenobiotica,34,875,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
dhea
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8096 4.5655 0 0 CFG=2
M  V30 2 C 3.8096 6.0655 0 0 CFG=1
M  V30 3 C 2.5106 3.8155 0 0 CFG=1
M  V30 4 C 5.1086 3.8155 0 0
M  V30 5 C 5.1086 6.8155 0 0 CFG=2
M  V30 6 C 2.5105 6.8155 0 0
M  V30 7 C 1.2115 4.5655 0 0 CFG=2
M  V30 8 C 2.1987 2.3483 0 0
M  V30 9 C 6.4077 4.5655 0 0
M  V30 10 C 6.4077 6.0655 0 0
M  V30 11 C 5.1086 8.3155 0 0
M  V30 12 C 3.8096 7.5655 0 0
M  V30 13 C 1.2115 6.0655 0 0
M  V30 14 C 0.0968 3.5618 0 0
M  V30 15 C -0.1588 5.1756 0 0
M  V30 16 C 0.7069 2.1915 0 0
M  V30 17 C 7.7067 6.8155 0 0
M  V30 18 C 6.4077 9.0655 0 0
M  V30 19 O -1.3704 3.8737 0 0
M  V30 20 C 7.7067 8.3155 0 0 CFG=2
M  V30 21 O 9.0057 9.0655 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=3
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 5 12 CFG=3
M  V30 12 1 6 13
M  V30 13 1 7 13
M  V30 14 1 7 14
M  V30 15 1 7 15 CFG=3
M  V30 16 1 8 16
M  V30 17 2 9 10
M  V30 18 1 10 17
M  V30 19 1 11 18
M  V30 20 1 14 16
M  V30 21 2 14 19
M  V30 22 1 17 20
M  V30 23 1 18 20
M  V30 24 1 20 21 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 1 2 3 5 7 20) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
dhea

> <ID>
dhea

> <PRIMARY_SOM>
16

> <SECONDARY_SOM>
4

> <Citation>
Miller et al.,Drug Metab. Disp.,32,305,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
diazepam
  SciTegic08102311032D

 20 22  0  0  0  0            999 V2000
   -0.4309    4.7726    0.0000 C   0  0
   -1.5305    3.7523    0.0000 C   0  0
   -2.9638    4.1944    0.0000 C   0  0
   -3.2977    5.6568    0.0000 C   0  0
   -2.1982    6.6771    0.0000 C   0  0
   -0.7648    6.2350    0.0000 C   0  0
    0.3347    7.2553    0.0000 Cl  0  0
   -4.6492    6.3075    0.0000 C   0  0
   -3.8990    3.0216    0.0000 N   0  0
   -3.2481    1.6702    0.0000 C   0  0
   -6.0498    1.6700    0.0000 O   0  0
   -5.3990    3.0215    0.0000 C   0  0
   -6.3343    4.1942    0.0000 C   0  0
   -6.0006    5.6566    0.0000 N   0  0
   -4.6493    7.8075    0.0000 C   0  0
   -3.3503    8.5576    0.0000 C   0  0
   -5.9483    8.5575    0.0000 C   0  0
   -3.3503   10.0576    0.0000 C   0  0
   -5.9484   10.0575    0.0000 C   0  0
   -4.6494   10.8075    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  3  4  1  0
  3  9  1  0
  4  5  2  0
  4  8  1  0
  5  6  1  0
  6  7  1  0
  8 14  2  0
  8 15  1  0
  9 10  1  0
  9 12  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 15 16  2  0
 15 17  1  0
 16 18  1  0
 17 19  2  0
 18 20  2  0
 19 20  1  0
M  END
> <Name>
diazepam

> <ID>
diazepam

> <PRIMARY_SOM>
13

> <SECONDARY_SOM>
10

> <Citation>
Yang et al.,Drug Metab. Disp.,27,102,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
diclofenac
  SciTegic08102311032D

 19 20  0  0  0  0            999 V2000
    5.5710    2.1498    0.0000 C   0  0
    5.5710    3.6498    0.0000 C   0  0
    4.2719    4.3997    0.0000 C   0  0
    2.9729    3.6497    0.0000 C   0  0
    2.9730    2.1497    0.0000 C   0  0
    4.2720    1.3997    0.0000 C   0  0
    6.8700    4.3999    0.0000 Cl  0  0
    4.2721   -0.1003    0.0000 Cl  0  0
    6.8701    1.3999    0.0000 N   0  0
    6.8702   -0.1001    0.0000 C   0  0
    8.1693   -0.8501    0.0000 C   0  0
    8.1694   -2.3501    0.0000 C   0  0
    6.8704   -3.1001    0.0000 C   0  0
    5.5713   -2.3502    0.0000 C   0  0
    5.5712   -0.8502    0.0000 C   0  0
    9.4683   -0.1000    0.0000 C   0  0
   10.7674   -0.8499    0.0000 C   0  0
   12.0663   -0.0999    0.0000 O   0  0
   10.7674   -2.3499    0.0000 O   0  0
  1  2  1  0
  1  6  2  0
  1  9  1  0
  2  3  2  0
  2  7  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  8  1  0
  9 10  1  0
 10 11  1  0
 10 15  2  0
 11 12  2  0
 11 16  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
M  END
> <Name>
diclofenac

> <ID>
diclofenac

> <PRIMARY_SOM>
13

> <Citation>
Tang et al.,Chem. Res. Toxicol.,12,192,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
digitoxin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 54 61 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1516 8.4747 0 0 CFG=2
M  V30 2 C 2.1516 9.9747 0 0 CFG=1
M  V30 3 C 0.8525 7.7247 0 0 CFG=1
M  V30 4 C 3.2663 7.471 0 0
M  V30 5 O 3.5219 9.0848 0 0
M  V30 6 C 0.8525 10.7247 0 0 CFG=1
M  V30 7 C 3.4506 10.7247 0 0
M  V30 8 C 1.1644 6.2574 0 0 CFG=2
M  V30 9 C -0.4465 8.4747 0 0
M  V30 10 C -0.361 6.843 0 0
M  V30 11 C 2.6562 6.1006 0 0
M  V30 12 C 0.8525 12.2247 0 0 CFG=2
M  V30 13 C -0.4465 9.9747 0 0
M  V30 14 C 3.4506 12.2247 0 0
M  V30 15 C 0.1607 5.1427 0 0
M  V30 16 C 2.1516 12.9747 0 0 CFG=2
M  V30 17 C -0.4465 12.9747 0 0
M  V30 18 C -0.4465 11.4747 0 0
M  V30 19 C -1.3311 5.2995 0 0
M  V30 20 C 0.4726 3.6755 0 0
M  V30 21 C 2.1516 14.4747 0 0
M  V30 22 C -0.4465 14.4747 0 0
M  V30 23 O -1.9412 3.9292 0 0
M  V30 24 C -0.8265 2.9255 0 0
M  V30 25 C 0.8525 15.2247 0 0 CFG=2
M  V30 26 O -0.9832 1.4337 0 0
M  V30 27 O 0.8525 16.7247 0 0
M  V30 28 C 2.1516 17.4747 0 0 CFG=1
M  V30 29 C 2.1516 18.9747 0 0
M  V30 30 O 3.4506 16.7247 0 0
M  V30 31 C 3.4506 19.7247 0 0 CFG=1
M  V30 32 C 4.7496 17.4747 0 0 CFG=1
M  V30 33 C 4.7496 18.9747 0 0 CFG=1
M  V30 34 O 3.4506 21.2247 0 0
M  V30 35 C 6.0487 16.7247 0 0
M  V30 36 O 6.0487 19.7247 0 0
M  V30 37 C 6.0487 21.2247 0 0 CFG=1
M  V30 38 C 7.3477 21.9747 0 0
M  V30 39 O 4.7496 21.9747 0 0
M  V30 40 C 7.3477 23.4747 0 0 CFG=1
M  V30 41 C 4.7496 23.4747 0 0 CFG=1
M  V30 42 C 6.0487 24.2247 0 0 CFG=1
M  V30 43 O 8.6467 24.2247 0 0
M  V30 44 C 3.4506 24.2247 0 0
M  V30 45 O 6.0487 25.7247 0 0
M  V30 46 C 7.3477 26.4747 0 0 CFG=2
M  V30 47 C 7.3477 27.9747 0 0
M  V30 48 O 8.6467 25.7247 0 0
M  V30 49 C 8.6467 28.7247 0 0 CFG=1
M  V30 50 C 9.9458 26.4747 0 0 CFG=1
M  V30 51 C 9.9458 27.9747 0 0 CFG=1
M  V30 52 O 8.6467 30.2247 0 0
M  V30 53 C 11.2448 25.7247 0 0
M  V30 54 O 11.2448 28.7247 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 2 7 CFG=1
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 3 10 CFG=3
M  V30 10 1 4 11
M  V30 11 1 6 12
M  V30 12 1 6 13 CFG=3
M  V30 13 1 7 14
M  V30 14 1 8 11
M  V30 15 1 8 15 CFG=3
M  V30 16 1 9 13
M  V30 17 1 12 16
M  V30 18 1 12 17
M  V30 19 1 12 18 CFG=3
M  V30 20 1 16 14 CFG=1
M  V30 21 1 15 19
M  V30 22 2 15 20
M  V30 23 1 16 21
M  V30 24 1 17 22
M  V30 25 1 19 23
M  V30 26 1 20 24
M  V30 27 1 21 25
M  V30 28 1 22 25
M  V30 29 1 23 24
M  V30 30 2 24 26
M  V30 31 1 25 27 CFG=3
M  V30 32 1 28 27 CFG=1
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 31 34 CFG=3
M  V30 39 1 32 33
M  V30 40 1 32 35 CFG=1
M  V30 41 1 33 36 CFG=3
M  V30 42 1 37 36 CFG=3
M  V30 43 1 37 38
M  V30 44 1 37 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 1 40 43 CFG=1
M  V30 49 1 41 42
M  V30 50 1 41 44 CFG=3
M  V30 51 1 42 45 CFG=1
M  V30 52 1 46 45 CFG=3
M  V30 53 1 46 47
M  V30 54 1 46 48
M  V30 55 1 47 49
M  V30 56 1 48 50
M  V30 57 1 49 51
M  V30 58 1 49 52 CFG=3
M  V30 59 1 50 51
M  V30 60 1 50 53 CFG=1
M  V30 61 1 51 54 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(20 1 2 3 6 8 12 16 25 28 31 32 33 37 40 41  -
M  V30 42 46 49 50 51) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
digitoxin

> <ID>
digitoxin

> <PRIMARY_SOM>
46

> <Citation>
Eberhart et al.,Molec. Pharm.,40,859,1992

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
dihydrocodeine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -1.5531 6.3099 0 0 CFG=2
M  V30 2 C -1.5531 7.8099 0 0
M  V30 3 C -2.8522 5.5599 0 0 CFG=2
M  V30 4 C -0.2541 5.5599 0 0 CFG=1
M  V30 5 C -1.5531 4.8099 0 0
M  V30 6 C -0.1042 8.1981 0 0
M  V30 7 C -2.8522 8.5599 0 0
M  V30 8 C -4.1512 6.3099 0 0 CFG=1
M  V30 9 C -2.8522 4.0599 0 0
M  V30 10 O 0.6458 6.8991 0 0
M  V30 11 C -0.2541 4.0599 0 0 CFG=2
M  V30 12 C -3.2404 4.111 0 0
M  V30 13 C -0.2376 9.724 0 0
M  V30 14 C -4.1512 7.8099 0 0
M  V30 15 C -2.7737 10.0578 0 0
M  V30 16 N -4.5394 4.861 0 0
M  V30 17 C -1.5531 3.3099 0 0
M  V30 18 O 1.0449 3.3099 0 0
M  V30 19 C -1.4034 10.6679 0 0
M  V30 20 O 1.0868 10.4281 0 0
M  V30 21 C -5.9253 4.287 0 0
M  V30 22 C 1.1392 11.9272 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5 CFG=3
M  V30 5 2 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 3 9 CFG=1
M  V30 9 1 4 10 CFG=1
M  V30 10 1 4 11
M  V30 11 1 5 12
M  V30 12 1 6 10
M  V30 13 1 6 13
M  V30 14 1 7 14
M  V30 15 2 7 15
M  V30 16 1 8 14 CFG=3
M  V30 17 1 8 16
M  V30 18 1 9 17
M  V30 19 1 11 17
M  V30 20 1 11 18 CFG=1
M  V30 21 1 12 16
M  V30 22 2 13 19
M  V30 23 1 13 20
M  V30 24 1 15 19
M  V30 25 1 16 21
M  V30 26 1 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 3 4 8 11) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
dihydrocodeine

> <ID>
dihydrocodeine

> <PRIMARY_SOM>
21

> <Citation>
Kirkwood et al.,Br. J. Clin. Pharm.,45,549,1997

> <DOI>
10.1046/j.1365-2125.1997.t01-1-00626.x.

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
diltiazem
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5986 -8.5883 0 0
M  V30 2 C 7.0328 -9.0275 0 0
M  V30 3 C 8.1303 -8.005 0 0
M  V30 4 C 7.7935 -6.5433 0 0
M  V30 5 C 6.3593 -6.1041 0 0
M  V30 6 C 5.2618 -7.1266 0 0
M  V30 7 N 3.909 -6.4786 0 0
M  V30 8 C 2.5589 -7.1321 0 0
M  V30 9 C 2.2281 -8.5952 0 0 CFG=1
M  V30 10 C 3.1657 -9.7661 0 0 CFG=1
M  V30 11 S 4.6657 -9.763 0 0
M  V30 12 C 3.9059 -4.9786 0 0
M  V30 13 C 2.6054 -4.2312 0 0
M  V30 14 N 2.6023 -2.7312 0 0
M  V30 15 C 1.3017 -1.9839 0 0
M  V30 16 C 3.8998 -1.9786 0 0
M  V30 17 O 1.3842 -6.1993 0 0
M  V30 18 O 0.7664 -8.932 0 0
M  V30 19 C -0.2561 -7.8345 0 0
M  V30 20 C 0.1831 -6.4003 0 0
M  V30 21 O -1.7178 -8.1713 0 0
M  V30 22 C 2.5177 -11.1188 0 0
M  V30 23 C 3.3652 -12.3565 0 0
M  V30 24 C 2.7171 -13.7092 0 0
M  V30 25 C 1.2216 -13.8244 0 0
M  V30 26 C 0.374 -12.5868 0 0
M  V30 27 C 1.0221 -11.234 0 0
M  V30 28 O 0.5735 -15.1772 0 0
M  V30 29 C -0.9221 -15.2923 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 11
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 7 12
M  V30 11 1 8 9
M  V30 12 2 8 17
M  V30 13 1 9 10
M  V30 14 1 9 18 CFG=1
M  V30 15 1 10 11
M  V30 16 1 10 22 CFG=1
M  V30 17 1 12 13
M  V30 18 1 13 14
M  V30 19 1 14 15
M  V30 20 1 14 16
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 1 22 23
M  V30 25 2 22 27
M  V30 26 2 23 24
M  V30 27 1 24 25
M  V30 28 2 25 26
M  V30 29 1 25 28
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 10) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
diltiazem

> <ID>
diltiazem

> <PRIMARY_SOM>
16 15

> <Citation>
Sutton et al.,J. Pham. Exp. Ther.,282,294,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
disopyramide
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -3.4486 -4.4731 0 0
M  V30 2 C -4.7476 -3.7231 0 0
M  V30 3 C -6.0466 -4.4731 0 0
M  V30 4 N -4.7476 -2.2231 0 0
M  V30 5 C -6.0466 -1.4731 0 0
M  V30 6 C -6.0466 0.0269 0 0
M  V30 7 C -7.3457 0.7769 0 0 CFG=2
M  V30 8 C -6.5957 2.076 0 0
M  V30 9 N -7.3457 3.375 0 0
M  V30 10 O -5.0957 2.076 0 0
M  V30 11 C -8.6447 1.5269 0 0
M  V30 12 C -8.6447 3.0269 0 0
M  V30 13 C -9.9438 3.7769 0 0
M  V30 14 C -11.2428 3.0269 0 0
M  V30 15 C -11.2428 1.5269 0 0
M  V30 16 C -9.9438 0.7769 0 0
M  V30 17 C -8.0957 -0.5221 0 0
M  V30 18 C -9.5957 -0.5221 0 0
M  V30 19 C -10.3457 -1.8212 0 0
M  V30 20 C -9.5957 -3.1202 0 0
M  V30 21 C -8.0957 -3.1202 0 0
M  V30 22 N -7.3457 -1.8212 0 0
M  V30 23 C -3.4486 -1.4731 0 0
M  V30 24 C -3.4486 0.0269 0 0
M  V30 25 C -2.1495 -2.2231 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 4 5
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 1 7 6 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 11
M  V30 10 1 7 17
M  V30 11 1 8 9
M  V30 12 2 8 10
M  V30 13 1 11 12
M  V30 14 2 11 16
M  V30 15 2 12 13
M  V30 16 1 13 14
M  V30 17 2 14 15
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 2 17 22
M  V30 21 2 18 19
M  V30 22 1 19 20
M  V30 23 2 20 21
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
disopyramide

> <ID>
disopyramide

> <PRIMARY_SOM>
23 2

> <Citation>
Eichizen et al.,Drug Metab. Disp.,28,937,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
docetaxel
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 58 63 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.9329 -9.4603 0 0 CFG=1
M  V30 2 C 3.4457 -9.6561 0 0 CFG=1
M  V30 3 C 5.8461 -10.6503 0 0 CFG=2
M  V30 4 C 6.1229 -8.5471 0 0
M  V30 5 O 4.8446 -11.4834 0 0
M  V30 6 C 2.8717 -8.2703 0 0 CFG=1
M  V30 7 C 2.8717 -11.0419 0 0 CFG=1
M  V30 8 O 7.0361 -9.7372 0 0
M  V30 9 C 5.272 -12.0361 0 0
M  V30 10 C 6.309 -11.808 0 0
M  V30 11 C 1.4859 -7.6962 0 0 CFG=1
M  V30 12 O 3.9324 -7.2096 0 0
M  V30 13 C 3.7849 -12.2319 0 0 CFG=2
M  V30 14 C 1.4859 -11.6159 0 0
M  V30 15 C 2.4835 -12.4908 0 0
M  V30 16 C 7.3224 -10.7021 0 0
M  V30 17 O 6.7601 -13.2386 0 0
M  V30 18 C 0.1001 -8.2703 0 0
M  V30 19 C 2.6265 -8.6704 0 0
M  V30 20 O 2.7649 -8.48 0 0
M  V30 21 C 3.5441 -5.7607 0 0
M  V30 22 O 3.2108 -13.6177 0 0
M  V30 23 C 0.1001 -11.0419 0 0 CFG=1
M  V30 24 O 1.4859 -13.1159 0 0
M  V30 25 C -0.474 -9.6561 0 0
M  V30 26 C -0.0957 -6.7831 0 0
M  V30 27 C -1.3871 -8.0745 0 0
M  V30 28 C 2.2763 -10.129 0 0 CFG=1
M  V30 29 C 4.6048 -4.7 0 0
M  V30 30 O 2.0953 -5.3725 0 0
M  V30 31 O -0.9606 -12.1026 0 0
M  V30 32 C 0.8178 -10.4791 0 0
M  V30 33 O 4.639 -12.4916 0 0
M  V30 34 C 6.0537 -5.0883 0 0
M  V30 35 C 4.2166 -3.2511 0 0
M  V30 36 C 0.5702 -11.9585 0 0
M  V30 37 C 4.005 -13.851 0 0
M  V30 38 C 7.1144 -4.0276 0 0
M  V30 39 C 5.2772 -2.1905 0 0
M  V30 40 C 4.639 -15.2105 0 0 CFG=1
M  V30 41 O 2.5107 -13.9818 0 0
M  V30 42 C 6.7261 -2.5787 0 0
M  V30 43 C 3.7786 -16.4392 0 0 CFG=2
M  V30 44 O 6.1333 -15.3412 0 0
M  V30 45 C 2.2843 -16.3085 0 0
M  V30 46 N 4.4125 -17.7987 0 0
M  V30 47 C 1.424 -17.5372 0 0
M  V30 48 C 1.6504 -14.949 0 0
M  V30 49 C 5.9068 -17.9294 0 0
M  V30 50 C -0.0703 -17.4065 0 0
M  V30 51 C 0.1561 -14.8183 0 0
M  V30 52 O 6.5408 -19.2889 0 0
M  V30 53 O 6.7672 -16.7007 0 0
M  V30 54 C -0.7043 -16.0471 0 0
M  V30 55 C 8.0351 -19.4196 0 0
M  V30 56 C 8.669 -20.7791 0 0
M  V30 57 C 8.8954 -18.1909 0 0
M  V30 58 C 9.5294 -19.5503 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5 CFG=1
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8 CFG=3
M  V30 8 1 3 9
M  V30 9 1 4 8
M  V30 10 1 5 10
M  V30 11 1 6 11
M  V30 12 1 6 12 CFG=1
M  V30 13 1 7 13
M  V30 14 1 7 14
M  V30 15 1 7 15 CFG=3
M  V30 16 1 9 13
M  V30 17 1 10 16
M  V30 18 2 10 17
M  V30 19 1 11 18
M  V30 20 1 11 19
M  V30 21 1 11 20 CFG=1
M  V30 22 1 12 21
M  V30 23 1 13 22 CFG=3
M  V30 24 1 14 23
M  V30 25 2 14 24
M  V30 26 1 18 25
M  V30 27 1 18 26
M  V30 28 1 18 27
M  V30 29 1 19 28
M  V30 30 1 21 29
M  V30 31 2 21 30
M  V30 32 1 23 25
M  V30 33 1 23 31 CFG=3
M  V30 34 2 25 32
M  V30 35 1 28 32
M  V30 36 1 28 33 CFG=3
M  V30 37 2 29 34
M  V30 38 1 29 35
M  V30 39 1 32 36
M  V30 40 1 33 37
M  V30 41 1 34 38
M  V30 42 2 35 39
M  V30 43 1 37 40
M  V30 44 2 37 41
M  V30 45 2 38 42
M  V30 46 1 39 42
M  V30 47 1 40 43
M  V30 48 1 40 44 CFG=3
M  V30 49 1 43 45
M  V30 50 1 43 46 CFG=1
M  V30 51 2 45 47
M  V30 52 1 45 48
M  V30 53 1 46 49
M  V30 54 1 47 50
M  V30 55 2 48 51
M  V30 56 1 49 52
M  V30 57 2 49 53
M  V30 58 2 50 54
M  V30 59 1 51 54
M  V30 60 1 52 55
M  V30 61 1 55 56
M  V30 62 1 55 57
M  V30 63 1 55 58
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 1 2 3 6 7 11 13 23 28 40 43) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
docetaxel

> <ID>
docetaxel

> <PRIMARY_SOM>
58 57 56

> <Citation>
Cresteil et al.,Drug Metab. Disp.,30,438,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
domperidone
  SciTegic08102311032D

 30 34  0  0  0  0            999 V2000
    6.3482   -2.9880    0.0000 N   0  0
    4.9216   -2.5245    0.0000 C   0  0
    6.8118   -4.4146    0.0000 C   0  0
    7.2299   -1.7745    0.0000 C   0  0
    4.9216   -1.0245    0.0000 C   0  0
    3.6226   -3.2745    0.0000 C   0  0
    5.8081   -5.5293    0.0000 C   0  0
    8.2790   -4.7265    0.0000 C   0  0
    6.3482   -0.5610    0.0000 N   0  0
    8.7299   -1.7745    0.0000 O   0  0
    3.6226   -0.2745    0.0000 C   0  0
    2.3236   -2.5245    0.0000 C   0  0
    6.2716   -6.9559    0.0000 C   0  0
    8.7425   -6.1531    0.0000 C   0  0
    2.3236   -1.0245    0.0000 C   0  0
    7.7388   -7.2678    0.0000 N   0  0
    1.0245   -0.2745    0.0000 Cl  0  0
    8.2023   -8.6944    0.0000 C   0  0
    9.6696   -9.0062    0.0000 C   0  0
   10.1331  -10.4328    0.0000 C   0  0
   11.6003  -10.7447    0.0000 N   0  0
   12.2104  -12.1150    0.0000 C   0  0
   12.7150   -9.7410    0.0000 C   0  0
   13.7022  -11.9582    0.0000 C   0  0
   11.6003  -13.4853    0.0000 C   0  0
   14.0141  -10.4910    0.0000 N   0  0
   12.5582   -8.2492    0.0000 O   0  0
   14.5839  -13.1717    0.0000 C   0  0
   12.4820  -14.6989    0.0000 C   0  0
   13.9738  -14.5421    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  4 10  2  0
  5  9  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  8 14  1  0
 11 15  2  0
 12 15  1  0
 13 16  1  0
 14 16  1  0
 15 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 22 24  2  0
 22 25  1  0
 23 26  1  0
 23 27  2  0
 24 26  1  0
 24 28  1  0
 25 29  2  0
 28 30  2  0
 29 30  1  0
M  END
> <Name>
domperidone

> <ID>
domperidone

> <PRIMARY_SOM>
30

> <SECONDARY_SOM>
18

> <Citation>
Ward et al.,Br. J. Clin. Pharm.,58,277,2004

> <DOI>
10.111/j.1365-2125.2004.02156.x

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
doxepin
  SciTegic08102311032D

 21 23  0  0  0  0            999 V2000
    6.3992   -2.4734    0.0000 C   0  0
    6.0654   -1.0110    0.0000 C   0  0
    5.4640   -3.6462    0.0000 C   0  0
    7.8616   -2.8072    0.0000 C   0  0
    4.7140   -0.3602    0.0000 C   0  0
    7.3048   -0.1660    0.0000 C   0  0
    3.9640   -3.6462    0.0000 C   0  0
    6.2140   -4.9452    0.0000 C   0  0
    8.3037   -4.2405    0.0000 C   0  0
    3.3625   -1.0110    0.0000 C   0  0
    4.6019    1.1356    0.0000 C   0  0
    7.1927    1.3298    0.0000 C   0  0
    3.0287   -2.4734    0.0000 O   0  0
    3.2140   -4.9452    0.0000 C   0  0
    5.4640   -6.2443    0.0000 C   0  0
    9.7661   -4.5743    0.0000 C   0  0
    5.8412    1.9806    0.0000 C   0  0
    3.9640   -6.2443    0.0000 C   0  0
   10.2083   -6.0077    0.0000 N   0  0
   11.6707   -6.3414    0.0000 C   0  0
    9.1880   -7.1073    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  7 14  1  0
  8 15  2  0
  9 16  1  0
 10 13  1  0
 11 17  2  0
 12 17  1  0
 14 18  2  0
 15 18  1  0
 16 19  1  0
 19 20  1  0
 19 21  1  0
M  END
> <Name>
doxepin

> <ID>
doxepin

> <PRIMARY_SOM>
21 20

> <Citation>
Haritos et al.,Pharmacogenetics,10,591,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
dy_9760e
  SciTegic08102311032D

 35 39  0  0  0  0            999 V2000
    1.2662   16.5643    0.0000 C   0  0
    1.2662   18.0643    0.0000 C   0  0
   -0.0328   18.8143    0.0000 C   0  0
   -1.3319   18.0643    0.0000 C   0  0
   -1.3319   16.5643    0.0000 C   0  0
   -0.0328   15.8143    0.0000 C   0  0
    2.3809   15.5606    0.0000 N   0  0
    0.2790   14.3471    0.0000 C   0  0
    1.7708   14.1903    0.0000 N   0  0
    3.8481   15.8724    0.0000 C   0  0
    4.8518   14.7577    0.0000 C   0  0
    6.3436   14.9145    0.0000 N   0  0
    6.9537   13.5442    0.0000 C   0  0
    5.8390   12.5405    0.0000 N   0  0
    4.5400   13.2905    0.0000 C   0  0
   -0.7247   13.2323    0.0000 C   0  0
   -0.2612   11.8057    0.0000 C   0  0
   -1.2648   10.6910    0.0000 N   0  0
   -0.8013    9.2644    0.0000 C   0  0
   -1.8050    8.1497    0.0000 C   0  0
   -3.2722    8.4616    0.0000 N   0  0
   -3.7358    9.8882    0.0000 C   0  0
   -2.7321   11.0029    0.0000 C   0  0
   -4.2759    7.3469    0.0000 C   0  0
   -3.8124    5.9203    0.0000 C   0  0
   -4.8161    4.8056    0.0000 C   0  0
   -6.2833    5.1174    0.0000 C   0  0
   -6.7469    6.5440    0.0000 C   0  0
   -5.7432    7.6587    0.0000 C   0  0
   -4.3526    3.3790    0.0000 Cl  0  0
   -2.3452    5.6084    0.0000 C   0  0
   -2.6309   18.8143    0.0000 O   0  0
   -0.0328   20.3143    0.0000 O   0  0
    1.2662   21.0643    0.0000 C   0  0
   -3.9300   18.0643    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  3  4  1  0
  3 33  1  0
  4  5  2  0
  4 32  1  0
  5  6  1  0
  6  8  1  0
  7  9  1  0
  7 10  1  0
  8  9  2  0
  8 16  1  0
 10 11  1  0
 11 12  1  0
 11 15  2  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 24  1  0
 22 23  1  0
 24 25  1  0
 24 29  2  0
 25 26  2  0
 25 31  1  0
 26 27  1  0
 26 30  1  0
 27 28  2  0
 28 29  1  0
 32 35  1  0
 33 34  1  0
M  END
> <Name>
dy_9760e

> <ID>
dy_9760e

> <PRIMARY_SOM>
13

> <SECONDARY_SOM>
10 27

> <TERTIARY_SOM>
15 34

> <Citation>
Tachibana et al.,Drug Metab. Disp.,33,1628,2005

> <DOI>
10.1124/dmd.105.004903

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
e_2101
  SciTegic08102311032D

 29 32  0  0  0  0            999 V2000
   10.2272    2.7141    0.0000 C   0  0
   11.6538    2.2505    0.0000 N   0  0
   10.2272    4.2140    0.0000 C   0  0
    8.9282    1.9640    0.0000 C   0  0
   12.1173    0.8239    0.0000 C   0  0
   12.5355    3.4641    0.0000 C   0  0
   11.6538    4.6776    0.0000 C   0  0
    8.9282    4.9640    0.0000 C   0  0
    7.6291    2.7140    0.0000 C   0  0
   11.1136   -0.2908    0.0000 C   0  0
   13.5845    0.5121    0.0000 C   0  0
    7.6291    4.2140    0.0000 C   0  0
    6.3301    1.9640    0.0000 C   0  0
   11.5771   -1.7174    0.0000 C   0  0
   14.0481   -0.9145    0.0000 C   0  0
    5.0310    2.7140    0.0000 C   0  0
   13.0444   -2.0292    0.0000 N   0  0
    3.7320    1.9640    0.0000 N   0  0
    5.0310    4.2140    0.0000 O   0  0
   13.5079   -3.4558    0.0000 C   0  0
    2.4330    2.7140    0.0000 C   0  0
   14.9751   -3.7677    0.0000 C   0  0
   15.4386   -5.1943    0.0000 C   0  0
   16.9059   -5.5061    0.0000 C   0  0
   14.4349   -6.3090    0.0000 C   0  0
   17.3694   -6.9327    0.0000 C   0  0
   17.9096   -4.3914    0.0000 F   0  0
   14.8985   -7.7356    0.0000 C   0  0
   16.3657   -8.0474    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  5 11  1  0
  6  7  2  0
  8 12  2  0
  9 12  1  0
  9 13  1  0
 10 14  1  0
 11 15  1  0
 13 16  1  0
 14 17  1  0
 15 17  1  0
 16 18  1  0
 16 19  2  0
 17 20  1  0
 18 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 24 26  1  0
 24 27  1  0
 25 28  2  0
 26 29  2  0
 28 29  1  0
M  END
> <Name>
e_2101

> <ID>
e_2101

> <PRIMARY_SOM>
20

> <SECONDARY_SOM>
22

> <Citation>
Zhang et al.,Drug Metab. Disp.,30,805,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ebastine
  SciTegic08102311032D

 34 37  0  0  0  0            999 V2000
   -5.9462    1.5000    0.0000 C   0  0
   -5.9462    3.0000    0.0000 C   0  0
   -7.2452    0.7500    0.0000 C   0  0
   -8.5442    1.5000    0.0000 C   0  0
   -8.5442    3.0000    0.0000 C   0  0
   -7.2452    3.7500    0.0000 C   0  0
   -7.2452    5.2500    0.0000 C   0  0
   -5.9462    6.0000    0.0000 C   0  0
   -5.9462    7.5000    0.0000 C   0  0
   -4.6471    8.2500    0.0000 C   0  0
   -3.3481    7.5000    0.0000 C   0  0
   -3.3481    6.0000    0.0000 C   0  0
   -4.6471    5.2500    0.0000 C   0  0
   -8.5442    6.0000    0.0000 O   0  0
   -8.5442    7.5000    0.0000 C   0  0
   -9.8433    8.2500    0.0000 C   0  0
   -9.8433    9.7500    0.0000 C   0  0
   -8.5442   10.5000    0.0000 N   0  0
   -7.2452    9.7500    0.0000 C   0  0
   -7.2452    8.2500    0.0000 C   0  0
   -8.5442   12.0000    0.0000 C   0  0
   -7.2452   12.7500    0.0000 C   0  0
   -7.2452   14.2500    0.0000 C   0  0
   -5.9462   15.0000    0.0000 C   0  0
   -8.5442   15.0000    0.0000 O   0  0
   -5.9462   16.5000    0.0000 C   0  0
   -4.6471   17.2500    0.0000 C   0  0
   -3.3481   16.5000    0.0000 C   0  0
   -3.3481   15.0000    0.0000 C   0  0
   -4.6471   14.2500    0.0000 C   0  0
   -2.0491   17.2500    0.0000 C   0  0
   -2.0491   18.7500    0.0000 C   0  0
   -0.7500   16.5000    0.0000 C   0  0
   -0.7500   18.0000    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  2  6  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7 14  1  0
  8  9  1  0
  8 13  2  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 14 15  1  0
 15 16  1  0
 15 20  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 21  1  0
 19 20  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 24 26  1  0
 24 30  2  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 31  1  0
 29 30  1  0
 31 32  1  0
 31 33  1  0
 31 34  1  0
M  END
> <Name>
ebastine

> <ID>
ebastine

> <PRIMARY_SOM>
21

> <Citation>
Hashizume et al.,Drug Metab. Disp.,26,566,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ecabapide
  SciTegic08102311032D

 27 28  0  0  0  0            999 V2000
   18.9365    3.0000    0.0000 C   0  0
   18.9365    4.5000    0.0000 C   0  0
   17.6375    2.2500    0.0000 C   0  0
   20.2356    2.2500    0.0000 O   0  0
   17.6375    5.2500    0.0000 C   0  0
   20.2356    5.2500    0.0000 O   0  0
   16.3385    3.0000    0.0000 C   0  0
   20.2356    0.7500    0.0000 C   0  0
   16.3385    4.5000    0.0000 C   0  0
   20.2356    6.7500    0.0000 C   0  0
   15.0394    5.2500    0.0000 C   0  0
   13.7404    4.5000    0.0000 C   0  0
   12.4413    5.2500    0.0000 N   0  0
   11.1423    4.5000    0.0000 C   0  0
    9.8433    5.2500    0.0000 C   0  0
   11.1423    3.0000    0.0000 O   0  0
    8.5442    4.5000    0.0000 N   0  0
    7.2452    5.2500    0.0000 C   0  0
    5.9462    4.5000    0.0000 C   0  0
    7.2452    6.7500    0.0000 C   0  0
    4.6471    5.2500    0.0000 C   0  0
    5.9462    7.5000    0.0000 C   0  0
    4.6471    6.7500    0.0000 C   0  0
    3.3481    4.5000    0.0000 C   0  0
    2.0490    5.2500    0.0000 N   0  0
    3.3481    3.0000    0.0000 O   0  0
    0.7500    4.5000    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  4  8  1  0
  5  9  2  0
  6 10  1  0
  7  9  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 19 21  1  0
 20 22  2  0
 21 23  2  0
 21 24  1  0
 22 23  1  0
 24 25  1  0
 24 26  2  0
 25 27  1  0
M  END
> <Name>
ecabapide

> <ID>
ecabapide

> <PRIMARY_SOM>
23

> <SECONDARY_SOM>
15

> <Citation>
Fujimaki et al.,Xenobiotica,29,1273,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
eletriptan
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7101 0.8129 0 0
M  V30 2 C 4.1783 0.5055 0 0 CFG=2
M  V30 3 C 2.5488 2.3042 0 0
M  V30 4 C 1.4993 -0.0725 0 0
M  V30 5 C 4.7926 -0.8629 0 0
M  V30 6 C 4.9243 1.8068 0 0
M  V30 7 N 3.9172 2.9185 0 0
M  V30 8 C 1.1766 2.9101 0 0
M  V30 9 C 0.1271 0.5334 0 0
M  V30 10 C 3.9147 -2.0792 0 0 CFG=2
M  V30 11 C -0.0342 2.0247 0 0
M  V30 12 C -1.0837 -0.352 0 0
M  V30 13 N 4.3826 -3.5043 0 0
M  V30 14 C 2.4147 -2.0838 0 0
M  V30 15 C -2.4559 0.2539 0 0
M  V30 16 C 3.1717 -4.3897 0 0
M  V30 17 C 5.8106 -3.9635 0 0
M  V30 18 C 1.9555 -3.5118 0 0
M  V30 19 S -3.6667 -0.6315 0 0
M  V30 20 C -4.5521 0.5793 0 0
M  V30 21 O -4.8775 -1.5169 0 0
M  V30 22 O -2.7813 -1.8423 0 0
M  V30 23 C -6.0434 0.4179 0 0
M  V30 24 C -3.9462 1.9515 0 0
M  V30 25 C -6.9288 1.6287 0 0
M  V30 26 C -4.8316 3.1623 0 0
M  V30 27 C -6.3229 3.0009 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5 CFG=1
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 10 5 CFG=3
M  V30 10 1 6 7
M  V30 11 2 8 11
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 2 19 22
M  V30 25 2 20 23
M  V30 26 1 20 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 10) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
eletriptan

> <ID>
eletriptan

> <PRIMARY_SOM>
17

> <Citation>
Evans et al.,Drug Metab. Disp.,31,861,2003

> <DOI>
10.1124/dmd.31.7.861

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ellipticine
  SciTegic08102311032D

 19 22  0  0  0  0            999 V2000
    5.9462    3.0000    0.0000 C   0  0
    5.9462    4.5000    0.0000 C   0  0
    7.3727    2.5365    0.0000 C   0  0
    4.6471    2.2500    0.0000 C   0  0
    4.6471    5.2500    0.0000 C   0  0
    7.3727    4.9635    0.0000 N   0  0
    8.2544    3.7500    0.0000 C   0  0
    7.9828    1.1662    0.0000 C   0  0
    3.3481    3.0000    0.0000 C   0  0
    4.6471    0.7500    0.0000 C   0  0
    3.3481    4.5000    0.0000 C   0  0
    4.6471    6.7500    0.0000 C   0  0
    9.7462    3.5932    0.0000 C   0  0
    9.4746    1.0094    0.0000 C   0  0
    2.0490    2.2500    0.0000 C   0  0
    2.0490    5.2500    0.0000 C   0  0
   10.3563    2.2229    0.0000 C   0  0
    0.7500    3.0000    0.0000 N   0  0
    0.7500    4.5000    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  1  0
  5 11  1  0
  5 12  1  0
  6  7  1  0
  7 13  1  0
  8 14  2  0
  9 11  2  0
  9 15  1  0
 11 16  1  0
 13 17  2  0
 14 17  1  0
 15 18  2  0
 16 19  2  0
 18 19  1  0
M  END
> <Name>
ellipticine

> <ID>
ellipticine

> <PRIMARY_SOM>
18

> <SECONDARY_SOM>
12

> <TERTIARY_SOM>
10 14

> <Citation>
M. Stiborova et al., Cancer Research, 2004, 64, 8374-8380

> <DOI>
10.1124/dmd.107.016048

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
emetine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.5197 -4.0245 0 0 CFG=1
M  V30 2 C 7.5197 -2.5245 0 0
M  V30 3 N 6.2207 -4.7745 0 0 CFG=1
M  V30 4 C 8.8188 -4.7745 0 0
M  V30 5 C 6.2207 -1.7745 0 0
M  V30 6 C 8.8188 -1.7745 0 0
M  V30 7 C 6.2207 -6.2745 0 0
M  V30 8 C 4.9216 -4.0245 0 0
M  V30 9 C 8.8188 -6.2745 0 0 CFG=1
M  V30 10 C 6.2207 -0.2745 0 0
M  V30 11 C 4.9216 -2.5245 0 0
M  V30 12 C 8.8188 -0.2745 0 0
M  V30 13 C 7.5197 -7.0245 0 0 CFG=2
M  V30 14 C 10.1178 -7.0245 0 0
M  V30 15 C 7.5197 0.4755 0 0
M  V30 16 O 10.1178 0.4755 0 0
M  V30 17 C 7.5197 -8.5245 0 0
M  V30 18 C 11.4168 -6.2745 0 0 CFG=2
M  V30 19 O 7.5197 1.9755 0 0
M  V30 20 C 11.4168 -0.2745 0 0
M  V30 21 C 6.2207 -9.2745 0 0
M  V30 22 C 12.7159 -7.0245 0 0
M  V30 23 N 11.4168 -4.7745 0 0
M  V30 24 C 6.2207 2.7255 0 0
M  V30 25 C 14.0149 -6.2745 0 0
M  V30 26 C 12.7159 -8.5245 0 0
M  V30 27 C 12.7159 -4.0245 0 0
M  V30 28 C 15.314 -7.0245 0 0
M  V30 29 C 14.0149 -4.7745 0 0
M  V30 30 C 14.0149 -9.2745 0 0
M  V30 31 C 15.314 -8.5245 0 0
M  V30 32 O 14.0149 -10.7745 0 0
M  V30 33 O 16.613 -9.2745 0 0
M  V30 34 C 12.7159 -11.5245 0 0
M  V30 35 C 17.912 -8.5245 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7 CFG=1
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 1 8 11
M  V30 14 1 9 13
M  V30 15 1 9 14 CFG=3
M  V30 16 2 10 15
M  V30 17 1 12 15
M  V30 18 1 12 16
M  V30 19 1 13 17 CFG=3
M  V30 20 1 18 14 CFG=1
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 1 17 21
M  V30 24 1 18 22
M  V30 25 1 18 23
M  V30 26 1 19 24
M  V30 27 2 22 25
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 25 28
M  V30 31 1 25 29
M  V30 32 2 26 30
M  V30 33 1 27 29
M  V30 34 2 28 31
M  V30 35 1 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 3 9 13 18) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
emetine

> <ID>
emetine

> <PRIMARY_SOM>
35

> <SECONDARY_SOM>
24

> <TERTIARY_SOM>
20

> <Citation>
Asano et al.,Biol. Pharm. Bull.,24,678,2001

> <DOI>
10.1248/bpb.24.678

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
eplerenone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 30 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -8.8187 -1.7745 0 0 CFG=2
M  V30 2 C -8.8188 -0.2745 0 0 CFG=2
M  V30 3 C -10.1178 -2.5245 0 0 CFG=2
M  V30 4 C -7.5197 -2.5245 0 0 CFG=2
M  V30 5 O -8.8187 -3.2745 0 0
M  V30 6 C -10.1178 0.4755 0 0 CFG=1
M  V30 7 C -7.5197 0.4755 0 0 CFG=1
M  V30 8 C -11.4168 -1.7745 0 0
M  V30 9 C -6.2207 -1.7745 0 0
M  V30 10 C -7.5197 -4.0245 0 0
M  V30 11 C -6.2207 -3.2745 0 0
M  V30 12 C -11.4168 -0.2745 0 0 CFG=2
M  V30 13 C -10.4297 1.9427 0 0
M  V30 14 C -6.2207 -0.2745 0 0
M  V30 15 C -7.5197 1.9755 0 0
M  V30 16 C -4.9216 -2.5245 0 0
M  V30 17 C -6.2207 -4.7745 0 0
M  V30 18 C -12.5316 0.7292 0 0 CFG=1
M  V30 19 C -12.7871 -0.8846 0 0
M  V30 20 C -11.9214 2.0995 0 0
M  V30 21 O -8.8188 2.7255 0 0
M  V30 22 O -6.2207 2.7255 0 0
M  V30 23 C -4.9216 -4.0245 0 0
M  V30 24 C -13.1417 -0.6412 0 0
M  V30 25 O -13.6463 1.7329 0 0
M  V30 26 C -8.8188 4.2255 0 0
M  V30 27 O -3.6226 -4.7745 0 0
M  V30 28 C -14.6334 -0.4844 0 0
M  V30 29 C -14.9453 0.9829 0 0
M  V30 30 O -16.3156 1.593 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 5 CFG=3
M  V30 8 1 3 8
M  V30 9 1 4 9
M  V30 10 1 4 10
M  V30 11 1 4 11 CFG=1
M  V30 12 1 6 12
M  V30 13 1 6 13 CFG=1
M  V30 14 1 7 14
M  V30 15 1 7 15 CFG=3
M  V30 16 1 8 12
M  V30 17 1 9 14
M  V30 18 2 9 16
M  V30 19 1 10 17
M  V30 20 1 12 18
M  V30 21 1 12 19 CFG=1
M  V30 22 1 13 20
M  V30 23 1 15 21
M  V30 24 2 15 22
M  V30 25 1 16 23
M  V30 26 1 17 23
M  V30 27 1 18 20 CFG=3
M  V30 28 1 18 24
M  V30 29 1 18 25
M  V30 30 1 21 26
M  V30 31 2 23 27
M  V30 32 1 24 28
M  V30 33 1 25 29
M  V30 34 1 28 29
M  V30 35 2 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 1 2 3 4 6 7 12 18) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
eplerenone

> <ID>
eplerenone

> <PRIMARY_SOM>
28

> <SECONDARY_SOM>
14

> <Citation>
Cook et al.,Drug Metab. Disp.,30,1344,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
erythromycin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 49 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -9.1286 -9.4532 0 0
M  V30 2 C -9.1286 -10.9532 0 0 CFG=1
M  V30 3 C -7.8296 -8.7032 0 0 CFG=1
M  V30 4 C -6.5306 -9.4532 0 0
M  V30 5 C -7.8296 -11.7032 0 0 CFG=2
M  V30 6 C -6.5306 -10.9532 0 0 CFG=2
M  V30 7 C -5.2315 -8.7032 0 0 CFG=2
M  V30 8 C -3.9325 -9.4532 0 0 CFG=1
M  V30 9 C -5.2315 -11.7032 0 0 CFG=2
M  V30 10 O -3.9325 -10.9532 0 0
M  V30 11 C -2.6334 -8.7032 0 0 CFG=2
M  V30 12 C -1.3344 -9.4532 0 0 CFG=1
M  V30 13 C -2.6334 -11.7032 0 0
M  V30 14 C -1.3344 -10.9532 0 0 CFG=2
M  V30 15 C -0.0354 -11.7032 0 0
M  V30 16 C -0.0353 -7.2032 0 0 CFG=1
M  V30 17 O 1.2637 -6.4532 0 0
M  V30 18 O -3.9325 -11.9282 0 0
M  V30 19 C -7.8296 -7.2032 0 0
M  V30 20 O -7.8296 -13.2032 0 0
M  V30 21 O -4.2673 -7.5541 0 0
M  V30 22 C -6.1957 -7.5541 0 0
M  V30 23 C -2.6334 -7.2032 0 0
M  V30 24 O -0.0354 -8.7032 0 0
M  V30 25 C -10.4277 -11.7032 0 0
M  V30 26 C -5.5664 -9.8041 0 0
M  V30 27 O -7.4947 -9.8041 0 0
M  V30 28 C -5.2315 -13.2032 0 0
M  V30 29 C -1.3344 -6.4532 0 0
M  V30 30 C -1.3344 -4.9532 0 0 CFG=2
M  V30 31 C -6.5306 -13.9532 0 0
M  V30 32 C -0.0353 -4.2032 0 0 CFG=2
M  V30 33 C 1.2637 -4.9532 0 0 CFG=2
M  V30 34 C 2.5627 -4.2032 0 0
M  V30 35 O -0.0353 -2.7032 0 0
M  V30 36 O -2.8116 -5.2137 0 0
M  V30 37 C -1.8474 -3.5437 0 0
M  V30 38 C -3.3246 -6.6232 0 0
M  V30 39 C -2.6334 -12.6782 0 0 CFG=1
M  V30 40 C -2.6334 -14.1782 0 0 CFG=1
M  V30 41 O -1.3344 -11.9282 0 0
M  V30 42 C -0.0353 -12.6782 0 0 CFG=1
M  V30 43 C -1.3344 -14.9282 0 0 CFG=2
M  V30 44 C -0.0353 -14.1782 0 0
M  V30 45 C 1.2637 -11.9282 0 0
M  V30 46 O -3.9325 -14.9282 0 0
M  V30 47 N -1.3344 -16.4282 0 0
M  V30 48 C -2.6334 -17.1782 0 0
M  V30 49 C -0.0353 -17.1782 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 5
M  V30 4 1 2 25 CFG=1
M  V30 5 1 3 4
M  V30 6 1 3 19 CFG=3
M  V30 7 1 4 7
M  V30 8 1 5 6
M  V30 9 1 5 20 CFG=3
M  V30 10 1 6 9
M  V30 11 1 6 26 CFG=1
M  V30 12 1 6 27
M  V30 13 1 7 8
M  V30 14 1 7 21 CFG=1
M  V30 15 1 7 22
M  V30 16 1 8 11
M  V30 17 1 8 18 CFG=1
M  V30 18 1 9 10
M  V30 19 1 9 28 CFG=3
M  V30 20 1 10 13
M  V30 21 1 11 12
M  V30 22 1 11 23 CFG=1
M  V30 23 1 12 14
M  V30 24 1 12 24 CFG=3
M  V30 25 1 13 14
M  V30 26 1 14 15 CFG=1
M  V30 27 1 16 17
M  V30 28 1 16 24 CFG=1
M  V30 29 1 16 29
M  V30 30 1 17 33
M  V30 31 1 39 18 CFG=3
M  V30 32 1 28 31
M  V30 33 1 29 30
M  V30 34 1 30 32
M  V30 35 1 30 36
M  V30 36 1 30 37 CFG=3
M  V30 37 1 32 33
M  V30 38 1 32 35 CFG=1
M  V30 39 1 33 34 CFG=3
M  V30 40 1 36 38
M  V30 41 1 39 40
M  V30 42 1 39 41
M  V30 43 1 40 43
M  V30 44 1 40 46 CFG=1
M  V30 45 1 41 42
M  V30 46 1 42 44
M  V30 47 1 42 45 CFG=3
M  V30 48 1 43 44
M  V30 49 1 43 47 CFG=3
M  V30 50 1 47 48
M  V30 51 1 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(18 2 3 5 6 7 8 9 11 12 14 16 30 32 33 39 40  -
M  V30 42 43) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
erythromycin

> <ID>
erythromycin

> <PRIMARY_SOM>
49 48

> <Citation>
Wang et al.,Drug Metab. Disp.,25,502,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
estazolam
  SciTegic08102311032D

 21 24  0  0  0  0            999 V2000
   -4.0488    4.2310    0.0000 C   0  0
   -4.3826    5.6934    0.0000 C   0  0
   -4.9840    3.0582    0.0000 N   0  0
   -2.6154    3.7889    0.0000 C   0  0
   -5.7340    6.3442    0.0000 C   0  0
   -3.2830    6.7136    0.0000 C   0  0
   -6.4840    3.0582    0.0000 C   0  0
   -4.5205    1.6317    0.0000 C   0  0
   -1.5158    4.8091    0.0000 C   0  0
   -5.7340    7.8442    0.0000 C   0  0
   -7.0855    5.6934    0.0000 N   0  0
   -1.8496    6.2715    0.0000 C   0  0
   -7.4192    4.2310    0.0000 C   0  0
   -6.9475    1.6316    0.0000 N   0  0
   -5.7340    0.7500    0.0000 N   0  0
   -4.4350    8.5942    0.0000 C   0  0
   -7.0331    8.5942    0.0000 C   0  0
   -0.7500    7.2918    0.0000 Cl  0  0
   -4.4350   10.0942    0.0000 C   0  0
   -7.0331   10.0942    0.0000 C   0  0
   -5.7340   10.8442    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  5 11  2  0
  6 12  2  0
  7 13  1  0
  7 14  2  0
  8 15  2  0
  9 12  1  0
 10 16  2  0
 10 17  1  0
 11 13  1  0
 12 18  1  0
 14 15  1  0
 16 19  1  0
 17 20  2  0
 19 21  2  0
 20 21  1  0
M  END
> <Name>
estazolam

> <ID>
estazolam

> <PRIMARY_SOM>
13

> <Citation>
Miura et al.,Xenobiotica,35,455,2005

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
estradiol
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.3584 -4.9906 0 0
M  V30 2 O 1.674 1.3995 0 0
M  V30 3 C 9.4683 -3.1005 0 0 CFG=1
M  V30 4 C 9.4683 -1.6005 0 0 CFG=2
M  V30 5 C 8.1692 -0.8505 0 0 CFG=1
M  V30 6 C 6.8702 -1.6005 0 0 CFG=2
M  V30 7 C 10.8949 -3.564 0 0 CFG=2
M  V30 8 C 8.1692 -3.8505 0 0
M  V30 9 C 10.8949 -1.1369 0 0
M  V30 10 C 6.8702 -3.1005 0 0
M  V30 11 C 11.7765 -2.3505 0 0
M  V30 12 C 8.1692 0.6495 0 0
M  V30 13 C 9.6251 -4.5922 0 0
M  V30 14 C 5.5712 -0.8505 0 0
M  V30 15 C 6.8702 1.3995 0 0
M  V30 16 C 5.5712 0.6495 0 0
M  V30 17 C 4.2721 -1.6005 0 0
M  V30 18 C 4.2721 1.3995 0 0
M  V30 19 C 2.9731 -0.8505 0 0
M  V30 20 C 2.9731 0.6495 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 7 1 CFG=3
M  V30 2 1 2 20
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 1 3 8
M  V30 6 1 3 13 CFG=3
M  V30 7 1 4 5
M  V30 8 1 4 9 CFG=3
M  V30 9 1 5 6
M  V30 10 1 5 12 CFG=1
M  V30 11 1 6 10 CFG=3
M  V30 12 1 6 14
M  V30 13 1 7 11
M  V30 14 1 8 10
M  V30 15 1 9 11
M  V30 16 1 12 15
M  V30 17 2 14 16
M  V30 18 1 14 17
M  V30 19 1 15 16
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 3 4 5 6 7) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
estradiol

> <ID>
estradiol

> <PRIMARY_SOM>
19

> <SECONDARY_SOM>
18

> <TERTIARY_SOM>
8 9 11 15

> <Citation>
Lee et al.,Endocrinology,144,3382,2003

> <DOI>
10.1210/en.2003-0192

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
estrone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.3584 -4.9906 0 0
M  V30 2 O 1.674 1.3995 0 0
M  V30 3 C 9.4683 -3.1005 0 0 CFG=1
M  V30 4 C 9.4683 -1.6005 0 0 CFG=2
M  V30 5 C 8.1692 -0.8505 0 0 CFG=1
M  V30 6 C 6.8702 -1.6005 0 0 CFG=2
M  V30 7 C 10.8949 -3.564 0 0
M  V30 8 C 8.1692 -3.8505 0 0
M  V30 9 C 10.8949 -1.1369 0 0
M  V30 10 C 6.8702 -3.1005 0 0
M  V30 11 C 11.7765 -2.3505 0 0
M  V30 12 C 8.1692 0.6495 0 0
M  V30 13 C 9.6251 -4.5922 0 0
M  V30 14 C 5.5712 -0.8505 0 0
M  V30 15 C 6.8702 1.3995 0 0
M  V30 16 C 5.5712 0.6495 0 0
M  V30 17 C 4.2721 -1.6005 0 0
M  V30 18 C 4.2721 1.3995 0 0
M  V30 19 C 2.9731 -0.8505 0 0
M  V30 20 C 2.9731 0.6495 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 20
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 1 3 8
M  V30 6 1 3 13 CFG=3
M  V30 7 1 4 5
M  V30 8 1 4 9 CFG=3
M  V30 9 1 5 6
M  V30 10 1 5 12 CFG=1
M  V30 11 1 6 10 CFG=3
M  V30 12 1 6 14
M  V30 13 1 7 11
M  V30 14 1 8 10
M  V30 15 1 9 11
M  V30 16 1 12 15
M  V30 17 2 14 16
M  V30 18 1 14 17
M  V30 19 1 15 16
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 3 4 5 6) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
estrone

> <ID>
estrone

> <PRIMARY_SOM>
19

> <SECONDARY_SOM>
18

> <TERTIARY_SOM>
11 15

> <Citation>
Lee et al.,Endocrinology,114,3382,2003

> <DOI>
10.1210/en.2003-0192

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ethosuximide
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.6046 -6.6601 0 0
M  V30 2 C 2.9749 -6.05 0 0
M  V30 3 C 3.1317 -4.5583 0 0 CFG=2
M  V30 4 C 3.5952 -3.1317 0 0
M  V30 5 C 2.3817 -2.25 0 0
M  V30 6 O 2.3817 -0.75 0 0
M  V30 7 N 1.1682 -3.1317 0 0
M  V30 8 C 1.6317 -4.5583 0 0
M  V30 9 O 0.75 -5.7718 0 0
M  V30 10 C 4.5989 -4.8701 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 1 3 10 CFG=3
M  V30 6 1 4 5
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 2 8 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
ethosuximide

> <ID>
ethosuximide

> <PRIMARY_SOM>
2

> <Citation>
Bachmann et al.,Xenobiotica,33,265,2003

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
etoperidone
  SciTegic08102311032D

 26 28  0  0  0  0            999 V2000
   12.1669  -11.5828    0.0000 N   0  0
   10.6669  -11.5828    0.0000 C   0  0
   12.6304  -10.1562    0.0000 C   0  0
   13.0485  -12.7963    0.0000 C   0  0
   10.2033  -10.1562    0.0000 N   0  0
    9.7852  -12.7963    0.0000 C   0  0
   11.4168   -9.2745    0.0000 N   0  0
   14.0570   -9.6926    0.0000 O   0  0
   14.5403  -12.6395    0.0000 C   0  0
    8.2934  -12.6395    0.0000 C   0  0
   11.4168   -7.7745    0.0000 C   0  0
   10.1178   -7.0245    0.0000 C   0  0
   10.1178   -5.5245    0.0000 C   0  0
    8.8188   -4.7745    0.0000 N   0  0
    8.8188   -3.2745    0.0000 C   0  0
    7.5197   -5.5245    0.0000 C   0  0
    7.5197   -2.5245    0.0000 C   0  0
    6.2207   -4.7745    0.0000 C   0  0
    6.2207   -3.2745    0.0000 N   0  0
    4.9216   -2.5245    0.0000 C   0  0
    4.9216   -1.0245    0.0000 C   0  0
    3.6226   -3.2745    0.0000 C   0  0
    3.6226   -0.2745    0.0000 C   0  0
    2.3236   -2.5245    0.0000 C   0  0
    2.3236   -1.0245    0.0000 C   0  0
    3.6226    1.2255    0.0000 Cl  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5  7  1  0
  6 10  1  0
  7 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 15 17  1  0
 16 18  1  0
 17 19  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 21 23  1  0
 22 24  2  0
 23 25  2  0
 23 26  1  0
 24 25  1  0
M  END
> <Name>
etoperidone

> <ID>
etoperidone

> <PRIMARY_SOM>
25

> <SECONDARY_SOM>
13

> <TERTIARY_SOM>
6

> <Citation>
Yan et al.,Xenobiotica,32,949,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
etoposide
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 42 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -8.1692 2.1495 0 0 CFG=2
M  V30 2 C -8.1692 3.6495 0 0
M  V30 3 C -9.4683 1.3995 0 0 CFG=2
M  V30 4 C -6.8702 1.3995 0 0
M  V30 5 C -9.4683 4.3995 0 0
M  V30 6 C -6.8702 4.3995 0 0
M  V30 7 C -10.7673 2.1495 0 0 CFG=1
M  V30 8 C -9.7801 -0.0677 0 0
M  V30 9 C -6.8702 -0.1005 0 0
M  V30 10 C -5.5712 2.1495 0 0
M  V30 11 C -10.7673 3.6495 0 0 CFG=1
M  V30 12 C -9.4683 5.8995 0 0
M  V30 13 C -6.8702 5.8995 0 0
M  V30 14 C -11.882 1.1458 0 0
M  V30 15 O -11.2719 -0.2245 0 0
M  V30 16 O -8.7764 -1.1824 0 0
M  V30 17 C -5.5712 -0.8505 0 0
M  V30 18 C -4.2721 1.3995 0 0
M  V30 19 O -12.0664 4.3995 0 0
M  V30 20 C -8.1692 6.6495 0 0
M  V30 21 O -5.7555 6.9032 0 0
M  V30 22 C -4.2721 -0.1005 0 0
M  V30 23 O -5.5712 -2.3505 0 0
M  V30 24 O -2.9731 2.1495 0 0
M  V30 25 C -12.0664 5.8995 0 0 CFG=1
M  V30 26 O -7.8574 8.1167 0 0
M  V30 27 C -6.3656 8.2735 0 0
M  V30 28 O -2.9731 -0.8505 0 0
M  V30 29 C -6.8702 -3.1005 0 0
M  V30 30 C -2.9731 3.6495 0 0
M  V30 31 O -10.7673 6.6495 0 0
M  V30 32 C -13.3654 6.6495 0 0 CFG=1
M  V30 33 C -10.7673 8.1495 0 0 CFG=2
M  V30 34 C -13.3654 8.1495 0 0 CFG=1
M  V30 35 O -14.6644 5.8995 0 0
M  V30 36 C -12.0664 8.8995 0 0 CFG=1
M  V30 37 C -9.4683 8.8995 0 0
M  V30 38 O -14.6644 8.8995 0 0
M  V30 39 O -12.0664 10.3995 0 0
M  V30 40 O -9.4683 10.3995 0 0
M  V30 41 C -10.7673 11.1495 0 0 CFG=1
M  V30 42 C -10.7673 12.6495 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=1
M  V30 8 2 4 9
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 12 2 6 13
M  V30 13 1 7 11
M  V30 14 1 7 14 CFG=3
M  V30 15 1 8 15
M  V30 16 2 8 16
M  V30 17 1 9 17
M  V30 18 2 10 18
M  V30 19 1 11 19 CFG=1
M  V30 20 2 12 20
M  V30 21 1 13 20
M  V30 22 1 13 21
M  V30 23 1 14 15
M  V30 24 2 17 22
M  V30 25 1 17 23
M  V30 26 1 18 22
M  V30 27 1 18 24
M  V30 28 1 25 19 CFG=3
M  V30 29 1 20 26
M  V30 30 1 21 27
M  V30 31 1 22 28
M  V30 32 1 23 29
M  V30 33 1 24 30
M  V30 34 1 25 31
M  V30 35 1 25 32
M  V30 36 1 26 27
M  V30 37 1 33 31 CFG=3
M  V30 38 1 32 34
M  V30 39 1 32 35 CFG=3
M  V30 40 1 33 36
M  V30 41 1 33 37
M  V30 42 1 34 36
M  V30 43 1 34 38 CFG=3
M  V30 44 1 36 39 CFG=1
M  V30 45 1 37 40
M  V30 46 1 39 41
M  V30 47 1 40 41
M  V30 48 1 41 42 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 1 3 7 11 25 32 33 34 36 41) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
etoposide

> <ID>
etoposide

> <PRIMARY_SOM>
30 29

> <Citation>
Kawashiro, T.; Yamashita, K.; Zhao, X.J.; Koyama, E.; Tani, M.; Chiba, K.; Ishizaki, T. A Study on the Metabolism of Etoposide and Possible Interactions with Antitumor or Supporting Agents by Human Li
ver Microsomes. J. Pharmacol. Exp. Ther. 1998, 286, 12941300.

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
etoricoxib
  SciTegic08102311032D

 24 26  0  0  0  0            999 V2000
    4.6471  -11.3101    0.0000 N   0  0
    4.6471   -9.8101    0.0000 C   0  0
    3.3481   -9.0601    0.0000 C   0  0
    2.0491   -9.8101    0.0000 C   0  0
    2.0491  -11.3101    0.0000 C   0  0
    3.3481  -12.0601    0.0000 C   0  0
    3.3481   -7.5601    0.0000 C   0  0
    5.9462   -9.0601    0.0000 C   0  0
    4.6471   -6.8101    0.0000 C   0  0
    4.6471   -5.3101    0.0000 C   0  0
    3.3481   -4.5601    0.0000 C   0  0
    2.0491   -5.3101    0.0000 C   0  0
    2.0491   -6.8101    0.0000 C   0  0
    7.2452   -9.8101    0.0000 C   0  0
    8.5443   -9.0601    0.0000 N   0  0
    8.5443   -7.5601    0.0000 C   0  0
    7.2452   -6.8101    0.0000 C   0  0
    5.9462   -7.5601    0.0000 C   0  0
    9.8433   -6.8101    0.0000 C   0  0
    0.7500  -12.0601    0.0000 Cl  0  0
    3.3481   -3.0601    0.0000 S   0  0
    1.8481   -3.0601    0.0000 C   0  0
    4.8481   -3.0601    0.0000 O   0  0
    3.3481   -1.5601    0.0000 O   0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  2  8  1  0
  3  4  1  0
  3  7  1  0
  4  5  2  0
  5  6  1  0
  5 20  1  0
  7  9  1  0
  7 13  2  0
  8 14  1  0
  8 18  2  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 21  1  0
 12 13  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 19  1  0
 17 18  1  0
 21 22  1  0
 21 23  2  0
 21 24  2  0
M  END
> <Name>
etoricoxib

> <ID>
etoricoxib

> <PRIMARY_SOM>
19

> <Citation>
Kassahun et al.,Drug Metab. Disp.,29,813,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
everolimus
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 68 71 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -2.8171 -10.6817 0 0
M  V30 2 C -1.8134 -11.7964 0 0 CFG=2
M  V30 3 C -2.0671 -9.3825 0 0
M  V30 4 C -4.2843 -10.9936 0 0
M  V30 5 C -1.8134 -13.2964 0 0
M  V30 6 C -2.2769 -13.223 0 0
M  V30 7 C -2.3789 -7.9153 0 0
M  V30 8 O -0.5855 -9.6171 0 0
M  V30 9 C -4.7478 -12.4202 0 0
M  V30 10 O -0.3868 -13.7599 0 0
M  V30 11 O -3.0269 -14.1781 0 0
M  V30 12 C -3.7441 -13.5349 0 0
M  V30 13 C -1.0798 -7.1653 0 0 CFG=2
M  V30 14 O -3.8343 -7.5524 0 0
M  V30 15 C -0.5436 -15.2517 0 0 CFG=2
M  V30 16 O -1.5433 -5.7387 0 0
M  V30 17 C -2.4745 -6.6131 0 0 CFG=1
M  V30 18 O 0.3205 -7.7029 0 0
M  V30 19 C -1.8426 -16.0017 0 0 CFG=1
M  V30 20 C 0.8267 -15.8618 0 0
M  V30 21 C -0.3298 -4.8571 0 0 CFG=2
M  V30 22 C -2.7555 -5.1396 0 0
M  V30 23 C -3.6303 -7.5692 0 0
M  V30 24 C -1.8426 -17.5017 0 0
M  V30 25 C -3.1417 -15.2517 0 0
M  V30 26 C 1.8304 -14.7471 0 0
M  V30 27 C 0.8837 -5.7388 0 0
M  V30 28 C -1.662 -4.1128 0 0
M  V30 29 C -3.1417 -18.2517 0 0 CFG=1
M  V30 30 C 3.1295 -15.4971 0 0 CFG=1
M  V30 31 O 1.5958 -13.2656 0 0
M  V30 32 C 1.9985 -4.7351 0 0 CFG=1
M  V30 33 C -3.1417 -19.7517 0 0
M  V30 34 C -4.4407 -17.5017 0 0
M  V30 35 C 4.2442 -14.4934 0 0
M  V30 36 C 3.2863 -16.9889 0 0
M  V30 37 C 3.2975 -5.4851 0 0
M  V30 38 O 1.8417 -3.2433 0 0
M  V30 39 C -4.4407 -20.5017 0 0 CFG=2
M  V30 40 C -5.7397 -18.2517 0 0
M  V30 41 C 5.4577 -15.3751 0 0
M  V30 42 C 4.3012 -4.3704 0 0
M  V30 43 C 3.5321 -6.9667 0 0
M  V30 44 C 0.4714 -2.6332 0 0
M  V30 45 C -5.7397 -19.7517 0 0 CFG=1
M  V30 46 O -4.4407 -22.0017 0 0
M  V30 47 C 6.6713 -14.4935 0 0 CFG=2
M  V30 48 C 5.4577 -16.8751 0 0
M  V30 49 C 5.6715 -4.9806 0 0
M  V30 50 O -7.0388 -20.5017 0 0
M  V30 51 C -3.1417 -22.7517 0 0
M  V30 52 C 6.2077 -13.0669 0 0 CFG=2
M  V30 53 O 8.0978 -14.957 0 0
M  V30 54 C 5.5147 -6.4723 0 0
M  V30 55 C -7.0388 -22.0017 0 0
M  V30 56 C 7.5068 -12.3169 0 0
M  V30 57 O 4.8074 -12.5293 0 0
M  V30 58 C 6.9413 -6.9359 0 0
M  V30 59 C -8.3378 -22.7517 0 0
M  V30 60 C 7.1949 -10.8496 0 0 CFG=1
M  V30 61 O 8.8771 -12.927 0 0
M  V30 62 C 3.6416 -13.4733 0 0
M  V30 63 C 6.9413 -8.4359 0 0
M  V30 64 O -8.3378 -24.2517 0 0
M  V30 65 C 8.5653 -10.2396 0 0
M  V30 66 C 5.8584 -10.1686 0 0
M  V30 67 C 8.4085 -8.7478 0 0 CFG=2
M  V30 68 C 9.5232 -7.7441 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 2 7 14
M  V30 14 1 9 12
M  V30 15 1 15 10 CFG=1
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18 CFG=3
M  V30 19 1 15 19
M  V30 20 1 15 20
M  V30 21 1 21 16 CFG=3
M  V30 22 1 17 22
M  V30 23 1 17 23 CFG=3
M  V30 24 1 19 24
M  V30 25 1 19 25 CFG=1
M  V30 26 1 20 26
M  V30 27 1 21 27
M  V30 28 1 21 28
M  V30 29 1 22 28
M  V30 30 1 29 24 CFG=1
M  V30 31 1 26 30
M  V30 32 2 26 31
M  V30 33 1 27 32
M  V30 34 1 29 33
M  V30 35 1 29 34
M  V30 36 1 30 35
M  V30 37 1 30 36 CFG=1
M  V30 38 1 32 37
M  V30 39 1 32 38 CFG=3
M  V30 40 1 33 39
M  V30 41 1 34 40
M  V30 42 2 35 41
M  V30 43 2 37 42
M  V30 44 1 37 43
M  V30 45 1 38 44
M  V30 46 1 39 45
M  V30 47 1 39 46 CFG=1
M  V30 48 1 40 45
M  V30 49 1 41 47
M  V30 50 1 41 48
M  V30 51 1 42 49
M  V30 52 1 45 50 CFG=3
M  V30 53 1 46 51
M  V30 54 1 47 52
M  V30 55 1 47 53 CFG=3
M  V30 56 2 49 54
M  V30 57 1 50 55
M  V30 58 1 52 56
M  V30 59 1 52 57 CFG=1
M  V30 60 1 54 58
M  V30 61 1 55 59
M  V30 62 1 56 60
M  V30 63 2 56 61
M  V30 64 1 57 62
M  V30 65 2 58 63
M  V30 66 1 59 64
M  V30 67 1 60 65
M  V30 68 1 60 66 CFG=3
M  V30 69 1 63 67
M  V30 70 1 65 67
M  V30 71 1 67 68 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(15 2 13 15 17 19 21 29 30 32 39 45 47 52 60  -
M  V30 67) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
everolimus

> <ID>
everolimus

> <PRIMARY_SOM>
67

> <SECONDARY_SOM>
60 55 22 17

> <Citation>
Kuhn et al.,J. Med. Chem.,44,2027,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
fenproporex
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2721 -1.3995 0 0
M  V30 2 C 5.5712 -2.1495 0 0
M  V30 3 C 4.2721 0.1005 0 0
M  V30 4 C 2.9731 -2.1495 0 0
M  V30 5 C 5.5712 -3.6495 0 0 CFG=1
M  V30 6 C 2.9731 0.8505 0 0
M  V30 7 C 1.674 -1.3995 0 0
M  V30 8 N 6.8702 -4.3995 0 0
M  V30 9 C 4.2721 -4.3995 0 0
M  V30 10 C 1.674 0.1005 0 0
M  V30 11 C 6.8702 -5.8995 0 0
M  V30 12 C 8.1692 -6.6495 0 0
M  V30 13 C 8.1693 -8.1495 0 0
M  V30 14 N 8.1693 -9.6495 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9 CFG=1
M  V30 9 2 6 10
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 3 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
fenproporex

> <ID>
fenproporex

> <PRIMARY_SOM>
11

> <Citation>
Kraemer et al.,Biochem. Pharm.,68,947,2004

> <DOI>
10.1016/j.bcp.2004.05.009

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
fentanyl
  SciTegic08102311032D

 25 27  0  0  0  0            999 V2000
    6.2207    3.2745    0.0000 C   0  0
    7.5197    2.5245    0.0000 C   0  0
    6.2207    4.7745    0.0000 C   0  0
    4.9216    5.5245    0.0000 C   0  0
    3.6226    4.7745    0.0000 C   0  0
    3.6226    3.2745    0.0000 C   0  0
    4.9216    2.5245    0.0000 C   0  0
    7.5197    1.0245    0.0000 C   0  0
    8.8188    0.2745    0.0000 N   0  0
    8.8188   -1.2255    0.0000 C   0  0
   10.1178   -1.9755    0.0000 C   0  0
   11.4168   -1.2255    0.0000 C   0  0
   12.7159   -1.9755    0.0000 N   0  0
   11.4168    0.2745    0.0000 C   0  0
   10.1178    1.0245    0.0000 C   0  0
   12.7159   -3.4755    0.0000 C   0  0
   14.0149   -1.2255    0.0000 C   0  0
   11.4168   -4.2255    0.0000 C   0  0
   11.4168   -5.7255    0.0000 C   0  0
   12.7159   -6.4755    0.0000 C   0  0
   14.0149   -5.7255    0.0000 C   0  0
   14.0149   -4.2255    0.0000 C   0  0
   14.0149    0.2745    0.0000 O   0  0
   15.3139   -1.9754    0.0000 C   0  0
   16.6130   -1.2254    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  7  2  0
  2  8  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  8  9  1  0
  9 10  1  0
  9 15  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 13 16  1  0
 13 17  1  0
 14 15  1  0
 16 18  1  0
 16 22  2  0
 17 23  2  0
 17 24  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 24 25  1  0
M  END
> <Name>
fentanyl

> <ID>
fentanyl

> <PRIMARY_SOM>
8

> <Citation>
Labroo et al.,Drug Metab. Disp.,25,1072,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
finasteride
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -0.2745 -5.5245 0 0
M  V30 2 C -0.2745 -4.0245 0 0
M  V30 3 N -1.5736 -3.2745 0 0
M  V30 4 C -2.8726 -4.0245 0 0 CFG=1
M  V30 5 C -2.8726 -5.5245 0 0 CFG=2
M  V30 6 C -1.5736 -6.2745 0 0
M  V30 7 C -4.1716 -3.2745 0 0
M  V30 8 C -5.4707 -4.0245 0 0
M  V30 9 C -5.4707 -5.5245 0 0 CFG=2
M  V30 10 C -4.1716 -6.2745 0 0 CFG=2
M  V30 11 C -6.7697 -6.2745 0 0 CFG=1
M  V30 12 C -6.7697 -7.7745 0 0 CFG=2
M  V30 13 C -5.4707 -8.5245 0 0
M  V30 14 C -4.1716 -7.7745 0 0
M  V30 15 C -8.1963 -5.811 0 0
M  V30 16 C -9.078 -7.0245 0 0
M  V30 17 C -8.1963 -8.2381 0 0 CFG=2
M  V30 18 O 1.0245 -3.2745 0 0
M  V30 19 C -2.8726 -7.0245 0 0
M  V30 20 C -6.9265 -9.2663 0 0
M  V30 21 C -8.6598 -9.6646 0 0
M  V30 22 O -10.127 -9.9765 0 0
M  V30 23 N -7.6561 -10.7794 0 0
M  V30 24 C -8.1196 -12.2059 0 0
M  V30 25 C -7.1159 -13.3207 0 0
M  V30 26 C -8.5832 -13.6325 0 0
M  V30 27 C -9.5869 -12.5178 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 2 3
M  V30 4 2 2 18
M  V30 5 1 4 3 CFG=1
M  V30 6 1 4 5
M  V30 7 1 4 7
M  V30 8 1 5 6
M  V30 9 1 5 10
M  V30 10 1 5 19 CFG=1
M  V30 11 1 7 8
M  V30 12 1 9 8 CFG=3
M  V30 13 1 9 10
M  V30 14 1 9 11
M  V30 15 1 10 14 CFG=1
M  V30 16 1 11 12
M  V30 17 1 11 15 CFG=1
M  V30 18 1 12 13
M  V30 19 1 12 17
M  V30 20 1 12 20 CFG=1
M  V30 21 1 13 14
M  V30 22 1 15 16
M  V30 23 1 16 17
M  V30 24 1 17 21 CFG=1
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 23 24
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 1 24 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 4 5 9 10 11 12 17) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
finasteride

> <ID>
finasteride

> <PRIMARY_SOM>
27 26 25

> <Citation>
Guengerich,Ann. Rev. Pharmacol. Toxicol.,39,1,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
fk_506
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 57 60 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -0.5045 1.8411 0 0 CFG=2
M  V30 2 C -0.6158 3.3385 0 0 CFG=2
M  V30 3 O 0.7948 1.0915 0 0
M  V30 4 C -1.619 0.8369 0 0 CFG=2
M  V30 5 C 0.6669 4.116 0 0
M  V30 6 O -1.9492 4.0256 0 0
M  V30 7 C 2.0525 1.9089 0 0 CFG=2
M  V30 8 C -3.0195 1.374 0 0
M  V30 9 O -1.3451 -0.6378 0 0
M  V30 10 C 1.9891 3.4076 0 0 CFG=2
M  V30 11 C -3.211 3.2145 0 0
M  V30 12 C 3.2185 0.9654 0 0
M  V30 13 O 3.3923 2.5834 0 0
M  V30 14 C -3.9631 0.2079 0 0 CFG=2
M  V30 15 C -2.4853 -1.6124 0 0
M  V30 16 C 3.2595 4.2052 0 0
M  V30 17 C 2.6815 -0.4352 0 0
M  V30 18 O 4.6673 1.3541 0 0
M  V30 19 C -3.1457 -1.0498 0 0
M  V30 20 C -5.4611 0.2858 0 0
M  V30 21 N 3.6856 -1.5495 0 0
M  V30 22 O 1.2067 -0.7091 0 0
M  V30 23 C -3.8952 -2.3491 0 0
M  V30 24 C 2.9361 -2.8488 0 0 CFG=2
M  V30 25 C 2.9351 -0.2508 0 0
M  V30 26 C -2.8911 -3.4635 0 0
M  V30 27 C -5.3869 -2.5065 0 0
M  V30 28 C 3.7535 -4.1066 0 0
M  V30 29 C 1.4361 -2.8494 0 0
M  V30 30 C 1.4351 -0.2513 0 0
M  V30 31 C -3.4281 -4.864 0 0 CFG=2
M  V30 32 O 2.8099 -5.2726 0 0
M  V30 33 O 5.2514 -4.1845 0 0
M  V30 34 C 0.6856 -1.5506 0 0
M  V30 35 C -2.262 -5.8076 0 0
M  V30 36 C -4.8768 -5.2528 0 0
M  V30 37 C 1.4094 -4.7356 0 0 CFG=2
M  V30 38 C -1.0043 -4.9902 0 0
M  V30 39 O -2.34 -7.3056 0 0
M  V30 40 C -5.9379 -4.1925 0 0
M  V30 41 C 0.6931 -3.4176 0 0
M  V30 42 C 1.098 -6.2029 0 0 CFG=1
M  V30 43 C -0.3937 -6.3603 0 0 CFG=1
M  V30 44 C -7.3866 -4.5813 0 0
M  V30 45 C -0.8064 -3.3789 0 0
M  V30 46 C 1.4764 -2.1384 0 0
M  V30 47 C 2.1021 -7.3173 0 0
M  V30 48 O -1.1432 -7.6596 0 0
M  V30 49 C -1.2829 -1.9566 0 0 CFG=1
M  V30 50 C -2.7528 -1.6581 0 0
M  V30 51 C -0.2893 -0.8328 0 0
M  V30 52 C -3.2293 -0.2358 0 0 CFG=2
M  V30 53 C -0.7658 0.5895 0 0
M  V30 54 C -2.2358 0.888 0 0 CFG=1
M  V30 55 O -4.6993 0.0628 0 0
M  V30 56 O -2.7123 2.3103 0 0
M  V30 57 C -5.6928 -1.061 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9 CFG=1
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 10
M  V30 12 1 7 12
M  V30 13 1 7 13 CFG=1
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 1 10 16 CFG=1
M  V30 17 1 12 17
M  V30 18 2 12 18
M  V30 19 1 14 19
M  V30 20 1 14 20 CFG=3
M  V30 21 1 17 21
M  V30 22 2 17 22
M  V30 23 1 19 23
M  V30 24 1 21 24
M  V30 25 1 21 25
M  V30 26 2 23 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 24 29 CFG=3
M  V30 30 1 25 30
M  V30 31 1 26 31
M  V30 32 1 28 32
M  V30 33 2 28 33
M  V30 34 1 29 34
M  V30 35 1 30 34
M  V30 36 1 31 35
M  V30 37 1 31 36 CFG=3
M  V30 38 1 32 37
M  V30 39 1 35 38
M  V30 40 2 35 39
M  V30 41 1 36 40
M  V30 42 1 37 41 CFG=1
M  V30 43 1 37 42
M  V30 44 1 38 43
M  V30 45 2 40 44
M  V30 46 2 41 45
M  V30 47 1 41 46
M  V30 48 1 42 43
M  V30 49 1 42 47 CFG=3
M  V30 50 1 43 48 CFG=1
M  V30 51 1 49 45 CFG=1
M  V30 52 1 49 50
M  V30 53 1 49 51
M  V30 54 1 50 52
M  V30 55 1 51 53
M  V30 56 1 52 54
M  V30 57 1 52 55 CFG=1
M  V30 58 1 53 54
M  V30 59 1 54 56 CFG=3
M  V30 60 1 55 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(14 1 2 4 7 10 14 24 31 37 42 43 49 52 54) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
fk_506

> <ID>
fk_506

> <PRIMARY_SOM>
11

> <Citation>
Vincent et al.,Arch. Biochem. Biophys.,294,454,1992

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
flosequinan
  SciTegic08102311032D

 16 17  0  0  0  0            999 V2000
   -0.4800    0.6970    0.0000 C   0  0
   -0.4800   -0.9440    0.0000 C   0  0
    0.7840    1.5230    0.0000 C   0  0
   -1.7520    1.5230    0.0000 C   0  0
    0.7840   -1.7670    0.0000 N   0  0
   -1.7520   -1.7670    0.0000 C   0  0
    2.0560    0.6970    0.0000 C   0  0
    0.7840    3.2860    0.0000 O   0  0
   -3.0240    0.6970    0.0000 C   0  0
    2.0560   -0.9440    0.0000 C   0  0
    0.7840   -3.5340    0.0000 C   0  0
   -3.0240   -0.9440    0.0000 C   0  0
    3.3280    1.5230    0.0000 S   0  0
   -4.2920   -1.7670    0.0000 F   0  0
    4.5960    0.6970    0.0000 C   0  0
    3.3280    3.2860    0.0000 O   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  2  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 10  2  0
  7 13  1  0
  9 12  1  0
 12 14  1  0
 13 15  1  0
 13 16  2  0
M  END
> <Name>
flosequinan

> <ID>
flosequinan

> <PRIMARY_SOM>
13 16

> <Citation>
Kashiyama et al.,Drug Metab. Disp.,25,716,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
flucloxacillin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -1.6019 5.9619 0 0
M  V30 2 C -1.1384 7.3885 0 0 CFG=1
M  V30 3 C -3.1019 5.9619 0 0 CFG=2
M  V30 4 C -0.1753 5.4983 0 0
M  V30 5 C 0.2882 6.9249 0 0 CFG=1
M  V30 6 S -2.3519 8.2701 0 0
M  V30 7 C -3.5654 7.3885 0 0
M  V30 8 C -3.9836 4.7483 0 0
M  V30 9 O 0.5057 4.1618 0 0
M  V30 10 N 1.6247 7.6059 0 0
M  V30 11 C -4.9358 6.7783 0 0
M  V30 12 C -4.3154 8.6875 0 0
M  V30 13 O -5.4754 4.9051 0 0
M  V30 14 O -3.3735 3.378 0 0
M  V30 15 C 1.7032 9.1039 0 0
M  V30 16 C 3.0397 9.7849 0 0
M  V30 17 O 0.4452 9.9208 0 0
M  V30 18 C 3.2744 11.2664 0 0
M  V30 19 C 4.3762 9.1039 0 0
M  V30 20 C 1.5243 13.0165 0 0
M  V30 21 N 4.7559 11.501 0 0
M  V30 22 O 5.4369 10.1645 0 0
M  V30 23 C 4.6109 7.6223 0 0
M  V30 24 C 0.0754 12.6282 0 0
M  V30 25 C 1.9125 14.4654 0 0
M  V30 26 C -0.9853 13.6889 0 0
M  V30 27 F -0.3128 11.1794 0 0
M  V30 28 C 0.8518 15.526 0 0
M  V30 29 Cl 3.3614 14.8536 0 0
M  V30 30 C -0.597 15.1378 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=1
M  V30 8 1 4 5
M  V30 9 2 4 9
M  V30 10 1 5 10 CFG=3
M  V30 11 1 6 7
M  V30 12 1 7 11
M  V30 13 1 7 12
M  V30 14 1 8 13
M  V30 15 2 8 14
M  V30 16 1 10 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 1 19 23
M  V30 25 2 20 24
M  V30 26 1 20 25 CFG=1
M  V30 27 1 21 22
M  V30 28 1 24 26
M  V30 29 1 24 27
M  V30 30 2 25 28
M  V30 31 1 25 29
M  V30 32 2 26 30
M  V30 33 1 28 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 3 5 20) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
flucloxacillin

> <ID>
flucloxacillin

> <PRIMARY_SOM>
23

> <Citation>
Lakehal et al.,Chem. Res. Toxicol.,14,694,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
flunitrazepam
  SciTegic08102311032D

 23 25  0  0  0  0            999 V2000
   -6.4273   -1.9675    0.0000 C   0  0
   -5.9851   -3.4008    0.0000 C   0  0
   -4.5227   -3.7345    0.0000 C   0  0
   -3.5025   -2.6349    0.0000 C   0  0
   -3.9447   -1.2016    0.0000 C   0  0
   -5.4071   -0.8679    0.0000 C   0  0
   -7.8897   -1.6338    0.0000 C   0  0
   -8.2236   -0.1714    0.0000 N   0  0
   -9.5751    0.4794    0.0000 C   0  0
  -10.9265   -0.1715    0.0000 C   0  0
  -11.2602   -1.6339    0.0000 N   0  0
   -8.8249   -2.8066    0.0000 C   0  0
  -10.3249   -2.8067    0.0000 C   0  0
  -11.0749   -4.1057    0.0000 C   0  0
  -10.3248   -5.4047    0.0000 C   0  0
   -8.8248   -5.4047    0.0000 C   0  0
   -8.0749   -4.1056    0.0000 C   0  0
   -8.0747   -6.7037    0.0000 N   0  3
   -5.8493    0.5655    0.0000 F   0  0
  -12.0993    0.7636    0.0000 O   0  0
  -12.7226   -1.9678    0.0000 C   0  0
   -6.5747   -6.7036    0.0000 O   0  0
   -8.8247   -8.0027    0.0000 O   0  5
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6 19  1  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 20  2  0
 11 13  1  0
 11 21  1  0
 12 13  1  0
 12 17  2  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 22  2  0
 18 23  1  0
M  CHG  2  18   1  23  -1
M  END
> <Name>
flunitrazepam

> <ID>
flunitrazepam

> <PRIMARY_SOM>
9

> <SECONDARY_SOM>
21

> <Citation>
Hesse et al.,Drug Metab. Disp.,29,133,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
fluoxetine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -10.7673 -0.6501 0 0 CFG=1
M  V30 2 C -12.0664 0.0998 0 0
M  V30 3 O -10.7672 -2.1501 0 0
M  V30 4 C -9.4683 0.1 0 0
M  V30 5 C -12.0664 1.5998 0 0
M  V30 6 C -13.3654 -0.6502 0 0
M  V30 7 C -9.4681 -2.9 0 0
M  V30 8 C -9.4684 1.6 0 0
M  V30 9 C -13.3655 2.3498 0 0
M  V30 10 C -14.6644 0.0997 0 0
M  V30 11 C -9.468 -4.4 0 0
M  V30 12 C -8.1691 -2.15 0 0
M  V30 13 N -8.1694 2.35 0 0
M  V30 14 C -14.6645 1.5997 0 0
M  V30 15 C -8.169 -5.15 0 0
M  V30 16 C -6.87 -2.8999 0 0
M  V30 17 C -8.1694 3.85 0 0
M  V30 18 C -6.87 -4.3999 0 0
M  V30 19 C -5.5709 -5.1498 0 0
M  V30 20 F -5.5708 -6.6498 0 0
M  V30 21 F -4.2719 -4.3998 0 0
M  V30 22 F -4.2718 -5.8998 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 15 18
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
fluoxetine

> <ID>
fluoxetine

> <PRIMARY_SOM>
17

> <SECONDARY_SOM>
1

> <Citation>
Mandrioli et al.,Curr. Drug Metab.,7,127,2006

> <DOI>
10.2174/138920006775541561

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
fluticasone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6472 -9 0 0 CFG=1
M  V30 2 C 4.6471 -7.5 0 0 CFG=1
M  V30 3 C 3.3481 -9.75 0 0 CFG=1
M  V30 4 C 5.7619 -10.0037 0 0
M  V30 5 C 3.3481 -6.75 0 0 CFG=1
M  V30 6 C 5.9462 -6.75 0 0
M  V30 7 C 3.66 -11.2172 0 0 CFG=2
M  V30 8 C 2.0491 -9 0 0
M  V30 9 C 2.1346 -10.6317 0 0
M  V30 10 C 5.1518 -11.374 0 0 CFG=2
M  V30 11 C 3.3481 -5.25 0 0 CFG=2
M  V30 12 C 2.0491 -7.5 0 0 CFG=2
M  V30 13 F 2.0491 -6 0 0
M  V30 14 C 5.9462 -5.25 0 0 CFG=1
M  V30 15 C 3.66 -12.7172 0 0
M  V30 16 O 2.1682 -11.374 0 0
M  V30 17 C 5.9018 -12.673 0 0
M  V30 18 C 4.6471 -4.5 0 0
M  V30 19 C 2.0491 -4.5 0 0
M  V30 20 C 2.0491 -6 0 0
M  V30 21 O 0.75 -6.75 0 0
M  V30 22 F 7.2452 -4.5 0 0
M  V30 23 S 4.959 -13.4672 0 0
M  V30 24 O 2.361 -13.4672 0 0
M  V30 25 C 4.6471 -3 0 0
M  V30 26 C 2.0491 -3 0 0
M  V30 27 C 4.6986 -14.9444 0 0
M  V30 28 C 3.3481 -2.25 0 0
M  V30 29 F 3.289 -15.4575 0 0
M  V30 30 O 3.3481 -0.75 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 9 CFG=3
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 12 1 5 13 CFG=1
M  V30 13 1 6 14
M  V30 14 1 7 10
M  V30 15 1 7 15
M  V30 16 1 7 16 CFG=1
M  V30 17 1 8 12
M  V30 18 1 10 17 CFG=1
M  V30 19 1 11 18
M  V30 20 1 11 19
M  V30 21 1 11 20 CFG=3
M  V30 22 1 12 21 CFG=3
M  V30 23 1 14 18
M  V30 24 1 14 22 CFG=1
M  V30 25 1 15 23
M  V30 26 2 15 24
M  V30 27 2 18 25
M  V30 28 2 19 26
M  V30 29 1 23 27
M  V30 30 1 25 28
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 1 2 3 5 7 10 11 12 14) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
fluticasone

> <ID>
fluticasone

> <PRIMARY_SOM>
23

> <Citation>
Pearce et al.,Drug Metab. Disp.,34,1035,2006

> <DOI>
10.1124/dmd.105.009043

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
fluvastatin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.1579 7.734 0 0
M  V30 2 C -1.2687 8.1975 0 0
M  V30 3 C 1.0395 8.9475 0 0
M  V30 4 C 0.6214 6.3074 0 0
M  V30 5 C -1.2687 9.6975 0 0
M  V30 6 C -2.5678 7.4475 0 0
M  V30 7 N 0.1579 10.161 0 0
M  V30 8 C 2.5395 8.9475 0 0
M  V30 9 C -0.3823 5.1927 0 0
M  V30 10 C 2.0886 5.9955 0 0
M  V30 11 C -2.5678 10.4475 0 0
M  V30 12 C -3.8668 8.1975 0 0
M  V30 13 C 0.6214 11.5876 0 0
M  V30 14 C 3.2895 10.2465 0 0
M  V30 15 C 0.0812 3.7661 0 0
M  V30 16 C 2.5521 4.5689 0 0
M  V30 17 C -3.8668 9.6975 0 0
M  V30 18 C 2.0886 11.8995 0 0
M  V30 19 C -0.3823 12.7023 0 0
M  V30 20 C 4.7895 10.2465 0 0 CFG=1
M  V30 21 C 1.5484 3.4542 0 0
M  V30 22 C 5.5395 11.5456 0 0
M  V30 23 O 5.5395 8.9475 0 0
M  V30 24 F 2.012 2.0276 0 0
M  V30 25 C 7.0395 11.5456 0 0 CFG=1
M  V30 26 C 7.7895 12.8446 0 0
M  V30 27 O 7.7895 10.2465 0 0
M  V30 28 C 9.2895 12.8446 0 0
M  V30 29 O 10.0395 11.5456 0 0
M  V30 30 O 10.0395 14.1436 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 4 10
M  V30 10 1 5 7
M  V30 11 1 5 11
M  V30 12 2 6 12
M  V30 13 1 7 13
M  V30 14 2 8 14
M  V30 15 1 9 15
M  V30 16 2 10 16
M  V30 17 2 11 17
M  V30 18 1 12 17
M  V30 19 1 13 18
M  V30 20 1 13 19
M  V30 21 1 14 20
M  V30 22 2 15 21
M  V30 23 1 16 21
M  V30 24 1 20 22
M  V30 25 1 20 23 CFG=1
M  V30 26 1 21 24
M  V30 27 1 22 25
M  V30 28 1 25 26
M  V30 29 1 25 27 CFG=1
M  V30 30 1 26 28
M  V30 31 1 28 29
M  V30 32 2 28 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 20 25) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
fluvastatin

> <ID>
fluvastatin

> <PRIMARY_SOM>
12

> <Citation>
Fischer et al.,Drug Metab. Disp.,27,410,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
foxy
  SciTegic08102311032D

 20 21  0  0  0  0            999 V2000
    8.6632   -0.6588    0.0000 C   0  0
   10.1304   -0.9706    0.0000 C   0  0
    8.1997    0.7678    0.0000 C   0  0
   10.5940   -2.3972    0.0000 N   0  0
    6.7731    1.2314    0.0000 C   0  0
    9.0814    1.9814    0.0000 C   0  0
    6.7731    2.7314    0.0000 C   0  0
    5.4741    0.4814    0.0000 C   0  0
    8.1997    3.1949    0.0000 N   0  0
    5.4741    3.4814    0.0000 C   0  0
    4.1750    1.2314    0.0000 C   0  0
    4.1750    2.7314    0.0000 C   0  0
   12.0612   -2.7091    0.0000 C   0  0
    9.5903   -3.5119    0.0000 C   0  0
    8.1230   -3.2001    0.0000 C   0  0
   10.0538   -4.9385    0.0000 C   0  0
   12.5247   -4.1356    0.0000 C   0  0
   13.0649   -1.5943    0.0000 C   0  0
    2.8760    0.4814    0.0000 O   0  0
    1.5769    1.2313    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  3  6  2  0
  4 13  1  0
  4 14  1  0
  5  7  2  0
  5  8  1  0
  6  9  1  0
  7  9  1  0
  7 10  1  0
  8 11  2  0
 10 12  2  0
 11 12  1  0
 11 19  1  0
 13 17  1  0
 13 18  1  0
 14 15  1  0
 14 16  1  0
 19 20  1  0
M  END
> <Name>
foxy

> <ID>
foxy

> <PRIMARY_SOM>
14 13

> <Citation>
Narimatsu et al.,Biochem. Pharmacol.,71,1377,2006

> <DOI>
10.1016/j.bcp.2006.01.015

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
furametpyr
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.0293 3.942 0 0
M  V30 2 C 9.659 3.3319 0 0
M  V30 3 C 9.8157 1.8402 0 0
M  V30 4 N 11.283 1.5283 0 0
M  V30 5 N 12.033 2.8273 0 0
M  V30 6 C 13.5248 2.9841 0 0
M  V30 7 C 8.3599 4.0819 0 0
M  V30 8 O 8.3599 5.5819 0 0
M  V30 9 N 7.0609 3.3319 0 0
M  V30 10 C 5.7618 4.0819 0 0
M  V30 11 C 5.7618 5.5819 0 0
M  V30 12 C 4.4628 6.3319 0 0
M  V30 13 C 3.1638 5.5819 0 0
M  V30 14 C 3.1638 4.0819 0 0
M  V30 15 C 4.4628 3.3319 0 0
M  V30 16 Cl 11.3411 5.4093 0 0
M  V30 17 C 2.049 3.0783 0 0
M  V30 18 C 4.1509 1.8647 0 0 CFG=1
M  V30 19 C 1.1674 4.2918 0 0
M  V30 20 C 0.75 2.3283 0 0
M  V30 21 C 5.1546 0.75 0 0
M  V30 22 O 2.6591 1.7079 0 0
M  V30 23 C 8.701 0.8365 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 16
M  V30 4 1 2 3
M  V30 5 1 2 7
M  V30 6 2 3 4
M  V30 7 1 3 23
M  V30 8 1 4 5
M  V30 9 1 5 6
M  V30 10 2 7 8
M  V30 11 1 7 9
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 2 10 15
M  V30 15 2 11 12
M  V30 16 1 12 13
M  V30 17 2 13 14
M  V30 18 1 14 15
M  V30 19 1 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 1 17 22
M  V30 24 1 18 21 CFG=1
M  V30 25 1 18 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 18) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
furametpyr

> <ID>
furametpyr

> <PRIMARY_SOM>
6

> <Citation>
Nagahori et al.,J. Agric. Food Chem.,48,5754,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
gefitinib
  SciTegic08102311032D

 31 34  0  0  0  0            999 V2000
  -12.0664    4.3995    0.0000 C   0  0
  -12.0664    5.8995    0.0000 C   0  0
  -13.3654    3.6495    0.0000 C   0  0
  -10.7673    3.6495    0.0000 C   0  0
  -13.3654    6.6495    0.0000 N   0  0
  -13.3654    2.1495    0.0000 C   0  0
  -10.7673    6.6495    0.0000 N   0  0
  -10.7673    2.1495    0.0000 C   0  0
  -12.0663    1.3995    0.0000 C   0  0
   -9.4683   10.3995    0.0000 C   0  0
  -14.6644    4.3995    0.0000 N   0  0
   -9.4683    8.8995    0.0000 C   0  0
   -4.2721    1.3995    0.0000 N   0  0
  -14.6644    5.8995    0.0000 C   0  0
  -10.7673    8.1495    0.0000 C   0  0
  -10.7673   11.1495    0.0000 C   0  0
   -1.6740   -0.1005    0.0000 O   0  0
  -12.0664   10.3995    0.0000 C   0  0
   -8.1692   11.1495    0.0000 Cl  0  0
  -12.0664    8.8995    0.0000 C   0  0
  -10.7673   12.6495    0.0000 F   0  0
   -9.4683    1.3995    0.0000 O   0  0
  -12.0663   -0.1005    0.0000 O   0  0
   -5.5712    2.1495    0.0000 C   0  0
   -6.8702    1.3995    0.0000 C   0  0
   -2.9731    2.1495    0.0000 C   0  0
   -4.2721   -0.1005    0.0000 C   0  0
   -1.6740    1.3995    0.0000 C   0  0
   -2.9731   -0.8505    0.0000 C   0  0
   -8.1692    2.1495    0.0000 C   0  0
  -13.3654   -0.8505    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  7  1  0
  3  6  1  0
  3 11  2  0
  4  8  2  0
  5 14  2  0
  6  9  2  0
  7 15  1  0
  8  9  1  0
  8 22  1  0
  9 23  1  0
 10 12  2  0
 10 16  1  0
 10 19  1  0
 11 14  1  0
 12 15  1  0
 13 24  1  0
 13 26  1  0
 13 27  1  0
 15 20  2  0
 16 18  2  0
 16 21  1  0
 17 28  1  0
 17 29  1  0
 18 20  1  0
 22 30  1  0
 23 31  1  0
 24 25  1  0
 25 30  1  0
 26 28  1  0
 27 29  1  0
M  END
> <Name>
gefitinib

> <ID>
gefitinib

> <PRIMARY_SOM>
27 26

> <SECONDARY_SOM>
16

> <Citation>
McKillop et al.,Xenobiotica,35,39,2005

> <DOI>
10.1080/00498250400026464

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
gepirone
  SciTegic08102311032D

 26 28  0  0  0  0            999 V2000
   -5.5712    0.8505    0.0000 N   0  0
   -4.2721    0.1005    0.0000 C   0  0
   -5.5712    2.3505    0.0000 C   0  0
   -6.8702    0.1005    0.0000 C   0  0
   -2.9731    0.8505    0.0000 N   0  0
   -4.2721   -1.3995    0.0000 N   0  0
   -6.8702    3.1005    0.0000 C   0  0
   -8.1692    0.8505    0.0000 C   0  0
   -1.6740    0.1005    0.0000 C   0  0
   -2.9731   -2.1495    0.0000 C   0  0
   -8.1692    2.3505    0.0000 N   0  0
   -1.6740   -1.3995    0.0000 C   0  0
   -9.4683    3.1005    0.0000 C   0  0
  -10.7673    2.3505    0.0000 C   0  0
  -12.0663    3.1005    0.0000 C   0  0
  -13.3654    2.3505    0.0000 C   0  0
  -14.6644    3.1005    0.0000 N   0  0
  -15.9635    2.3505    0.0000 C   0  0
  -14.6644    4.6005    0.0000 C   0  0
  -17.2625    3.1005    0.0000 C   0  0
  -15.9635    0.8505    0.0000 O   0  0
  -15.9635    5.3505    0.0000 C   0  0
  -13.3654    5.3505    0.0000 O   0  0
  -17.2625    4.6005    0.0000 C   0  0
  -18.7397    4.3400    0.0000 C   0  0
  -17.7755    6.0100    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  1  0
  5  9  1  0
  6 10  2  0
  7 11  1  0
  8 11  1  0
  9 12  2  0
 10 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 18 20  1  0
 18 21  2  0
 19 22  1  0
 19 23  2  0
 20 24  1  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
M  END
> <Name>
gepirone

> <ID>
gepirone

> <PRIMARY_SOM>
13 12

> <SECONDARY_SOM>
22 20

> <TERTIARY_SOM>
3 4

> <Citation>
Greenblatt et al.,Biopharm. Drug Disp.,24,87,2003
von Moltke et al.,Psychopharmacology,140,293,1998

> <DOI>
10.10002/bdd.340

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
h259_31
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.1757 11.9434 0 0
M  V30 2 C 12.1756 13.4434 0 0
M  V30 3 C 10.8765 14.1933 0 0
M  V30 4 C 9.5775 13.4432 0 0
M  V30 5 C 9.5776 11.9432 0 0
M  V30 6 C 10.8767 11.1933 0 0
M  V30 7 F 10.8764 15.6933 0 0
M  V30 8 N 10.5649 9.7261 0 0
M  V30 9 C 9.0731 9.5692 0 0
M  V30 10 N 8.4629 10.9395 0 0
M  V30 11 S 8.3231 8.2701 0 0 CFG=2
M  V30 12 C 6.8231 8.27 0 0
M  V30 13 O 9.0732 6.9711 0 0
M  V30 14 C 6.0732 6.971 0 0
M  V30 15 C 4.5732 6.9709 0 0
M  V30 16 C 3.8233 5.6718 0 0
M  V30 17 C 4.5733 4.3728 0 0
M  V30 18 C 6.0733 4.3729 0 0
M  V30 19 N 6.8233 5.672 0 0
M  V30 20 O 2.3233 5.6718 0 0
M  V30 21 C 1.5733 4.3727 0 0
M  V30 22 C 0.0733 4.3726 0 0
M  V30 23 C -1.2257 3.6226 0 0
M  V30 24 C -1.2257 5.1226 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 7
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 1 5 10
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 11 12 CFG=1
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 2 14 19
M  V30 18 2 15 16
M  V30 19 1 16 17
M  V30 20 1 16 20
M  V30 21 2 17 18
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
h259_31

> <ID>
h259_31

> <PRIMARY_SOM>
11

> <SECONDARY_SOM>
2

> <TERTIARY_SOM>
21

> <Citation>
Abelo et al.,Drug Metab. Disp.,28,58,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
halofantrine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -12.4413 -4.5 0 0
M  V30 2 C -12.4413 -3 0 0
M  V30 3 C -13.7404 -2.25 0 0
M  V30 4 C -15.0394 -3 0 0
M  V30 5 C -15.0394 -4.5 0 0
M  V30 6 C -13.7404 -5.25 0 0
M  V30 7 C -13.7404 -6.75 0 0
M  V30 8 C -15.0394 -7.5 0 0
M  V30 9 C -15.0394 -9 0 0
M  V30 10 C -13.7404 -9.75 0 0
M  V30 11 C -12.4413 -9 0 0
M  V30 12 C -12.4413 -7.5 0 0
M  V30 13 C -11.1423 -6.75 0 0
M  V30 14 C -11.1423 -5.25 0 0
M  V30 15 C -9.8433 -4.5 0 0 CFG=1
M  V30 16 C -8.5442 -5.25 0 0
M  V30 17 C -7.2452 -4.5 0 0
M  V30 18 N -5.9461 -5.25 0 0
M  V30 19 C -4.6471 -4.5 0 0
M  V30 20 C -3.3481 -5.25 0 0
M  V30 21 C -2.049 -4.5 0 0
M  V30 22 C -0.75 -5.25 0 0
M  V30 23 C -5.9461 -6.75 0 0
M  V30 24 C -4.6471 -7.5 0 0
M  V30 25 C -4.6471 -9 0 0
M  V30 26 C -3.3481 -9.75 0 0
M  V30 27 O -9.8433 -3 0 0
M  V30 28 C -16.3385 -2.25 0 0
M  V30 29 F -16.3385 -0.75 0 0
M  V30 30 F -17.6375 -3 0 0
M  V30 31 F -17.6375 -1.5 0 0
M  V30 32 Cl -11.1423 -9.75 0 0
M  V30 33 Cl -16.3385 -9.75 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 1 14
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 4 28
M  V30 8 1 5 6
M  V30 9 2 6 7
M  V30 10 1 7 8
M  V30 11 1 7 12
M  V30 12 2 8 9
M  V30 13 1 9 10
M  V30 14 1 9 33
M  V30 15 2 10 11
M  V30 16 1 11 12
M  V30 17 1 11 32
M  V30 18 2 12 13
M  V30 19 1 13 14
M  V30 20 1 14 15
M  V30 21 1 15 16
M  V30 22 1 15 27 CFG=3
M  V30 23 1 16 17
M  V30 24 1 17 18
M  V30 25 1 18 19
M  V30 26 1 18 23
M  V30 27 1 19 20
M  V30 28 1 20 21
M  V30 29 1 21 22
M  V30 30 1 23 24
M  V30 31 1 24 25
M  V30 32 1 25 26
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 28 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
halofantrine

> <ID>
halofantrine

> <PRIMARY_SOM>
23 19

> <Citation>
Flinois et al.,J. Pharm. Pharmacol.,51,419,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
haloperidol
  SciTegic08102311032D

 26 28  0  0  0  0            999 V2000
   -0.7500   12.0000    0.0000 C   0  0
   -0.7500   13.5000    0.0000 C   0  0
   -2.0490   14.2500    0.0000 C   0  0
   -3.3481   13.5000    0.0000 C   0  0
   -3.3481   12.0000    0.0000 C   0  0
   -2.0491   11.2500    0.0000 N   0  0
   -2.0491    9.7500    0.0000 C   0  0
   -1.0849   15.3991    0.0000 O   0  0
   -3.0132   15.3991    0.0000 C   0  0
   -4.4904   15.1386    0.0000 C   0  0
   -5.4546   16.2877    0.0000 C   0  0
   -4.9416   17.6972    0.0000 C   0  0
   -3.4644   17.9577    0.0000 C   0  0
   -2.5002   16.8086    0.0000 C   0  0
   -5.9058   18.8463    0.0000 Cl  0  0
   -3.3481    9.0000    0.0000 C   0  0
   -3.3481    7.5000    0.0000 C   0  0
   -4.6471    6.7500    0.0000 C   0  0
   -4.6471    5.2500    0.0000 C   0  0
   -5.9462    4.5000    0.0000 C   0  0
   -5.9462    3.0000    0.0000 C   0  0
   -4.6471    2.2500    0.0000 C   0  0
   -3.3481    3.0000    0.0000 C   0  0
   -3.3481    4.5000    0.0000 C   0  0
   -4.6471    0.7500    0.0000 F   0  0
   -5.9462    7.5000    0.0000 O   0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  3  8  1  0
  3  9  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7 16  1  0
  9 10  1  0
  9 14  2  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 15  1  0
 13 14  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 26  2  0
 19 20  1  0
 19 24  2  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 22 25  1  0
 23 24  1  0
M  END
> <Name>
haloperidol

> <ID>
haloperidol

> <PRIMARY_SOM>
7

> <SECONDARY_SOM>
5 1

> <TERTIARY_SOM>
3

> <Citation>
Fang et al.,Drug Metab. Disp.,12,1638,2001
Avent et al.,Chem. Res. Toxicol.,19,914,2006

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
hydrocodone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -1.5531 6.3099 0 0 CFG=2
M  V30 2 C -1.5531 7.8099 0 0
M  V30 3 C -2.8522 5.5599 0 0 CFG=2
M  V30 4 C -0.2541 5.5599 0 0 CFG=1
M  V30 5 C -1.5531 4.8099 0 0
M  V30 6 C -0.1042 8.1981 0 0
M  V30 7 C -2.8522 8.5599 0 0
M  V30 8 C -4.1512 6.3099 0 0 CFG=1
M  V30 9 C -2.8522 4.0599 0 0
M  V30 10 O 0.6458 6.8991 0 0
M  V30 11 C -0.2541 4.0599 0 0
M  V30 12 C -3.2404 4.111 0 0
M  V30 13 C -0.2376 9.724 0 0
M  V30 14 C -4.1512 7.8099 0 0
M  V30 15 C -2.7737 10.0578 0 0
M  V30 16 N -4.5394 4.861 0 0
M  V30 17 C -1.5531 3.3099 0 0
M  V30 18 O 1.0449 3.3099 0 0
M  V30 19 C -1.4034 10.6679 0 0
M  V30 20 O 1.0868 10.4281 0 0
M  V30 21 C -5.9253 4.287 0 0
M  V30 22 C 1.1392 11.9272 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5 CFG=3
M  V30 5 2 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 3 9 CFG=1
M  V30 9 1 4 10 CFG=1
M  V30 10 1 4 11
M  V30 11 1 5 12
M  V30 12 1 6 10
M  V30 13 1 6 13
M  V30 14 1 7 14
M  V30 15 2 7 15
M  V30 16 1 8 14 CFG=3
M  V30 17 1 8 16
M  V30 18 1 9 17
M  V30 19 1 11 17
M  V30 20 2 11 18
M  V30 21 1 12 16
M  V30 22 2 13 19
M  V30 23 1 13 20
M  V30 24 1 15 19
M  V30 25 1 16 21
M  V30 26 1 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 3 4 8) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
hydrocodone

> <ID>
hydrocodone

> <PRIMARY_SOM>
21

> <Citation>
Hutchinson et al.,Br. J. Clin. Pharm.,57,287,2004

> <DOI>
10.1046/j.1365-2125.2003.02002.x

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
hydromorphone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0274 -9.7563 0 0
M  V30 2 C 1.7284 -9.0063 0 0
M  V30 3 C 1.7284 -7.5063 0 0 CFG=2
M  V30 4 C 0.4294 -9.7563 0 0
M  V30 5 C 0.4294 -6.7563 0 0 CFG=1
M  V30 6 O 2.6283 -6.1671 0 0
M  V30 7 C -0.8697 -9.0063 0 0
M  V30 8 C 0.4294 -5.2563 0 0
M  V30 9 C -0.8697 -7.5063 0 0 CFG=2
M  V30 10 C 0.4294 -8.2563 0 0
M  V30 11 C 1.8783 -4.8681 0 0
M  V30 12 C -0.8697 -4.5063 0 0
M  V30 13 C -2.1687 -6.7563 0 0 CFG=2
M  V30 14 C -1.2579 -8.9552 0 0
M  V30 15 C 1.7449 -3.3423 0 0
M  V30 16 C -2.1687 -5.2563 0 0
M  V30 17 C -0.7912 -3.0084 0 0
M  V30 18 N -2.5569 -8.2052 0 0
M  V30 19 O 3.0693 -2.6381 0 0
M  V30 20 C 0.5791 -2.3983 0 0
M  V30 21 C -3.9428 -8.7792 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6 CFG=3
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 5 10 CFG=1
M  V30 10 1 6 11
M  V30 11 1 9 7 CFG=3
M  V30 12 2 8 11
M  V30 13 1 8 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 2 12 17
M  V30 19 1 13 16 CFG=1
M  V30 20 1 13 18
M  V30 21 1 14 18
M  V30 22 1 15 19
M  V30 23 2 15 20
M  V30 24 1 17 20
M  V30 25 1 18 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 3 5 9 13) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
hydromorphone

> <ID>
hydromorphone

> <PRIMARY_SOM>
21

> <Citation>
Benetton et al.,Xenobiotica,34,335,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ifosfamide
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.3164 -0.126 0 0 CFG=1
M  V30 2 N 4.3164 1.374 0 0
M  V30 3 O 3.0174 -0.876 0 0
M  V30 4 O 4.8294 -1.5356 0 0
M  V30 5 N 5.7936 0.1344 0 0
M  V30 6 C 5.6154 2.124 0 0
M  V30 7 C 6.7578 -1.0146 0 0
M  V30 8 C 3.0174 2.124 0 0
M  V30 9 Cl 6.9145 4.374 0 0
M  V30 10 Cl 9.1992 -1.9032 0 0
M  V30 11 C 1.7183 1.374 0 0
M  V30 12 C 1.7183 -0.126 0 0
M  V30 13 C 5.6154 3.624 0 0
M  V30 14 C 8.235 -0.7542 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 1 5 CFG=1
M  V30 5 1 2 6
M  V30 6 1 2 8
M  V30 7 1 3 12
M  V30 8 1 5 7
M  V30 9 1 6 13
M  V30 10 1 7 14
M  V30 11 1 8 11
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
ifosfamide

> <ID>
ifosfamide

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
7 6

> <Citation>
Roy et al.,Drug Metab. Disp.,27,655,1999
Roy et al.,Drug Metab. Disp.,27,1309,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
iloperidone
  SciTegic08102311032D

 31 34  0  0  0  0            999 V2000
    4.6471    5.7680    0.0000 C   0  0
    5.7618    4.7643    0.0000 C   0  0
    4.6471    7.2680    0.0000 C   0  0
    3.3481    8.0180    0.0000 C   0  0
    2.0490    7.2680    0.0000 C   0  0
    2.0490    5.7680    0.0000 C   0  0
    3.3481    5.0180    0.0000 C   0  0
    0.7500    8.0180    0.0000 F   0  0
    3.6599    3.5507    0.0000 O   0  0
    5.1517    3.3939    0.0000 N   0  0
    7.2291    5.0761    0.0000 C   0  0
    7.6926    6.5027    0.0000 C   0  0
    9.1598    6.8146    0.0000 C   0  0
   10.1635    5.6999    0.0000 N   0  0
    9.7000    4.2733    0.0000 C   0  0
    8.2328    3.9614    0.0000 C   0  0
   11.6307    6.0117    0.0000 C   0  0
   12.6344    4.8970    0.0000 C   0  0
   14.1016    5.2089    0.0000 C   0  0
   15.1053    4.0942    0.0000 O   0  0
   16.5726    4.4060    0.0000 C   0  0
   17.0361    5.8326    0.0000 C   0  0
   18.5033    6.1445    0.0000 C   0  0
   19.5070    5.0298    0.0000 C   0  0
   19.0435    3.6032    0.0000 C   0  0
   17.5763    3.2913    0.0000 C   0  0
   20.9742    5.3416    0.0000 C   0  0
   17.1127    1.8647    0.0000 O   0  0
   18.1164    0.7500    0.0000 C   0  0
   21.9779    4.2269    0.0000 O   0  0
   21.4378    6.7682    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  7  2  0
  2 10  2  0
  2 11  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  8  1  0
  6  7  1  0
  7  9  1  0
  9 10  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 17  1  0
 15 16  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 26  2  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 24 27  1  0
 25 26  1  0
 26 28  1  0
 27 30  2  0
 27 31  1  0
 28 29  1  0
M  END
> <Name>
iloperidone

> <ID>
iloperidone

> <PRIMARY_SOM>
29

> <SECONDARY_SOM>
27 30

> <Citation>
Mutlib et al.,J. Pharm. Exp. Ther.,286,1285,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
imatinib
  SciTegic08102311032D

 37 41  0  0  0  0            999 V2000
    2.3226   19.0246    0.0000 N   0  0
    2.3225   20.5246    0.0000 C   0  0
    1.0234   21.2746    0.0000 C   0  0
   -0.2756   20.5245    0.0000 N   0  0
   -0.2755   19.0245    0.0000 C   0  0
    1.0236   18.2746    0.0000 C   0  0
   -1.5746   21.2745    0.0000 C   0  0
    3.6217   18.2747    0.0000 C   0  0
    3.6217   16.7747    0.0000 C   0  0
    4.9208   16.0248    0.0000 C   0  0
    4.9209   14.5248    0.0000 C   0  0
    3.6219   13.7747    0.0000 C   0  0
    2.3228   14.5246    0.0000 C   0  0
    2.3227   16.0246    0.0000 C   0  0
    3.6220   12.2747    0.0000 C   0  0
    4.9210   11.5248    0.0000 O   0  0
    2.3230   11.5246    0.0000 N   0  0
    2.3230   10.0246    0.0000 C   0  0
    1.0240    9.2746    0.0000 C   0  0
    1.0241    7.7746    0.0000 C   0  0
    2.3232    7.0246    0.0000 C   0  0
    3.6222    7.7747    0.0000 C   0  0
    3.6221    9.2747    0.0000 C   0  0
    2.3233    5.5246    0.0000 C   0  0
   -0.2749    7.0245    0.0000 N   0  0
   -1.5740    7.7744    0.0000 C   0  0
   -2.8730    7.0244    0.0000 N   0  0
   -4.1720    7.7743    0.0000 C   0  0
   -4.1721    9.2743    0.0000 C   0  0
   -2.8731   10.0244    0.0000 C   0  0
   -1.5740    9.2744    0.0000 N   0  0
   -5.4710    7.0242    0.0000 C   0  0
   -5.4710    5.5242    0.0000 C   0  0
   -6.7700    4.7742    0.0000 C   0  0
   -8.0690    5.5241    0.0000 C   0  0
   -8.0691    7.0241    0.0000 N   0  0
   -6.7701    7.7742    0.0000 C   0  0
  1  2  1  0
  1  6  1  0
  1  8  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  7  1  0
  5  6  1  0
  8  9  1  0
  9 10  1  0
  9 14  2  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 15  1  0
 13 14  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 18 23  2  0
 19 20  2  0
 20 21  1  0
 20 25  1  0
 21 22  2  0
 21 24  1  0
 22 23  1  0
 25 26  1  0
 26 27  1  0
 26 31  2  0
 27 28  2  0
 28 29  1  0
 28 32  1  0
 29 30  2  0
 30 31  1  0
 32 33  1  0
 32 37  2  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
M  END
> <Name>
imatinib

> <ID>
imatinib

> <PRIMARY_SOM>
7

> <Citation>
Novartis Pharmaceuticals,Gleevec(imatinib mesylate)[full prescribing information],2002

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
imidacloprid
  SciTegic08102311032D

 17 18  0  0  0  0            999 V2000
    8.0572   -1.0445    0.0000 N   0  0
    9.2707   -1.9262    0.0000 C   0  0
    8.0572    0.4555    0.0000 C   0  0
    6.8437   -1.9262    0.0000 C   0  0
    8.8072   -3.3528    0.0000 N   0  0
   10.6973   -1.4627    0.0000 N   0  0
    6.7582    1.2055    0.0000 C   0  0
    7.3072   -3.3528    0.0000 C   0  0
   11.8120   -2.4663    0.0000 N   0  3
    6.7582    2.7055    0.0000 C   0  0
    5.4591    0.4555    0.0000 C   0  0
   11.5002   -3.9336    0.0000 O   0  5
   13.2386   -2.0028    0.0000 O   0  0
    5.4591    3.4555    0.0000 C   0  0
    4.1601    1.2055    0.0000 N   0  0
    4.1601    2.7055    0.0000 C   0  0
    2.8610    3.4555    0.0000 Cl  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  4  8  1  0
  5  8  1  0
  6  9  1  0
  7 10  2  0
  7 11  1  0
  9 12  1  0
  9 13  2  0
 10 14  1  0
 11 15  2  0
 14 16  2  0
 15 16  1  0
 16 17  1  0
M  CHG  2   9   1  12  -1
M  END
> <Name>
imidacloprid

> <ID>
imidacloprid

> <PRIMARY_SOM>
8

> <Citation>
Schultz-Jander et al.,Chem. Res. Toxicol.,15,1158,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
imipramine
  SciTegic08102311032D

 21 23  0  0  0  0            999 V2000
    7.8616   -2.8072    0.0000 C   0  0
    8.3037   -4.2405    0.0000 C   0  0
    6.3992   -2.4734    0.0000 N   0  0
    9.7661   -4.5743    0.0000 C   0  0
    6.0654   -1.0110    0.0000 C   0  0
    5.4640   -3.6462    0.0000 C   0  0
   10.2083   -6.0077    0.0000 N   0  0
    4.7140   -0.3602    0.0000 C   0  0
    7.3048   -0.1660    0.0000 C   0  0
    3.9640   -3.6462    0.0000 C   0  0
    6.2140   -4.9452    0.0000 C   0  0
   11.6707   -6.3414    0.0000 C   0  0
    9.1880   -7.1073    0.0000 C   0  0
    3.3625   -1.0110    0.0000 C   0  0
    4.6019    1.1356    0.0000 C   0  0
    7.1927    1.3298    0.0000 C   0  0
    3.0287   -2.4734    0.0000 C   0  0
    3.2140   -4.9452    0.0000 C   0  0
    5.4640   -6.2443    0.0000 C   0  0
    5.8412    1.9806    0.0000 C   0  0
    3.9640   -6.2443    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  3  6  1  0
  4  7  1  0
  5  8  2  0
  5  9  1  0
  6 10  2  0
  6 11  1  0
  7 12  1  0
  7 13  1  0
  8 14  1  0
  8 15  1  0
  9 16  2  0
 10 17  1  0
 10 18  1  0
 11 19  2  0
 14 17  1  0
 15 20  2  0
 16 20  1  0
 18 21  2  0
 19 21  1  0
M  END
> <Name>
imipramine

> <ID>
imipramine

> <PRIMARY_SOM>
12 13

> <SECONDARY_SOM>
20 21

> <Citation>
E. Koyama, K. Chiba, M. Tani, T. Ishizaki, J. Pharmacol. Exp. Ther. 1997, 281, 1199-1210.

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
indinavir
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 45 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3493 -3 0 0
M  V30 2 C 7.7759 -3.4635 0 0 CFG=1
M  V30 3 C 6.3493 -1.5 0 0
M  V30 4 C 5.0503 -3.75 0 0
M  V30 5 C 8.6576 -2.25 0 0 CFG=1
M  V30 6 N 8.2394 -4.8901 0 0
M  V30 7 C 7.7759 -1.0364 0 0
M  V30 8 C 5.0502 -0.75 0 0
M  V30 9 C 3.7512 -3 0 0
M  V30 10 O 10.1576 -2.25 0 0
M  V30 11 C 7.2357 -6.0048 0 0
M  V30 12 C 3.7512 -1.5 0 0
M  V30 13 C 7.6993 -7.4314 0 0 CFG=2
M  V30 14 O 5.7685 -5.6929 0 0
M  V30 15 C 9.1665 -7.7432 0 0
M  V30 16 C 6.6956 -8.5461 0 0
M  V30 17 C 10.1702 -6.6285 0 0
M  V30 18 C 7.1591 -9.9727 0 0 CFG=1
M  V30 19 C 11.6374 -6.9404 0 0
M  V30 20 C 9.7066 -5.2019 0 0
M  V30 21 C 6.1554 -11.0874 0 0
M  V30 22 O 8.6263 -10.2845 0 0
M  V30 23 C 12.6411 -5.8256 0 0
M  V30 24 C 10.7103 -4.0872 0 0
M  V30 25 N 6.6189 -12.514 0 0
M  V30 26 C 12.1775 -4.3991 0 0
M  V30 27 C 5.6153 -13.6287 0 0 CFG=1
M  V30 28 C 8.0862 -12.8259 0 0
M  V30 29 C 6.0788 -15.0553 0 0
M  V30 30 C 4.148 -13.3169 0 0
M  V30 31 C 8.5497 -14.2524 0 0
M  V30 32 N 7.546 -15.3672 0 0
M  V30 33 N 3.6845 -11.8903 0 0
M  V30 34 O 3.1443 -14.4316 0 0
M  V30 35 C 8.0095 -16.7937 0 0
M  V30 36 C 2.2173 -11.5784 0 0
M  V30 37 C 9.4768 -17.1056 0 0
M  V30 38 C 1.7537 -10.1518 0 0
M  V30 39 C 0.75 -11.2666 0 0
M  V30 40 C 1.2136 -12.6931 0 0
M  V30 41 C 9.9403 -18.5322 0 0
M  V30 42 C 10.4805 -15.9909 0 0
M  V30 43 C 11.4075 -18.844 0 0
M  V30 44 N 11.9477 -16.3027 0 0
M  V30 45 C 12.4112 -17.7293 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 5 7
M  V30 10 1 5 10 CFG=1
M  V30 11 1 6 11
M  V30 12 2 8 12
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 13 15 CFG=3
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 18 22 CFG=3
M  V30 24 1 19 23
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 2 23 26
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 1 27 29
M  V30 32 1 27 30 CFG=1
M  V30 33 1 28 31
M  V30 34 1 29 32
M  V30 35 1 30 33
M  V30 36 2 30 34
M  V30 37 1 31 32
M  V30 38 1 32 35
M  V30 39 1 33 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 36 39
M  V30 43 1 36 40
M  V30 44 2 37 41
M  V30 45 1 37 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 2 5 13 18 27) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
indinavir

> <ID>
indinavir

> <PRIMARY_SOM>
35

> <SECONDARY_SOM>
44

> <TERTIARY_SOM>
26 7

> <Citation>
Chiba et al.,Biochem. Pharmacol.,53,1187,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
indomethacin_phenethylamide
  SciTegic08102311032D

 33 36  0  0  0  0            999 V2000
    0.2238    8.6124    0.0000 C   0  0
    0.2237   10.1124    0.0000 C   0  0
    1.6503    8.1489    0.0000 N   0  0
   -1.0753    7.8624    0.0000 C   0  0
    1.6503   10.5760    0.0000 C   0  0
   -1.0753   10.8624    0.0000 C   0  0
    2.5320    9.3624    0.0000 C   0  0
    2.1139    6.7223    0.0000 C   0  0
   -2.3743    8.6124    0.0000 C   0  0
    2.1139   12.0026    0.0000 C   0  0
   -2.3743   10.1124    0.0000 C   0  0
    4.0320    9.3624    0.0000 C   0  0
    3.5811    6.4105    0.0000 C   0  0
    1.1102    5.6076    0.0000 O   0  0
    3.5811   12.3144    0.0000 C   0  0
   -3.6734   10.8624    0.0000 O   0  0
    4.0446    4.9839    0.0000 C   0  0
    4.5848    7.5252    0.0000 C   0  0
    4.5848   11.1997    0.0000 O   0  0
   -4.9724   10.1125    0.0000 C   0  0
    5.5118    4.6720    0.0000 C   0  0
    6.0520    7.2133    0.0000 C   0  0
    6.5155    5.7867    0.0000 C   0  0
    7.9827    5.4749    0.0000 Cl  0  0
    4.0446   13.7410    0.0000 N   0  0
    5.5118   14.0529    0.0000 C   0  0
    5.9754   15.4795    0.0000 C   0  0
    7.4426   15.7913    0.0000 C   0  0
    7.9061   17.2179    0.0000 C   0  0
    9.3733   17.5298    0.0000 C   0  0
   10.3770   16.4151    0.0000 C   0  0
    9.9135   14.9885    0.0000 C   0  0
    8.4463   14.6766    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  5  7  2  0
  5 10  1  0
  6 11  2  0
  7 12  1  0
  8 13  1  0
  8 14  2  0
  9 11  1  0
 10 15  1  0
 11 16  1  0
 13 17  2  0
 13 18  1  0
 15 19  2  0
 15 25  1  0
 16 20  1  0
 17 21  1  0
 18 22  2  0
 21 23  2  0
 22 23  1  0
 23 24  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 33  2  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
M  END
> <Name>
indomethacin_phenethylamide

> <ID>
indomethacin_phenethylamide

> <PRIMARY_SOM>
27

> <SECONDARY_SOM>
26

> <Citation>
Remmel et al.,Drug Metab. Disp.,32,113,2004

> <DOI>
10.1124/dmd.32.1.113

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
irinotecan
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 43 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -18.0963 -8.3884 0 0
M  V30 2 C -20.6944 -8.3884 0 0
M  V30 3 C -18.0963 -6.8884 0 0
M  V30 4 C -20.6944 -6.8884 0 0
M  V30 5 C -19.3954 -9.1384 0 0
M  V30 6 C -16.6697 -6.4248 0 0
M  V30 7 C -15.7881 -7.6383 0 0
M  V30 8 C -19.3954 -6.1384 0 0
M  V30 9 N -16.0596 -5.0545 0 0
M  V30 10 C -21.9934 -6.1384 0 0 CFG=1
M  V30 11 C -16.6697 -8.8519 0 0
M  V30 12 C -9.4824 -3.057 0 0
M  V30 13 C -14.2963 -7.4816 0 0
M  V30 14 N -7.9906 -2.9002 0 0
M  V30 15 C -23.2925 -6.8884 0 0
M  V30 16 C -13.6862 -6.1112 0 0
M  V30 17 C -14.5678 -4.8977 0 0
M  V30 18 C -21.9934 -9.1384 0 0
M  V30 19 O -23.2925 -8.3884 0 0
M  V30 20 N -3.5153 -2.4298 0 0
M  V30 21 O -10.0925 -4.4273 0 0
M  V30 22 C -5.007 -2.5866 0 0
M  V30 23 O -19.3953 -10.6384 0 0
M  V30 24 C -12.1944 -5.9544 0 0
M  V30 25 C -5.8887 -1.3731 0 0
M  V30 26 C -5.6171 -3.9569 0 0
M  V30 27 C -7.3805 -1.5299 0 0
M  V30 28 C -7.1089 -4.1137 0 0
M  V30 29 O -10.3641 -1.8435 0 0
M  V30 30 C -11.5843 -4.5841 0 0
M  V30 31 O -24.5915 -6.1384 0 0
M  V30 32 C -13.9577 -3.5274 0 0
M  V30 33 O -22.9576 -4.9893 0 0
M  V30 34 C -12.466 -3.3706 0 0
M  V30 35 C -21.0293 -4.9893 0 0
M  V30 36 C -13.4146 -8.6951 0 0
M  V30 37 C -2.9052 -1.0595 0 0
M  V30 38 C -2.6336 -3.6433 0 0
M  V30 39 C -21.5423 -3.5798 0 0
M  V30 40 C -11.9228 -8.5383 0 0
M  V30 41 C -1.4134 -0.9027 0 0
M  V30 42 C -1.1418 -3.4866 0 0
M  V30 43 C -0.5317 -2.1162 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 1 2 5
M  V30 6 1 2 18
M  V30 7 1 3 6
M  V30 8 2 3 8
M  V30 9 1 4 8
M  V30 10 1 4 10
M  V30 11 2 5 23
M  V30 12 1 6 7
M  V30 13 2 6 9
M  V30 14 1 7 11
M  V30 15 2 7 13
M  V30 16 1 9 17
M  V30 17 1 10 15
M  V30 18 1 10 33 CFG=1
M  V30 19 1 10 35
M  V30 20 1 12 14
M  V30 21 1 12 21
M  V30 22 2 12 29
M  V30 23 1 13 16
M  V30 24 1 13 36
M  V30 25 1 14 27
M  V30 26 1 14 28
M  V30 27 1 15 19
M  V30 28 2 15 31
M  V30 29 2 16 17
M  V30 30 1 16 24
M  V30 31 1 17 32
M  V30 32 1 18 19
M  V30 33 1 20 22
M  V30 34 1 20 37
M  V30 35 1 20 38
M  V30 36 1 21 30
M  V30 37 1 22 25
M  V30 38 1 22 26
M  V30 39 2 24 30
M  V30 40 1 25 27
M  V30 41 1 26 28
M  V30 42 1 30 34
M  V30 43 2 32 34
M  V30 44 1 35 39
M  V30 45 1 36 40
M  V30 46 1 37 41
M  V30 47 1 38 42
M  V30 48 1 41 43
M  V30 49 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
irinotecan

> <ID>
irinotecan

> <PRIMARY_SOM>
38 37

> <Citation>
Sai et al.,Drug Metab. Disp.,29,1505,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
isoquinoline
  SciTegic08102311032D

 10 11  0  0  0  0            999 V2000
    0.0000    0.8760    0.0000 C   0  0
    0.0000   -0.8760    0.0000 C   0  0
   -1.5210    1.7520    0.0000 C   0  0
    1.5170    1.7550    0.0000 C   0  0
   -1.5170   -1.7550    0.0000 C   0  0
    1.5210   -1.7520    0.0000 C   0  0
   -3.0450    0.8790    0.0000 C   0  0
    3.0410    0.8760    0.0000 C   0  0
   -3.0410   -0.8760    0.0000 C   0  0
    3.0450   -0.8790    0.0000 N   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  4  8  2  0
  5  9  2  0
  6 10  2  0
  7  9  1  0
  8 10  1  0
M  END
> <Name>
isoquinoline

> <ID>
isoquinoline

> <PRIMARY_SOM>
10

> <Citation>
Dowers et al.,Drug Metab. Disp.,32,328,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
itraconazole
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 49 55 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -2.3493 7.2303 0 0 CFG=2
M  V30 2 C -3.6483 7.9803 0 0
M  V30 3 O -1.7392 8.6006 0 0
M  V30 4 C -3.231 6.0168 0 0
M  V30 5 O -1.2346 6.2266 0 0
M  V30 6 C -3.6483 9.4803 0 0
M  V30 7 C -4.9474 7.2303 0 0
M  V30 8 C -0.2474 8.4438 0 0 CFG=1
M  V30 9 N -2.6209 4.6465 0 0
M  V30 10 C 0.0645 6.9766 0 0
M  V30 11 C -4.9474 10.2303 0 0
M  V30 12 Cl -2.3493 10.2303 0 0
M  V30 13 C -6.2464 7.9803 0 0
M  V30 14 C 0.7563 9.5585 0 0
M  V30 15 C -3.3709 3.3474 0 0
M  V30 16 N -1.1536 4.3346 0 0
M  V30 17 C -6.2464 9.4803 0 0
M  V30 18 O 0.2928 10.9851 0 0
M  V30 19 N -2.3672 2.2327 0 0
M  V30 20 C -0.9968 2.8428 0 0
M  V30 21 Cl -7.5454 10.2303 0 0
M  V30 22 C 1.2965 12.0998 0 0
M  V30 23 C 0.833 13.5264 0 0
M  V30 24 C 2.7637 11.788 0 0
M  V30 25 C 1.8366 14.6411 0 0
M  V30 26 C 3.7674 12.9027 0 0
M  V30 27 C 3.3039 14.3293 0 0
M  V30 28 N 4.3076 15.444 0 0
M  V30 29 C 3.844 16.8706 0 0
M  V30 30 C 5.7748 15.1321 0 0
M  V30 31 C 4.8477 17.9853 0 0
M  V30 32 C 6.7785 16.2469 0 0
M  V30 33 N 6.315 17.6734 0 0
M  V30 34 C 7.3187 18.7882 0 0
M  V30 35 C 6.8551 20.2147 0 0
M  V30 36 C 8.7859 18.4763 0 0
M  V30 37 C 7.8588 21.3295 0 0
M  V30 38 C 9.7896 19.591 0 0
M  V30 39 C 9.326 21.0176 0 0
M  V30 40 N 10.3297 22.1323 0 0
M  V30 41 C 10.0179 23.5995 0 0
M  V30 42 C 11.8215 21.9755 0 0
M  V30 43 N 11.3169 24.3495 0 0
M  V30 44 O 8.6476 24.2096 0 0
M  V30 45 N 12.4316 23.3458 0 0
M  V30 46 C 11.4737 25.8413 0 0 CFG=2
M  V30 47 C 12.844 26.4514 0 0
M  V30 48 C 10.2602 26.723 0 0
M  V30 49 C 13.0008 27.9432 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 1 5
M  V30 5 2 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 2 7 13
M  V30 13 1 8 10
M  V30 14 1 8 14 CFG=3
M  V30 15 1 9 15
M  V30 16 1 9 16
M  V30 17 2 11 17
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 20
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 1 27 28
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 38 1 33 34
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 45 1 39 40
M  V30 46 1 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 2 41 44
M  V30 50 2 42 45
M  V30 51 1 43 45
M  V30 52 1 43 46
M  V30 53 1 46 47
M  V30 54 1 46 48 CFG=1
M  V30 55 1 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 8 46) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
itraconazole

> <ID>
itraconazole

> <PRIMARY_SOM>
47 46

> <Citation>
Isoherranen et al.,Drug Metab. Disp.,32,1121,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ivermectin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 61 67 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6887 -19.0125 0 0 CFG=1
M  V30 2 C 12.055 -19.6315 0 0 CFG=1
M  V30 3 C 9.4694 -19.8862 0 0 CFG=1
M  V30 4 C 10.5417 -17.5197 0 0
M  V30 5 O 10.8357 -20.5052 0 0
M  V30 6 C 12.8192 -18.2106 0 0
M  V30 7 C 12.202 -21.1243 0 0 CFG=1
M  V30 8 C 9.6164 -21.3789 0 0
M  V30 9 C 8.034 -20.3216 0 0
M  V30 10 C 11.9455 -16.9913 0 0
M  V30 11 C 9.8205 -13.2801 0 0
M  V30 12 C 10.9827 -21.998 0 0
M  V30 13 O 13.5682 -21.7434 0 0
M  V30 14 O 6.5348 -20.2725 0 0
M  V30 15 O 8.2297 -21.8087 0 0
M  V30 16 C 10.2359 -12.104 0 0
M  V30 17 C 11.1297 -23.4908 0 0
M  V30 18 C 5.1309 -19.7441 0 0 CFG=2
M  V30 19 C 8.7559 -11.8596 0 0
M  V30 20 C 5.3504 -17.2761 0 0
M  V30 21 C 3.9714 -18.7925 0 0
M  V30 22 C 7.433 -11.1525 0 0 CFG=1
M  V30 23 C 5.3602 -15.7761 0 0 CFG=1
M  V30 24 C 5.9531 -11.3969 0 0 CFG=2
M  V30 25 C 7.433 -9.6525 0 0
M  V30 26 O 4.0106 -15.1215 0 0
M  V30 27 C 6.6831 -16.4833 0 0
M  V30 28 O 5.3111 -14.2769 0 0
M  V30 29 O 5.2316 -10.0818 0 0
M  V30 30 C 4.6302 -12.104 0 0
M  V30 31 C 2.8387 -16.0579 0 0 CFG=2
M  V30 32 C 7.9569 -15.6911 0 0
M  V30 33 C 6.5849 -13.4849 0 0
M  V30 34 C 6.0097 -8.7994 0 0 CFG=1
M  V30 35 C 3.9095 -13.4024 0 0
M  V30 36 C 3.717 -10.914 0 0
M  V30 37 C 2.9857 -14.5651 0 0
M  V30 38 C 3.1793 -17.5187 0 0
M  V30 39 C 7.9078 -14.192 0 0 CFG=1
M  V30 40 C 5.2883 -7.4843 0 0
M  V30 41 O 7.5094 -8.8322 0 0
M  V30 42 C 9.1816 -13.3999 0 0
M  V30 43 C 6.0664 -6.202 0 0 CFG=1
M  V30 44 C 8.2876 -7.5498 0 0 CFG=2
M  V30 45 C 7.5661 -6.2347 0 0 CFG=2
M  V30 46 O 5.3449 -4.8869 0 0
M  V30 47 C 9.7872 -7.5825 0 0
M  V30 48 O 8.3442 -4.9523 0 0
M  V30 49 C 3.8453 -4.8542 0 0
M  V30 50 C 7.6227 -3.6372 0 0 CFG=1
M  V30 51 C 8.4009 -2.3549 0 0
M  V30 52 O 6.1231 -3.6045 0 0
M  V30 53 C 7.6794 -1.0398 0 0 CFG=1
M  V30 54 C 5.4016 -2.2894 0 0 CFG=2
M  V30 55 C 6.1798 -1.0071 0 0 CFG=2
M  V30 56 O 8.4576 0.2426 0 0
M  V30 57 C 3.902 -2.2567 0 0
M  V30 58 O 5.4583 0.308 0 0
M  V30 59 C 9.9572 0.2099 0 0
M  V30 60 C 9.1325 -11.9007 0 0
M  V30 61 C 10.5045 -14.1069 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5 CFG=3
M  V30 5 1 2 6 CFG=1
M  V30 6 1 2 7
M  V30 7 1 3 8 CFG=1
M  V30 8 1 3 9
M  V30 9 1 4 10
M  V30 10 2 4 11
M  V30 11 1 6 10
M  V30 12 1 7 12
M  V30 13 1 7 13 CFG=3
M  V30 14 2 8 12
M  V30 15 1 9 14
M  V30 16 2 9 15
M  V30 17 1 11 16
M  V30 18 1 12 17
M  V30 19 1 18 14 CFG=1
M  V30 20 2 16 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 23 20 CFG=3
M  V30 25 1 21 38
M  V30 26 1 22 24
M  V30 27 1 22 25 CFG=1
M  V30 28 1 23 26
M  V30 29 1 23 27
M  V30 30 1 23 28
M  V30 31 1 24 29 CFG=1
M  V30 32 1 24 30
M  V30 33 1 31 26 CFG=3
M  V30 34 1 27 32
M  V30 35 1 28 33
M  V30 36 1 34 29 CFG=1
M  V30 37 2 30 35
M  V30 38 1 30 36
M  V30 39 1 31 37
M  V30 40 1 31 38
M  V30 41 1 32 39
M  V30 42 1 33 39
M  V30 43 1 34 40
M  V30 44 1 34 41
M  V30 45 1 35 37
M  V30 46 1 39 42 CFG=1
M  V30 47 1 40 43
M  V30 48 1 41 44
M  V30 49 1 42 60
M  V30 50 1 42 61
M  V30 51 1 43 45
M  V30 52 1 43 46 CFG=3
M  V30 53 1 44 45
M  V30 54 1 44 47 CFG=3
M  V30 55 1 45 48 CFG=1
M  V30 56 1 46 49
M  V30 57 1 50 48 CFG=3
M  V30 58 1 50 51
M  V30 59 1 50 52
M  V30 60 1 51 53
M  V30 61 1 52 54
M  V30 62 1 53 55
M  V30 63 1 53 56 CFG=1
M  V30 64 1 54 55
M  V30 65 1 54 57 CFG=1
M  V30 66 1 55 58 CFG=3
M  V30 67 1 56 59
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(18 1 2 3 7 18 22 23 24 31 34 39 43 44 45 50  -
M  V30 53 54 55) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
ivermectin

> <ID>
ivermectin

> <PRIMARY_SOM>
59

> <SECONDARY_SOM>
42

> <TERTIARY_SOM>
17

> <Citation>
Zeng et al.,Xenobiotica,28,313,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
k_11777
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 41 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -11.5591 -5.2171 0 0 CFG=1
M  V30 2 C -11.5549 -3.7171 0 0
M  V30 3 C -10.2622 -5.9708 0 0
M  V30 4 N -12.8603 -5.9634 0 0
M  V30 5 C -10.2537 -2.9708 0 0
M  V30 6 N -8.9611 -5.2245 0 0
M  V30 7 O -10.2665 -7.4708 0 0
M  V30 8 C -14.1572 -5.2097 0 0
M  V30 9 C -10.2494 -1.4708 0 0
M  V30 10 C -8.9568 -3.7245 0 0
M  V30 11 C -7.6642 -5.9782 0 0 CFG=1
M  V30 12 N -15.4584 -5.956 0 0
M  V30 13 O -14.1529 -3.7097 0 0
M  V30 14 C -8.9483 -0.7245 0 0
M  V30 15 C -7.6556 -2.9782 0 0
M  V30 16 C -7.6684 -7.4782 0 0
M  V30 17 C -6.363 -5.2319 0 0
M  V30 18 C -16.7553 -5.2024 0 0
M  V30 19 C -15.4626 -7.456 0 0
M  V30 20 C -7.6514 -1.4782 0 0
M  V30 21 C -6.3715 -8.2319 0 0
M  V30 22 C -5.0661 -5.9856 0 0
M  V30 23 C -18.0564 -5.9487 0 0
M  V30 24 C -16.7638 -8.2023 0 0
M  V30 25 C -6.3758 -9.7319 0 0
M  V30 26 S -3.7649 -5.2393 0 0
M  V30 27 N -18.0607 -7.4487 0 0
M  V30 28 C -5.0789 -10.4856 0 0
M  V30 29 C -7.677 -10.4782 0 0
M  V30 30 C -3.0186 -6.5405 0 0
M  V30 31 O -2.4638 -4.493 0 0
M  V30 32 O -4.5112 -3.9381 0 0
M  V30 33 C -19.3618 -8.195 0 0
M  V30 34 C -5.0832 -11.9856 0 0
M  V30 35 C -7.6812 -11.9782 0 0
M  V30 36 C -3.7723 -7.8374 0 0
M  V30 37 C -1.5186 -6.5447 0 0
M  V30 38 C -6.3843 -12.7319 0 0
M  V30 39 C -3.026 -9.1385 0 0
M  V30 40 C -0.7723 -7.8459 0 0
M  V30 41 C -1.526 -9.1428 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 11 6 CFG=3
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 2 10 15
M  V30 15 1 11 16
M  V30 16 1 11 17
M  V30 17 1 12 18
M  V30 18 1 12 19
M  V30 19 2 14 20
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 2 17 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 1 24 27
M  V30 29 2 25 28
M  V30 30 1 25 29
M  V30 31 1 26 30
M  V30 32 2 26 31
M  V30 33 2 26 32
M  V30 34 1 27 33
M  V30 35 1 28 34
M  V30 36 2 29 35
M  V30 37 2 30 36
M  V30 38 1 30 37
M  V30 39 2 34 38
M  V30 40 1 35 38
M  V30 41 1 36 39
M  V30 42 2 37 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 11) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
k_11777

> <ID>
k_11777

> <PRIMARY_SOM>
33

> <SECONDARY_SOM>
27

> <TERTIARY_SOM>
16

> <Citation>
Jacobsen et al.,Drug Metab. Disp.,28,1343,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ketamine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -2.7972 4.9274 0 0
M  V30 2 C -2.7972 6.4274 0 0
M  V30 3 C -4.0962 7.1774 0 0
M  V30 4 C -5.3953 6.4274 0 0
M  V30 5 C -5.3953 4.9274 0 0
M  V30 6 C -4.0962 4.1774 0 0
M  V30 7 Cl -1.4982 4.1774 0 0
M  V30 8 C -4.0963 2.6774 0 0 CFG=1
M  V30 9 C -4.6093 1.2679 0 0
M  V30 10 C -3.6451 0.1188 0 0
M  V30 11 C -2.1679 0.3793 0 0
M  V30 12 C -1.6549 1.7889 0 0
M  V30 13 C -2.619 2.9379 0 0
M  V30 14 O -6.0865 1.0074 0 0
M  V30 15 N -5.5735 2.9379 0 0
M  V30 16 C -6.0865 4.3475 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 7
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 13
M  V30 11 1 8 15 CFG=1
M  V30 12 1 9 10
M  V30 13 2 9 14
M  V30 14 1 10 11
M  V30 15 1 11 12
M  V30 16 1 12 13
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
ketamine

> <ID>
ketamine

> <PRIMARY_SOM>
16

> <Citation>
Hijazi et al.,Drug Metab. Dispos.,30,853,2002

> <DOI>
10.1124/dmd.30.7.853

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ketobemidone
  SciTegic08102311032D

 18 19  0  0  0  0            999 V2000
    4.9216   -2.5245    0.0000 C   0  0
    5.4347   -3.9340    0.0000 C   0  0
    4.9216   -1.0245    0.0000 C   0  0
    3.6226   -3.2745    0.0000 C   0  0
    6.3989   -2.2640    0.0000 C   0  0
    6.9119   -4.1945    0.0000 C   0  0
    4.4705   -5.0831    0.0000 C   0  0
    3.6226   -0.2745    0.0000 C   0  0
    2.3236   -2.5245    0.0000 C   0  0
    6.9119   -0.8545    0.0000 C   0  0
    7.3630   -3.4131    0.0000 O   0  0
    7.4249   -5.6041    0.0000 C   0  0
    4.9835   -6.4927    0.0000 C   0  0
    2.3236   -1.0245    0.0000 N   0  0
    8.3891   -0.5940    0.0000 C   0  0
    6.4607   -6.7531    0.0000 C   0  0
    8.9021   -5.8645    0.0000 O   0  0
    1.0245   -0.2745    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  2  0
  2  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  2  0
  6 12  1  0
  7 13  2  0
  8 14  1  0
  9 14  1  0
 10 15  1  0
 12 16  2  0
 12 17  1  0
 13 16  1  0
 14 18  1  0
M  END
> <Name>
ketobemidone

> <ID>
ketobemidone

> <PRIMARY_SOM>
18

> <Citation>
Yasar et al.,Xenobiotica,35,785,2005

> <DOI>
10.1080/00498250500183181

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
kr_33028
  SciTegic08102311032D

 17 18  0  0  0  0            999 V2000
    6.8702    0.1005    0.0000 C   0  0
    6.8702    1.6005    0.0000 C   0  0
    5.5712    2.3505    0.0000 C   0  0
    4.2721    1.6005    0.0000 C   0  0
    4.2721    0.1005    0.0000 C   0  0
    5.5712   -0.6495    0.0000 C   0  0
    7.9849   -0.9032    0.0000 S   0  0
    5.8830   -2.1167    0.0000 C   0  0
    7.3748   -2.2735    0.0000 C   0  0
    8.1248   -3.5726    0.0000 C   0  0
    9.6248   -3.5726    0.0000 O   0  0
    7.3748   -4.8716    0.0000 N   0  0
    8.1248   -6.1706    0.0000 C   0  0
    7.3748   -7.4697    0.0000 N   0  0
    9.6248   -6.1706    0.0000 N   0  0
    2.9731   -0.6495    0.0000 C   0  0
    1.6740   -1.3995    0.0000 N   0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5 16  1  0
  6  8  1  0
  7  9  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 16 17  3  0
M  END
> <Name>
kr_33028

> <ID>
kr_33028

> <PRIMARY_SOM>
4

> <SECONDARY_SOM>
2

> <Citation>
Kim et al.,Toxicol. Lett.,166,105,2006

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
kr_60436
  SciTegic08102311032D

 31 34  0  0  0  0            999 V2000
    8.8188    0.2745    0.0000 C   0  0
    8.8187    1.7745    0.0000 C   0  0
    7.5197   -0.4755    0.0000 C   0  0
    9.9335   -0.7292    0.0000 N   0  0
    7.5197    2.5245    0.0000 C   0  0
   10.1178    2.5245    0.0000 C   0  0
    6.2207    0.2745    0.0000 C   0  0
    7.8316   -1.9427    0.0000 C   0  0
   11.4007   -0.4173    0.0000 C   0  0
    9.3234   -2.0995    0.0000 C   0  0
    7.5197    4.0245    0.0000 C   0  0
    6.2207    1.7745    0.0000 N   0  0
   10.1178    4.0245    0.0000 C   0  0
    4.9216   -0.4755    0.0000 N   0  0
   12.4044   -1.5320    0.0000 C   0  0
   11.8642    1.0093    0.0000 C   0  0
    8.8187    4.7745    0.0000 C   0  0
    6.2207    4.7745    0.0000 O   0  0
    3.6226    0.2745    0.0000 C   0  0
   13.8716   -1.2201    0.0000 C   0  0
   11.9409   -2.9586    0.0000 C   0  0
   13.3314    1.3212    0.0000 C   0  0
    6.2207    6.2745    0.0000 C   0  0
    2.3236   -0.4755    0.0000 C   0  0
   14.3351    0.2064    0.0000 C   0  0
    4.9216    7.0245    0.0000 F   0  0
    7.5197    7.0245    0.0000 F   0  0
    6.2207    7.7745    0.0000 F   0  0
    1.0245    0.2745    0.0000 O   0  0
   15.8024    0.5183    0.0000 O   0  0
   16.2659    1.9449    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  1  0
  5 11  1  0
  5 12  2  0
  6 13  2  0
  7 12  1  0
  7 14  1  0
  8 10  1  0
  9 15  2  0
  9 16  1  0
 11 17  2  0
 11 18  1  0
 13 17  1  0
 14 19  1  0
 15 20  1  0
 15 21  1  0
 16 22  2  0
 18 23  1  0
 19 24  1  0
 20 25  2  0
 22 25  1  0
 23 26  1  0
 23 27  1  0
 23 28  1  0
 24 29  1  0
 25 30  1  0
 30 31  1  0
M  END
> <Name>
kr_60436

> <ID>
kr_60436

> <PRIMARY_SOM>
8 10

> <SECONDARY_SOM>
19

> <TERTIARY_SOM>
31

> <Citation>
Ji et al.,Toxicology Lett.,155,103,2005

> <DOI>
10.1016/j.toxlet.2004.9.001

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
laam
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -1.722 8.9166 0 0
M  V30 2 C -1.2097 10.3264 0 0
M  V30 3 C -0.222 8.9173 0 0 CFG=2
M  V30 4 C -3.222 8.9159 0 0
M  V30 5 C -1.7212 7.4166 0 0
M  V30 6 C -2.1744 11.475 0 0 CFG=2
M  V30 7 O 0.5287 7.6187 0 0
M  V30 8 C 0.5274 10.2168 0 0
M  V30 9 C -3.9726 10.2145 0 0
M  V30 10 C -3.9713 7.6164 0 0
M  V30 11 C -3.0199 6.666 0 0
M  V30 12 C -0.4218 6.6672 0 0
M  V30 13 N -1.6621 12.8848 0 0
M  V30 14 C -3.6515 11.2138 0 0
M  V30 15 C 2.0287 7.6194 0 0
M  V30 16 C -5.4726 10.2138 0 0
M  V30 17 C -5.4713 7.6157 0 0
M  V30 18 C -3.0191 5.166 0 0
M  V30 19 C -0.4211 5.1672 0 0
M  V30 20 C -2.6268 14.0334 0 0
M  V30 21 C -0.185 13.146 0 0
M  V30 22 C -6.222 8.9144 0 0
M  V30 23 C -1.7197 4.4166 0 0
M  V30 24 O 2.7793 6.3208 0 0
M  V30 25 C -0.2233 11.5154 0 0
M  V30 26 C 2.778 8.9188 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7 CFG=1
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 4 10
M  V30 10 2 5 11
M  V30 11 1 5 12
M  V30 12 1 6 13
M  V30 13 1 6 14 CFG=1
M  V30 14 1 7 15
M  V30 15 1 8 25
M  V30 16 1 9 16
M  V30 17 2 10 17
M  V30 18 1 11 18
M  V30 19 2 12 19
M  V30 20 1 13 20
M  V30 21 1 13 21
M  V30 22 2 15 24
M  V30 23 1 15 26
M  V30 24 2 16 22
M  V30 25 1 17 22
M  V30 26 2 18 23
M  V30 27 1 19 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 3 6) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
laam

> <ID>
laam

> <PRIMARY_SOM>
20 21

> <Citation>
Moody et al.,Drug Metab. Disp.,25,1347,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
lansoprazole
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2722 -0.0947 0 0
M  V30 2 N 5.6995 -0.5563 0 0
M  V30 3 C 4.2702 1.4053 0 0
M  V30 4 C 2.9702 2.1536 0 0
M  V30 5 C 1.6721 1.4018 0 0
M  V30 6 C 1.6742 -0.0982 0 0
M  V30 7 C 2.9742 -0.8464 0 0
M  V30 8 N 5.6962 1.8708 0 0
M  V30 9 C 6.5795 0.6584 0 0
M  V30 10 S 8.0795 0.6605 0 0 CFG=2
M  V30 11 O 8.8277 1.9605 0 0
M  V30 12 C 8.8313 -0.6375 0 0
M  V30 13 C 10.3312 -0.6355 0 0
M  V30 14 C 11.083 -1.9335 0 0
M  V30 15 C 12.583 -1.9315 0 0
M  V30 16 C 13.3312 -0.6315 0 0
M  V30 17 C 12.5795 0.6666 0 0
M  V30 18 N 11.0795 0.6645 0 0
M  V30 19 C 10.3348 -3.2336 0 0
M  V30 20 O 13.3348 -3.2295 0 0
M  V30 21 C 14.8348 -3.2275 0 0
M  V30 22 C 15.5865 -4.5255 0 0
M  V30 23 F 17.0865 -4.5235 0 0
M  V30 24 F 14.8383 -5.8256 0 0
M  V30 25 F 16.3383 -5.8235 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 7
M  V30 4 1 2 9
M  V30 5 2 3 4
M  V30 6 1 3 8
M  V30 7 1 4 5
M  V30 8 2 5 6
M  V30 9 1 6 7
M  V30 10 2 8 9
M  V30 11 1 9 10
M  V30 12 2 10 11
M  V30 13 1 10 12 CFG=3
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 2 13 18
M  V30 17 2 14 15
M  V30 18 1 14 19
M  V30 19 1 15 16
M  V30 20 1 15 20
M  V30 21 2 16 17
M  V30 22 1 17 18
M  V30 23 1 20 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
lansoprazole

> <ID>
lansoprazole

> <PRIMARY_SOM>
10 11

> <SECONDARY_SOM>
5 6

> <Citation>
Kim et al.,Drug Metab. Disp.,31,1227,2003

> <DOI>
10.1124/dmd.31.10.1227

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
laquinimod
  SciTegic08102311032D

 25 27  0  0  0  0            999 V2000
    9.8433    3.7500    0.0000 C   0  0
    9.8433    5.2500    0.0000 C   0  0
    8.5442    3.0000    0.0000 C   0  0
   11.1423    3.0000    0.0000 C   0  0
    8.5442    6.0000    0.0000 N   0  0
   11.1423    6.0000    0.0000 C   0  0
    7.2452    3.7500    0.0000 C   0  0
    8.5442    1.5000    0.0000 O   0  0
   12.4413    3.7500    0.0000 C   0  0
   11.1423    1.5000    0.0000 Cl  0  0
    7.2452    5.2500    0.0000 C   0  0
    8.5442    7.5000    0.0000 C   0  0
   12.4413    5.2500    0.0000 C   0  0
    5.9462    3.0000    0.0000 C   0  0
    5.9461    6.0000    0.0000 O   0  0
    4.6471    3.7500    0.0000 N   0  0
    5.9462    1.5000    0.0000 O   0  0
    3.3481    3.0000    0.0000 C   0  0
    4.6471    5.2500    0.0000 C   0  0
    2.0490    3.7500    0.0000 C   0  0
    3.3481    1.5000    0.0000 C   0  0
    3.3481    6.0000    0.0000 C   0  0
    0.7500    3.0000    0.0000 C   0  0
    2.0490    0.7500    0.0000 C   0  0
    0.7500    1.5000    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  5 12  1  0
  6 13  2  0
  7 11  1  0
  7 14  1  0
  9 13  1  0
 11 15  2  0
 14 16  1  0
 14 17  2  0
 16 18  1  0
 16 19  1  0
 18 20  2  0
 18 21  1  0
 19 22  1  0
 20 23  1  0
 21 24  2  0
 23 25  2  0
 24 25  1  0
M  END
> <Name>
laquinimod

> <ID>
laquinimod

> <PRIMARY_SOM>
13 9 6

> <SECONDARY_SOM>
12

> <Citation>
Tuvesson et al.,Drug Metab. Disp.,33,866,2005

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
lidocaine
  SciTegic08102311032D

 17 17  0  0  0  0            999 V2000
    2.9731    9.6495    0.0000 C   0  0
    2.9731   11.1495    0.0000 C   0  0
    1.6740   11.8995    0.0000 C   0  0
    0.3750   11.1495    0.0000 C   0  0
    0.3750    9.6495    0.0000 C   0  0
    1.6740    8.8995    0.0000 C   0  0
    1.6740    7.3995    0.0000 N   0  0
    0.3750    6.6495    0.0000 C   0  0
    0.3750    5.1495    0.0000 C   0  0
   -0.9240    4.3995    0.0000 N   0  0
   -0.9240    2.8995    0.0000 C   0  0
   -2.2231    5.1495    0.0000 C   0  0
   -0.9240    7.3995    0.0000 O   0  0
    4.2721    8.8995    0.0000 C   0  0
   -0.9240    8.8995    0.0000 C   0  0
   -2.2231    2.1495    0.0000 C   0  0
   -3.5221    4.3995    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  1 14  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 15  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 13  2  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 11 16  1  0
 12 17  1  0
M  END
> <Name>
lidocaine

> <ID>
lidocaine

> <PRIMARY_SOM>
12 11

> <Citation>
Wang et al.,Drug Metab. Disp.,28,959,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
lilopristone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.4614 3.0254 0 0
M  V30 2 N 15.1635 2.2734 0 0
M  V30 3 C 15.1658 0.7734 0 0
M  V30 4 C 13.8633 3.0214 0 0
M  V30 5 C 12.5654 2.2694 0 0
M  V30 6 C 11.2652 3.0174 0 0
M  V30 7 C 11.2629 4.5174 0 0
M  V30 8 C 12.5608 5.2694 0 0
M  V30 9 C 13.861 4.5214 0 0
M  V30 10 C 9.9627 5.2654 0 0 CFG=2
M  V30 11 C 9.9604 6.7654 0 0
M  V30 12 C 8.6602 7.5134 0 0 CFG=2
M  V30 13 C 7.3623 6.7614 0 0 CFG=1
M  V30 14 C 7.3646 5.2614 0 0 CFG=2
M  V30 15 C 8.6648 4.5134 0 0
M  V30 16 C 11.2583 7.5174 0 0
M  V30 17 C 11.256 9.0174 0 0
M  V30 18 C 9.9558 9.7654 0 0
M  V30 19 C 8.6579 9.0134 0 0
M  V30 20 C 12.5585 6.7694 0 0
M  V30 21 C 13.8563 7.5214 0 0
M  V30 22 C 13.854 9.0214 0 0
M  V30 23 C 12.5538 9.7694 0 0
M  V30 24 O 15.1519 9.7734 0 0
M  V30 25 C 5.9388 4.7957 0 0 CFG=1
M  V30 26 C 5.0552 6.0078 0 0
M  V30 27 C 5.935 7.2227 0 0
M  V30 28 C 7.2101 3.7694 0 0
M  V30 29 C 4.6409 4.0437 0 0
M  V30 30 O 6.3039 3.3408 0 0
M  V30 31 C 3.3407 4.7917 0 0
M  V30 32 C 2.0428 4.0397 0 0
M  V30 33 O 0.7426 4.7876 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 4 5
M  V30 5 2 4 9
M  V30 6 2 5 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 10 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 15
M  V30 13 1 11 12
M  V30 14 2 11 16
M  V30 15 1 12 13
M  V30 16 1 12 19 CFG=3
M  V30 17 1 13 14
M  V30 18 1 13 27 CFG=1
M  V30 19 1 14 15
M  V30 20 1 14 25
M  V30 21 1 14 28 CFG=1
M  V30 22 1 16 17
M  V30 23 1 16 20
M  V30 24 1 17 18
M  V30 25 2 17 23
M  V30 26 1 18 19
M  V30 27 1 20 21
M  V30 28 1 21 22
M  V30 29 1 22 23
M  V30 30 2 22 24
M  V30 31 1 25 26
M  V30 32 1 25 29
M  V30 33 1 25 30 CFG=1
M  V30 34 1 26 27
M  V30 35 2 29 31
M  V30 36 1 31 32
M  V30 37 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 10 12 13 14 25) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
lilopristone

> <ID>
lilopristone

> <PRIMARY_SOM>
3 1

> <Citation>
Jang and Benet,Drug Metab. Disp.,25,1119,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
linoleic_acid
  SciTegic08102311032D

 20 19  0  0  0  0            999 V2000
    9.8433    1.5000    0.0000 C   0  0
   11.1423    0.7500    0.0000 C   0  0
    8.5442    0.7500    0.0000 C   0  0
   12.4413    1.5000    0.0000 C   0  0
    7.2452    1.5000    0.0000 C   0  0
   13.7404    0.7500    0.0000 C   0  0
    5.9462    0.7500    0.0000 C   0  0
   15.0394    1.5000    0.0000 C   0  0
    4.6471    1.5000    0.0000 C   0  0
   16.3385    0.7500    0.0000 C   0  0
    3.3481    0.7500    0.0000 C   0  0
   17.6375    1.5000    0.0000 C   0  0
    2.0490    1.5000    0.0000 C   0  0
   18.9365    0.7500    0.0000 C   0  0
    0.7500    0.7500    0.0000 O   0  0
    2.0490    3.0000    0.0000 O   0  0
   20.2356    1.5000    0.0000 C   0  0
   21.5346    0.7500    0.0000 C   0  0
   22.8337    1.5000    0.0000 C   0  0
   24.1327    0.7500    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  4  6  2  0
  5  7  1  0
  6  8  1  0
  7  9  1  0
  8 10  1  0
  9 11  1  0
 10 12  2  0
 11 13  1  0
 12 14  1  0
 13 15  2  0
 13 16  1  0
 14 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
M  END
> <Name>
linoleic_acid

> <ID>
linoleic_acid

> <PRIMARY_SOM>
4 6

> <SECONDARY_SOM>
8

> <TERTIARY_SOM>
10 12

> <Citation>
Bylund et al.,J. Pharm. Exp. Ther.,284,51,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
lisofylline
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.1423 3 0 0
M  V30 2 C 11.1423 4.5 0 0
M  V30 3 C 9.8433 2.25 0 0
M  V30 4 N 12.5689 2.5365 0 0
M  V30 5 N 9.8433 5.25 0 0
M  V30 6 N 12.5689 4.9635 0 0
M  V30 7 N 8.5442 3 0 0
M  V30 8 O 9.8433 0.75 0 0
M  V30 9 C 13.4506 3.75 0 0
M  V30 10 C 13.0324 1.1099 0 0
M  V30 11 C 8.5442 4.5 0 0
M  V30 12 C 9.8433 6.75 0 0
M  V30 13 C 7.2452 2.25 0 0
M  V30 14 O 7.2452 5.25 0 0
M  V30 15 C 5.9462 3 0 0
M  V30 16 C 4.6471 2.25 0 0
M  V30 17 C 3.3481 3 0 0
M  V30 18 C 2.049 2.25 0 0 CFG=1
M  V30 19 C 2.049 0.75 0 0
M  V30 20 O 0.75 3 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 12 2 6 9
M  V30 13 1 7 11
M  V30 14 1 7 13
M  V30 15 2 11 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19 CFG=1
M  V30 21 1 18 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 18) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
lisofylline

> <ID>
lisofylline

> <PRIMARY_SOM>
18 17

> <Citation>
Shin and Slattery,J. Pharm. Sci.,87,390,1998

> <DOI>
10.1021/js970382f

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
lithocholic_acid
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1903 8.5417 0 0 CFG=1
M  V30 2 C 2.1903 10.0417 0 0 CFG=1
M  V30 3 C 0.8912 7.7917 0 0 CFG=1
M  V30 4 C 3.305 7.538 0 0
M  V30 5 C 0.8912 10.7917 0 0 CFG=1
M  V30 6 C 3.4893 10.7917 0 0
M  V30 7 C 1.2031 6.3245 0 0 CFG=2
M  V30 8 C -0.4078 8.5417 0 0
M  V30 9 C -0.3223 6.91 0 0
M  V30 10 C 2.6949 6.1677 0 0
M  V30 11 C 0.8912 12.2917 0 0 CFG=2
M  V30 12 C -0.4078 10.0417 0 0
M  V30 13 C 3.4893 12.2917 0 0
M  V30 14 C 0.1994 5.2098 0 0 CFG=1
M  V30 15 C 2.1903 13.0417 0 0 CFG=1
M  V30 16 C -0.4078 13.0417 0 0
M  V30 17 C -0.4078 11.5417 0 0
M  V30 18 C -1.2678 5.5216 0 0
M  V30 19 C 0.6629 3.7832 0 0
M  V30 20 C 2.1903 14.5417 0 0
M  V30 21 C -0.4078 14.5417 0 0
M  V30 22 C -2.2715 4.4069 0 0
M  V30 23 C 0.8912 15.2917 0 0 CFG=1
M  V30 24 C -3.7387 4.7188 0 0
M  V30 25 O 0.8912 16.7917 0 0
M  V30 26 O -4.2023 6.1454 0 0
M  V30 27 O -4.7424 3.6041 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 9 CFG=3
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 1 5 12 CFG=3
M  V30 12 1 6 13
M  V30 13 1 7 10 CFG=3
M  V30 14 1 7 14
M  V30 15 1 8 12
M  V30 16 1 11 15
M  V30 17 1 11 16
M  V30 18 1 11 17 CFG=3
M  V30 19 1 15 13 CFG=3
M  V30 20 1 14 18
M  V30 21 1 14 19 CFG=3
M  V30 22 1 15 20
M  V30 23 1 16 21
M  V30 24 1 18 22
M  V30 25 1 20 23
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25 CFG=1
M  V30 29 1 24 26
M  V30 30 2 24 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 1 2 3 5 7 11 14 15 23) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
lithocholic_acid

> <ID>
lithocholic_acid

> <PRIMARY_SOM>
13

> <Citation>
Araya and Wikvall,Biochim. Biophys. Acta,1438,47,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
loperamide
  SciTegic08102311032D

 34 37  0  0  0  0            999 V2000
   -1.5015  -13.1007    0.0000 C   0  0
   -2.8006  -12.3507    0.0000 C   0  0
   -0.2025  -13.8507    0.0000 C   0  0
   -0.7515  -11.8016    0.0000 C   0  0
   -2.2515  -14.3997    0.0000 C   0  0
   -2.8006  -10.8507    0.0000 C   0  0
   -4.0996  -13.1007    0.0000 C   0  0
    1.0965  -13.1007    0.0000 C   0  0
   -0.2025  -15.3507    0.0000 C   0  0
    0.7485  -11.8016    0.0000 C   0  0
   -1.5015  -15.6988    0.0000 N   0  0
   -3.7515  -14.3997    0.0000 O   0  0
   -4.0996  -10.1007    0.0000 C   0  0
   -5.3986  -12.3507    0.0000 C   0  0
    2.3956  -13.8507    0.0000 C   0  0
    1.0965  -16.1007    0.0000 C   0  0
    1.4985  -10.5026    0.0000 N   0  0
   -2.2515  -16.9978    0.0000 C   0  0
   -0.0015  -15.6987    0.0000 C   0  0
   -5.3987  -10.8507    0.0000 C   0  0
    2.3956  -15.3507    0.0000 C   0  0
    2.9985  -10.5026    0.0000 C   0  0
    0.7485   -9.2036    0.0000 C   0  0
    3.7485   -9.2036    0.0000 C   0  0
    1.4985   -7.9045    0.0000 C   0  0
    2.9985   -7.9045    0.0000 C   0  0
    2.7380   -6.4273    0.0000 C   0  0
    4.4080   -7.3915    0.0000 O   0  0
    1.3285   -5.9143    0.0000 C   0  0
    3.8871   -5.4631    0.0000 C   0  0
    1.0680   -4.4371    0.0000 C   0  0
    3.6266   -3.9859    0.0000 C   0  0
    2.2171   -3.4729    0.0000 C   0  0
    1.9566   -1.9957    0.0000 Cl  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  2  0
  2  7  1  0
  3  8  2  0
  3  9  1  0
  4 10  1  0
  5 11  1  0
  5 12  2  0
  6 13  1  0
  7 14  2  0
  8 15  1  0
  9 16  2  0
 10 17  1  0
 11 18  1  0
 11 19  1  0
 13 20  2  0
 14 20  1  0
 15 21  2  0
 16 21  1  0
 17 22  1  0
 17 23  1  0
 22 24  1  0
 23 25  1  0
 24 26  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
 27 29  2  0
 27 30  1  0
 29 31  1  0
 30 32  2  0
 31 33  2  0
 32 33  1  0
 33 34  1  0
M  END
> <Name>
loperamide

> <ID>
loperamide

> <PRIMARY_SOM>
19 18

> <Citation>
Kim et al.,Eur. J. Clin. Pharm.,60,575,2004

> <DOI>
10.1007/s00228-004-0815-3

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
loratadine
  SciTegic08102311032D

 27 30  0  0  0  0            999 V2000
    9.2197    2.7967    0.0000 C   0  0
   10.6531    2.3546    0.0000 C   0  0
   10.9869    0.8922    0.0000 C   0  0
    9.8873   -0.1281    0.0000 N   0  0
    8.4540    0.3140    0.0000 C   0  0
    8.1202    1.7764    0.0000 C   0  0
    6.7687    2.4272    0.0000 C   0  0
    5.4173    1.7764    0.0000 C   0  0
    5.0835    0.3140    0.0000 C   0  0
    6.0187   -0.8587    0.0000 C   0  0
    5.4707   -2.2550    0.0000 C   0  0
    3.9875   -2.4786    0.0000 C   0  0
    3.0522   -1.3059    0.0000 C   0  0
    3.6002    0.0905    0.0000 C   0  0
    7.5187   -0.8587    0.0000 C   0  0
    8.1696   -2.2102    0.0000 C   0  0
    9.6654   -2.3223    0.0000 C   0  0
   10.3162   -3.6737    0.0000 C   0  0
    9.4712   -4.9131    0.0000 N   0  0
    7.9754   -4.8010    0.0000 C   0  0
    7.3246   -3.4495    0.0000 C   0  0
   10.1220   -6.2645    0.0000 C   0  0
    9.2771   -7.5039    0.0000 O   0  0
    9.9279   -8.8553    0.0000 C   0  0
    9.0829  -10.0947    0.0000 C   0  0
   11.6178   -6.3766    0.0000 O   0  0
    1.5690   -1.5294    0.0000 Cl  0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 15  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 14  2  0
 10 11  2  0
 10 15  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 27  1  0
 15 16  2  0
 16 17  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 22  1  0
 20 21  1  0
 22 23  1  0
 22 26  2  0
 23 24  1  0
 24 25  1  0
M  END
> <Name>
loratadine

> <ID>
loratadine

> <PRIMARY_SOM>
24

> <Citation>
Ghosal et al.,Drug Metab. Letters,3,162,2009

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
losartan
  SciTegic08102311032D

 30 33  0  0  0  0            999 V2000
    2.2231    2.1495    0.0000 C   0  0
    2.2231    3.6495    0.0000 C   0  0
    0.9240    4.3995    0.0000 C   0  0
   -0.3750    3.6495    0.0000 C   0  0
   -0.3750    2.1495    0.0000 C   0  0
    0.9240    1.3995    0.0000 C   0  0
    3.5221    4.3995    0.0000 C   0  0
    4.8212    3.6495    0.0000 C   0  0
    6.1202    4.3995    0.0000 C   0  0
    6.1202    5.8995    0.0000 C   0  0
    4.8212    6.6495    0.0000 C   0  0
    3.5221    5.8995    0.0000 C   0  0
    0.9240    5.8995    0.0000 C   0  0
    2.1376    6.7812    0.0000 N   0  0
    1.6740    8.2078    0.0000 N   0  0
    0.1740    8.2078    0.0000 N   0  0
   -0.2895    6.7812    0.0000 N   0  0
    7.4192    6.6495    0.0000 C   0  0
    7.4192    8.1495    0.0000 N   0  0
    8.6328    9.0312    0.0000 C   0  0
    8.1692   10.4578    0.0000 C   0  0
    6.6692   10.4578    0.0000 N   0  0
    6.2057    9.0312    0.0000 C   0  0
    4.7791    8.5677    0.0000 C   0  0
    3.6644    9.5714    0.0000 C   0  0
    2.2378    9.1079    0.0000 C   0  0
    1.1231   10.1116    0.0000 C   0  0
    9.0509   11.6713    0.0000 Cl  0  0
   10.0593    8.5677    0.0000 C   0  0
   11.1741    9.5714    0.0000 O   0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  2  7  1  0
  3  4  1  0
  3 13  1  0
  4  5  2  0
  5  6  1  0
  7  8  1  0
  7 12  2  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 18  1  0
 11 12  1  0
 13 14  2  0
 13 17  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 18 19  1  0
 19 20  1  0
 19 23  1  0
 20 21  2  0
 20 29  1  0
 21 22  1  0
 21 28  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 29 30  1  0
M  END
> <Name>
losartan

> <ID>
losartan

> <PRIMARY_SOM>
29

> <SECONDARY_SOM>
24 26

> <Citation>
Stearns et al.,Drug Metab. Disp.,23,207,1995

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
lovastatin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2452 -3 0 0
M  V30 2 C 7.2452 -1.5 0 0 CFG=2
M  V30 3 C 5.9462 -0.75 0 0
M  V30 4 C 5.9462 -3.75 0 0 CFG=1
M  V30 5 C 4.6471 -1.5 0 0
M  V30 6 C 4.6471 -3 0 0 CFG=1
M  V30 7 C 3.3481 -0.75 0 0
M  V30 8 C 2.049 -1.5 0 0
M  V30 9 C 2.049 -3 0 0 CFG=1
M  V30 10 C 3.3481 -3.75 0 0 CFG=2
M  V30 11 C 8.5442 -0.75 0 0
M  V30 12 O 5.9462 -5.25 0 0
M  V30 13 C 0.75 -3.75 0 0
M  V30 14 C 3.3481 -5.25 0 0
M  V30 15 C 2.049 -6 0 0
M  V30 16 C 2.049 -7.5 0 0 CFG=2
M  V30 17 C 0.75 -8.25 0 0
M  V30 18 O 3.3481 -8.25 0 0
M  V30 19 C 7.2452 -6 0 0
M  V30 20 C 0.75 -9.75 0 0 CFG=2
M  V30 21 C 3.3481 -9.75 0 0
M  V30 22 C 2.049 -10.5 0 0
M  V30 23 O 4.6471 -10.5 0 0
M  V30 24 O -0.549 -10.5 0 0
M  V30 25 C 7.2452 -7.5 0 0 CFG=2
M  V30 26 O 8.5442 -5.25 0 0
M  V30 27 C 8.5442 -8.25 0 0
M  V30 28 C 5.9462 -8.25 0 0
M  V30 29 C 8.5443 -9.75 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 1 2 11 CFG=3
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 12 CFG=3
M  V30 8 1 6 5 CFG=3
M  V30 9 1 5 7
M  V30 10 1 6 10
M  V30 11 2 7 8
M  V30 12 1 8 9
M  V30 13 1 9 10
M  V30 14 1 9 13 CFG=1
M  V30 15 1 10 14 CFG=1
M  V30 16 1 12 19
M  V30 17 1 14 15
M  V30 18 1 16 15 CFG=1
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 19 25
M  V30 24 2 19 26
M  V30 25 1 20 22
M  V30 26 1 20 24 CFG=3
M  V30 27 1 21 22
M  V30 28 2 21 23
M  V30 29 1 25 27
M  V30 30 1 25 28 CFG=3
M  V30 31 1 27 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 2 4 6 9 10 16 20 25) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
lovastatin

> <ID>
lovastatin

> <PRIMARY_SOM>
2

> <Citation>
Jacobsen et al.,Drug Metab. Disp.,27,173,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ly_333531
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 35 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -12.4413 -5.547 0 0
M  V30 2 C -12.4413 -7.047 0 0
M  V30 3 C -11.1423 -4.797 0 0
M  V30 4 C -11.1423 -7.797 0 0
M  V30 5 C -13.8679 -5.0834 0 0
M  V30 6 C -13.8679 -7.5105 0 0
M  V30 7 N -14.7496 -6.297 0 0
M  V30 8 N -8.5442 -4.797 0 0
M  V30 9 C -9.8433 -5.547 0 0
M  V30 10 C -9.8433 -7.047 0 0
M  V30 11 N -8.5442 -7.797 0 0
M  V30 12 C -10.4325 -9.2459 0 0
M  V30 13 C -10.7541 -3.3481 0 0
M  V30 14 C -9.2541 -3.3481 0 0
M  V30 15 C -8.9325 -9.2459 0 0
M  V30 16 O -14.3315 -3.6569 0 0
M  V30 17 O -14.3315 -8.9371 0 0
M  V30 18 C -7.2452 -5.547 0 0
M  V30 19 O -4.6471 -7.047 0 0
M  V30 20 C -5.9461 -4.797 0 0
M  V30 21 C -4.6471 -5.547 0 0 CFG=1
M  V30 22 N -2.049 -5.547 0 0
M  V30 23 C -7.2452 -7.047 0 0
M  V30 24 C -3.3481 -4.797 0 0
M  V30 25 C -5.9462 -7.797 0 0
M  V30 26 C -11.1825 -10.5449 0 0
M  V30 27 C -11.5041 -2.0491 0 0
M  V30 28 C -8.1825 -10.5449 0 0
M  V30 29 C -8.5041 -2.0491 0 0
M  V30 30 C -0.75 -4.797 0 0
M  V30 31 C -2.049 -7.047 0 0
M  V30 32 C -10.4325 -11.8439 0 0
M  V30 33 C -10.7541 -0.75 0 0
M  V30 34 C -8.9325 -11.8439 0 0
M  V30 35 C -9.2541 -0.75 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5 CFG=1
M  V30 4 1 2 4
M  V30 5 1 2 6 CFG=1
M  V30 6 2 3 9
M  V30 7 1 3 13
M  V30 8 2 4 10
M  V30 9 1 4 12
M  V30 10 1 5 7
M  V30 11 2 5 16
M  V30 12 1 6 7
M  V30 13 2 6 17
M  V30 14 1 8 9
M  V30 15 1 8 14
M  V30 16 1 8 18
M  V30 17 1 10 11
M  V30 18 1 11 15
M  V30 19 1 11 23
M  V30 20 2 12 15
M  V30 21 1 12 26
M  V30 22 2 13 14
M  V30 23 1 13 27
M  V30 24 1 14 29
M  V30 25 1 15 28
M  V30 26 1 18 20
M  V30 27 1 19 21
M  V30 28 1 19 25
M  V30 29 1 20 21
M  V30 30 1 21 24 CFG=1
M  V30 31 1 22 24
M  V30 32 1 22 30
M  V30 33 1 22 31
M  V30 34 1 23 25
M  V30 35 2 26 32
M  V30 36 2 27 33
M  V30 37 2 28 34
M  V30 38 2 29 35
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 21) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
ly_333531

> <ID>
ly_333531

> <PRIMARY_SOM>
31 30

> <Citation>
Hyland et al.,Drug Metab. Disp.,30,957,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
malathion
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 19 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5576 7.7777 0 0 CFG=1
M  V30 2 S 0.2571 8.5251 0 0
M  V30 3 C 2.8551 8.5304 0 0
M  V30 4 C 1.5607 6.2777 0 0
M  V30 5 P -1.0404 7.7724 0 0
M  V30 6 C 4.1557 7.783 0 0
M  V30 7 O 2.8613 5.5304 0 0
M  V30 8 O 0.2632 5.5251 0 0
M  V30 9 O -2.3379 7.0197 0 0
M  V30 10 O -0.2878 6.4749 0 0
M  V30 11 S -1.7931 9.0699 0 0
M  V30 12 O 5.4532 8.5357 0 0
M  V30 13 O 4.1588 6.2831 0 0
M  V30 14 C 2.8644 4.0304 0 0
M  V30 15 C -2.3349 5.5197 0 0
M  V30 16 C -1.0351 5.1743 0 0
M  V30 17 C 6.7538 7.7884 0 0
M  V30 18 C 4.1649 3.2831 0 0
M  V30 19 C 8.0513 8.541 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 6 12
M  V30 12 2 6 13
M  V30 13 1 7 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 12 17
M  V30 17 1 14 18
M  V30 18 1 17 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
malathion

> <ID>
malathion

> <PRIMARY_SOM>
5 11

> <Citation>
Buratti et al.,Drug Metab. Disp.,33,295,2005

> <DOI>
10.1124/dmd.104.001693

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
mde
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.8433 1.5 0 0
M  V30 2 C 9.8433 3 0 0
M  V30 3 C 8.5442 0.75 0 0
M  V30 4 O 11.2699 1.0365 0 0
M  V30 5 C 8.5442 3.75 0 0
M  V30 6 O 11.2699 3.4635 0 0
M  V30 7 C 7.2452 1.5 0 0
M  V30 8 C 12.1515 2.25 0 0
M  V30 9 C 7.2452 3 0 0
M  V30 10 C 5.9462 0.75 0 0
M  V30 11 C 4.6471 1.5 0 0 CFG=1
M  V30 12 N 3.3481 0.75 0 0
M  V30 13 C 4.6471 3 0 0
M  V30 14 C 2.049 1.5 0 0
M  V30 15 C 0.75 0.75 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 11 13 CFG=1
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
mde

> <ID>
mde

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
14

> <Citation>
Kreth et al.,Biochem. Pharm.,59,1563,2000

> <DOI>
10.1016/S0006-2952(00)00284-7

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
meloxicam
  SciTegic08102311032D

 23 25  0  0  0  0            999 V2000
   -2.0490    3.7500    0.0000 C   0  0
   -2.0490    5.2500    0.0000 C   0  0
   -3.3481    3.0000    0.0000 C   0  0
   -3.3481    1.5000    0.0000 C   0  0
   -2.0490    0.7500    0.0000 C   0  0
   -0.7500    1.5000    0.0000 C   0  0
   -0.7500    3.0000    0.0000 C   0  0
   -4.6471    3.7500    0.0000 S   0  0
   -3.3481    6.0000    0.0000 C   0  0
   -4.6471    5.2500    0.0000 N   0  0
   -5.1602    2.3405    0.0000 O   0  0
   -6.1243    4.0105    0.0000 O   0  0
   -0.7500    6.0000    0.0000 O   0  0
   -3.3481    7.5000    0.0000 C   0  0
   -4.6471    8.2500    0.0000 N   0  0
   -4.6471    9.7500    0.0000 C   0  0
   -2.0490    8.2500    0.0000 O   0  0
   -5.8607   10.6317    0.0000 N   0  0
   -3.4336   10.6317    0.0000 S   0  0
   -5.3971   12.0583    0.0000 C   0  0
   -3.8971   12.0583    0.0000 C   0  0
   -3.0155   13.2718    0.0000 C   0  0
   -5.9462    6.0000    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  7  2  0
  2  9  2  0
  2 13  1  0
  3  4  2  0
  3  8  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  8 10  1  0
  8 11  2  0
  8 12  2  0
  9 10  1  0
  9 14  1  0
 10 23  1  0
 14 15  1  0
 14 17  2  0
 15 16  1  0
 16 18  2  0
 16 19  1  0
 18 20  1  0
 19 21  1  0
 20 21  2  0
 21 22  1  0
M  END
> <Name>
meloxicam

> <ID>
meloxicam

> <PRIMARY_SOM>
22

> <Citation>
Chesne et al.,Xenobiotica,28,1,1998

> <DOI>
10.1080/004982598239704

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
methadone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2931 4.6471 0 0
M  V30 2 C 7.6606 3.2802 0 0
M  V30 3 C 4.5431 3.3481 0 0
M  V30 4 C 3.9941 5.3971 0 0
M  V30 5 C 6.3056 6.4008 0 0
M  V30 6 C 8.9596 4.0302 0 0 CFG=2
M  V30 7 C 5.5556 1.5944 0 0
M  V30 8 O 3.0431 3.3481 0 0
M  V30 9 C 3.9941 6.8971 0 0
M  V30 10 C 2.695 4.6471 0 0
M  V30 11 C 7.8056 6.4008 0 0
M  V30 12 C 5.5556 7.6999 0 0
M  V30 13 N 10.2587 3.2802 0 0
M  V30 14 C 8.9596 5.5302 0 0
M  V30 15 C 4.8056 0.2953 0 0
M  V30 16 C 2.695 7.6471 0 0
M  V30 17 C 1.396 5.3971 0 0
M  V30 18 C 8.5556 7.6999 0 0
M  V30 19 C 6.3056 8.9989 0 0
M  V30 20 C 11.5577 4.0302 0 0
M  V30 21 C 10.2587 1.7802 0 0
M  V30 22 C 1.396 6.8971 0 0
M  V30 23 C 7.8056 8.9989 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 4 9
M  V30 9 1 4 10
M  V30 10 2 5 11
M  V30 11 1 5 12
M  V30 12 1 6 13
M  V30 13 1 6 14 CFG=1
M  V30 14 1 7 15
M  V30 15 1 9 16
M  V30 16 2 10 17
M  V30 17 1 11 18
M  V30 18 2 12 19
M  V30 19 1 13 20
M  V30 20 1 13 21
M  V30 21 2 16 22
M  V30 22 1 17 22
M  V30 23 2 18 23
M  V30 24 1 19 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
methadone

> <ID>
methadone

> <PRIMARY_SOM>
20 21

> <Citation>
Iribarne et al.,Chem. Res. Toxicol.,9,365,1996

> <DOI>
10.1021/tx9500116m

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
methiocarb
  SciTegic08102311032D

 15 15  0  0  0  0            999 V2000
    6.8702   -0.1005    0.0000 C   0  0
    6.8702    1.3995    0.0000 C   0  0
    5.5712   -0.8505    0.0000 C   0  0
    8.1692   -0.8505    0.0000 O   0  0
    5.5712    2.1495    0.0000 C   0  0
    4.2721   -0.1005    0.0000 C   0  0
    8.1692   -2.3505    0.0000 C   0  0
    4.2721    1.3995    0.0000 C   0  0
    5.5712    3.6495    0.0000 C   0  0
    2.9731   -0.8505    0.0000 C   0  0
    9.4683   -3.1005    0.0000 N   0  0
    6.8702   -3.1005    0.0000 O   0  0
    2.9731    2.1495    0.0000 S   0  0
    9.4683   -4.6005    0.0000 C   0  0
    1.6740    1.3995    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  6  2  0
  4  7  1  0
  5  8  2  0
  5  9  1  0
  6  8  1  0
  6 10  1  0
  7 11  1  0
  7 12  2  0
  8 13  1  0
 11 14  1  0
 13 15  1  0
M  END
> <Name>
methiocarb

> <ID>
methiocarb

> <PRIMARY_SOM>
13

> <Citation>
Usmani et al.,Drug Metab. Disp.,32,333,2004

> <DOI>
10.1124/dmd.32.3.333

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
methoxychlor_mono_OH
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.5197 -2.5245 0 0 CFG=1
M  V30 2 C 6.2207 -1.7745 0 0
M  V30 3 C 7.5197 -4.0245 0 0
M  V30 4 C 8.8188 -1.7745 0 0
M  V30 5 C 6.2207 -0.2745 0 0
M  V30 6 C 4.9216 -2.5245 0 0
M  V30 7 C 8.8188 -4.7745 0 0
M  V30 8 C 6.2207 -4.7745 0 0
M  V30 9 Cl 10.1178 -2.5245 0 0
M  V30 10 Cl 10.1178 -1.0245 0 0
M  V30 11 Cl 8.8187 -0.2745 0 0
M  V30 12 C 4.9216 0.4755 0 0
M  V30 13 C 3.6226 -1.7745 0 0
M  V30 14 C 8.8188 -6.2745 0 0
M  V30 15 C 6.2207 -6.2745 0 0
M  V30 16 C 3.6226 -0.2745 0 0
M  V30 17 C 7.5197 -7.0245 0 0
M  V30 18 O 2.3236 0.4755 0 0
M  V30 19 O 7.5197 -8.5245 0 0
M  V30 20 C 1.0245 -0.2745 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 4 11
M  V30 11 1 5 12
M  V30 12 2 6 13
M  V30 13 1 7 14
M  V30 14 2 8 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
methoxychlor_mono_OH

> <ID>
methoxychlor_mono_OH

> <PRIMARY_SOM>
14 15

> <Citation>
Hu et al.,Drug Metab. Disp.,30,1035,2002

> <DOI>
10.1124/dmd.30.9.1035

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
mexazolam
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.6163 5.5701 0 0 CFG=2
M  V30 2 C 1.2825 7.0325 0 0
M  V30 3 N 0.6811 4.3973 0 0 CFG=1
M  V30 4 C 4.6916 8.257 0 0
M  V30 5 O 3.0207 5.043 0 0
M  V30 6 C -0.0689 7.6833 0 0
M  V30 7 C 2.5219 7.8775 0 0
M  V30 8 C 1.5074 3.1455 0 0 CFG=1
M  V30 9 C -0.8189 4.3973 0 0
M  V30 10 C 6.1111 7.7722 0 0
M  V30 11 C 4.4018 9.7287 0 0
M  V30 12 C 2.9534 3.5445 0 0
M  V30 13 N -1.4204 7.0325 0 0
M  V30 14 C -0.181 9.1791 0 0
M  V30 15 C 2.4098 9.3733 0 0
M  V30 16 C 0.9804 1.7411 0 0
M  V30 17 C -1.7542 5.5701 0 0
M  V30 18 C 7.2407 8.7591 0 0
M  V30 19 Cl 6.401 6.3004 0 0
M  V30 20 C 5.5314 10.7156 0 0
M  V30 21 C 1.0583 10.0241 0 0
M  V30 22 Cl 3.6491 10.2183 0 0
M  V30 23 O -3.2166 5.2363 0 0
M  V30 24 C 6.9509 10.2308 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 1 5
M  V30 5 2 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 3 9 CFG=1
M  V30 9 2 4 10
M  V30 10 1 4 11
M  V30 11 1 5 12
M  V30 12 1 6 13
M  V30 13 1 6 14
M  V30 14 2 7 15
M  V30 15 1 8 12
M  V30 16 1 8 16 CFG=1
M  V30 17 1 9 17
M  V30 18 1 10 18
M  V30 19 1 10 19
M  V30 20 2 11 20
M  V30 21 1 13 17
M  V30 22 2 14 21
M  V30 23 1 15 21
M  V30 24 1 15 22
M  V30 25 2 17 23
M  V30 26 2 18 24
M  V30 27 1 20 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 3 8) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
mexazolam

> <ID>
mexazolam

> <PRIMARY_SOM>
8

> <Citation>
Ishigami et al.,Drug Metab. Disp.,29,282,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
mianserin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2914 3.7807 0 0
M  V30 2 C 9.391 4.8009 0 0
M  V30 3 C 9.0572 6.2633 0 0
M  V30 4 C 6.8581 4.2228 0 0
M  V30 5 C 6.5243 5.6852 0 0
M  V30 6 C 7.6239 6.7054 0 0
M  V30 7 C 5.9228 3.05 0 0
M  V30 8 C 4.4228 3.05 0 0
M  V30 9 C 3.4876 4.2228 0 0
M  V30 10 C 2.0044 3.9992 0 0
M  V30 11 C 3.8748 1.6537 0 0
M  V30 12 C 2.3916 1.4301 0 0
M  V30 13 C 1.4563 2.6029 0 0
M  V30 14 N 5.1728 6.336 0 0
M  V30 15 C 3.8214 5.6852 0 0 CFG=1
M  V30 16 C 5.2849 7.8318 0 0
M  V30 17 C 4.0456 8.6768 0 0
M  V30 18 N 2.6941 8.0259 0 0
M  V30 19 C 2.582 6.5301 0 0
M  V30 20 C 1.4548 8.8709 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 2 3 6
M  V30 5 2 4 5
M  V30 6 1 4 7
M  V30 7 1 5 6
M  V30 8 1 5 14
M  V30 9 1 7 8
M  V30 10 2 8 9
M  V30 11 1 8 11
M  V30 12 1 9 10
M  V30 13 1 9 15
M  V30 14 2 10 13
M  V30 15 2 11 12
M  V30 16 1 12 13
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 19 CFG=3
M  V30 20 1 16 17
M  V30 21 1 17 18
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
mianserin

> <ID>
mianserin

> <PRIMARY_SOM>
18

> <SECONDARY_SOM>
2

> <TERTIARY_SOM>
20

> <Citation>
Koyama et al.,J. Pharm. Exp. Ther.,278,21,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
mifepristone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.1623 3.0234 0 0
M  V30 2 N 13.8644 2.2714 0 0
M  V30 3 C 13.8668 0.7714 0 0
M  V30 4 C 12.5642 3.0194 0 0
M  V30 5 C 11.2664 2.2674 0 0
M  V30 6 C 9.9662 3.0154 0 0
M  V30 7 C 9.9639 4.5154 0 0
M  V30 8 C 11.2617 5.2674 0 0
M  V30 9 C 12.5619 4.5194 0 0
M  V30 10 C 8.6637 5.2634 0 0 CFG=2
M  V30 11 C 8.6614 6.7634 0 0
M  V30 12 C 7.3612 7.5114 0 0 CFG=2
M  V30 13 C 6.0633 6.7594 0 0 CFG=1
M  V30 14 C 6.0656 5.2594 0 0 CFG=2
M  V30 15 C 7.3658 4.5114 0 0
M  V30 16 C 9.9592 7.5154 0 0
M  V30 17 C 9.9569 9.0154 0 0
M  V30 18 C 8.6567 9.7634 0 0
M  V30 19 C 7.3588 9.0114 0 0
M  V30 20 C 11.2594 6.7674 0 0
M  V30 21 C 12.5573 7.5194 0 0
M  V30 22 C 12.555 9.0194 0 0
M  V30 23 C 11.2548 9.7674 0 0
M  V30 24 O 13.8529 9.7714 0 0
M  V30 25 C 4.6397 4.7937 0 0 CFG=1
M  V30 26 C 3.7562 6.0058 0 0
M  V30 27 C 4.636 7.2207 0 0
M  V30 28 C 5.9111 3.7674 0 0
M  V30 29 C 3.3418 4.0417 0 0
M  V30 30 O 5.0049 3.3388 0 0
M  V30 31 C 2.044 3.2897 0 0
M  V30 32 C 0.7461 2.5376 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 4 5
M  V30 5 2 4 9
M  V30 6 2 5 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 10 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 15
M  V30 13 1 11 12
M  V30 14 2 11 16
M  V30 15 1 12 13
M  V30 16 1 12 19 CFG=3
M  V30 17 1 13 14
M  V30 18 1 13 27 CFG=1
M  V30 19 1 14 15
M  V30 20 1 14 25
M  V30 21 1 14 28 CFG=1
M  V30 22 1 16 17
M  V30 23 1 16 20
M  V30 24 1 17 18
M  V30 25 2 17 23
M  V30 26 1 18 19
M  V30 27 1 20 21
M  V30 28 1 21 22
M  V30 29 1 22 23
M  V30 30 2 22 24
M  V30 31 1 25 26
M  V30 32 1 25 29
M  V30 33 1 25 30 CFG=1
M  V30 34 1 26 27
M  V30 35 3 29 31
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 10 12 13 14 25) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
mifepristone

> <ID>
mifepristone

> <PRIMARY_SOM>
3 1

> <SECONDARY_SOM>
32

> <Citation>
Jang et al.,Biochem. Pharm.,52,753,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
miocamycin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 63 65 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3558 -12.8706 0 0 CFG=2
M  V30 2 C 8.9101 -14.2644 0 0 CFG=2
M  V30 3 C 9.6841 -12.1737 0 0 CFG=2
M  V30 4 O 6.9491 -12.3498 0 0
M  V30 5 C 9.742 -15.5126 0 0 CFG=1
M  V30 6 O 7.5818 -14.9613 0 0
M  V30 7 C 8.9789 -10.8498 0 0
M  V30 8 C 11.1176 -12.6156 0 0
M  V30 9 C 6.6968 -10.8711 0 0 CFG=2
M  V30 10 C 11.0703 -14.8157 0 0
M  V30 11 O 9.3711 -16.966 0 0
M  V30 12 C 6.3141 -14.1594 0 0
M  V30 13 C 9.7808 -9.5821 0 0 CFG=2
M  V30 14 C 11.7004 -13.9978 0 0
M  V30 15 C 5.2901 -10.3503 0 0 CFG=1
M  V30 16 O 7.8512 -9.9133 0 0
M  V30 17 C 12.5545 -15.0327 0 0
M  V30 18 C 7.9269 -17.3715 0 0
M  V30 19 C 11.2791 -9.6522 0 0 CFG=2
M  V30 20 C 9.0881 -8.2517 0 0
M  V30 21 O 13.1888 -14.1841 0 0
M  V30 22 C 5.0378 -8.8717 0 0 CFG=1
M  V30 23 O 4.1358 -11.3081 0 0
M  V30 24 C 7.5989 -8.4347 0 0 CFG=1
M  V30 25 O 14.0514 -14.9363 0 0
M  V30 26 O 12.4939 -16.5314 0 0
M  V30 27 C 7.556 -18.8249 0 0
M  V30 28 O 6.8537 -16.3236 0 0
M  V30 29 C 12.776 -9.5558 0 0
M  V30 30 O 11.2923 -11.1522 0 0
M  V30 31 C 6.1922 -7.9139 0 0 CFG=1
M  V30 32 N 3.6311 -8.3509 0 0
M  V30 33 C 8.7533 -7.4768 0 0
M  V30 34 C 15.5498 -15.0064 0 0 CFG=1
M  V30 35 C 6.1119 -19.2304 0 0
M  V30 36 C 13.608 -10.804 0 0
M  V30 37 C 12.5979 -11.8908 0 0
M  V30 38 O 5.9399 -6.4352 0 0
M  V30 39 C 2.4768 -9.3087 0 0
M  V30 40 C 3.3788 -6.8722 0 0
M  V30 41 C 16.3517 -13.7387 0 0
M  V30 42 C 16.2425 -16.3368 0 0
M  V30 43 C 15.0922 -11.021 0 0
M  V30 44 C 13.8903 -11.1294 0 0
M  V30 45 O 12.611 -13.3907 0 0
M  V30 46 C 7.0943 -5.4774 0 0 CFG=1
M  V30 47 C 15.6464 -12.4148 0 0
M  V30 48 C 6.8419 -3.9988 0 0
M  V30 49 O 8.501 -5.9982 0 0
M  V30 50 C 7.9963 -3.0409 0 0 CFG=2
M  V30 51 C 9.6553 -5.0404 0 0 CFG=1
M  V30 52 C 9.403 -3.5617 0 0 CFG=2
M  V30 53 O 8.7535 -1.746 0 0
M  V30 54 C 6.8526 -2.0704 0 0
M  V30 55 C 11.062 -5.5612 0 0
M  V30 56 O 10.5574 -2.6039 0 0
M  V30 57 C 8.0106 -0.4429 0 0
M  V30 58 C 11.9641 -3.1247 0 0
M  V30 59 C 6.5107 -0.4346 0 0
M  V30 60 O 8.7678 0.852 0 0
M  V30 61 C 13.1184 -2.1669 0 0
M  V30 62 O 12.2164 -4.6033 0 0
M  V30 63 C 14.5251 -2.6877 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=3
M  V30 8 1 9 4 CFG=3
M  V30 9 1 5 10
M  V30 10 1 5 11 CFG=1
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 10 17
M  V30 17 1 11 18
M  V30 18 1 13 19
M  V30 19 1 13 20 CFG=1
M  V30 20 2 14 21
M  V30 21 1 15 22
M  V30 22 1 15 23 CFG=3
M  V30 23 1 16 24
M  V30 24 1 17 25
M  V30 25 2 17 26
M  V30 26 1 18 27
M  V30 27 2 18 28
M  V30 28 1 19 29
M  V30 29 1 19 30 CFG=3
M  V30 30 1 22 31
M  V30 31 1 22 32 CFG=3
M  V30 32 1 24 31
M  V30 33 1 24 33 CFG=1
M  V30 34 1 25 34
M  V30 35 1 27 35
M  V30 36 2 29 36
M  V30 37 1 30 37
M  V30 38 1 31 38 CFG=3
M  V30 39 1 32 39
M  V30 40 1 32 40
M  V30 41 1 34 41
M  V30 42 1 34 42 CFG=1
M  V30 43 1 36 43
M  V30 44 1 37 44
M  V30 45 2 37 45
M  V30 46 1 46 38 CFG=1
M  V30 47 1 41 47
M  V30 48 2 43 47
M  V30 49 1 46 48
M  V30 50 1 46 49
M  V30 51 1 48 50
M  V30 52 1 49 51
M  V30 53 1 50 52
M  V30 54 1 50 53
M  V30 55 1 50 54 CFG=3
M  V30 56 1 51 52
M  V30 57 1 51 55 CFG=1
M  V30 58 1 52 56 CFG=1
M  V30 59 1 53 57
M  V30 60 1 56 58
M  V30 61 1 57 59
M  V30 62 2 57 60
M  V30 63 1 58 61
M  V30 64 2 58 62
M  V30 65 1 61 63
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(16 1 2 3 5 9 13 15 19 22 24 31 34 46 50 51  -
M  V30 52) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
miocamycin

> <ID>
miocamycin

> <PRIMARY_SOM>
52

> <Citation>
Kashahara et al.,Drug Metab. Disp.,28,409,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
mirtazapine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -4.0488 5.7699 0 0
M  V30 2 C -4.3826 7.2322 0 0 CFG=1
M  V30 3 C -4.984 4.5971 0 0
M  V30 4 C -5.734 7.8831 0 0
M  V30 5 C -6.484 4.5971 0 0
M  V30 6 C -7.0855 7.2322 0 0
M  V30 7 C -2.6154 5.3277 0 0
M  V30 8 C -7.4192 5.7698 0 0
M  V30 9 N -1.8496 7.8104 0 0
M  V30 10 C -3.283 8.2525 0 0
M  V30 11 N -4.234 3.2981 0 0
M  V30 12 C -1.5158 6.348 0 0
M  V30 13 C -5.6219 9.3789 0 0
M  V30 14 C -7.234 3.298 0 0
M  V30 15 C -0.75 8.8306 0 0
M  V30 16 C -8.3248 8.0772 0 0
M  V30 17 C -4.984 1.999 0 0
M  V30 18 C -6.484 1.999 0 0
M  V30 19 C -6.8613 10.2238 0 0
M  V30 20 C -8.2127 9.573 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 2 10 CFG=1
M  V30 6 2 3 5
M  V30 7 1 3 11
M  V30 8 2 4 6
M  V30 9 1 4 13
M  V30 10 1 5 8
M  V30 11 1 5 14
M  V30 12 1 6 8
M  V30 13 1 6 16
M  V30 14 1 7 12
M  V30 15 1 9 10
M  V30 16 1 9 12
M  V30 17 1 9 15
M  V30 18 2 11 17
M  V30 19 2 13 19
M  V30 20 2 14 18
M  V30 21 2 16 20
M  V30 22 1 17 18
M  V30 23 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
mirtazapine

> <ID>
mirtazapine

> <PRIMARY_SOM>
15

> <SECONDARY_SOM>
9

> <TERTIARY_SOM>
18

> <Citation>
Stormer et al.,Drug Metab. Disp.,28,1168,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
montelukast
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.9126 -10.0236 0 0
M  V30 2 C 18.8768 -11.1726 0 0
M  V30 3 C 17.3996 -11.4331 0 0
M  V30 4 C 16.6135 -9.2736 0 0
M  V30 5 C 18.8767 -8.8744 0 0
M  V30 6 S 15.3145 -10.0237 0 0
M  V30 7 C 18.3636 -7.4649 0 0
M  V30 8 C 14.0154 -9.2738 0 0 CFG=1
M  V30 9 O 16.8863 -7.2045 0 0
M  V30 10 O 19.3277 -6.3158 0 0
M  V30 11 C 14.0153 -7.7738 0 0
M  V30 12 C 12.7164 -10.0238 0 0
M  V30 13 C 12.7162 -7.0238 0 0
M  V30 14 C 15.3143 -7.0237 0 0
M  V30 15 C 11.4173 -9.2739 0 0
M  V30 16 C 12.7162 -5.5238 0 0
M  V30 17 C 15.3142 -5.5237 0 0
M  V30 18 C 10.1183 -10.024 0 0
M  V30 19 C 11.4171 -4.7739 0 0
M  V30 20 C 14.0152 -4.7738 0 0
M  V30 21 C 8.8192 -9.2741 0 0
M  V30 22 C 10.1184 -11.524 0 0
M  V30 23 C 11.417 -3.2739 0 0
M  V30 24 C 7.5202 -10.0241 0 0
M  V30 25 C 8.8192 -7.7741 0 0
M  V30 26 C 8.8194 -12.2741 0 0
M  V30 27 C 10.1179 -2.524 0 0
M  V30 28 C 7.5203 -11.5241 0 0
M  V30 29 C 7.5201 -7.0241 0 0
M  V30 30 C 9.5691 -6.475 0 0
M  V30 31 O 10.3192 -7.774 0 0
M  V30 32 N 10.1178 -1.024 0 0
M  V30 33 C 8.8189 -3.274 0 0
M  V30 34 C 8.8188 -0.274 0 0
M  V30 35 C 7.5198 -2.5241 0 0
M  V30 36 C 7.5198 -1.0241 0 0
M  V30 37 C 8.8187 1.226 0 0
M  V30 38 C 6.2207 -0.2742 0 0
M  V30 39 C 7.5196 1.9759 0 0
M  V30 40 C 6.2206 1.2258 0 0
M  V30 41 Cl 7.5195 3.4759 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 8 6 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 20
M  V30 22 2 18 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 1 21 24
M  V30 26 1 21 25
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 2 24 28
M  V30 30 1 25 29
M  V30 31 1 25 30
M  V30 32 1 25 31
M  V30 33 1 26 28
M  V30 34 2 27 32
M  V30 35 1 27 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 34 37
M  V30 40 1 35 36
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 1 39 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
montelukast

> <ID>
montelukast

> <PRIMARY_SOM>
6

> <SECONDARY_SOM>
15

> <Citation>
Chiba et al.,Drug Metab. Disp.,25,1022,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
mycophenolic_acid
  SciTegic08102311032D

 23 24  0  0  0  0            999 V2000
   12.4413    3.0000    0.0000 C   0  0
   12.4413    4.5000    0.0000 C   0  0
   11.1423    2.2500    0.0000 C   0  0
   13.8679    2.5365    0.0000 C   0  0
   11.1423    5.2500    0.0000 C   0  0
   13.8679    4.9635    0.0000 C   0  0
    9.8433    3.0000    0.0000 C   0  0
   11.1423    0.7500    0.0000 C   0  0
   14.7496    3.7500    0.0000 O   0  0
    9.8433    4.5000    0.0000 C   0  0
   11.1423    6.7500    0.0000 O   0  0
   14.3315    6.3901    0.0000 O   0  0
    8.5442    2.2500    0.0000 O   0  0
    8.5442    5.2500    0.0000 C   0  0
    7.2452    3.0000    0.0000 C   0  0
    7.2452    4.5000    0.0000 C   0  0
    5.9462    5.2500    0.0000 C   0  0
    4.6471    4.5000    0.0000 C   0  0
    5.9462    6.7500    0.0000 C   0  0
    3.3481    5.2500    0.0000 C   0  0
    2.0490    4.5000    0.0000 C   0  0
    2.0490    3.0000    0.0000 O   0  0
    0.7500    5.2500    0.0000 O   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  2  0
  5 11  1  0
  6  9  1  0
  6 12  2  0
  7 10  1  0
  7 13  1  0
 10 14  1  0
 13 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
M  END
> <Name>
mycophenolic_acid

> <ID>
mycophenolic_acid

> <PRIMARY_SOM>
15

> <Citation>
Picard et al.,Ther. Drug. Mon.,26,600,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
myristicin
  SciTegic08102311032D

 14 15  0  0  0  0            999 V2000
    7.2452    3.7500    0.0000 C   0  0
    7.2452    5.2500    0.0000 C   0  0
    5.9461    3.0000    0.0000 C   0  0
    8.6718    3.2865    0.0000 O   0  0
    5.9462    6.0000    0.0000 C   0  0
    8.6718    5.7135    0.0000 O   0  0
    4.6471    3.7500    0.0000 C   0  0
    5.9461    1.5000    0.0000 O   0  0
    9.5535    4.5000    0.0000 C   0  0
    4.6471    5.2500    0.0000 C   0  0
    4.6471    0.7500    0.0000 C   0  0
    3.3481    6.0000    0.0000 C   0  0
    2.0490    5.2500    0.0000 C   0  0
    0.7500    6.0000    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  2  0
  6  9  1  0
  7 10  1  0
  8 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
M  END
> <Name>
myristicin

> <ID>
myristicin

> <PRIMARY_SOM>
9

> <Citation>
Yun et al.,Toxicol. Lett.,137,143,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
naphthalene
  SciTegic08102311032D

 10 11  0  0  0  0            999 V2000
   -2.9732    2.1494    0.0000 C   0  0
   -2.9733    3.6494    0.0000 C   0  0
   -4.2723    4.3993    0.0000 C   0  0
   -5.5713    3.6492    0.0000 C   0  0
   -5.5713    2.1492    0.0000 C   0  0
   -4.2722    1.3993    0.0000 C   0  0
   -1.6741    1.3994    0.0000 C   0  0
   -4.2721   -0.1007    0.0000 C   0  0
   -1.6740   -0.1006    0.0000 C   0  0
   -2.9730   -0.8506    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  8  1  0
  7  9  2  0
  8 10  2  0
  9 10  1  0
M  END
> <Name>
naphthalene

> <ID>
naphthalene

> <PRIMARY_SOM>
10 9 3 4

> <Citation>
Cho et al.,Drug Metab. Disp.,34,176,2006

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ne_100
  SciTegic08102311032D

 26 27  0  0  0  0            999 V2000
   12.7159    2.5245    0.0000 C   0  0
   12.7159    4.0245    0.0000 C   0  0
   11.4168    1.7745    0.0000 C   0  0
   11.4168    4.7745    0.0000 C   0  0
   10.1178    2.5245    0.0000 C   0  0
    6.2207    1.7745    0.0000 N   0  0
   14.0149    1.7745    0.0000 O   0  0
   10.1178    4.0245    0.0000 C   0  0
    7.5197    2.5245    0.0000 C   0  0
    8.8187    1.7745    0.0000 C   0  0
   14.0149    4.7745    0.0000 O   0  0
   14.0149    0.2745    0.0000 C   0  0
   15.3139   -1.9755    0.0000 C   0  0
   15.3139   -0.4755    0.0000 C   0  0
    4.9216    2.5245    0.0000 C   0  0
    6.2207    0.2745    0.0000 C   0  0
   14.0149    6.2745    0.0000 C   0  0
   16.6130   -2.7255    0.0000 C   0  0
   14.0149   -2.7255    0.0000 C   0  0
    3.6226    1.7745    0.0000 C   0  0
    4.9216   -0.4755    0.0000 C   0  0
    2.3236    2.5245    0.0000 C   0  0
    4.9216   -1.9755    0.0000 C   0  0
   16.6130   -4.2255    0.0000 C   0  0
   14.0149   -4.2255    0.0000 C   0  0
   15.3140   -4.9755    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  7  1  0
  2  4  1  0
  2 11  1  0
  3  5  2  0
  4  8  2  0
  5  8  1  0
  5 10  1  0
  6  9  1  0
  6 15  1  0
  6 16  1  0
  7 12  1  0
  9 10  1  0
 11 17  1  0
 12 14  1  0
 13 14  1  0
 13 18  2  0
 13 19  1  0
 15 20  1  0
 16 21  1  0
 18 24  1  0
 19 25  2  0
 20 22  1  0
 21 23  1  0
 24 26  2  0
 25 26  1  0
M  END
> <Name>
ne_100

> <ID>
ne_100

> <PRIMARY_SOM>
16 15

> <SECONDARY_SOM>
26 25 24

> <Citation>
Yamamoto et al.,Drug Metab. Pharmacokin.,18,173,2003

> <DOI>
10.2133/dmpk.18.173

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
nefazodone
  SciTegic08102311032D

 33 36  0  0  0  0            999 V2000
    3.3481   -3.0000    0.0000 C   0  0
    3.3481   -1.5000    0.0000 C   0  0
    2.0490   -0.7500    0.0000 C   0  0
    0.7500   -1.5000    0.0000 C   0  0
    0.7500   -3.0000    0.0000 C   0  0
    2.0490   -3.7500    0.0000 C   0  0
    4.6471   -3.7500    0.0000 O   0  0
    4.6471   -5.2500    0.0000 C   0  0
    5.9462   -6.0000    0.0000 C   0  0
    5.9462   -7.5000    0.0000 N   0  0
    7.1597   -8.3817    0.0000 C   0  0
    6.6962   -9.8083    0.0000 N   0  0
    5.1962   -9.8083    0.0000 N   0  0
    4.7326   -8.3817    0.0000 C   0  0
    3.3061   -7.9182    0.0000 O   0  0
    8.5863   -7.9181    0.0000 C   0  0
    9.7010   -8.9218    0.0000 C   0  0
    4.3145  -11.0218    0.0000 C   0  0
    4.9246  -12.3921    0.0000 C   0  0
    4.0429  -13.6056    0.0000 C   0  0
    4.6530  -14.9760    0.0000 N   0  0
    3.7714  -16.1895    0.0000 C   0  0
    4.3815  -17.5598    0.0000 C   0  0
    5.8733  -17.7166    0.0000 N   0  0
    6.7549  -16.5031    0.0000 C   0  0
    6.1448  -15.1327    0.0000 C   0  0
    6.4834  -19.0869    0.0000 C   0  0
    5.6017  -20.3004    0.0000 C   0  0
    6.2118  -21.6707    0.0000 C   0  0
    7.7036  -21.8275    0.0000 C   0  0
    8.5853  -20.6140    0.0000 C   0  0
    7.9752  -19.2437    0.0000 C   0  0
    5.3301  -22.8843    0.0000 Cl  0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 14  1  0
 11 12  2  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 13 18  1  0
 14 15  2  0
 16 17  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 26  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 27  1  0
 25 26  1  0
 27 28  1  0
 27 32  2  0
 28 29  2  0
 29 30  1  0
 29 33  1  0
 30 31  2  0
 31 32  1  0
M  END
> <Name>
nefazodone

> <ID>
nefazodone

> <PRIMARY_SOM>
16

> <SECONDARY_SOM>
20

> <TERTIARY_SOM>
30

> <Citation>
von Moltke et al.,Psychopharmacology,145,113,1999

> <DOI>
10.1007/s002130051039

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
nevirapine
  SciTegic08102311032D

 20 23  0  0  0  0            999 V2000
    9.0053   -1.2369    0.0000 C   0  0
    8.6715    0.2255    0.0000 N   0  0
    8.0700   -2.4096    0.0000 C   0  0
    8.6181   -3.8059    0.0000 C   0  0
   10.1013   -4.0295    0.0000 C   0  0
   11.0366   -2.8567    0.0000 C   0  0
   10.4885   -1.4604    0.0000 N   0  0
    6.5700   -2.4096    0.0000 C   0  0
    9.8442    1.1608    0.0000 C   0  0
    5.6348   -1.2369    0.0000 N   0  0
    5.9686    0.2255    0.0000 C   0  0
    7.3200    0.8763    0.0000 C   0  0
    7.4321    2.3722    0.0000 N   0  0
    6.1927    3.2171    0.0000 C   0  0
    4.8413    2.5663    0.0000 C   0  0
    4.7292    1.0705    0.0000 C   0  0
    5.9192   -3.7611    0.0000 O   0  0
   11.3275    1.3843    0.0000 C   0  0
    3.3778    0.4197    0.0000 C   0  0
   10.3922    2.5571    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  7  2  0
  2  9  1  0
  2 12  1  0
  3  4  2  0
  3  8  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  8 10  1  0
  8 17  2  0
  9 18  1  0
  9 20  1  0
 10 11  1  0
 11 12  1  0
 11 16  2  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 19  1  0
 18 20  1  0
M  END
> <Name>
nevirapine

> <ID>
nevirapine

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
19

> <TERTIARY_SOM>
5

> <Citation>
Erickson et al.,Drug Metab. Disp.,27,1488,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
nicardipine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -2.8726 8.5245 0 0 CFG=1
M  V30 2 C -1.5736 7.7745 0 0
M  V30 3 C -2.8726 10.0245 0 0
M  V30 4 C -4.1716 7.7745 0 0
M  V30 5 C -1.5736 6.2745 0 0
M  V30 6 C -0.2745 8.5245 0 0
M  V30 7 C -4.1716 10.7745 0 0
M  V30 8 C -1.5736 10.7745 0 0
M  V30 9 C -5.4707 8.5245 0 0
M  V30 10 C -4.1716 6.2745 0 0
M  V30 11 C -0.2745 5.5245 0 0
M  V30 12 C 1.0245 7.7745 0 0
M  V30 13 N -5.4707 10.0245 0 0
M  V30 14 C -4.1716 12.2745 0 0
M  V30 15 O -1.5736 12.2745 0 0
M  V30 16 O -0.2745 10.0245 0 0
M  V30 17 C -6.7697 7.7745 0 0
M  V30 18 O -5.4707 5.5245 0 0
M  V30 19 O -2.8726 5.5245 0 0
M  V30 20 C 1.0245 6.2745 0 0
M  V30 21 N -0.2745 4.0245 0 0 CHG=1
M  V30 22 C -0.2745 13.0245 0 0
M  V30 23 C -5.4707 4.0245 0 0
M  V30 24 O -1.5736 3.2745 0 0 CHG=-1
M  V30 25 O 1.0245 3.2745 0 0
M  V30 26 C -0.2745 14.5245 0 0
M  V30 27 N 1.0245 15.2745 0 0
M  V30 28 C 1.0245 16.7745 0 0
M  V30 29 C 2.3236 14.5245 0 0
M  V30 30 C 2.3235 17.5245 0 0
M  V30 31 C 2.3235 19.0245 0 0
M  V30 32 C 3.6226 16.7745 0 0
M  V30 33 C 3.6226 19.7745 0 0
M  V30 34 C 4.9216 17.5245 0 0
M  V30 35 C 4.9216 19.0245 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 1 7 14
M  V30 14 1 8 15
M  V30 15 2 8 16
M  V30 16 1 9 13
M  V30 17 1 9 17
M  V30 18 1 10 18
M  V30 19 2 10 19
M  V30 20 2 11 20
M  V30 21 1 11 21
M  V30 22 1 12 20
M  V30 23 1 15 22
M  V30 24 1 18 23
M  V30 25 1 21 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 1 26 27
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
nicardipine

> <ID>
nicardipine

> <PRIMARY_SOM>
28

> <SECONDARY_SOM>
1 13

> <Citation>
Nakamura et al.,Biol. Pharm. Bull.,28,882,2005

> <DOI>
10.1248/bpb.28.882

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
nifedipine
  SciTegic08102311032D

 25 26  0  0  0  0            999 V2000
    7.2452    8.5838    0.0000 C   0  0
    7.2452   10.0838    0.0000 C   0  0
    5.9462   10.8338    0.0000 C   0  0
    4.6471   10.0838    0.0000 C   0  0
    4.6471    8.5838    0.0000 C   0  0
    5.9462    7.8338    0.0000 C   0  0
    5.9462    3.7500    0.0000 C   0  0
    4.6471    3.0000    0.0000 C   0  0
    4.6471    1.5000    0.0000 C   0  0
    5.9461    0.7500    0.0000 N   0  0
    7.2452    1.5000    0.0000 C   0  0
    7.2452    3.0000    0.0000 C   0  0
    3.3481    0.7500    0.0000 C   0  0
    8.5442    0.7500    0.0000 C   0  0
    3.3481    3.7500    0.0000 C   0  0
    2.0490    3.0000    0.0000 O   0  0
    3.3481    5.2500    0.0000 O   0  0
    8.5442    3.7500    0.0000 C   0  0
    9.8433    3.0000    0.0000 O   0  0
    8.5442    5.2500    0.0000 O   0  0
   11.1423    3.7500    0.0000 C   0  0
    8.5442    6.3338    0.0000 O   0  5
    9.8433    8.5838    0.0000 O   0  0
    0.7500    3.7500    0.0000 C   0  0
    8.5442    7.8338    0.0000 N   0  3
  1  2  1  0
  1  6  2  0
  1 25  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7 12  1  0
  8  9  2  0
  8 15  1  0
  9 10  1  0
  9 13  1  0
 10 11  1  0
 11 12  2  0
 11 14  1  0
 12 18  1  0
 15 16  1  0
 15 17  2  0
 16 24  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  0
 22 25  1  0
 23 25  2  0
M  CHG  2  22  -1  25   1
M  END
> <Name>
nifedipine

> <ID>
nifedipine

> <PRIMARY_SOM>
7 10

> <Citation>
Guengerich et al.,J. Biol. Chem.,261,5051,1986

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
nitrendipine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.8187 3.2745 0 0
M  V30 2 C 8.8187 4.7745 0 0
M  V30 3 C 7.5197 5.5245 0 0
M  V30 4 C 6.2207 4.7745 0 0
M  V30 5 C 6.2207 3.2745 0 0
M  V30 6 C 7.5197 2.5245 0 0
M  V30 7 C 7.5197 1.0245 0 0 CFG=1
M  V30 8 C 6.2207 0.2745 0 0
M  V30 9 C 6.2207 -1.2255 0 0
M  V30 10 N 7.5197 -1.9755 0 0
M  V30 11 C 8.8187 -1.2255 0 0
M  V30 12 C 8.8187 0.2745 0 0
M  V30 13 C 4.9216 -1.9755 0 0
M  V30 14 C 10.1178 -1.9755 0 0
M  V30 15 C 4.9216 1.0245 0 0
M  V30 16 O 3.6226 0.2745 0 0
M  V30 17 O 4.9216 2.5245 0 0
M  V30 18 C 10.1178 1.0245 0 0
M  V30 19 O 11.4168 0.2745 0 0
M  V30 20 O 10.1178 2.5245 0 0
M  V30 21 C 12.7159 1.0245 0 0
M  V30 22 N 4.9216 5.5245 0 0 CHG=1
M  V30 23 O 4.9216 7.0245 0 0 CHG=-1
M  V30 24 O 3.6226 4.7745 0 0
M  V30 25 C 2.3236 1.0245 0 0
M  V30 26 C 1.0245 0.2745 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 4 22
M  V30 7 1 5 6
M  V30 8 1 7 6 CFG=3
M  V30 9 1 7 8
M  V30 10 1 7 12
M  V30 11 2 8 9
M  V30 12 1 8 15
M  V30 13 1 9 10
M  V30 14 1 9 13
M  V30 15 1 10 11
M  V30 16 2 11 12
M  V30 17 1 11 14
M  V30 18 1 12 18
M  V30 19 1 15 16
M  V30 20 2 15 17
M  V30 21 1 16 25
M  V30 22 1 18 19
M  V30 23 2 18 20
M  V30 24 1 19 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
nitrendipine

> <ID>
nitrendipine

> <PRIMARY_SOM>
7 10

> <Citation>
Guengerich et al.,J. Med. Chem.,34,1838,1991

> <DOI>
10.1021/jm00110a012

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
no_1886
  SciTegic08102311032D

 27 28  0  0  0  0            999 V2000
   14.4904   -3.0000    0.0000 C   0  0
   14.4904   -1.5000    0.0000 C   0  0
   13.1913   -0.7500    0.0000 C   0  0
   11.8923   -1.5000    0.0000 C   0  0
   11.8923   -3.0000    0.0000 C   0  0
   13.1913   -3.7500    0.0000 C   0  0
   15.7894   -3.7500    0.0000 Br  0  0
   10.5933   -3.7500    0.0000 C   0  0
    9.2942   -4.5000    0.0000 N   0  0
   10.5933   -0.7500    0.0000 N   0  0
   10.5933    0.7500    0.0000 C   0  0
    9.2942    1.5000    0.0000 C   0  0
   11.8923    1.5000    0.0000 O   0  0
    9.2942    3.0000    0.0000 C   0  0
    7.9952    3.7500    0.0000 C   0  0
    6.6961    3.0000    0.0000 C   0  0
    6.6962    1.5000    0.0000 C   0  0
    7.9952    0.7500    0.0000 C   0  0
    5.3971    3.7500    0.0000 C   0  0
    4.2480    2.7858    0.0000 P   0  0
    3.0990    1.8217    0.0000 O   0  0
    3.2839    3.9349    0.0000 O   0  0
    5.2122    1.6368    0.0000 O   0  0
    3.7969    5.3444    0.0000 C   0  0
    2.8327    6.4935    0.0000 C   0  0
    1.6894    2.3347    0.0000 C   0  0
    0.5404    1.3705    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4 10  1  0
  5  6  1  0
  5  8  1  0
  8  9  3  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 12 18  2  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 19  1  0
 17 18  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  2  0
 21 26  1  0
 22 24  1  0
 24 25  1  0
 26 27  1  0
M  END
> <Name>
no_1886

> <ID>
no_1886

> <PRIMARY_SOM>
24 26

> <Citation>
Morioka et al.,Drug Metab. Disp.,30,301,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
nortriptyline
  SciTegic08102311032D

 20 22  0  0  0  0            999 V2000
    1.5306    6.1081    0.0000 C   0  0
    1.1968    7.5705    0.0000 C   0  0
    0.5954    4.9353    0.0000 C   0  0
    2.9930    5.7743    0.0000 C   0  0
   -0.1546    8.2213    0.0000 C   0  0
    2.4362    8.4154    0.0000 C   0  0
   -0.9046    4.9353    0.0000 C   0  0
    1.3454    3.6363    0.0000 C   0  0
    4.0133    6.8739    0.0000 C   0  0
   -1.5061    7.5704    0.0000 C   0  0
   -0.2667    9.7171    0.0000 C   0  0
    2.3241    9.9112    0.0000 C   0  0
   -1.8398    6.1081    0.0000 C   0  0
   -1.6546    3.6363    0.0000 C   0  0
    0.5954    2.3372    0.0000 C   0  0
    5.4757    6.5401    0.0000 C   0  0
    0.9726   10.5621    0.0000 C   0  0
   -0.9046    2.3372    0.0000 C   0  0
    6.4959    7.6397    0.0000 N   0  0
    7.9583    7.3059    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  7 14  1  0
  8 15  2  0
  9 16  1  0
 10 13  1  0
 11 17  2  0
 12 17  1  0
 14 18  2  0
 15 18  1  0
 16 19  1  0
 19 20  1  0
M  END
> <Name>
nortriptyline

> <ID>
nortriptyline

> <PRIMARY_SOM>
13 10

> <SECONDARY_SOM>
20

> <Citation>
Venkatakrishnan et al.,J. Clin. Pharm.,39,567,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ns_21
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5712 -2.1495 0 0 CFG=1
M  V30 2 C 4.2721 -1.3995 0 0
M  V30 3 C 6.8702 -1.3995 0 0
M  V30 4 C 5.5712 -3.6495 0 0
M  V30 5 O 5.5712 -0.6495 0 0
M  V30 6 C 4.2721 0.1005 0 0
M  V30 7 C 2.9731 -2.1495 0 0
M  V30 8 C 8.1692 -2.1495 0 0
M  V30 9 C 6.8702 0.1005 0 0
M  V30 10 O 6.8702 -4.3995 0 0
M  V30 11 O 4.2721 -4.3995 0 0
M  V30 12 C 2.9731 0.8505 0 0
M  V30 13 C 1.674 -1.3995 0 0
M  V30 14 C 9.4683 -1.3995 0 0
M  V30 15 C 8.1692 0.8505 0 0
M  V30 16 C 6.8702 -5.8995 0 0
M  V30 17 C 1.674 0.1005 0 0
M  V30 18 C 9.4683 0.1005 0 0
M  V30 19 C 8.1692 -6.6495 0 0
M  V30 20 C 5.3702 -5.8995 0 0
M  V30 21 C 6.1202 -7.1985 0 0
M  V30 22 C 9.4683 -7.3995 0 0
M  V30 23 C 10.7673 -8.1495 0 0
M  V30 24 N 10.7673 -9.6495 0 0
M  V30 25 C 12.0664 -10.3995 0 0
M  V30 26 C 9.4683 -10.3995 0 0
M  V30 27 C 12.0664 -11.8995 0 0
M  V30 28 C 9.4683 -11.8995 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5 CFG=3
M  V30 5 2 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 4 10
M  V30 10 2 4 11
M  V30 11 1 6 12
M  V30 12 2 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 2 12 17
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 3 19 22
M  V30 24 1 22 23
M  V30 25 1 23 24
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
ns_21

> <ID>
ns_21

> <PRIMARY_SOM>
26 25

> <SECONDARY_SOM>
18

> <Citation>
Nakamura et al.,Xenobiotica,29,243,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
olopatadine
  SciTegic08102311032D

 25 27  0  0  0  0            999 V2000
    6.9715   -1.4855    0.0000 C   0  0
    6.6377   -0.0231    0.0000 C   0  0
    6.0363   -2.6582    0.0000 C   0  0
    8.4548   -1.7090    0.0000 C   0  0
    5.2863    0.6277    0.0000 C   0  0
    7.8105    0.9122    0.0000 C   0  0
    4.5363   -2.6582    0.0000 O   0  0
    6.5843   -4.0546    0.0000 C   0  0
    9.0028   -3.1053    0.0000 C   0  0
    3.9348   -0.0231    0.0000 C   0  0
    5.3984    2.1235    0.0000 C   0  0
    9.2068    0.3642    0.0000 C   0  0
    3.6010   -1.4855    0.0000 C   0  0
    8.0676   -4.2781    0.0000 C   0  0
   10.4861   -3.3289    0.0000 C   0  0
    2.6955    0.8219    0.0000 C   0  0
    4.1590    2.9685    0.0000 C   0  0
   10.3795    1.2994    0.0000 C   0  0
   11.0341   -4.7252    0.0000 C   0  0
    2.8075    2.3177    0.0000 C   0  0
   11.7758    0.7514    0.0000 N   0  0
   10.0988   -5.8980    0.0000 O   0  0
   12.5173   -4.9488    0.0000 O   0  0
   12.9486    1.6866    0.0000 C   0  0
   11.9994   -0.7318    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  5 10  2  0
  5 11  1  0
  6 12  1  0
  7 13  1  0
  8 14  2  0
  9 14  1  0
  9 15  1  0
 10 13  1  0
 10 16  1  0
 11 17  2  0
 12 18  1  0
 15 19  1  0
 16 20  2  0
 17 20  1  0
 18 21  1  0
 19 22  1  0
 19 23  2  0
 21 24  1  0
 21 25  1  0
M  END
> <Name>
olopatadine

> <ID>
olopatadine

> <PRIMARY_SOM>
25 24

> <Citation>
Kajita et al.,Drug Metab. Disp.,30,1504,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
omeprazole
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.46 8.3764 0 0
M  V30 2 C 6.96 8.3733 0 0
M  V30 3 C 9.2073 9.677 0 0
M  V30 4 C 10.7073 9.6802 0 0
M  V30 5 C 11.46 8.3827 0 0
M  V30 6 C 10.7128 7.0821 0 0
M  V30 7 N 9.2128 7.079 0 0
M  V30 8 C 8.4546 10.9745 0 0
M  V30 9 O 11.4546 10.9808 0 0
M  V30 10 C 12.96 8.3859 0 0
M  V30 11 C 12.9546 10.9839 0 0
M  V30 12 S 6.2128 7.0727 0 0 CFG=1
M  V30 13 C 4.7128 7.0695 0 0
M  V30 14 N 3.8336 5.8541 0 0
M  V30 15 C 2.4061 6.3147 0 0
M  V30 16 C 2.4029 7.8147 0 0
M  V30 17 C 1.1023 8.5619 0 0
M  V30 18 C -0.1951 7.8092 0 0
M  V30 19 C -0.192 6.3092 0 0
M  V30 20 C 1.1086 5.562 0 0
M  V30 21 N 3.8285 8.2812 0 0
M  V30 22 O -1.4895 5.5565 0 0
M  V30 23 O 6.9655 5.7752 0 0
M  V30 24 C -1.4863 4.0565 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 7
M  V30 4 1 12 2 CFG=3
M  V30 5 2 3 4
M  V30 6 1 3 8
M  V30 7 1 4 5
M  V30 8 1 4 9
M  V30 9 2 5 6
M  V30 10 1 5 10
M  V30 11 1 6 7
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 2 12 23
M  V30 15 2 13 14
M  V30 16 1 13 21
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 2 15 20
M  V30 20 2 16 17
M  V30 21 1 16 21
M  V30 22 1 17 18
M  V30 23 2 18 19
M  V30 24 1 19 20
M  V30 25 1 19 22
M  V30 26 1 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
omeprazole

> <ID>
omeprazole

> <PRIMARY_SOM>
12 23

> <SECONDARY_SOM>
10

> <TERTIARY_SOM>
24

> <Citation>
Abelo et al.,Drug Metab. Disp.,28,966,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
onapristone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.4614 3.0254 0 0
M  V30 2 N 15.1635 2.2734 0 0
M  V30 3 C 15.1658 0.7734 0 0
M  V30 4 C 13.8633 3.0214 0 0
M  V30 5 C 12.5654 2.2694 0 0
M  V30 6 C 11.2652 3.0174 0 0
M  V30 7 C 11.2629 4.5174 0 0
M  V30 8 C 12.5608 5.2694 0 0
M  V30 9 C 13.861 4.5214 0 0
M  V30 10 C 9.9627 5.2654 0 0 CFG=2
M  V30 11 C 9.9604 6.7654 0 0
M  V30 12 C 8.6602 7.5134 0 0 CFG=2
M  V30 13 C 7.3623 6.7614 0 0 CFG=2
M  V30 14 C 7.3646 5.2614 0 0 CFG=1
M  V30 15 C 8.6648 4.5134 0 0
M  V30 16 C 11.2583 7.5174 0 0
M  V30 17 C 11.256 9.0174 0 0
M  V30 18 C 9.9558 9.7654 0 0
M  V30 19 C 8.6579 9.0134 0 0
M  V30 20 C 12.5585 6.7694 0 0
M  V30 21 C 13.8563 7.5214 0 0
M  V30 22 C 13.854 9.0214 0 0
M  V30 23 C 12.5538 9.7694 0 0
M  V30 24 O 15.1519 9.7734 0 0
M  V30 25 C 5.9388 4.7957 0 0 CFG=2
M  V30 26 C 5.0552 6.0078 0 0
M  V30 27 C 5.935 7.2227 0 0
M  V30 28 C 7.2101 3.7694 0 0
M  V30 29 C 4.6409 4.0437 0 0
M  V30 30 O 6.3039 3.3408 0 0
M  V30 31 C 3.3407 4.7917 0 0
M  V30 32 C 2.0428 4.0397 0 0
M  V30 33 O 0.7426 4.7876 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 4 5
M  V30 5 2 4 9
M  V30 6 2 5 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 10 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 15
M  V30 13 1 11 12
M  V30 14 2 11 16
M  V30 15 1 12 13
M  V30 16 1 12 19 CFG=3
M  V30 17 1 13 14
M  V30 18 1 13 27 CFG=3
M  V30 19 1 14 15
M  V30 20 1 14 25
M  V30 21 1 14 28 CFG=3
M  V30 22 1 16 17
M  V30 23 1 16 20
M  V30 24 1 17 18
M  V30 25 2 17 23
M  V30 26 1 18 19
M  V30 27 1 20 21
M  V30 28 1 21 22
M  V30 29 1 22 23
M  V30 30 2 22 24
M  V30 31 1 25 26
M  V30 32 1 25 29
M  V30 33 1 25 30 CFG=3
M  V30 34 1 26 27
M  V30 35 1 29 31
M  V30 36 1 31 32
M  V30 37 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 10 12 13 14 25) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
onapristone

> <ID>
onapristone

> <PRIMARY_SOM>
3 1

> <Citation>
Jang and Benet,Drug Metab. Disp.,25,1119,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
org_30659
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.1178 -1.9755 0 0 CFG=2
M  V30 2 C 7.5197 -1.9755 0 0
M  V30 3 C 10.1178 -0.4755 0 0 CFG=2
M  V30 4 C 8.8187 0.2745 0 0 CFG=1
M  V30 5 C 7.5197 -0.4755 0 0 CFG=1
M  V30 6 C 6.2207 1.7745 0 0
M  V30 7 C 8.8187 -2.7255 0 0
M  V30 8 C 11.5444 -2.439 0 0 CFG=1
M  V30 9 C 6.2207 0.2745 0 0 CFG=1
M  V30 10 C 11.5444 -0.0119 0 0
M  V30 11 C 4.9216 2.5245 0 0
M  V30 12 C 12.4261 -1.2255 0 0
M  V30 13 C 12.8434 -3.189 0 0
M  V30 14 C 8.8187 1.7745 0 0
M  V30 15 C 14.1425 -3.939 0 0
M  V30 16 C 4.9216 -0.4755 0 0
M  V30 17 C 7.5197 2.5245 0 0
M  V30 18 C 3.6226 1.7745 0 0
M  V30 19 C 6.2207 -2.7255 0 0
M  V30 20 O 2.3236 2.5245 0 0
M  V30 21 C 3.6226 0.2745 0 0
M  V30 22 O 10.9343 -3.8093 0 0
M  V30 23 C 10.0132 -3.4718 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 7
M  V30 3 1 1 8
M  V30 4 1 1 23 CFG=3
M  V30 5 1 5 2 CFG=3
M  V30 6 1 2 7
M  V30 7 2 2 19
M  V30 8 1 3 4
M  V30 9 1 3 10 CFG=3
M  V30 10 1 4 5
M  V30 11 1 4 14 CFG=1
M  V30 12 1 5 9
M  V30 13 1 6 9
M  V30 14 2 6 11
M  V30 15 1 6 17
M  V30 16 1 8 12
M  V30 17 1 8 13
M  V30 18 1 8 22 CFG=3
M  V30 19 1 9 16 CFG=3
M  V30 20 2 10 12
M  V30 21 1 11 18
M  V30 22 3 13 15
M  V30 23 1 14 17
M  V30 24 1 16 21
M  V30 25 2 18 20
M  V30 26 1 18 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 1 3 4 5 8 9) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
org_30659

> <ID>
org_30659

> <PRIMARY_SOM>
17

> <Citation>
Verhoeven et al.,Xenobiotica,32,109,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ortho_dichlorobenzene
  SciTegic08102311032D

  8  8  0  0  0  0            999 V2000
    4.6917    1.5000    0.0000 C   0  0
    4.6917    3.0000    0.0000 C   0  0
    3.3927    3.7500    0.0000 C   0  0
    2.0936    3.0000    0.0000 C   0  0
    2.0936    1.5000    0.0000 C   0  0
    3.3927    0.7500    0.0000 C   0  0
    0.7946    3.7500    0.0000 Cl  0  0
    0.7946    0.7500    0.0000 Cl  0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  7  1  0
  5  6  1  0
  5  8  1  0
M  END
> <Name>
ortho_dichlorobenzene

> <ID>
ortho_dichlorobenzene

> <PRIMARY_SOM>
6 3

> <SECONDARY_SOM>
1 2

> <Citation>
Bogaards et al.,Toxicol. Appl. Pharmacol.,132,44,1995

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
osu_6162
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S -2.049 2.049 0 0
M  V30 2 C -3.3481 2.799 0 0
M  V30 3 N -3.3481 8.799 0 0
M  V30 4 C -3.3481 4.299 0 0
M  V30 5 C -4.6471 5.049 0 0
M  V30 6 O -1.299 3.3481 0 0
M  V30 7 O -2.799 0.75 0 0
M  V30 8 C -4.6471 6.549 0 0 CFG=1
M  V30 9 C -3.3481 7.299 0 0
M  V30 10 C -0.75 1.299 0 0
M  V30 11 C -4.6471 9.549 0 0
M  V30 12 C -2.049 9.549 0 0
M  V30 13 C -4.6471 2.049 0 0
M  V30 14 C -5.9462 4.299 0 0
M  V30 15 C -5.9462 8.799 0 0
M  V30 16 C -5.9462 2.799 0 0
M  V30 17 C -5.9462 7.299 0 0
M  V30 18 C -2.049 11.049 0 0
M  V30 19 C -0.75 11.799 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 2 1 7
M  V30 4 1 1 10
M  V30 5 2 2 4
M  V30 6 1 2 13
M  V30 7 1 3 9
M  V30 8 1 3 11
M  V30 9 1 3 12
M  V30 10 1 4 5
M  V30 11 1 8 5 CFG=3
M  V30 12 2 5 14
M  V30 13 1 8 9
M  V30 14 1 8 17
M  V30 15 1 11 15
M  V30 16 1 12 18
M  V30 17 2 13 16
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
osu_6162

> <ID>
osu_6162

> <PRIMARY_SOM>
12

> <Citation>
Wienkers and Wynalda,Drug Metab. Disp.,30,1372,2002

> <DOI>
10.1124/dmd.30.12.1372

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
oxybutynin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2721 -1.3995 0 0
M  V30 2 C 5.5712 -2.1495 0 0 CFG=1
M  V30 3 C 4.2721 0.1005 0 0
M  V30 4 C 2.9731 0.8505 0 0
M  V30 5 C 1.674 0.1005 0 0
M  V30 6 C 1.674 -1.3995 0 0
M  V30 7 C 2.9731 -2.1495 0 0
M  V30 8 C 5.5712 -3.6495 0 0
M  V30 9 O 5.5712 -0.6495 0 0
M  V30 10 C 6.8702 -1.3995 0 0
M  V30 11 C 8.1692 -2.1495 0 0
M  V30 12 C 6.8702 0.1005 0 0
M  V30 13 C 8.1692 0.8505 0 0
M  V30 14 C 9.4683 -1.3995 0 0
M  V30 15 C 9.4683 0.1005 0 0
M  V30 16 O 6.8702 -4.3995 0 0
M  V30 17 C 6.8702 -5.8995 0 0
M  V30 18 C 8.1692 -6.6495 0 0
M  V30 19 C 9.4683 -7.3995 0 0
M  V30 20 C 10.7673 -8.1495 0 0
M  V30 21 N 10.7673 -9.6495 0 0
M  V30 22 C 12.0664 -10.3995 0 0
M  V30 23 C 12.0664 -11.8995 0 0
M  V30 24 C 9.4683 -10.3995 0 0
M  V30 25 C 9.4683 -11.8995 0 0
M  V30 26 O 4.2721 -4.3995 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 7
M  V30 4 1 2 8
M  V30 5 1 2 9 CFG=3
M  V30 6 1 2 10
M  V30 7 2 3 4
M  V30 8 1 4 5
M  V30 9 2 5 6
M  V30 10 1 6 7
M  V30 11 1 8 16
M  V30 12 2 8 26
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 1 12 13
M  V30 17 1 13 15
M  V30 18 1 14 15
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 3 18 19
M  V30 22 1 19 20
M  V30 23 1 20 21
M  V30 24 1 21 22
M  V30 25 1 21 24
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
oxybutynin

> <ID>
oxybutynin

> <PRIMARY_SOM>
24 22

> <Citation>
Yaich et al.,Pharmacogenetics,8,449,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
oxycodone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -1.5531 6.3099 0 0 CFG=2
M  V30 2 C -1.5531 7.8099 0 0
M  V30 3 C -2.8522 5.5599 0 0 CFG=2
M  V30 4 C -0.2541 5.5599 0 0 CFG=1
M  V30 5 C -1.5531 4.8099 0 0
M  V30 6 C -0.1043 8.1981 0 0
M  V30 7 C -2.8522 8.5599 0 0
M  V30 8 C -4.1512 6.3099 0 0 CFG=1
M  V30 9 C -2.8522 4.0599 0 0
M  V30 10 O -4.1512 4.8099 0 0
M  V30 11 O 0.6457 6.8991 0 0
M  V30 12 C -0.2541 4.0599 0 0
M  V30 13 C -3.2404 4.111 0 0
M  V30 14 C -0.2376 9.724 0 0
M  V30 15 C -4.1512 7.8099 0 0
M  V30 16 C -2.7737 10.0578 0 0
M  V30 17 N -4.5394 4.861 0 0
M  V30 18 C -1.5531 3.3099 0 0
M  V30 19 O 1.0449 3.3099 0 0
M  V30 20 C -1.4034 10.6679 0 0
M  V30 21 O 1.0868 10.4281 0 0
M  V30 22 C -5.9253 4.287 0 0
M  V30 23 C 1.1392 11.9272 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5 CFG=3
M  V30 5 2 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 3 10 CFG=3
M  V30 10 1 4 11 CFG=1
M  V30 11 1 4 12
M  V30 12 1 5 13
M  V30 13 1 6 11
M  V30 14 1 6 14
M  V30 15 1 7 15
M  V30 16 2 7 16
M  V30 17 1 8 15 CFG=3
M  V30 18 1 8 17
M  V30 19 1 9 18
M  V30 20 1 12 18
M  V30 21 2 12 19
M  V30 22 1 13 17
M  V30 23 2 14 20
M  V30 24 1 14 21
M  V30 25 1 16 20
M  V30 26 1 17 22
M  V30 27 1 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 3 4 8) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
oxycodone

> <ID>
oxycodone

> <PRIMARY_SOM>
22

> <Citation>
Lalovic et al.,Drug Metab. Disp.,32,447,2004

> <DOI>
10.1124/dmd.32.4.447

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
parathion
  SciTegic08102311032D

 18 18  0  0  0  0            999 V2000
    1.2170   -1.5269    0.0000 P   0  0
   -0.2820   -1.4705    0.0000 O   0  0
    2.7159   -1.5833    0.0000 O   0  0
    1.1606   -3.0258    0.0000 O   0  0
    1.2734   -0.0279    0.0000 S   0  0
   -0.7416   -0.0426    0.0000 C   0  0
    3.4165   -2.9096    0.0000 C   0  0
   -0.1658   -3.7264    0.0000 C   0  0
   -2.2080    0.2732    0.0000 C   0  0
    0.2651    1.0694    0.0000 C   0  0
    4.9155   -2.9660    0.0000 C   0  0
   -0.2222   -5.2254    0.0000 C   0  0
   -2.6676    1.7011    0.0000 C   0  0
   -0.1945    2.4972    0.0000 C   0  0
   -1.6609    2.8131    0.0000 C   0  0
   -2.1206    4.2409    0.0000 N   0  3
   -3.5869    4.5567    0.0000 O   0  5
   -1.1139    5.3529    0.0000 O   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  1  0
  6  9  2  0
  6 10  1  0
  7 11  1  0
  8 12  1  0
  9 13  1  0
 10 14  2  0
 13 15  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
M  CHG  2  16   1  17  -1
M  END
> <Name>
parathion

> <ID>
parathion

> <PRIMARY_SOM>
1 5

> <Citation>
Mutch et al.,Toxicology,224,22,2006

> <DOI>
10.1016/j.tox.2006.04.024

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
pentachlorobenzene
  SciTegic08102311032D

 11 11  0  0  0  0            999 V2000
    6.5006   -3.7587    0.0000 Cl  0  0
    5.2015   -3.0088    0.0000 C   0  0
    5.2015   -1.5088    0.0000 C   0  0
    3.9025   -3.7588    0.0000 C   0  0
    6.5005   -0.7587    0.0000 Cl  0  0
    3.9024   -0.7588    0.0000 C   0  0
    3.9026   -5.2588    0.0000 Cl  0  0
    2.6035   -3.0089    0.0000 C   0  0
    3.9023    0.7412    0.0000 Cl  0  0
    2.6034   -1.5089    0.0000 C   0  0
    1.3043   -0.7590    0.0000 Cl  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  3  5  1  0
  3  6  1  0
  4  7  1  0
  4  8  2  0
  6  9  1  0
  6 10  2  0
  8 10  1  0
 10 11  1  0
M  END
> <Name>
pentachlorobenzene

> <ID>
pentachlorobenzene

> <PRIMARY_SOM>
8

> <Citation>
Mehmood et al.,Chemosphere,33,759,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
perazine
  SciTegic08102311032D

 24 27  0  0  0  0            999 V2000
    6.8702   -1.3995    0.0000 N   0  0
    6.8702    0.1005    0.0000 C   0  0
    5.5712   -2.1495    0.0000 C   0  0
    8.1692   -2.1495    0.0000 C   0  0
    5.5712    0.8505    0.0000 C   0  0
    8.1692    0.8505    0.0000 C   0  0
    4.2721   -1.3995    0.0000 C   0  0
    5.5712   -3.6495    0.0000 C   0  0
    8.1692   -3.6495    0.0000 C   0  0
    4.2721    0.1005    0.0000 S   0  0
    5.5712    2.3505    0.0000 C   0  0
    8.1692    2.3505    0.0000 C   0  0
    2.9731   -2.1495    0.0000 C   0  0
    4.2721   -4.3995    0.0000 C   0  0
    9.4683   -4.3995    0.0000 C   0  0
    6.8702    3.1005    0.0000 C   0  0
    2.9731   -3.6495    0.0000 C   0  0
    9.4683   -5.8995    0.0000 N   0  0
   10.7673   -6.6495    0.0000 C   0  0
    8.1692   -6.6495    0.0000 C   0  0
   10.7673   -8.1495    0.0000 C   0  0
    8.1692   -8.1495    0.0000 C   0  0
    9.4683   -8.8995    0.0000 N   0  0
    9.4683  -10.3995    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 10  1  0
  7 13  1  0
  8 14  2  0
  9 15  1  0
 11 16  2  0
 12 16  1  0
 13 17  2  0
 14 17  1  0
 15 18  1  0
 18 19  1  0
 18 20  1  0
 19 21  1  0
 20 22  1  0
 21 23  1  0
 22 23  1  0
 23 24  1  0
M  END
> <Name>
perazine

> <ID>
perazine

> <PRIMARY_SOM>
10

> <Citation>
Wojcikowski et al.,Europ. Neuropsychopharm.,14,199,2004

> <DOI>
10.1016/S0924-977X(03)00105-6

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
perphenazine
  SciTegic08102311032D

 27 30  0  0  0  0            999 V2000
    4.6471   -5.2500    0.0000 N   0  0
    4.6471   -3.7500    0.0000 C   0  0
    3.3481   -6.0000    0.0000 C   0  0
    5.9462   -6.0000    0.0000 C   0  0
    3.3481   -3.0000    0.0000 C   0  0
    5.9462   -3.0000    0.0000 C   0  0
    2.0491   -5.2500    0.0000 C   0  0
    3.3481   -7.5000    0.0000 C   0  0
    5.9462   -7.5000    0.0000 C   0  0
    2.0491   -3.7500    0.0000 S   0  0
    3.3481   -1.5000    0.0000 C   0  0
    5.9462   -1.5000    0.0000 C   0  0
    0.7500   -6.0000    0.0000 C   0  0
    2.0491   -8.2500    0.0000 C   0  0
    7.2452   -8.2500    0.0000 C   0  0
    4.6471   -0.7500    0.0000 C   0  0
    7.2452   -0.7500    0.0000 Cl  0  0
    0.7500   -7.5000    0.0000 C   0  0
    7.2452   -9.7500    0.0000 N   0  0
    8.5443  -10.5000    0.0000 C   0  0
    5.9462  -10.5000    0.0000 C   0  0
    8.5443  -12.0000    0.0000 C   0  0
    5.9462  -12.0000    0.0000 C   0  0
    7.2452  -12.7500    0.0000 N   0  0
    7.2452  -14.2500    0.0000 C   0  0
    5.9462  -15.0000    0.0000 C   0  0
    5.9462  -16.5000    0.0000 O   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 10  1  0
  7 13  1  0
  8 14  2  0
  9 15  1  0
 11 16  2  0
 12 16  1  0
 12 17  1  0
 13 18  2  0
 14 18  1  0
 15 19  1  0
 19 20  1  0
 19 21  1  0
 20 22  1  0
 21 23  1  0
 22 24  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
M  END
> <Name>
perphenazine

> <ID>
perphenazine

> <PRIMARY_SOM>
25

> <Citation>
Olesen and Linnet,Br. J. Clin. Pharm.,50,563,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
phenacetin
  SciTegic08102311032D

 13 13  0  0  0  0            999 V2000
    2.8660   -2.0000    0.0000 O   0  0
    4.5980    2.0000    0.0000 O   0  0
    2.8660    2.0000    0.0000 N   0  0
    2.8660    1.0000    0.0000 C   0  0
    2.8660   -1.0000    0.0000 C   0  0
    2.0000    0.5000    0.0000 C   0  0
    3.7320    0.5000    0.0000 C   0  0
    2.0000   -0.5000    0.0000 C   0  0
    3.7320   -0.5000    0.0000 C   0  0
    2.0000   -2.5000    0.0000 C   0  0
    2.0000   -3.5000    0.0000 C   0  0
    3.7320    2.5000    0.0000 C   0  0
    3.7320    3.5000    0.0000 C   0  0
  1  5  1  0
  1 10  1  0
  2 12  2  0
  3  4  1  0
  3 12  1  0
  4  6  2  0
  4  7  1  0
  5  8  2  0
  5  9  1  0
  6  8  1  0
  7  9  2  0
 10 11  1  0
 12 13  1  0
M  END
> <Name>
phenacetin

> <ID>
phenacetin

> <PRIMARY_SOM>
10

> <Citation>
Nakajima et al.,Xenobiotica,29,885,1999

> <DOI>
10.1080/004982599238137

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
phencyclidine
  SciTegic08102311032D

 18 20  0  0  0  0            999 V2000
    6.9213    0.8025    0.0000 C   0  0
    8.3985    1.0629    0.0000 C   0  0
    7.4343   -0.6071    0.0000 N   0  0
    6.9213    2.3025    0.0000 C   0  0
    5.6222    0.0525    0.0000 C   0  0
    9.3627   -0.0861    0.0000 C   0  0
    8.9115    2.4725    0.0000 C   0  0
    8.9115   -0.8675    0.0000 C   0  0
    6.4701   -1.7561    0.0000 C   0  0
    5.6222    3.0525    0.0000 C   0  0
    4.3232    0.8025    0.0000 C   0  0
   10.8399    0.1744    0.0000 C   0  0
   10.3887    2.7330    0.0000 C   0  0
    9.4245   -2.2771    0.0000 C   0  0
    6.9831   -3.1657    0.0000 C   0  0
    4.3232    2.3025    0.0000 C   0  0
   11.3529    1.5839    0.0000 C   0  0
    8.4604   -3.4261    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  2  0
  2  7  1  0
  3  8  1  0
  3  9  1  0
  4 10  1  0
  5 11  1  0
  6 12  1  0
  7 13  2  0
  8 14  1  0
  9 15  1  0
 10 16  1  0
 11 16  1  0
 12 17  2  0
 13 17  1  0
 14 18  1  0
 15 18  1  0
M  END
> <Name>
phencyclidine

> <ID>
phencyclidine

> <PRIMARY_SOM>
16

> <Citation>
Laurenzana and Owens,Drug Metab. Disp.,25,557,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
phenprocoumon
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5712 -3.6495 0 0
M  V30 2 C 6.8702 -4.3995 0 0 CFG=1
M  V30 3 C 5.5712 -2.1495 0 0
M  V30 4 C 4.2721 -4.3995 0 0
M  V30 5 C 6.8702 -5.8995 0 0
M  V30 6 C 8.1692 -3.6495 0 0
M  V30 7 C 4.2721 -1.3995 0 0
M  V30 8 O 6.8702 -1.3995 0 0
M  V30 9 O 2.9731 -3.6495 0 0
M  V30 10 O 4.2721 -5.8995 0 0
M  V30 11 C 8.1692 -6.6495 0 0
M  V30 12 C 5.5712 -6.6495 0 0
M  V30 13 C 8.1692 -2.1495 0 0
M  V30 14 C 2.9731 -2.1495 0 0
M  V30 15 C 4.2721 0.1005 0 0
M  V30 16 C 8.1692 -8.1495 0 0
M  V30 17 C 5.5712 -8.1495 0 0
M  V30 18 C 1.674 -1.3995 0 0
M  V30 19 C 2.9731 0.8505 0 0
M  V30 20 C 6.8702 -8.8995 0 0
M  V30 21 C 1.674 0.1005 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 2 5 11
M  V30 11 1 5 12
M  V30 12 1 6 13
M  V30 13 2 7 14
M  V30 14 1 7 15
M  V30 15 1 9 14
M  V30 16 1 11 16
M  V30 17 2 12 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 2 16 20
M  V30 21 1 17 20
M  V30 22 2 18 21
M  V30 23 1 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
phenprocoumon

> <ID>
phenprocoumon

> <PRIMARY_SOM>
21

> <SECONDARY_SOM>
20

> <TERTIARY_SOM>
19

> <Citation>
Ufer et al.,Eur. J. Clin. Pharm.,60,173,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
phenytoin
  SciTegic08102311032D

 19 21  0  0  0  0            999 V2000
   -4.6698   -1.5558    0.0000 C   0  0
   -3.1780   -1.7126    0.0000 N   0  0
   -5.2799   -2.9261    0.0000 C   0  0
   -2.8662   -3.1798    0.0000 C   0  0
   -4.1652   -3.9298    0.0000 N   0  0
   -5.4198   -0.2568    0.0000 O   0  0
   -1.4959   -3.7899    0.0000 O   0  0
   -6.5790   -2.1761    0.0000 C   0  0
   -6.1616   -4.1396    0.0000 C   0  0
   -6.5790   -0.6761    0.0000 C   0  0
   -7.8780   -2.9261    0.0000 C   0  0
   -5.5515   -5.5100    0.0000 C   0  0
   -7.6534   -3.9828    0.0000 C   0  0
   -9.1771   -2.1761    0.0000 C   0  0
   -6.4332   -6.7235    0.0000 C   0  0
   -8.5351   -5.1964    0.0000 C   0  0
   -7.8780    0.0739    0.0000 C   0  0
   -9.1771   -0.6761    0.0000 C   0  0
   -7.9250   -6.5667    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  6  2  0
  2  4  1  0
  3  5  1  0
  3  8  1  0
  3  9  1  0
  4  5  1  0
  4  7  2  0
  8 10  2  0
  8 11  1  0
  9 12  2  0
  9 13  1  0
 10 17  1  0
 11 14  2  0
 12 15  1  0
 13 16  2  0
 14 18  1  0
 15 19  2  0
 16 19  1  0
 17 18  2  0
M  END
> <Name>
phenytoin

> <ID>
phenytoin

> <PRIMARY_SOM>
19 18 17 16 15 14

> <Citation>
Komatsu et al.,Drug Metab. Disp.,28,1361,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
phorate
  SciTegic08102311032D

 13 12  0  0  0  0            999 V2000
    4.5000    2.2500    0.0000 P   0  0
    6.0000    2.2500    0.0000 S   0  0
    3.0000    2.2500    0.0000 O   0  0
    4.5000    3.7500    0.0000 O   0  0
    4.5000    0.7500    0.0000 S   0  0
    6.7500    3.5490    0.0000 C   0  0
    2.2500    3.5490    0.0000 C   0  0
    5.7990    4.5000    0.0000 C   0  0
    8.2500    3.5490    0.0000 S   0  0
    0.7500    3.5490    0.0000 C   0  0
    5.7990    6.0000    0.0000 C   0  0
    9.0000    4.8481    0.0000 C   0  0
   10.5000    4.8481    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  1  0
  6  9  1  0
  7 10  1  0
  8 11  1  0
  9 12  1  0
 12 13  1  0
M  END
> <Name>
phorate

> <ID>
phorate

> <PRIMARY_SOM>
9

> <Citation>
Usmani et al.,Drug Metab. Disp.,32,333,2004

> <DOI>
10.1124/dmd.32.3.333

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
pimobendan
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.6025 0.9509 0 0
M  V30 2 C 13.1025 0.951 0 0
M  V30 3 C 12.3525 2.25 0 0
M  V30 4 C 13.1025 3.549 0 0
M  V30 5 C 14.6025 3.549 0 0
M  V30 6 C 15.3525 2.25 0 0
M  V30 7 O 16.8525 2.25 0 0
M  V30 8 C 17.6025 3.549 0 0
M  V30 9 C 10.8525 2.25 0 0
M  V30 10 N 9.9708 1.0365 0 0
M  V30 11 N 9.9708 3.4635 0 0
M  V30 12 C 8.5442 1.5 0 0
M  V30 13 C 8.5442 3 0 0
M  V30 14 C 7.2452 3.75 0 0
M  V30 15 C 5.9461 3 0 0
M  V30 16 C 5.9461 1.5 0 0
M  V30 17 C 7.2452 0.75 0 0
M  V30 18 C 4.6471 3.75 0 0
M  V30 19 N 3.3481 3 0 0
M  V30 20 N 2.049 3.75 0 0
M  V30 21 C 2.049 5.25 0 0
M  V30 22 O 0.75 6 0 0
M  V30 23 C 3.3481 6 0 0
M  V30 24 C 4.6471 5.25 0 0 CFG=2
M  V30 25 C 5.9462 6 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 9
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 12 17
M  V30 16 2 13 14
M  V30 17 1 14 15
M  V30 18 2 15 16
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 24
M  V30 23 1 19 20
M  V30 24 1 20 21
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 23 24
M  V30 28 1 24 25 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 24) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
pimobendan

> <ID>
pimobendan

> <PRIMARY_SOM>
8

> <Citation>
Kuriya et al.,Drug Metab. Disp.,28,73,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
pimozide
  SciTegic08102311032D

 34 38  0  0  0  0            999 V2000
    5.6987   -1.8630    0.0000 N   0  0
    4.2721   -1.3995    0.0000 C   0  0
    4.2721    0.1005    0.0000 C   0  0
    2.9731    0.8505    0.0000 C   0  0
    1.6740    0.1005    0.0000 C   0  0
    1.6740   -1.3995    0.0000 C   0  0
    2.9731   -2.1495    0.0000 C   0  0
    5.6987    0.5640    0.0000 N   0  0
    6.5804   -0.6495    0.0000 C   0  0
    8.0804   -0.6495    0.0000 O   0  0
    6.1622   -3.2896    0.0000 C   0  0
    5.1585   -4.4043    0.0000 C   0  0
    5.6221   -5.8309    0.0000 C   0  0
    7.0893   -6.1428    0.0000 N   0  0
    8.0930   -5.0281    0.0000 C   0  0
    7.6295   -3.6015    0.0000 C   0  0
    7.5528   -7.5694    0.0000 C   0  0
    9.0200   -7.8812    0.0000 C   0  0
    9.4836   -9.3078    0.0000 C   0  0
   10.9508   -9.6197    0.0000 C   0  0
   11.4143  -11.0463    0.0000 C   0  0
   11.9545   -8.5050    0.0000 C   0  0
   13.4217   -8.8168    0.0000 C   0  0
   14.4254   -7.7021    0.0000 C   0  0
   13.9619   -6.2755    0.0000 C   0  0
   12.4947   -5.9637    0.0000 C   0  0
   11.4910   -7.0784    0.0000 C   0  0
   14.9656   -5.1608    0.0000 F   0  0
   12.8815  -11.3581    0.0000 C   0  0
   13.3451  -12.7847    0.0000 C   0  0
   12.3414  -13.8994    0.0000 C   0  0
   10.8741  -13.5876    0.0000 C   0  0
   10.4106  -12.1610    0.0000 C   0  0
   12.8049  -15.3260    0.0000 F   0  0
  1  2  1  0
  1  9  1  0
  1 11  1  0
  2  3  1  0
  2  7  2  0
  3  4  2  0
  3  8  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  8  9  1  0
  9 10  2  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 17  1  0
 15 16  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 21 29  1  0
 21 33  2  0
 22 23  1  0
 22 27  2  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 25 28  1  0
 26 27  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 31 34  1  0
 32 33  1  0
M  END
> <Name>
pimozide

> <ID>
pimozide

> <PRIMARY_SOM>
17

> <Citation>
Desta et al.,J. Pharmacol. Exp. Ther.,285,428,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
pinacidil
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2207 -3.2745 0 0
M  V30 2 N 6.2207 -1.7745 0 0
M  V30 3 N 7.5197 -4.0245 0 0
M  V30 4 N 4.9216 -4.0245 0 0
M  V30 5 C 4.9216 -1.0245 0 0
M  V30 6 C 7.5197 -5.5245 0 0 CFG=1
M  V30 7 C 4.9216 0.4755 0 0
M  V30 8 C 3.6226 -1.7745 0 0
M  V30 9 C 8.8188 -6.2745 0 0
M  V30 10 C 6.2207 -6.2745 0 0
M  V30 11 C 3.6226 1.2255 0 0
M  V30 12 C 2.3236 -1.0245 0 0
M  V30 13 C 8.8188 -7.7745 0 0
M  V30 14 C 10.1178 -5.5245 0 0
M  V30 15 C 10.1178 -7.0245 0 0
M  V30 16 N 2.3236 0.4755 0 0
M  V30 17 C 4.9217 -5.5245 0 0
M  V30 18 N 4.9217 -7.0245 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 17
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10 CFG=1
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 2 11 16
M  V30 17 1 12 16
M  V30 18 3 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
pinacidil

> <ID>
pinacidil

> <PRIMARY_SOM>
17 18

> <SECONDARY_SOM>
16

> <Citation>
Zhang et al.,Biochemistry,41,2712,2002

> <DOI>
10.1021/bi0119971

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
pradefovir
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.9216 -2.5245 0 0
M  V30 2 C 4.9216 -1.0245 0 0
M  V30 3 N 6.3482 -2.988 0 0
M  V30 4 N 3.6226 -3.2745 0 0
M  V30 5 N 6.3482 -0.561 0 0
M  V30 6 C 3.6226 -0.2745 0 0
M  V30 7 C 7.2299 -1.7745 0 0
M  V30 8 C 6.8118 -4.4146 0 0
M  V30 9 C 2.3236 -2.5245 0 0
M  V30 10 N 2.3236 -1.0245 0 0
M  V30 11 N 3.6226 1.2255 0 0
M  V30 12 C 8.279 -4.7265 0 0
M  V30 13 O 8.7425 -6.1531 0 0
M  V30 14 C 10.2097 -6.4649 0 0
M  V30 15 P 10.6733 -7.8915 0 0 CFG=1
M  V30 16 O 11.5967 -9.0735 0 0
M  V30 17 O 9.1878 -8.1003 0 0
M  V30 18 O 11.9977 -7.1873 0 0
M  V30 19 C 11.0348 -10.4643 0 0 CFG=1
M  V30 20 C 8.6259 -9.4911 0 0
M  V30 21 C 9.5494 -10.6731 0 0
M  V30 22 C 11.9583 -11.6463 0 0
M  V30 23 C 11.3964 -13.0371 0 0
M  V30 24 C 12.3199 -14.2191 0 0
M  V30 25 C 13.8053 -14.0104 0 0
M  V30 26 C 14.3672 -12.6196 0 0
M  V30 27 C 13.4437 -11.4376 0 0
M  V30 28 Cl 15.8526 -12.4108 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 2 5 7
M  V30 10 2 6 10
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 9 10
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 15 14 CFG=1
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 19 21
M  V30 23 1 19 22 CFG=3
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 2 22 27
M  V30 27 2 23 24
M  V30 28 1 24 25
M  V30 29 2 25 26
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 19) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
pradefovir

> <ID>
pradefovir

> <PRIMARY_SOM>
20

> <SECONDARY_SOM>
19

> <Citation>
Lin et al.,Antimicrob. Agents Chemother.,50,2926,2006

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
progesterone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2081 -11.5085 0 0
M  V30 2 C 4.2081 -10.0085 0 0
M  V30 3 C 2.9091 -12.2585 0 0
M  V30 4 C 1.61 -11.5085 0 0
M  V30 5 O 2.9091 -13.7585 0 0
M  V30 6 C 1.61 -10.0085 0 0
M  V30 7 C 2.9091 -9.2585 0 0 CFG=1
M  V30 8 C 5.5071 -9.2585 0 0
M  V30 9 C 1.61 -8.5085 0 0
M  V30 10 C 2.9091 -7.7585 0 0 CFG=2
M  V30 11 C 4.2081 -7.0085 0 0 CFG=1
M  V30 12 C 5.5071 -7.7585 0 0
M  V30 13 C 1.61 -7.0085 0 0
M  V30 14 C 1.61 -5.5085 0 0
M  V30 15 C 2.9091 -4.7585 0 0 CFG=1
M  V30 16 C 4.2081 -5.5085 0 0 CFG=1
M  V30 17 C 5.3228 -4.5048 0 0
M  V30 18 C 3.2209 -3.2913 0 0 CFG=2
M  V30 19 C 4.7127 -3.1345 0 0
M  V30 20 C 1.6955 -3.8768 0 0
M  V30 21 C 2.2172 -2.1766 0 0
M  V30 22 C 2.6807 -0.75 0 0
M  V30 23 O 0.75 -2.4885 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 2 7
M  V30 4 1 2 8
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 7 9 CFG=1
M  V30 10 1 7 10
M  V30 11 1 8 12
M  V30 12 1 10 11
M  V30 13 1 10 13 CFG=1
M  V30 14 1 11 12 CFG=3
M  V30 15 1 11 16
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 1 15 18
M  V30 20 1 15 20 CFG=1
M  V30 21 1 16 17 CFG=1
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 24 1 18 21 CFG=1
M  V30 25 1 21 22
M  V30 26 2 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 7 10 11 15 16 18) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
progesterone

> <ID>
progesterone

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
19

> <TERTIARY_SOM>
4 22

> <Citation>
Yamazaki and Shimada,Arch. Biochem. Biophys.,346,161,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
promazine
  SciTegic08102311032D

 20 22  0  0  0  0            999 V2000
    6.8702   -1.3995    0.0000 N   0  0
    6.8702    0.1005    0.0000 C   0  0
    5.5712   -2.1495    0.0000 C   0  0
    8.1692   -2.1495    0.0000 C   0  0
    5.5712    0.8505    0.0000 C   0  0
    8.1692    0.8505    0.0000 C   0  0
    4.2721   -1.3995    0.0000 C   0  0
    5.5712   -3.6495    0.0000 C   0  0
    8.1692   -3.6495    0.0000 C   0  0
    4.2721    0.1005    0.0000 S   0  0
    5.5712    2.3505    0.0000 C   0  0
    8.1692    2.3505    0.0000 C   0  0
    2.9731   -2.1495    0.0000 C   0  0
    4.2721   -4.3995    0.0000 C   0  0
    9.4683   -4.3995    0.0000 C   0  0
    6.8702    3.1005    0.0000 C   0  0
    2.9731   -3.6495    0.0000 C   0  0
    9.4683   -5.8995    0.0000 N   0  0
   10.7673   -6.6495    0.0000 C   0  0
    8.1692   -6.6495    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 10  1  0
  7 13  1  0
  8 14  2  0
  9 15  1  0
 11 16  2  0
 12 16  1  0
 13 17  2  0
 14 17  1  0
 15 18  1  0
 18 19  1  0
 18 20  1  0
M  END
> <Name>
promazine

> <ID>
promazine

> <PRIMARY_SOM>
10

> <SECONDARY_SOM>
20 19

> <Citation>
Wojcikowski et al.,Br. J. Pharm.,138,1465,2003

> <DOI>
10.1038/sj.bjp.0705195

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
propafenone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2207 3.2745 0 0
M  V30 2 C 7.5197 2.5245 0 0
M  V30 3 C 6.2207 4.7745 0 0
M  V30 4 C 4.9216 5.5245 0 0
M  V30 5 C 3.6226 4.7745 0 0
M  V30 6 C 3.6226 3.2745 0 0
M  V30 7 C 4.9216 2.5245 0 0
M  V30 8 C 7.5197 1.0245 0 0
M  V30 9 C 8.8187 0.2745 0 0
M  V30 10 C 8.8188 -1.2255 0 0
M  V30 11 C 7.5197 -1.9755 0 0
M  V30 12 C 7.5197 -3.4755 0 0
M  V30 13 C 8.8188 -4.2255 0 0
M  V30 14 C 10.1178 -3.4755 0 0
M  V30 15 C 10.1178 -1.9755 0 0
M  V30 16 O 11.4168 -1.2255 0 0
M  V30 17 O 10.1178 1.0245 0 0
M  V30 18 C 12.7159 -1.9755 0 0
M  V30 19 C 14.0149 -1.2255 0 0 CFG=2
M  V30 20 C 15.3139 -1.9755 0 0
M  V30 21 N 16.613 -1.2254 0 0
M  V30 22 O 14.0149 0.2745 0 0
M  V30 23 C 17.912 -1.9754 0 0
M  V30 24 C 19.2111 -1.2254 0 0
M  V30 25 C 20.5101 -1.9754 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 7
M  V30 4 1 2 8
M  V30 5 2 3 4
M  V30 6 1 4 5
M  V30 7 2 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 17
M  V30 12 1 10 11
M  V30 13 2 10 15
M  V30 14 2 11 12
M  V30 15 1 12 13
M  V30 16 2 13 14
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 19 22 CFG=1
M  V30 23 1 20 21
M  V30 24 1 21 23
M  V30 25 1 23 24
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 19) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
propafenone

> <ID>
propafenone

> <PRIMARY_SOM>
23

> <Citation>
S. Botsch, J. C. Gautier, P. Beaune, M. Eichelbaum, H. K. Kroemer, Mol. Pharmacol. 1993, 43, 120-126.

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
py74
  SciTegic08102311032D

 28 29  0  0  0  0            999 V2000
   -1.5736    3.2745    0.0000 C   0  0
   -1.5736    4.7745    0.0000 C   0  0
   -2.8726    5.5245    0.0000 C   0  0
   -4.1716    4.7745    0.0000 C   0  0
   -4.1716    3.2745    0.0000 C   0  0
   -2.8726    2.5245    0.0000 C   0  0
   -0.2745    2.5245    0.0000 O   0  0
   -0.2745    1.0245    0.0000 C   0  0
   -0.2745    5.5245    0.0000 N   0  0
   -0.2745    7.0245    0.0000 C   0  0
   -1.5736    7.7745    0.0000 O   0  0
    1.0245    7.7745    0.0000 C   0  0
    1.0245    9.2745    0.0000 N   0  0
    2.3236    7.0245    0.0000 C   0  0
    3.6226    7.7745    0.0000 O   0  0
    2.3236    5.5245    0.0000 C   0  0
    2.3236   10.0245    0.0000 N   0  0
    2.3236   11.5245    0.0000 C   0  0
    1.0245   12.2745    0.0000 C   0  0
    1.0245   13.7745    0.0000 C   0  0
    2.3236   14.5245    0.0000 C   0  0
    3.6226   13.7745    0.0000 C   0  0
    3.6226   12.2745    0.0000 C   0  0
    4.9216   11.5245    0.0000 O   0  0
    6.2207   12.2745    0.0000 C   0  0
    2.3236   16.0245    0.0000 N   0  3
    3.6226   16.7745    0.0000 O   0  0
    1.0245   16.7745    0.0000 O   0  5
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  2  9  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  7  8  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 12 14  1  0
 13 17  1  0
 14 15  2  0
 14 16  1  0
 17 18  1  0
 18 19  1  0
 18 23  2  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 21 26  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 26 27  2  0
 26 28  1  0
M  CHG  2  26   1  28  -1
M  END
> <Name>
py74

> <ID>
py74

> <PRIMARY_SOM>
5

> <Citation>
Cui et al.,Drug Metab. Disp.,33,1459,2005

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
pyrazoloacridine
  SciTegic08102311032D

 27 30  0  0  0  0            999 V2000
    6.3844    5.2500    0.0000 C   0  0
    6.3844    6.7500    0.0000 C   0  0
    5.0854    4.5000    0.0000 C   0  0
    7.6835    4.5000    0.0000 C   0  0
    5.0854    7.5000    0.0000 C   0  0
    7.8333    7.1382    0.0000 N   0  0
    5.0854    3.0000    0.0000 C   0  0
    3.7863    5.2500    0.0000 N   0  0
    8.5833    5.8392    0.0000 N   0  0
    7.6835    3.0000    0.0000 C   0  0
    3.7863    6.7500    0.0000 C   0  0
    5.0854    9.0000    0.0000 C   0  0
    6.3844    2.2500    0.0000 C   0  0
    3.7863    2.2500    0.0000 N   0  3
   10.0824    5.7882    0.0000 C   0  0
    2.4873    7.5000    0.0000 C   0  0
    3.7863    9.7500    0.0000 C   0  0
    2.4873    3.0000    0.0000 O   0  5
    3.7863    0.7500    0.0000 O   0  0
   10.8762    7.0610    0.0000 C   0  0
    2.4873    9.0000    0.0000 C   0  0
    3.7863   11.2500    0.0000 O   0  0
   12.3753    7.0099    0.0000 C   0  0
    2.4873   12.0000    0.0000 C   0  0
   13.1691    8.2827    0.0000 N   0  0
   14.6682    8.2317    0.0000 C   0  0
   12.4637    9.6065    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  4 10  2  0
  5 11  2  0
  5 12  1  0
  6  9  1  0
  7 13  2  0
  7 14  1  0
  8 11  1  0
  9 15  1  0
 10 13  1  0
 11 16  1  0
 12 17  2  0
 14 18  1  0
 14 19  2  0
 15 20  1  0
 16 21  2  0
 17 21  1  0
 17 22  1  0
 20 23  1  0
 22 24  1  0
 23 25  1  0
 25 26  1  0
 25 27  1  0
M  CHG  2  14   1  18  -1
M  END
> <Name>
pyrazoloacridine

> <ID>
pyrazoloacridine

> <PRIMARY_SOM>
27 26

> <Citation>
Reid et al.,Clin. Cancer Res.,10,1471,2004

> <DOI>
10.1158/1078-0432.CCR-0557-03

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
quazepam
  SciTegic08102311032D

 25 27  0  0  0  0            999 V2000
   -4.0487    5.8650    0.0000 C   0  0
   -4.3825    7.3274    0.0000 C   0  0
   -4.9840    4.6923    0.0000 N   0  0
   -2.6154    5.4229    0.0000 C   0  0
   -5.7340    7.9782    0.0000 C   0  0
   -3.2829    8.3477    0.0000 C   0  0
   -6.4840    4.6923    0.0000 C   0  0
   -4.3331    3.3408    0.0000 C   0  0
   -1.5158    6.4431    0.0000 C   0  0
   -5.7340    9.4782    0.0000 C   0  0
   -7.0854    7.3274    0.0000 N   0  0
   -1.8496    7.9055    0.0000 C   0  0
   -7.4192    5.8650    0.0000 C   0  0
   -7.1348    3.3408    0.0000 S   0  0
   -5.1781    2.1015    0.0000 C   0  0
   -4.4349   10.2282    0.0000 C   0  0
   -7.0330   10.2282    0.0000 C   0  0
   -0.7500    8.9258    0.0000 Cl  0  0
   -4.5273    0.7500    0.0000 F   0  0
   -6.6739    2.2136    0.0000 F   0  0
   -6.0231    0.8621    0.0000 F   0  0
   -4.4349   11.7282    0.0000 C   0  0
   -3.1359    9.4782    0.0000 F   0  0
   -7.0330   11.7282    0.0000 C   0  0
   -5.7340   12.4782    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  5 11  2  0
  6 12  2  0
  7 13  1  0
  7 14  2  0
  8 15  1  0
  9 12  1  0
 10 16  2  0
 10 17  1  0
 11 13  1  0
 12 18  1  0
 15 19  1  0
 15 20  1  0
 15 21  1  0
 16 22  1  0
 16 23  1  0
 17 24  2  0
 22 25  2  0
 24 25  1  0
M  END
> <Name>
quazepam

> <ID>
quazepam

> <PRIMARY_SOM>
14 7

> <Citation>
Miura and Ohkubo,Xenobiotica,34,1001,2004

> <DOI>
10.1080/0277224040001524

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
quinacrine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.4683 -1.3995 0 0
M  V30 2 C 9.4683 -2.8995 0 0 CFG=1
M  V30 3 C 8.1692 -0.6495 0 0
M  V30 4 C 10.7673 -3.6495 0 0
M  V30 5 C 8.1692 -3.6495 0 0
M  V30 6 C 8.1692 0.8505 0 0
M  V30 7 C 6.8702 -1.3995 0 0
M  V30 8 C 10.7673 -5.1495 0 0
M  V30 9 C 6.8702 1.6005 0 0
M  V30 10 C 9.4683 1.6005 0 0
M  V30 11 C 5.5712 -0.6495 0 0
M  V30 12 C 6.8702 -2.8995 0 0
M  V30 13 C 12.0664 -5.8995 0 0
M  V30 14 N 5.5712 0.8505 0 0
M  V30 15 C 6.8702 3.1005 0 0
M  V30 16 C 9.4683 3.1005 0 0
M  V30 17 C 4.2721 -1.3995 0 0
M  V30 18 C 5.5712 -3.6495 0 0
M  V30 19 N 12.0664 -7.3995 0 0
M  V30 20 C 8.1692 3.8505 0 0
M  V30 21 O 10.7673 3.8505 0 0
M  V30 22 C 4.2721 -2.8995 0 0
M  V30 23 C 13.3654 -8.1495 0 0
M  V30 24 C 10.7673 -8.1495 0 0
M  V30 25 C 10.7673 5.3505 0 0
M  V30 26 Cl 2.9731 -3.6495 0 0
M  V30 27 C 13.3654 -9.6495 0 0
M  V30 28 C 10.7673 -9.6495 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5 CFG=1
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 1 9 15
M  V30 15 2 10 16
M  V30 16 1 11 14
M  V30 17 1 11 17
M  V30 18 2 12 18
M  V30 19 1 13 19
M  V30 20 2 15 20
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 2 17 22
M  V30 24 1 18 22
M  V30 25 1 19 23
M  V30 26 1 19 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 24 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
quinacrine

> <ID>
quinacrine

> <PRIMARY_SOM>
24 23

> <Citation>
Huang et al.,Drug Metab. Disp.,34,1136,2006

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
quinidine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.0245 -4.7745 0 0
M  V30 2 C 1.0245 -3.2745 0 0
M  V30 3 C -0.2745 -2.5245 0 0
M  V30 4 C -1.5736 -3.2745 0 0
M  V30 5 C -1.5736 -4.7745 0 0
M  V30 6 C -0.2745 -5.5245 0 0
M  V30 7 N -2.8726 -2.5245 0 0
M  V30 8 C -4.1717 -3.2745 0 0
M  V30 9 C -4.1717 -4.7745 0 0
M  V30 10 C -2.8726 -5.5245 0 0
M  V30 11 C -2.8726 -7.0245 0 0 CFG=1
M  V30 12 C -4.1717 -7.7745 0 0 CFG=2
M  V30 13 N -4.9217 -9.0736 0 0 CFG=2
M  V30 14 C -6.861 -8.0129 0 0
M  V30 15 C -7.9217 -9.0736 0 0 CFG=1
M  V30 16 C -6.4217 -9.0736 0 0 CFG=1
M  V30 17 C -5.6717 -7.7745 0 0
M  V30 18 C -9.3075 -9.6476 0 0
M  V30 19 C -9.5033 -11.1347 0 0
M  V30 20 C -5.6717 -10.3726 0 0
M  V30 21 C -4.1717 -10.3726 0 0
M  V30 22 O 2.3235 -5.5245 0 0
M  V30 23 C 2.3235 -7.0245 0 0
M  V30 24 O -1.5736 -7.7745 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 22
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 7
M  V30 8 1 5 6
M  V30 9 2 5 10
M  V30 10 1 7 8
M  V30 11 2 8 9
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 1 11 24 CFG=3
M  V30 16 1 12 13
M  V30 17 1 12 17 CFG=3
M  V30 18 1 13 14 CFG=1
M  V30 19 1 13 21
M  V30 20 1 14 15
M  V30 21 1 15 16
M  V30 22 1 15 18 CFG=1
M  V30 23 1 16 17 CFG=1
M  V30 24 1 16 20
M  V30 25 2 18 19
M  V30 26 1 20 21
M  V30 27 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 13 15 16) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
quinidine

> <ID>
quinidine

> <PRIMARY_SOM>
15

> <SECONDARY_SOM>
13

> <Citation>
Nielsen et al.,J. Pharmacol. Exp. Ther.,289,31,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
quinine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -0.5866 -1.4451 0 0
M  V30 2 C -0.5932 0.0548 0 0
M  V30 3 C -1.8824 -2.2008 0 0
M  V30 4 C 0.7157 -2.1895 0 0
M  V30 5 C 0.7025 0.8105 0 0 CFG=2
M  V30 6 C -1.8955 0.7992 0 0
M  V30 7 C -1.8758 -3.7008 0 0
M  V30 8 N -3.1847 -1.4565 0 0
M  V30 9 C 0.7222 -3.6894 0 0
M  V30 10 C 0.9565 2.2889 0 0 CFG=1
M  V30 11 O 2.0048 0.0662 0 0
M  V30 12 C -3.1913 0.0435 0 0
M  V30 13 C -0.5735 -4.4451 0 0
M  V30 14 O 2.0245 -4.4337 0 0
M  V30 15 N -0.1967 3.248 0 0 CFG=2
M  V30 16 C 2.3638 2.8081 0 0
M  V30 17 C 2.0311 -5.9337 0 0
M  V30 18 C -1.604 2.7288 0 0
M  V30 19 C 0.0573 4.7263 0 0
M  V30 20 C 1.2105 3.7672 0 0 CFG=1
M  V30 21 C -0.2418 2.1008 0 0 CFG=1
M  V30 22 C 1.4645 5.2455 0 0
M  V30 23 C 0.0723 0.6341 0 0
M  V30 24 C 1.4996 0.1728 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11 CFG=3
M  V30 11 2 6 12
M  V30 12 2 7 13
M  V30 13 1 8 12
M  V30 14 1 9 13
M  V30 15 1 9 14
M  V30 16 1 10 15
M  V30 17 1 10 16 CFG=1
M  V30 18 1 14 17
M  V30 19 1 15 18 CFG=3
M  V30 20 1 15 19
M  V30 21 1 20 16 CFG=1
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23 CFG=1
M  V30 27 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 5 10 15 20 21) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
quinine

> <ID>
quinine

> <PRIMARY_SOM>
21

> <Citation>
Mirghani et al.,Drug Metab. Disp.,30,1368,2002
Zhao et al.,J. Pharmacol. Exp. Ther.,279,1327,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
quinoline
  SciTegic08102311032D

 10 11  0  0  0  0            999 V2000
    3.3481    1.5000    0.0000 C   0  0
    3.3481    3.0000    0.0000 C   0  0
    2.0490    0.7500    0.0000 C   0  0
    4.6471    0.7500    0.0000 C   0  0
    4.6471    3.7500    0.0000 C   0  0
    2.0490    3.7500    0.0000 N   0  0
    0.7500    1.5000    0.0000 C   0  0
    5.9462    1.5000    0.0000 C   0  0
    5.9462    3.0000    0.0000 C   0  0
    0.7500    3.0000    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  4  8  2  0
  5  9  2  0
  6 10  2  0
  7 10  1  0
  8  9  1  0
M  END
> <Name>
quinoline

> <ID>
quinoline

> <PRIMARY_SOM>
6

> <SECONDARY_SOM>
7 5

> <TERTIARY_SOM>
8 4

> <Citation>
Dowers et al.,Drug Metab. Disp.,32,328,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
rabeprazole_thioether
  SciTegic08102311032D

 24 26  0  0  0  0            999 V2000
    2.7665    5.9405    0.0000 C   0  0
    1.8874    4.7251    0.0000 N   0  0
    1.8823    7.1521    0.0000 N   0  0
    4.2665    5.9436    0.0000 S   0  0
    6.5138    7.2474    0.0000 C   0  0
    5.0138    7.2442    0.0000 C   0  0
    7.2611    8.5480    0.0000 C   0  0
    0.4598    5.1856    0.0000 C   0  0
    0.4567    6.6856    0.0000 C   0  0
    7.2665    5.9499    0.0000 N   0  0
    8.7611    8.5511    0.0000 C   0  0
    8.7665    5.9531    0.0000 C   0  0
    9.5138    7.2537    0.0000 C   0  0
    9.5083    9.8517    0.0000 O   0  0
   11.7556   11.1555    0.0000 C   0  0
    6.5083    9.8454    0.0000 C   0  0
   -0.8376    4.4329    0.0000 C   0  0
   14.0029   12.4593    0.0000 O   0  0
   -0.8439    7.4329    0.0000 C   0  0
   11.0083    9.8549    0.0000 C   0  0
   13.2556   11.1587    0.0000 C   0  0
   15.5028   12.4624    0.0000 C   0  0
   -2.1414    6.6801    0.0000 C   0  0
   -2.1382    5.1801    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  8  1  0
  3  9  1  0
  4  6  1  0
  5  6  1  0
  5  7  2  0
  5 10  1  0
  7 11  1  0
  7 16  1  0
  8  9  2  0
  8 17  1  0
  9 19  1  0
 10 12  2  0
 11 13  2  0
 11 14  1  0
 12 13  1  0
 14 20  1  0
 15 20  1  0
 15 21  1  0
 17 24  2  0
 18 21  1  0
 18 22  1  0
 19 23  2  0
 23 24  1  0
M  END
> <Name>
rabeprazole_thioether

> <ID>
rabeprazole_thioether

> <PRIMARY_SOM>
4

> <SECONDARY_SOM>
22

> <Citation>
Miura et al.,Eur. J. Clin. Pharmacol.,62,113,2006

> <DOI>
10.1007/s00228-005-0077-8

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
raloxifene
  SciTegic08102311032D

 34 38  0  0  0  0            999 V2000
   -2.0808    1.4867    0.0000 C   0  0
   -1.6648    0.0456    0.0000 C   0  0
   -2.7049   -1.0353    0.0000 C   0  0
   -4.1610   -0.6750    0.0000 C   0  0
   -4.5770    0.7662    0.0000 C   0  0
   -3.5369    1.8470    0.0000 C   0  0
   -5.2011   -1.7558    0.0000 O   0  0
   -3.6442    3.3432    0.0000 S   0  0
   -2.2544    3.9076    0.0000 C   0  0
   -1.2882    2.7602    0.0000 C   0  0
    0.2080    2.8675    0.0000 C   0  0
    0.8632    4.2168    0.0000 O   0  0
    1.0490    1.6254    0.0000 C   0  0
    2.5451    1.7326    0.0000 C   0  0
    3.3861    0.4906    0.0000 C   0  0
    2.7309   -0.8588    0.0000 C   0  0
    1.2347   -0.9660    0.0000 C   0  0
    0.3938    0.2760    0.0000 C   0  0
    3.5719   -2.1009    0.0000 O   0  0
    2.9167   -3.4502    0.0000 C   0  0
    3.7577   -4.6923    0.0000 C   0  0
    3.1025   -6.0416    0.0000 N   0  0
    3.9435   -7.2837    0.0000 C   0  0
    3.2883   -8.6331    0.0000 C   0  0
    1.7921   -8.7403    0.0000 C   0  0
    0.9512   -7.4982    0.0000 C   0  0
    1.6063   -6.1489    0.0000 C   0  0
   -1.8941    5.3636    0.0000 C   0  0
   -0.4529    5.7796    0.0000 C   0  0
   -0.0926    7.2357    0.0000 C   0  0
   -1.1734    8.2758    0.0000 C   0  0
   -2.6146    7.8598    0.0000 C   0  0
   -2.9749    6.4037    0.0000 C   0  0
   -0.8131    9.7319    0.0000 O   0  0
  1  2  1  0
  1  6  2  0
  1 10  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  7  1  0
  5  6  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9 28  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 18  2  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 19  1  0
 17 18  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 28 29  1  0
 28 33  2  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 31 34  1  0
 32 33  1  0
M  END
> <Name>
raloxifene

> <ID>
raloxifene

> <PRIMARY_SOM>
3 5 30 32

> <Citation>
Chen et al.,Chem. Res. Toxicol.,15,907,2002

> <DOI>
10.1021/tx0200109

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
rebamipide
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -0.924 4.3995 0 0
M  V30 2 C -0.924 5.8995 0 0
M  V30 3 C -2.2231 3.6495 0 0
M  V30 4 C 0.375 3.6495 0 0
M  V30 5 C 0.375 6.6495 0 0
M  V30 6 C -2.2231 6.6495 0 0
M  V30 7 N -3.5221 4.3995 0 0
M  V30 8 C -2.2231 2.1495 0 0
M  V30 9 C 0.375 2.1495 0 0
M  V30 10 C 0.375 8.1495 0 0 CFG=1
M  V30 11 C -3.5221 5.8995 0 0
M  V30 12 C -0.924 1.3995 0 0
M  V30 13 N 1.674 8.8995 0 0
M  V30 14 C -0.9241 8.8995 0 0
M  V30 15 O -4.8212 6.6495 0 0
M  V30 16 C 1.674 10.3995 0 0
M  V30 17 O -2.2231 8.1495 0 0
M  V30 18 O -0.9241 10.3995 0 0
M  V30 19 C 2.9731 11.1495 0 0
M  V30 20 O 0.375 11.1495 0 0
M  V30 21 C 2.9731 12.6495 0 0
M  V30 22 C 4.2721 10.3995 0 0
M  V30 23 C 4.2721 13.3995 0 0
M  V30 24 C 5.5711 11.1495 0 0
M  V30 25 C 5.5711 12.6495 0 0
M  V30 26 Cl 6.8702 13.3995 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 10 5 CFG=3
M  V30 10 1 6 11
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 2 11 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 2 19 21
M  V30 23 1 19 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
rebamipide

> <ID>
rebamipide

> <PRIMARY_SOM>
8

> <Citation>
Koyama et al.,Xenobiotica,32,573,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
reboxetine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3242 10.7217 0 0
M  V30 2 C 4.0251 11.4717 0 0
M  V30 3 O 2.7261 10.7217 0 0
M  V30 4 C 1.427 11.4717 0 0
M  V30 5 C 1.427 12.9717 0 0
M  V30 6 C 0.128 13.7217 0 0
M  V30 7 C -1.171 12.9717 0 0
M  V30 8 C -1.171 11.4717 0 0
M  V30 9 C 0.128 10.7217 0 0
M  V30 10 O 0.128 9.2217 0 0
M  V30 11 C -1.171 8.4717 0 0 CFG=2
M  V30 12 C -2.4701 9.2217 0 0 CFG=2
M  V30 13 C -3.7691 8.4717 0 0
M  V30 14 N -5.0682 9.2217 0 0
M  V30 15 C -5.0682 10.7217 0 0
M  V30 16 C -3.7691 11.4717 0 0
M  V30 17 O -2.4701 10.7217 0 0
M  V30 18 C -1.171 6.9717 0 0
M  V30 19 C -2.4701 6.2217 0 0
M  V30 20 C -2.4701 4.7217 0 0
M  V30 21 C -1.171 3.9717 0 0
M  V30 22 C 0.128 4.7217 0 0
M  V30 23 C 0.128 6.2217 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 3 4
M  V30 4 1 4 5
M  V30 5 2 4 9
M  V30 6 2 5 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 10 CFG=1
M  V30 12 1 11 12
M  V30 13 1 11 18
M  V30 14 1 12 13 CFG=3
M  V30 15 1 12 17
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 2 18 23
M  V30 22 2 19 20
M  V30 23 1 20 21
M  V30 24 2 21 22
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 12) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
reboxetine

> <ID>
reboxetine

> <PRIMARY_SOM>
2

> <TERTIARY_SOM>
7 6

> <Citation>
Wienkers et al.,Drug Metab. Disp.,27,1334,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
reduced_haloperidol
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.6644 -3.1005 0 0
M  V30 2 O 16.1416 -2.84 0 0
M  V30 3 C 15.1775 -4.51 0 0
M  V30 4 C 14.6644 -1.6005 0 0
M  V30 5 C 13.3654 -3.8505 0 0
M  V30 6 C 16.6547 -4.7705 0 0
M  V30 7 C 14.2133 -5.6591 0 0
M  V30 8 C 13.3654 -0.8505 0 0
M  V30 9 C 12.0663 -3.1005 0 0
M  V30 10 C 17.1677 -6.18 0 0
M  V30 11 C 14.7263 -7.0686 0 0
M  V30 12 N 12.0663 -1.6005 0 0
M  V30 13 C 16.2035 -7.3291 0 0
M  V30 14 C 10.7673 -0.8505 0 0
M  V30 15 Cl 16.7166 -8.7386 0 0
M  V30 16 C 9.4683 -1.6005 0 0
M  V30 17 C 8.1692 -0.8505 0 0
M  V30 18 C 6.8702 -1.6005 0 0 CFG=1
M  V30 19 C 5.5712 -0.8505 0 0
M  V30 20 O 6.8702 -3.1005 0 0
M  V30 21 C 4.2721 -1.6005 0 0
M  V30 22 C 5.5712 0.6495 0 0
M  V30 23 C 2.9731 -0.8505 0 0
M  V30 24 C 4.2721 1.3995 0 0
M  V30 25 C 2.9731 0.6495 0 0
M  V30 26 F 1.674 1.3995 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 18 20 CFG=3
M  V30 22 2 19 21
M  V30 23 1 19 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 18) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
reduced_haloperidol

> <ID>
reduced_haloperidol

> <PRIMARY_SOM>
18

> <SECONDARY_SOM>
14

> <TERTIARY_SOM>
1 9 8

> <Citation>
Fang et al.,Drug Metab. Disp.,12,1638,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
repaglinide
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3481 3.75 0 0
M  V30 2 C 3.3481 5.25 0 0
M  V30 3 N 4.6471 3 0 0
M  V30 4 C 2.049 3 0 0
M  V30 5 C 4.6471 6 0 0 CFG=1
M  V30 6 C 2.049 6 0 0
M  V30 7 C 5.9462 3.75 0 0
M  V30 8 C 4.6471 1.5 0 0
M  V30 9 C 0.75 3.75 0 0
M  V30 10 N 5.9462 5.25 0 0
M  V30 11 C 4.6471 7.5 0 0
M  V30 12 C 0.75 5.25 0 0
M  V30 13 C 7.2452 3 0 0
M  V30 14 C 5.9462 0.75 0 0
M  V30 15 C 7.2452 6 0 0
M  V30 16 C 3.3481 8.25 0 0
M  V30 17 C 7.2452 1.5 0 0
M  V30 18 C 8.5442 5.25 0 0
M  V30 19 O 7.2452 7.5 0 0
M  V30 20 C 3.3481 9.75 0 0
M  V30 21 C 2.049 7.5 0 0
M  V30 22 C 9.8433 6 0 0
M  V30 23 C 11.1423 5.25 0 0
M  V30 24 C 9.8433 7.5 0 0
M  V30 25 C 12.4413 6 0 0
M  V30 26 C 11.1423 8.25 0 0
M  V30 27 C 12.4413 7.5 0 0
M  V30 28 O 13.7404 5.25 0 0
M  V30 29 C 13.7404 8.25 0 0
M  V30 30 C 13.7404 3.75 0 0
M  V30 31 O 15.0394 7.5 0 0
M  V30 32 O 13.7404 9.75 0 0
M  V30 33 C 15.0394 3 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 5 10 CFG=3
M  V30 10 1 5 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 12
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 1 18 22
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 25 28
M  V30 30 1 26 27
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 29 32
M  V30 35 1 30 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
repaglinide

> <ID>
repaglinide

> <PRIMARY_SOM>
8 7

> <SECONDARY_SOM>
30

> <TERTIARY_SOM>
13 14 16

> <Citation>
Bidstrup et al.,Br. J. Clin. Pharm.,56,305,2003

> <DOI>
10.1046/j.0306-5251.2003.01872.x

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
riddelliine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -6.5207 -4.8275 0 0 CFG=1
M  V30 2 C -6.5207 -6.3275 0 0 CFG=2
M  V30 3 C -5.2216 -4.0775 0 0
M  V30 4 N -7.8197 -4.0775 0 0 CFG=2
M  V30 5 O -5.2216 -7.0775 0 0
M  V30 6 C -7.9696 -6.7158 0 0
M  V30 7 C -5.2216 -2.5775 0 0
M  V30 8 C -5.6099 -5.5264 0 0
M  V30 9 C -8.7196 -5.4167 0 0
M  V30 10 C -7.1099 -5.5264 0 0
M  V30 11 C -3.9226 -6.3275 0 0
M  V30 12 O -3.9226 -1.8275 0 0
M  V30 13 C -2.6236 -7.0775 0 0
M  V30 14 O -3.9226 -4.8275 0 0
M  V30 15 C -2.6236 -2.5775 0 0
M  V30 16 C -1.3245 -6.3275 0 0
M  V30 17 C -2.6236 -8.5775 0 0
M  V30 18 C -2.6236 -4.0775 0 0 CFG=2
M  V30 19 O -1.3245 -1.8275 0 0
M  V30 20 C -1.3245 -4.8275 0 0
M  V30 21 C -3.9226 -9.3275 0 0
M  V30 22 C -4.1008 -3.817 0 0
M  V30 23 O -3.1366 -5.4871 0 0
M  V30 24 C -0.0255 -4.0775 0 0
M  V30 25 O -4.6138 -2.4075 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9 CFG=1
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 1 6 9
M  V30 12 1 7 12
M  V30 13 1 8 10
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 15 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 20
M  V30 24 1 18 22
M  V30 25 1 18 23 CFG=1
M  V30 26 2 20 24
M  V30 27 1 22 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 2 4 18) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
riddelliine

> <ID>
riddelliine

> <PRIMARY_SOM>
1 10

> <SECONDARY_SOM>
4

> <Citation>
Xia et al.,Chem. Res. Toxicol.,16,66,2003

> <DOI>
10.1021/tx025605i

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
rifabutin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 61 66 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -2.6138 2.3831 0 0
M  V30 2 C -1.1538 2.0387 0 0
M  V30 3 C -2.182 0.9466 0 0
M  V30 4 C -1.5856 3.4753 0 0
M  V30 5 C -0.3309 3.2928 0 0
M  V30 6 N -0.2154 0.8685 0 0
M  V30 7 C -0.7221 0.6022 0 0
M  V30 8 C -3.715 -8.3941 0 0
M  V30 9 C -2.5031 4.7182 0 0
M  V30 10 C -0.1256 3.1309 0 0
M  V30 11 C -1.0055 4.6326 0 0
M  V30 12 N 1.1161 2.8977 0 0
M  V30 13 C 1.7402 1.0367 0 0
M  V30 14 O -1.3901 -8.0112 0 0
M  V30 15 C 0.3061 1.6943 0 0
M  V30 16 C -2.4017 -9.1188 0 0 CFG=2
M  V30 17 O -5.0644 -9.0491 0 0
M  V30 18 O -3.8223 5.4321 0 0
M  V30 19 O 0.9026 4.223 0 0
M  V30 20 C 0.4879 4.7735 0 0
M  V30 21 C 3.08 1.7113 0 0
M  V30 22 C 1.6546 -0.4609 0 0
M  V30 23 C 1.766 1.35 0 0
M  V30 24 O -0.9671 -9.557 0 0
M  V30 25 C -0.9549 -8.7229 0 0
M  V30 26 C 1.9782 4.6034 0 0
M  V30 27 C 4.3341 0.8884 0 0
M  V30 28 C 2.9087 -1.2838 0 0
M  V30 29 C 0.527 -9.6899 0 0
M  V30 30 C 3.4014 4.1295 0 0
M  V30 31 O 2.3019 6.0681 0 0
M  V30 32 N 4.2484 -0.6092 0 0
M  V30 33 C 1.9476 -9.2083 0 0
M  V30 34 C 4.6962 3.3722 0 0
M  V30 35 C 4.0203 5.4959 0 0
M  V30 36 C 5.5025 -1.4321 0 0
M  V30 37 C 3.437 -9.0302 0 0 CFG=1
M  V30 38 C 5.8069 2.3642 0 0
M  V30 39 C 5.4169 -2.9297 0 0
M  V30 40 C 4.7277 -8.2659 0 0 CFG=2
M  V30 41 O 4.0633 -10.3931 0 0
M  V30 42 C 6.4162 0.9935 0 0
M  V30 43 C 6.671 -3.7526 0 0
M  V30 44 C 4.0772 -3.6043 0 0
M  V30 45 C 5.8329 -7.2518 0 0 CFG=2
M  V30 46 C 5.6217 -9.4704 0 0
M  V30 47 C 3.196 -11.617 0 0
M  V30 48 C 7.2951 -0.2221 0 0 CFG=1
M  V30 49 C 6.7052 -6.0315 0 0 CFG=1
M  V30 50 O 7.6863 -8.8922 0 0
M  V30 51 C 7.6085 -1.689 0 0 CFG=1
M  V30 52 C 8.7216 0.2417 0 0
M  V30 53 C 7.3071 -4.6575 0 0 CFG=1
M  V30 54 C 8.0094 -6.7726 0 0
M  V30 55 C 7.3869 -10.362 0 0
M  V30 56 C 7.6125 -3.189 0 0 CFG=1
M  V30 57 O 9.1 -1.5294 0 0
M  V30 58 O 8.736 -5.1137 0 0
M  V30 59 C 5.9643 -10.8377 0 0
M  V30 60 O 8.5102 -11.3561 0 0
M  V30 61 C 9.1049 -3.3405 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 2 5 11
M  V30 11 1 5 12
M  V30 12 1 6 13
M  V30 13 1 7 14
M  V30 14 2 7 15
M  V30 15 1 8 16
M  V30 16 2 8 17
M  V30 17 1 9 11
M  V30 18 2 9 18
M  V30 19 1 10 15
M  V30 20 1 10 19
M  V30 21 1 11 20
M  V30 22 1 12 13
M  V30 23 1 13 21
M  V30 24 1 13 22
M  V30 25 1 14 16
M  V30 26 1 15 23
M  V30 27 1 16 24
M  V30 28 1 16 25 CFG=1
M  V30 29 1 20 26
M  V30 30 1 21 27
M  V30 31 1 22 28
M  V30 32 1 24 29
M  V30 33 1 26 30
M  V30 34 2 26 31
M  V30 35 1 27 32
M  V30 36 1 28 32
M  V30 37 2 29 33
M  V30 38 2 30 34
M  V30 39 1 30 35
M  V30 40 1 32 36
M  V30 41 1 33 37
M  V30 42 1 34 38
M  V30 43 1 36 39
M  V30 44 1 37 40
M  V30 45 1 37 41 CFG=1
M  V30 46 2 38 42
M  V30 47 1 39 43
M  V30 48 1 39 44
M  V30 49 1 40 45
M  V30 50 1 40 46 CFG=3
M  V30 51 1 41 47
M  V30 52 1 42 48
M  V30 53 1 45 49
M  V30 54 1 45 50 CFG=3
M  V30 55 1 48 51
M  V30 56 1 48 52 CFG=3
M  V30 57 1 49 53
M  V30 58 1 49 54 CFG=1
M  V30 59 1 50 55
M  V30 60 1 51 56
M  V30 61 1 51 57 CFG=3
M  V30 62 1 53 56
M  V30 63 1 53 58 CFG=1
M  V30 64 1 55 59
M  V30 65 2 55 60
M  V30 66 1 56 61 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 16 37 40 45 48 49 51 53 56) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
rifabutin

> <ID>
rifabutin

> <PRIMARY_SOM>
48

> <SECONDARY_SOM>
47 52 61

> <Citation>
Iatsimirskaia et al.,Clin. Pharm. Ther.,61,554,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
rifalazil
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 68 74 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -2.5258 2.2829 0 0
M  V30 2 C -1.0517 2.0053 0 0
M  V30 3 C -2.0291 0.8675 0 0
M  V30 4 C -1.5484 3.4207 0 0
M  V30 5 C -0.2868 3.2957 0 0
M  V30 6 N -0.3167 0.6977 0 0
M  V30 7 C -0.555 0.59 0 0
M  V30 8 C -3.1348 -8.5333 0 0
M  V30 9 C -2.5216 4.6206 0 0
M  V30 10 C -0.0743 3.1432 0 0
M  V30 11 C -1.0217 4.6033 0 0
M  V30 12 O 1.2132 3.2783 0 0
M  V30 13 C 1.1832 0.6804 0 0
M  V30 14 O -0.8298 -8.0449 0 0
M  V30 15 C 0.4224 1.7279 0 0
M  V30 16 C -1.7898 -9.1975 0 0 CFG=2
M  V30 17 O -4.4529 -9.2492 0 0
M  V30 18 O -3.872 5.2736 0 0
M  V30 19 O 0.9031 4.2811 0 0
M  V30 20 N 0.4637 4.8121 0 0
M  V30 21 C 1.9481 1.9707 0 0
M  V30 22 C 1.9181 -0.6272 0 0
M  V30 23 C 1.8965 1.4504 0 0
M  V30 24 O -0.3368 -9.5699 0 0
M  V30 25 C -0.3626 -8.736 0 0
M  V30 26 C 1.9602 4.7101 0 0
M  V30 27 C 3.448 1.9534 0 0
M  V30 28 C 3.418 -0.6445 0 0
M  V30 29 O 1.1532 -1.9175 0 0
M  V30 30 C 1.1618 -9.6345 0 0
M  V30 31 C 3.4035 4.3015 0 0
M  V30 32 O 2.2169 6.188 0 0
M  V30 33 C 4.183 0.6458 0 0
M  V30 34 C 2.559 -9.0887 0 0
M  V30 35 C 4.7315 3.6041 0 0
M  V30 36 C 3.9595 5.6947 0 0
M  V30 37 N 10.8319 1.7392 0 0
M  V30 38 C 4.0387 -8.8428 0 0 CFG=1
M  V30 39 C 5.887 2.6476 0 0
M  V30 40 C 11.3611 3.1427 0 0
M  V30 41 C 11.7827 0.579 0 0
M  V30 42 C 5.2932 -8.0206 0 0 CFG=1
M  V30 43 O 4.7265 -10.1759 0 0
M  V30 44 C 6.5581 1.3061 0 0
M  V30 45 C 12.8413 3.3861 0 0
M  V30 46 C 13.2628 0.8224 0 0
M  V30 47 C 6.3512 -6.9572 0 0 CFG=2
M  V30 48 C 6.2412 -9.183 0 0
M  V30 49 C 3.9159 -11.438 0 0
M  V30 50 C 7.4914 0.1319 0 0 CFG=1
M  V30 51 N 13.7921 2.226 0 0
M  V30 52 C 7.167 -5.6984 0 0 CFG=1
M  V30 53 O 8.2773 -8.5114 0 0
M  V30 54 C 7.8714 -1.3192 0 0 CFG=2
M  V30 55 C 8.8953 0.6602 0 0
M  V30 56 C 15.2722 2.4694 0 0
M  V30 57 C 7.7056 -4.2984 0 0 CFG=2
M  V30 58 C 8.5035 -6.3793 0 0
M  V30 59 C 8.0453 -9.9933 0 0
M  V30 60 C 7.9438 -2.8175 0 0 CFG=2
M  V30 61 O 9.354 -1.0918 0 0
M  V30 62 C 16.2231 1.3092 0 0
M  V30 63 O 9.1538 -4.6889 0 0
M  V30 64 C 6.6458 -10.5333 0 0
M  V30 65 O 9.2126 -10.9352 0 0
M  V30 66 C 9.4415 -2.9008 0 0
M  V30 67 C 17.7032 1.5526 0 0
M  V30 68 C 15.6938 -0.0943 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 2 5 11
M  V30 11 1 5 12
M  V30 12 1 6 13
M  V30 13 1 7 14
M  V30 14 2 7 15
M  V30 15 1 8 16
M  V30 16 2 8 17
M  V30 17 1 9 11
M  V30 18 2 9 18
M  V30 19 1 10 15
M  V30 20 1 10 19
M  V30 21 1 11 20
M  V30 22 1 12 21
M  V30 23 2 13 21
M  V30 24 1 13 22
M  V30 25 1 14 16
M  V30 26 1 15 23
M  V30 27 1 16 24
M  V30 28 1 16 25 CFG=1
M  V30 29 1 20 26
M  V30 30 1 21 27
M  V30 31 2 22 28
M  V30 32 1 22 29
M  V30 33 1 24 30
M  V30 34 1 26 31
M  V30 35 2 26 32
M  V30 36 2 27 33
M  V30 37 1 28 33
M  V30 38 2 30 34
M  V30 39 2 31 35
M  V30 40 1 31 36
M  V30 41 1 33 37
M  V30 42 1 34 38
M  V30 43 1 35 39
M  V30 44 1 37 40
M  V30 45 1 37 41
M  V30 46 1 38 42
M  V30 47 1 38 43 CFG=1
M  V30 48 2 39 44
M  V30 49 1 40 45
M  V30 50 1 41 46
M  V30 51 1 42 47
M  V30 52 1 42 48 CFG=1
M  V30 53 1 43 49
M  V30 54 1 44 50
M  V30 55 1 45 51
M  V30 56 1 46 51
M  V30 57 1 47 52
M  V30 58 1 47 53 CFG=3
M  V30 59 1 50 54
M  V30 60 1 50 55 CFG=3
M  V30 61 1 51 56
M  V30 62 1 52 57
M  V30 63 1 52 58 CFG=1
M  V30 64 1 53 59
M  V30 65 1 54 60
M  V30 66 1 54 61 CFG=1
M  V30 67 1 56 62
M  V30 68 1 57 60
M  V30 69 1 57 63 CFG=3
M  V30 70 1 59 64
M  V30 71 2 59 65
M  V30 72 1 60 66 CFG=1
M  V30 73 1 62 67
M  V30 74 1 62 68
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 16 38 42 47 50 52 54 57 60) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
rifalazil

> <ID>
rifalazil

> <PRIMARY_SOM>
66

> <Citation>
Mae et al.,Xenobiotica,30,565,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
risperidone
  SciTegic08102311032D

 30 34  0  0  0  0            999 V2000
   12.0659   -8.9001    0.0000 C   0  0
   12.2226  -10.3919    0.0000 C   0  0
   10.7669   -8.1500    0.0000 C   0  0
   13.4363   -8.2901    0.0000 N   0  0
   13.6898  -10.7038    0.0000 C   0  0
   11.2189  -11.5066    0.0000 C   0  0
    9.4678   -8.9000    0.0000 C   0  0
   10.7670   -6.6500    0.0000 C   0  0
   14.4399   -9.4048    0.0000 O   0  0
   14.1533  -12.1304    0.0000 C   0  0
   11.6823  -12.9332    0.0000 C   0  0
    8.1688   -8.1499    0.0000 C   0  0
    9.4680   -5.9000    0.0000 C   0  0
   13.1496  -13.2451    0.0000 C   0  0
    8.1689   -6.6499    0.0000 N   0  0
   13.6130  -14.6717    0.0000 F   0  0
    6.8699   -5.8998    0.0000 C   0  0
    6.8700   -4.3998    0.0000 C   0  0
    5.5710   -3.6498    0.0000 C   0  0
    5.5711   -2.1498    0.0000 C   0  0
    4.2719   -4.3997    0.0000 C   0  0
    4.2721   -1.3997    0.0000 N   0  0
    6.8701   -1.3998    0.0000 O   0  0
    2.9729   -3.6497    0.0000 N   0  0
    4.2718   -5.8997    0.0000 C   0  0
    2.9730   -2.1497    0.0000 C   0  0
    4.2721    0.1003    0.0000 C   0  0
    1.6740   -1.3996    0.0000 C   0  0
    2.9731    0.8503    0.0000 C   0  0
    1.6741    0.1004    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5  9  1  0
  5 10  1  0
  6 11  2  0
  7 12  1  0
  8 13  1  0
 10 14  2  0
 11 14  1  0
 12 15  1  0
 13 15  1  0
 14 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 20 22  1  0
 20 23  2  0
 21 24  1  0
 21 25  1  0
 22 26  1  0
 22 27  1  0
 24 26  2  0
 26 28  1  0
 27 29  1  0
 28 30  1  0
 29 30  1  0
M  END
> <Name>
risperidone

> <ID>
risperidone

> <PRIMARY_SOM>
28

> <SECONDARY_SOM>
17

> <Citation>
Shen W.,Ann. Clin. Pschia.,11,145,1999

> <DOI>
10.1023/A:1022312111429

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ropinirole
  SciTegic08102311032D

 19 20  0  0  0  0            999 V2000
    4.8994   -2.4860    0.0000 C   0  0
    6.1985   -3.2360    0.0000 C   0  0
    4.8994   -0.9860    0.0000 C   0  0
    3.6004   -0.2360    0.0000 C   0  0
    2.3013   -0.9860    0.0000 C   0  0
    2.3013   -2.4860    0.0000 C   0  0
    3.6004   -3.2360    0.0000 C   0  0
    6.0141    0.0177    0.0000 C   0  0
    3.9123    1.2312    0.0000 N   0  0
    6.1985   -4.7360    0.0000 C   0  0
    7.4975   -5.4860    0.0000 N   0  0
    7.4975   -6.9860    0.0000 C   0  0
    8.7965   -4.7360    0.0000 C   0  0
    8.7965   -7.7360    0.0000 C   0  0
    8.7966   -9.2360    0.0000 C   0  0
   10.0956   -5.4860    0.0000 C   0  0
   11.3946   -4.7360    0.0000 C   0  0
    5.4040    1.3880    0.0000 C   0  0
    6.1540    2.6870    0.0000 O   0  0
  1  2  1  0
  1  3  1  0
  1  7  2  0
  2 10  1  0
  3  4  2  0
  3  8  1  0
  4  5  1  0
  4  9  1  0
  5  6  2  0
  6  7  1  0
  8 18  1  0
  9 18  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 12 14  1  0
 13 16  1  0
 14 15  1  0
 16 17  1  0
 18 19  2  0
M  END
> <Name>
ropinirole

> <ID>
ropinirole

> <PRIMARY_SOM>
13 12

> <SECONDARY_SOM>
5

> <Citation>
Bloomer et al.,Drug Metab. Disp.,25,840,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ropivacaine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.8702 -1.3995 0 0
M  V30 2 C 5.5712 -0.6495 0 0
M  V30 3 C 5.5712 0.8505 0 0
M  V30 4 C 4.2721 1.6005 0 0
M  V30 5 C 2.9731 0.8505 0 0
M  V30 6 C 2.9731 -0.6495 0 0
M  V30 7 C 4.2721 -1.3995 0 0
M  V30 8 C 6.8702 1.6005 0 0
M  V30 9 C 4.2721 -2.8995 0 0
M  V30 10 C 6.8702 -2.8995 0 0
M  V30 11 C 8.1692 -3.6495 0 0 CFG=1
M  V30 12 O 5.5712 -3.6495 0 0
M  V30 13 N 8.1692 -5.1495 0 0
M  V30 14 C 9.4683 -2.8995 0 0
M  V30 15 C 10.7673 -3.6495 0 0
M  V30 16 C 9.4683 -5.8995 0 0
M  V30 17 C 10.7673 -5.1495 0 0
M  V30 18 C 6.8702 -5.8995 0 0
M  V30 19 C 6.8702 -7.3995 0 0
M  V30 20 C 5.5712 -8.1495 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 7
M  V30 5 2 3 4
M  V30 6 1 3 8
M  V30 7 1 4 5
M  V30 8 2 5 6
M  V30 9 1 6 7
M  V30 10 1 7 9
M  V30 11 1 11 10 CFG=3
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 13 16
M  V30 16 1 13 18
M  V30 17 1 14 15
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
ropivacaine

> <ID>
ropivacaine

> <PRIMARY_SOM>
18

> <SECONDARY_SOM>
5

> <TERTIARY_SOM>
8 9

> <Citation>
Ekstrom and Gunnarson,Drug Metab. Disp.,24,955,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
roquinimex
  SciTegic08102311032D

 23 25  0  0  0  0            999 V2000
    7.4192    6.6495    0.0000 C   0  0
    7.4192    8.1495    0.0000 C   0  0
    6.1202    5.8995    0.0000 C   0  0
    8.7183    5.8995    0.0000 C   0  0
    6.1202    8.8995    0.0000 N   0  0
    8.7183    8.8995    0.0000 C   0  0
    4.8212    6.6495    0.0000 C   0  0
    6.1202    4.3995    0.0000 O   0  0
   10.0173    6.6495    0.0000 C   0  0
    4.8212    8.1495    0.0000 C   0  0
    6.1202   10.3995    0.0000 C   0  0
   10.0173    8.1495    0.0000 C   0  0
    3.5221    5.8995    0.0000 C   0  0
    3.5221    8.8995    0.0000 O   0  0
    2.2231    6.6495    0.0000 N   0  0
    3.5221    4.3995    0.0000 O   0  0
    0.9240    5.8995    0.0000 C   0  0
    2.2231    8.1495    0.0000 C   0  0
   -0.3750    6.6495    0.0000 C   0  0
    0.9240    4.3995    0.0000 C   0  0
   -1.6740    5.8995    0.0000 C   0  0
   -0.3750    3.6495    0.0000 C   0  0
   -1.6740    4.3995    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 10  1  0
  7 13  1  0
  9 12  1  0
 10 14  2  0
 13 15  1  0
 13 16  2  0
 15 17  1  0
 15 18  1  0
 17 19  2  0
 17 20  1  0
 19 21  1  0
 20 22  2  0
 21 23  2  0
 22 23  1  0
M  END
> <Name>
roquinimex

> <ID>
roquinimex

> <PRIMARY_SOM>
12 9 6

> <SECONDARY_SOM>
18 11

> <TERTIARY_SOM>
23

> <Citation>
Tuvesson et al.,Xenobiotica,30,905,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
rotenone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -3.5046 10.5 0 0
M  V30 2 C -3.5046 12 0 0
M  V30 3 C -4.8037 9.75 0 0
M  V30 4 O -2.2056 9.75 0 0
M  V30 5 C -4.8037 12.75 0 0
M  V30 6 C -2.3899 13.0037 0 0
M  V30 7 C -4.8037 8.25 0 0
M  V30 8 C -6.1027 10.5 0 0
M  V30 9 C -2.2056 8.25 0 0 CFG=1
M  V30 10 O -4.4918 14.2172 0 0
M  V30 11 C -6.1027 12 0 0
M  V30 12 C -3 14.374 0 0 CFG=1
M  V30 13 C -3.5046 7.5 0 0 CFG=1
M  V30 14 O -6.1027 7.5 0 0
M  V30 15 C -0.9066 7.5 0 0
M  V30 16 C -2.25 15.673 0 0
M  V30 17 C -3.5046 6 0 0
M  V30 18 O -0.9066 6 0 0
M  V30 19 C -0.75 15.673 0 0
M  V30 20 C -3 16.9721 0 0
M  V30 21 C -2.2056 5.25 0 0
M  V30 22 C -4.8037 5.25 0 0
M  V30 23 C -2.2056 3.75 0 0
M  V30 24 C -4.8037 3.75 0 0
M  V30 25 C -3.5046 3 0 0
M  V30 26 O -6.1027 3 0 0
M  V30 27 O -3.5046 1.5 0 0
M  V30 28 C -7.4017 3.75 0 0
M  V30 29 C -2.2056 0.75 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 9 4 CFG=3
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 6 12
M  V30 12 1 13 7 CFG=1
M  V30 13 2 7 14
M  V30 14 1 8 11
M  V30 15 1 9 13
M  V30 16 1 9 15
M  V30 17 1 10 12
M  V30 18 1 12 16 CFG=1
M  V30 19 1 13 17
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 2 16 20
M  V30 23 2 17 21
M  V30 24 1 17 22
M  V30 25 1 18 21
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 9 12 13) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
rotenone

> <ID>
rotenone

> <PRIMARY_SOM>
13

> <SECONDARY_SOM>
16 19 20

> <TERTIARY_SOM>
28

> <Citation>
Caboni et al.,Chem. Res. Toxicol.,17,1540,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
roxithromycin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 58 60 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -12.2088 9.5292 0 0 CFG=2
M  V30 2 C -12.2087 8.0292 0 0 CFG=1
M  V30 3 O -13.5078 10.2792 0 0
M  V30 4 C -10.9097 10.2792 0 0 CFG=2
M  V30 5 C -10.9097 7.2792 0 0 CFG=1
M  V30 6 C -13.5078 7.2792 0 0
M  V30 7 C -13.5078 11.7792 0 0 CFG=2
M  V30 8 C -9.6107 9.5292 0 0
M  V30 9 C -10.9097 11.7792 0 0
M  V30 10 O -10.9097 5.7792 0 0
M  V30 11 C -9.6107 8.0292 0 0 CFG=2
M  V30 12 C -14.8068 12.5292 0 0
M  V30 13 O -12.2087 12.5292 0 0
M  V30 14 O -8.3116 10.2792 0 0
M  V30 15 O -9.6107 8.0292 0 0
M  V30 16 C -12.2087 5.0292 0 0 CFG=1
M  V30 17 C -8.3116 7.2792 0 0
M  V30 18 C -8.6465 9.1783 0 0
M  V30 19 O -10.5749 9.1783 0 0
M  V30 20 C -14.8068 14.0292 0 0 CFG=1
M  V30 21 C -12.2087 14.0292 0 0 CFG=1
M  V30 22 C -7.0126 9.5292 0 0 CFG=1
M  V30 23 C -12.2087 3.5292 0 0 CFG=1
M  V30 24 O -13.5078 5.7792 0 0
M  V30 25 C -7.0126 8.0292 0 0 CFG=2
M  V30 26 C -13.5078 14.7792 0 0 CFG=1
M  V30 27 O -15.3199 15.4388 0 0
M  V30 28 C -16.284 13.7688 0 0
M  V30 29 C -10.9097 14.7792 0 0
M  V30 30 C -5.7135 10.2792 0 0 CFG=1
M  V30 31 C -7.0126 7.0542 0 0
M  V30 32 C -13.5078 2.7792 0 0 CFG=1
M  V30 33 O -10.9097 2.7792 0 0
M  V30 34 C -14.8068 5.0292 0 0 CFG=1
M  V30 35 C -5.7136 7.2792 0 0
M  V30 36 C -7.2731 9.5064 0 0
M  V30 37 O -13.5078 16.2792 0 0
M  V30 38 C -16.7971 15.6993 0 0
M  V30 39 C -4.4145 9.5292 0 0 CFG=1
M  V30 40 C -4.7494 11.4283 0 0
M  V30 41 O -6.6777 11.4283 0 0
M  V30 42 C -8.3116 6.3042 0 0
M  V30 43 C -14.8068 3.5292 0 0
M  V30 44 N -13.5078 1.2792 0 0
M  V30 45 C -16.1059 5.7792 0 0
M  V30 46 C -4.4145 8.0292 0 0 CFG=1
M  V30 47 N -5.7136 5.7792 0 0
M  V30 48 O -3.1155 10.2792 0 0
M  V30 49 C -12.2087 0.5292 0 0
M  V30 50 C -14.8068 0.5292 0 0
M  V30 51 C -3.1155 7.2792 0 0
M  V30 52 O -7.0126 5.0292 0 0
M  V30 53 C -7.0126 3.5292 0 0
M  V30 54 O -8.3116 2.7792 0 0
M  V30 55 C -8.3116 1.2792 0 0
M  V30 56 C -9.6107 0.5292 0 0
M  V30 57 O -9.6107 -0.9708 0 0
M  V30 58 C -10.9097 -1.7208 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 7 3 CFG=3
M  V30 7 1 4 8
M  V30 8 1 4 9 CFG=1
M  V30 9 1 5 10 CFG=3
M  V30 10 1 5 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 2 8 15
M  V30 15 1 16 10 CFG=1
M  V30 16 1 11 17
M  V30 17 1 11 18 CFG=1
M  V30 18 1 11 19
M  V30 19 1 12 20
M  V30 20 1 13 21
M  V30 21 1 14 22
M  V30 22 1 16 23
M  V30 23 1 16 24
M  V30 24 1 17 25
M  V30 25 1 20 26
M  V30 26 1 20 27
M  V30 27 1 20 28 CFG=1
M  V30 28 1 21 26
M  V30 29 1 21 29 CFG=1
M  V30 30 1 22 30
M  V30 31 1 22 31 CFG=1
M  V30 32 1 23 32
M  V30 33 1 23 33 CFG=3
M  V30 34 1 24 34
M  V30 35 1 25 35
M  V30 36 1 25 36 CFG=1
M  V30 37 1 26 37 CFG=3
M  V30 38 1 27 38
M  V30 39 1 30 39
M  V30 40 1 30 40 CFG=3
M  V30 41 1 30 41
M  V30 42 1 31 42
M  V30 43 1 32 43
M  V30 44 1 32 44 CFG=3
M  V30 45 1 34 43
M  V30 46 1 34 45 CFG=1
M  V30 47 1 35 46
M  V30 48 2 35 47
M  V30 49 1 39 46
M  V30 50 1 39 48 CFG=3
M  V30 51 1 44 49
M  V30 52 1 44 50
M  V30 53 1 46 51 CFG=1
M  V30 54 1 47 52
M  V30 55 1 52 53
M  V30 56 1 53 54
M  V30 57 1 54 55
M  V30 58 1 55 56
M  V30 59 1 56 57
M  V30 60 1 57 58
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(18 1 2 4 5 7 11 16 20 21 22 23 25 26 30 32  -
M  V30 34 39 46) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
roxithromycin

> <ID>
roxithromycin

> <PRIMARY_SOM>
50 49

> <Citation>
Yamazaki and Shimada,Drug Metab. Disp.,26,1053,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
rpr_106541
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5444 -2.439 0 0 CFG=1
M  V30 2 C 10.1178 -1.9755 0 0 CFG=2
M  V30 3 C 6.2207 0.2745 0 0 CFG=2
M  V30 4 C 7.5197 -0.4755 0 0 CFG=2
M  V30 5 C 10.1178 -0.4755 0 0 CFG=2
M  V30 6 C 6.2207 1.7745 0 0
M  V30 7 C 8.8187 0.2745 0 0 CFG=2
M  V30 8 C 12.4261 -1.2255 0 0 CFG=1
M  V30 9 O 12.4261 -3.6525 0 0
M  V30 10 C 7.5197 -1.9755 0 0 CFG=2
M  V30 11 C 8.8188 -2.7255 0 0
M  V30 12 C 11.5444 -0.0119 0 0
M  V30 13 O 13.8526 -1.689 0 0
M  V30 14 C 8.8187 1.7745 0 0
M  V30 15 C 7.5197 2.5245 0 0 CFG=2
M  V30 16 C 4.9216 2.5245 0 0
M  V30 17 C 13.8526 -3.189 0 0 CFG=1
M  V30 18 C 4.9216 -0.4755 0 0
M  V30 19 C 3.6226 1.7745 0 0
M  V30 20 S 10.0896 -4.4413 0 0
M  V30 21 F 6.2207 -1.2255 0 0
M  V30 22 O 2.3235 2.5245 0 0
M  V30 23 C 10.2746 -3.4672 0 0
M  V30 24 C 5.9602 -1.2027 0 0
M  V30 25 C 3.6226 0.2745 0 0
M  V30 26 O 6.2207 -2.7255 0 0
M  V30 27 F 7.5197 4.0245 0 0
M  V30 28 C 15.0662 -4.0707 0 0
M  V30 29 C 8.5978 -4.2845 0 0
M  V30 30 C 14.9094 -5.5624 0 0
M  V30 31 C 16.1229 -6.4441 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 9
M  V30 4 1 1 20 CFG=3
M  V30 5 1 2 5
M  V30 6 1 2 11
M  V30 7 1 2 23 CFG=3
M  V30 8 1 3 4
M  V30 9 1 3 6
M  V30 10 1 3 18
M  V30 11 1 3 24 CFG=3
M  V30 12 1 4 7
M  V30 13 1 4 10
M  V30 14 1 4 21 CFG=1
M  V30 15 1 5 7
M  V30 16 1 5 12 CFG=3
M  V30 17 1 6 15
M  V30 18 2 6 16
M  V30 19 1 7 14 CFG=1
M  V30 20 1 8 12 CFG=1
M  V30 21 1 8 13
M  V30 22 1 9 17
M  V30 23 1 10 11
M  V30 24 1 10 26 CFG=3
M  V30 25 1 13 17
M  V30 26 1 14 15
M  V30 27 1 15 27 CFG=1
M  V30 28 1 16 19
M  V30 29 1 17 28 CFG=1
M  V30 30 1 18 25
M  V30 31 2 19 22
M  V30 32 1 19 25
M  V30 33 1 20 29
M  V30 34 1 28 30
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 1 2 3 4 5 7 8 10 15 17) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
rpr_106541

> <ID>
rpr_106541

> <PRIMARY_SOM>
20

> <Citation>
Stevens et al.,J. Pharm. Exp. Ther.,290,594,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
rutaecarpine
  SciTegic08102311032D

 22 26  0  0  0  0            999 V2000
   -3.3481    5.7079    0.0000 C   0  0
   -3.3481    7.2079    0.0000 C   0  0
   -4.6471    4.9579    0.0000 C   0  0
   -2.2334    4.7042    0.0000 N   0  0
   -4.6471    7.9579    0.0000 N   0  0
   -2.0490    7.9579    0.0000 N   0  0
   -4.3352    3.4906    0.0000 C   0  0
   -5.9462    5.7079    0.0000 C   0  0
   -2.8435    3.3338    0.0000 C   0  0
   -4.6471    9.4579    0.0000 C   0  0
   -5.9462    7.2079    0.0000 C   0  0
   -2.0490    9.4579    0.0000 C   0  0
   -5.2169    2.2771    0.0000 C   0  0
   -2.2333    1.9635    0.0000 C   0  0
   -3.3481   10.2079    0.0000 C   0  0
   -5.9462   10.2079    0.0000 O   0  0
   -0.7500   10.2079    0.0000 C   0  0
   -4.6068    0.9068    0.0000 C   0  0
   -3.1150    0.7500    0.0000 C   0  0
   -3.3481   11.7079    0.0000 C   0  0
   -0.7500   11.7079    0.0000 C   0  0
   -2.0490   12.4579    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  1  0
  7  9  2  0
  7 13  1  0
  8 11  1  0
  9 14  1  0
 10 15  1  0
 10 16  2  0
 12 15  2  0
 12 17  1  0
 13 18  2  0
 14 19  2  0
 15 20  1  0
 17 21  2  0
 18 19  1  0
 20 22  2  0
 21 22  1  0
M  END
> <Name>
rutaecarpine

> <ID>
rutaecarpine

> <PRIMARY_SOM>
22

> <SECONDARY_SOM>
18

> <TERTIARY_SOM>
19 14 13

> <Citation>
Ueng et al.,Drug Metab. Disp.,34,821,2006
Lee et al.,J. Pharm. Bio. Anal.,41,304,2006

> <DOI>
10.1124/dmd.105.007849
10.1016/j.jpba.2005.10.039

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
s_145
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -2.4034 -0.574 0 0 CFG=2
M  V30 2 C -2.2518 0.9183 0 0 CFG=2
M  V30 3 C -3.8695 -0.891 0 0 CFG=1
M  V30 4 N -1.2852 -1.5739 0 0
M  V30 5 C -3.6242 1.5237 0 0 CFG=1
M  V30 6 C -0.9553 1.6728 0 0
M  V30 7 C -2.8697 0.2272 0 0
M  V30 8 C -5.242 -0.2856 0 0
M  V30 9 S -1.5921 -3.0422 0 0
M  V30 10 C -5.0903 1.2067 0 0
M  V30 11 C -0.9605 3.1728 0 0
M  V30 12 C -0.1238 -3.349 0 0
M  V30 13 O -1.8989 -4.5105 0 0
M  V30 14 O -3.0603 -2.7354 0 0
M  V30 15 C 0.336 3.9272 0 0
M  V30 16 C 0.8761 -2.2308 0 0
M  V30 17 C 0.3447 -4.774 0 0
M  V30 18 C 1.6376 3.1817 0 0
M  V30 19 C 2.3444 -2.5376 0 0
M  V30 20 C 1.813 -5.0808 0 0
M  V30 21 C 2.934 3.9362 0 0
M  V30 22 C 2.8128 -3.9626 0 0
M  V30 23 C 4.2356 3.1907 0 0
M  V30 24 C 5.5321 3.9451 0 0
M  V30 25 O 5.5269 5.4451 0 0
M  V30 26 O 6.8337 3.1996 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7 CFG=1
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 7 CFG=3
M  V30 10 1 5 10
M  V30 11 1 6 11
M  V30 12 1 8 10
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 2 9 14
M  V30 16 2 11 15
M  V30 17 2 12 16
M  V30 18 1 12 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 2 19 22
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 2 3 5) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
s_145

> <ID>
s_145

> <PRIMARY_SOM>
8

> <Citation>
Yamaguchi et al.,Drug Metab. Disp.,25,75,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
salicylate
  SciTegic08102311032D

 10 10  0  0  0  0            999 V2000
    4.2721   -0.1003    0.0000 C   0  0
    4.2720    1.3997    0.0000 C   0  0
    2.9730    2.1497    0.0000 C   0  0
    1.6740    1.3996    0.0000 C   0  0
    1.6740   -0.1004    0.0000 C   0  0
    2.9731   -0.8503    0.0000 C   0  0
    5.5712   -0.8502    0.0000 C   0  0
    5.5713   -2.3502    0.0000 O   0  0
    6.8702   -0.1001    0.0000 O   0  0
    5.5710    2.1498    0.0000 O   0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  2 10  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  7  8  2  0
  7  9  1  0
M  END
> <Name>
salicylate

> <ID>
salicylate

> <PRIMARY_SOM>
5

> <Citation>
Dupont et al.,Drug Metab. Disp.,27,322,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
salmeterol
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 25.4317 3.75 0 0
M  V30 2 C 25.4317 5.25 0 0
M  V30 3 C 24.1327 3 0 0
M  V30 4 C 24.1327 6 0 0
M  V30 5 C 22.8337 3.75 0 0
M  V30 6 C 22.8337 5.25 0 0
M  V30 7 O 26.7308 6 0 0
M  V30 8 C 26.7308 3 0 0
M  V30 9 O 26.7308 1.5 0 0
M  V30 10 C 21.5346 3 0 0 CFG=1
M  V30 11 C 20.2356 3.75 0 0
M  V30 12 O 21.5346 1.5 0 0
M  V30 13 N 18.9365 3 0 0
M  V30 14 C 17.6375 3.75 0 0
M  V30 15 C 16.3385 3 0 0
M  V30 16 C 15.0394 3.75 0 0
M  V30 17 C 13.7404 3 0 0
M  V30 18 C 12.4413 3.75 0 0
M  V30 19 C 11.1423 3 0 0
M  V30 20 O 9.8433 3.75 0 0
M  V30 21 C 8.5442 3 0 0
M  V30 22 C 7.2452 3.75 0 0
M  V30 23 C 5.9462 3 0 0
M  V30 24 C 4.6471 3.75 0 0
M  V30 25 C 3.3481 3 0 0
M  V30 26 C 2.049 3.75 0 0
M  V30 27 C 3.3481 1.5 0 0
M  V30 28 C 0.75 3 0 0
M  V30 29 C 2.049 0.75 0 0
M  V30 30 C 0.75 1.5 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 2 7
M  V30 6 2 3 5
M  V30 7 2 4 6
M  V30 8 1 5 6
M  V30 9 1 5 10
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
salmeterol

> <ID>
salmeterol

> <PRIMARY_SOM>
24

> <Citation>
Manchee et al.,Drug Metab. Disp.,24,555,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
saquinavir
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 49 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -0.9241 17.8995 0 0
M  V30 2 C -0.9241 19.3995 0 0 CFG=1
M  V30 3 C -2.2231 17.1495 0 0
M  V30 4 C 0.375 17.1495 0 0
M  V30 5 C -2.2231 20.1495 0 0
M  V30 6 C 0.3749 20.1495 0 0
M  V30 7 C -3.5222 17.8995 0 0 CFG=2
M  V30 8 C 0.375 15.6495 0 0 CFG=2
M  V30 9 C -3.5222 19.3995 0 0 CFG=1
M  V30 10 N 1.674 19.3995 0 0
M  V30 11 O 0.3749 21.6495 0 0
M  V30 12 C -4.8212 17.1495 0 0
M  V30 13 C 1.674 14.8995 0 0 CFG=2
M  V30 14 O -0.9241 14.8995 0 0
M  V30 15 C -4.8212 20.1495 0 0
M  V30 16 C 2.973 20.1495 0 0
M  V30 17 C -6.1202 17.8995 0 0
M  V30 18 C 2.973 15.6495 0 0
M  V30 19 N 1.674 13.3995 0 0
M  V30 20 C -6.1202 19.3995 0 0
M  V30 21 C 4.2721 19.3995 0 0
M  V30 22 C 4.2721 20.8995 0 0
M  V30 23 C 2.973 21.6495 0 0
M  V30 24 C 4.2721 14.8995 0 0
M  V30 25 C 0.375 12.6495 0 0
M  V30 26 C 5.5711 15.6495 0 0
M  V30 27 C 4.2721 13.3995 0 0
M  V30 28 C 0.375 11.1495 0 0 CFG=1
M  V30 29 O -0.9241 13.3995 0 0
M  V30 30 C 6.8701 14.8996 0 0
M  V30 31 C 5.5711 12.6495 0 0
M  V30 32 N -0.9241 10.3995 0 0
M  V30 33 C 1.674 10.3995 0 0
M  V30 34 C 6.8702 13.3996 0 0
M  V30 35 C -0.9241 8.8995 0 0
M  V30 36 C 2.9731 11.1495 0 0
M  V30 37 C -2.2231 8.1495 0 0
M  V30 38 O 0.375 8.1495 0 0
M  V30 39 N 2.973 12.6495 0 0
M  V30 40 O 4.2721 10.3995 0 0
M  V30 41 N -2.2231 6.6495 0 0
M  V30 42 C -3.5221 8.8995 0 0
M  V30 43 C -3.5221 5.8995 0 0
M  V30 44 C -4.8212 8.1495 0 0
M  V30 45 C -4.8212 6.6495 0 0
M  V30 46 C -3.5221 4.3995 0 0
M  V30 47 C -6.1202 5.8995 0 0
M  V30 48 C -4.8212 3.6495 0 0
M  V30 49 C -6.1202 4.3995 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 7 3 CFG=1
M  V30 7 1 4 8
M  V30 8 1 9 5 CFG=1
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 9
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 8 14 CFG=3
M  V30 15 1 9 15
M  V30 16 1 10 16
M  V30 17 1 12 17
M  V30 18 1 13 18 CFG=3
M  V30 19 1 13 19
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 1 16 22
M  V30 23 1 16 23
M  V30 24 1 17 20
M  V30 25 1 18 24
M  V30 26 1 19 25
M  V30 27 2 24 26
M  V30 28 1 24 27
M  V30 29 1 25 28
M  V30 30 2 25 29
M  V30 31 1 26 30
M  V30 32 2 27 31
M  V30 33 1 28 32 CFG=3
M  V30 34 1 28 33
M  V30 35 2 30 34
M  V30 36 1 31 34
M  V30 37 1 32 35
M  V30 38 1 33 36
M  V30 39 1 35 37
M  V30 40 2 35 38
M  V30 41 1 36 39
M  V30 42 2 36 40
M  V30 43 2 37 41
M  V30 44 1 37 42
M  V30 45 1 41 43
M  V30 46 2 42 44
M  V30 47 2 43 45
M  V30 48 1 43 46
M  V30 49 1 44 45
M  V30 50 1 45 47
M  V30 51 2 46 48
M  V30 52 2 47 49
M  V30 53 1 48 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 2 7 8 9 13 28) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
saquinavir

> <ID>
saquinavir

> <PRIMARY_SOM>
12

> <Citation>
Fitzsimmons and Collins,Drug Metab. Disp.,25,256,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
sdz_imm_125
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 89 89 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -14.529 -11.4461 0 0 CFG=2
M  V30 2 N -13.6416 -12.6554 0 0
M  V30 3 C -13.6433 -10.2282 0 0
M  V30 4 C -16.029 -11.4493 0 0 CFG=1
M  V30 5 C -13.9143 -14.1304 0 0
M  V30 6 C -12.1794 -12.3206 0 0
M  V30 7 N -13.918 -8.7535 0 0
M  V30 8 O -12.1802 -10.5589 0 0
M  V30 9 C -16.7762 -12.7499 0 0 CFG=1
M  V30 10 O -16.7818 -10.1518 0 0
M  V30 11 C -12.5901 -14.835 0 0 CFG=1
M  V30 12 O -15.2653 -14.7822 0 0
M  V30 13 C -12.5947 -8.0472 0 0 CFG=2
M  V30 14 C -18.2762 -12.7531 0 0
M  V30 15 C -16.0235 -14.0473 0 0
M  V30 16 N -13.1162 -16.2397 0 0
M  V30 17 C -11.3007 -14.0685 0 0
M  V30 18 C -13.1228 -6.6432 0 0
M  V30 19 C -11.1911 -8.5761 0 0
M  V30 20 C -19.0235 -14.0537 0 0
M  V30 21 C -11.9428 -17.1741 0 0
M  V30 22 C -14.5618 -16.6398 0 0
M  V30 23 C -11.3197 -12.5687 0 0
M  V30 24 C -9.9922 -14.802 0 0
M  V30 25 N -11.9506 -5.7071 0 0
M  V30 26 O -14.569 -6.2451 0 0
M  V30 27 C -10.9474 -10.0562 0 0
M  V30 28 C -20.5235 -14.0569 0 0
M  V30 29 C -10.6915 -16.3469 0 0 CFG=1
M  V30 30 O -12.009 -18.6726 0 0
M  V30 31 C -10.6982 -6.5326 0 0
M  V30 32 C -12.0189 -4.2087 0 0
M  V30 33 C -21.2707 -15.3576 0 0
M  V30 34 N -9.7083 -17.4798 0 0
M  V30 35 C -10.2332 -14.9186 0 0
M  V30 36 C -9.7166 -5.3984 0 0
M  V30 37 C -8.3318 -16.8837 0 0
M  V30 38 C -10.0411 -18.9424 0 0
M  V30 39 C -8.7671 -14.6013 0 0
M  V30 40 N -8.3393 -5.9926 0 0
M  V30 41 O -10.0514 -3.9362 0 0
M  V30 42 C -6.9545 -17.4778 0 0 CFG=1
M  V30 43 O -8.3329 -15.3837 0 0
M  V30 44 C -8.3088 -13.1731 0 0
M  V30 45 C -7.7593 -15.7124 0 0
M  V30 46 C -6.9628 -5.3965 0 0 CFG=2
M  V30 47 C -8.3383 -7.4926 0 0
M  V30 48 N -5.9729 -16.3436 0 0
M  V30 49 C -6.6197 -18.94 0 0
M  V30 50 C -5.9797 -6.5294 0 0
M  V30 51 C -6.63 -3.9339 0 0
M  V30 52 C -4.7205 -17.1691 0 0
M  V30 53 C -6.1783 -14.8577 0 0
M  V30 54 C -7.7186 -19.961 0 0
M  V30 55 N -4.7284 -5.7022 0 0
M  V30 56 O -6.183 -8.0156 0 0
M  V30 57 C -5.197 -3.4908 0 0
M  V30 58 C -3.5484 -16.233 0 0 CFG=2
M  V30 59 O -4.6522 -18.6675 0 0
M  V30 60 C -7.3838 -21.4232 0 0
M  V30 61 C -9.1522 -19.5199 0 0
M  V30 62 C -3.555 -6.6367 0 0 CFG=2
M  V30 63 C -4.8642 -2.0282 0 0
M  V30 64 C -4.0967 -4.5103 0 0
M  V30 65 N -4.0764 -14.829 0 0
M  V30 66 C -2.1022 -16.6311 0 0
M  V30 67 C -4.0811 -8.0414 0 0
M  V30 68 C -2.1093 -6.2366 0 0
M  V30 69 C -2.7532 -14.1226 0 0
M  V30 70 O -1.7238 -18.0826 0 0
M  V30 71 N -2.7569 -8.746 0 0
M  V30 72 O -5.484 -8.5722 0 0
M  V30 73 C -1.0401 -7.2886 0 0
M  V30 74 C -1.7329 -4.7846 0 0
M  V30 75 C -3.028 -12.648 0 0 CFG=1
M  V30 76 O -1.4013 -14.7725 0 0
M  V30 77 C -0.2776 -18.4806 0 0
M  V30 78 C -3.0297 -10.221 0 0 CFG=2
M  V30 79 C -1.4059 -8.0942 0 0
M  V30 80 N -1.6017 -12.1835 0 0
M  V30 81 C -4.3177 -11.8821 0 0
M  V30 82 C 0.1008 -19.9321 0 0
M  V30 83 C -1.6027 -10.6835 0 0
M  V30 84 C -5.156 -11.4876 0 0
M  V30 85 O 1.547 -20.3302 0 0
M  V30 86 O -0.3898 -9.801 0 0
M  V30 87 C -6.4651 -10.7554 0 0
M  V30 88 C -7.7538 -11.523 0 0
M  V30 89 C -6.4856 -9.2555 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 4 10 CFG=1
M  V30 10 1 5 11
M  V30 11 2 5 12
M  V30 12 1 7 13
M  V30 13 1 9 14
M  V30 14 1 9 15 CFG=3
M  V30 15 1 11 16
M  V30 16 1 11 17 CFG=3
M  V30 17 1 13 18
M  V30 18 1 13 19 CFG=3
M  V30 19 1 14 20
M  V30 20 1 16 21
M  V30 21 1 16 22
M  V30 22 1 17 23
M  V30 23 1 17 24
M  V30 24 1 18 25
M  V30 25 2 18 26
M  V30 26 1 19 27
M  V30 27 2 20 28
M  V30 28 1 21 29
M  V30 29 2 21 30
M  V30 30 1 25 31
M  V30 31 1 25 32
M  V30 32 1 28 33
M  V30 33 1 29 34
M  V30 34 1 29 35 CFG=3
M  V30 35 1 31 36
M  V30 36 1 34 37
M  V30 37 1 34 38
M  V30 38 1 35 39
M  V30 39 1 36 40
M  V30 40 2 36 41
M  V30 41 1 37 42
M  V30 42 2 37 43
M  V30 43 1 39 44
M  V30 44 1 39 45
M  V30 45 1 40 46
M  V30 46 1 40 47
M  V30 47 1 42 48
M  V30 48 1 42 49 CFG=1
M  V30 49 1 46 50
M  V30 50 1 46 51 CFG=1
M  V30 51 1 48 52
M  V30 52 1 48 53
M  V30 53 1 49 54
M  V30 54 1 50 55
M  V30 55 2 50 56
M  V30 56 1 51 57
M  V30 57 1 52 58
M  V30 58 2 52 59
M  V30 59 1 54 60
M  V30 60 1 54 61
M  V30 61 1 55 62
M  V30 62 1 57 63
M  V30 63 1 57 64
M  V30 64 1 58 65
M  V30 65 1 58 66 CFG=3
M  V30 66 1 62 67
M  V30 67 1 62 68 CFG=1
M  V30 68 1 65 69
M  V30 69 1 66 70
M  V30 70 1 67 71
M  V30 71 2 67 72
M  V30 72 1 68 73
M  V30 73 1 68 74
M  V30 74 1 69 75
M  V30 75 2 69 76
M  V30 76 1 70 77
M  V30 77 1 71 78
M  V30 78 1 71 79
M  V30 79 1 75 80
M  V30 80 1 75 81 CFG=3
M  V30 81 1 77 82
M  V30 82 1 78 83
M  V30 83 1 78 84 CFG=3
M  V30 84 1 80 83
M  V30 85 1 82 85
M  V30 86 2 83 86
M  V30 87 1 84 87
M  V30 88 1 87 88
M  V30 89 1 87 89
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(12 1 4 9 11 13 29 42 46 58 62 75 78) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
sdz_imm_125

> <ID>
sdz_imm_125

> <PRIMARY_SOM>
54

> <SECONDARY_SOM>
47

> <TERTIARY_SOM>
33

> <Citation>
Vickers et al.,Drug Metab. Disp.,23,321,1995

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
selegiline
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.1423 1.5 0 0
M  V30 2 C 11.1423 3 0 0
M  V30 3 C 9.8433 3.75 0 0
M  V30 4 C 8.5442 3 0 0
M  V30 5 C 8.5442 1.5 0 0
M  V30 6 C 9.8433 0.75 0 0
M  V30 7 C 7.2452 3.75 0 0
M  V30 8 C 5.9462 3 0 0 CFG=2
M  V30 9 N 4.6471 3.75 0 0
M  V30 10 C 5.9461 1.5 0 0
M  V30 11 C 4.6471 5.25 0 0
M  V30 12 C 2.049 3.75 0 0
M  V30 13 C 0.75 4.5 0 0
M  V30 14 C 3.3481 3 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 4 7
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10 CFG=1
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 3 12 13
M  V30 14 1 12 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
selegiline

> <ID>
selegiline

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
11

> <Citation>
Benetton et al., Drug Metab. Pharma.,2,78,2007

> <DOI>
10.2133/dmpk.22.78

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
seratrodast
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -0.375 -11.1495 0 0 CFG=1
M  V30 2 C -1.6741 -10.3995 0 0
M  V30 3 C -1.6741 -8.8995 0 0
M  V30 4 C -2.9731 -8.1495 0 0
M  V30 5 C -4.2722 -8.8995 0 0
M  V30 6 C -4.2722 -10.3995 0 0
M  V30 7 C -2.9731 -11.1495 0 0
M  V30 8 C -0.375 -12.6495 0 0
M  V30 9 C 0.924 -10.3995 0 0
M  V30 10 C 0.924 -13.3995 0 0
M  V30 11 C -1.6741 -13.3995 0 0
M  V30 12 C 0.924 -14.8995 0 0
M  V30 13 O -2.9731 -12.6495 0 0
M  V30 14 C -1.6741 -14.8995 0 0
M  V30 15 O 2.223 -15.6495 0 0
M  V30 16 C -0.375 -15.6495 0 0
M  V30 17 C -0.375 -17.1495 0 0
M  V30 18 C -2.9731 -15.6495 0 0
M  V30 19 C 2.223 -12.6495 0 0
M  V30 20 C 0.924 -8.8995 0 0
M  V30 21 C 2.223 -8.1495 0 0
M  V30 22 C 2.223 -6.6495 0 0
M  V30 23 C 3.5221 -5.8995 0 0
M  V30 24 C 3.5221 -4.3995 0 0
M  V30 25 O 2.223 -3.6495 0 0
M  V30 26 O 4.8211 -3.6495 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 9 CFG=3
M  V30 4 1 2 3
M  V30 5 2 2 7
M  V30 6 2 3 4
M  V30 7 1 4 5
M  V30 8 2 5 6
M  V30 9 1 6 7
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 20
M  V30 13 1 10 12
M  V30 14 1 10 19
M  V30 15 2 11 13
M  V30 16 1 11 14
M  V30 17 2 12 15
M  V30 18 1 12 16
M  V30 19 2 14 16
M  V30 20 1 14 18
M  V30 21 1 16 17
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 1 22 23
M  V30 25 1 23 24
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
seratrodast

> <ID>
seratrodast

> <PRIMARY_SOM>
17

> <Citation>
Kumar et al.,Drug Metab. Disp.,25,110,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
serm_I
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -2.3236 1.0245 0 0
M  V30 2 C -2.3236 2.5245 0 0
M  V30 3 C -3.6226 3.2745 0 0
M  V30 4 C -4.9216 2.5245 0 0
M  V30 5 C -4.9216 1.0245 0 0
M  V30 6 C -3.6226 0.2745 0 0
M  V30 7 O -6.2207 3.2745 0 0
M  V30 8 C -7.5197 2.5245 0 0 CFG=2
M  V30 9 C -7.5197 1.0245 0 0 CFG=2
M  V30 10 S -6.2207 0.2745 0 0
M  V30 11 O -1.0245 0.2745 0 0
M  V30 12 C -8.8188 3.2745 0 0
M  V30 13 C -8.8188 0.2745 0 0
M  V30 14 C -8.8188 -1.2255 0 0
M  V30 15 C -10.1178 -1.9755 0 0
M  V30 16 C -11.4168 -1.2255 0 0
M  V30 17 C -11.4168 0.2745 0 0
M  V30 18 C -10.1178 1.0245 0 0
M  V30 19 C -10.1178 2.5245 0 0
M  V30 20 C -11.4168 3.2745 0 0
M  V30 21 C -11.4168 4.7745 0 0
M  V30 22 C -10.1178 5.5245 0 0
M  V30 23 C -8.8188 4.7745 0 0
M  V30 24 O -12.7159 -1.9755 0 0
M  V30 25 O -12.7159 5.5245 0 0
M  V30 26 C -12.7159 7.0245 0 0
M  V30 27 C -14.0149 7.7745 0 0
M  V30 28 N -14.0149 9.2745 0 0
M  V30 29 C -15.3139 10.0245 0 0
M  V30 30 C -15.3139 11.5245 0 0
M  V30 31 C -14.0149 12.2745 0 0
M  V30 32 C -12.7159 11.5245 0 0
M  V30 33 C -12.7159 10.0245 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 11
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 4 7
M  V30 8 1 5 6
M  V30 9 1 5 10
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 8 12 CFG=3
M  V30 13 1 9 10
M  V30 14 1 9 13 CFG=3
M  V30 15 1 12 19
M  V30 16 2 12 23
M  V30 17 1 13 14
M  V30 18 2 13 18
M  V30 19 2 14 15
M  V30 20 1 15 16
M  V30 21 2 16 17
M  V30 22 1 16 24
M  V30 23 1 17 18
M  V30 24 2 19 20
M  V30 25 1 20 21
M  V30 26 2 21 22
M  V30 27 1 21 25
M  V30 28 1 22 23
M  V30 29 1 25 26
M  V30 30 1 26 27
M  V30 31 1 27 28
M  V30 32 1 28 29
M  V30 33 1 28 33
M  V30 34 1 29 30
M  V30 35 1 30 31
M  V30 36 1 31 32
M  V30 37 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 9) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
serm_I

> <ID>
serm_I

> <PRIMARY_SOM>
10

> <SECONDARY_SOM>
33 29

> <Citation>
Zhang et al.,Chem. Res. Toxicol.,18,675,2005

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
sertraline
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -0.75 3.75 0 0
M  V30 2 C -0.75 5.25 0 0
M  V30 3 C -2.049 3 0 0
M  V30 4 C -2.049 6 0 0
M  V30 5 C -3.3481 5.25 0 0
M  V30 6 C -3.3481 3.75 0 0
M  V30 7 C -4.6471 6 0 0 CFG=1
M  V30 8 C -4.6471 3 0 0 CFG=2
M  V30 9 C -5.9462 3.75 0 0
M  V30 10 C -5.9462 5.25 0 0
M  V30 11 C -4.6471 7.5 0 0
M  V30 12 C -5.9462 8.25 0 0
M  V30 13 C -5.9462 9.75 0 0
M  V30 14 C -3.3481 8.25 0 0
M  V30 15 C -3.3481 9.75 0 0
M  V30 16 C -4.6471 10.5 0 0
M  V30 17 N -4.6471 1.5 0 0
M  V30 18 Cl -4.6471 12 0 0
M  V30 19 Cl -2.049 10.5 0 0
M  V30 20 C -3.3481 0.75 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 3 6
M  V30 5 2 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 10
M  V30 10 1 7 11 CFG=1
M  V30 11 1 8 9
M  V30 12 1 8 17 CFG=1
M  V30 13 1 9 10
M  V30 14 2 11 12
M  V30 15 1 11 14
M  V30 16 1 12 13
M  V30 17 2 13 16
M  V30 18 2 14 15
M  V30 19 1 15 16
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 22 1 17 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
sertraline

> <ID>
sertraline

> <PRIMARY_SOM>
20

> <SECONDARY_SOM>
8

> <Citation>
Obach et al.,Drug Metab. Disp.,33,262,2005
Kobayashi et al.,Drug Metab. Disp.,27,763,1999

> <DOI>
10.1124/dmd.104.002428

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
sildenafil
  SciTegic08102311032D

 33 36  0  0  0  0            999 V2000
    5.1273   11.3996    0.0000 C   0  0
    6.4256   12.1508    0.0000 N   0  0
    3.8276   12.1483    0.0000 C   0  0
    3.8261   13.6483    0.0000 N   0  0
    5.1245   14.3996    0.0000 C   0  0
    6.4242   13.6508    0.0000 C   0  0
    2.5264   14.3971    0.0000 C   0  0
    9.0251   10.6533    0.0000 O   0  0
    7.7254   11.4020    0.0000 S   0  0
    8.4741   12.7018    0.0000 O   0  0
    5.4766   10.1009    0.0000 C   0  0
    6.9766   10.1023    0.0000 C   0  0
    4.7278    8.8011    0.0000 C   0  0
    5.4791    7.5028    0.0000 C   0  0
    6.9791    7.5042    0.0000 C   0  0
    7.7278    8.8040    0.0000 C   0  0
    4.7328    3.6050    0.0000 C   0  0
    5.4815    4.9047    0.0000 C   0  0
    4.7303    6.2030    0.0000 O   0  0
    2.4791    7.4999    0.0000 N   0  0
    3.2278    8.7997    0.0000 C   0  0
    0.9791    7.4985    0.0000 C   0  0
    0.2278    8.7968    0.0000 C   0  0
    0.9766   10.0966    0.0000 C   0  0
    2.4766   10.0980    0.0000 N   0  0
   -1.2391    8.4836    0.0000 N   0  0
   -1.3945    6.9917    0.0000 N   0  0
   -0.0236    6.3828    0.0000 C   0  0
   -0.8241    3.9112    0.0000 C   0  0
    0.2897    4.9159    0.0000 C   0  0
   -0.5108    2.4442    0.0000 C   0  0
    0.2254   11.3949    0.0000 O   0  0
   -2.3548    9.4862    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  2  6  1  0
  2  9  1  0
  3  4  1  0
  4  5  1  0
  4  7  1  0
  5  6  1  0
  8  9  2  0
  9 10  2  0
  9 12  1  0
 11 12  1  0
 11 13  2  0
 12 16  2  0
 13 14  1  0
 13 21  1  0
 14 15  2  0
 14 19  1  0
 15 16  1  0
 17 18  1  0
 18 19  1  0
 20 21  2  0
 20 22  1  0
 21 25  1  0
 22 23  2  0
 22 28  1  0
 23 24  1  0
 23 26  1  0
 24 25  1  0
 24 32  2  0
 26 27  1  0
 26 33  1  0
 27 28  2  0
 28 30  1  0
 29 30  1  0
 29 31  1  0
M  END
> <Name>
sildenafil

> <ID>
sildenafil

> <PRIMARY_SOM>
7

> <Citation>
Hyland et al.,Br. J. Clin. Pharm.,51,239,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
simvastatin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.4414 7.5 0 0
M  V30 2 C 12.4413 6 0 0
M  V30 3 C 11.1423 5.25 0 0 CFG=1
M  V30 4 C 9.8433 6 0 0
M  V30 5 O 13.7404 8.25 0 0
M  V30 6 O 11.1423 8.25 0 0
M  V30 7 C 9.8433 7.5 0 0 CFG=2
M  V30 8 O 11.1423 3.75 0 0
M  V30 9 C 8.5442 8.25 0 0
M  V30 10 C 7.2452 7.5 0 0
M  V30 11 C 5.9462 8.25 0 0 CFG=1
M  V30 12 C 5.9462 9.75 0 0 CFG=2
M  V30 13 C 4.6471 7.5 0 0 CFG=2
M  V30 14 C 4.6471 10.5 0 0
M  V30 15 C 3.3481 8.25 0 0
M  V30 16 C 3.3481 9.75 0 0
M  V30 17 C 7.2452 10.5 0 0
M  V30 18 C 4.6471 6 0 0 CFG=2
M  V30 19 C 3.3481 5.25 0 0
M  V30 20 C 2.049 6 0 0 CFG=2
M  V30 21 C 2.049 7.5 0 0
M  V30 22 C 0.75 5.25 0 0
M  V30 23 O 5.9462 5.25 0 0
M  V30 24 C 5.9462 3.75 0 0
M  V30 25 C 7.2452 3 0 0
M  V30 26 C 7.2452 1.5 0 0
M  V30 27 C 8.7452 3 0 0
M  V30 28 C 7.9952 4.299 0 0
M  V30 29 C 8.5442 0.75 0 0
M  V30 30 O 4.6471 3 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 5
M  V30 3 1 1 6
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 3 8 CFG=3
M  V30 7 1 4 7
M  V30 8 1 6 7
M  V30 9 1 7 9 CFG=1
M  V30 10 1 9 10
M  V30 11 1 11 10 CFG=3
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 17 CFG=3
M  V30 16 1 13 15 CFG=1
M  V30 17 1 13 18
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 15 21
M  V30 21 1 18 19
M  V30 22 1 18 23 CFG=1
M  V30 23 1 19 20
M  V30 24 1 20 21
M  V30 25 1 20 22 CFG=1
M  V30 26 1 23 24
M  V30 27 1 24 25
M  V30 28 2 24 30
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 25 28
M  V30 32 1 26 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 3 7 11 12 13 18 20) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
simvastatin

> <ID>
simvastatin

> <PRIMARY_SOM>
21 14

> <SECONDARY_SOM>
20

> <TERTIARY_SOM>
22

> <Citation>
Prueksaritanont et al.,Drug Metab. Disp.,25,1191,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
sirolimus
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 65 68 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -1.8721 -10.2868 0 0
M  V30 2 C -0.8684 -11.4016 0 0 CFG=2
M  V30 3 C -1.1221 -8.9876 0 0
M  V30 4 C -3.3393 -10.5987 0 0
M  V30 5 C -0.8684 -12.9016 0 0
M  V30 6 C -1.3319 -12.8281 0 0
M  V30 7 C -1.4339 -7.5204 0 0
M  V30 8 O 0.3594 -9.2223 0 0
M  V30 9 C -3.8029 -12.0253 0 0
M  V30 10 O 0.5582 -13.3651 0 0
M  V30 11 O -2.0819 -13.7832 0 0
M  V30 12 C -2.7992 -13.14 0 0
M  V30 13 C -0.1349 -6.7704 0 0 CFG=2
M  V30 14 O -2.8894 -7.1575 0 0
M  V30 15 C 0.4014 -14.8569 0 0 CFG=2
M  V30 16 O -0.5984 -5.3439 0 0
M  V30 17 C -1.5295 -6.2182 0 0 CFG=1
M  V30 18 O 1.2655 -7.308 0 0
M  V30 19 C -0.8977 -15.6069 0 0 CFG=1
M  V30 20 C 1.7717 -15.467 0 0
M  V30 21 C 0.6152 -4.4622 0 0 CFG=2
M  V30 22 C -1.8106 -4.7448 0 0
M  V30 23 C -2.6853 -7.1743 0 0
M  V30 24 C -0.8977 -17.1069 0 0
M  V30 25 C -2.1967 -14.8569 0 0
M  V30 26 C 2.7754 -14.3522 0 0
M  V30 27 C 1.8287 -5.3439 0 0
M  V30 28 C -0.7171 -3.718 0 0
M  V30 29 C -2.1967 -17.8569 0 0 CFG=1
M  V30 30 C 4.0744 -15.1023 0 0 CFG=1
M  V30 31 O 2.5407 -12.8707 0 0
M  V30 32 C 2.9434 -4.3402 0 0 CFG=1
M  V30 33 C -2.1967 -19.3569 0 0
M  V30 34 C -3.4957 -17.1069 0 0
M  V30 35 C 5.1891 -14.0986 0 0
M  V30 36 C 4.2312 -16.594 0 0
M  V30 37 C 4.2424 -5.0903 0 0
M  V30 38 O 2.7866 -2.8484 0 0
M  V30 39 C -3.4957 -20.1069 0 0 CFG=2
M  V30 40 C -4.7948 -17.8569 0 0
M  V30 41 C 6.4027 -14.9802 0 0
M  V30 42 C 5.2462 -3.9756 0 0
M  V30 43 C 4.4771 -6.5718 0 0
M  V30 44 C 1.4163 -2.2383 0 0
M  V30 45 C -4.7948 -19.3569 0 0 CFG=1
M  V30 46 O -3.4957 -21.6069 0 0
M  V30 47 C 7.6162 -14.0986 0 0 CFG=2
M  V30 48 C 6.4027 -16.4802 0 0
M  V30 49 C 6.6165 -4.5857 0 0
M  V30 50 O -6.0938 -20.1069 0 0
M  V30 51 C -2.1967 -22.3569 0 0
M  V30 52 C 7.1527 -12.672 0 0 CFG=2
M  V30 53 O 9.0428 -14.5621 0 0
M  V30 54 C 6.4596 -6.0775 0 0
M  V30 55 C 8.4517 -11.922 0 0
M  V30 56 O 5.7523 -12.1344 0 0
M  V30 57 C 7.8862 -6.541 0 0
M  V30 58 C 8.1399 -10.4548 0 0 CFG=1
M  V30 59 O 9.822 -12.5321 0 0
M  V30 60 C 4.5866 -13.0784 0 0
M  V30 61 C 7.8862 -8.041 0 0
M  V30 62 C 9.5102 -9.8447 0 0
M  V30 63 C 6.8034 -9.7738 0 0
M  V30 64 C 9.3534 -8.3529 0 0 CFG=2
M  V30 65 C 10.4681 -7.3492 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 2 7 14
M  V30 14 1 9 12
M  V30 15 1 15 10 CFG=1
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18 CFG=3
M  V30 19 1 15 19
M  V30 20 1 15 20
M  V30 21 1 21 16 CFG=3
M  V30 22 1 17 22
M  V30 23 1 17 23 CFG=3
M  V30 24 1 19 24
M  V30 25 1 19 25 CFG=1
M  V30 26 1 20 26
M  V30 27 1 21 27
M  V30 28 1 21 28
M  V30 29 1 22 28
M  V30 30 1 29 24 CFG=1
M  V30 31 1 26 30
M  V30 32 2 26 31
M  V30 33 1 27 32
M  V30 34 1 29 33
M  V30 35 1 29 34
M  V30 36 1 30 35
M  V30 37 1 30 36 CFG=1
M  V30 38 1 32 37
M  V30 39 1 32 38 CFG=3
M  V30 40 1 33 39
M  V30 41 1 34 40
M  V30 42 2 35 41
M  V30 43 2 37 42
M  V30 44 1 37 43
M  V30 45 1 38 44
M  V30 46 1 39 45
M  V30 47 1 39 46 CFG=1
M  V30 48 1 40 45
M  V30 49 1 41 47
M  V30 50 1 41 48
M  V30 51 1 42 49
M  V30 52 1 45 50 CFG=3
M  V30 53 1 46 51
M  V30 54 1 47 52
M  V30 55 1 47 53 CFG=3
M  V30 56 2 49 54
M  V30 57 1 52 55
M  V30 58 1 52 56 CFG=1
M  V30 59 1 54 57
M  V30 60 1 55 58
M  V30 61 2 55 59
M  V30 62 1 56 60
M  V30 63 2 57 61
M  V30 64 1 58 62
M  V30 65 1 58 63 CFG=3
M  V30 66 1 61 64
M  V30 67 1 62 64
M  V30 68 1 64 65 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(15 2 13 15 17 19 21 29 30 32 39 45 47 52 58  -
M  V30 64) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
sirolimus

> <ID>
sirolimus

> <PRIMARY_SOM>
51

> <SECONDARY_SOM>
63 62 58 22 17

> <TERTIARY_SOM>
44

> <Citation>
Cummins et al.,J. Pharm. Exp. Thera.,308,143,2004

> <DOI>
10.1124/jpet.103.058065

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
sulfinpyrazone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4458 0.4328 0 0
M  V30 2 S 8.7448 -0.3172 0 0 CFG=2
M  V30 3 C 7.4458 1.9328 0 0
M  V30 4 C 6.1467 2.6828 0 0
M  V30 5 C 4.8477 1.9328 0 0
M  V30 6 C 4.8477 0.4328 0 0
M  V30 7 C 6.1467 -0.3172 0 0
M  V30 8 C 8.7448 -1.8172 0 0
M  V30 9 C 10.0438 -2.5672 0 0
M  V30 10 C 10.0438 -4.0672 0 0
M  V30 11 C 11.2574 -4.9489 0 0
M  V30 12 N 10.7938 -6.3755 0 0
M  V30 13 N 9.2938 -6.3755 0 0
M  V30 14 C 8.8303 -4.9489 0 0
M  V30 15 C 8.4122 -7.589 0 0
M  V30 16 C 11.6755 -7.589 0 0
M  V30 17 C 13.1673 -7.4322 0 0
M  V30 18 C 14.049 -8.6457 0 0
M  V30 19 C 13.4389 -10.016 0 0
M  V30 20 C 11.9471 -10.1728 0 0
M  V30 21 C 11.0654 -8.9593 0 0
M  V30 22 C 9.0223 -8.9593 0 0
M  V30 23 C 8.1406 -10.1728 0 0
M  V30 24 C 6.6488 -10.016 0 0
M  V30 25 C 6.0387 -8.6457 0 0
M  V30 26 C 6.9204 -7.4322 0 0
M  V30 27 O 12.684 -4.4853 0 0
M  V30 28 O 7.4037 -4.4854 0 0
M  V30 29 O 10.0438 0.4328 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 7
M  V30 4 1 2 8 CFG=1
M  V30 5 2 2 29
M  V30 6 2 3 4
M  V30 7 1 4 5
M  V30 8 2 5 6
M  V30 9 1 6 7
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 2 11 27
M  V30 16 1 12 13
M  V30 17 1 12 16
M  V30 18 1 13 14
M  V30 19 1 13 15
M  V30 20 2 14 28
M  V30 21 1 15 22
M  V30 22 2 15 26
M  V30 23 1 16 17
M  V30 24 2 16 21
M  V30 25 2 17 18
M  V30 26 1 18 19
M  V30 27 2 19 20
M  V30 28 1 20 21
M  V30 29 2 22 23
M  V30 30 1 23 24
M  V30 31 2 24 25
M  V30 32 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
sulfinpyrazone

> <ID>
sulfinpyrazone

> <PRIMARY_SOM>
2 29

> <SECONDARY_SOM>
24 19

> <Citation>
He et al.,Drug Metab. Disp.,29,701,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
sulfinpyrazone_sulfide
  SciTegic08102311032D

 28 31  0  0  0  0            999 V2000
    7.4458    0.4328    0.0000 C   0  0
    8.7448   -0.3172    0.0000 S   0  0
    7.4458    1.9328    0.0000 C   0  0
    6.1467    2.6828    0.0000 C   0  0
    4.8477    1.9328    0.0000 C   0  0
    4.8477    0.4328    0.0000 C   0  0
    6.1467   -0.3172    0.0000 C   0  0
    8.7448   -1.8172    0.0000 C   0  0
   10.0438   -2.5672    0.0000 C   0  0
   10.0438   -4.0672    0.0000 C   0  0
   11.2574   -4.9489    0.0000 C   0  0
   10.7938   -6.3755    0.0000 N   0  0
    9.2938   -6.3755    0.0000 N   0  0
    8.8303   -4.9489    0.0000 C   0  0
    8.4122   -7.5890    0.0000 C   0  0
   11.6755   -7.5890    0.0000 C   0  0
   13.1673   -7.4322    0.0000 C   0  0
   14.0490   -8.6457    0.0000 C   0  0
   13.4389  -10.0160    0.0000 C   0  0
   11.9471  -10.1728    0.0000 C   0  0
   11.0654   -8.9593    0.0000 C   0  0
    9.0223   -8.9593    0.0000 C   0  0
    8.1406  -10.1728    0.0000 C   0  0
    6.6488  -10.0161    0.0000 C   0  0
    6.0387   -8.6457    0.0000 C   0  0
    6.9204   -7.4322    0.0000 C   0  0
   12.6840   -4.4853    0.0000 O   0  0
    7.4037   -4.4854    0.0000 O   0  0
  1  2  1  0
  1  3  1  0
  1  7  2  0
  2  8  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 14  1  0
 11 12  1  0
 11 27  2  0
 12 13  1  0
 12 16  1  0
 13 14  1  0
 13 15  1  0
 14 28  2  0
 15 22  1  0
 15 26  2  0
 16 17  1  0
 16 21  2  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
M  END
> <Name>
sulfinpyrazone_sulfide

> <ID>
sulfinpyrazone_sulfide

> <PRIMARY_SOM>
2

> <SECONDARY_SOM>
5

> <TERTIARY_SOM>
24 19

> <Citation>
He et al.,Drug Metab. Disp.,29,701,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
tamoxifen
  SciTegic08102311032D

 28 30  0  0  0  0            999 V2000
   -4.6471   -3.7500    0.0000 C   0  0
   -4.6471   -5.2500    0.0000 C   0  0
   -5.9462   -3.0000    0.0000 C   0  0
   -3.3481   -3.0000    0.0000 C   0  0
   -5.9461   -6.0000    0.0000 C   0  0
   -3.3481   -6.0000    0.0000 C   0  0
   -5.9462   -1.5000    0.0000 C   0  0
   -7.2452   -3.7500    0.0000 C   0  0
   -2.0490   -3.7500    0.0000 C   0  0
   -3.3481   -1.5000    0.0000 C   0  0
   -5.9461   -7.5000    0.0000 C   0  0
   -7.2452   -5.2500    0.0000 C   0  0
   -2.0490   -5.2500    0.0000 C   0  0
   -7.2452   -0.7500    0.0000 C   0  0
   -8.5442   -3.0000    0.0000 C   0  0
   -0.7500   -3.0000    0.0000 C   0  0
   -2.0490   -0.7500    0.0000 C   0  0
   -7.2452   -8.2500    0.0000 C   0  0
   -8.5442   -6.0000    0.0000 C   0  0
   -8.5442   -1.5000    0.0000 C   0  0
   -0.7500   -1.5000    0.0000 C   0  0
   -8.5442   -7.5000    0.0000 C   0  0
   -9.8433   -0.7500    0.0000 O   0  0
  -11.1423   -1.5000    0.0000 C   0  0
  -12.4413   -0.7500    0.0000 C   0  0
  -13.7404   -1.5000    0.0000 N   0  0
  -15.0394   -0.7500    0.0000 C   0  0
  -13.7404   -3.0000    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  2  0
  5 12  1  0
  6 13  1  0
  7 14  1  0
  8 15  2  0
  9 16  1  0
 10 17  2  0
 11 18  1  0
 12 19  2  0
 14 20  2  0
 15 20  1  0
 16 21  2  0
 17 21  1  0
 18 22  2  0
 19 22  1  0
 20 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
M  END
> <Name>
tamoxifen

> <ID>
tamoxifen

> <PRIMARY_SOM>
27 28

> <SECONDARY_SOM>
6

> <TERTIARY_SOM>
21 22

> <Citation>
Desta et al.,J. Pharm. Exp. Ther.,310,1062,2004

> <DOI>
10.1124/jpet.104.065607

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
tamsulosin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.0394 3.75 0 0
M  V30 2 C 15.0394 5.25 0 0
M  V30 3 C 13.7404 3 0 0
M  V30 4 S 16.3385 3 0 0
M  V30 5 C 13.7404 6 0 0
M  V30 6 O 16.3385 6 0 0
M  V30 7 C 12.4413 3.75 0 0
M  V30 8 N 15.5885 1.701 0 0
M  V30 9 O 17.0885 4.299 0 0
M  V30 10 O 17.6375 2.25 0 0
M  V30 11 C 12.4414 5.25 0 0
M  V30 12 C 16.3385 7.5 0 0
M  V30 13 C 11.1423 3 0 0
M  V30 14 C 9.8433 3.75 0 0 CFG=2
M  V30 15 N 8.5442 3 0 0
M  V30 16 C 9.8433 5.25 0 0
M  V30 17 C 7.2452 3.75 0 0
M  V30 18 C 5.9462 3 0 0
M  V30 19 O 4.6471 3.75 0 0
M  V30 20 C 3.3481 3 0 0
M  V30 21 C 2.049 3.75 0 0
M  V30 22 C 3.3481 1.5 0 0
M  V30 23 C 0.75 3 0 0
M  V30 24 O 2.049 5.25 0 0
M  V30 25 C 2.049 0.75 0 0
M  V30 26 C 0.75 1.5 0 0
M  V30 27 C 0.75 6 0 0
M  V30 28 C 0.75 7.5 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 2 4 10
M  V30 10 2 5 11
M  V30 11 1 6 12
M  V30 12 1 7 11
M  V30 13 1 7 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 14 16 CFG=3
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 21 24
M  V30 25 2 22 25
M  V30 26 2 23 26
M  V30 27 1 24 27
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
tamsulosin

> <ID>
tamsulosin

> <PRIMARY_SOM>
27

> <SECONDARY_SOM>
17

> <Citation>
Kamimura et al.,Xenobiotica,28,909,1998

> <DOI>
10.1080/004982598238985

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
tangeretin
  SciTegic08102311032D

 27 29  0  0  0  0            999 V2000
    4.1714    4.7747    0.0000 O   0  0
    4.1715    3.2747    0.0000 C   0  0
    2.8723    5.5247    0.0000 C   0  0
    2.8723    7.0247    0.0000 C   0  0
    1.5733    4.7746    0.0000 C   0  0
    1.5732    7.7746    0.0000 C   0  0
    4.1713    7.7747    0.0000 O   0  0
    1.5734    3.2746    0.0000 O   0  0
    0.2743    5.5245    0.0000 C   0  0
    0.2742    7.0245    0.0000 C   0  0
    1.5731    9.2746    0.0000 C   0  0
    4.1712    9.2747    0.0000 C   0  0
    0.2744    2.5245    0.0000 C   0  0
   -1.0247    4.7745    0.0000 O   0  0
   -1.0249    7.7745    0.0000 O   0  0
    0.2740   10.0245    0.0000 O   0  0
    2.8721   10.0247    0.0000 C   0  0
    5.4702   10.0248    0.0000 C   0  0
   -2.3238    5.5244    0.0000 C   0  0
   -2.3239    7.0244    0.0000 C   0  0
    5.4701   11.5248    0.0000 C   0  0
    6.7693    9.2749    0.0000 C   0  0
    6.7691   12.2749    0.0000 C   0  0
    8.0683   10.0249    0.0000 C   0  0
    8.0682   11.5249    0.0000 C   0  0
    9.3672   12.2750    0.0000 O   0  0
   10.6663   11.5251    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  3  4  2  0
  3  5  1  0
  4  6  1  0
  4  7  1  0
  5  8  1  0
  5  9  2  0
  6 10  2  0
  6 11  1  0
  7 12  1  0
  8 13  1  0
  9 10  1  0
  9 14  1  0
 10 15  1  0
 11 16  2  0
 11 17  1  0
 12 17  2  0
 12 18  1  0
 14 19  1  0
 15 20  1  0
 18 21  2  0
 18 22  1  0
 21 23  1  0
 22 24  2  0
 23 25  2  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
M  END
> <Name>
tangeretin

> <ID>
tangeretin

> <PRIMARY_SOM>
27

> <SECONDARY_SOM>
20

> <TERTIARY_SOM>
19

> <Citation>
Brienholt et al.,Pharmacol. Toxicol.,93,14,2003

> <DOI>
10.1034/j.1600-0773.2003.930102.x

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
tauromustine
  SciTegic08102311032D

 17 16  0  0  0  0            999 V2000
    4.9195    1.0349    0.0000 N   0  0
    6.2201    0.2876    0.0000 C   0  0
    3.6220    0.2821    0.0000 C   0  0
    4.9163    2.5349    0.0000 N   0  0
    7.5175    1.0403    0.0000 N   0  0
    6.2232   -1.2124    0.0000 O   0  0
    2.3214    1.0294    0.0000 C   0  0
    3.6157    3.2821    0.0000 O   0  0
    8.8182    0.2931    0.0000 C   0  0
    1.0239    0.2767    0.0000 Cl  0  0
   10.1156    1.0458    0.0000 C   0  0
   11.4162    0.2985    0.0000 S   0  0
   12.1635    1.5991    0.0000 N   0  0
   12.7168   -0.4488    0.0000 O   0  0
   10.6690   -1.0021    0.0000 O   0  0
   13.6635    1.6023    0.0000 C   0  0
   11.4108    2.8966    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  4  8  2  0
  5  9  1  0
  7 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 12 15  2  0
 13 16  1  0
 13 17  1  0
M  END
> <Name>
tauromustine

> <ID>
tauromustine

> <PRIMARY_SOM>
4 8

> <SECONDARY_SOM>
16 17

> <Citation>
Tuvesson et al.,Xenobiotica,29,783,1999

> <DOI>
10.1080/004982599238236

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
tazofelone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0572 -4.9555 0 0
M  V30 2 C 8.0572 -3.4555 0 0
M  V30 3 C 6.7582 -5.7055 0 0
M  V30 4 C 5.3736 -0.3238 0 0
M  V30 5 N 4.9101 1.1028 0 0
M  V30 6 C 4.1601 -1.2055 0 0 CFG=1
M  V30 7 C 5.4591 -3.4555 0 0
M  V30 8 S 2.9466 -0.3238 0 0
M  V30 9 C 9.3562 -2.7055 0 0
M  V30 10 C 6.7582 -7.2055 0 0
M  V30 11 C 5.4591 -4.9555 0 0
M  V30 12 C 6.7582 -2.7055 0 0
M  V30 13 C 3.4101 1.1028 0 0
M  V30 14 C 4.1601 -2.7055 0 0
M  V30 15 O 6.8002 -0.7873 0 0
M  V30 16 O 9.3563 -5.7055 0 0
M  V30 17 C 10.6553 -3.4555 0 0
M  V30 18 C 9.3562 -1.2055 0 0
M  V30 19 C 10.6553 -1.9555 0 0
M  V30 20 C 8.0572 -7.9555 0 0
M  V30 21 C 5.4591 -7.9555 0 0
M  V30 22 C 6.7582 -8.7055 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 9
M  V30 5 1 2 12
M  V30 6 1 3 10
M  V30 7 2 3 11
M  V30 8 1 4 5
M  V30 9 1 4 6
M  V30 10 2 4 15
M  V30 11 1 5 13
M  V30 12 1 6 8
M  V30 13 1 6 14 CFG=3
M  V30 14 1 7 11
M  V30 15 2 7 12
M  V30 16 1 7 14
M  V30 17 1 8 13
M  V30 18 1 9 17
M  V30 19 1 9 18
M  V30 20 1 9 19
M  V30 21 1 10 20
M  V30 22 1 10 21
M  V30 23 1 10 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
tazofelone

> <ID>
tazofelone

> <PRIMARY_SOM>
8

> <Citation>
Surapaneni et al.,Drug Metab. Disp.,25,1383,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
teniposide
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 46 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.1439 12.5137 0 0
M  V30 2 C 2.6767 12.2018 0 0
M  V30 3 C 1.562 13.2055 0 0 CFG=2
M  V30 4 O 2.0666 10.8315 0 0
M  V30 5 C 1.562 14.7055 0 0 CFG=1
M  V30 6 C 0.263 12.4555 0 0 CFG=2
M  V30 7 C 0.5748 10.9883 0 0
M  V30 8 C 0.263 15.4555 0 0
M  V30 9 C 2.861 15.4555 0 0
M  V30 10 C -1.0361 13.2055 0 0 CFG=1
M  V30 11 C -1.0361 14.7055 0 0
M  V30 12 C 0.263 16.9555 0 0
M  V30 13 C 2.861 16.9555 0 0
M  V30 14 C 4.1601 14.7055 0 0
M  V30 15 O -2.3351 12.4555 0 0
M  V30 16 C -2.3351 15.4555 0 0
M  V30 17 C -1.0361 17.7055 0 0
M  V30 18 C 4.1601 17.7055 0 0
M  V30 19 C 5.4591 15.4555 0 0
M  V30 20 C -2.3351 10.9555 0 0 CFG=2
M  V30 21 C -2.3351 16.9555 0 0
M  V30 22 O -1.3479 19.1727 0 0
M  V30 23 O 4.1601 19.2055 0 0
M  V30 24 C 5.4591 16.9555 0 0
M  V30 25 O 6.7582 14.7055 0 0
M  V30 26 O -1.0361 10.2055 0 0
M  V30 27 C -3.6342 10.2055 0 0 CFG=2
M  V30 28 O -3.4498 17.9592 0 0
M  V30 29 C -2.8397 19.3295 0 0
M  V30 30 C 2.861 19.9555 0 0
M  V30 31 O 6.7581 17.7055 0 0
M  V30 32 C 6.7582 13.2055 0 0
M  V30 33 C -1.0361 8.7055 0 0 CFG=1
M  V30 34 O -4.9332 10.9555 0 0
M  V30 35 C -3.6342 8.7055 0 0 CFG=2
M  V30 36 C -2.3351 7.9555 0 0 CFG=2
M  V30 37 C 0.2629 7.9555 0 0
M  V30 38 O -4.9332 7.9555 0 0
M  V30 39 O -2.3351 6.4555 0 0
M  V30 40 O 0.2629 6.4555 0 0
M  V30 41 C -1.0361 5.7055 0 0 CFG=1
M  V30 42 C -1.0361 4.2055 0 0
M  V30 43 C 0.1774 3.3238 0 0
M  V30 44 S -2.2496 3.3238 0 0
M  V30 45 C -0.2861 1.8972 0 0
M  V30 46 C -1.7861 1.8972 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 3 2 CFG=1
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9 CFG=1
M  V30 9 1 6 7 CFG=3
M  V30 10 1 6 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 9 14
M  V30 15 1 10 11
M  V30 16 1 10 15 CFG=3
M  V30 17 1 11 16
M  V30 18 2 12 17
M  V30 19 1 13 18
M  V30 20 2 14 19
M  V30 21 1 20 15 CFG=3
M  V30 22 2 16 21
M  V30 23 1 17 21
M  V30 24 1 17 22
M  V30 25 1 18 23
M  V30 26 2 18 24
M  V30 27 1 19 24
M  V30 28 1 19 25
M  V30 29 1 20 26
M  V30 30 1 20 27
M  V30 31 1 21 28
M  V30 32 1 22 29
M  V30 33 1 23 30
M  V30 34 1 24 31
M  V30 35 1 25 32
M  V30 36 1 33 26 CFG=3
M  V30 37 1 27 34 CFG=1
M  V30 38 1 27 35
M  V30 39 1 28 29
M  V30 40 1 33 36
M  V30 41 1 33 37
M  V30 42 1 35 36
M  V30 43 1 35 38 CFG=3
M  V30 44 1 36 39 CFG=1
M  V30 45 1 37 40
M  V30 46 1 39 41
M  V30 47 1 40 41
M  V30 48 1 41 42 CFG=1
M  V30 49 2 42 43
M  V30 50 1 42 44
M  V30 51 1 43 45
M  V30 52 1 44 46
M  V30 53 2 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 3 5 6 10 20 27 33 35 36 41) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
teniposide

> <ID>
teniposide

> <PRIMARY_SOM>
32 30

> <Citation>
Relling et al.,Mol. Pharmacol.,45,352,1994

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
tentoxin
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -1.7702 -1.02 0 0
M  V30 2 C -0.9419 -2.2706 0 0 CFG=2
M  V30 3 C 0.5553 -2.1785 0 0
M  V30 4 O 1.3836 -3.4291 0 0
M  V30 5 C -1.6107 -3.6132 0 0
M  V30 6 N 1.2242 -0.8359 0 0
M  V30 7 C 2.7213 -0.7438 0 0 CFG=2
M  V30 8 C 3.3902 0.5988 0 0
M  V30 9 O 4.8874 0.6909 0 0
M  V30 10 C 3.5496 -1.9944 0 0
M  V30 11 C 5.0081 -1.6437 0 0
M  V30 12 C 5.4336 -0.2053 0 0
M  V30 13 C 6.041 -2.7314 0 0
M  V30 14 N 2.5619 1.8494 0 0
M  V30 15 C 1.0647 1.7573 0 0
M  V30 16 C 0.2364 3.0079 0 0
M  V30 17 O 0.9052 4.3505 0 0
M  V30 18 C 0.3958 0.4147 0 0
M  V30 19 C -3.6802 0.164 0 0
M  V30 20 C -4.5085 1.4146 0 0
M  V30 21 C -4.3491 -1.1786 0 0
M  V30 22 C -6.0057 1.3225 0 0
M  V30 23 C -5.8462 -1.2707 0 0
M  V30 24 C -6.6745 -0.0201 0 0
M  V30 25 N -1.2608 2.9158 0 0
M  V30 26 C -1.9296 1.5732 0 0
M  V30 27 C -1.1013 0.3226 0 0
M  V30 28 O 0.3571 0.6733 0 0
M  V30 29 C -3.2674 -1.1121 0 0
M  V30 30 C 3.2307 3.192 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 1 29
M  V30 4 1 2 3
M  V30 5 1 2 5 CFG=3
M  V30 6 2 3 4
M  V30 7 1 3 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 7 10 CFG=3
M  V30 11 2 8 9
M  V30 12 1 8 14
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 14 15
M  V30 17 1 14 30
M  V30 18 1 15 16
M  V30 19 2 15 18
M  V30 20 2 16 17
M  V30 21 1 16 25
M  V30 22 1 18 19
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 1 26 27
M  V30 31 2 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 7) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
tentoxin

> <ID>
tentoxin

> <PRIMARY_SOM>
29

> <Citation>
Delaforge et al.,Eur. J. Biochem.,250,150,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
terbinafine
  SciTegic08102311032D

 22 23  0  0  0  0            999 V2000
   -0.7500   -6.0000    0.0000 C   0  0
   -0.7500   -4.5000    0.0000 C   0  0
   -2.0490   -3.7500    0.0000 C   0  0
   -3.3481   -4.5000    0.0000 C   0  0
   -3.3481   -6.0000    0.0000 C   0  0
   -2.0490   -6.7500    0.0000 C   0  0
   -2.0490   -2.2500    0.0000 C   0  0
   -3.3481   -1.5000    0.0000 C   0  0
   -4.6471   -2.2500    0.0000 C   0  0
   -4.6471   -3.7500    0.0000 C   0  0
   -5.9461   -4.5000    0.0000 C   0  0
   -7.2452   -3.7500    0.0000 N   0  0
   -7.2452   -2.2500    0.0000 C   0  0
   -8.5442   -4.5000    0.0000 C   0  0
   -9.8433   -3.7500    0.0000 C   0  0
  -11.1423   -4.5000    0.0000 C   0  0
  -12.4413   -3.7500    0.0000 C   0  0
  -13.7404   -3.0000    0.0000 C   0  0
  -15.0394   -2.2500    0.0000 C   0  0
  -16.3385   -3.0000    0.0000 C   0  0
  -16.3385   -1.5000    0.0000 C   0  0
  -15.0394   -0.7500    0.0000 C   0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  3  7  2  0
  4  5  1  0
  4 10  2  0
  5  6  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  3  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
M  END
> <Name>
terbinafine

> <ID>
terbinafine

> <PRIMARY_SOM>
11

> <SECONDARY_SOM>
13

> <Citation>
Vickers et al.,Drug Metab. Disp.,27,1029,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
terbuthylazine
  SciTegic08102311032D

 15 15  0  0  0  0            999 V2000
    2.3236    5.5245    0.0000 N   0  0
    2.3236    7.0245    0.0000 C   0  0
    1.0245    7.7745    0.0000 N   0  0
   -0.2745    7.0245    0.0000 C   0  0
   -0.2745    5.5245    0.0000 N   0  0
    1.0245    4.7745    0.0000 C   0  0
    1.0245    3.2745    0.0000 N   0  0
   -0.2745    2.5245    0.0000 C   0  0
   -0.2745    1.0245    0.0000 C   0  0
    3.6226    7.7745    0.0000 N   0  0
    3.6226    9.2745    0.0000 C   0  0
    4.9216   10.0245    0.0000 C   0  0
    2.3236   10.0245    0.0000 C   0  0
   -1.5736    7.7745    0.0000 Cl  0  0
    3.6226   10.7745    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  2 10  1  0
  3  4  1  0
  4  5  2  0
  4 14  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 11 15  1  0
M  END
> <Name>
terbuthylazine

> <ID>
terbuthylazine

> <PRIMARY_SOM>
8

> <Citation>
Lang et al.,Chem. Res. Toxicol.,10,1037,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
terbutryne
  SciTegic08102311032D

 16 16  0  0  0  0            999 V2000
    2.3233    5.5246    0.0000 N   0  0
    2.3232    7.0246    0.0000 C   0  0
    1.0241    7.7746    0.0000 N   0  0
   -0.2749    7.0245    0.0000 C   0  0
   -0.2748    5.5245    0.0000 N   0  0
    1.0243    4.7746    0.0000 C   0  0
    1.0243    3.2746    0.0000 N   0  0
   -0.2747    2.5245    0.0000 C   0  0
   -0.2746    1.0245    0.0000 C   0  0
    3.6222    7.7747    0.0000 N   0  0
    3.6221    9.2747    0.0000 C   0  0
    4.9211   10.0248    0.0000 C   0  0
    2.3231   10.0246    0.0000 C   0  0
   -1.5739    7.7744    0.0000 S   0  0
    3.6221   10.7747    0.0000 C   0  0
   -2.8729    7.0244    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  2 10  1  0
  3  4  1  0
  4  5  2  0
  4 14  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 11 15  1  0
 14 16  1  0
M  END
> <Name>
terbutryne

> <ID>
terbutryne

> <PRIMARY_SOM>
14

> <TERTIARY_SOM>
8

> <Citation>
Lang et al.,Chem. Res. Toxicol,10,1037,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
terfenadine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3481 -3 0 0
M  V30 2 C 4.6471 -3.75 0 0
M  V30 3 O 5.9462 -4.5 0 0
M  V30 4 C 5.9462 -3 0 0
M  V30 5 C 4.6471 -5.25 0 0
M  V30 6 C 3.3481 -1.5 0 0
M  V30 7 C 2.049 -0.75 0 0
M  V30 8 C 0.75 -1.5 0 0
M  V30 9 C 0.75 -3 0 0
M  V30 10 C 2.049 -3.75 0 0
M  V30 11 C 7.2452 -3.75 0 0
M  V30 12 C 8.5442 -3 0 0
M  V30 13 C 8.5442 -1.5 0 0
M  V30 14 C 7.2452 -0.75 0 0
M  V30 15 C 5.9462 -1.5 0 0
M  V30 16 C 5.9462 -6 0 0
M  V30 17 C 3.3481 -6 0 0
M  V30 18 C 3.3481 -7.5 0 0
M  V30 19 C 5.9462 -7.5 0 0
M  V30 20 N 4.6471 -8.25 0 0
M  V30 21 C 4.6471 -9.75 0 0
M  V30 22 C 5.9462 -10.5 0 0
M  V30 23 C 5.9462 -12 0 0
M  V30 24 C 7.2452 -12.75 0 0 CFG=1
M  V30 25 C 7.2452 -14.25 0 0
M  V30 26 C 8.5442 -15 0 0
M  V30 27 C 8.5442 -16.5 0 0
M  V30 28 C 7.2452 -17.25 0 0
M  V30 29 C 5.9462 -16.5 0 0
M  V30 30 C 5.9462 -15 0 0
M  V30 31 C 7.2452 -18.75 0 0
M  V30 32 C 8.5443 -19.5 0 0
M  V30 33 C 5.9462 -19.5 0 0
M  V30 34 C 7.2452 -20.25 0 0
M  V30 35 O 8.5442 -12 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 1 10
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 5
M  V30 7 1 4 11
M  V30 8 2 4 15
M  V30 9 1 5 16
M  V30 10 1 5 17
M  V30 11 2 6 7
M  V30 12 1 7 8
M  V30 13 2 8 9
M  V30 14 1 9 10
M  V30 15 2 11 12
M  V30 16 1 12 13
M  V30 17 2 13 14
M  V30 18 1 14 15
M  V30 19 1 16 19
M  V30 20 1 17 18
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 1 20 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 1 24 25
M  V30 28 1 24 35 CFG=3
M  V30 29 1 25 26
M  V30 30 2 25 30
M  V30 31 2 26 27
M  V30 32 1 27 28
M  V30 33 2 28 29
M  V30 34 1 28 31
M  V30 35 1 29 30
M  V30 36 1 31 32
M  V30 37 1 31 33
M  V30 38 1 31 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 24) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
terfenadine

> <ID>
terfenadine

> <PRIMARY_SOM>
34 33 32

> <SECONDARY_SOM>
21

> <Citation>
Jones et al.,Drug Metab. Disp.,26,875,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
territrem_A
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 37 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -6.9797 -1.3267 0 0
M  V30 2 C -5.6795 -0.5787 0 0
M  V30 3 C -4.3816 -1.3307 0 0
M  V30 4 C -4.3839 -2.8307 0 0
M  V30 5 C -5.6841 -3.5787 0 0
M  V30 6 C -6.982 -2.8267 0 0
M  V30 7 O -2.9543 -0.8694 0 0
M  V30 8 O -2.958 -3.2965 0 0
M  V30 9 C -2.0745 -2.0843 0 0
M  V30 10 O -5.6864 -5.0787 0 0
M  V30 11 C -6.9866 -5.8267 0 0
M  V30 12 C -8.2775 -0.5747 0 0
M  V30 13 O -9.5777 -1.3227 0 0
M  V30 14 C -10.8756 -0.5707 0 0
M  V30 15 C -10.8733 0.9293 0 0
M  V30 16 C -9.5731 1.6773 0 0
M  V30 17 C -8.2752 0.9253 0 0
M  V30 18 O -12.1758 -1.3187 0 0
M  V30 19 O -9.5708 3.1773 0 0
M  V30 20 C -12.1712 1.6813 0 0
M  V30 21 C -10.8686 3.9293 0 0 CFG=1
M  V30 22 C -12.1688 3.1813 0 0 CFG=1
M  V30 23 C -13.4667 3.9333 0 0 CFG=2
M  V30 24 C -10.8663 5.4293 0 0
M  V30 25 C -13.4644 5.4333 0 0 CFG=1
M  V30 26 O -13.4621 6.9333 0 0
M  V30 27 C -12.1642 6.1813 0 0
M  V30 28 C -9.5684 4.6773 0 0
M  V30 29 O -13.469 2.4333 0 0
M  V30 30 C -14.7669 3.1853 0 0
M  V30 31 C -14.7623 6.1853 0 0
M  V30 32 O -14.7692 1.6853 0 0
M  V30 33 C -16.0648 3.9374 0 0
M  V30 34 C -16.0625 5.4374 0 0
M  V30 35 C -13.469 2.4333 0 0
M  V30 36 C -14.7646 4.6853 0 0
M  V30 37 C -14.76 7.6853 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 12
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 1 3 7
M  V30 7 2 4 5
M  V30 8 1 4 8
M  V30 9 1 5 6
M  V30 10 1 5 10
M  V30 11 1 7 9
M  V30 12 1 8 9
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 2 12 17
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 2 14 18
M  V30 19 2 15 16
M  V30 20 1 15 20
M  V30 21 1 16 17
M  V30 22 1 16 19
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 1 21 24
M  V30 27 1 21 28 CFG=3
M  V30 28 1 22 23
M  V30 29 1 22 29 CFG=1
M  V30 30 1 23 25
M  V30 31 1 23 30
M  V30 32 1 23 35 CFG=3
M  V30 33 1 24 27
M  V30 34 1 25 26 CFG=1
M  V30 35 1 25 27
M  V30 36 1 25 31
M  V30 37 2 30 32
M  V30 38 1 30 33
M  V30 39 1 31 34
M  V30 40 1 31 36
M  V30 41 1 31 37
M  V30 42 2 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 21 22 23 25) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
territrem_A

> <ID>
territrem_A

> <PRIMARY_SOM>
36 37

> <Citation>
Peng et al.,J. Tox. Env. Health A,66,1237,2003

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
testosterone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -0.2745 -5.5245 0 0
M  V30 2 C -0.2745 -4.0245 0 0
M  V30 3 C -1.5736 -3.2745 0 0
M  V30 4 C -2.8726 -4.0245 0 0
M  V30 5 C -2.8726 -5.5245 0 0 CFG=2
M  V30 6 C -1.5736 -6.2745 0 0
M  V30 7 C -4.1716 -3.2745 0 0
M  V30 8 C -5.4707 -4.0245 0 0
M  V30 9 C -5.4707 -5.5245 0 0 CFG=2
M  V30 10 C -4.1716 -6.2745 0 0 CFG=2
M  V30 11 C -6.7697 -6.2745 0 0 CFG=1
M  V30 12 C -6.7697 -7.7745 0 0 CFG=2
M  V30 13 C -5.4707 -8.5245 0 0
M  V30 14 C -4.1716 -7.7745 0 0
M  V30 15 C -8.1963 -5.811 0 0
M  V30 16 C -9.078 -7.0245 0 0
M  V30 17 C -8.1963 -8.2381 0 0 CFG=2
M  V30 18 C -2.8726 -7.0245 0 0
M  V30 19 C -6.9265 -9.2663 0 0
M  V30 20 O -8.6598 -9.6646 0 0
M  V30 21 O 1.0245 -3.2745 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 21
M  V30 5 2 3 4
M  V30 6 1 4 5
M  V30 7 1 4 7
M  V30 8 1 5 6
M  V30 9 1 5 10
M  V30 10 1 5 18 CFG=1
M  V30 11 1 7 8
M  V30 12 1 9 8 CFG=3
M  V30 13 1 9 10
M  V30 14 1 9 11
M  V30 15 1 10 14 CFG=1
M  V30 16 1 11 12
M  V30 17 1 11 15 CFG=1
M  V30 18 1 12 13
M  V30 19 1 12 17
M  V30 20 1 12 19 CFG=1
M  V30 21 1 13 14
M  V30 22 1 15 16
M  V30 23 1 16 17
M  V30 24 1 17 20 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 5 9 10 11 12 17) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
testosterone

> <ID>
testosterone

> <PRIMARY_SOM>
7

> <SECONDARY_SOM>
15

> <TERTIARY_SOM>
1 16 17 20

> <Citation>
Yamazaki and Shimada,Arch. Biochem. Biophys.,346,161,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
thioridazine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7262 -2.8821 0 0
M  V30 2 C 7.7262 -1.3821 0 0
M  V30 3 S 5.1281 -1.3821 0 0
M  V30 4 C 6.4272 -3.6321 0 0
M  V30 5 C 6.4272 -0.6321 0 0
M  V30 6 C 5.1281 -2.8821 0 0
M  V30 7 C 9.0252 -3.6321 0 0
M  V30 8 N 11.6233 -5.1321 0 0
M  V30 9 C 9.0252 -0.6321 0 0
M  V30 10 C 9.0252 -5.1321 0 0
M  V30 11 C 10.3243 -5.8821 0 0 CFG=1
M  V30 12 C 6.4272 0.8679 0 0
M  V30 13 C 9.0252 0.8679 0 0
M  V30 14 S 10.3243 1.6179 0 0
M  V30 15 C 7.7262 1.6179 0 0
M  V30 16 C 11.6233 -3.6321 0 0
M  V30 17 C 12.9224 -5.8821 0 0
M  V30 18 C 6.4272 -5.1321 0 0
M  V30 19 C 3.8291 -3.6321 0 0
M  V30 20 C 10.3243 -7.3821 0 0
M  V30 21 C 10.3243 3.1179 0 0
M  V30 22 C 12.9224 -7.3821 0 0
M  V30 23 C 5.1281 -5.8821 0 0
M  V30 24 C 3.8291 -5.1321 0 0
M  V30 25 C 11.6233 -8.1321 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 1 7
M  V30 4 2 2 5
M  V30 5 1 2 9
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 2 4 6
M  V30 9 1 4 18
M  V30 10 1 5 12
M  V30 11 1 6 19
M  V30 12 1 7 10
M  V30 13 1 8 11
M  V30 14 1 8 16
M  V30 15 1 8 17
M  V30 16 2 9 13
M  V30 17 1 11 10 CFG=3
M  V30 18 1 11 20
M  V30 19 2 12 15
M  V30 20 1 13 14
M  V30 21 1 13 15
M  V30 22 1 14 21
M  V30 23 1 17 22
M  V30 24 2 18 23
M  V30 25 2 19 24
M  V30 26 1 20 25
M  V30 27 1 22 25
M  V30 28 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
thioridazine

> <ID>
thioridazine

> <PRIMARY_SOM>
16

> <SECONDARY_SOM>
3

> <TERTIARY_SOM>
14

> <Citation>
Wojcikowski,Drug Metab. Disp.,34,471,2006

> <DOI>
10.1124/dmd.105.006445

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
tolterodine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -2.2231 6.6495 0 0
M  V30 2 C -0.924 5.8995 0 0 CFG=1
M  V30 3 C -2.2231 8.1495 0 0
M  V30 4 C -3.5221 8.8995 0 0
M  V30 5 C -4.8212 8.1495 0 0
M  V30 6 C -4.8212 6.6495 0 0
M  V30 7 C -3.5221 5.8995 0 0
M  V30 8 O -0.924 8.8995 0 0
M  V30 9 C -6.1202 5.8995 0 0
M  V30 10 C -0.924 4.3995 0 0
M  V30 11 C 0.375 6.6495 0 0
M  V30 12 C 0.375 3.6495 0 0
M  V30 13 C 0.375 2.1495 0 0
M  V30 14 C -0.924 1.3995 0 0
M  V30 15 C -2.2231 2.1495 0 0
M  V30 16 C -2.2231 3.6495 0 0
M  V30 17 C 0.375 8.1495 0 0
M  V30 18 N 1.674 8.8995 0 0
M  V30 19 C 1.674 10.3995 0 0
M  V30 20 C 2.9731 8.1495 0 0
M  V30 21 C 2.9731 6.6495 0 0
M  V30 22 C 4.2721 8.8995 0 0
M  V30 23 C 2.9731 11.1495 0 0
M  V30 24 C 0.375 11.1495 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 7
M  V30 4 1 2 10
M  V30 5 1 2 11 CFG=3
M  V30 6 2 3 4
M  V30 7 1 3 8
M  V30 8 1 4 5
M  V30 9 2 5 6
M  V30 10 1 6 7
M  V30 11 1 6 9
M  V30 12 1 10 12
M  V30 13 2 10 16
M  V30 14 1 11 17
M  V30 15 2 12 13
M  V30 16 1 13 14
M  V30 17 2 14 15
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 23
M  V30 23 1 19 24
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
tolterodine

> <ID>
tolterodine

> <PRIMARY_SOM>
20 19

> <Citation>
Postlind et al.,Drug Metab. Disp.,26,289,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
toremifene
  SciTegic08102311032D

 29 31  0  0  0  0            999 V2000
  -10.0173  -11.1496    0.0000 C   0  0
   -8.7182  -11.8996    0.0000 C   0  0
   -7.4192  -11.1496    0.0000 C   0  0
   -7.4192   -9.6496    0.0000 C   0  0
   -8.7182   -8.8996    0.0000 C   0  0
   -8.7182   -7.3996    0.0000 C   0  0
  -10.0173   -6.6496    0.0000 C   0  0
  -11.3163   -7.3996    0.0000 C   0  0
  -11.3163   -8.8996    0.0000 C   0  0
  -10.0173   -9.6496    0.0000 C   0  0
   -6.1201   -8.8996    0.0000 C   0  0
   -4.8211   -9.6495    0.0000 C   0  0
   -3.5221   -8.8995    0.0000 C   0  0
   -3.5221   -7.3995    0.0000 C   0  0
   -2.2230   -6.6495    0.0000 O   0  0
   -2.2231   -5.1495    0.0000 C   0  0
   -0.9240   -4.3995    0.0000 C   0  0
   -0.9240   -2.8995    0.0000 N   0  0
    0.3750   -2.1495    0.0000 C   0  0
   -2.2231   -2.1495    0.0000 C   0  0
   -4.8211   -6.6495    0.0000 C   0  0
   -6.1202   -7.3995    0.0000 C   0  0
   -6.1201  -11.8996    0.0000 C   0  0
   -6.1201  -13.3996    0.0000 C   0  0
   -4.8211  -14.1495    0.0000 C   0  0
   -3.5221  -13.3995    0.0000 C   0  0
   -3.5221  -11.8995    0.0000 C   0  0
   -4.8211  -11.1495    0.0000 C   0  0
  -11.3163  -11.8996    0.0000 Cl  0  0
  1  2  1  0
  1 29  1  0
  2  3  1  0
  3  4  2  0
  3 23  1  0
  4  5  1  0
  4 11  1  0
  5  6  1  0
  5 10  2  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 11 12  1  0
 11 22  2  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 21  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 21 22  1  0
 23 24  1  0
 23 28  2  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
M  END
> <Name>
toremifene

> <ID>
toremifene

> <PRIMARY_SOM>
20 19

> <Citation>
Berthou et al.,Biochem. Pharmacol.,47,1883,1994

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
tramadol
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -0.4079 6.3075 0 0
M  V30 2 C -0.4079 7.8075 0 0
M  V30 3 C -1.7069 8.5575 0 0
M  V30 4 C -3.0059 7.8075 0 0
M  V30 5 C -3.0059 6.3075 0 0
M  V30 6 C -1.7069 5.5575 0 0
M  V30 7 O -1.7069 10.0575 0 0
M  V30 8 C -0.4079 10.8075 0 0
M  V30 9 C -4.305 5.5575 0 0 CFG=1
M  V30 10 C -5.7822 5.2971 0 0
M  V30 11 C -6.2952 3.8875 0 0
M  V30 12 C -5.331 2.7385 0 0
M  V30 13 C -3.8538 2.9989 0 0
M  V30 14 C -3.3408 4.4085 0 0 CFG=2
M  V30 15 O -4.818 6.9671 0 0
M  V30 16 C -1.8636 4.6689 0 0
M  V30 17 N -0.8994 3.5199 0 0
M  V30 18 C 0.5778 3.7804 0 0
M  V30 19 C -1.4124 2.1103 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 7
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 1 5 9
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 14
M  V30 12 1 9 15 CFG=1
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 14 16 CFG=1
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 14) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
tramadol

> <ID>
tramadol

> <PRIMARY_SOM>
19 18

> <Citation>
Subrahmanyam et al.,Drug Metab. Disp.,29,1146,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
trans_phenylpropene
  SciTegic08102311032D

  9  9  0  0  0  0            999 V2000
    4.2721   -0.1005    0.0000 C   0  0
    4.2721    1.3995    0.0000 C   0  0
    2.9731    2.1495    0.0000 C   0  0
    1.6740    1.3995    0.0000 C   0  0
    1.6740   -0.1005    0.0000 C   0  0
    2.9731   -0.8505    0.0000 C   0  0
    5.5712   -0.8505    0.0000 C   0  0
    5.5712   -2.3505    0.0000 C   0  0
    6.8702   -3.1005    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  7  8  2  0
  8  9  1  0
M  END
> <Name>
trans_phenylpropene

> <ID>
trans_phenylpropene

> <PRIMARY_SOM>
9

> <SECONDARY_SOM>
8

> <TERTIARY_SOM>
7

> <Citation>
Sanga et al.,Tox. Appl. Pharmacol.,211,148,2006

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
trans_retinoic_acid
  SciTegic08102311032D

 22 22  0  0  0  0            999 V2000
    3.3481    3.0000    0.0000 C   0  0
    4.6471    2.2500    0.0000 C   0  0
    3.3481    4.5000    0.0000 C   0  0
    2.0490    2.2500    0.0000 C   0  0
    5.9462    3.0000    0.0000 C   0  0
   13.7404    3.0000    0.0000 C   0  0
   15.0394    2.2500    0.0000 C   0  0
    9.8433    2.2500    0.0000 C   0  0
   12.4413    2.2500    0.0000 C   0  0
    7.2452    2.2500    0.0000 C   0  0
   11.1423    3.0000    0.0000 C   0  0
    8.5442    3.0000    0.0000 C   0  0
   16.3385    3.0000    0.0000 O   0  0
   15.0394    0.7500    0.0000 O   0  0
    2.0490    5.2500    0.0000 C   0  0
    0.7500    3.0000    0.0000 C   0  0
    4.6471    5.2500    0.0000 C   0  0
    3.0132    1.1009    0.0000 C   0  0
    1.0849    1.1009    0.0000 C   0  0
    0.7500    4.5000    0.0000 C   0  0
   12.4413    0.7500    0.0000 C   0  0
    7.2452    0.7500    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  3 15  1  0
  3 17  1  0
  4 16  1  0
  4 18  1  0
  4 19  1  0
  5 10  1  0
  6  7  1  0
  6  9  2  0
  7 13  2  0
  7 14  1  0
  8 11  2  0
  8 12  1  0
  9 11  1  0
  9 21  1  0
 10 12  2  0
 10 22  1  0
 15 20  1  0
 16 20  1  0
M  END
> <Name>
trans_retinoic_acid

> <ID>
trans_retinoic_acid

> <PRIMARY_SOM>
15

> <SECONDARY_SOM>
17

> <Citation>
Marill et al.,Current Drug. Metab.,4,1,2003

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
trazodone
  SciTegic08102311032D

 26 29  0  0  0  0            999 V2000
   14.1429   10.7171    0.0000 C   0  0
   14.1376   12.2171    0.0000 C   0  0
   12.8465    9.9625    0.0000 C   0  0
   11.5449   10.7079    0.0000 C   0  0
   10.1199   10.2393    0.0000 N   0  0
   11.5395   12.2079    0.0000 N   0  0
   12.8359   12.9625    0.0000 C   0  0
    9.2340   11.4497    0.0000 N   0  0
   10.1113   12.6663    0.0000 C   0  0
    9.6427   14.0912    0.0000 O   0  0
    7.7340   11.4443    0.0000 C   0  0
    6.9886   10.1427    0.0000 C   0  0
    5.4886   10.1373    0.0000 C   0  0
    4.7432    8.8356    0.0000 N   0  0
    3.2432    8.8303    0.0000 C   0  0
    2.4978    7.5286    0.0000 C   0  0
    3.2524    6.2323    0.0000 N   0  0
    4.7524    6.2376    0.0000 C   0  0
    5.4978    7.5393    0.0000 C   0  0
    2.5070    4.9306    0.0000 C   0  0
    1.0071    4.9252    0.0000 C   0  0
    0.2617    3.6235    0.0000 C   0  0
    1.0163    2.3272    0.0000 C   0  0
    2.5163    2.3325    0.0000 C   0  0
    3.2616    3.6342    0.0000 C   0  0
   -1.2383    3.6182    0.0000 Cl  0  0
  1  2  1  0
  1  3  2  0
  2  7  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  5  8  1  0
  6  7  1  0
  6  9  1  0
  8  9  1  0
  8 11  1  0
  9 10  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 20  1  0
 18 19  1  0
 20 21  1  0
 20 25  2  0
 21 22  2  0
 22 23  1  0
 22 26  1  0
 23 24  2  0
 24 25  1  0
M  END
> <Name>
trazodone

> <ID>
trazodone

> <PRIMARY_SOM>
13

> <SECONDARY_SOM>
23

> <TERTIARY_SOM>
1 3

> <Citation>
Wen et al.,Drug Metab. Disp.,36,841,2008

> <DOI>
10.1124/dmd.107.019471

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
trimethadione
  SciTegic08102311032D

 10 10  0  0  0  0            999 V2000
    4.9333   -2.7381    0.0000 C   0  0
    5.3968   -1.3116    0.0000 C   0  0
    3.4333   -2.7381    0.0000 O   0  0
    4.1833   -0.4299    0.0000 N   0  0
    2.9698   -1.3116    0.0000 C   0  0
    1.5432   -0.8480    0.0000 O   0  0
    4.1833    1.0701    0.0000 C   0  0
    6.8234   -0.8480    0.0000 O   0  0
    6.4005   -3.0500    0.0000 C   0  0
    4.7765   -4.2299    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  9  1  0
  1 10  1  0
  2  4  1  0
  2  8  2  0
  3  5  1  0
  4  5  1  0
  4  7  1  0
  5  6  2  0
M  END
> <Name>
trimethadione

> <ID>
trimethadione

> <PRIMARY_SOM>
7

> <Citation>
Tanaka et al.,J. Clin. Pharm. Ther.,28,493,2003

> <DOI>
10.1046/j.1365-2710.2003.00524.x

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
trofosfamide
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.8253 2.7877 0 0
M  V30 2 C 5.3383 4.1972 0 0
M  V30 3 C 5.7895 1.6386 0 0
M  V30 4 P 3.3481 2.5272 0 0 CFG=1
M  V30 5 C 6.8383 4.1972 0 0
M  V30 6 C 7.2667 1.8991 0 0
M  V30 7 O 3.8611 1.1177 0 0
M  V30 8 N 3.3481 4.0272 0 0
M  V30 9 O 2.049 1.7772 0 0
M  V30 10 Cl 7.5883 2.8982 0 0
M  V30 11 Cl 8.2309 0.75 0 0
M  V30 12 C 4.6471 4.7772 0 0
M  V30 13 C 2.049 4.7772 0 0
M  V30 14 C 0.75 2.5272 0 0
M  V30 15 C 4.6471 6.2772 0 0
M  V30 16 C 0.75 4.0272 0 0
M  V30 17 Cl 5.9462 7.0272 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 4 1 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
trofosfamide

> <ID>
trofosfamide

> <PRIMARY_SOM>
3 2

> <SECONDARY_SOM>
13

> <TERTIARY_SOM>
12

> <Citation>
May-Manke et al.,Cancer Chemother. Pharmacol.,44,327,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
troglitazone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7047 13.6846 0 0
M  V30 2 C 2.7047 15.1846 0 0
M  V30 3 O 1.4056 12.9346 0 0
M  V30 4 C 4.0037 12.9346 0 0
M  V30 5 C 1.4056 15.9346 0 0
M  V30 6 C 4.0037 15.9346 0 0
M  V30 7 C 0.1066 13.6846 0 0 CFG=1
M  V30 8 C 5.3027 13.6846 0 0
M  V30 9 C 4.0037 11.4346 0 0
M  V30 10 C 0.1066 15.1846 0 0
M  V30 11 C 5.3027 15.1846 0 0
M  V30 12 C 4.0037 17.4346 0 0
M  V30 13 C -0.4065 12.2751 0 0
M  V30 14 C -1.3706 13.9451 0 0
M  V30 15 C 6.6018 12.9346 0 0
M  V30 16 O 6.6018 15.9346 0 0
M  V30 17 O 0.5577 11.126 0 0
M  V30 18 C 0.0447 9.7165 0 0
M  V30 19 C 1.0089 8.5674 0 0
M  V30 20 C -1.4325 9.456 0 0
M  V30 21 C 0.4958 7.1579 0 0
M  V30 22 C -1.9456 8.0464 0 0
M  V30 23 C -0.9814 6.8974 0 0
M  V30 24 C -1.4944 5.4878 0 0
M  V30 25 C -2.9716 5.2274 0 0 CFG=1
M  V30 26 C -3.6292 3.8792 0 0
M  V30 27 S -4.0506 6.2694 0 0
M  V30 28 N -5.1146 4.0879 0 0
M  V30 29 O -2.925 2.5548 0 0
M  V30 30 C -5.3751 5.5651 0 0
M  V30 31 O -6.7232 6.2227 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 6 11
M  V30 11 1 6 12
M  V30 12 1 7 10
M  V30 13 1 7 13
M  V30 14 1 7 14 CFG=1
M  V30 15 1 8 11
M  V30 16 1 8 15
M  V30 17 1 11 16
M  V30 18 1 13 17
M  V30 19 1 17 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 1 25 24 CFG=1
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 30
M  V30 33 1 28 30
M  V30 34 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 25) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
troglitazone

> <ID>
troglitazone

> <PRIMARY_SOM>
16

> <SECONDARY_SOM>
25 27

> <Citation>
Yamazaki et al., Drug Metab. Dispos.,27,1260,1999; He et al., Drug Metab. Dispos., 2004, 32, 442-446; He et al., Drug Metab. Dispos., 2004, 32, 639-646

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
uk_343664
  SciTegic08102311032D

 40 44  0  0  0  0            999 V2000
    5.0957    8.7721    0.0000 C   0  0
    5.0957   10.2721    0.0000 C   0  0
   -0.1005    4.2721    0.0000 S   0  0
    3.7966    8.0221    0.0000 N   0  0
    6.5223   10.7356    0.0000 N   0  0
    2.4976    8.7721    0.0000 C   0  0
    7.4039    9.5221    0.0000 N   0  0
    6.5223    8.3086    0.0000 C   0  0
    2.4976   10.2721    0.0000 N   0  0
    3.7966   11.0221    0.0000 C   0  0
    1.1986    8.0221    0.0000 C   0  0
    1.3995    4.2721    0.0000 N   0  0
   -0.1005    5.7721    0.0000 C   0  0
    1.1986    6.5221    0.0000 C   0  0
    8.9039    9.5221    0.0000 C   0  0
   -1.6005    4.2721    0.0000 O   0  0
   -0.1005    2.7721    0.0000 O   0  0
    4.3995    4.2721    0.0000 N   0  0
    2.1495    2.9731    0.0000 C   0  0
    2.1495    5.5712    0.0000 C   0  0
   -0.1005    8.7721    0.0000 C   0  0
    3.7966   12.5221    0.0000 O   0  0
   11.1540   10.8211    0.0000 N   0  0
   -1.3995    6.5221    0.0000 C   0  0
   -1.3995    8.0221    0.0000 C   0  0
    9.6540   10.8211    0.0000 C   0  0
    3.6495    2.9731    0.0000 C   0  0
    3.6495    5.5712    0.0000 C   0  0
    6.9858    6.8820    0.0000 C   0  0
   -0.1005   10.2721    0.0000 O   0  0
    5.8995    4.2721    0.0000 C   0  0
   11.9040   12.1202    0.0000 C   0  0
    8.9040   12.1202    0.0000 C   0  0
   -1.3995   11.0221    0.0000 C   0  0
    8.4530    6.5701    0.0000 C   0  0
   -1.3995   12.5221    0.0000 C   0  0
    6.6495    5.5712    0.0000 C   0  0
   11.1540   13.4192    0.0000 C   0  0
   -2.6985   13.2721    0.0000 C   0  0
    9.6540   13.4192    0.0000 C   0  0
  1  2  1  0
  1  4  1  0
  1  8  2  0
  2  5  2  0
  2 10  1  0
  3 12  1  0
  3 13  1  0
  3 16  2  0
  3 17  2  0
  4  6  2  0
  5  7  1  0
  6  9  1  0
  6 11  1  0
  7  8  1  0
  7 15  1  0
  8 29  1  0
  9 10  1  0
 10 22  2  0
 11 14  2  0
 11 21  1  0
 12 19  1  0
 12 20  1  0
 13 14  1  0
 13 24  2  0
 15 26  1  0
 18 27  1  0
 18 28  1  0
 18 31  1  0
 19 27  1  0
 20 28  1  0
 21 25  2  0
 21 30  1  0
 23 26  2  0
 23 32  1  0
 24 25  1  0
 26 33  1  0
 29 35  1  0
 30 34  1  0
 31 37  1  0
 32 38  2  0
 33 40  2  0
 34 36  1  0
 36 39  1  0
 38 40  1  0
M  END
> <Name>
uk_343664

> <ID>
uk_343664

> <PRIMARY_SOM>
31

> <Citation>
Abel et al.,Xenobiotica,31,665,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
valdecoxib
  SciTegic08102311032D

 22 24  0  0  0  0            999 V2000
    7.2452    3.2455    0.0000 C   0  0
    8.6155    3.8556    0.0000 C   0  0
    5.9462    3.9955    0.0000 C   0  0
    7.4020    1.7537    0.0000 C   0  0
    8.9274    5.3228    0.0000 C   0  0
    9.6192    2.7409    0.0000 N   0  0
    5.9462    5.4955    0.0000 C   0  0
    4.6471    3.2455    0.0000 C   0  0
    8.8692    1.4418    0.0000 O   0  0
    6.2873    0.7500    0.0000 C   0  0
    7.8127    6.3265    0.0000 C   0  0
   10.3540    5.7863    0.0000 C   0  0
    4.6471    6.2455    0.0000 C   0  0
    3.3481    3.9955    0.0000 C   0  0
    8.1245    7.7937    0.0000 C   0  0
   10.6658    7.2536    0.0000 C   0  0
    3.3481    5.4955    0.0000 C   0  0
    9.5511    8.2572    0.0000 C   0  0
    2.0490    6.2455    0.0000 S   0  0
    1.2990    4.9465    0.0000 N   0  0
    2.7990    7.5445    0.0000 O   0  0
    0.7500    6.9955    0.0000 O   0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  2  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  1  0
  5 11  2  0
  5 12  1  0
  6  9  1  0
  7 13  1  0
  8 14  2  0
 11 15  1  0
 12 16  2  0
 13 17  2  0
 14 17  1  0
 15 18  2  0
 16 18  1  0
 17 19  1  0
 19 20  1  0
 19 21  2  0
 19 22  2  0
M  END
> <Name>
valdecoxib

> <ID>
valdecoxib

> <PRIMARY_SOM>
10

> <Citation>
Ibrahim et al.,Anesthesiology,96,88,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
valspodar
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 86 86 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -11.7523 -10.6357 0 0 CFG=2
M  V30 2 N -11.1572 -12.0125 0 0
M  V30 3 C -10.6171 -9.6461 0 0
M  V30 4 C -13.2152 -10.304 0 0
M  V30 5 C -11.7522 -13.3895 0 0
M  V30 6 C -9.6572 -12.0125 0 0
M  V30 7 N -10.5558 -8.1474 0 0
M  V30 8 O -9.2647 -10.295 0 0
M  V30 9 C -14.2338 -11.4051 0 0 CFG=1
M  V30 10 O -13.6594 -8.8713 0 0
M  V30 11 C -10.6186 -14.3718 0 0 CFG=1
M  V30 12 O -13.2146 -13.7233 0 0
M  V30 13 C -9.1083 -7.7542 0 0 CFG=2
M  V30 14 C -15.6967 -11.0734 0 0
M  V30 15 C -13.7896 -12.8378 0 0
M  V30 16 N -11.4449 -15.6237 0 0
M  V30 17 C -9.1907 -13.9125 0 0
M  V30 18 C -9.3096 -6.2677 0 0
M  V30 19 C -7.8581 -8.583 0 0
M  V30 20 C -16.7154 -12.1745 0 0
M  V30 21 C -10.5097 -16.7964 0 0
M  V30 22 C -12.9434 -15.691 0 0
M  V30 23 C -8.8745 -12.4462 0 0
M  V30 24 C -8.0789 -14.9195 0 0
M  V30 25 N -7.9582 -5.6169 0 0
M  V30 26 O -10.6305 -5.5569 0 0
M  V30 27 C -6.5152 -7.9148 0 0
M  V30 28 C -7.9508 -10.0802 0 0
M  V30 29 C -18.1783 -11.8428 0 0
M  V30 30 C -9.1053 -16.2693 0 0 CFG=1
M  V30 31 O -10.9087 -18.2424 0 0
M  V30 32 C -6.9216 -6.7011 0 0
M  V30 33 C -7.6903 -4.141 0 0
M  V30 34 C -19.1969 -12.9439 0 0
M  V30 35 N -8.3998 -17.593 0 0
M  V30 36 C -8.3398 -14.9793 0 0
M  V30 37 C -5.7116 -5.8145 0 0
M  V30 38 C -6.925 -17.3192 0 0
M  V30 39 C -9.0506 -18.9445 0 0
M  V30 40 C -6.8399 -14.9973 0 0
M  V30 41 N -4.5016 -6.7011 0 0
M  V30 42 O -5.7116 -4.3145 0 0
M  V30 43 C -5.715 -18.2058 0 0 CFG=1
M  V30 44 O -6.5913 -15.8568 0 0
M  V30 45 C -6.0745 -13.7073 0 0
M  V30 46 C -6.1055 -16.3052 0 0
M  V30 47 C -3.0268 -6.4273 0 0 CFG=2
M  V30 48 C -4.8354 -8.1635 0 0
M  V30 49 N -4.5051 -17.3192 0 0
M  V30 50 C -5.715 -19.7058 0 0
M  V30 51 C -2.3214 -7.7511 0 0
M  V30 52 C -2.376 -5.0759 0 0
M  V30 53 C -3.4685 -18.4033 0 0
M  V30 54 C -4.3737 -15.8249 0 0
M  V30 55 C -7.014 -20.4558 0 0
M  V30 56 N -0.917 -7.224 0 0
M  V30 57 O -2.8512 -9.1543 0 0
M  V30 58 C -0.8802 -4.9638 0 0
M  V30 59 C -2.117 -17.7525 0 0 CFG=2
M  V30 60 O -3.7363 -19.8792 0 0
M  V30 61 C -7.014 -21.9558 0 0
M  V30 62 C -8.3131 -19.7058 0 0
M  V30 63 C 0.0182 -8.3967 0 0 CFG=2
M  V30 64 C -0.2294 -3.6123 0 0
M  V30 65 C -0.0352 -6.2031 0 0
M  V30 66 N -2.3184 -16.2661 0 0
M  V30 67 C -0.7961 -18.4633 0 0
M  V30 68 C -0.8081 -9.6486 0 0
M  V30 69 C 1.5167 -8.3294 0 0
M  V30 70 C -0.8709 -15.8728 0 0
M  V30 71 N 0.3255 -10.6309 0 0
M  V30 72 O -2.2941 -9.8529 0 0
M  V30 73 C 2.3243 -9.5935 0 0
M  V30 74 C 2.2077 -6.998 0 0
M  V30 75 C -0.8096 -14.3741 0 0 CFG=1
M  V30 76 O 0.3019 -16.808 0 0
M  V30 77 C -0.2696 -12.0078 0 0 CFG=2
M  V30 78 C 1.7879 -10.2971 0 0
M  V30 79 N 0.6843 -14.2396 0 0
M  V30 80 C -1.8959 -13.3397 0 0
M  V30 81 C 1.0181 -12.7772 0 0
M  V30 82 C -2.625 -12.768 0 0
M  V30 83 O 2.3974 -12.1876 0 0
M  V30 84 C -3.7377 -11.762 0 0
M  V30 85 C -5.1652 -12.2227 0 0
M  V30 86 C -3.4229 -10.2954 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 2 5 12
M  V30 12 1 7 13
M  V30 13 1 9 14
M  V30 14 1 9 15 CFG=3
M  V30 15 1 11 16
M  V30 16 1 11 17 CFG=3
M  V30 17 1 13 18
M  V30 18 1 13 19 CFG=3
M  V30 19 1 14 20
M  V30 20 1 16 21
M  V30 21 1 16 22
M  V30 22 1 17 23
M  V30 23 1 17 24
M  V30 24 1 18 25
M  V30 25 2 18 26
M  V30 26 1 19 27
M  V30 27 1 19 28
M  V30 28 2 20 29
M  V30 29 1 21 30
M  V30 30 2 21 31
M  V30 31 1 25 32
M  V30 32 1 25 33
M  V30 33 1 29 34
M  V30 34 1 30 35
M  V30 35 1 30 36 CFG=3
M  V30 36 1 32 37
M  V30 37 1 35 38
M  V30 38 1 35 39
M  V30 39 1 36 40
M  V30 40 1 37 41
M  V30 41 2 37 42
M  V30 42 1 38 43
M  V30 43 2 38 44
M  V30 44 1 40 45
M  V30 45 1 40 46
M  V30 46 1 41 47
M  V30 47 1 41 48
M  V30 48 1 43 49
M  V30 49 1 43 50 CFG=1
M  V30 50 1 47 51
M  V30 51 1 47 52 CFG=1
M  V30 52 1 49 53
M  V30 53 1 49 54
M  V30 54 1 50 55
M  V30 55 1 51 56
M  V30 56 2 51 57
M  V30 57 1 52 58
M  V30 58 1 53 59
M  V30 59 2 53 60
M  V30 60 1 55 61
M  V30 61 1 55 62
M  V30 62 1 56 63
M  V30 63 1 58 64
M  V30 64 1 58 65
M  V30 65 1 59 66
M  V30 66 1 59 67 CFG=3
M  V30 67 1 63 68
M  V30 68 1 63 69 CFG=1
M  V30 69 1 66 70
M  V30 70 1 68 71
M  V30 71 2 68 72
M  V30 72 1 69 73
M  V30 73 1 69 74
M  V30 74 1 70 75
M  V30 75 2 70 76
M  V30 76 1 71 77
M  V30 77 1 71 78
M  V30 78 1 75 79
M  V30 79 1 75 80 CFG=3
M  V30 80 1 77 81
M  V30 81 1 77 82 CFG=3
M  V30 82 1 79 81
M  V30 83 2 81 83
M  V30 84 1 82 84
M  V30 85 1 84 85
M  V30 86 1 84 86
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 1 9 11 13 30 43 47 59 63 75 77) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
valspodar

> <ID>
valspodar

> <PRIMARY_SOM>
62 61

> <Citation>
Fischer et al.,Drug Metab. Disp.,26,802,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
venlafaxine
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0082 7.5533 0 0 CFG=1
M  V30 2 C 3.0034 9.0533 0 0
M  V30 3 C 1.7116 6.7991 0 0
M  V30 4 C 4.3097 6.8074 0 0
M  V30 5 C 0.4102 7.545 0 0
M  V30 6 C 1.7164 5.2991 0 0
M  V30 7 N 5.6063 7.5616 0 0
M  V30 8 O 4.4815 8.7975 0 0
M  V30 9 C -0.8817 5.2908 0 0
M  V30 10 C 0.4198 4.545 0 0
M  V30 11 C -0.8865 6.7908 0 0
M  V30 12 O -2.1783 4.5367 0 0
M  V30 13 C 3.5119 10.4644 0 0
M  V30 14 C 1.5271 8.7881 0 0
M  V30 15 C 6.9077 6.8157 0 0
M  V30 16 C 5.6015 9.0616 0 0
M  V30 17 C -3.4797 5.2825 0 0
M  V30 18 C 2.5441 11.6104 0 0
M  V30 19 C 0.5592 9.934 0 0
M  V30 20 C 1.0677 11.3452 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 8
M  V30 5 1 2 13
M  V30 6 1 2 14
M  V30 7 2 3 5
M  V30 8 1 3 6
M  V30 9 1 4 7
M  V30 10 1 5 11
M  V30 11 2 6 10
M  V30 12 1 7 15
M  V30 13 1 7 16
M  V30 14 1 9 10
M  V30 15 2 9 11
M  V30 16 1 9 12
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 14 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
venlafaxine

> <ID>
venlafaxine

> <PRIMARY_SOM>
16 15

> <Citation>
Fogelman et al.,Neuropsychopharmacology,20,480,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
verapamil
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 33 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0585 10.3901 0 0
M  V30 2 C 12.8066 11.6902 0 0
M  V30 3 C 12.0547 12.9882 0 0
M  V30 4 C 10.5547 12.986 0 0
M  V30 5 O 4.1669 3.2806 0 0
M  V30 6 O 1.571 1.7768 0 0
M  V30 7 O 12.8029 14.2883 0 0
M  V30 8 O 14.3066 11.6924 0 0
M  V30 9 C 1.5601 9.2768 0 0
M  V30 10 C 0.0623 7.7746 0 0
M  V30 11 C -0.6896 9.0726 0 0
M  V30 12 C -0.6858 6.4745 0 0
M  V30 13 C 5.3066 11.6793 0 0
M  V30 14 C 2.8668 4.0287 0 0
M  V30 15 C 1.5688 3.2768 0 0
M  V30 16 C 0.2687 4.0249 0 0
M  V30 17 C 0.2665 5.5249 0 0
M  V30 18 C 1.5645 6.2768 0 0
M  V30 19 C 2.8646 5.5287 0 0
M  V30 20 C 1.5623 7.7768 0 0 CFG=2
M  V30 21 C 3.0623 7.779 0 0
M  V30 22 C 3.8104 9.0791 0 0
M  V30 23 C 5.3104 9.0813 0 0
M  V30 24 N 6.0585 10.3814 0 0
M  V30 25 C 7.5585 10.3836 0 0
M  V30 26 C 8.3066 11.6837 0 0
M  V30 27 C 9.8066 11.6859 0 0
M  V30 28 C 10.5585 10.3879 0 0
M  V30 29 C 5.4648 4.0324 0 0
M  V30 30 C 0.273 1.0249 0 0
M  V30 31 C 12.051 15.5862 0 0
M  V30 32 C 15.0585 10.3944 0 0
M  V30 33 N 1.5579 10.7768 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 28
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 1 3 4
M  V30 6 1 3 7
M  V30 7 2 4 27
M  V30 8 1 5 14
M  V30 9 1 5 29
M  V30 10 1 6 15
M  V30 11 1 6 30
M  V30 12 1 7 31
M  V30 13 1 8 32
M  V30 14 1 20 9 CFG=1
M  V30 15 3 9 33
M  V30 16 1 10 11
M  V30 17 1 10 12
M  V30 18 1 10 20
M  V30 19 1 13 24
M  V30 20 1 14 15
M  V30 21 2 14 19
M  V30 22 2 15 16
M  V30 23 1 16 17
M  V30 24 2 17 18
M  V30 25 1 18 19
M  V30 26 1 18 20
M  V30 27 1 20 21
M  V30 28 1 21 22
M  V30 29 1 22 23
M  V30 30 1 23 24
M  V30 31 1 24 25
M  V30 32 1 25 26
M  V30 33 1 26 27
M  V30 34 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
verapamil

> <ID>
verapamil

> <PRIMARY_SOM>
13

> <SECONDARY_SOM>
25

> <Citation>
Tracy et al.,Br. J. Clin. Pharma.,47,545,1999

> <DOI>
10.1046/j.136502125.1999.00923.x.

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
vitamin_d2
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6387 9.5345 0 0
M  V30 2 C 4.6387 11.0345 0 0
M  V30 3 C 3.3397 11.7845 0 0
M  V30 4 C 2.0407 11.0345 0 0 CFG=1
M  V30 5 C 2.0407 9.5345 0 0 CFG=2
M  V30 6 C 3.3397 8.7845 0 0
M  V30 7 C 0.6141 11.4981 0 0
M  V30 8 C -0.2676 10.2845 0 0
M  V30 9 C 0.6141 9.071 0 0 CFG=1
M  V30 10 C 1.8839 8.0427 0 0
M  V30 11 C 3.3397 13.2845 0 0
M  V30 12 C 4.6387 14.0345 0 0
M  V30 13 C 4.6387 15.5345 0 0
M  V30 14 C 5.9378 16.2845 0 0
M  V30 15 C 5.9378 17.7845 0 0 CFG=2
M  V30 16 C 4.6387 18.5345 0 0
M  V30 17 C 3.3397 17.7845 0 0
M  V30 18 C 3.3397 16.2845 0 0
M  V30 19 C 2.0407 15.5345 0 0
M  V30 20 O 7.2368 18.5345 0 0
M  V30 21 C 0.1505 7.6444 0 0 CFG=1
M  V30 22 C 1.1542 6.5297 0 0
M  V30 23 C -1.3167 7.3326 0 0
M  V30 24 C -1.7802 5.906 0 0
M  V30 25 C -3.2474 5.5941 0 0 CFG=1
M  V30 26 C -4.2511 6.7088 0 0
M  V30 27 C -3.711 4.1675 0 0
M  V30 28 C -5.1782 3.8556 0 0
M  V30 29 C -2.7073 3.0528 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 11
M  V30 6 1 4 5
M  V30 7 1 4 7 CFG=1
M  V30 8 1 5 6
M  V30 9 1 5 9
M  V30 10 1 5 10 CFG=1
M  V30 11 1 7 8
M  V30 12 1 9 8 CFG=3
M  V30 13 1 9 21
M  V30 14 1 11 12
M  V30 15 2 12 13
M  V30 16 1 13 14
M  V30 17 1 13 18
M  V30 18 1 14 15
M  V30 19 1 15 16
M  V30 20 1 15 20 CFG=3
M  V30 21 1 16 17
M  V30 22 1 17 18
M  V30 23 2 18 19
M  V30 24 1 21 22 CFG=1
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 24 25
M  V30 28 1 25 26 CFG=3
M  V30 29 1 25 27
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 4 5 9 15 21 25) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
vitamin_d2

> <ID>
vitamin_d2

> <PRIMARY_SOM>
25

> <Citation>
Gupta et al.,J. Clin. Endocr. Metab.,90,1210,2005

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
voriconazole
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9462 4.8037 0 0 CFG=2
M  V30 2 C 4.6471 5.5537 0 0
M  V30 3 C 7.2452 5.5537 0 0 CFG=2
M  V30 4 C 5.9461 3.3037 0 0
M  V30 5 O 5.9462 6.3037 0 0
M  V30 6 C 4.6471 7.0537 0 0
M  V30 7 C 3.3481 4.8037 0 0
M  V30 8 C 8.5442 4.8036 0 0
M  V30 9 C 7.2452 7.0537 0 0
M  V30 10 N 4.6471 2.5537 0 0
M  V30 11 C 3.3481 7.8037 0 0
M  V30 12 F 5.9462 7.8037 0 0
M  V30 13 C 2.049 5.5537 0 0
M  V30 14 C 9.8433 5.5536 0 0
M  V30 15 N 8.5442 3.3036 0 0
M  V30 16 C 4.4903 1.0619 0 0
M  V30 17 N 3.2768 3.1638 0 0
M  V30 18 C 2.049 7.0537 0 0
M  V30 19 C 11.1423 4.8036 0 0
M  V30 20 F 9.8433 7.0536 0 0
M  V30 21 C 9.8433 2.5536 0 0
M  V30 22 N 3.0231 0.75 0 0
M  V30 23 C 2.2731 2.049 0 0
M  V30 24 F 0.75 7.8037 0 0
M  V30 25 N 11.1423 3.3036 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5 CFG=1
M  V30 5 2 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 3 9 CFG=1
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 2 7 13
M  V30 13 2 8 14
M  V30 14 1 8 15
M  V30 15 1 10 16
M  V30 16 1 10 17
M  V30 17 2 11 18
M  V30 18 1 13 18
M  V30 19 1 14 19
M  V30 20 1 14 20
M  V30 21 2 15 21
M  V30 22 2 16 22
M  V30 23 2 17 23
M  V30 24 1 18 24
M  V30 25 2 19 25
M  V30 26 1 21 25
M  V30 27 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 3) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
voriconazole

> <ID>
voriconazole

> <PRIMARY_SOM>
9

> <SECONDARY_SOM>
25

> <Citation>
Murayama et al.,Biochem. Pharma.,73,2020,2007

> <DOI>
10.106/j.bcp.2007.03.012

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
zafirlukast
  SciTegic08102311032D

 41 45  0  0  0  0            999 V2000
   21.1482    4.5851    0.0000 S   0  0
   19.6809    4.8970    0.0000 N   0  0
   12.3448    6.4563    0.0000 C   0  0
   12.3448    8.8834    0.0000 N   0  0
   10.9183    6.9199    0.0000 C   0  0
   13.2265    7.6699    0.0000 C   0  0
   10.9183    8.4199    0.0000 C   0  0
   18.6772    3.7823    0.0000 C   0  0
    5.7221    6.9199    0.0000 C   0  0
   21.4600    6.0523    0.0000 C   0  0
   12.8084    5.0298    0.0000 C   0  0
   17.2100    4.0941    0.0000 C   0  0
   14.2756    4.7179    0.0000 C   0  0
   22.6154    4.2733    0.0000 O   0  0
   20.8363    3.1179    0.0000 O   0  0
   14.7391    3.2913    0.0000 C   0  0
    7.0211    6.1699    0.0000 N   0  0
   16.2063    2.9794    0.0000 C   0  0
    9.6192    9.1699    0.0000 C   0  0
    9.6192    6.1699    0.0000 C   0  0
    4.4231    6.1699    0.0000 O   0  0
    8.3202    6.9199    0.0000 C   0  0
    5.7221    8.4199    0.0000 O   0  0
   19.1408    2.3557    0.0000 O   0  0
   16.7465    5.5207    0.0000 C   0  0
   15.2793    5.8326    0.0000 C   0  0
   22.8866    6.5159    0.0000 C   0  0
    8.3202    8.4199    0.0000 C   0  0
   12.8084   10.3100    0.0000 C   0  0
   13.7354    2.1766    0.0000 O   0  0
    3.1240    6.9199    0.0000 C   0  0
   20.3453    7.0560    0.0000 C   0  0
   24.0013    5.5122    0.0000 C   0  0
   23.1985    7.9831    0.0000 C   0  0
   14.1989    0.7500    0.0000 C   0  0
    1.7537    6.3098    0.0000 C   0  0
    2.9672    8.4117    0.0000 C   0  0
   20.6572    8.5233    0.0000 C   0  0
   22.0838    8.9868    0.0000 C   0  0
    0.7500    7.4245    0.0000 C   0  0
    1.5000    8.7235    0.0000 C   0  0
  1  2  1  0
  1 10  1  0
  1 14  2  0
  1 15  2  0
  2  8  1  0
  3  5  1  0
  3  6  2  0
  3 11  1  0
  4  6  1  0
  4  7  1  0
  4 29  1  0
  5  7  2  0
  5 20  1  0
  7 19  1  0
  8 12  1  0
  8 24  2  0
  9 17  1  0
  9 21  1  0
  9 23  2  0
 10 27  2  0
 10 32  1  0
 11 13  1  0
 12 18  1  0
 12 25  2  0
 13 16  1  0
 13 26  2  0
 16 18  2  0
 16 30  1  0
 17 22  1  0
 19 28  2  0
 20 22  2  0
 21 31  1  0
 22 28  1  0
 25 26  1  0
 27 33  1  0
 27 34  1  0
 30 35  1  0
 31 36  1  0
 31 37  1  0
 32 38  2  0
 34 39  2  0
 36 40  1  0
 37 41  1  0
 38 39  1  0
 40 41  1  0
M  END
> <Name>
zafirlukast

> <ID>
zafirlukast

> <PRIMARY_SOM>
29

> <SECONDARY_SOM>
11

> <Citation>
Kassahun et al.,Chem. Res. Toxicol.,18,1427,2005

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
zaleplon
  SciTegic08102311032D

 23 25  0  0  0  0            999 V2000
   11.0447    1.9736    0.0000 C   0  0
   12.3426    1.2215    0.0000 C   0  0
   12.3402   -0.2785    0.0000 C   0  0
   11.0400   -1.0264    0.0000 C   0  0
    9.7421   -0.2744    0.0000 C   0  0
    9.7445    1.2256    0.0000 C   0  0
    8.4467    1.9777    0.0000 C   0  0
    8.4491    3.4777    0.0000 C   0  0
    7.1512    4.2298    0.0000 C   0  0
    5.8510    3.4818    0.0000 N   0  0
    5.8486    1.9818    0.0000 C   0  0
    7.1464    1.2298    0.0000 N   0  0
    4.7323    0.9799    0.0000 C   0  0
    5.3402   -0.3914    0.0000 C   0  0
    6.8322   -0.2369    0.0000 N   0  0
    3.2656    1.2941    0.0000 C   0  0
    1.7988    1.6084    0.0000 N   0  0
   11.0376   -2.5264    0.0000 N   0  0
    9.7373   -3.2744    0.0000 C   0  0
    8.4395   -2.5223    0.0000 C   0  0
    9.7349   -4.7744    0.0000 O   0  0
   12.3354   -3.2785    0.0000 C   0  0
   12.3330   -4.7785    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4 18  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 15  1  0
 13 14  1  0
 13 16  1  0
 14 15  2  0
 16 17  3  0
 18 19  1  0
 18 22  1  0
 19 20  1  0
 19 21  2  0
 22 23  1  0
M  END
> <Name>
zaleplon

> <ID>
zaleplon

> <PRIMARY_SOM>
22

> <Citation>
Renwick et al.,Xenobiotica,28,337,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
zileuton
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6563 2.25 0 0
M  V30 2 C 7.1563 2.25 0 0 CFG=1
M  V30 3 C 4.7747 1.0365 0 0
M  V30 4 S 4.7747 3.4635 0 0
M  V30 5 N 7.9063 3.549 0 0
M  V30 6 C 7.9063 0.951 0 0
M  V30 7 C 3.3481 1.5 0 0
M  V30 8 C 3.3481 3 0 0
M  V30 9 C 9.4063 3.549 0 0
M  V30 10 O 7.1563 4.8481 0 0
M  V30 11 C 2.049 0.75 0 0
M  V30 12 C 2.049 3.75 0 0
M  V30 13 N 10.1563 2.25 0 0
M  V30 14 O 10.1563 4.8481 0 0
M  V30 15 C 0.75 1.5 0 0
M  V30 16 C 0.75 3 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 2 7 8
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
zileuton

> <ID>
zileuton

> <PRIMARY_SOM>
4

> <Citation>
Macinist et al.,Drug Metab. Disp.,23,1163,1995

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ziprasidone
  SciTegic08102311032D

 28 32  0  0  0  0            999 V2000
    8.6458    1.6288    0.0000 C   0  0
    8.6458    3.1288    0.0000 C   0  0
    7.3467    3.8788    0.0000 C   0  0
    6.0477    3.1288    0.0000 C   0  0
    6.0477    1.6288    0.0000 C   0  0
    7.3467    0.8788    0.0000 C   0  0
    9.9448    3.8788    0.0000 Cl  0  0
    4.6211    3.5924    0.0000 N   0  0
    4.6211    1.1653    0.0000 C   0  0
    3.7394    2.3788    0.0000 C   0  0
    2.2394    2.3788    0.0000 O   0  0
    9.9448    0.8788    0.0000 C   0  0
    9.9448   -0.6212    0.0000 C   0  0
   11.2439   -1.3712    0.0000 N   0  0
   11.2439   -2.8712    0.0000 C   0  0
   12.5429   -3.6212    0.0000 C   0  0
   13.8419   -2.8711    0.0000 N   0  0
   13.8419   -1.3712    0.0000 C   0  0
   12.5429   -0.6212    0.0000 C   0  0
   15.1410   -3.6212    0.0000 C   0  0
   15.2978   -5.1129    0.0000 C   0  0
   16.7650   -5.4248    0.0000 C   0  0
   17.5150   -4.1258    0.0000 S   0  0
   16.5113   -3.0110    0.0000 N   0  0
   17.2285   -6.8514    0.0000 C   0  0
   14.2941   -6.2277    0.0000 C   0  0
   16.2248   -7.9661    0.0000 C   0  0
   14.7576   -7.6542    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  1 12  1  0
  2  3  2  0
  2  7  1  0
  3  4  1  0
  4  5  2  0
  4  8  1  0
  5  6  1  0
  5  9  1  0
  8 10  1  0
  9 10  1  0
 10 11  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 20  1  0
 18 19  1  0
 20 21  1  0
 20 24  2  0
 21 22  2  0
 21 26  1  0
 22 23  1  0
 22 25  1  0
 23 24  1  0
 25 27  2  0
 26 28  2  0
 27 28  1  0
M  END
> <Name>
ziprasidone

> <ID>
ziprasidone

> <PRIMARY_SOM>
23

> <SECONDARY_SOM>
13

> <Citation>
Prakash et al.,Br. J. Clin. Pharm.,49 (Suppl 1),35S,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
zolpidem
  SciTegic08102311032D

 23 25  0  0  0  0            999 V2000
    6.0737    5.0298    0.0000 C   0  0
    6.9554    6.2433    0.0000 C   0  0
    4.6471    5.4933    0.0000 N   0  0
    6.5372    3.6032    0.0000 C   0  0
    8.4554    6.2433    0.0000 C   0  0
    6.0737    7.4568    0.0000 N   0  0
    4.6471    6.9933    0.0000 C   0  0
    3.3481    4.7433    0.0000 C   0  0
    5.5335    2.4885    0.0000 C   0  0
    9.2054    4.9442    0.0000 C   0  0
    9.2054    7.5423    0.0000 C   0  0
    3.3481    7.7433    0.0000 C   0  0
    2.0490    5.4933    0.0000 C   0  0
    5.9971    1.0619    0.0000 N   0  0
    4.0663    2.8003    0.0000 O   0  0
   10.7054    4.9442    0.0000 C   0  0
   10.7054    7.5423    0.0000 C   0  0
    2.0490    6.9933    0.0000 C   0  0
    0.7500    4.7433    0.0000 C   0  0
    4.9934   -0.0528    0.0000 C   0  0
    7.4643    0.7500    0.0000 C   0  0
   11.4554    6.2433    0.0000 C   0  0
   12.9554    6.2433    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  2  0
  5 11  1  0
  6  7  2  0
  7 12  1  0
  8 13  2  0
  9 14  1  0
  9 15  2  0
 10 16  1  0
 11 17  2  0
 12 18  2  0
 13 18  1  0
 13 19  1  0
 14 20  1  0
 14 21  1  0
 16 22  2  0
 17 22  1  0
 22 23  1  0
M  END
> <Name>
zolpidem

> <ID>
zolpidem

> <PRIMARY_SOM>
19

> <SECONDARY_SOM>
21 20

> <TERTIARY_SOM>
23

> <Citation>
von Moltke et al.,Br. J. Clin. Pharm.,48,89,1999

> <DOI>
10.1046/j.1365-2125.1999.00953.x

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
zonisamide
  SciTegic08102311032D

 14 15  0  0  0  0            999 V2000
    4.4500    0.2077    0.0000 C   0  0
    5.8766   -0.2558    0.0000 C   0  0
    4.4500    1.7077    0.0000 C   0  0
    3.1510   -0.5423    0.0000 C   0  0
    6.7583    0.9577    0.0000 N   0  0
    6.3402   -1.6824    0.0000 C   0  0
    5.8766    2.1712    0.0000 O   0  0
    3.1510    2.4577    0.0000 C   0  0
    1.8520    0.2077    0.0000 C   0  0
    7.8074   -1.9943    0.0000 S   0  0
    1.8520    1.7077    0.0000 C   0  0
    8.1192   -0.5270    0.0000 N   0  0
    7.4955   -3.4615    0.0000 O   0  0
    9.2746   -2.3061    0.0000 O   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  5  7  1  0
  6 10  1  0
  8 11  2  0
  9 11  1  0
 10 12  1  0
 10 13  2  0
 10 14  2  0
M  END
> <Name>
zonisamide

> <ID>
zonisamide

> <PRIMARY_SOM>
2

> <Citation>
Nakasa et al.,Molec. Pharm.,44,216,1993

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
zopiclone
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.6564 -5.5414 0 0
M  V30 2 C 11.6564 -4.0414 0 0
M  V30 3 N 10.3573 -3.2914 0 0
M  V30 4 C 9.0583 -4.0414 0 0
M  V30 5 C 9.0583 -5.5414 0 0
M  V30 6 N 10.3573 -6.2914 0 0
M  V30 7 C 7.6317 -3.5779 0 0
M  V30 8 O 7.1682 -2.1513 0 0
M  V30 9 N 6.75 -4.7914 0 0
M  V30 10 C 7.6317 -6.005 0 0 CFG=1
M  V30 11 C 5.25 -4.7914 0 0
M  V30 12 N 4.5 -6.0905 0 0
M  V30 13 C 3 -6.0905 0 0
M  V30 14 C 2.25 -4.7914 0 0
M  V30 15 C 3 -3.4924 0 0
M  V30 16 C 4.5 -3.4924 0 0
M  V30 17 Cl 0.75 -4.7914 0 0
M  V30 18 O 7.1682 -7.4315 0 0
M  V30 19 C 8.1719 -8.5463 0 0
M  V30 20 N 7.7084 -9.9729 0 0
M  V30 21 C 8.712 -11.0876 0 0
M  V30 22 C 6.2411 -10.2847 0 0
M  V30 23 C 8.2485 -12.5142 0 0
M  V30 24 C 5.7776 -11.7113 0 0
M  V30 25 N 6.7813 -12.826 0 0
M  V30 26 C 6.3178 -14.2526 0 0
M  V30 27 O 9.6391 -8.2344 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 4 7
M  V30 7 1 5 6
M  V30 8 1 5 10
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 18 CFG=3
M  V30 14 1 11 12
M  V30 15 2 11 16
M  V30 16 2 12 13
M  V30 17 1 13 14
M  V30 18 2 14 15
M  V30 19 1 14 17
M  V30 20 1 15 16
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 2 19 27
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
zopiclone

> <ID>
zopiclone

> <PRIMARY_SOM>
25

> <SECONDARY_SOM>
26

> <Citation>
Becquemont et al.,Drug Metab. Disp.,27,1068,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
0

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
zotepine
  SciTegic08102311032D

 22 24  0  0  0  0            999 V2000
   -4.7163   10.5164    0.0000 C   0  0
   -5.0501   11.9788    0.0000 C   0  0
   -5.6516    9.3436    0.0000 C   0  0
   -3.2830   10.0743    0.0000 C   0  0
   -6.4016   12.6296    0.0000 S   0  0
   -3.9506   12.9990    0.0000 C   0  0
   -7.1516    9.3436    0.0000 C   0  0
   -5.0008    7.9922    0.0000 O   0  0
   -2.1834   11.0945    0.0000 C   0  0
   -7.7530   11.9788    0.0000 C   0  0
   -2.5172   12.5569    0.0000 C   0  0
   -8.0868   10.5164    0.0000 C   0  0
   -5.8457    6.7528    0.0000 C   0  0
   -0.7501   10.6524    0.0000 Cl  0  0
   -8.8526   12.9990    0.0000 C   0  0
   -9.5202   10.0742    0.0000 C   0  0
   -5.1949    5.4014    0.0000 C   0  0
  -10.2860   12.5569    0.0000 C   0  0
  -10.6198   11.0945    0.0000 C   0  0
   -6.0399    4.1620    0.0000 N   0  0
   -5.3891    2.8105    0.0000 C   0  0
   -7.5357    4.2741    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  6 11  2  0
  7 12  1  0
  8 13  1  0
  9 11  1  0
  9 14  1  0
 10 12  2  0
 10 15  1  0
 12 16  1  0
 13 17  1  0
 15 18  2  0
 16 19  2  0
 17 20  1  0
 18 19  1  0
 20 21  1  0
 20 22  1  0
M  END
> <Name>
zotepine

> <ID>
zotepine

> <PRIMARY_SOM>
22 21

> <SECONDARY_SOM>
5

> <TERTIARY_SOM>
18

> <Citation>
Shigura et al.,Xenobiotica,29,217,1999

> <DOI>
10.1080/004982599238623

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
13_cis_retinoic_acid
  SciTegic08102311032D

 22 22  0  0  0  0            999 V2000
   -2.8726    5.5245    0.0000 O   0  0
   -4.1716    3.2745    0.0000 O   0  0
    4.9216   13.0245    0.0000 C   0  0
    4.9216   14.5245    0.0000 C   0  0
    3.6226   15.2745    0.0000 C   0  0
    3.6226   12.2745    0.0000 C   0  0
    2.3236   14.5245    0.0000 C   0  0
    2.3236   13.0245    0.0000 C   0  0
    5.4347   11.6150    0.0000 C   0  0
    6.3989   13.2850    0.0000 C   0  0
    3.6226   10.7745    0.0000 C   0  0
    1.0245   12.2745    0.0000 C   0  0
    2.3236   10.0245    0.0000 C   0  0
    2.3236    8.5245    0.0000 C   0  0
    3.6226    7.7745    0.0000 C   0  0
    1.0245    7.7745    0.0000 C   0  0
    1.0245    6.2745    0.0000 C   0  0
   -0.2745    5.5245    0.0000 C   0  0
   -0.2745    4.0245    0.0000 C   0  0
    1.0245    3.2745    0.0000 C   0  0
   -1.5736    3.2745    0.0000 C   0  0
   -2.8726    4.0245    0.0000 C   0  0
  1 22  1  0
  2 22  2  0
  3  4  1  0
  3  6  1  0
  3  9  1  0
  3 10  1  0
  4  5  1  0
  5  7  1  0
  6  8  2  0
  6 11  1  0
  7  8  1  0
  8 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 21 22  1  0
M  END
> <Name>
13_cis_retinoic_acid

> <ID>
13_cis_retinoic_acid

> <PRIMARY_SOM>
7

> <Citation>
Marill et al.,Biochem. Pharmacol.,63,933,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
2-2prime-4-5-5prime-pentachlorobiphenyl
  SciTegic08102311032D

 17 18  0  0  0  0            999 V2000
    6.2207    0.2745    0.0000 C   0  0
    7.5197   -0.4755    0.0000 C   0  0
    6.2207    1.7745    0.0000 C   0  0
    4.9216    2.5245    0.0000 C   0  0
    4.9216    4.0245    0.0000 Cl  0  0
    3.6226    1.7745    0.0000 C   0  0
    2.3236    2.5245    0.0000 Cl  0  0
    3.6226    0.2745    0.0000 C   0  0
    4.9216   -0.4755    0.0000 C   0  0
    4.9216   -1.9755    0.0000 Cl  0  0
    7.5197   -1.9755    0.0000 C   0  0
    8.8188   -2.7255    0.0000 C   0  0
    8.8188   -4.2255    0.0000 Cl  0  0
   10.1178   -1.9755    0.0000 C   0  0
   10.1178   -0.4755    0.0000 C   0  0
    8.8188    0.2745    0.0000 C   0  0
    8.8188    1.7745    0.0000 Cl  0  0
  1  2  1  0
  1  3  1  0
  1  9  2  0
  2 11  1  0
  2 16  2  0
  3  4  2  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  9 10  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
M  END
> <Name>
2-2prime-4-5-5prime-pentachlorobiphenyl

> <ID>
2-2prime-4-5-5prime-pentachlorobiphenyl

> <PRIMARY_SOM>
14

> <Citation>
McGraw and Waller,Biochem. Biophys. Res. Comm.,344,129,2006

> <DOI>
10.1016/j.bbrc.2006.03.122

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
2-acetylbenzothiophene
  SciTegic08102311032D

 12 13  0  0  0  0            999 V2000
    5.6563    2.2500    0.0000 C   0  0
    4.7747    1.0365    0.0000 C   0  0
    3.3481    1.5000    0.0000 C   0  0
    3.3481    3.0000    0.0000 C   0  0
    4.7747    3.4635    0.0000 S   0  0
    2.0490    0.7500    0.0000 C   0  0
    0.7500    1.5000    0.0000 C   0  0
    0.7500    3.0000    0.0000 C   0  0
    2.0490    3.7500    0.0000 C   0  0
    7.1563    2.2500    0.0000 C   0  0
    7.9063    3.5490    0.0000 O   0  0
    7.9063    0.9510    0.0000 C   0  0
  1  2  2  0
  1  5  1  0
  1 10  1  0
  2  3  1  0
  3  4  1  0
  3  6  2  0
  4  5  1  0
  4  9  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
 10 11  2  0
 10 12  1  0
M  END
> <Name>
2-acetylbenzothiophene

> <ID>
2-acetylbenzothiophene

> <PRIMARY_SOM>
5

> <Citation>
Elizabeth M. Joshi, Brian H. Heasley, Mahendra D. Chordia, and Timothy L. Macdonald, In Vitro Metabolism of 2-Acetylbenzothiophene:  Relevance to Zileuton Hepatotoxicity, Chem. Res. Toxicol., 2004, 17
 (2), pp 137143

> <DOI>
10.1021/tx0341409

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
2-oxo-clopidogrel
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 11.9997 -1.562 0 0
M  V30 2 S 4.0779 2.6515 0 0
M  V30 3 O 10.7007 2.188 0 0
M  V30 4 O 11.9997 -0.062 0 0
M  V30 5 N 8.1026 0.688 0 0
M  V30 6 C 8.1026 2.188 0 0
M  V30 7 C 6.8036 -0.062 0 0
M  V30 8 C 9.4016 -0.062 0 0 CFG=1
M  V30 9 C 6.8036 2.938 0 0
M  V30 10 C 5.5045 0.688 0 0
M  V30 11 C 5.5045 2.188 0 0
M  V30 12 C 9.4016 -1.562 0 0
M  V30 13 C 4.0779 0.2245 0 0
M  V30 14 C 10.7007 0.688 0 0
M  V30 15 C 3.1962 1.438 0 0
M  V30 16 O 1.6962 1.438 0 0
M  V30 17 C 10.7007 -2.312 0 0
M  V30 18 C 8.1026 -2.312 0 0
M  V30 19 C 10.7007 -3.812 0 0
M  V30 20 C 8.1026 -3.812 0 0
M  V30 21 C 9.4016 -4.562 0 0
M  V30 22 C 11.9997 2.938 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 11
M  V30 3 1 2 15
M  V30 4 1 3 14
M  V30 5 1 3 22
M  V30 6 2 4 14
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 8 5 CFG=3
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 8 12
M  V30 13 1 8 14
M  V30 14 1 9 11
M  V30 15 2 10 11
M  V30 16 1 10 13
M  V30 17 2 12 17
M  V30 18 1 12 18
M  V30 19 1 13 15
M  V30 20 2 15 16
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
2-oxo-clopidogrel

> <ID>
2-oxo-clopidogrel

> <PRIMARY_SOM>
2

> <Citation>
Kazui et al., Drug Metab. Dispos.,2010, 38, 92-99

> <DOI>
10.1124/dmd.109.029132

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
2-oxoquazepam
  SciTegic08102311032D

 25 27  0  0  0  0            999 V2000
   -4.0487    5.8650    0.0000 C   0  0
   -4.3825    7.3274    0.0000 C   0  0
   -4.9840    4.6923    0.0000 N   0  0
   -2.6154    5.4229    0.0000 C   0  0
   -5.7340    7.9782    0.0000 C   0  0
   -3.2829    8.3477    0.0000 C   0  0
   -6.4840    4.6923    0.0000 C   0  0
   -4.3331    3.3408    0.0000 C   0  0
   -1.5158    6.4431    0.0000 C   0  0
   -5.7340    9.4782    0.0000 C   0  0
   -7.0854    7.3274    0.0000 N   0  0
   -1.8496    7.9055    0.0000 C   0  0
   -7.4192    5.8650    0.0000 C   0  0
   -7.1348    3.3408    0.0000 O   0  0
   -5.1781    2.1015    0.0000 C   0  0
   -4.4349   10.2282    0.0000 C   0  0
   -7.0330   10.2282    0.0000 C   0  0
   -0.7500    8.9258    0.0000 Cl  0  0
   -4.5273    0.7500    0.0000 F   0  0
   -6.6739    2.2136    0.0000 F   0  0
   -6.0231    0.8621    0.0000 F   0  0
   -4.4349   11.7282    0.0000 C   0  0
   -3.1359    9.4782    0.0000 F   0  0
   -7.0330   11.7282    0.0000 C   0  0
   -5.7340   12.4782    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  5 11  2  0
  6 12  2  0
  7 13  1  0
  7 14  2  0
  8 15  1  0
  9 12  1  0
 10 16  2  0
 10 17  1  0
 11 13  1  0
 12 18  1  0
 15 19  1  0
 15 20  1  0
 15 21  1  0
 16 22  1  0
 16 23  1  0
 17 24  2  0
 22 25  2  0
 24 25  1  0
M  END
> <Name>
2-oxoquazepam

> <ID>
2-oxoquazepam

> <PRIMARY_SOM>
13

> <SECONDARY_SOM>
8

> <Citation>
Miura and Ohkubo,Xenobiotica,34,1001,2004

> <DOI>
10.1080/0277224040001524

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
2n_propylquinoline
  SciTegic08102311032D

 13 14  0  0  0  0            999 V2000
    3.3481    1.5000    0.0000 C   0  0
    3.3481    3.0000    0.0000 C   0  0
    2.0490    3.7500    0.0000 C   0  0
    0.7500    3.0000    0.0000 C   0  0
    0.7500    1.5000    0.0000 C   0  0
    2.0490    0.7500    0.0000 C   0  0
    4.6471    0.7500    0.0000 C   0  0
    4.6471    3.7500    0.0000 N   0  0
    5.9462    1.5000    0.0000 C   0  0
    5.9462    3.0000    0.0000 C   0  0
    7.2452    3.7500    0.0000 C   0  0
    8.5442    3.0000    0.0000 C   0  0
    9.8433    3.7500    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  2  8  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  7  9  2  0
  8 10  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
M  END
> <Name>
2n_propylquinoline

> <ID>
2n_propylquinoline

> <PRIMARY_SOM>
11

> <SECONDARY_SOM>
13

> <TERTIARY_SOM>
3 4 5 6 7 9

> <Citation>
Belliard et al.,Xenobiotica,33,341,2003

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
2prime_hydroxy_indomethacin_phenethylamide
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.2237 8.6124 0 0
M  V30 2 C 0.2237 10.1124 0 0
M  V30 3 N 1.6503 8.1489 0 0
M  V30 4 C -1.0753 7.8624 0 0
M  V30 5 C 1.6503 10.576 0 0
M  V30 6 C -1.0753 10.8624 0 0
M  V30 7 C 2.532 9.3624 0 0
M  V30 8 C 2.1139 6.7223 0 0
M  V30 9 C -2.3743 8.6124 0 0
M  V30 10 C 2.1139 12.0026 0 0
M  V30 11 C -2.3743 10.1124 0 0
M  V30 12 C 4.032 9.3624 0 0
M  V30 13 C 3.5811 6.4105 0 0
M  V30 14 O 1.1102 5.6076 0 0
M  V30 15 C 3.5811 12.3144 0 0
M  V30 16 O -3.6734 10.8624 0 0
M  V30 17 C 4.0446 4.9839 0 0
M  V30 18 C 4.5848 7.5252 0 0
M  V30 19 O 4.5848 11.1997 0 0
M  V30 20 C -4.9724 10.1125 0 0
M  V30 21 C 5.5118 4.672 0 0
M  V30 22 C 6.052 7.2133 0 0
M  V30 23 C 6.5155 5.7867 0 0
M  V30 24 Cl 7.9827 5.4749 0 0
M  V30 25 N 4.0446 13.741 0 0
M  V30 26 C 5.5118 14.0529 0 0
M  V30 27 C 5.9754 15.4795 0 0 CFG=1
M  V30 28 O 4.9717 16.5942 0 0
M  V30 29 C 7.4426 15.7913 0 0
M  V30 30 C 7.9061 17.2179 0 0
M  V30 31 C 9.3733 17.5298 0 0
M  V30 32 C 10.377 16.4151 0 0
M  V30 33 C 9.9135 14.9885 0 0
M  V30 34 C 8.4463 14.6766 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 2 5 7
M  V30 10 1 5 10
M  V30 11 2 6 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 2 8 14
M  V30 15 1 9 11
M  V30 16 1 10 15
M  V30 17 1 11 16
M  V30 18 2 13 17
M  V30 19 1 13 18
M  V30 20 2 15 19
M  V30 21 1 15 25
M  V30 22 1 16 20
M  V30 23 1 17 21
M  V30 24 2 18 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 26 27
M  V30 30 1 27 28 CFG=1
M  V30 31 1 27 29
M  V30 32 1 29 30
M  V30 33 2 29 34
M  V30 34 2 30 31
M  V30 35 1 31 32
M  V30 36 2 32 33
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 27) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
2prime_hydroxy_indomethacin_phenethylamide

> <ID>
2prime_hydroxy_indomethacin_phenethylamide

> <PRIMARY_SOM>
27 28

> <Citation>
Remmel et al.,Drug Metab. Disp.,32,113,2004

> <DOI>
10.1124/dmd.32.1.113

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
3-methylether-estradiol
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.0079 -5.3656 0 0
M  V30 2 O 2.3236 1.0245 0 0
M  V30 3 C 10.1178 -3.4755 0 0 CFG=2
M  V30 4 C 10.1178 -1.9755 0 0 CFG=2
M  V30 5 C 8.8188 -1.2255 0 0 CFG=1
M  V30 6 C 7.5197 -1.9755 0 0 CFG=2
M  V30 7 C 11.5444 -3.939 0 0 CFG=1
M  V30 8 C 8.8188 -4.2255 0 0
M  V30 9 C 11.5444 -1.5119 0 0
M  V30 10 C 7.5197 -3.4755 0 0
M  V30 11 C 12.4261 -2.7255 0 0
M  V30 12 C 8.8188 0.2745 0 0
M  V30 13 C 10.2746 -4.9672 0 0
M  V30 14 C 6.2207 -1.2255 0 0
M  V30 15 C 7.5197 1.0245 0 0
M  V30 16 C 6.2207 0.2745 0 0
M  V30 17 C 4.9216 -1.9755 0 0
M  V30 18 C 4.9216 1.0245 0 0
M  V30 19 C 3.6226 -1.2255 0 0
M  V30 20 C 3.6226 0.2745 0 0
M  V30 21 C 1.0245 0.2745 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 7 1 CFG=1
M  V30 2 1 2 20
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 1 3 7
M  V30 6 1 3 8
M  V30 7 1 3 13 CFG=1
M  V30 8 1 4 5
M  V30 9 1 4 9 CFG=3
M  V30 10 1 5 6
M  V30 11 1 5 12 CFG=1
M  V30 12 1 6 10 CFG=3
M  V30 13 1 6 14
M  V30 14 1 7 11
M  V30 15 1 8 10
M  V30 16 1 9 11
M  V30 17 1 12 15
M  V30 18 2 14 16
M  V30 19 1 14 17
M  V30 20 1 15 16
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 3 4 5 6 7) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
3-methylether-estradiol

> <ID>
3-methylether-estradiol

> <PRIMARY_SOM>
21

> <Citation>
D. M. Stresser, D. Kupfer, Biochem. Pharmacol. 1998, 55, 1861-1871.

> <DOI>
10.1016/S0006-2952(98)00060-4

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
4-chloromethyl-7-ethoxycoumarin
  SciTegic08102311032D

 16 17  0  0  0  0            999 V2000
   -3.3481    5.2500    0.0000 C   0  0
   -3.3481    6.7500    0.0000 C   0  0
   -4.6471    7.5000    0.0000 C   0  0
   -4.6471    9.0000    0.0000 O   0  0
   -5.9462    9.7500    0.0000 C   0  0
   -5.9462   11.2500    0.0000 C   0  0
   -5.9462    6.7500    0.0000 C   0  0
   -5.9462    5.2500    0.0000 C   0  0
   -4.6471    4.5000    0.0000 C   0  0
   -4.6471    3.0000    0.0000 C   0  0
   -5.9462    2.2500    0.0000 C   0  0
   -5.9462    0.7500    0.0000 Cl  0  0
   -3.3481    2.2500    0.0000 C   0  0
   -2.0490    3.0000    0.0000 C   0  0
   -0.7500    2.2500    0.0000 O   0  0
   -2.0490    4.5000    0.0000 O   0  0
  1  2  1  0
  1  9  2  0
  1 16  1  0
  2  3  2  0
  3  4  1  0
  3  7  1  0
  4  5  1  0
  5  6  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 13  2  0
 11 12  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
M  END
> <Name>
4-chloromethyl-7-ethoxycoumarin

> <ID>
4-chloromethyl-7-ethoxycoumarin

> <PRIMARY_SOM>
5

> <Citation>
Ekins et al.,J. Pharmacol. Exp. Ther.,286,1253,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
4-nitroanisole
  SciTegic08102311032D

 11 11  0  0  0  0            999 V2000
    4.1716    3.2745    0.0000 C   0  0
    4.1716    4.7745    0.0000 C   0  0
    2.8726    5.5245    0.0000 C   0  0
    1.5736    4.7745    0.0000 C   0  0
    1.5736    3.2745    0.0000 C   0  0
    0.2745    2.5245    0.0000 O   0  0
    0.2745    1.0245    0.0000 C   0  0
    2.8726    2.5245    0.0000 C   0  0
    5.4707    5.5245    0.0000 N   0  3
    5.4707    7.0245    0.0000 O   0  0
    6.7697    4.7745    0.0000 O   0  5
  1  2  1  0
  1  8  2  0
  2  3  2  0
  2  9  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  8  1  0
  6  7  1  0
  9 10  2  0
  9 11  1  0
M  CHG  2   9   1  11  -1
M  END
> <Name>
4-nitroanisole

> <ID>
4-nitroanisole

> <PRIMARY_SOM>
7

> <Citation>
B.C. Jones et al., Xenobiotica, 1997, 27, 1025-1037

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
5betacholestane-3_7_12_trihydroxy
  SciTegic08102311032D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 39 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.6399 -3.5444 0 0
M  V30 2 O 9.1168 3.5143 0 0
M  V30 3 O 1.9305 1.8439 0 0
M  V30 4 C 9.903 -1.6452 0 0 CFG=1
M  V30 5 C 9.903 -0.1452 0 0 CFG=2
M  V30 6 C 8.6039 0.6047 0 0 CFG=1
M  V30 7 C 7.3049 -0.1453 0 0 CFG=1
M  V30 8 C 6.0058 0.6046 0 0 CFG=2
M  V30 9 C 11.3296 -2.1087 0 0 CFG=2
M  V30 10 C 8.604 -2.3953 0 0 CFG=2
M  V30 11 C 7.305 -1.6453 0 0
M  V30 12 C 6.0057 2.1046 0 0 CFG=2
M  V30 13 C 11.3295 0.3184 0 0
M  V30 14 C 8.6038 2.1047 0 0 CFG=1
M  V30 15 C 12.2113 -0.8951 0 0
M  V30 16 C 7.3047 2.8547 0 0
M  V30 17 C 4.7068 -0.1455 0 0
M  V30 18 C 8.604 -0.8953 0 0
M  V30 19 C 12.6287 -2.8586 0 0 CFG=1
M  V30 20 C 4.7067 2.8545 0 0
M  V30 21 C 7.3048 1.3547 0 0
M  V30 22 C 3.4077 0.6045 0 0
M  V30 23 C 3.4077 2.1045 0 0 CFG=1
M  V30 24 C 13.9278 -3.6086 0 0
M  V30 25 C 11.8788 -4.1577 0 0
M  V30 26 C 15.2268 -2.8585 0 0
M  V30 27 C 16.5259 -3.6084 0 0
M  V30 28 C 17.8249 -2.8584 0 0
M  V30 29 C 19.124 -3.6083 0 0
M  V30 30 C 17.8248 -1.3584 0 0
M  V30 31 H 10.0597 1.3466 0 0
M  V30 32 H 9.9029 1.3548 0 0
M  V30 33 H 6.0059 -0.8954 0 0
M  V30 34 H 10.7196 -3.479 0 0
M  V30 35 H 9.5683 -3.5443 0 0
M  V30 36 H 6.0057 3.6046 0 0
M  V30 37 H 10.081 2.3653 0 0
M  V30 38 H 13.3787 -1.5595 0 0
M  V30 39 H 2.8946 3.514 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 14
M  V30 3 1 3 23
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 4 10
M  V30 7 1 4 18 CFG=3
M  V30 8 1 5 6
M  V30 9 1 5 13
M  V30 10 1 5 31 CFG=1
M  V30 11 1 6 7
M  V30 12 1 6 14
M  V30 13 1 6 32 CFG=3
M  V30 14 1 7 8
M  V30 15 1 7 11
M  V30 16 1 7 33 CFG=1
M  V30 17 1 8 12
M  V30 18 1 8 17
M  V30 19 1 8 21 CFG=3
M  V30 20 1 9 15
M  V30 21 1 9 19
M  V30 22 1 9 34 CFG=1
M  V30 23 1 10 11
M  V30 24 1 10 35 CFG=3
M  V30 25 1 12 16
M  V30 26 1 12 20
M  V30 27 1 12 36 CFG=3
M  V30 28 1 13 15
M  V30 29 1 14 16
M  V30 30 1 14 37 CFG=3
M  V30 31 1 17 22
M  V30 32 1 19 24
M  V30 33 1 19 25
M  V30 34 1 19 38 CFG=3
M  V30 35 1 20 23
M  V30 36 1 22 23
M  V30 37 1 23 39 CFG=3
M  V30 38 1 24 26
M  V30 39 1 26 27
M  V30 40 1 27 28
M  V30 41 1 28 29
M  V30 42 1 28 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 4 5 6 7 8 9 10 12 14 19 23) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
5betacholestane-3_7_12_trihydroxy

> <ID>
5betacholestane-3_7_12_trihydroxy

> <PRIMARY_SOM>
28

> <Citation>
Furster and Wikvall, Biochim. Biophys. Acta, 1999, 1437, 46-52

> <DOI>
10.1016/S0005-2760(98)00175-1

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
6-aminochrysene
  SciTegic08102311032D

 19 22  0  0  0  0            999 V2000
   -3.3484    5.9998    0.0000 C   0  0
   -3.3485    7.4998    0.0000 C   0  0
   -4.6474    5.2498    0.0000 C   0  0
   -2.0493    5.2499    0.0000 C   0  0
   -4.6473    3.7498    0.0000 C   0  0
   -4.6475    8.2498    0.0000 C   0  0
   -2.0495    8.2499    0.0000 C   0  0
   -3.3482    2.9998    0.0000 C   0  0
   -2.0492    3.7499    0.0000 C   0  0
   -0.7502    3.0000    0.0000 N   0  0
   -5.9465    5.9997    0.0000 C   0  0
   -5.9465    7.4997    0.0000 C   0  0
   -4.6476    9.7498    0.0000 C   0  0
   -2.0495    9.7499    0.0000 C   0  0
   -5.9463    2.9997    0.0000 C   0  0
   -3.3482    1.4998    0.0000 C   0  0
   -3.3486   10.4998    0.0000 C   0  0
   -5.9462    1.4997    0.0000 C   0  0
   -4.6472    0.7498    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  6  1  0
  2  7  1  0
  3  5  1  0
  3 11  2  0
  4  9  2  0
  5  8  2  0
  5 15  1  0
  6 12  2  0
  6 13  1  0
  7 14  2  0
  8  9  1  0
  8 16  1  0
  9 10  1  0
 11 12  1  0
 13 17  2  0
 14 17  1  0
 15 18  2  0
 16 19  2  0
 18 19  1  0
M  END
> <Name>
6-aminochrysene

> <ID>
6-aminochrysene

> <PRIMARY_SOM>
10

> <SECONDARY_SOM>
13 17

> <Citation>
Yamazaki et al.,Carcinogenesis,14,1271,1993
Koehl et al.,Cancer Res.,56,316,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
6_methylchrysene
  SciTegic08102311032D

 19 22  0  0  0  0            999 V2000
    3.5219    4.3997    0.0000 C   0  0
    3.5218    5.8997    0.0000 C   0  0
    2.2229    3.6496    0.0000 C   0  0
    4.8210    3.6498    0.0000 C   0  0
    4.8208    6.6498    0.0000 C   0  0
    2.2227    6.6496    0.0000 C   0  0
    0.9238    4.3996    0.0000 C   0  0
    2.2230    2.1496    0.0000 C   0  0
    6.1200    4.3998    0.0000 C   0  0
    6.1199    5.8998    0.0000 C   0  0
    4.8207    8.1498    0.0000 C   0  0
    0.9237    5.8996    0.0000 C   0  0
   -0.3753    6.6495    0.0000 C   0  0
   -0.3752    3.6495    0.0000 C   0  0
    0.9240    1.3996    0.0000 C   0  0
    7.4189    6.6499    0.0000 C   0  0
    6.1197    8.8998    0.0000 C   0  0
   -0.3751    2.1495    0.0000 C   0  0
    7.4188    8.1499    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  2  0
  5 11  1  0
  6 12  2  0
  7 12  1  0
  7 14  1  0
  8 15  2  0
  9 10  1  0
 10 16  1  0
 11 17  2  0
 12 13  1  0
 14 18  2  0
 15 18  1  0
 16 19  2  0
 17 19  1  0
M  END
> <Name>
6_methylchrysene

> <ID>
6_methylchrysene

> <PRIMARY_SOM>
13

> <SECONDARY_SOM>
16 18

> <TERTIARY_SOM>
14 11

> <Citation>
Koehl et al.,Cancer Res.,56,316,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
6-nitrochrysene
  SciTegic08102311032D

 21 24  0  0  0  0            999 V2000
    1.7860    2.0620    0.0000 C   0  0
    2.5010    1.6500    0.0000 C   0  0
    2.5010    0.8250    0.0000 C   0  0
    1.7860    0.4120    0.0000 C   0  0
    1.0720    0.8250    0.0000 C   0  0
    0.3570    0.4120    0.0000 C   0  0
    0.3570   -0.4120    0.0000 C   0  0
   -0.3570   -0.8250    0.0000 C   0  0
   -1.0720   -0.4120    0.0000 C   0  0
   -1.7860   -0.8250    0.0000 C   0  0
   -2.5010   -0.4120    0.0000 C   0  0
   -2.5010    0.4120    0.0000 C   0  0
   -1.7860    0.8250    0.0000 C   0  0
   -1.0720    0.4120    0.0000 C   0  0
   -0.3570    0.8250    0.0000 C   0  0
   -0.3570    1.6500    0.0000 C   0  0
    0.3570    2.0620    0.0000 C   0  0
    1.0720    1.6500    0.0000 C   0  0
   -0.3570   -1.6500    0.0000 N   0  3
    0.3570   -2.0620    0.0000 O   0  0
   -1.0720   -2.0620    0.0000 O   0  5
  1  2  1  0
  1 18  2  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 18  1  0
  6  7  1  0
  6 15  2  0
  7  8  2  0
  8  9  1  0
  8 19  1  0
  9 10  1  0
  9 14  2  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 19 20  2  0
 19 21  1  0
M  CHG  2  19   1  21  -1
M  END
> <Name>
6-nitrochrysene

> <ID>
6-nitrochrysene

> <PRIMARY_SOM>
1 2 19

> <Citation>
Chae, Y.H.; Yun, C.H.; Guengerich, F.P.; Kadlubar, F.F.; El-Bayoumy, K. Roles of Human Hepatic and Pulmonary Cytochrome P450 Enzymes in the Metabolism of the Environmental Carcinogen 6-Nitrochrysene. 
Cancer Res. 1993, 53, 20282034.

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
7-benzyloxy-4-trifluoromethylcoumarin
  SciTegic08102311042D

 20 21  0  0  0  0            999 V2000
   -3.3481    5.2500    0.0000 C   0  0
   -3.3481    6.7500    0.0000 C   0  0
   -4.6471    7.5000    0.0000 C   0  0
   -4.6471    9.0000    0.0000 O   0  0
   -5.9462    9.7500    0.0000 C   0  0
   -5.9462   11.2500    0.0000 C   0  0
   -7.2452   12.0000    0.0000 C   0  0
   -7.2452   13.5000    0.0000 C   0  0
   -5.9462    6.7500    0.0000 C   0  0
   -5.9462    5.2500    0.0000 C   0  0
   -4.6471    4.5000    0.0000 C   0  0
   -4.6471    3.0000    0.0000 C   0  0
   -5.9462    2.2500    0.0000 C   0  0
   -7.2452    3.0000    0.0000 F   0  0
   -5.9462    0.7500    0.0000 F   0  0
   -7.2452    1.5000    0.0000 F   0  0
   -3.3481    2.2500    0.0000 C   0  0
   -2.0490    3.0000    0.0000 C   0  0
   -0.7500    2.2500    0.0000 O   0  0
   -2.0490    4.5000    0.0000 O   0  0
  1  2  1  0
  1 11  2  0
  1 20  1  0
  2  3  2  0
  3  4  1  0
  3  9  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 17  2  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
M  END
> <Name>
7-benzyloxy-4-trifluoromethylcoumarin

> <ID>
7-benzyloxy-4-trifluoromethylcoumarin

> <PRIMARY_SOM>
5

> <Citation>
Donato et al.,Drug Metab. Disp.32,699,2004

> <DOI>
10.1124/dmd.32.7.699

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
7-benzyloxyquinoline
  SciTegic08102311042D

 18 20  0  0  0  0            999 V2000
    3.3481    1.5000    0.0000 C   0  0
    3.3481    3.0000    0.0000 C   0  0
    2.0490    0.7500    0.0000 C   0  0
    4.6471    0.7500    0.0000 C   0  0
    4.6471    3.7500    0.0000 C   0  0
    2.0490    3.7500    0.0000 N   0  0
    0.7500    1.5000    0.0000 C   0  0
    5.9462    1.5000    0.0000 C   0  0
    5.9462    3.0000    0.0000 C   0  0
    7.2452    3.7500    0.0000 O   0  0
    8.5442    3.0000    0.0000 C   0  0
    9.8433    3.7500    0.0000 C   0  0
    0.7500    3.0000    0.0000 C   0  0
   11.1423    3.0000    0.0000 C   0  0
   12.4413    3.7500    0.0000 C   0  0
   12.4413    5.2500    0.0000 C   0  0
   11.1423    6.0000    0.0000 C   0  0
    9.8433    5.2500    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  4  8  2  0
  5  9  2  0
  6 13  2  0
  7 13  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 14  1  0
 12 18  2  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
M  END
> <Name>
7-benzyloxyquinoline

> <ID>
7-benzyloxyquinoline

> <PRIMARY_SOM>
11

> <Citation>
Stresser et al.,Drug Metab. Disp.,30,845,2002

> <DOI>
10.1124/dmd.30.7.845

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
7-benzyloxyresorufin
  SciTegic08102311042D

 23 26  0  0  0  0            999 V2000
    0.3750    6.6495    0.0000 O   0  0
    2.9731   11.1495    0.0000 O   0  0
   -2.2231    2.1495    0.0000 O   0  0
   -2.2231    8.1495    0.0000 N   0  0
    0.3750    8.1495    0.0000 C   0  0
   -0.9241    8.8995    0.0000 C   0  0
   -0.9241    5.8995    0.0000 C   0  0
   -2.2231    6.6495    0.0000 C   0  0
    1.6740    8.8995    0.0000 C   0  0
    1.6740   10.3995    0.0000 C   0  0
   -0.9240   10.3995    0.0000 C   0  0
    0.3750   11.1495    0.0000 C   0  0
   -0.9241    4.3995    0.0000 C   0  0
   -3.5221    5.8995    0.0000 C   0  0
   -2.2231    3.6495    0.0000 C   0  0
   -3.5221    4.3995    0.0000 C   0  0
    2.9731   12.6495    0.0000 C   0  0
    4.2721   13.3995    0.0000 C   0  0
    4.2721   14.8995    0.0000 C   0  0
    5.5711   15.6495    0.0000 C   0  0
    6.8702   14.8995    0.0000 C   0  0
    6.8702   13.3995    0.0000 C   0  0
    5.5712   12.6495    0.0000 C   0  0
  1  5  1  0
  1  7  1  0
  2 10  1  0
  2 17  1  0
  3 15  2  0
  4  6  1  0
  4  8  2  0
  5  6  2  0
  5  9  1  0
  6 11  1  0
  7  8  1  0
  7 13  2  0
  8 14  1  0
  9 10  2  0
 10 12  1  0
 11 12  2  0
 13 15  1  0
 14 16  2  0
 15 16  1  0
 17 18  1  0
 18 19  1  0
 18 23  2  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
M  END
> <Name>
7-benzyloxyresorufin

> <ID>
7-benzyloxyresorufin

> <PRIMARY_SOM>
17

> <Citation>
Niwa et al.,Xenobiotica,33,717,2003

> <DOI>
10.1080/0049825031000121617

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
7-butoxycoumarin
  SciTegic08102311042D

 16 17  0  0  0  0            999 V2000
   -3.6226    3.2745    0.0000 C   0  0
   -3.6226    4.7745    0.0000 C   0  0
   -4.9217    5.5245    0.0000 C   0  0
   -4.9217    7.0245    0.0000 O   0  0
   -6.2207    7.7745    0.0000 C   0  0
   -6.2207    9.2745    0.0000 C   0  0
   -7.5197   10.0245    0.0000 C   0  0
   -7.5197   11.5245    0.0000 C   0  0
   -6.2207    4.7745    0.0000 C   0  0
   -6.2207    3.2745    0.0000 C   0  0
   -4.9217    2.5245    0.0000 C   0  0
   -4.9217    1.0245    0.0000 C   0  0
   -3.6226    0.2745    0.0000 C   0  0
   -2.3236    1.0245    0.0000 C   0  0
   -1.0245    0.2745    0.0000 O   0  0
   -2.3236    2.5245    0.0000 O   0  0
  1  2  1  0
  1 11  2  0
  1 16  1  0
  2  3  2  0
  3  4  1  0
  3  9  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
M  END
> <Name>
7-butoxycoumarin

> <ID>
7-butoxycoumarin

> <PRIMARY_SOM>
7

> <SECONDARY_SOM>
5

> <TERTIARY_SOM>
8

> <Citation>
Khan and Halpert,Arch. Biochem. Biophys.,373,335,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
7-ethoxycoumarin
  SciTegic08102311042D

 14 15  0  0  0  0            999 V2000
   -3.6226    3.2745    0.0000 C   0  0
   -3.6226    4.7745    0.0000 C   0  0
   -4.9217    5.5245    0.0000 C   0  0
   -4.9217    7.0245    0.0000 O   0  0
   -6.2207    7.7745    0.0000 C   0  0
   -6.2207    9.2745    0.0000 C   0  0
   -6.2207    4.7745    0.0000 C   0  0
   -6.2207    3.2745    0.0000 C   0  0
   -4.9217    2.5245    0.0000 C   0  0
   -4.9216    1.0245    0.0000 C   0  0
   -3.6226    0.2745    0.0000 C   0  0
   -2.3236    1.0245    0.0000 C   0  0
   -1.0245    0.2745    0.0000 O   0  0
   -2.3236    2.5245    0.0000 O   0  0
  1  2  1  0
  1  9  2  0
  1 14  1  0
  2  3  2  0
  3  4  1  0
  3  7  1  0
  4  5  1  0
  5  6  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
M  END
> <Name>
7-ethoxycoumarin

> <ID>
7-ethoxycoumarin

> <PRIMARY_SOM>
5

> <Citation>
T. Shimada, F. Tsumura, H. Yamazaki, Drug Metab. Dispos. 1999, 27, 1274-1280.

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
7-hexoxycoumarin
  SciTegic08102311042D

 18 19  0  0  0  0            999 V2000
   -3.6228    3.2743    0.0000 C   0  0
   -3.6229    4.7743    0.0000 C   0  0
   -4.9219    5.5243    0.0000 C   0  0
   -4.9220    7.0243    0.0000 O   0  0
   -6.2211    7.7742    0.0000 C   0  0
   -6.2212    9.2742    0.0000 C   0  0
   -7.5202   10.0241    0.0000 C   0  0
   -7.5203   11.5241    0.0000 C   0  0
   -8.8194   12.2741    0.0000 C   0  0
   -8.8195   13.7741    0.0000 C   0  0
   -6.2209    4.7742    0.0000 C   0  0
   -6.2209    3.2742    0.0000 C   0  0
   -4.9218    2.5243    0.0000 C   0  0
   -4.9217    1.0243    0.0000 C   0  0
   -3.6226    0.2743    0.0000 C   0  0
   -2.3236    1.0244    0.0000 C   0  0
   -1.0246    0.2745    0.0000 O   0  0
   -2.3237    2.5244    0.0000 O   0  0
  1  2  1  0
  1 13  2  0
  1 18  1  0
  2  3  2  0
  3  4  1  0
  3 11  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
M  END
> <Name>
7-hexoxycoumarin

> <ID>
7-hexoxycoumarin

> <PRIMARY_SOM>
8 9

> <SECONDARY_SOM>
7

> <TERTIARY_SOM>
5

> <Citation>
Khan and Halpert,Arch. Biochem. Biophys.,373,335,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
7-hydroxy-delta_8_tetrahydrocannabinol
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -0.2745 -7.0245 0 0
M  V30 2 C -0.2745 -5.5245 0 0 CFG=1
M  V30 3 C -1.5736 -4.7745 0 0 CFG=2
M  V30 4 C -2.8726 -5.5245 0 0
M  V30 5 C -4.1716 -4.7745 0 0
M  V30 6 C -5.4707 -5.5245 0 0
M  V30 7 C -5.4707 -7.0245 0 0
M  V30 8 C -4.1716 -7.7745 0 0
M  V30 9 C -2.8726 -7.0245 0 0
M  V30 10 O -1.5735 -7.7745 0 0
M  V30 11 C -1.5736 -3.2745 0 0
M  V30 12 C -0.2745 -2.5245 0 0
M  V30 13 C 1.0245 -3.2745 0 0
M  V30 14 C 1.0245 -4.7745 0 0 CFG=2
M  V30 15 O -4.1716 -3.2745 0 0
M  V30 16 C -6.7697 -7.7745 0 0
M  V30 17 C -6.7697 -9.2745 0 0
M  V30 18 C -8.0687 -10.0245 0 0
M  V30 19 C -8.0687 -11.5245 0 0
M  V30 20 C -9.3678 -12.2745 0 0
M  V30 21 C -0.2745 -1.0245 0 0
M  V30 22 C 1.2027 -6.7641 0 0
M  V30 23 C 0.2385 -8.4341 0 0
M  V30 24 O 2.3236 -5.5245 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=1
M  V30 2 1 1 10
M  V30 3 1 1 22
M  V30 4 1 1 23
M  V30 5 1 2 3
M  V30 6 1 2 14
M  V30 7 1 3 4
M  V30 8 1 3 11 CFG=3
M  V30 9 1 4 5
M  V30 10 2 4 9
M  V30 11 2 5 6
M  V30 12 1 5 15
M  V30 13 1 6 7
M  V30 14 2 7 8
M  V30 15 1 7 16
M  V30 16 1 8 9
M  V30 17 1 9 10
M  V30 18 1 11 12
M  V30 19 2 12 13
M  V30 20 1 12 21
M  V30 21 1 13 14
M  V30 22 1 14 24 CFG=3
M  V30 23 1 16 17
M  V30 24 1 17 18
M  V30 25 1 18 19
M  V30 26 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 3 14) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
7-hydroxy-delta_8_tetrahydrocannabinol

> <ID>
7-hydroxy-delta_8_tetrahydrocannabinol

> <PRIMARY_SOM>
14

> <Citation>
Matsunaga, T.; Kishi, N.; Higuchi, S.; Watanabe, K.; Ohshima, T.; Yamamoto, I. CYP3A4 is a Major Isoform Responsible for Oxidation of 7-Hydroxy-Delta(8)-Tetrahydrocannabinol to 7-Oxo-Delta(8)-Tetrahyd
rocannabinol in Human Liver Microsomes. Drug Metab. Dispos. 2000, 28, 12911296.

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
7-pentoxycoumarin
  SciTegic08102311042D

 17 18  0  0  0  0            999 V2000
   -3.6226    3.2745    0.0000 C   0  0
   -3.6226    4.7745    0.0000 C   0  0
   -4.9217    5.5245    0.0000 C   0  0
   -4.9217    7.0245    0.0000 O   0  0
   -6.2207    7.7745    0.0000 C   0  0
   -6.2207    9.2745    0.0000 C   0  0
   -7.5197   10.0245    0.0000 C   0  0
   -7.5197   11.5245    0.0000 C   0  0
   -8.8188   12.2745    0.0000 C   0  0
   -6.2207    4.7745    0.0000 C   0  0
   -6.2207    3.2745    0.0000 C   0  0
   -4.9217    2.5245    0.0000 C   0  0
   -4.9217    1.0245    0.0000 C   0  0
   -3.6226    0.2745    0.0000 C   0  0
   -2.3236    1.0245    0.0000 C   0  0
   -1.0245    0.2745    0.0000 O   0  0
   -2.3236    2.5245    0.0000 O   0  0
  1  2  1  0
  1 12  2  0
  1 17  1  0
  2  3  2  0
  3  4  1  0
  3 10  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
M  END
> <Name>
7-pentoxycoumarin

> <ID>
7-pentoxycoumarin

> <PRIMARY_SOM>
7 8

> <SECONDARY_SOM>
5

> <Citation>
Khan and Halpert,Arch. Biochem. Biophys.,373,335,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
7-pentoxyresorufin
  SciTegic08102311042D

 21 23  0  0  0  0            999 V2000
    2.3235    5.5245    0.0000 O   0  0
    4.9216   10.0245    0.0000 O   0  0
   -0.2745    1.0245    0.0000 O   0  0
   -0.2745    7.0245    0.0000 N   0  0
    2.3235    7.0245    0.0000 C   0  0
    1.0245    7.7745    0.0000 C   0  0
    1.0245    4.7745    0.0000 C   0  0
   -0.2745    5.5245    0.0000 C   0  0
    3.6226    7.7745    0.0000 C   0  0
    3.6226    9.2745    0.0000 C   0  0
    1.0245    9.2745    0.0000 C   0  0
    2.3236   10.0245    0.0000 C   0  0
    1.0245    3.2745    0.0000 C   0  0
   -1.5736    4.7745    0.0000 C   0  0
   -0.2745    2.5245    0.0000 C   0  0
   -1.5736    3.2745    0.0000 C   0  0
    4.9216   11.5245    0.0000 C   0  0
    6.2207   12.2745    0.0000 C   0  0
    6.2207   13.7745    0.0000 C   0  0
    7.5197   14.5245    0.0000 C   0  0
    7.5197   16.0245    0.0000 C   0  0
  1  5  1  0
  1  7  1  0
  2 10  1  0
  2 17  1  0
  3 15  2  0
  4  6  1  0
  4  8  2  0
  5  6  2  0
  5  9  1  0
  6 11  1  0
  7  8  1  0
  7 13  2  0
  8 14  1  0
  9 10  2  0
 10 12  1  0
 11 12  2  0
 13 15  1  0
 14 16  2  0
 15 16  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
M  END
> <Name>
7-pentoxyresorufin

> <ID>
7-pentoxyresorufin

> <PRIMARY_SOM>
17

> <Citation>
Qwihee P. Lee, Alan G. Fantel and Mont R. Juchau Biochemical Pharmacology Volume 42, Issue 12, 27 November 1991, Pages 2377-2385

> <DOI>
10.1016/0006-2952(91)90244-Y

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
7MBAC
  SciTegic08102311042D

 19 22  0  0  0  0            999 V2000
    1.0720   -1.0310    0.0000 C   0  0
    1.7860   -0.6190    0.0000 C   0  0
    1.7860    0.2060    0.0000 C   0  0
    1.0720    0.6190    0.0000 C   0  0
    0.3570    0.2060    0.0000 C   0  0
   -0.3570    0.6190    0.0000 N   0  0
   -1.0720    0.2060    0.0000 C   0  0
   -1.7860    0.6190    0.0000 C   0  0
   -2.5010    0.2060    0.0000 C   0  0
   -2.5010   -0.6190    0.0000 C   0  0
   -1.7860   -1.0310    0.0000 C   0  0
   -1.0720   -0.6190    0.0000 C   0  0
   -0.3570   -1.0310    0.0000 C   0  0
    0.3570   -0.6190    0.0000 C   0  0
    1.0720    1.4440    0.0000 C   0  0
    1.7860    1.8560    0.0000 C   0  0
    2.5010    1.4440    0.0000 C   0  0
    2.5010    0.6190    0.0000 C   0  0
   -0.3570   -1.8560    0.0000 C   0  0
  1  2  2  0
  1 14  1  0
  2  3  1  0
  3  4  1  0
  3 18  2  0
  4  5  1  0
  4 15  2  0
  5  6  1  0
  5 14  2  0
  6  7  2  0
  7  8  1  0
  7 12  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 19  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
M  END
> <Name>
7MBAC

> <ID>
7MBAC

> <PRIMARY_SOM>
10 11

> <SECONDARY_SOM>
1 2 19

> <TERTIARY_SOM>
17 18

> <Citation>
Roberts-Thompson, S.J.; McManus, M.E.; Tukey, R.H.; Gonzales, F.J.; Holder, G.M.
Metabolism of Polycyclic Aza-aromatic Carcinogens Catalyzed by Four Expressed Human
Cytochromes P450. Cancer Res. 1995, 55, 10521059.

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
9_cis_retinal
  SciTegic08102311042D

 21 21  0  0  0  0            999 V2000
   -2.3236    5.5245    0.0000 O   0  0
    9.3678   10.7745    0.0000 C   0  0
    9.3678   12.2745    0.0000 C   0  0
    8.0688   13.0245    0.0000 C   0  0
    8.0688   10.0245    0.0000 C   0  0
    6.7697   12.2745    0.0000 C   0  0
    6.7697   10.7745    0.0000 C   0  0
    9.8808    9.3650    0.0000 C   0  0
   10.8450   11.0350    0.0000 C   0  0
    8.0688    8.5245    0.0000 C   0  0
    5.4707   10.0245    0.0000 C   0  0
    6.7697    7.7745    0.0000 C   0  0
    6.7697    6.2745    0.0000 C   0  0
    8.0688    5.5245    0.0000 C   0  0
    5.4707    5.5245    0.0000 C   0  0
    4.1716    6.2745    0.0000 C   0  0
    2.8726    5.5245    0.0000 C   0  0
    1.5736    6.2745    0.0000 C   0  0
    1.5736    7.7745    0.0000 C   0  0
    0.2745    5.5245    0.0000 C   0  0
   -1.0245    6.2745    0.0000 C   0  0
  1 21  2  0
  2  3  1  0
  2  5  1  0
  2  8  1  0
  2  9  1  0
  3  4  1  0
  4  6  1  0
  5  7  2  0
  5 10  1  0
  6  7  1  0
  7 11  1  0
 10 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 21  1  0
M  END
> <Name>
9_cis_retinal

> <ID>
9_cis_retinal

> <PRIMARY_SOM>
21

> <Citation>
Zhang et al.,Drug Metab. Dispos.,28,292,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
11_oxo_delta8_tetrahydrocannabinol
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -3.3481 5.25 0 0 CFG=2
M  V30 2 C -3.3481 6.75 0 0
M  V30 3 C -4.6471 4.5 0 0 CFG=1
M  V30 4 C -2.049 4.5 0 0
M  V30 5 C -4.6471 7.5 0 0
M  V30 6 C -2.049 7.5 0 0
M  V30 7 C -5.9462 5.25 0 0
M  V30 8 C -4.6471 3 0 0
M  V30 9 C -2.049 3 0 0
M  V30 10 O -5.9462 6.75 0 0
M  V30 11 C -4.6471 9 0 0
M  V30 12 C -2.049 9 0 0
M  V30 13 O -0.75 6.75 0 0
M  V30 14 C -6.4592 3.8405 0 0
M  V30 15 C -7.4234 5.5105 0 0
M  V30 16 C -3.3481 2.25 0 0
M  V30 17 C -0.75 2.25 0 0
M  V30 18 C -3.3481 9.75 0 0
M  V30 19 C -3.3481 11.25 0 0
M  V30 20 C -2.049 12 0 0
M  V30 21 C -2.049 13.5 0 0
M  V30 22 C -0.75 14.25 0 0
M  V30 23 C -0.75 15.75 0 0
M  V30 24 O -0.75 0.75 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=3
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 2 6 12
M  V30 12 1 6 13
M  V30 13 1 7 10
M  V30 14 1 7 14
M  V30 15 1 7 15
M  V30 16 1 8 16
M  V30 17 2 9 16
M  V30 18 1 9 17
M  V30 19 2 11 18
M  V30 20 1 12 18
M  V30 21 2 17 24
M  V30 22 1 18 19
M  V30 23 1 19 20
M  V30 24 1 20 21
M  V30 25 1 21 22
M  V30 26 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 3) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
11_oxo_delta8_tetrahydrocannabinol

> <ID>
11_oxo_delta8_tetrahydrocannabinol

> <PRIMARY_SOM>
17

> <Citation>
Watanabe eta al.,Drug Metab. Pharmacokin.,17,516,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
BDB
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8153 0.3187 0 0
M  V30 2 O 1.7135 -0.8948 0 0
M  V30 3 N 5.4263 -6.3985 0 0
M  V30 4 C 6.7253 -5.6485 0 0 CFG=2
M  V30 5 C 6.7253 -4.1485 0 0
M  V30 6 C 8.0243 -6.3985 0 0
M  V30 7 C 5.4263 -3.3985 0 0
M  V30 8 C 5.4263 -1.8985 0 0
M  V30 9 C 8.0243 -7.8985 0 0
M  V30 10 C 4.1272 -4.1485 0 0
M  V30 11 C 4.1272 -1.1485 0 0
M  V30 12 C 2.8282 -1.8985 0 0
M  V30 13 C 2.8282 -3.3985 0 0
M  V30 14 C 2.3236 0.4755 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 14
M  V30 3 1 2 12
M  V30 4 1 2 14
M  V30 5 1 4 3 CFG=3
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 9
M  V30 10 2 7 8
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 2 10 13
M  V30 14 2 11 12
M  V30 15 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
BDB

> <ID>
BDB

> <PRIMARY_SOM>
14

> <Citation>
Maurer et al.,Toxicol. Lett.,112'96113,133,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
CP_122_721
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -9.3493 -7.5 0 0
M  V30 2 C -9.3493 -6 0 0
M  V30 3 C -10.6483 -5.25 0 0
M  V30 4 C -10.6483 -3.75 0 0 CFG=1
M  V30 5 C -11.9473 -6 0 0
M  V30 6 C -11.9473 -7.5 0 0
M  V30 7 C -10.6483 -8.25 0 0
M  V30 8 C -9.3493 -3 0 0 CFG=2
M  V30 9 N -8.0502 -3.75 0 0
M  V30 10 C -8.0502 -5.25 0 0
M  V30 11 C -6.7512 -6 0 0
M  V30 12 C -9.3493 -1.5 0 0
M  V30 13 C -10.6483 -0.75 0 0
M  V30 14 C -11.9473 -1.5 0 0
M  V30 15 N -11.9473 -3 0 0
M  V30 16 C -6.7512 -7.5 0 0
M  V30 17 O -8.0502 -8.25 0 0
M  V30 18 C -8.0502 -9.75 0 0
M  V30 19 C -5.4521 -8.25 0 0
M  V30 20 C -4.1531 -7.5 0 0
M  V30 21 C -4.1531 -6 0 0
M  V30 22 O -2.8541 -5.25 0 0
M  V30 23 C -2.8541 -3.75 0 0
M  V30 24 F -1.555 -3 0 0
M  V30 25 F -4.1531 -3 0 0
M  V30 26 F -2.8541 -2.25 0 0
M  V30 27 C -5.4521 -5.25 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 7
M  V30 3 2 2 3
M  V30 4 1 4 3 CFG=3
M  V30 5 1 3 5
M  V30 6 1 4 8
M  V30 7 1 4 15
M  V30 8 2 5 6
M  V30 9 1 6 7
M  V30 10 1 8 9 CFG=1
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 11 16
M  V30 15 2 11 27
M  V30 16 1 12 13
M  V30 17 1 13 14
M  V30 18 1 14 15
M  V30 19 1 16 17
M  V30 20 2 16 19
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 2 20 21
M  V30 24 1 21 22
M  V30 25 1 21 27
M  V30 26 1 22 23
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 23 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 8) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
CP_122_721

> <ID>
CP_122_721

> <PRIMARY_SOM>
8

> <Citation>
Obach et al.,Drug Metab. Pharma.,22,336,2007

> <DOI>
10.2133/dmpk.22.336

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
CP_677_623
  SciTegic08102311042D

 15 15  0  0  0  0            999 V2000
    1.6740    4.3995    0.0000 N   0  0
    1.6740    5.8995    0.0000 C   0  0
    0.3750    6.6495    0.0000 C   0  0
    0.3750    8.1495    0.0000 C   0  0
    1.6740    8.8995    0.0000 O   0  0
    1.6740   10.3995    0.0000 C   0  0
   -0.9240    8.8995    0.0000 C   0  0
   -2.2231    8.1495    0.0000 C   0  0
   -2.2231    6.6495    0.0000 C   0  0
   -3.5221    5.8995    0.0000 O   0  0
   -3.5221    4.3995    0.0000 C   0  0
   -4.8212    3.6495    0.0000 F   0  0
   -2.2231    3.6495    0.0000 F   0  0
   -3.5221    2.8995    0.0000 F   0  0
   -0.9240    5.8995    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3 15  2  0
  4  5  1  0
  4  7  2  0
  5  6  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 15  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 11 14  1  0
M  END
> <Name>
CP_677_623

> <ID>
CP_677_623

> <PRIMARY_SOM>
6

> <Citation>
Obach et al.,Drug Metab. Pharma.,22,336,2007

> <DOI>
10.2133/dmpk.22.336

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
CP_125_611
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -8.5442 -7.5 0 0
M  V30 2 C -8.5442 -6 0 0
M  V30 3 C -9.8433 -5.25 0 0
M  V30 4 C -9.8433 -3.75 0 0 CFG=1
M  V30 5 C -11.1423 -6 0 0
M  V30 6 C -11.1423 -7.5 0 0
M  V30 7 C -9.8433 -8.25 0 0
M  V30 8 C -8.5442 -3 0 0 CFG=2
M  V30 9 N -7.2452 -3.75 0 0
M  V30 10 C -7.2452 -5.25 0 0
M  V30 11 C -5.9462 -6 0 0
M  V30 12 C -8.5442 -1.5 0 0
M  V30 13 C -9.8433 -0.75 0 0
M  V30 14 C -11.1423 -1.5 0 0
M  V30 15 N -11.1423 -3 0 0
M  V30 16 C -5.9461 -7.5 0 0
M  V30 17 O -7.2452 -8.25 0 0
M  V30 18 C -4.6471 -8.25 0 0
M  V30 19 C -3.3481 -7.5 0 0
M  V30 20 C -3.3481 -6 0 0
M  V30 21 O -2.049 -5.25 0 0
M  V30 22 C -2.049 -3.75 0 0
M  V30 23 F -0.75 -3 0 0
M  V30 24 F -3.3481 -3 0 0
M  V30 25 F -2.049 -2.25 0 0
M  V30 26 C -4.6471 -5.25 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 7
M  V30 3 2 2 3
M  V30 4 1 4 3 CFG=3
M  V30 5 1 3 5
M  V30 6 1 4 8
M  V30 7 1 4 15
M  V30 8 2 5 6
M  V30 9 1 6 7
M  V30 10 1 8 9 CFG=1
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 11 16
M  V30 15 2 11 26
M  V30 16 1 12 13
M  V30 17 1 13 14
M  V30 18 1 14 15
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 1 18 19
M  V30 22 2 19 20
M  V30 23 1 20 21
M  V30 24 1 20 26
M  V30 25 1 21 22
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 22 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 8) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
CP_125_611

> <ID>
CP_125_611

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
17

> <Citation>
Obach et al.,Drug Metab. Pharma.,22,336,2007

> <DOI>
10.2133/dmpk.22.336

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
DBAJAC
  SciTegic08102311042D

 22 26  0  0  0  0            999 V2000
    1.4290    0.2060    0.0000 C   0  0
    2.1430   -0.2060    0.0000 C   0  0
    2.1430   -1.0310    0.0000 C   0  0
    1.4290   -1.4440    0.0000 C   0  0
    0.7140   -1.0310    0.0000 C   0  0
    0.0000   -1.4440    0.0000 N   0  0
   -0.7140   -1.0310    0.0000 C   0  0
   -1.4290   -1.4440    0.0000 C   0  0
   -2.1430   -1.0310    0.0000 C   0  0
   -2.1430   -0.2060    0.0000 C   0  0
   -1.4290    0.2060    0.0000 C   0  0
   -0.7140   -0.2060    0.0000 C   0  0
    0.0000    0.2060    0.0000 C   0  0
    0.7140   -0.2060    0.0000 C   0  0
    2.8580    0.2060    0.0000 C   0  0
    2.8580    1.0310    0.0000 C   0  0
    2.1430    1.4440    0.0000 C   0  0
    1.4290    1.0310    0.0000 C   0  0
   -1.4290    1.0310    0.0000 C   0  0
   -2.1430    1.4440    0.0000 C   0  0
   -2.8580    1.0310    0.0000 C   0  0
   -2.8580    0.2060    0.0000 C   0  0
  1  2  1  0
  1 14  1  0
  1 18  2  0
  2  3  1  0
  2 15  2  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5 14  2  0
  6  7  2  0
  7  8  1  0
  7 12  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 22  2  0
 11 12  1  0
 11 19  2  0
 12 13  2  0
 13 14  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
M  END
> <Name>
DBAJAC

> <ID>
DBAJAC

> <PRIMARY_SOM>
15 16 21 22

> <SECONDARY_SOM>
3 4 8 9

> <TERTIARY_SOM>
17 18 19 20

> <Citation>
Roberts-Thompson, S.J.; McManus, M.E.; Tukey, R.H.; Gonzales, F.J.; Holder, G.M.
Metabolism of Polycyclic Aza-aromatic Carcinogens Catalyzed by Four Expressed Human
Cytochromes P450. Cancer Res. 1995, 55, 10521059.

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
DDTC_Me
  SciTegic08102311042D

  9  8  0  0  0  0            999 V2000
    1.5803    3.2713    0.0000 N   0  0
    0.2828    4.0239    0.0000 C   0  0
    1.5772    1.7713    0.0000 C   0  0
    0.2766    1.0240    0.0000 C   0  0
   -1.0178    3.2766    0.0000 C   0  0
    2.8808    4.0186    0.0000 C   0  0
    2.8839    5.5186    0.0000 S   0  0
    4.1783    3.2660    0.0000 S   0  0
    5.4789    4.0133    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  6  1  0
  2  5  1  0
  3  4  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
M  END
> <Name>
DDTC_Me

> <ID>
DDTC_Me

> <PRIMARY_SOM>
6 7

> <SECONDARY_SOM>
8

> <Citation>
Madan et al.,Alcohol. Clin. Exp. Res.,22,1212,1998

> <DOI>
10.111/j.1530-0277.1998.tb03901.x

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
DMBA
  SciTegic08102311042D

 20 23  0  0  0  0            999 V2000
    1.0720    0.6190    0.0000 C   0  0
    1.7860    0.2060    0.0000 C   0  0
    1.7860   -0.6190    0.0000 C   0  0
    1.0720   -1.0310    0.0000 C   0  0
    0.3570   -0.6190    0.0000 C   0  0
   -0.3570   -1.0310    0.0000 C   0  0
   -1.0720   -0.6190    0.0000 C   0  0
   -1.7860   -1.0310    0.0000 C   0  0
   -2.5010   -0.6190    0.0000 C   0  0
   -2.5010    0.2060    0.0000 C   0  0
   -1.7860    0.6190    0.0000 C   0  0
   -1.0720    0.2060    0.0000 C   0  0
   -0.3570    0.6190    0.0000 C   0  0
    0.3570    0.2060    0.0000 C   0  0
    2.5010    0.6190    0.0000 C   0  0
    2.5010    1.4440    0.0000 C   0  0
    1.7860    1.8560    0.0000 C   0  0
    1.0720    1.4440    0.0000 C   0  0
   -0.3570    1.4440    0.0000 C   0  0
   -0.3570   -1.8560    0.0000 C   0  0
  1  2  1  0
  1 14  1  0
  1 18  2  0
  2  3  1  0
  2 15  2  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5 14  2  0
  6  7  2  0
  6 20  1  0
  7  8  1  0
  7 12  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 19  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
M  END
> <Name>
DMBA

> <ID>
DMBA

> <PRIMARY_SOM>
19 20

> <SECONDARY_SOM>
3 4 8 9

> <TERTIARY_SOM>
15 16 17

> <Citation>
Shou, M.; Korzekwa, K.R.; Krausz, K.W.; Buters, J.T.; Grogan, J.; Goldfarb, I.; Ardwick, J.P.H.; Gonzalez, F.J.; Gelboin, H.V. Specificity of cDNA-Expressed Human and Rodent Cytochrome P450s in the Ox
idative Metabolism of the Potent Carcinogen 7,12-Dimethylbenz[a]anthracene. Mol. Carcinog. 1996, 17, 241249.

> <DOI>
10.1002/(SICI)1098-2744(199612)17:4<241::AID-MC8>3.0.CO;2-G

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
E3179
  SciTegic08102311042D

 30 33  0  0  0  0            999 V2000
    2.2231    2.1495    0.0000 C   0  0
    2.2231    3.6495    0.0000 C   0  0
    0.9240    4.3995    0.0000 C   0  0
   -0.3750    3.6495    0.0000 C   0  0
   -0.3750    2.1495    0.0000 C   0  0
    0.9240    1.3995    0.0000 C   0  0
    3.5221    4.3995    0.0000 C   0  0
    4.8212    3.6495    0.0000 C   0  0
    6.1202    4.3995    0.0000 C   0  0
    6.1202    5.8995    0.0000 C   0  0
    4.8212    6.6495    0.0000 C   0  0
    3.5221    5.8995    0.0000 C   0  0
    0.9240    5.8995    0.0000 C   0  0
    2.1376    6.7812    0.0000 N   0  0
    1.6740    8.2078    0.0000 N   0  0
    0.1740    8.2078    0.0000 N   0  0
   -0.2895    6.7812    0.0000 N   0  0
    7.4192    6.6495    0.0000 C   0  0
    7.4192    8.1495    0.0000 N   0  0
    8.6328    9.0312    0.0000 C   0  0
    8.1692   10.4578    0.0000 C   0  0
    6.6692   10.4578    0.0000 N   0  0
    6.2057    9.0312    0.0000 C   0  0
    4.7791    8.5677    0.0000 C   0  0
    3.6644    9.5714    0.0000 C   0  0
    2.2378    9.1079    0.0000 C   0  0
    1.1231   10.1116    0.0000 C   0  0
    9.0509   11.6713    0.0000 Cl  0  0
   10.0593    8.5677    0.0000 C   0  0
   11.1741    9.5714    0.0000 O   0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  2  7  1  0
  3  4  1  0
  3 13  1  0
  4  5  2  0
  5  6  1  0
  7  8  1  0
  7 12  2  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 18  1  0
 11 12  1  0
 13 14  2  0
 13 17  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 18 19  1  0
 19 20  1  0
 19 23  1  0
 20 21  2  0
 20 29  1  0
 21 22  1  0
 21 28  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 29 30  2  0
M  END
> <Name>
E3179

> <ID>
E3179

> <PRIMARY_SOM>
29

> <SECONDARY_SOM>
24

> <Citation>
Stearns et al.,Drug Metab. Disp.,23,207,1995

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
GTS-21
  SciTegic08102311042D

 23 25  0  0  0  0            999 V2000
    6.2207   -1.2252    0.0000 O   0  0
    3.6224    3.2747    0.0000 O   0  0
   12.7158    1.0252    0.0000 N   0  0
   12.7160   -3.4748    0.0000 N   0  0
   10.1177    2.5250    0.0000 C   0  0
   11.4167    3.2751    0.0000 C   0  0
   10.1177    1.0250    0.0000 C   0  0
   12.7157    2.5252    0.0000 C   0  0
   11.4168    0.2751    0.0000 C   0  0
    8.8187    0.2750    0.0000 C   0  0
   11.4169   -1.2249    0.0000 C   0  0
    7.5197    1.0249    0.0000 C   0  0
    6.2207    0.2748    0.0000 C   0  0
    7.5196    2.5249    0.0000 C   0  0
   10.1179   -1.9750    0.0000 C   0  0
   12.7160   -1.9748    0.0000 C   0  0
    4.9216    1.0248    0.0000 C   0  0
    6.2205    3.2748    0.0000 C   0  0
    4.9215    2.5248    0.0000 C   0  0
   10.1180   -3.4750    0.0000 C   0  0
   11.4170   -4.2249    0.0000 C   0  0
    4.9217   -1.9752    0.0000 C   0  0
    3.6223    4.7747    0.0000 C   0  0
  1 13  1  0
  1 22  1  0
  2 19  1  0
  2 23  1  0
  3  8  1  0
  3  9  2  0
  4 16  2  0
  4 21  1  0
  5  6  1  0
  5  7  1  0
  6  8  1  0
  7  9  1  0
  7 10  2  0
  9 11  1  0
 10 12  1  0
 11 15  2  0
 11 16  1  0
 12 13  2  0
 12 14  1  0
 13 17  1  0
 14 18  2  0
 15 20  1  0
 17 19  2  0
 18 19  1  0
 20 21  2  0
M  END
> <Name>
GTS-21

> <ID>
GTS-21

> <PRIMARY_SOM>
23

> <SECONDARY_SOM>
22

> <Citation>
R. Azuma, M. Komuro, B. H. Korsch, J. C. Andre, O. Onnagawa, S. R. Black, J. M. Mathews, Xenobiotica 1999, 29, 747-762.

> <DOI>
10.1080/004982599238362

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
L_775606
  SciTegic08102311042D

 32 36  0  0  0  0            999 V2000
   -3.2171    3.1749    0.0000 C   0  0
   -2.2172    2.0567    0.0000 N   0  0
   -2.9717    0.7602    0.0000 N   0  0
   -4.4378    1.0772    0.0000 C   0  0
   -4.5895    2.5695    0.0000 N   0  0
   -5.8859    3.3240    0.0000 C   0  0
   -5.8808    4.8240    0.0000 C   0  0
   -7.1772    5.5784    0.0000 C   0  0
   -8.4788    4.8329    0.0000 C   0  0
   -8.4840    3.3329    0.0000 C   0  0
   -7.1875    2.5784    0.0000 C   0  0
   -9.5901    5.8404    0.0000 N   0  0
   -8.9752    7.2087    0.0000 C   0  0
   -7.4840    7.0467    0.0000 C   0  0
   -9.7208    8.5103    0.0000 C   0  0
   -8.9663    9.8067    0.0000 C   0  0
   -9.7118   11.1083    0.0000 C   0  0
   -8.9573   12.4048    0.0000 N   0  0
   -9.7028   13.7064    0.0000 C   0  0
   -8.9483   15.0028    0.0000 C   0  0
   -7.4484   14.9977    0.0000 N   0  0
   -6.6939   16.2941    0.0000 C   0  0
   -5.1939   16.2889    0.0000 C   0  0
   -4.4394   17.5854    0.0000 C   0  0
   -2.9394   17.5802    0.0000 C   0  0
   -2.1850   18.8767    0.0000 C   0  0
   -0.6850   18.8715    0.0000 F   0  0
   -2.9305   20.1783    0.0000 C   0  0
   -4.4305   20.1834    0.0000 C   0  0
   -5.1849   18.8870    0.0000 C   0  0
   -6.7028   13.6960    0.0000 C   0  0
   -7.4573   12.3996    0.0000 C   0  0
  1  2  2  0
  1  5  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6 11  2  0
  7  8  2  0
  8  9  1  0
  8 14  1  0
  9 10  2  0
  9 12  1  0
 10 11  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 32  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 31  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 30  2  0
 25 26  2  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 29 30  1  0
 31 32  1  0
M  END
> <Name>
L_775606

> <ID>
L_775606

> <PRIMARY_SOM>
23

> <SECONDARY_SOM>
22

> <Citation>
Prueksaritanont et al., Xenobiotica, 2000, 30, 47-59

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
KR_31543
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -2.4753 9.82 0 0
M  V30 2 C -2.4753 11.32 0 0
M  V30 3 C -3.7744 12.07 0 0
M  V30 4 N -3.7744 13.57 0 0
M  V30 5 C -5.0734 11.32 0 0
M  V30 6 C -5.0734 9.82 0 0
M  V30 7 C -3.7744 9.07 0 0
M  V30 8 O -3.7744 7.57 0 0
M  V30 9 C -2.4753 6.82 0 0 CFG=2
M  V30 10 C -1.5111 5.6709 0 0
M  V30 11 C -3.4395 5.6709 0 0
M  V30 12 O -4.9167 5.9314 0 0
M  V30 13 C -5.8809 4.7823 0 0
M  V30 14 O -2.9265 4.2614 0 0
M  V30 15 C -3.8906 3.1123 0 0
M  V30 16 C -1.1763 7.57 0 0 CFG=2
M  V30 17 O 0.1228 6.82 0 0
M  V30 18 C -1.1763 9.07 0 0 CFG=1
M  V30 19 N 0.1228 9.82 0 0
M  V30 20 C 0.1228 11.32 0 0
M  V30 21 C 1.4218 9.07 0 0
M  V30 22 C 2.7208 9.82 0 0
M  V30 23 C -1.1763 12.07 0 0
M  V30 24 C -1.1763 13.57 0 0
M  V30 25 C 0.1227 14.32 0 0
M  V30 26 Cl 0.1227 15.82 0 0
M  V30 27 C 1.4218 13.57 0 0
M  V30 28 C 1.4218 12.07 0 0
M  V30 29 N 4.0912 9.2099 0 0
M  V30 30 N 5.0949 10.3246 0 0
M  V30 31 N 4.3449 11.6236 0 0
M  V30 32 C 4.955 12.9939 0 0
M  V30 33 N 2.8776 11.3117 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 7
M  V30 3 1 1 18
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 1 3 5
M  V30 7 2 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10 CFG=3
M  V30 12 1 9 11
M  V30 13 1 9 16
M  V30 14 1 11 12
M  V30 15 1 11 14
M  V30 16 1 12 13
M  V30 17 1 14 15
M  V30 18 1 16 17 CFG=1
M  V30 19 1 16 18
M  V30 20 1 18 19 CFG=3
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 23
M  V30 24 2 20 28
M  V30 25 1 21 22
M  V30 26 1 22 29
M  V30 27 2 22 33
M  V30 28 2 23 24
M  V30 29 1 24 25
M  V30 30 1 25 26
M  V30 31 2 25 27
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 30 31
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 9 16 18) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
KR_31543

> <ID>
KR_31543

> <PRIMARY_SOM>
18

> <SECONDARY_SOM>
2 4 5 6

> <Citation>
Ji et al,Arch. Pharm. Res.,27,239,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
MBDB
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8153 0.3187 0 0
M  V30 2 O 1.7135 -0.8948 0 0
M  V30 3 N 8.0243 -6.3985 0 0
M  V30 4 C 6.7253 -5.6485 0 0 CFG=2
M  V30 5 C 6.7253 -4.1485 0 0
M  V30 6 C 5.4263 -6.3985 0 0
M  V30 7 C 5.4263 -3.3985 0 0
M  V30 8 C 5.4263 -1.8985 0 0
M  V30 9 C 4.1272 -5.6485 0 0
M  V30 10 C 4.1272 -4.1485 0 0
M  V30 11 C 4.1272 -1.1485 0 0
M  V30 12 C 2.8282 -1.8985 0 0
M  V30 13 C 2.8282 -3.3985 0 0
M  V30 14 C 8.0243 -7.8985 0 0
M  V30 15 C 2.3236 0.4755 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 15
M  V30 3 1 2 12
M  V30 4 1 2 15
M  V30 5 1 4 3 CFG=1
M  V30 6 1 3 14
M  V30 7 1 4 5
M  V30 8 1 4 6
M  V30 9 1 5 7
M  V30 10 1 6 9
M  V30 11 2 7 8
M  V30 12 1 7 10
M  V30 13 1 8 11
M  V30 14 2 10 13
M  V30 15 2 11 12
M  V30 16 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
MBDB

> <ID>
MBDB

> <PRIMARY_SOM>
15

> <SECONDARY_SOM>
14

> <Citation>
Maurer et al.,Toxicol. Lett.,112'96113,133,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
MDA
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.4263 -3.3985 0 0
M  V30 2 C 5.4263 -1.8985 0 0
M  V30 3 C 4.1272 -4.1485 0 0
M  V30 4 C 6.7253 -4.1485 0 0
M  V30 5 C 4.1272 -1.1485 0 0
M  V30 6 C 2.8282 -3.3985 0 0
M  V30 7 C 6.7253 -5.6485 0 0 CFG=1
M  V30 8 C 2.8282 -1.8985 0 0
M  V30 9 C 5.4263 -6.3985 0 0
M  V30 10 N 8.0243 -6.3985 0 0
M  V30 11 O 3.8153 0.3187 0 0
M  V30 12 C 2.3236 0.4755 0 0
M  V30 13 O 1.7135 -0.8948 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 11
M  V30 9 1 6 8
M  V30 10 1 7 9 CFG=3
M  V30 11 1 7 10
M  V30 12 1 8 13
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
MDA

> <ID>
MDA

> <PRIMARY_SOM>
12

> <Citation>
Maurer et al.,Toxicol. Lett.,112'96113,133,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
MDMA
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.4263 -3.3985 0 0
M  V30 2 C 5.4263 -1.8985 0 0
M  V30 3 C 4.1272 -4.1485 0 0
M  V30 4 C 6.7253 -4.1485 0 0
M  V30 5 C 4.1272 -1.1485 0 0
M  V30 6 C 2.8282 -3.3985 0 0
M  V30 7 C 6.7253 -5.6485 0 0 CFG=1
M  V30 8 C 2.8282 -1.8985 0 0
M  V30 9 C 5.4263 -6.3985 0 0
M  V30 10 N 8.0243 -6.3985 0 0
M  V30 11 C 8.0243 -7.8985 0 0
M  V30 12 O 3.8153 0.3187 0 0
M  V30 13 C 2.3236 0.4755 0 0
M  V30 14 O 1.7135 -0.8948 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 12
M  V30 9 1 6 8
M  V30 10 1 7 9 CFG=3
M  V30 11 1 7 10
M  V30 12 1 8 14
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
MDMA

> <ID>
MDMA

> <PRIMARY_SOM>
13

> <Citation>
Maurer et al.,Toxicol. Lett.,112'96113,133,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
MOCA
  SciTegic08102311042D

 17 18  0  0  0  0            999 V2000
    6.2207   -1.7745    0.0000 C   0  0
    7.5197   -2.5245    0.0000 C   0  0
    7.5197   -4.0245    0.0000 C   0  0
    6.2207   -0.2745    0.0000 C   0  0
    4.9216    0.4755    0.0000 C   0  0
    4.9216    1.9755    0.0000 Cl  0  0
    3.6226   -0.2745    0.0000 C   0  0
    2.3236    0.4755    0.0000 N   0  0
    3.6226   -1.7745    0.0000 C   0  0
    4.9216   -2.5245    0.0000 C   0  0
    8.8188   -4.7745    0.0000 C   0  0
    8.8188   -6.2745    0.0000 C   0  0
    7.5197   -7.0245    0.0000 C   0  0
    7.5197   -8.5245    0.0000 N   0  0
    6.2207   -6.2745    0.0000 C   0  0
    4.9217   -7.0245    0.0000 Cl  0  0
    6.2207   -4.7745    0.0000 C   0  0
  1  2  1  0
  1  4  1  0
  1 10  2  0
  2  3  1  0
  3 11  1  0
  3 17  2  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  2  0
  9 10  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 15 17  1  0
M  END
> <Name>
MOCA

> <ID>
MOCA

> <PRIMARY_SOM>
8 14

> <Citation>
Yun et al.,Carcinogenesis 13,217,1992

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
MOP-13031
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8702 -1.3995 0 0 CFG=2
M  V30 2 C 8.1692 -2.1495 0 0
M  V30 3 C 6.8702 0.1005 0 0
M  V30 4 C 5.5712 -2.1495 0 0
M  V30 5 C 8.1692 -3.6495 0 0
M  V30 6 C 9.4683 -1.3995 0 0
M  V30 7 C 5.5712 0.8505 0 0
M  V30 8 C 8.1692 0.8505 0 0
M  V30 9 C 4.2721 -1.3995 0 0
M  V30 10 C 5.5712 -3.6495 0 0
M  V30 11 C 9.4683 -4.3995 0 0
M  V30 12 C 10.7673 -2.1495 0 0
M  V30 13 N 4.2721 0.1005 0 0
M  V30 14 C 5.5712 2.3505 0 0
M  V30 15 O 9.4683 0.1005 0 0
M  V30 16 O 8.1692 2.3505 0 0
M  V30 17 C 2.9731 -2.1495 0 0
M  V30 18 O 4.2721 -4.3995 0 0
M  V30 19 O 6.8702 -4.3995 0 0
M  V30 20 C 10.7673 -3.6495 0 0
M  V30 21 N 9.4683 -5.8995 0 0 CHG=1
M  V30 22 C 4.2721 -5.8995 0 0
M  V30 23 O 8.1692 -6.6495 0 0 CHG=-1
M  V30 24 O 10.7673 -6.6495 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 1 7 14
M  V30 14 1 8 15
M  V30 15 2 8 16
M  V30 16 1 9 13
M  V30 17 1 9 17
M  V30 18 1 10 18
M  V30 19 2 10 19
M  V30 20 2 11 20
M  V30 21 1 11 21
M  V30 22 1 12 20
M  V30 23 1 18 22
M  V30 24 1 21 23
M  V30 25 2 21 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
MOP-13031

> <ID>
MOP-13031

> <PRIMARY_SOM>
13 1

> <Citation>
Kudo et al.,Drug Metab. Disp.,27,303,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
NDEA
  SciTegic08102311042D

  7  6  0  0  0  0            999 V2000
   -4.6487   -0.7404    0.0000 N   0  0
   -5.9492   -1.4877    0.0000 O   0  0
   -3.3512   -1.4931    0.0000 N   0  0
   -2.0506   -0.7458    0.0000 C   0  0
   -0.7531   -1.4984    0.0000 C   0  0
   -3.3543   -2.9931    0.0000 C   0  0
   -2.0568   -3.7458    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  3  6  1  0
  4  5  1  0
  6  7  1  0
M  END
> <Name>
NDEA

> <ID>
NDEA

> <PRIMARY_SOM>
4 6

> <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
NDMA
  SciTegic08102311042D

  5  4  0  0  0  0            999 V2000
   -3.3481   -0.7500    0.0000 N   0  0
   -4.6471   -1.5000    0.0000 O   0  0
   -2.0490   -1.5000    0.0000 N   0  0
   -0.7500   -0.7500    0.0000 C   0  0
   -2.0490   -3.0000    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  3  5  1  0
M  END
> <Name>
NDMA

> <ID>
NDMA

> <PRIMARY_SOM>
4 5

> <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
NDPA
  SciTegic08102311042D

  9  8  0  0  0  0            999 V2000
    4.6411    3.0094    0.0000 N   0  0
    5.9386    3.7620    0.0000 O   0  0
    4.6441    1.5094    0.0000 N   0  0
    3.3466    0.7567    0.0000 C   0  0
    5.9446    0.7620    0.0000 C   0  0
    2.0460    1.5041    0.0000 C   0  0
    0.7485    0.7515    0.0000 C   0  0
    7.2422    1.5146    0.0000 C   0  0
    8.5427    0.7672    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  3  5  1  0
  4  6  1  0
  5  8  1  0
  6  7  1  0
  8  9  1  0
M  END
> <Name>
NDPA

> <ID>
NDPA

> <PRIMARY_SOM>
4 5

> <Citation>
Teiber et al., Carcinogenesis, 2000, 21, 1559-1566

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
NMBA
  SciTegic08102311042D

  8  7  0  0  0  0            999 V2000
   -7.2452   -0.7500    0.0000 N   0  0
   -8.5442   -1.5000    0.0000 O   0  0
   -5.9462   -1.5000    0.0000 N   0  0
   -4.6471   -0.7500    0.0000 C   0  0
   -5.9461   -3.0000    0.0000 C   0  0
   -3.3481   -1.5000    0.0000 C   0  0
   -2.0490   -0.7500    0.0000 C   0  0
   -0.7500   -1.5000    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  3  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
M  END
> <Name>
NMBA

> <ID>
NMBA

> <PRIMARY_SOM>
4

> <SECONDARY_SOM>
5

> <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
NMEA
  SciTegic08102311042D

  6  5  0  0  0  0            999 V2000
   -4.6471   -0.7500    0.0000 N   0  0
   -5.9462   -1.5000    0.0000 O   0  0
   -3.3481   -1.5000    0.0000 N   0  0
   -3.3481   -3.0000    0.0000 C   0  0
   -2.0490   -0.7500    0.0000 C   0  0
   -0.7500   -1.5000    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
M  END
> <Name>
NMEA

> <ID>
NMEA

> <PRIMARY_SOM>
5

> <SECONDARY_SOM>
4

> <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
NNAL
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2721 -1.3995 0 0
M  V30 2 C 4.2721 0.1005 0 0
M  V30 3 N 2.9731 0.8505 0 0
M  V30 4 C 1.674 0.1005 0 0
M  V30 5 C 1.674 -1.3995 0 0
M  V30 6 C 2.9731 -2.1495 0 0
M  V30 7 C 5.5712 -2.1495 0 0
M  V30 8 O 6.8702 -1.3995 0 0
M  V30 9 C 5.5712 -3.6495 0 0 CFG=1
M  V30 10 O 4.2721 -4.3995 0 0
M  V30 11 C 6.8702 -4.3995 0 0
M  V30 12 C 6.8702 -5.8995 0 0
M  V30 13 N 8.1692 -6.6495 0 0
M  V30 14 C 9.4683 -5.8995 0 0
M  V30 15 N 8.1693 -8.1495 0 0
M  V30 16 O 9.4683 -8.8995 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 7
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 9 10 CFG=3
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
NNAL

> <ID>
NNAL

> <PRIMARY_SOM>
12

> <SECONDARY_SOM>
3

> <Citation>
Staretz et al.,Drug Metab. Disp.,25,154,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
N_desacetyl_indiplon
  SciTegic08102311042D

 24 27  0  0  0  0            999 V2000
    4.7549   14.4837    0.0000 C   0  0
    6.2466   14.3269    0.0000 C   0  0
    6.5585   12.8597    0.0000 C   0  0
    5.2595   12.1097    0.0000 S   0  0
    4.1448   13.1134    0.0000 C   0  0
    2.6775   12.8015    0.0000 C   0  0
    2.2140   11.3749    0.0000 C   0  0
    1.6738   13.9162    0.0000 O   0  0
    3.0957   10.1614    0.0000 C   0  0
    2.2140    8.9479    0.0000 N   0  0
    0.7874    9.4114    0.0000 N   0  0
    0.7874   10.9114    0.0000 C   0  0
   -0.5116    8.6614    0.0000 C   0  0
   -0.5116    7.1614    0.0000 C   0  0
   -1.8107    9.4114    0.0000 C   0  0
   -1.8107   10.9114    0.0000 C   0  0
   -0.5116   11.6614    0.0000 N   0  0
   -1.8107    6.4114    0.0000 C   0  0
   -1.8107    4.9114    0.0000 C   0  0
   -3.1097    4.1614    0.0000 N   0  0
   -3.1097    2.6614    0.0000 C   0  0
   -0.5116    4.1614    0.0000 C   0  0
    0.7874    4.9114    0.0000 C   0  0
    0.7874    6.4114    0.0000 C   0  0
  1  2  1  0
  1  5  2  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  7  9  1  0
  7 12  2  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 12 17  1  0
 13 14  1  0
 13 15  2  0
 14 18  1  0
 14 24  2  0
 15 16  1  0
 16 17  2  0
 18 19  2  0
 19 20  1  0
 19 22  1  0
 20 21  1  0
 22 23  2  0
 23 24  1  0
M  END
> <Name>
N_desacetyl_indiplon

> <ID>
N_desacetyl_indiplon

> <PRIMARY_SOM>
21

> <Citation>
Madan et al.,Xenobiotica,37,736,2007

> <DOI>
10.1080/00498250701433054

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
RHP+
  SciTegic08102311042D

 25 27  0  0  0  0            999 V2000
    0.7140    0.4120    0.0000 C   0  0
    1.4290    0.8250    0.0000 C   0  0
    2.1430    0.4120    0.0000 C   0  0
    2.1430   -0.4120    0.0000 C   0  0
    1.4290   -0.8250    0.0000 C   0  0
    0.7140   -0.4120    0.0000 N   0  3
    0.0000   -0.8250    0.0000 C   0  0
   -0.7140   -0.4120    0.0000 C   0  0
   -1.4290   -0.8250    0.0000 C   0  0
   -2.1430   -0.4120    0.0000 C   0  0
   -2.1430    0.4120    0.0000 O   0  0
   -2.8580   -0.8250    0.0000 C   0  0
   -2.8580   -1.6500    0.0000 C   0  0
   -3.5720   -2.0620    0.0000 C   0  0
   -4.2870   -1.6500    0.0000 C   0  0
   -4.2870   -0.8250    0.0000 C   0  0
   -3.5720   -0.4120    0.0000 C   0  0
   -5.0010   -2.0620    0.0000 F   0  0
    2.8580    0.8250    0.0000 C   0  0
    2.8580    1.6500    0.0000 C   0  0
    3.5720    2.0620    0.0000 C   0  0
    4.2870    1.6500    0.0000 C   0  0
    4.2870    0.8250    0.0000 C   0  0
    3.5720    0.4120    0.0000 C   0  0
    5.0010    2.0620    0.0000 Cl  0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  3  4  1  0
  3 19  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 12 17  2  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 15 18  1  0
 16 17  1  0
 19 20  1  0
 19 24  2  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 22 25  1  0
 23 24  1  0
M  CHG  1   6   1
M  END
> <Name>
RHP+

> <ID>
RHP+

> <PRIMARY_SOM>
10

> <Citation>
Fang et al.,Drug Metab. Disp.,29,1638,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
O6-benzylguanine
  SciTegic08102311042D

 18 20  0  0  0  0            999 V2000
    1.2220   -1.1890    0.0000 N   0  0
    1.7060   -1.8560    0.0000 C   0  0
    1.2220   -2.5240    0.0000 N   0  0
    0.4370   -2.2690    0.0000 C   0  0
   -0.2780   -2.6810    0.0000 N   0  0
   -0.9920   -2.2690    0.0000 C   0  0
   -1.7060   -2.6810    0.0000 N   0  0
   -0.9920   -1.4440    0.0000 N   0  0
   -0.2780   -1.0310    0.0000 C   0  0
   -0.2780   -0.2060    0.0000 O   0  0
    0.4370   -1.4440    0.0000 C   0  0
   -0.9920    0.2060    0.0000 C   0  0
   -0.9920    1.0310    0.0000 C   0  0
   -1.7060    1.4440    0.0000 C   0  0
   -1.7060    2.2690    0.0000 C   0  0
   -0.9920    2.6810    0.0000 C   0  0
   -0.2780    2.2690    0.0000 C   0  0
   -0.2780    1.4440    0.0000 C   0  0
  1  2  1  0
  1 11  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4 11  2  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 13 18  2  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
M  END
> <Name>
O6-benzylguanine

> <ID>
O6-benzylguanine

> <PRIMARY_SOM>
2

> <Citation>
Roy, S.K.; Korzekwa, K.R.; Gonzalez, F.J.; Moschel, R.C.; Dolan, M.E. Human Liver Oxidative Metabolism of O6-Benzylguanine. Biochem. Pharmacol. 1995, 50, 13851389.

> <DOI>
10.1016/0006-2952(95)02019-5

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
TFMPP
  SciTegic08102311042D

 16 17  0  0  0  0            999 V2000
    9.8433    1.5000    0.0000 N   0  0
    9.8433    3.0000    0.0000 C   0  0
    8.5442    3.7500    0.0000 C   0  0
    7.2452    3.0000    0.0000 N   0  0
    5.9462    3.7500    0.0000 C   0  0
    7.2452    1.5000    0.0000 C   0  0
    8.5442    0.7500    0.0000 C   0  0
    5.9462    5.2500    0.0000 C   0  0
    4.6471    6.0000    0.0000 C   0  0
    3.3481    5.2500    0.0000 C   0  0
    3.3481    3.7500    0.0000 C   0  0
    2.0490    3.0000    0.0000 C   0  0
    0.7500    3.7500    0.0000 F   0  0
    2.0490    1.5000    0.0000 F   0  0
    0.7500    2.2500    0.0000 F   0  0
    4.6471    3.0000    0.0000 C   0  0
  1  2  1  0
  1  7  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  5  8  1  0
  5 16  2  0
  6  7  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
M  END
> <Name>
TFMPP

> <ID>
TFMPP

> <PRIMARY_SOM>
9 10

> <Citation>
Staack et al.,Biochem. Pharma.,67,235,2004

> <DOI>
10.1016/j.bcp.2003.08.029

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
abbott-66193
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6563 2.25 0 0
M  V30 2 C 7.1563 2.25 0 0 CFG=1
M  V30 3 C 4.7747 1.0365 0 0
M  V30 4 S 4.7747 3.4635 0 0
M  V30 5 N 7.9063 3.549 0 0
M  V30 6 C 7.9063 0.951 0 0
M  V30 7 C 3.3481 1.5 0 0
M  V30 8 C 3.3481 3 0 0
M  V30 9 C 9.4063 3.549 0 0
M  V30 10 C 2.049 0.75 0 0
M  V30 11 C 2.049 3.75 0 0
M  V30 12 N 10.1563 2.25 0 0
M  V30 13 O 10.1563 4.8481 0 0
M  V30 14 C 0.75 1.5 0 0
M  V30 15 C 0.75 3 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 7 8
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
abbott-66193

> <ID>
abbott-66193

> <PRIMARY_SOM>
4

> <Citation>
J. M. Machinist, M. D. Mayer, M. S. Shet, J. L. Ferrero, A. D. Rodrigues, Drug Metab. Dispos. 1995, 23, 1163-1174.

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
abt_761
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2721 -1.3995 0 0
M  V30 2 C 4.2721 0.1005 0 0
M  V30 3 C 2.9731 0.8505 0 0
M  V30 4 C 1.674 0.1005 0 0
M  V30 5 C 1.674 -1.3995 0 0
M  V30 6 C 2.9731 -2.1495 0 0
M  V30 7 C 5.5712 -2.1495 0 0
M  V30 8 C 5.5712 -3.6495 0 0
M  V30 9 S 6.7847 -4.5312 0 0
M  V30 10 C 6.3212 -5.9578 0 0
M  V30 11 C 4.8212 -5.9578 0 0
M  V30 12 C 4.3576 -4.5312 0 0
M  V30 13 C 7.2028 -7.1713 0 0
M  V30 14 C 8.0845 -8.3848 0 0
M  V30 15 C 8.9662 -9.5983 0 0 CFG=2
M  V30 16 C 8.3561 -10.9687 0 0
M  V30 17 N 10.458 -9.4415 0 0
M  V30 18 O 11.0681 -8.0712 0 0
M  V30 19 C 11.3397 -10.6551 0 0
M  V30 20 O 12.8315 -10.4983 0 0
M  V30 21 N 10.7296 -12.0254 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 7
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 12
M  V30 11 1 9 10
M  V30 12 2 10 11
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 15 3 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16 CFG=1
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
abt_761

> <ID>
abt_761

> <PRIMARY_SOM>
7

> <Citation>
Machinist et al.,Drug Metab. Disp.,26,970,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
acetaminophen
  SciTegic08102311042D

 11 11  0  0  0  0            999 V2000
    1.0245   -0.2745    0.0000 O   0  0
    7.5197   -5.5245    0.0000 O   0  0
    6.2207   -3.2745    0.0000 N   0  0
    4.9216   -2.5245    0.0000 C   0  0
    4.9216   -1.0245    0.0000 C   0  0
    3.6226   -3.2745    0.0000 C   0  0
    3.6226   -0.2745    0.0000 C   0  0
    2.3236   -2.5245    0.0000 C   0  0
    2.3236   -1.0245    0.0000 C   0  0
    6.2207   -4.7745    0.0000 C   0  0
    4.9216   -5.5245    0.0000 C   0  0
  1  9  1  0
  2 10  2  0
  3  4  1  0
  3 10  1  0
  4  5  2  0
  4  6  1  0
  5  7  1  0
  6  8  2  0
  7  9  2  0
  8  9  1  0
 10 11  1  0
M  END
> <Name>
acetaminophen

> <ID>
acetaminophen

> <PRIMARY_SOM>
1 3

> <Citation>
Patten et al.,Chem. Res. Toxicol.,6,511,1993

> <DOI>
10.1021/tx0034a019

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
all_trans_retinal
  SciTegic08102311042D

 21 21  0  0  0  0            999 V2000
    3.3481    3.0000    0.0000 C   0  0
    4.6471    2.2500    0.0000 C   0  0
    3.3481    4.5000    0.0000 C   0  0
    2.0490    2.2500    0.0000 C   0  0
    5.9462    3.0000    0.0000 C   0  0
   13.7404    3.0000    0.0000 C   0  0
   15.0394    2.2500    0.0000 C   0  0
    9.8433    2.2500    0.0000 C   0  0
   12.4413    2.2500    0.0000 C   0  0
    7.2452    2.2500    0.0000 C   0  0
   11.1423    3.0000    0.0000 C   0  0
    8.5442    3.0000    0.0000 C   0  0
   16.3385    3.0000    0.0000 O   0  0
    2.0490    5.2500    0.0000 C   0  0
    0.7500    3.0000    0.0000 C   0  0
    4.6471    5.2500    0.0000 C   0  0
    3.0132    1.1009    0.0000 C   0  0
    1.0849    1.1009    0.0000 C   0  0
    0.7500    4.5000    0.0000 C   0  0
   12.4413    0.7500    0.0000 C   0  0
    7.2452    0.7500    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  3 14  1  0
  3 16  1  0
  4 15  1  0
  4 17  1  0
  4 18  1  0
  5 10  1  0
  6  7  1  0
  6  9  2  0
  7 13  2  0
  8 11  2  0
  8 12  1  0
  9 11  1  0
  9 20  1  0
 10 12  2  0
 10 21  1  0
 14 19  1  0
 15 19  1  0
M  END
> <Name>
all_trans_retinal

> <ID>
all_trans_retinal

> <PRIMARY_SOM>
7

> <Citation>
Zhang et al.,Drug Metab. Disp.,28,292,2000
Chen et al.,Drug Metab. Disp.,28,315,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
aminopyrine
  SciTegic08102311042D

 16 17  0  0  0  0            999 V2000
    7.0879    6.5073    0.0000 C   0  0
    7.0879    8.0073    0.0000 C   0  0
    5.7888    8.7573    0.0000 C   0  0
    4.4898    8.0072    0.0000 C   0  0
    4.4899    6.5072    0.0000 C   0  0
    3.1909    5.7571    0.0000 N   0  0
    5.7889    5.7573    0.0000 C   0  0
    1.8205    6.3672    0.0000 C   0  0
    1.5086    7.8344    0.0000 O   0  0
    0.8169    5.2524    0.0000 C   0  0
   -0.6749    5.4091    0.0000 N   0  0
   -1.5565    4.1956    0.0000 C   0  0
   -1.2851    6.7794    0.0000 C   0  0
    1.5669    3.9534    0.0000 C   0  0
    3.0341    4.2653    0.0000 N   0  0
    4.1489    3.2617    0.0000 C   0  0
  1  2  1  0
  1  7  2  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  6  8  1  0
  6 15  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 10 14  2  0
 11 12  1  0
 11 13  1  0
 14 15  1  0
 15 16  1  0
M  END
> <Name>
aminopyrine

> <ID>
aminopyrine

> <PRIMARY_SOM>
12 13

> <Citation>
Niwa et al.,Xenobiotica,29,187,1999

> <DOI>
10.1080/004982599238731

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
antipyrine
  SciTegic08102311042D

 14 15  0  0  0  0            999 V2000
    5.2839   -2.1843    0.0000 O   0  0
    6.2417    0.3113    0.0000 N   0  0
    7.6120    0.9214    0.0000 N   0  0
    8.6157   -0.1932    0.0000 C   0  0
    4.9426    1.0612    0.0000 C   0  0
    6.3985   -1.1805    0.0000 C   0  0
    7.8658   -1.4923    0.0000 C   0  0
    7.9238    2.3887    0.0000 C   0  0
   10.1075   -0.0364    0.0000 C   0  0
    4.9425    2.5612    0.0000 C   0  0
    3.6436    0.3111    0.0000 C   0  0
    3.6434    3.3111    0.0000 C   0  0
    2.3445    1.0611    0.0000 C   0  0
    2.3444    2.5611    0.0000 C   0  0
  1  6  2  0
  2  3  1  0
  2  5  1  0
  2  6  1  0
  3  4  1  0
  3  8  1  0
  4  7  2  0
  4  9  1  0
  5 10  2  0
  5 11  1  0
  6  7  1  0
 10 12  1  0
 11 13  2  0
 12 14  2  0
 13 14  1  0
M  END
> <Name>
antipyrine

> <ID>
antipyrine

> <PRIMARY_SOM>
7

> <SECONDARY_SOM>
8

> <Citation>
G. Engel, U. Hofmann, H. Heidemann, J. Cosme, M. Eichelbaum, Clin. Pharmacol. Ther. 1996, 59, 613-623.
Sharer et al.,Drug Metab. Disp.,24,487,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
aprepitant_M1
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -6.8702 -3.1005 0 0
M  V30 2 C -8.1692 -0.8505 0 0 CFG=1
M  V30 3 C -6.8702 5.8995 0 0
M  V30 4 C -12.0663 5.8995 0 0
M  V30 5 C -6.8702 -1.6005 0 0 CFG=2
M  V30 6 C -8.1692 5.1495 0 0
M  V30 7 C -10.7673 5.1495 0 0
M  V30 8 O -8.1692 0.6495 0 0
M  V30 9 C -9.4683 2.8995 0 0
M  V30 10 C -9.4683 5.8995 0 0
M  V30 11 C -10.7673 3.6495 0 0
M  V30 12 C -8.1692 3.6495 0 0
M  V30 13 O -9.4683 -1.6005 0 0
M  V30 14 C -9.4683 1.3995 0 0 CFG=1
M  V30 15 C -5.5712 -0.8505 0 0
M  V30 16 F -6.8702 7.3995 0 0
M  V30 17 F -5.5711 5.1495 0 0
M  V30 18 F -5.5711 6.6495 0 0
M  V30 19 F -12.0663 7.3995 0 0
M  V30 20 F -13.3654 5.1495 0 0
M  V30 21 F -13.3654 6.6495 0 0
M  V30 22 C -5.5712 0.6495 0 0
M  V30 23 C -4.2721 -1.6005 0 0
M  V30 24 C -8.1692 -3.8505 0 0
M  V30 25 C -2.9731 0.6495 0 0
M  V30 26 C -9.4683 -3.1005 0 0
M  V30 27 C -2.9731 -0.8505 0 0
M  V30 28 C -4.2721 1.3995 0 0
M  V30 29 F -1.674 1.3995 0 0
M  V30 30 C -10.7673 0.6495 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 24
M  V30 3 1 2 5
M  V30 4 1 2 8 CFG=3
M  V30 5 1 2 13
M  V30 6 1 3 6
M  V30 7 1 3 16
M  V30 8 1 3 17
M  V30 9 1 3 18
M  V30 10 1 4 7
M  V30 11 1 4 19
M  V30 12 1 4 20
M  V30 13 1 4 21
M  V30 14 1 5 15 CFG=3
M  V30 15 2 6 10
M  V30 16 1 6 12
M  V30 17 1 7 10
M  V30 18 2 7 11
M  V30 19 1 8 14
M  V30 20 1 9 11
M  V30 21 2 9 12
M  V30 22 1 9 14
M  V30 23 1 13 26
M  V30 24 1 14 30 CFG=3
M  V30 25 2 15 22
M  V30 26 1 15 23
M  V30 27 1 22 28
M  V30 28 2 23 27
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 25 28
M  V30 32 1 25 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 5 14) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
aprepitant_M1

> <ID>
aprepitant_M1

> <PRIMARY_SOM>
1 5

> <Citation>
Sanchez et al.,Drug Metab. Disp.,32,1287,2004

> <DOI>
10.1124/dmd.104.000216

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
arachidonic_acid
  SciTegic08102311042D

 22 21  0  0  0  0            999 V2000
   -7.2459    0.7433    0.0000 O   0  0
   -4.6478    0.7457    0.0000 O   0  0
   -1.7920    3.7712    0.0000 C   0  0
   -0.3820    3.2594    0.0000 C   0  0
   -2.0539    5.2481    0.0000 C   0  0
   -0.1202    1.7824    0.0000 C   0  0
   -0.7555    5.9993    0.0000 C   0  0
    1.2898    1.2707    0.0000 C   0  0
   -7.2486    3.7433    0.0000 C   0  0
   -7.2500    5.2433    0.0000 C   0  0
   -0.7569    7.4993    0.0000 C   0  0
   -2.0566    8.2481    0.0000 C   0  0
   -5.9489    2.9945    0.0000 C   0  0
   -8.5497    5.9922    0.0000 C   0  0
   -7.2528    8.2433    0.0000 C   0  0
   -2.0580    9.7481    0.0000 C   0  0
   -8.5511    7.4922    0.0000 C   0  0
   -4.6561    9.7457    0.0000 C   0  0
   -3.3577   10.4969    0.0000 C   0  0
   -7.2541    9.7433    0.0000 C   0  0
   -5.9558   10.4945    0.0000 C   0  0
   -5.9475    1.4945    0.0000 C   0  0
  1 22  1  0
  2 22  2  0
  3  4  1  0
  3  5  1  0
  4  6  1  0
  5  7  1  0
  6  8  1  0
  7 11  2  0
  9 10  1  0
  9 13  1  0
 10 14  1  0
 11 12  1  0
 12 16  1  0
 13 22  1  0
 14 17  2  0
 15 17  1  0
 15 20  1  0
 16 19  2  0
 18 19  1  0
 18 21  1  0
 20 21  2  0
M  END
> <Name>
arachidonic_acid

> <ID>
arachidonic_acid

> <PRIMARY_SOM>
6

> <SECONDARY_SOM>
8

> <TERTIARY_SOM>
12 15 18

> <Citation>
Rifkind et al.,Arch. Biochem. Biophys.,320,380,1995
Bylund et al.,J. Pharma. Exp. Thera.,284,51,1998

> <DOI>
10.1016/0003-9861(95)90023-3

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
atomoxetine
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4173 -1.6506 0 0
M  V30 2 C 4.4172 -0.1506 0 0
M  V30 3 C 3.1181 0.5994 0 0
M  V30 4 C 1.8191 -0.1507 0 0
M  V30 5 C 1.8192 -1.6507 0 0
M  V30 6 C 3.1183 -2.4006 0 0
M  V30 7 C 5.7164 -2.4005 0 0 CFG=1
M  V30 8 O 5.7164 -3.9005 0 0
M  V30 9 C 7.0155 -4.6504 0 0
M  V30 10 C 8.3145 -3.9004 0 0
M  V30 11 C 9.6136 -4.6503 0 0
M  V30 12 C 9.6137 -6.1503 0 0
M  V30 13 C 8.3147 -6.9004 0 0
M  V30 14 C 7.0156 -6.1505 0 0
M  V30 15 C 5.7166 -6.9005 0 0
M  V30 16 C 7.0154 -1.6504 0 0
M  V30 17 C 7.0153 -0.1504 0 0
M  V30 18 N 8.3143 0.5996 0 0
M  V30 19 C 8.3142 2.0996 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 7
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8 CFG=3
M  V30 9 1 7 16
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 2 9 14
M  V30 13 2 10 11
M  V30 14 1 11 12
M  V30 15 2 12 13
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
atomoxetine

> <ID>
atomoxetine

> <PRIMARY_SOM>
12

> <SECONDARY_SOM>
19

> <Citation>
Ring et al.,30,319,2002

> <DOI>
10.1124/dmd.30.3.319

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
benzo_a_pyrene
  SciTegic08102311042D

 20 24  0  0  0  0            999 V2000
   -3.3484    5.9998    0.0000 C   0  0
   -3.3485    7.4998    0.0000 C   0  0
   -4.6474    5.2498    0.0000 C   0  0
   -2.0493    5.2499    0.0000 C   0  0
   -4.6473    3.7498    0.0000 C   0  0
   -4.6475    8.2498    0.0000 C   0  0
   -2.0495    8.2499    0.0000 C   0  0
   -3.3482    2.9998    0.0000 C   0  0
   -2.0492    3.7499    0.0000 C   0  0
   -5.9465    5.9997    0.0000 C   0  0
   -0.7503    6.0000    0.0000 C   0  0
   -5.9465    7.4997    0.0000 C   0  0
   -0.7504    7.5000    0.0000 C   0  0
   -4.6476    9.7498    0.0000 C   0  0
   -2.0495    9.7499    0.0000 C   0  0
   -5.9463    2.9997    0.0000 C   0  0
   -3.3482    1.4998    0.0000 C   0  0
   -3.3486   10.4998    0.0000 C   0  0
   -5.9462    1.4997    0.0000 C   0  0
   -4.6472    0.7498    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  6  1  0
  2  7  1  0
  3  5  1  0
  3 10  2  0
  4  9  2  0
  4 11  1  0
  5  8  2  0
  5 16  1  0
  6 12  2  0
  6 14  1  0
  7 13  1  0
  7 15  2  0
  8  9  1  0
  8 17  1  0
 10 12  1  0
 11 13  2  0
 14 18  2  0
 15 18  1  0
 16 19  2  0
 17 20  2  0
 19 20  1  0
M  END
> <Name>
benzo_a_pyrene

> <ID>
benzo_a_pyrene

> <PRIMARY_SOM>
15

> <SECONDARY_SOM>
19 16 13 11 20 17

> <Citation>
Bauer et al.,Chem. Res. Toxicol.,8,136,1995

> <DOI>
10.1021/tx00043a018

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
benzphetamine
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -1.5736 3.2745 0 0
M  V30 2 C -1.5736 4.7745 0 0
M  V30 3 C -0.2745 5.5245 0 0
M  V30 4 C -0.2745 7.0245 0 0 CFG=2
M  V30 5 N 1.0245 7.7745 0 0
M  V30 6 C 2.3236 7.0245 0 0
M  V30 7 C 1.0245 9.2745 0 0
M  V30 8 C 2.3236 10.0245 0 0
M  V30 9 C -1.5736 7.7745 0 0
M  V30 10 C -2.8726 5.5245 0 0
M  V30 11 C -4.1716 4.7745 0 0
M  V30 12 C -4.1716 3.2745 0 0
M  V30 13 C -2.8726 2.5245 0 0
M  V30 14 C 2.3236 11.5245 0 0
M  V30 15 C 3.6226 12.2745 0 0
M  V30 16 C 4.9216 11.5245 0 0
M  V30 17 C 4.9216 10.0245 0 0
M  V30 18 C 3.6226 9.2745 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 13
M  V30 3 1 2 3
M  V30 4 2 2 10
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 4 9 CFG=1
M  V30 8 1 5 6
M  V30 9 1 5 7
M  V30 10 1 7 8
M  V30 11 1 8 14
M  V30 12 2 8 18
M  V30 13 1 10 11
M  V30 14 2 11 12
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 15 16
M  V30 18 2 16 17
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
benzphetamine

> <ID>
benzphetamine

> <PRIMARY_SOM>
6

> <Citation>
Maenpaa et al.,J. Steroid Biochem. Mol. Biol.,44,61,1993

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
bisnor
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -1.8011 -0.0165 0 0 CFG=2
M  V30 2 C -1.4359 1.4384 0 0 CFG=2
M  V30 3 C -3.2976 -0.1187 0 0 CFG=1
M  V30 4 N -0.8388 -1.1671 0 0
M  V30 5 C -2.7067 2.2353 0 0 CFG=1
M  V30 6 C -0.0442 1.9981 0 0
M  V30 7 C -2.147 0.8436 0 0
M  V30 8 C -4.5684 0.6782 0 0
M  V30 9 S -1.3541 -2.5758 0 0
M  V30 10 C -4.2032 2.1331 0 0
M  V30 11 C 0.1669 3.4831 0 0
M  V30 12 C 0.0547 -3.0911 0 0
M  V30 13 O -1.8693 -3.9845 0 0
M  V30 14 O -2.7628 -2.0605 0 0
M  V30 15 C 1.5586 4.0428 0 0
M  V30 16 C 1.2053 -2.1287 0 0
M  V30 17 C 0.3128 -4.5687 0 0
M  V30 18 C 2.7391 3.1174 0 0
M  V30 19 C 2.614 -2.644 0 0
M  V30 20 C 1.7215 -5.084 0 0
M  V30 21 C 2.8721 -4.1217 0 0
M  V30 22 C 4.1308 3.6771 0 0
M  V30 23 O 4.342 5.1622 0 0
M  V30 24 O 5.3113 2.7517 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7 CFG=1
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 7 CFG=3
M  V30 10 1 5 10
M  V30 11 1 6 11
M  V30 12 1 8 10
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 2 9 14
M  V30 16 2 11 15
M  V30 17 2 12 16
M  V30 18 1 12 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 20
M  V30 22 1 18 22
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 2 3 5) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
bisnor

> <ID>
bisnor

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
10

> <Citation>
Yamaguchi et al.,Drug Metab. Disp.,25,75,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
bms_275183
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 60 64 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.3448 1.7235 0 0
M  V30 2 O 12.7288 1.6424 0 0
M  V30 3 O 10.2411 -0.8041 0 0
M  V30 4 O 9.0736 0.4663 0 0
M  V30 5 O 9.5196 5.6041 0 0
M  V30 6 O 5.3481 4.0889 0 0
M  V30 7 O 7.7946 5.1023 0 0
M  V30 8 O 9.2256 4.506 0 0
M  V30 9 O 12.6155 -0.9532 0 0
M  V30 10 O 14.92 0.2465 0 0
M  V30 11 O 8.4039 -2.6412 0 0
M  V30 12 O 3.8579 6.2171 0 0
M  V30 13 O 7.0974 5.9962 0 0
M  V30 14 O 10.9464 6.9634 0 0
M  V30 15 O 5.1957 10.0746 0 0
M  V30 16 O 7.5503 11.1726 0 0
M  V30 17 N 7.3239 8.5844 0 0
M  V30 18 C 9.7545 1.6424 0 0 CFG=2
M  V30 19 C 11.2416 1.4466 0 0 CFG=2
M  V30 20 C 9.1804 3.0283 0 0 CFG=1
M  V30 21 C 9.1804 0.2566 0 0 CFG=1
M  V30 22 C 12.1548 2.6367 0 0 CFG=1
M  V30 23 C 7.7946 -0.3174 0 0 CFG=2
M  V30 24 C 10.0936 4.2183 0 0 CFG=2
M  V30 25 C 11.5808 4.0225 0 0
M  V30 26 C 6.4088 0.2566 0 0
M  V30 27 C 12.4317 0.5335 0 0
M  V30 28 C 7.7946 3.6023 0 0
M  V30 29 C 8.9352 0.6567 0 0
M  V30 30 C 5.8347 1.6424 0 0
M  V30 31 C 8.7922 4.4771 0 0
M  V30 32 C 6.4088 3.0283 0 0 CFG=1
M  V30 33 C 8.585 2.1153 0 0 CFG=1
M  V30 34 C 7.1265 2.4655 0 0
M  V30 35 C 6.213 -1.2306 0 0
M  V30 36 C 4.9216 0.0608 0 0
M  V30 37 C 6.8789 3.9449 0 0
M  V30 38 C 13.4214 0.3119 0 0
M  V30 39 C 9.8529 -2.253 0 0
M  V30 40 C 5.2174 5.5832 0 0
M  V30 41 C 8.5917 5.8654 0 0
M  V30 42 C 10.9135 -3.3136 0 0
M  V30 43 C 9.4521 7.0942 0 0 CFG=1
M  V30 44 C 6.4461 6.4436 0 0
M  V30 45 C 8.8182 8.4536 0 0 CFG=2
M  V30 46 C 10.5253 -4.7625 0 0
M  V30 47 C 12.3624 -2.9254 0 0
M  V30 48 C 13.3081 -2.2837 0 0
M  V30 49 C 9.6785 9.6824 0 0
M  V30 50 C 11.5859 -5.8232 0 0
M  V30 51 C 13.4231 -3.9861 0 0
M  V30 52 C 13.0348 -5.435 0 0
M  V30 53 C 11.1728 9.5516 0 0
M  V30 54 C 10.5389 10.9111 0 0
M  V30 55 C 9.0446 11.0418 0 0
M  V30 56 C 6.6899 9.9439 0 0
M  V30 57 C 4.5617 11.4341 0 0
M  V30 58 C 3.0674 11.5648 0 0
M  V30 59 C 5.4221 12.6628 0 0
M  V30 60 C 3.9278 12.7936 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 22 1 CFG=1
M  V30 2 1 1 27
M  V30 3 1 19 2 CFG=3
M  V30 4 1 2 38
M  V30 5 1 21 3 CFG=3
M  V30 6 1 3 39
M  V30 7 1 23 4 CFG=3
M  V30 8 1 24 5 CFG=1
M  V30 9 1 32 6 CFG=1
M  V30 10 1 6 40
M  V30 11 2 7 28
M  V30 12 1 33 8 CFG=1
M  V30 13 1 8 41
M  V30 14 1 9 38
M  V30 15 1 9 48
M  V30 16 2 10 38
M  V30 17 2 11 39
M  V30 18 2 12 40
M  V30 19 2 13 41
M  V30 20 1 43 14 CFG=1
M  V30 21 1 15 56
M  V30 22 1 15 57
M  V30 23 2 16 56
M  V30 24 1 45 17 CFG=1
M  V30 25 1 17 56
M  V30 26 1 18 19 CFG=1
M  V30 27 1 18 20
M  V30 28 1 18 21
M  V30 29 1 19 22
M  V30 30 1 19 27
M  V30 31 1 20 24
M  V30 32 1 20 28
M  V30 33 1 20 31 CFG=1
M  V30 34 1 21 23
M  V30 35 1 22 25
M  V30 36 1 23 26
M  V30 37 1 23 29
M  V30 38 1 24 25
M  V30 39 1 26 30
M  V30 40 1 26 35
M  V30 41 1 26 36
M  V30 42 1 28 32
M  V30 43 1 29 33
M  V30 44 1 30 32
M  V30 45 2 30 34
M  V30 46 1 33 34
M  V30 47 1 34 37
M  V30 48 1 39 42
M  V30 49 1 40 44
M  V30 50 1 41 43
M  V30 51 2 42 46
M  V30 52 1 42 47
M  V30 53 1 43 45
M  V30 54 1 45 49
M  V30 55 1 46 50
M  V30 56 2 47 51
M  V30 57 1 49 53
M  V30 58 1 49 54
M  V30 59 1 49 55
M  V30 60 2 50 52
M  V30 61 1 51 52
M  V30 62 1 57 58
M  V30 63 1 57 59
M  V30 64 1 57 60
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 18 19 20 21 22 23 24 32 33 43 45) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
bms_275183

> <ID>
bms_275183

> <PRIMARY_SOM>
53 54 55

> <SECONDARY_SOM>
58 59 60

> <Citation>
Zhang et al.,Drug Metab. Disp.,37,710,2009

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
bpr0l075
  SciTegic08102311042D

 25 27  0  0  0  0            999 V2000
    7.1908    0.4549    0.0000 C   0  0
    7.1908    1.9549    0.0000 C   0  0
    5.8918    2.7049    0.0000 C   0  0
    4.5928    1.9549    0.0000 C   0  0
    4.5928    0.4549    0.0000 C   0  0
    5.8918   -0.2951    0.0000 C   0  0
    3.2937    2.7049    0.0000 O   0  0
    1.9947    1.9549    0.0000 C   0  0
    8.6174   -0.0086    0.0000 C   0  0
    9.4991    1.2049    0.0000 C   0  0
    8.6174    2.4185    0.0000 N   0  0
    9.0810   -1.4352    0.0000 C   0  0
   10.5482   -1.7470    0.0000 C   0  0
    8.0773   -2.5499    0.0000 O   0  0
   11.0117   -3.1736    0.0000 C   0  0
   12.4789   -3.4855    0.0000 C   0  0
   13.4826   -2.3708    0.0000 C   0  0
   13.0191   -0.9442    0.0000 C   0  0
   11.5519   -0.6323    0.0000 C   0  0
   12.9425   -4.9121    0.0000 O   0  0
   11.9388   -6.0268    0.0000 C   0  0
   14.9499   -2.6826    0.0000 O   0  0
   15.9535   -1.5679    0.0000 C   0  0
   14.0228    0.1705    0.0000 O   0  0
   13.5593    1.5971    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  1  9  1  0
  2  3  2  0
  2 11  1  0
  3  4  1  0
  4  5  2  0
  4  7  1  0
  5  6  1  0
  7  8  1  0
  9 10  2  0
  9 12  1  0
 10 11  1  0
 12 13  1  0
 12 14  2  0
 13 15  1  0
 13 19  2  0
 15 16  2  0
 16 17  1  0
 16 20  1  0
 17 18  2  0
 17 22  1  0
 18 19  1  0
 18 24  1  0
 20 21  1  0
 22 23  1  0
 24 25  1  0
M  END
> <Name>
bpr0l075

> <ID>
bpr0l075

> <PRIMARY_SOM>
5 8

> <SECONDARY_SOM>
3

> <TERTIARY_SOM>
21 23 25

> <Citation>
Yao et al.,Drug Metab. Disp.,35,1042,2007

> <DOI>
10.1124/dmd.106.014597

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
bromodichloromethane
  SciTegic08102311042D

  4  3  0  0  0  0            999 V2000
    0.0000   -0.2060    0.0000 C   0  0
   -0.7140   -0.6190    0.0000 Cl  0  0
    0.7140   -0.6190    0.0000 Cl  0  0
    0.0000    0.6190    0.0000 Br  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
M  END
> <Name>
bromodichloromethane

> <ID>
bromodichloromethane

> <PRIMARY_SOM>
1 4

> <Citation>
John W. Allis and Guangyu Zhao, Chemico-Biological Interactions 140 (2002) 137153

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
butachlor
  SciTegic08102311042D

 21 21  0  0  0  0            999 V2000
    5.5712   -0.6495    0.0000 C   0  0
    6.8702   -1.3995    0.0000 N   0  0
    5.5712    0.8505    0.0000 C   0  0
    4.2721   -1.3995    0.0000 C   0  0
    8.1692   -0.6495    0.0000 C   0  0
    6.8702   -2.8995    0.0000 C   0  0
    4.2721    1.6005    0.0000 C   0  0
    6.8702    1.6005    0.0000 C   0  0
    2.9731   -0.6495    0.0000 C   0  0
    4.2721   -2.8995    0.0000 C   0  0
    9.4683   -1.3995    0.0000 C   0  0
    8.1692    0.8505    0.0000 O   0  0
    8.1692   -3.6495    0.0000 O   0  0
    2.9731    0.8505    0.0000 C   0  0
    6.8702    3.1005    0.0000 C   0  0
    2.9731   -3.6495    0.0000 C   0  0
   10.7673   -0.6495    0.0000 Cl  0  0
    8.1692   -5.1495    0.0000 C   0  0
    9.4683   -5.8995    0.0000 C   0  0
    9.4683   -7.3995    0.0000 C   0  0
   10.7673   -8.1495    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  5 12  2  0
  6 13  1  0
  7 14  2  0
  8 15  1  0
  9 14  1  0
 10 16  1  0
 11 17  1  0
 13 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
M  END
> <Name>
butachlor

> <ID>
butachlor

> <PRIMARY_SOM>
18

> <Citation>
Coleman et al.,Env. Health Perspec.,108,1151,2000
Coleman et al.,Chem. Biol. Inter.,122,27,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
caffeine
  SciTegic08102311042D

 14 15  0  0  0  0            999 V2000
   -5.9462    5.2500    0.0000 O   0  0
   -3.3481    0.7500    0.0000 O   0  0
   -2.0490    3.0000    0.0000 N   0  0
   -3.0362    6.7172    0.0000 N   0  0
   -4.6471    3.0000    0.0000 N   0  0
   -0.9343    5.5037    0.0000 N   0  0
   -3.3481    5.2500    0.0000 C   0  0
   -2.0490    4.5000    0.0000 C   0  0
   -4.6471    4.5000    0.0000 C   0  0
   -3.3481    2.2500    0.0000 C   0  0
   -1.5444    6.8740    0.0000 C   0  0
   -0.7500    2.2500    0.0000 C   0  0
   -4.0399    7.8319    0.0000 C   0  0
   -5.9462    2.2500    0.0000 C   0  0
  1  9  2  0
  2 10  2  0
  3  8  1  0
  3 10  1  0
  3 12  1  0
  4  7  1  0
  4 11  1  0
  4 13  1  0
  5  9  1  0
  5 10  1  0
  5 14  1  0
  6  8  1  0
  6 11  2  0
  7  8  2  0
  7  9  1  0
M  END
> <Name>
caffeine

> <ID>
caffeine

> <PRIMARY_SOM>
11

> <Citation>
Ha et al.,Eur. J. Clin. Pharmacol.,49,309,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
celecoxib
  SciTegic08102311042D

 26 28  0  0  0  0            999 V2000
    3.9432    2.1961    0.0000 S   0  0
   10.4918   -5.1914    0.0000 F   0  0
   12.8653   -4.1347    0.0000 F   0  0
   11.9836   -5.3482    0.0000 F   0  0
    4.6932    3.4951    0.0000 O   0  0
    3.1932    0.8970    0.0000 O   0  0
    9.1394   -0.8039    0.0000 N   0  0
    9.2962   -2.2957    0.0000 N   0  0
    2.6442    2.9461    0.0000 N   0  0
   10.5097   -0.1938    0.0000 C   0  0
    7.8404   -0.0539    0.0000 C   0  0
   10.8216    1.2734    0.0000 C   0  0
   11.5134   -1.3085    0.0000 C   0  0
   10.7634   -2.6076    0.0000 C   0  0
    7.8404    1.4461    0.0000 C   0  0
    6.5413   -0.8039    0.0000 C   0  0
    5.2423    1.4461    0.0000 C   0  0
    9.7069    2.2771    0.0000 C   0  0
   12.2482    1.7369    0.0000 C   0  0
    6.5413    2.1961    0.0000 C   0  0
    5.2423   -0.0539    0.0000 C   0  0
   11.4453    4.2079    0.0000 C   0  0
   10.0187    3.7443    0.0000 C   0  0
   12.5600    3.2042    0.0000 C   0  0
   11.3735   -3.9779    0.0000 C   0  0
   11.7572    5.6751    0.0000 C   0  0
  1  5  2  0
  1  6  2  0
  1  9  1  0
  1 17  1  0
  2 25  1  0
  3 25  1  0
  4 25  1  0
  7  8  1  0
  7 10  1  0
  7 11  1  0
  8 14  2  0
 10 12  1  0
 10 13  2  0
 11 15  2  0
 11 16  1  0
 12 18  2  0
 12 19  1  0
 13 14  1  0
 14 25  1  0
 15 20  1  0
 16 21  2  0
 17 20  2  0
 17 21  1  0
 18 23  1  0
 19 24  2  0
 22 23  2  0
 22 24  1  0
 22 26  1  0
M  END
> <Name>
celecoxib

> <ID>
celecoxib

> <PRIMARY_SOM>
26

> <Citation>
Tang et al.,J. Pharmacol. Exp. Ther.,293,453,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
chenodeoxycholic_acid
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0553 -3.8469 0 0
M  V30 2 C 9.8984 -2.3552 0 0 CFG=2
M  V30 3 C 9.8983 -0.8552 0 0 CFG=2
M  V30 4 C 11.325 -2.8186 0 0 CFG=1
M  V30 5 C 8.5994 -3.1052 0 0
M  V30 6 C 8.5992 -0.1052 0 0 CFG=1
M  V30 7 C 11.3249 -0.3916 0 0
M  V30 8 C 11.7886 -4.2452 0 0 CFG=1
M  V30 9 C 12.2066 -1.6051 0 0
M  V30 10 C 7.3003 -2.3553 0 0
M  V30 11 C 7.3002 -0.8553 0 0 CFG=2
M  V30 12 C 8.5992 1.3948 0 0 CFG=1
M  V30 13 O 9.8982 2.1448 0 0
M  V30 14 C 13.2558 -4.557 0 0
M  V30 15 C 10.785 -5.36 0 0
M  V30 16 C 6.0012 -0.1054 0 0 CFG=2
M  V30 17 C 7.3001 2.1447 0 0
M  V30 18 C 13.7194 -5.9835 0 0
M  V30 19 C 6.0012 -1.6054 0 0
M  V30 20 C 6.0011 1.3946 0 0 CFG=1
M  V30 21 C 4.7022 -0.8554 0 0
M  V30 22 C 15.1867 -6.2953 0 0
M  V30 23 C 4.702 2.1446 0 0
M  V30 24 C 3.4031 -0.1055 0 0
M  V30 25 O 15.6503 -7.7219 0 0
M  V30 26 O 16.1903 -5.1806 0 0
M  V30 27 C 3.403 1.3945 0 0 CFG=1
M  V30 28 O 2.1039 2.1444 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 6 3 CFG=1
M  V30 6 1 3 7 CFG=3
M  V30 7 1 4 8
M  V30 8 1 4 9 CFG=3
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 1 7 9
M  V30 13 1 8 14
M  V30 14 1 8 15 CFG=1
M  V30 15 1 11 10 CFG=3
M  V30 16 1 11 16
M  V30 17 1 12 13 CFG=3
M  V30 18 1 12 17
M  V30 19 1 14 18
M  V30 20 1 16 19 CFG=3
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 1 20 17 CFG=3
M  V30 24 1 18 22
M  V30 25 1 20 23
M  V30 26 1 21 24
M  V30 27 2 22 25
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 24 27
M  V30 31 1 27 28 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 2 3 4 6 8 11 12 16 20 27) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
chenodeoxycholic_acid

> <ID>
chenodeoxycholic_acid

> <PRIMARY_SOM>
27

> <SECONDARY_SOM>
17

> <Citation>
Deo and Bandiera,Drug Metab. Disp.,36,1983,2008

> <DOI>
10.1124/dmd.108.022194

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
chlorpromazine_compound_1
  SciTegic08102311042D

 26 28  0  0  0  0            999 V2000
    7.4192   12.6495    0.0000 C   0  0
    6.1202   13.3995    0.0000 F   0  0
    8.7183   13.3995    0.0000 F   0  0
    7.4192   14.1495    0.0000 F   0  0
    7.4192    6.6495    0.0000 S   0  0
    4.8211    8.1495    0.0000 N   0  0
    3.5221    8.8995    0.0000 C   0  0
    2.2231    8.1495    0.0000 C   0  0
    0.9240    8.8995    0.0000 C   0  0
   -0.3750    8.1495    0.0000 C   0  0
   -1.6740    8.8995    0.0000 C   0  0
   -2.9731    8.1495    0.0000 N   0  0
   -4.2721    8.8995    0.0000 C   0  0
   -2.9731    6.6495    0.0000 C   0  0
    6.1202    8.8995    0.0000 C   0  0
    4.8211    6.6495    0.0000 C   0  0
    7.4192    8.1495    0.0000 C   0  0
    6.1202    5.8995    0.0000 C   0  0
    6.1202   10.3995    0.0000 C   0  0
    3.5221    5.8995    0.0000 C   0  0
    8.7183    8.8995    0.0000 C   0  0
    6.1202    4.3995    0.0000 C   0  0
    7.4192   11.1495    0.0000 C   0  0
    3.5221    4.3995    0.0000 C   0  0
    8.7183   10.3995    0.0000 C   0  0
    4.8211    3.6495    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1 23  1  0
  5 17  1  0
  5 18  1  0
  6  7  1  0
  6 15  1  0
  6 16  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 15 17  2  0
 15 19  1  0
 16 18  2  0
 16 20  1  0
 17 21  1  0
 18 22  1  0
 19 23  2  0
 20 24  2  0
 21 25  2  0
 22 26  2  0
 23 25  1  0
 24 26  1  0
M  END
> <Name>
chlorpromazine_compound_1

> <ID>
chlorpromazine_compound_1

> <PRIMARY_SOM>
5

> <Citation>
Cashman et al.,Drug Metab. Disp.,21,492,1993

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
chlorpropamide
  SciTegic08102311042D

 17 17  0  0  0  0            999 V2000
    4.6471    2.7990    0.0000 C   0  0
    5.9462    2.0490    0.0000 S   0  0
    4.6471    4.2990    0.0000 C   0  0
    3.3481    2.0490    0.0000 C   0  0
    6.6961    3.3481    0.0000 N   0  0
    5.1961    0.7500    0.0000 O   0  0
    7.2452    1.2990    0.0000 O   0  0
    3.3481    5.0490    0.0000 C   0  0
    2.0490    2.7990    0.0000 C   0  0
    8.1961    3.3481    0.0000 C   0  0
    2.0490    4.2990    0.0000 C   0  0
    8.9461    4.6471    0.0000 N   0  0
    8.9462    2.0490    0.0000 O   0  0
    0.7500    5.0490    0.0000 Cl  0  0
   10.4461    4.6471    0.0000 C   0  0
   11.1961    5.9462    0.0000 C   0  0
   12.6961    5.9462    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  2  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  8 11  2  0
  9 11  1  0
 10 12  1  0
 10 13  2  0
 11 14  1  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
M  END
> <Name>
chlorpropamide

> <ID>
chlorpropamide

> <PRIMARY_SOM>
4 3

> <Citation>
Shon et al.,Brit. J. Clin. Pharma.,59,552,2005

> <DOI>
10.1111/j.1365-2125.2005.02364.x

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
cholic_acid
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.2746 -3.4672 0 0
M  V30 2 C 10.1178 -1.9755 0 0 CFG=2
M  V30 3 C 10.1178 -0.4755 0 0 CFG=2
M  V30 4 C 11.5444 -2.439 0 0 CFG=1
M  V30 5 C 8.8188 -2.7255 0 0 CFG=2
M  V30 6 C 8.8188 0.2745 0 0 CFG=1
M  V30 7 C 11.5444 -0.0119 0 0
M  V30 8 C 12.0079 -3.8656 0 0 CFG=1
M  V30 9 C 12.4261 -1.2255 0 0
M  V30 10 O 8.8188 -4.2255 0 0
M  V30 11 C 7.5197 -1.9755 0 0
M  V30 12 C 7.5197 -0.4755 0 0 CFG=2
M  V30 13 C 8.8188 1.7745 0 0 CFG=1
M  V30 14 O 10.1178 2.5245 0 0
M  V30 15 C 13.4751 -4.1774 0 0
M  V30 16 C 11.0042 -4.9803 0 0
M  V30 17 C 6.2207 0.2745 0 0 CFG=2
M  V30 18 C 7.5197 2.5245 0 0
M  V30 19 C 13.9387 -5.604 0 0
M  V30 20 C 6.2207 -1.2255 0 0
M  V30 21 C 6.2207 1.7745 0 0 CFG=1
M  V30 22 C 4.9216 -0.4755 0 0
M  V30 23 C 15.4059 -5.9159 0 0
M  V30 24 C 4.9216 2.5245 0 0
M  V30 25 C 3.6226 0.2745 0 0
M  V30 26 O 15.8694 -7.3425 0 0
M  V30 27 O 16.4096 -4.8012 0 0
M  V30 28 C 3.6226 1.7745 0 0 CFG=1
M  V30 29 O 2.3236 2.5245 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 6 3 CFG=1
M  V30 6 1 3 7 CFG=3
M  V30 7 1 4 8
M  V30 8 1 4 9 CFG=3
M  V30 9 1 5 10 CFG=3
M  V30 10 1 5 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 7 9
M  V30 14 1 8 15
M  V30 15 1 8 16 CFG=1
M  V30 16 1 12 11 CFG=3
M  V30 17 1 12 17
M  V30 18 1 13 14 CFG=3
M  V30 19 1 13 18
M  V30 20 1 15 19
M  V30 21 1 17 20 CFG=3
M  V30 22 1 17 21
M  V30 23 1 17 22
M  V30 24 1 21 18 CFG=3
M  V30 25 1 19 23
M  V30 26 1 21 24
M  V30 27 1 22 25
M  V30 28 2 23 26
M  V30 29 1 23 27
M  V30 30 1 24 28
M  V30 31 1 25 28
M  V30 32 1 28 29 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 2 3 4 5 6 8 12 13 17 21 28) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
cholic_acid

> <ID>
cholic_acid

> <PRIMARY_SOM>
28 29

> <Citation>
Deo and Bandiera,Drug Metab. Disp.,36,1983,2008

> <DOI>
10.1124/dmd.108.022194

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
cibenzoline
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.8033 -7.4481 0 0
M  V30 2 C 3.7675 -6.2991 0 0 CFG=2
M  V30 3 C 1.5042 -6.6981 0 0
M  V30 4 C 2.2902 -8.8577 0 0
M  V30 5 C 4.2805 -7.7086 0 0
M  V30 6 C 4.0279 -4.8219 0 0
M  V30 7 C 1.5042 -5.1981 0 0
M  V30 8 C 0.2052 -7.4481 0 0
M  V30 9 C 3.2544 -10.0068 0 0
M  V30 10 C 0.813 -9.1182 0 0
M  V30 11 N 2.9859 -3.7429 0 0
M  V30 12 N 5.3761 -4.1643 0 0
M  V30 13 C 0.2052 -4.4481 0 0
M  V30 14 C -1.0938 -6.6981 0 0
M  V30 15 C 2.7414 -11.4163 0 0
M  V30 16 C 0.3 -10.5277 0 0
M  V30 17 C 3.6901 -2.4184 0 0
M  V30 18 C 5.1674 -2.6789 0 0
M  V30 19 C -1.0938 -5.1981 0 0
M  V30 20 C 1.2642 -11.6768 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 5
M  V30 6 1 2 6 CFG=1
M  V30 7 2 3 7
M  V30 8 1 3 8
M  V30 9 2 4 9
M  V30 10 1 4 10
M  V30 11 1 6 11
M  V30 12 2 6 12
M  V30 13 1 7 13
M  V30 14 2 8 14
M  V30 15 1 9 15
M  V30 16 2 10 16
M  V30 17 1 11 17
M  V30 18 1 12 18
M  V30 19 2 13 19
M  V30 20 1 14 19
M  V30 21 2 15 20
M  V30 22 1 16 20
M  V30 23 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
cibenzoline

> <ID>
cibenzoline

> <PRIMARY_SOM>
17 18

> <Citation>
Niwa et al.,Drug Metab. Disp.,28,1128,2000

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
clopidogrel
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.354 6.9571 0 0
M  V30 2 C 6.7805 6.4936 0 0
M  V30 3 C 7.6622 7.7071 0 0
M  V30 4 S 6.7805 8.9207 0 0
M  V30 5 C 5.354 8.4571 0 0
M  V30 6 C 4.0549 9.2071 0 0
M  V30 7 C 2.7559 8.4571 0 0
M  V30 8 N 2.7559 6.9571 0 0
M  V30 9 C 1.4568 6.2071 0 0 CFG=2
M  V30 10 C 1.4568 4.7071 0 0
M  V30 11 C 4.0549 6.2071 0 0
M  V30 12 C 0.1578 3.9571 0 0
M  V30 13 Cl -1.1412 4.7071 0 0
M  V30 14 C 0.1578 2.4571 0 0
M  V30 15 C 1.4568 1.7071 0 0
M  V30 16 C 2.7559 2.4571 0 0
M  V30 17 C 2.7559 3.9571 0 0
M  V30 18 C 0.1578 6.9571 0 0
M  V30 19 O -1.1412 6.2071 0 0
M  V30 20 O 0.1578 8.4571 0 0
M  V30 21 C -1.1412 9.2071 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 5
M  V30 3 1 1 11
M  V30 4 2 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 8 CFG=3
M  V30 11 1 8 11
M  V30 12 1 9 10
M  V30 13 1 9 18
M  V30 14 1 10 12
M  V30 15 2 10 17
M  V30 16 1 12 13
M  V30 17 2 12 14
M  V30 18 1 14 15
M  V30 19 2 15 16
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
clopidogrel

> <ID>
clopidogrel

> <PRIMARY_SOM>
3

> <Citation>
Dansette et al.,Chem. Res. Toxicol.,22,369,2009

> <DOI>
10.1021/tx8004828

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
clotiazepam
  SciTegic08102311042D

 21 23  0  0  0  0            999 V2000
   10.4039   -0.4040    0.0000 C   0  0
    9.9618    1.0294    0.0000 Cl  0  0
    9.3837   -1.5036    0.0000 C   0  0
    7.9213   -1.1698    0.0000 C   0  0
    9.8258   -2.9369    0.0000 C   0  0
   11.2882   -3.2707    0.0000 C   0  0
   12.3085   -2.1711    0.0000 C   0  0
   11.8663   -0.7378    0.0000 C   0  0
    7.5875    0.2926    0.0000 C   0  0
    6.2360    0.9434    0.0000 C   0  0
    4.8846    0.2926    0.0000 N   0  0
    3.7118    1.2278    0.0000 C   0  0
    4.5508   -1.1698    0.0000 C   0  0
    3.0884   -1.5036    0.0000 O   0  0
    5.4860   -2.3426    0.0000 C   0  0
    6.9860   -2.3426    0.0000 N   0  0
    8.6241    1.3768    0.0000 C   0  0
    7.9133    2.6977    0.0000 C   0  0
    8.5641    4.0491    0.0000 C   0  0
    7.7191    5.2885    0.0000 C   0  0
    6.4374    2.4298    0.0000 S   0  0
  1  2  1  0
  1  3  1  0
  1  8  2  0
  3  4  1  0
  3  5  2  0
  4  9  1  0
  4 16  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  9 10  2  0
  9 17  1  0
 10 11  1  0
 10 21  1  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 17 18  2  0
 18 19  1  0
 18 21  1  0
 19 20  1  0
M  END
> <Name>
clotiazepam

> <ID>
clotiazepam

> <PRIMARY_SOM>
12 19

> <Citation>
Mandrioli et al.,Curr. Drug Metab.,9,827,2008
Niwa et al.,Biol. Pharm. Bull.,28,1711,2005

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
coumarin
  SciTegic08102311042D

 11 12  0  0  0  0            999 V2000
   -3.6228    3.2743    0.0000 C   0  0
   -3.6228    4.7743    0.0000 C   0  0
   -4.9219    5.5243    0.0000 C   0  0
   -6.2209    4.7742    0.0000 C   0  0
   -6.2208    3.2742    0.0000 C   0  0
   -4.9218    2.5243    0.0000 C   0  0
   -4.9217    1.0243    0.0000 C   0  0
   -3.6226    0.2743    0.0000 C   0  0
   -2.3236    1.0244    0.0000 C   0  0
   -1.0245    0.2745    0.0000 O   0  0
   -2.3237    2.5244    0.0000 O   0  0
  1  2  1  0
  1  6  2  0
  1 11  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
M  END
> <Name>
coumarin

> <ID>
coumarin

> <PRIMARY_SOM>
7 8

> <Citation>
Lewis et al.,Toxic.,20,256,2006

> <DOI>
10.1016/.tiv.2005.08.001

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
cyamemazine
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6471 -8.25 0 0
M  V30 2 C 5.9462 -7.5 0 0 CFG=1
M  V30 3 C 5.9462 -6 0 0
M  V30 4 N 4.6471 -5.25 0 0
M  V30 5 C 4.6471 -3.75 0 0
M  V30 6 C 5.9462 -3 0 0
M  V30 7 C 5.9462 -1.5 0 0
M  V30 8 C 4.6471 -0.75 0 0
M  V30 9 C 3.3481 -1.5 0 0
M  V30 10 C 3.3481 -3 0 0
M  V30 11 S 2.0491 -3.75 0 0
M  V30 12 C 2.0491 -5.25 0 0
M  V30 13 C 3.3481 -6 0 0
M  V30 14 C 3.3481 -7.5 0 0
M  V30 15 C 2.0491 -8.25 0 0
M  V30 16 C 0.75 -7.5 0 0
M  V30 17 C 0.75 -6 0 0
M  V30 18 C 2.0491 -9.75 0 0
M  V30 19 N 2.0491 -11.25 0 0
M  V30 20 C 7.2452 -8.25 0 0
M  V30 21 N 7.2452 -9.75 0 0
M  V30 22 C 8.5443 -10.5 0 0
M  V30 23 C 5.9462 -10.5 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 13
M  V30 7 1 5 6
M  V30 8 2 5 10
M  V30 9 2 6 7
M  V30 10 1 7 8
M  V30 11 2 8 9
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 2 12 17
M  V30 17 2 13 14
M  V30 18 1 14 15
M  V30 19 2 15 16
M  V30 20 1 15 18
M  V30 21 1 16 17
M  V30 22 3 18 19
M  V30 23 1 20 21
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
cyamemazine

> <ID>
cyamemazine

> <PRIMARY_SOM>
22 23

> <SECONDARY_SOM>
6 7 8 9 11

> <Citation>
Arbus et al., European Journal of Pharmaceutical Sciences, 2007, 32, 357-366

> <DOI>
10.1016/j.ejps.2007.09.003

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
dapsone
  SciTegic08102311042D

 17 18  0  0  0  0            999 V2000
   -2.1212   -2.1778    0.0000 N   0  0
   -3.6212   -2.1788    0.0000 C   0  0
   -4.3720   -0.8802    0.0000 C   0  0
   -5.8720   -0.8812    0.0000 C   0  0
   -6.6212   -2.1807    0.0000 C   0  0
   -5.8703   -3.4793    0.0000 C   0  0
   -4.3703   -3.4783    0.0000 C   0  0
   -8.1212   -2.1817    0.0000 S   0  0
   -8.1221   -0.6817    0.0000 C   0  0
   -9.6212   -2.1827    0.0000 O   0  0
   -8.1202   -3.6817    0.0000 O   0  0
   -9.4217    0.0674    0.0000 C   0  0
   -9.4226    1.5674    0.0000 C   0  0
   -8.1241    2.3183    0.0000 C   0  0
   -8.1251    3.8183    0.0000 N   0  0
   -6.8246    1.5691    0.0000 C   0  0
   -6.8236    0.0691    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  7  2  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  8  1  0
  6  7  1  0
  8  9  1  0
  8 10  2  0
  8 11  2  0
  9 12  1  0
  9 17  2  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
M  END
> <Name>
dapsone

> <ID>
dapsone

> <PRIMARY_SOM>
1 15

> <Citation>
Mitra et al.,Clin. Pharmacol. Ther.,58,556,1995

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
delta9_tetrahydrocannabinol
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -3.3481 3.75 0 0 CFG=2
M  V30 2 C -3.3481 5.25 0 0
M  V30 3 C -4.6471 3 0 0 CFG=1
M  V30 4 C -2.049 3 0 0
M  V30 5 C -4.6471 6 0 0
M  V30 6 C -2.0491 6 0 0
M  V30 7 C -5.9462 3.75 0 0
M  V30 8 C -4.6471 1.5 0 0
M  V30 9 C -2.049 1.5 0 0
M  V30 10 O -5.9462 5.25 0 0
M  V30 11 C -4.6471 7.5 0 0
M  V30 12 C -2.0491 7.5 0 0
M  V30 13 O -0.75 5.25 0 0
M  V30 14 C -6.4592 2.3405 0 0
M  V30 15 C -7.4234 4.0105 0 0
M  V30 16 C -3.3481 0.75 0 0
M  V30 17 C -0.75 0.75 0 0
M  V30 18 C -3.3481 8.25 0 0
M  V30 19 C -3.3481 9.75 0 0
M  V30 20 C -2.0491 10.5 0 0
M  V30 21 C -2.0491 12 0 0
M  V30 22 C -0.75 12.75 0 0
M  V30 23 C -0.75 14.25 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=3
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 2 6 12
M  V30 12 1 6 13
M  V30 13 1 7 10
M  V30 14 1 7 14
M  V30 15 1 7 15
M  V30 16 1 8 16
M  V30 17 1 9 16
M  V30 18 1 9 17
M  V30 19 2 11 18
M  V30 20 1 12 18
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 1 20 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 3) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
delta9_tetrahydrocannabinol

> <ID>
delta9_tetrahydrocannabinol

> <PRIMARY_SOM>
16

> <SECONDARY_SOM>
4 9

> <Citation>
Maurer et al.,Ther. Drug. Monit.,28,447,2006

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
deoxypodophyllotoxin
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.254 -1.4765 0 0
M  V30 2 O 11.8359 -4.1166 0 0
M  V30 3 O 3.323 -2.6901 0 0
M  V30 4 O 3.323 -0.263 0 0
M  V30 5 O 11.2448 -7.4765 0 0
M  V30 6 O 6.0487 -7.4765 0 0
M  V30 7 O 8.6468 -8.9765 0 0
M  V30 8 C 9.9458 -2.2265 0 0 CFG=1
M  V30 9 C 9.9458 -0.7265 0 0 CFG=1
M  V30 10 C 8.6467 -2.9765 0 0 CFG=1
M  V30 11 C 8.6467 0.0235 0 0
M  V30 12 C 7.3477 -2.2265 0 0
M  V30 13 C 11.3724 -0.263 0 0
M  V30 14 C 7.3477 -0.7265 0 0
M  V30 15 C 11.3724 -2.6901 0 0
M  V30 16 C 8.6467 -4.4765 0 0
M  V30 17 C 6.0487 -2.9765 0 0
M  V30 18 C 6.0487 0.0235 0 0
M  V30 19 C 4.7496 -2.2266 0 0
M  V30 20 C 4.7496 -0.7266 0 0
M  V30 21 C 7.3477 -5.2265 0 0
M  V30 22 C 9.9458 -5.2265 0 0
M  V30 23 C 9.9458 -6.7265 0 0
M  V30 24 C 7.3477 -6.7265 0 0
M  V30 25 C 8.6468 -7.4765 0 0
M  V30 26 C 2.4414 -1.4766 0 0
M  V30 27 C 12.5439 -6.7265 0 0
M  V30 28 C 4.7496 -6.7266 0 0
M  V30 29 C 7.3477 -9.7265 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 15
M  V30 3 2 2 15
M  V30 4 1 3 19
M  V30 5 1 3 26
M  V30 6 1 4 20
M  V30 7 1 4 26
M  V30 8 1 5 23
M  V30 9 1 5 27
M  V30 10 1 6 24
M  V30 11 1 6 28
M  V30 12 1 7 25
M  V30 13 1 7 29
M  V30 14 1 8 9
M  V30 15 1 8 10
M  V30 16 1 8 15 CFG=3
M  V30 17 1 9 11 CFG=1
M  V30 18 1 9 13
M  V30 19 1 10 12
M  V30 20 1 10 16 CFG=3
M  V30 21 1 11 14
M  V30 22 2 12 14
M  V30 23 1 12 17
M  V30 24 1 14 18
M  V30 25 2 16 21
M  V30 26 1 16 22
M  V30 27 2 17 19
M  V30 28 2 18 20
M  V30 29 1 19 20
M  V30 30 1 21 24
M  V30 31 2 22 23
M  V30 32 1 23 25
M  V30 33 2 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 9 10) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
deoxypodophyllotoxin

> <ID>
deoxypodophyllotoxin

> <PRIMARY_SOM>
11 26 27 28 29

> <Citation>
Kye Lee et al., Rapid Commun. Mass Spectrom., 2008, 22, 52-58

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
diazinon
  SciTegic08102311042D

 19 19  0  0  0  0            999 V2000
    0.9441   -1.7902    0.0000 P   0  0
    1.2115   -0.3142    0.0000 O   0  0
    0.6766   -3.2662    0.0000 O   0  0
    2.4200   -2.0576    0.0000 O   0  0
   -0.5319   -1.5228    0.0000 S   0  0
   -0.0840    0.4419    0.0000 C   0  0
    1.8211   -4.2358    0.0000 C   0  0
    3.3896   -0.9131    0.0000 C   0  0
   -0.0769    1.9419    0.0000 N   0  0
   -1.3866   -0.3020    0.0000 C   0  0
    1.5537   -5.7117    0.0000 C   0  0
    4.8656   -1.1806    0.0000 C   0  0
   -1.3724    2.6980    0.0000 C   0  0
   -1.3653    4.1980    0.0000 C   0  0
   -2.6608    4.9541    0.0000 C   0  0
   -0.0628    4.9418    0.0000 C   0  0
   -2.6820    0.4541    0.0000 C   0  0
   -3.9846   -0.2897    0.0000 C   0  0
   -2.6750    1.9541    0.0000 N   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  1  0
  6  9  2  0
  6 10  1  0
  7 11  1  0
  8 12  1  0
  9 13  1  0
 10 17  2  0
 13 14  1  0
 13 19  2  0
 14 15  1  0
 14 16  1  0
 17 18  1  0
 17 19  1  0
M  END
> <Name>
diazinon

> <ID>
diazinon

> <PRIMARY_SOM>
1 5

> <Citation>
Mutch et al.,Toxicology,224,22,2006

> <DOI>
10.1016/j.tox.2006.04.024

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
dibenzo_a_h_anthracene
  SciTegic08102311042D

 22 26  0  0  0  0            999 V2000
    6.7693    7.7749    0.0000 C   0  0
    6.7693    9.2749    0.0000 C   0  0
    5.4702   10.0248    0.0000 C   0  0
    4.1712    9.2747    0.0000 C   0  0
    4.1713    7.7747    0.0000 C   0  0
    2.8723    7.0247    0.0000 C   0  0
    2.8723    5.5247    0.0000 C   0  0
    1.5733    4.7746    0.0000 C   0  0
    1.5734    3.2746    0.0000 C   0  0
    2.8725    2.5247    0.0000 C   0  0
    4.1715    3.2747    0.0000 C   0  0
    4.1714    4.7747    0.0000 C   0  0
    5.4704    5.5248    0.0000 C   0  0
    5.4703    7.0248    0.0000 C   0  0
    8.0683   10.0249    0.0000 C   0  0
    9.3673    9.2750    0.0000 C   0  0
    9.3674    7.7750    0.0000 C   0  0
    8.0684    7.0249    0.0000 C   0  0
    0.2744    2.5245    0.0000 C   0  0
   -1.0247    3.2745    0.0000 C   0  0
   -1.0248    4.7745    0.0000 C   0  0
    0.2742    5.5245    0.0000 C   0  0
  1  2  1  0
  1 14  1  0
  1 18  2  0
  2  3  1  0
  2 15  2  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5 14  2  0
  6  7  2  0
  7  8  1  0
  7 12  1  0
  8  9  1  0
  8 22  2  0
  9 10  1  0
  9 19  2  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
M  END
> <Name>
dibenzo_a_h_anthracene

> <ID>
dibenzo_a_h_anthracene

> <PRIMARY_SOM>
3 4 10 11

> <SECONDARY_SOM>
15 16 19 20

> <TERTIARY_SOM>
17 18 21 22

> <Citation>
Shou, M.G.; Krausz, K.W.; Gonzalez, F.J.; Gelboin, H.V. Metabolic Activation of the Potent Carcinogen Dibenzo[a,h]Anthracene by cDNA-Expresed Human Cytochromes P450. Arch. Biochem. Biophys. 1996, 328,
 201207.

> <DOI>
10.1006/abbi.1996.0161

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
dibenzo_a_l_pyrene
  SciTegic08102311042D

 24 29  0  0  0  0            999 V2000
    4.1713    7.7747    0.0000 C   0  0
    4.1712    9.2747    0.0000 C   0  0
    2.8721   10.0247    0.0000 C   0  0
    1.5731    9.2746    0.0000 C   0  0
    0.2740   10.0245    0.0000 C   0  0
   -1.0250    9.2745    0.0000 C   0  0
   -1.0249    7.7745    0.0000 C   0  0
   -2.3239    7.0244    0.0000 C   0  0
   -2.3238    5.5244    0.0000 C   0  0
   -1.0248    4.7745    0.0000 C   0  0
    0.2743    5.5245    0.0000 C   0  0
    1.5733    4.7746    0.0000 C   0  0
    2.8723    5.5247    0.0000 C   0  0
    2.8723    7.0247    0.0000 C   0  0
    1.5732    7.7746    0.0000 C   0  0
    0.2742    7.0245    0.0000 C   0  0
    5.4702   10.0248    0.0000 C   0  0
    6.7693    9.2749    0.0000 C   0  0
    6.7693    7.7749    0.0000 C   0  0
    5.4703    7.0248    0.0000 C   0  0
    4.1714    4.7747    0.0000 C   0  0
    4.1715    3.2747    0.0000 C   0  0
    2.8725    2.5247    0.0000 C   0  0
    1.5734    3.2746    0.0000 C   0  0
  1  2  1  0
  1 14  1  0
  1 20  2  0
  2  3  1  0
  2 17  2  0
  3  4  2  0
  4  5  1  0
  4 15  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7 16  2  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 12 24  2  0
 13 14  1  0
 13 21  2  0
 14 15  2  0
 15 16  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
M  END
> <Name>
dibenzo_a_l_pyrene

> <ID>
dibenzo_a_l_pyrene

> <PRIMARY_SOM>
8 17 18

> <SECONDARY_SOM>
5 6 19 20

> <Citation>
Shou, M.; Krausz, K.W.; Gonzalez, F.J.; Gelboin, H.V. Metabolic Activation of the Potent Carcinogen Dibenzo[a,l ]pyrene by Human Recombinant Cytochromes P450, Lung and Liver Microsomes. Carcinogenesis
 1996, 17, 24292433.

> <DOI>
10.1093/carcin/17.11.2429

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
diphenhydramine
  SciTegic08102311042D

 19 20  0  0  0  0            999 V2000
    4.2722   -1.3993    0.0000 C   0  0
    5.5713   -2.1492    0.0000 C   0  0
    6.8703   -1.3992    0.0000 C   0  0
    5.5713   -3.6492    0.0000 O   0  0
    6.8704   -4.3992    0.0000 C   0  0
    6.8705   -5.8992    0.0000 C   0  0
    8.1696   -6.6491    0.0000 N   0  0
    8.1697   -8.1491    0.0000 C   0  0
    9.4686   -5.8990    0.0000 C   0  0
    4.2721    0.1007    0.0000 C   0  0
    2.9730    0.8506    0.0000 C   0  0
    1.6740    0.1006    0.0000 C   0  0
    1.6741   -1.3994    0.0000 C   0  0
    2.9732   -2.1494    0.0000 C   0  0
    6.8702    0.1008    0.0000 C   0  0
    8.1692    0.8509    0.0000 C   0  0
    9.4683    0.1010    0.0000 C   0  0
    9.4683   -1.3990    0.0000 C   0  0
    8.1693   -2.1491    0.0000 C   0  0
  1  2  1  0
  1 10  1  0
  1 14  2  0
  2  3  1  0
  2  4  1  0
  3 15  1  0
  3 19  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
M  END
> <Name>
diphenhydramine

> <ID>
diphenhydramine

> <PRIMARY_SOM>
8 9

> <Citation>
Tomoko Akutsu, Kaoru Kobayashi, Koichi Sakurada, Hiroshi Ikegaya, Tomomi Furihata, and Kan Chiba, Identification of Human Cytochrome P450 Isozymes Involved in Diphenhydramine N-Demethylation, DRUG MET
ABOLISM AND DISPOSITION, 35:7278, 2007

> <DOI>
10.1124/dmd.106.012088

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
diuron
  SciTegic08102311042D

 14 14  0  0  0  0            999 V2000
    3.6226    1.2255    0.0000 Cl  0  0
    1.0245   -0.2745    0.0000 Cl  0  0
    4.9216   -5.5245    0.0000 O   0  0
    7.5197   -5.5245    0.0000 N   0  0
    6.2207   -3.2745    0.0000 N   0  0
    4.9216   -2.5245    0.0000 C   0  0
    6.2207   -4.7745    0.0000 C   0  0
    4.9216   -1.0245    0.0000 C   0  0
    3.6226   -3.2745    0.0000 C   0  0
    7.5197   -7.0245    0.0000 C   0  0
    8.8188   -4.7745    0.0000 C   0  0
    3.6226   -0.2745    0.0000 C   0  0
    2.3236   -2.5245    0.0000 C   0  0
    2.3236   -1.0245    0.0000 C   0  0
  1 12  1  0
  2 14  1  0
  3  7  2  0
  4  7  1  0
  4 10  1  0
  4 11  1  0
  5  6  1  0
  5  7  1  0
  6  8  2  0
  6  9  1  0
  8 12  1  0
  9 13  2  0
 12 14  2  0
 13 14  1  0
M  END
> <Name>
diuron

> <ID>
diuron

> <PRIMARY_SOM>
10 11

> <Citation>
Abass et al.,Drug Metab. Disp.,35,1634,2007

> <DOI>
10.1124/dmd.107.016295

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
efavirenz
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl -10.0412 4.5198 0 0
M  V30 2 F -7.8943 2.5784 0 0
M  V30 3 F -6.4171 2.8389 0 0
M  V30 4 F -5.4529 1.6898 0 0
M  V30 5 O -7.4431 -1.4802 0 0
M  V30 6 O -8.7422 -3.7302 0 0
M  V30 7 N -10.0412 -1.4802 0 0
M  V30 8 C -3.0115 -0.7616 0 0
M  V30 9 C -1.8624 -1.7258 0 0
M  V30 10 C -1.6019 -0.2486 0 0
M  V30 11 C -7.4431 0.0198 0 0 CFG=2
M  V30 12 C -4.4887 -0.5011 0 0
M  V30 13 C -8.7422 0.7698 0 0
M  V30 14 C -5.9659 -0.2407 0 0
M  V30 15 C -10.0412 0.0198 0 0
M  V30 16 C -6.9301 1.4293 0 0
M  V30 17 C -8.7422 2.2698 0 0
M  V30 18 C -11.3402 0.7698 0 0
M  V30 19 C -8.7422 -2.2302 0 0
M  V30 20 C -10.0412 3.0198 0 0
M  V30 21 C -11.3402 2.2698 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 2 16
M  V30 3 1 3 16
M  V30 4 1 4 16
M  V30 5 1 5 11
M  V30 6 1 5 19
M  V30 7 2 6 19
M  V30 8 1 7 15
M  V30 9 1 7 19
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 12
M  V30 13 1 9 10
M  V30 14 1 11 13
M  V30 15 1 11 14 CFG=3
M  V30 16 1 11 16
M  V30 17 3 12 14
M  V30 18 2 13 15
M  V30 19 1 13 17
M  V30 20 1 15 18
M  V30 21 2 17 20
M  V30 22 2 18 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
efavirenz

> <ID>
efavirenz

> <PRIMARY_SOM>
18

> <Citation>
Ward et al., J. Pharm. Exp. Ther., 2003, 306, 287-300

> <DOI>
10.1124/jpet.103.049601

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ethanol
  SciTegic08102311042D

  3  2  0  0  0  0            999 V2000
   -1.2990   -0.2500    0.0000 C   0  0
    0.0000    0.5000    0.0000 C   0  0
    1.2990   -0.2500    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
M  END
> <Name>
ethanol

> <ID>
ethanol

> <PRIMARY_SOM>
2

> <Citation>
Hamitouche et al.,Toxic. Let.,167,221,2006

> <DOI>
10.1016/j.toxlet.2006,09.011

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ethinylestradiol
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O -2.3236 -2.5245 0 0
M  V30 2 C -3.6226 -1.7745 0 0
M  V30 3 C -3.6226 -0.2745 0 0
M  V30 4 C -4.9216 0.4755 0 0
M  V30 5 C -4.9216 1.9755 0 0
M  V30 6 C -6.2207 2.7255 0 0
M  V30 7 C -7.5197 1.9755 0 0 CFG=1
M  V30 8 C -8.8188 2.7255 0 0 CFG=2
M  V30 9 C -9.1306 4.1927 0 0
M  V30 10 C -10.6224 4.3495 0 0
M  V30 11 C -11.2325 2.9792 0 0 CFG=1
M  V30 12 O -12.1142 1.7657 0 0
M  V30 13 C -12.5316 3.7292 0 0
M  V30 14 C -13.8306 4.4792 0 0
M  V30 15 C -10.1178 1.9755 0 0 CFG=1
M  V30 16 C -10.1178 0.4755 0 0
M  V30 17 C -8.8188 -0.2745 0 0
M  V30 18 C -7.5197 0.4755 0 0 CFG=2
M  V30 19 C -6.2207 -0.2745 0 0
M  V30 20 C -6.2207 -1.7745 0 0
M  V30 21 C -4.9216 -2.5245 0 0
M  V30 22 C -11.3614 1.1367 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 2 2 21
M  V30 4 2 3 4
M  V30 5 1 4 5
M  V30 6 1 4 19
M  V30 7 1 5 6
M  V30 8 1 7 6 CFG=3
M  V30 9 1 7 8
M  V30 10 1 7 18
M  V30 11 1 8 9 CFG=1
M  V30 12 1 8 15
M  V30 13 1 9 10
M  V30 14 1 10 11
M  V30 15 1 11 12 CFG=1
M  V30 16 1 11 13
M  V30 17 1 11 15
M  V30 18 3 13 14
M  V30 19 1 15 16
M  V30 20 1 15 22 CFG=1
M  V30 21 1 16 17
M  V30 22 1 18 17 CFG=1
M  V30 23 1 18 19
M  V30 24 2 19 20
M  V30 25 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 7 8 11 15 18) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
ethinylestradiol

> <ID>
ethinylestradiol

> <PRIMARY_SOM>
21

> <SECONDARY_SOM>
3

> <Citation>
Wang et al., Drug Metab. Dispos. 2004, 32, 1209-1212

> <DOI>
10.1124/dmd.104.000182

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ethylmorphine
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O -4.1429 3.2143 0 0
M  V30 2 O -5.7739 4.0981 0 0
M  V30 3 O -4.784 6.6666 0 0
M  V30 4 N 1.7153 -0.9903 0 0
M  V30 5 C -1.7153 0.9903 0 0 CFG=1
M  V30 6 C 0 1.9807 0 0 CFG=2
M  V30 7 C 1.7153 0.9903 0 0 CFG=1
M  V30 8 C -3.7311 1.2769 0 0 CFG=2
M  V30 9 C -1.7153 -0.9903 0 0
M  V30 10 C -0.9556 2.8793 0 0
M  V30 11 C 1.9697 3.3603 0 0
M  V30 12 C 0 -1.9807 0 0
M  V30 13 C 0.2933 4.4153 0 0
M  V30 14 C -3.9348 3.3629 0 0 CFG=2
M  V30 15 C -0.5654 4.0081 0 0
M  V30 16 C -2.4276 4.2046 0 0
M  V30 17 C -2.4364 4.6582 0 0
M  V30 18 C 0.5017 6.2695 0 0
M  V30 19 C 3.4306 -1.9807 0 0
M  V30 20 C -2.9187 6.0044 0 0
M  V30 21 C -1.285 7.1243 0 0
M  V30 22 C -5.1455 8.6151 0 0
M  V30 23 C -7.0122 9.2771 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=1
M  V30 2 1 1 16
M  V30 3 1 14 2 CFG=1
M  V30 4 1 3 20
M  V30 5 1 3 22
M  V30 6 1 4 7
M  V30 7 1 4 12
M  V30 8 1 4 19
M  V30 9 1 5 6
M  V30 10 1 5 8
M  V30 11 1 5 9 CFG=1
M  V30 12 1 5 10
M  V30 13 1 6 7
M  V30 14 1 6 15 CFG=1
M  V30 15 1 7 11 CFG=1
M  V30 16 1 8 14
M  V30 17 1 9 12
M  V30 18 2 10 13
M  V30 19 1 10 16
M  V30 20 1 11 13
M  V30 21 1 13 18
M  V30 22 1 14 17
M  V30 23 2 15 17
M  V30 24 2 16 20
M  V30 25 2 18 21
M  V30 26 1 20 21
M  V30 27 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 5 6 7 8 14) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
ethylmorphine

> <ID>
ethylmorphine

> <PRIMARY_SOM>
19

> <Citation>
Liu et al.,Br. J. Clin. Pharmacol.,39,77,1995

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

> <CleanMessage>
Could not clean structure or member

$$$$
etizolam
  SciTegic08102311042D

 23 26  0  0  0  0            999 V2000
    9.2097    1.7283    0.0000 C   0  0
    8.7676    3.1617    0.0000 Cl  0  0
    8.1894    0.6287    0.0000 C   0  0
    6.7271    0.9625    0.0000 C   0  0
    8.6316   -0.8046    0.0000 C   0  0
   10.0940   -1.1384    0.0000 C   0  0
   11.1142   -0.0388    0.0000 C   0  0
   10.6721    1.3945    0.0000 C   0  0
    6.3933    2.4249    0.0000 C   0  0
    5.0418    3.0757    0.0000 C   0  0
    3.6904    2.4249    0.0000 N   0  0
    3.3566    0.9625    0.0000 C   0  0
    4.2918   -0.2103    0.0000 C   0  0
    5.7918   -0.2103    0.0000 N   0  0
    7.4298    3.5091    0.0000 C   0  0
    6.7190    4.8300    0.0000 C   0  0
    7.3699    6.1814    0.0000 C   0  0
    6.5249    7.4208    0.0000 C   0  0
    5.2431    4.5621    0.0000 S   0  0
    2.4027    3.1942    0.0000 C   0  0
    2.2682    4.6882    0.0000 C   0  0
    1.2731    2.2073    0.0000 N   0  0
    1.8626    0.8280    0.0000 N   0  0
  1  2  1  0
  1  3  1  0
  1  8  2  0
  3  4  1  0
  3  5  2  0
  4  9  1  0
  4 14  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  9 10  2  0
  9 15  1  0
 10 11  1  0
 10 19  1  0
 11 12  1  0
 11 20  1  0
 12 13  1  0
 12 23  2  0
 13 14  1  0
 15 16  2  0
 16 17  1  0
 16 19  1  0
 17 18  1  0
 20 21  1  0
 20 22  2  0
 22 23  1  0
M  END
> <Name>
etizolam

> <ID>
etizolam

> <PRIMARY_SOM>
13 21

> <Citation>
Mandrioli et al.,Curr. Drug Metab.,9,827,2008
Niwa et al.,Biol. Pharm. Bull.,28,1711,2005

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
fk_506_M1
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 56 59 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -2.825 1.8855 0 0 CFG=2
M  V30 2 C -3.7661 0.7175 0 0 CFG=1
M  V30 3 O -1.3429 1.6546 0 0
M  V30 4 C -3.225 -0.6816 0 0 CFG=2
M  V30 5 C -2.6856 3.493 0 0
M  V30 6 O -5.2482 0.9484 0 0
M  V30 7 C -0.4018 2.8227 0 0 CFG=2
M  V30 8 C -4.1661 -1.8496 0 0
M  V30 9 O -1.9412 0.0942 0 0
M  V30 10 C -1.2865 4.034 0 0 CFG=2
M  V30 11 C 1.0803 2.5917 0 0
M  V30 12 O 0.3787 4.1036 0 0
M  V30 13 C -3.6251 -3.2487 0 0 CFG=2
M  V30 14 C -1.9712 1.5939 0 0
M  V30 15 C -0.8641 5.4733 0 0
M  V30 16 C 1.6213 1.1927 0 0
M  V30 17 O 2.0214 3.7598 0 0
M  V30 18 C -2.1429 -3.4796 0 0
M  V30 19 C -4.5661 -4.4167 0 0
M  V30 20 N 3.1035 0.9617 0 0
M  V30 21 O 0.6803 0.0246 0 0
M  V30 22 C -1.6019 -4.8786 0 0
M  V30 23 C 3.6445 -0.4373 0 0 CFG=2
M  V30 24 C 4.0445 2.1298 0 0
M  V30 25 C -0.1198 -5.1096 0 0
M  V30 26 C -2.543 -6.0467 0 0
M  V30 27 C 5.1266 -0.6682 0 0
M  V30 28 C 4.9381 -0.4871 0 0
M  V30 29 C 5.5266 1.8989 0 0
M  V30 30 C 0.4213 -6.5086 0 0 CFG=2
M  V30 31 O 5.6677 -2.0673 0 0
M  V30 32 O 6.0677 0.4998 0 0
M  V30 33 C 6.0677 0.4998 0 0
M  V30 34 C 1.9034 -6.7396 0 0
M  V30 35 C -0.5198 -7.6767 0 0
M  V30 36 C 4.7266 -3.2354 0 0 CFG=2
M  V30 37 C 2.8445 -5.5715 0 0
M  V30 38 O 2.4444 -8.1386 0 0
M  V30 39 C 0.0212 -9.0757 0 0
M  V30 40 C 3.2445 -3.0044 0 0
M  V30 41 C 5.2677 -4.6344 0 0 CFG=1
M  V30 42 C 4.3266 -5.8025 0 0 CFG=1
M  V30 43 C -0.9199 -10.2438 0 0
M  V30 44 C 2.7034 -1.6054 0 0
M  V30 45 C 2.3034 -4.1725 0 0
M  V30 46 C 6.7498 -4.8653 0 0
M  V30 47 O 4.8676 -7.2015 0 0
M  V30 48 C 1.2213 -1.3744 0 0 CFG=1
M  V30 49 C 0.2802 -2.5425 0 0
M  V30 50 C 0.6803 0.0246 0 0
M  V30 51 C -1.2019 -2.3115 0 0 CFG=2
M  V30 52 C -0.8019 0.2556 0 0
M  V30 53 C -1.7429 -0.9125 0 0 CFG=1
M  V30 54 O -2.6214 -1.8267 0 0
M  V30 55 O -3.225 -0.6816 0 0
M  V30 56 C -3.751 -2.8137 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9 CFG=1
M  V30 9 1 5 10
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 12 CFG=1
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 1 10 15 CFG=1
M  V30 16 1 11 16
M  V30 17 2 11 17
M  V30 18 1 13 18
M  V30 19 1 13 19 CFG=3
M  V30 20 1 16 20
M  V30 21 2 16 21
M  V30 22 1 18 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 2 22 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 1 23 28 CFG=3
M  V30 29 1 24 29
M  V30 30 1 25 30
M  V30 31 1 27 31
M  V30 32 2 27 32
M  V30 33 1 28 33
M  V30 34 1 29 33
M  V30 35 1 30 34
M  V30 36 1 30 35 CFG=3
M  V30 37 1 31 36
M  V30 38 1 34 37
M  V30 39 2 34 38
M  V30 40 1 35 39
M  V30 41 1 36 40 CFG=1
M  V30 42 1 36 41
M  V30 43 1 37 42
M  V30 44 2 39 43
M  V30 45 2 40 44
M  V30 46 1 40 45
M  V30 47 1 41 42
M  V30 48 1 41 46 CFG=3
M  V30 49 1 42 47 CFG=1
M  V30 50 1 48 44 CFG=1
M  V30 51 1 48 49
M  V30 52 1 48 50
M  V30 53 1 49 51
M  V30 54 1 50 52
M  V30 55 1 51 53
M  V30 56 1 51 54 CFG=1
M  V30 57 1 52 53
M  V30 58 1 53 55 CFG=3
M  V30 59 1 54 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(14 1 2 4 7 10 13 23 30 36 41 42 48 51 53) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
fk_506_M1

> <ID>
fk_506_M1

> <PRIMARY_SOM>
14

> <Citation>
Vincent et al.,Arch. Biochem. Biophys.,294,454,1992

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
indiplon
  SciTegic08102311042D

 27 30  0  0  0  0            999 V2000
    5.4044   15.6087    0.0000 C   0  0
    6.8962   15.4519    0.0000 C   0  0
    7.2080   13.9847    0.0000 C   0  0
    5.9090   13.2347    0.0000 S   0  0
    4.7943   14.2384    0.0000 C   0  0
    3.3271   13.9265    0.0000 C   0  0
    2.8635   12.4999    0.0000 C   0  0
    2.3234   15.0412    0.0000 O   0  0
    3.7452   11.2864    0.0000 C   0  0
    2.8635   10.0729    0.0000 N   0  0
    1.4369   10.5364    0.0000 N   0  0
    1.4369   12.0364    0.0000 C   0  0
    0.1379    9.7864    0.0000 C   0  0
    0.1379    8.2864    0.0000 C   0  0
   -1.1611   10.5364    0.0000 C   0  0
   -1.1611   12.0364    0.0000 C   0  0
    0.1379   12.7864    0.0000 N   0  0
   -1.1611    7.5364    0.0000 C   0  0
   -1.1611    6.0364    0.0000 C   0  0
   -2.4602    5.2864    0.0000 N   0  0
   -3.7592    6.0364    0.0000 C   0  0
   -2.4602    3.7864    0.0000 C   0  0
   -1.1611    3.0364    0.0000 C   0  0
   -3.7592    3.0364    0.0000 O   0  0
    0.1379    5.2864    0.0000 C   0  0
    1.4369    6.0364    0.0000 C   0  0
    1.4369    7.5364    0.0000 C   0  0
  1  2  1  0
  1  5  2  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  7  9  1  0
  7 12  2  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 12 17  1  0
 13 14  1  0
 13 15  2  0
 14 18  1  0
 14 27  2  0
 15 16  1  0
 16 17  2  0
 18 19  2  0
 19 20  1  0
 19 25  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 22 24  2  0
 25 26  2  0
 26 27  1  0
M  END
> <Name>
indiplon

> <ID>
indiplon

> <PRIMARY_SOM>
21

> <Citation>
Madan et al.,Xenobiotica,37,736,2007

> <DOI>
10.1080/00498250701433054

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ipriflavone
  SciTegic08102311042D

 21 23  0  0  0  0            999 V2000
   13.3654   -5.3504    0.0000 C   0  0
   12.0664   -4.6005    0.0000 C   0  0
   10.7673   -5.3505    0.0000 C   0  0
   12.0663   -3.1005    0.0000 O   0  0
   10.7673   -2.3505    0.0000 C   0  0
   10.7673   -0.8505    0.0000 C   0  0
    9.4683   -0.1005    0.0000 C   0  0
    8.1692   -0.8505    0.0000 C   0  0
    8.1692   -2.3505    0.0000 C   0  0
    9.4683   -3.1005    0.0000 C   0  0
    6.8702   -0.1005    0.0000 C   0  0
    5.5712   -0.8505    0.0000 O   0  0
    6.8702    1.3995    0.0000 C   0  0
    8.1692    2.1495    0.0000 C   0  0
    9.4683    1.3995    0.0000 O   0  0
    5.5712    2.1495    0.0000 C   0  0
    4.2721    1.3995    0.0000 C   0  0
    2.9731    2.1495    0.0000 C   0  0
    2.9731    3.6495    0.0000 C   0  0
    4.2721    4.3995    0.0000 C   0  0
    5.5712    3.6495    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  5 10  2  0
  6  7  2  0
  7  8  1  0
  7 15  1  0
  8  9  2  0
  8 11  1  0
  9 10  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 13 16  1  0
 14 15  1  0
 16 17  1  0
 16 21  2  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
M  END
> <Name>
ipriflavone

> <ID>
ipriflavone

> <PRIMARY_SOM>
2

> <Citation>
Moon et al., Xenobiotica, 2007, 37, 246-259

> <DOI>
10.1080/00498250601146962

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
jpc_2056
  SciTegic08102311042D

 27 27  0  0  0  0            999 V2000
    2.3236   -2.5245    0.0000 O   0  0
    7.5197   -5.5245    0.0000 O   0  0
   10.1178  -10.0245    0.0000 O   0  0
   12.7159  -16.0245    0.0000 N   0  0
   10.1178  -11.5245    0.0000 N   0  0
   11.4169  -13.7745    0.0000 N   0  0
   14.0149  -13.7745    0.0000 N   0  0
   12.7159  -11.5245    0.0000 N   0  0
    8.8188   -7.7745    0.0000 C   0  0
    7.5197   -7.0245    0.0000 C   0  0
    8.8188   -9.2745    0.0000 C   0  0
   14.0149  -16.7745    0.0000 C   0  0
    6.2207   -4.7745    0.0000 C   0  0
   14.0149  -18.2745    0.0000 C   0  0
   15.3140  -16.0245    0.0000 C   0  0
    6.2207   -3.2745    0.0000 C   0  0
    4.9216   -5.5245    0.0000 C   0  0
    3.6226   -4.7745    0.0000 C   0  0
    4.9216   -2.5245    0.0000 C   0  0
    3.6226   -3.2745    0.0000 C   0  0
   12.7159  -14.5245    0.0000 C   0  0
   11.4169  -12.2745    0.0000 C   0  0
    7.5197   -2.5245    0.0000 Cl  0  0
    2.3236   -1.0245    0.0000 C   0  0
    1.0245   -0.2745    0.0000 F   0  0
    3.6226   -0.2745    0.0000 F   0  0
    2.3236    0.4755    0.0000 F   0  0
  1 20  1  0
  1 24  1  0
  2 10  1  0
  2 13  1  0
  3  5  1  0
  3 11  1  0
  4 12  1  0
  4 21  2  0
  5 22  1  0
  6 21  1  0
  6 22  2  0
  7 21  1  0
  8 22  1  0
  9 10  1  0
  9 11  1  0
 12 14  1  0
 12 15  1  0
 13 16  2  0
 13 17  1  0
 16 19  1  0
 16 23  1  0
 17 18  2  0
 18 20  1  0
 19 20  2  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
M  END
> <Name>
jpc_2056

> <ID>
jpc_2056

> <PRIMARY_SOM>
5 12

> <Citation>
Diaz et al.,Drug Metab. Disp.,36,380,2008

> <DOI>
10.1124/dmd.106.013920

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
licofelone
  SciTegic08102311042D

 27 30  0  0  0  0            999 V2000
   -5.1286    1.2704    0.0000 Cl  0  0
   -1.6856   10.1595    0.0000 O   0  0
    0.0528    8.2287    0.0000 O   0  0
   -4.3786    9.5787    0.0000 N   0  0
   -5.1286   11.8869    0.0000 C   0  0
   -3.9150   11.0052    0.0000 C   0  0
   -6.3421   11.0052    0.0000 C   0  0
   -5.8786    9.5787    0.0000 C   0  0
   -3.9150    8.1521    0.0000 C   0  0
   -6.3421    8.1521    0.0000 C   0  0
   -4.1249   13.0016    0.0000 C   0  0
   -6.1323   13.0016    0.0000 C   0  0
   -5.1286    7.2704    0.0000 C   0  0
   -2.4885    7.6885    0.0000 C   0  0
   -7.7687    7.6885    0.0000 C   0  0
   -5.1286    5.7704    0.0000 C   0  0
   -8.8834    8.6922    0.0000 C   0  0
   -8.0805    6.2213    0.0000 C   0  0
   -1.3737    8.6922    0.0000 C   0  0
   -6.4276    5.0204    0.0000 C   0  0
   -3.8295    5.0204    0.0000 C   0  0
  -10.3100    8.2287    0.0000 C   0  0
   -9.5071    5.7578    0.0000 C   0  0
   -6.4276    3.5204    0.0000 C   0  0
   -3.8295    3.5204    0.0000 C   0  0
  -10.6218    6.7615    0.0000 C   0  0
   -5.1286    2.7704    0.0000 C   0  0
  1 27  1  0
  2 19  1  0
  3 19  2  0
  4  6  1  0
  4  8  1  0
  4  9  1  0
  5  6  1  0
  5  7  1  0
  5 11  1  0
  5 12  1  0
  7  8  1  0
  8 10  2  0
  9 13  2  0
  9 14  1  0
 10 13  1  0
 10 15  1  0
 13 16  1  0
 14 19  1  0
 15 17  2  0
 15 18  1  0
 16 20  2  0
 16 21  1  0
 17 22  1  0
 18 23  2  0
 20 24  1  0
 21 25  2  0
 22 26  2  0
 23 26  1  0
 24 27  2  0
 25 27  1  0
M  END
> <Name>
licofelone

> <ID>
licofelone

> <PRIMARY_SOM>
26

> <Citation>
Albrecht et al.,Drug Metab. Disp.,36,894,2008

> <DOI>
10.1124/dmd.108.020347

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
limonene
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5712 -0.8502 0 0 CFG=1
M  V30 2 C 6.8703 -1.6001 0 0
M  V30 3 C 5.5711 0.6498 0 0
M  V30 4 C 4.2722 -1.6003 0 0
M  V30 5 C 8.1693 -0.8501 0 0
M  V30 6 C 6.8704 -3.1001 0 0
M  V30 7 C 4.272 1.3997 0 0
M  V30 8 C 2.9731 -0.8503 0 0
M  V30 9 C 2.973 0.6497 0 0
M  V30 10 C 1.674 1.3996 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
limonene

> <ID>
limonene

> <PRIMARY_SOM>
10

> <SECONDARY_SOM>
7

> <Citation>
Miyazawa et al.,Drug Metab. Disp.,30,602,2002

> <DOI>
10.1124/dmd.30.5.602

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
melatonin
  SciTegic08102311042D

 17 18  0  0  0  0            999 V2000
    6.2207    0.2748    0.0000 C   0  0
    6.2206    1.7748    0.0000 C   0  0
    7.6473   -0.1886    0.0000 C   0  0
    4.9217   -0.4752    0.0000 C   0  0
    7.6471    2.2384    0.0000 N   0  0
    4.9215    2.5248    0.0000 C   0  0
    8.5289    1.0250    0.0000 C   0  0
    8.1109   -1.6152    0.0000 C   0  0
    3.6226    0.2747    0.0000 C   0  0
    3.6225    1.7747    0.0000 C   0  0
    9.5781   -1.9270    0.0000 C   0  0
    2.3236   -0.4754    0.0000 O   0  0
   10.0417   -3.3535    0.0000 N   0  0
    1.0245    0.2746    0.0000 C   0  0
   11.5089   -3.6653    0.0000 C   0  0
   12.5126   -2.5506    0.0000 C   0  0
   11.9725   -5.0919    0.0000 O   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5  7  1  0
  6 10  2  0
  8 11  1  0
  9 10  1  0
  9 12  1  0
 11 13  1  0
 12 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  2  0
M  END
> <Name>
melatonin

> <ID>
melatonin

> <PRIMARY_SOM>
10

> <Citation>
X. C. Ma, J. R. Idle, K. W. Krausz, F. J. Gonzalez, Drug Metab. Dispos. 2005, 33, 489-494.

> <DOI>
10.1124/dmd.104.002410

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
meperidine
  SciTegic08102311042D

 18 19  0  0  0  0            999 V2000
    6.4170    4.1853    0.0000 C   0  0
    7.7160    3.4353    0.0000 C   0  0
    6.4170    5.6853    0.0000 C   0  0
    5.1180    3.4353    0.0000 C   0  0
    5.1180    6.4353    0.0000 C   0  0
    3.8189    4.1853    0.0000 C   0  0
    3.8189    5.6853    0.0000 C   0  0
    8.2291    4.8449    0.0000 C   0  0
    9.7063    5.1054    0.0000 C   0  0
   10.6705    3.9563    0.0000 N   0  0
   12.1477    4.2168    0.0000 C   0  0
   10.1574    2.5467    0.0000 C   0  0
    8.6802    2.2863    0.0000 C   0  0
    6.7519    2.2863    0.0000 C   0  0
    5.2746    2.5467    0.0000 O   0  0
    7.2649    0.8767    0.0000 O   0  0
    6.3007   -0.2723    0.0000 C   0  0
    6.8138   -1.6819    0.0000 C   0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  8  1  0
  2 13  1  0
  2 14  1  0
  3  5  1  0
  4  6  2  0
  5  7  2  0
  6  7  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
M  END
> <Name>
meperidine

> <ID>
meperidine

> <PRIMARY_SOM>
11

> <Citation>
Ramirez et al.,Drug Metab. Disp.,32,930,2004

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
mesoridazine
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7262 -2.8821 0 0
M  V30 2 C 7.7262 -1.3821 0 0
M  V30 3 S 5.1281 -1.3821 0 0
M  V30 4 C 6.4272 -3.6321 0 0
M  V30 5 C 6.4272 -0.6321 0 0
M  V30 6 C 5.1281 -2.8821 0 0
M  V30 7 C 9.0252 -3.6321 0 0
M  V30 8 N 11.6233 -5.1321 0 0
M  V30 9 C 9.0252 -0.6321 0 0
M  V30 10 C 9.0252 -5.1321 0 0
M  V30 11 C 10.3243 -5.8821 0 0 CFG=1
M  V30 12 C 6.4272 0.8679 0 0
M  V30 13 C 9.0252 0.8679 0 0
M  V30 14 S 10.3243 1.6179 0 0 CFG=2
M  V30 15 O 10.3243 3.1179 0 0
M  V30 16 C 7.7262 1.6179 0 0
M  V30 17 C 11.6233 -3.6321 0 0
M  V30 18 C 12.9224 -5.8821 0 0
M  V30 19 C 6.4272 -5.1321 0 0
M  V30 20 C 3.8291 -3.6321 0 0
M  V30 21 C 10.3243 -7.3821 0 0
M  V30 22 C 11.6233 0.8679 0 0
M  V30 23 C 12.9224 -7.3821 0 0
M  V30 24 C 5.1281 -5.8821 0 0
M  V30 25 C 3.8291 -5.1321 0 0
M  V30 26 C 11.6233 -8.1321 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 1 7
M  V30 4 2 2 5
M  V30 5 1 2 9
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 2 4 6
M  V30 9 1 4 19
M  V30 10 1 5 12
M  V30 11 1 6 20
M  V30 12 1 7 10
M  V30 13 1 8 11
M  V30 14 1 8 17
M  V30 15 1 8 18
M  V30 16 2 9 13
M  V30 17 1 11 10 CFG=3
M  V30 18 1 11 21
M  V30 19 2 12 16
M  V30 20 1 13 14
M  V30 21 1 13 16
M  V30 22 2 14 15
M  V30 23 1 14 22 CFG=3
M  V30 24 1 18 23
M  V30 25 2 19 24
M  V30 26 2 20 25
M  V30 27 1 21 26
M  V30 28 1 23 26
M  V30 29 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 14) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
mesoridazine

> <ID>
mesoridazine

> <PRIMARY_SOM>
14

> <Citation>
Wojcikowski et al.,Drug Metab. Disp.,34,471,2006

> <DOI>
10.1124/dmd.105.006445

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
methoxychlor
  SciTegic08102311042D

 21 22  0  0  0  0            999 V2000
    7.5197   -2.5245    0.0000 C   0  0
    6.2207   -1.7745    0.0000 C   0  0
    7.5197   -4.0245    0.0000 C   0  0
    8.8188   -1.7745    0.0000 C   0  0
    6.2207   -0.2745    0.0000 C   0  0
    4.9216   -2.5245    0.0000 C   0  0
    8.8188   -4.7745    0.0000 C   0  0
    6.2207   -4.7745    0.0000 C   0  0
   10.1178   -2.5245    0.0000 Cl  0  0
   10.1178   -1.0245    0.0000 Cl  0  0
    8.8187   -0.2745    0.0000 Cl  0  0
    4.9216    0.4755    0.0000 C   0  0
    3.6226   -1.7745    0.0000 C   0  0
    8.8188   -6.2745    0.0000 C   0  0
    6.2207   -6.2745    0.0000 C   0  0
    3.6226   -0.2745    0.0000 C   0  0
    7.5197   -7.0245    0.0000 C   0  0
    2.3236    0.4755    0.0000 O   0  0
    7.5197   -8.5245    0.0000 O   0  0
    1.0245   -0.2745    0.0000 C   0  0
    6.2207   -9.2745    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  1  0
  4 11  1  0
  5 12  1  0
  6 13  2  0
  7 14  1  0
  8 15  2  0
 12 16  2  0
 13 16  1  0
 14 17  2  0
 15 17  1  0
 16 18  1  0
 17 19  1  0
 18 20  1  0
 19 21  1  0
M  END
> <Name>
methoxychlor

> <ID>
methoxychlor

> <PRIMARY_SOM>
20 21

> <Citation>
Hu et al.,Drug Metab. Disp.,30,1035,2002

> <DOI>
10.1124/dmd.30.9.1035

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
methoxychlor_bis_OH
  SciTegic08102311042D

 19 20  0  0  0  0            999 V2000
    6.2207   -3.2745    0.0000 C   0  0
    4.9216   -2.5245    0.0000 C   0  0
    6.2207   -4.7745    0.0000 C   0  0
    7.5197   -2.5245    0.0000 C   0  0
    4.9216   -1.0245    0.0000 C   0  0
    3.6226   -3.2745    0.0000 C   0  0
    7.5197   -5.5245    0.0000 C   0  0
    4.9216   -5.5245    0.0000 C   0  0
    8.8188   -3.2745    0.0000 Cl  0  0
    8.8187   -1.7745    0.0000 Cl  0  0
    7.5197   -1.0245    0.0000 Cl  0  0
    3.6226   -0.2745    0.0000 C   0  0
    2.3236   -2.5245    0.0000 C   0  0
    7.5197   -7.0245    0.0000 C   0  0
    4.9216   -7.0245    0.0000 C   0  0
    2.3236   -1.0245    0.0000 C   0  0
    6.2207   -7.7745    0.0000 C   0  0
    1.0245   -0.2745    0.0000 O   0  0
    6.2207   -9.2745    0.0000 O   0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  1  0
  4 11  1  0
  5 12  1  0
  6 13  2  0
  7 14  1  0
  8 15  2  0
 12 16  2  0
 13 16  1  0
 14 17  2  0
 15 17  1  0
 16 18  1  0
 17 19  1  0
M  END
> <Name>
methoxychlor_bis_OH

> <ID>
methoxychlor_bis_OH

> <PRIMARY_SOM>
12 13 14 15

> <Citation>
Hu et al.,Drug Metab. Disp.,30,1035,2002

> <DOI>
10.1124/dmd.30.9.1035

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
metoclopramide
  SciTegic08102311042D

 20 20  0  0  0  0            999 V2000
    6.2207   -1.7745    0.0000 C   0  0
    6.2207   -0.2745    0.0000 C   0  0
    4.9216   -2.5245    0.0000 C   0  0
    7.5197   -2.5245    0.0000 C   0  0
    4.9216    0.4755    0.0000 C   0  0
    7.5197    0.4755    0.0000 O   0  0
    3.6226   -1.7745    0.0000 C   0  0
    7.5197   -4.0245    0.0000 N   0  0
    8.8188   -1.7745    0.0000 O   0  0
    3.6226   -0.2745    0.0000 C   0  0
    7.5197    1.9755    0.0000 C   0  0
    2.3236   -2.5245    0.0000 Cl  0  0
    8.8188   -4.7745    0.0000 C   0  0
    2.3236    0.4755    0.0000 N   0  0
    8.8188   -6.2745    0.0000 C   0  0
   10.1178   -7.0245    0.0000 N   0  0
   10.1178   -8.5245    0.0000 C   0  0
   11.4168   -6.2745    0.0000 C   0  0
   11.4168   -9.2745    0.0000 C   0  0
   12.7159   -7.0245    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  4  8  1  0
  4  9  2  0
  5 10  2  0
  6 11  1  0
  7 10  1  0
  7 12  1  0
  8 13  1  0
 10 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 17 19  1  0
 18 20  1  0
M  END
> <Name>
metoclopramide

> <ID>
metoclopramide

> <PRIMARY_SOM>
18 17

> <Citation>
Desta et al.,Drug Metab. Disp.,30,336,2002

> <DOI>
10.1124/dmd.30.3.336

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
metolachlor
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2721 -1.3995 0 0
M  V30 2 N 5.5712 -2.1495 0 0
M  V30 3 C 4.2721 0.1005 0 0
M  V30 4 C 2.9731 -2.1495 0 0
M  V30 5 C 6.8702 -1.3995 0 0
M  V30 6 C 5.5712 -3.6495 0 0 CFG=1
M  V30 7 C 4.2721 -4.3995 0 0
M  V30 8 C 2.9731 0.8505 0 0
M  V30 9 C 5.5712 0.8505 0 0
M  V30 10 C 1.674 -1.3995 0 0
M  V30 11 C 2.9731 -3.6495 0 0
M  V30 12 C 8.1692 -2.1495 0 0
M  V30 13 O 6.8702 0.1005 0 0
M  V30 14 C 6.8702 -4.3995 0 0
M  V30 15 C 1.674 0.1005 0 0
M  V30 16 C 5.5712 2.3505 0 0
M  V30 17 Cl 9.4683 -1.3995 0 0
M  V30 18 O 6.8702 -5.8995 0 0
M  V30 19 C 8.1693 -6.6495 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 8
M  V30 7 1 3 9
M  V30 8 2 4 10
M  V30 9 1 4 11
M  V30 10 1 5 12
M  V30 11 2 5 13
M  V30 12 1 6 7 CFG=3
M  V30 13 1 6 14
M  V30 14 2 8 15
M  V30 15 1 9 16
M  V30 16 1 10 15
M  V30 17 1 12 17
M  V30 18 1 14 18
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
metolachlor

> <ID>
metolachlor

> <PRIMARY_SOM>
19

> <Citation>
Coleman et al.,Env. Health Perspec.,108,1151,2000
Coleman et al.,Chem. Biol. Inter.,122,27,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
mk_0457
  SciTegic08102311042D

 33 37  0  0  0  0            999 V2000
    9.8433    7.8036    0.0000 S   0  0
   13.7404    2.5536    0.0000 O   0  0
   15.0394    4.8036    0.0000 N   0  0
    4.6471    7.8037    0.0000 N   0  0
    2.0490    9.3037    0.0000 N   0  0
    7.2452    7.8037    0.0000 N   0  0
    8.5442    5.5536    0.0000 N   0  0
    7.2452    3.3037    0.0000 N   0  0
    5.7893    1.0619    0.0000 N   0  0
    4.3221    0.7500    0.0000 N   0  0
   16.3385    2.5536    0.0000 C   0  0
   17.0885    1.2546    0.0000 C   0  0
   17.8385    2.5536    0.0000 C   0  0
   15.0394    3.3036    0.0000 C   0  0
    4.6471    9.3037    0.0000 C   0  0
    3.3481    7.0537    0.0000 C   0  0
    3.3481   10.0537    0.0000 C   0  0
    2.0490    7.8037    0.0000 C   0  0
    5.9462    7.0537    0.0000 C   0  0
   13.7404    5.5536    0.0000 C   0  0
    0.7500   10.0537    0.0000 C   0  0
    5.9461    5.5537    0.0000 C   0  0
   13.7404    7.0536    0.0000 C   0  0
   12.4413    4.8036    0.0000 C   0  0
    7.2452    4.8037    0.0000 C   0  0
    8.5442    7.0536    0.0000 C   0  0
   11.1423    7.0536    0.0000 C   0  0
   12.4413    7.8036    0.0000 C   0  0
   11.1423    5.5536    0.0000 C   0  0
    5.9461    2.5537    0.0000 C   0  0
    4.5758    3.1638    0.0000 C   0  0
    3.5721    2.0490    0.0000 C   0  0
    2.0803    2.2058    0.0000 C   0  0
  1 26  1  0
  1 27  1  0
  2 14  2  0
  3 14  1  0
  3 20  1  0
  4 15  1  0
  4 16  1  0
  4 19  1  0
  5 17  1  0
  5 18  1  0
  5 21  1  0
  6 19  2  0
  6 26  1  0
  7 25  1  0
  7 26  2  0
  8 25  1  0
  8 30  1  0
  9 10  1  0
  9 30  2  0
 10 32  1  0
 11 12  1  0
 11 13  1  0
 11 14  1  0
 12 13  1  0
 15 17  1  0
 16 18  1  0
 19 22  1  0
 20 23  2  0
 20 24  1  0
 22 25  2  0
 23 28  1  0
 24 29  2  0
 27 28  2  0
 27 29  1  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
M  END
> <Name>
mk_0457

> <ID>
mk_0457

> <PRIMARY_SOM>
21

> <SECONDARY_SOM>
5

> <Citation>
Ballard et al.,Drug Metab. Disp.,35,1447,2007

> <DOI>
10.1124/dmd.107.015438

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ml_3403
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S -1.7402 6.9411 0 0
M  V30 2 F 6.4277 12.0998 0 0
M  V30 3 N 7.3218 6.5933 0 0
M  V30 4 N 0.5016 8.3969 0 0
M  V30 5 N 0.7553 5.9832 0 0
M  V30 6 N 6.0228 4.3433 0 0
M  V30 7 C 7.3218 8.0933 0 0 CFG=1
M  V30 8 C 8.6208 8.8433 0 0
M  V30 9 C 2.1256 6.5933 0 0
M  V30 10 C 3.4247 5.8433 0 0
M  V30 11 C 1.9688 8.0851 0 0
M  V30 12 C 6.0228 5.8433 0 0
M  V30 13 C 6.0227 8.8433 0 0
M  V30 14 C 4.7237 6.5933 0 0
M  V30 15 C 3.0836 9.0887 0 0
M  V30 16 C 8.6208 10.3433 0 0
M  V30 17 C 9.9199 8.0933 0 0
M  V30 18 C 3.4247 4.3433 0 0
M  V30 19 C -0.2484 7.0979 0 0
M  V30 20 C 4.7237 3.5933 0 0
M  V30 21 C 4.5102 8.6252 0 0
M  V30 22 C 2.7717 10.556 0 0
M  V30 23 C 9.9199 11.0933 0 0
M  V30 24 C 11.2189 8.8433 0 0
M  V30 25 C 11.2189 10.3433 0 0
M  V30 26 C 5.6249 9.6289 0 0
M  V30 27 C 3.8864 11.5597 0 0
M  V30 28 C 5.313 11.0961 0 0
M  V30 29 C -2.3503 5.5708 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 1 29
M  V30 3 1 2 28
M  V30 4 1 3 7
M  V30 5 1 3 12
M  V30 6 1 4 11
M  V30 7 1 4 19
M  V30 8 1 5 9
M  V30 9 2 5 19
M  V30 10 1 6 12
M  V30 11 2 6 20
M  V30 12 1 7 8
M  V30 13 1 7 13 CFG=3
M  V30 14 2 8 16
M  V30 15 1 8 17
M  V30 16 1 9 10
M  V30 17 2 9 11
M  V30 18 1 10 14
M  V30 19 2 10 18
M  V30 20 1 11 15
M  V30 21 2 12 14
M  V30 22 2 15 21
M  V30 23 1 15 22
M  V30 24 1 16 23
M  V30 25 2 17 24
M  V30 26 1 18 20
M  V30 27 1 21 26
M  V30 28 2 22 27
M  V30 29 2 23 25
M  V30 30 1 24 25
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
ml_3403

> <ID>
ml_3403

> <PRIMARY_SOM>
1

> <SECONDARY_SOM>
6

> <TERTIARY_SOM>
7

> <Citation>
Kammerer et al.,Drug Metab. Disp.,35,875,2007

> <DOI>
10.1124/dmd.106.013409

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ml_3603
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S -1.7402 6.9411 0 0 CFG=1
M  V30 2 O -2.3503 5.5708 0 0
M  V30 3 F 6.4277 12.0998 0 0
M  V30 4 N 7.3218 6.5933 0 0
M  V30 5 N 0.5016 8.3969 0 0
M  V30 6 N 0.7553 5.9832 0 0
M  V30 7 N 6.0228 4.3433 0 0
M  V30 8 C 7.3218 8.0933 0 0 CFG=1
M  V30 9 C 8.6208 8.8433 0 0
M  V30 10 C 2.1256 6.5933 0 0
M  V30 11 C 3.4247 5.8433 0 0
M  V30 12 C 1.9688 8.0851 0 0
M  V30 13 C 6.0228 5.8433 0 0
M  V30 14 C 6.0228 8.8433 0 0
M  V30 15 C 4.7237 6.5933 0 0
M  V30 16 C 3.0836 9.0887 0 0
M  V30 17 C 8.6208 10.3433 0 0
M  V30 18 C 9.9199 8.0933 0 0
M  V30 19 C 3.4247 4.3433 0 0
M  V30 20 C -0.2484 7.0979 0 0
M  V30 21 C 4.7237 3.5933 0 0
M  V30 22 C 4.5102 8.6252 0 0
M  V30 23 C 2.7717 10.556 0 0
M  V30 24 C 9.9199 11.0933 0 0
M  V30 25 C 11.2189 8.8433 0 0
M  V30 26 C 11.2189 10.3433 0 0
M  V30 27 C 5.6249 9.6289 0 0
M  V30 28 C 3.8864 11.5597 0 0
M  V30 29 C 5.313 11.0961 0 0
M  V30 30 C -2.6218 8.1546 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 20
M  V30 3 1 1 30 CFG=3
M  V30 4 1 3 29
M  V30 5 1 4 8
M  V30 6 1 4 13
M  V30 7 1 5 12
M  V30 8 1 5 20
M  V30 9 1 6 10
M  V30 10 2 6 20
M  V30 11 1 7 13
M  V30 12 2 7 21
M  V30 13 1 8 9
M  V30 14 1 8 14 CFG=3
M  V30 15 2 9 17
M  V30 16 1 9 18
M  V30 17 1 10 11
M  V30 18 2 10 12
M  V30 19 1 11 15
M  V30 20 2 11 19
M  V30 21 1 12 16
M  V30 22 2 13 15
M  V30 23 2 16 22
M  V30 24 1 16 23
M  V30 25 1 17 24
M  V30 26 2 18 25
M  V30 27 1 19 21
M  V30 28 1 22 27
M  V30 29 2 23 28
M  V30 30 2 24 26
M  V30 31 1 25 26
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
ml_3603

> <ID>
ml_3603

> <PRIMARY_SOM>
1 2

> <SECONDARY_SOM>
7

> <TERTIARY_SOM>
8

> <Citation>
Kammerer et al.,Drug Metab. Disp.,35,875,2007

> <DOI>
10.1124/dmd.106.013409

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
morphine
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.8498 7.8179 0 0
M  V30 2 C 6.0604 7.1254 0 0
M  V30 3 C 6.0604 5.7197 0 0
M  V30 4 C 4.8498 5.0221 0 0
M  V30 5 C 3.6443 5.7197 0 0
M  V30 6 C 3.6443 7.1254 0 0
M  V30 7 O 2.3461 7.8768 0 0
M  V30 8 C 4.8498 3.6319 0 0 CFG=1
M  V30 9 C 3.6443 2.9239 0 0 CFG=1
M  V30 10 O 2.4542 4.2988 0 0
M  V30 11 C 6.0809 2.9086 0 0 CFG=2
M  V30 12 C 6.0809 1.4979 0 0
M  V30 13 C 4.8703 0.7848 0 0
M  V30 14 C 3.6443 1.4979 0 0 CFG=1
M  V30 15 O 2.3441 0.75 0 0
M  V30 16 C 7.2916 5.0221 0 0
M  V30 17 C 7.3019 3.6319 0 0 CFG=1
M  V30 18 C 4.8703 2.1443 0 0
M  V30 19 N 8.256 2.1443 0 0
M  V30 20 C 9.6821 1.7749 0 0
M  V30 21 C 8.256 2.9855 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 16
M  V30 6 2 4 5
M  V30 7 1 4 8
M  V30 8 1 5 6
M  V30 9 1 5 10
M  V30 10 1 6 7
M  V30 11 1 8 9
M  V30 12 1 8 11
M  V30 13 1 8 18 CFG=1
M  V30 14 1 9 10 CFG=3
M  V30 15 1 9 14
M  V30 16 1 11 12 CFG=1
M  V30 17 1 11 17
M  V30 18 2 12 13
M  V30 19 1 13 14
M  V30 20 1 14 15 CFG=1
M  V30 21 1 17 16 CFG=1
M  V30 22 1 17 21
M  V30 23 1 18 19
M  V30 24 1 19 20
M  V30 25 1 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 8 9 11 14 17) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
morphine

> <ID>
morphine

> <PRIMARY_SOM>
20

> <Citation>
Projean et al.,Xeno.,33,841,2003

> <DOI>
10.1080/0049825031000121608

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
muraglitazar
  SciTegic08102311042D

 38 41  0  0  0  0            999 V2000
    8.9831   10.5000    0.0000 O   0  0
    2.7120    9.2454    0.0000 O   0  0
   12.8803    3.7500    0.0000 O   0  0
   11.5812    6.0000    0.0000 O   0  0
   16.7774    7.5000    0.0000 O   0  0
   18.0764    5.2500    0.0000 O   0  0
    7.6841    0.7500    0.0000 O   0  0
   14.1793    6.0000    0.0000 N   0  0
    4.9292    8.2582    0.0000 N   0  0
    6.3851   10.5000    0.0000 C   0  0
   14.1793    7.5000    0.0000 C   0  0
   12.8803    8.2500    0.0000 C   0  0
    5.0860    9.7500    0.0000 C   0  0
    7.6841    9.7500    0.0000 C   0  0
   10.2822    9.7500    0.0000 C   0  0
    3.7157   10.3601    0.0000 C   0  0
   12.8803    9.7500    0.0000 C   0  0
   11.5812    7.5000    0.0000 C   0  0
   11.5812   10.5000    0.0000 C   0  0
   10.2822    8.2500    0.0000 C   0  0
   15.4783    5.2500    0.0000 C   0  0
    3.4620    7.9464    0.0000 C   0  0
    2.8519    6.5761    0.0000 C   0  0
    3.4038   11.8274    0.0000 C   0  0
   12.8802    5.2500    0.0000 C   0  0
    3.7336    5.3625    0.0000 C   0  0
    1.3601    6.4193    0.0000 C   0  0
   16.7774    6.0000    0.0000 C   0  0
   11.5812    3.0000    0.0000 C   0  0
    3.1235    3.9922    0.0000 C   0  0
    0.7500    5.0489    0.0000 C   0  0
    1.6317    3.8354    0.0000 C   0  0
   11.5812    1.5000    0.0000 C   0  0
   10.2822    3.7500    0.0000 C   0  0
   10.2822    0.7500    0.0000 C   0  0
    8.9831    3.0000    0.0000 C   0  0
    8.9831    1.5000    0.0000 C   0  0
    6.3851    1.5000    0.0000 C   0  0
  1 14  1  0
  1 15  1  0
  2 16  1  0
  2 22  1  0
  3 25  1  0
  3 29  1  0
  4 25  2  0
  5 28  1  0
  6 28  2  0
  7 37  1  0
  7 38  1  0
  8 11  1  0
  8 21  1  0
  8 25  1  0
  9 13  1  0
  9 22  2  0
 10 13  1  0
 10 14  1  0
 11 12  1  0
 12 17  2  0
 12 18  1  0
 13 16  2  0
 15 19  2  0
 15 20  1  0
 16 24  1  0
 17 19  1  0
 18 20  2  0
 21 28  1  0
 22 23  1  0
 23 26  2  0
 23 27  1  0
 26 30  1  0
 27 31  2  0
 29 33  2  0
 29 34  1  0
 30 32  2  0
 31 32  1  0
 33 35  1  0
 34 36  2  0
 35 37  2  0
 36 37  1  0
M  END
> <Name>
muraglitazar

> <ID>
muraglitazar

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
24 10

> <TERTIARY_SOM>
13 16

> <Citation>
Zhang et al.,Drug Metab. Disp.,35,139,2007

> <DOI>
10.1124/dmd.106.011932

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
nelfinavir
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 40 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S -3.7583 -13.536 0 0
M  V30 2 O -6.3564 -13.5359 0 0
M  V30 3 O -3.7584 -9.0359 0 0
M  V30 4 O -2.4593 -8.2859 0 0
M  V30 5 O 1.4378 -4.5359 0 0
M  V30 6 N -6.3564 -10.5359 0 0
M  V30 7 N -8.9545 -13.5359 0 0
M  V30 8 N -1.1603 -10.5359 0 0
M  V30 9 C -8.9545 -9.0359 0 0 CFG=2
M  V30 10 C -7.6555 -8.2859 0 0 CFG=1
M  V30 11 C -8.9545 -10.5359 0 0
M  V30 12 C -6.3564 -9.0359 0 0
M  V30 13 C -10.2536 -8.2859 0 0
M  V30 14 C -7.6555 -6.7859 0 0
M  V30 15 C -7.6555 -11.2859 0 0 CFG=1
M  V30 16 C -10.2536 -6.7859 0 0
M  V30 17 C -8.9545 -6.0359 0 0
M  V30 18 C -5.0574 -11.2859 0 0
M  V30 19 C -7.6555 -12.7859 0 0
M  V30 20 C -3.7584 -10.5359 0 0 CFG=2
M  V30 21 C -2.4593 -11.2859 0 0 CFG=2
M  V30 22 C -8.9545 -15.0359 0 0
M  V30 23 C -2.4593 -12.7859 0 0
M  V30 24 C -10.2535 -15.786 0 0
M  V30 25 C -8.9545 -16.5359 0 0
M  V30 26 C -7.6555 -15.7859 0 0
M  V30 27 C -1.1603 -9.0359 0 0
M  V30 28 C 0.1388 -8.2859 0 0
M  V30 29 C -3.7583 -15.0359 0 0
M  V30 30 C 0.1388 -6.7859 0 0
M  V30 31 C 1.4378 -9.0359 0 0
M  V30 32 C -5.0574 -15.786 0 0
M  V30 33 C -2.4593 -15.786 0 0
M  V30 34 C 1.4378 -6.0359 0 0
M  V30 35 C -1.1603 -6.0359 0 0
M  V30 36 C 2.7368 -8.2859 0 0
M  V30 37 C -5.0574 -17.286 0 0
M  V30 38 C -2.4593 -17.286 0 0
M  V30 39 C 2.7368 -6.7859 0 0
M  V30 40 C -3.7583 -18.036 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 23
M  V30 2 1 1 29
M  V30 3 2 2 19
M  V30 4 1 20 3 CFG=1
M  V30 5 2 4 27
M  V30 6 1 5 34
M  V30 7 1 6 12
M  V30 8 1 6 15
M  V30 9 1 6 18
M  V30 10 1 7 19
M  V30 11 1 7 22
M  V30 12 1 21 8 CFG=1
M  V30 13 1 8 27
M  V30 14 1 9 10
M  V30 15 1 9 11 CFG=3
M  V30 16 1 9 13
M  V30 17 1 10 12 CFG=3
M  V30 18 1 10 14
M  V30 19 1 11 15
M  V30 20 1 13 16
M  V30 21 1 14 17
M  V30 22 1 15 19 CFG=3
M  V30 23 1 16 17
M  V30 24 1 18 20
M  V30 25 1 20 21
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 22 25
M  V30 29 1 22 26
M  V30 30 1 27 28
M  V30 31 2 28 30
M  V30 32 1 28 31
M  V30 33 2 29 32
M  V30 34 1 29 33
M  V30 35 1 30 34
M  V30 36 1 30 35
M  V30 37 2 31 36
M  V30 38 1 32 37
M  V30 39 2 33 38
M  V30 40 2 34 39
M  V30 41 1 36 39
M  V30 42 2 37 40
M  V30 43 1 38 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 9 10 15 20 21) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
nelfinavir

> <ID>
nelfinavir

> <PRIMARY_SOM>
39

> <SECONDARY_SOM>
5

> <Citation>
Vandana et al.,Drug Metab. Disp.,32,1462,2004

> <DOI>
10.1124/dmd.104.001743

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
nicotine
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.5703 -2.0042 0 0
M  V30 2 N 7.5702 -0.5042 0 0
M  V30 3 C 6.2711 0.2457 0 0
M  V30 4 C 3.673 0.2456 0 0 CFG=1
M  V30 5 C 4.9721 -0.5044 0 0
M  V30 6 C 4.9722 -2.0044 0 0
M  V30 7 C 6.2713 -2.7543 0 0
M  V30 8 N 3.5162 1.7374 0 0
M  V30 9 C 4.6308 2.7411 0 0
M  V30 10 C 2.0489 2.0492 0 0
M  V30 11 C 1.299 0.7501 0 0
M  V30 12 C 2.3028 -0.3646 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 7
M  V30 3 2 2 3
M  V30 4 1 3 5
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 8
M  V30 7 1 4 12
M  V30 8 2 5 6
M  V30 9 1 6 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
nicotine

> <ID>
nicotine

> <PRIMARY_SOM>
9

> <SECONDARY_SOM>
10

> <Citation>
Yamazaki et al.,Arch. Toxicol.,73,65,1999
Yamanaka et al.,Drug Metab. Disp.,33,1811,2005

> <DOI>
10.1007/s002040050588
10.1124/dmd.105.006254

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
nor_laam
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -3.5226 -6.3675 0 0
M  V30 2 C -3.0103 -4.9577 0 0
M  V30 3 C -2.0226 -6.3668 0 0 CFG=2
M  V30 4 C -5.0226 -6.3683 0 0
M  V30 5 C -3.5219 -7.8675 0 0
M  V30 6 C -3.9751 -3.8091 0 0 CFG=2
M  V30 7 O -1.272 -7.6654 0 0
M  V30 8 C -1.2733 -5.0674 0 0
M  V30 9 C -5.7733 -5.0696 0 0
M  V30 10 C -5.772 -7.6677 0 0
M  V30 11 C -4.8205 -8.6182 0 0
M  V30 12 C -2.2225 -8.6169 0 0
M  V30 13 N -3.4627 -2.3994 0 0
M  V30 14 C -5.4521 -4.0704 0 0
M  V30 15 C 0.228 -7.6647 0 0
M  V30 16 C -7.2733 -5.0704 0 0
M  V30 17 C -7.272 -7.6684 0 0
M  V30 18 C -4.8198 -10.1182 0 0
M  V30 19 C -2.2217 -10.1169 0 0
M  V30 20 C -4.4275 -1.2508 0 0
M  V30 21 C -8.0226 -6.3698 0 0
M  V30 22 C -3.5204 -10.8675 0 0
M  V30 23 O 0.9787 -8.9634 0 0
M  V30 24 C -2.0239 -3.7687 0 0
M  V30 25 C 0.9774 -6.3653 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7 CFG=1
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 4 10
M  V30 10 2 5 11
M  V30 11 1 5 12
M  V30 12 1 6 13
M  V30 13 1 6 14 CFG=1
M  V30 14 1 7 15
M  V30 15 1 8 24
M  V30 16 1 9 16
M  V30 17 2 10 17
M  V30 18 1 11 18
M  V30 19 2 12 19
M  V30 20 1 13 20
M  V30 21 2 15 23
M  V30 22 1 15 25
M  V30 23 2 16 21
M  V30 24 1 17 21
M  V30 25 2 18 22
M  V30 26 1 19 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 3 6) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
nor_laam

> <ID>
nor_laam

> <PRIMARY_SOM>
20

> <Citation>
Neff et al.,Biochem. Biophy. Resea. Commun.,284,751,2001

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
nordiazepam
  SciTegic08102311042D

 19 21  0  0  0  0            999 V2000
   -0.4307    4.7727    0.0000 C   0  0
   -1.5303    3.7524    0.0000 C   0  0
   -2.9636    4.1945    0.0000 C   0  0
   -3.2974    5.6569    0.0000 C   0  0
   -2.1978    6.6772    0.0000 C   0  0
   -0.7645    6.2350    0.0000 C   0  0
    0.3351    7.2553    0.0000 Cl  0  0
   -4.6489    6.3078    0.0000 C   0  0
   -3.8989    3.0218    0.0000 N   0  0
   -6.0497    1.6703    0.0000 O   0  0
   -5.3989    3.0218    0.0000 C   0  0
   -6.3341    4.1945    0.0000 C   0  0
   -6.0003    5.6569    0.0000 N   0  0
   -4.6489    7.8078    0.0000 C   0  0
   -3.3498    8.5578    0.0000 C   0  0
   -5.9479    8.5578    0.0000 C   0  0
   -3.3498   10.0578    0.0000 C   0  0
   -5.9479   10.0578    0.0000 C   0  0
   -4.6489   10.8078    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  3  4  1  0
  3  9  1  0
  4  5  2  0
  4  8  1  0
  5  6  1  0
  6  7  1  0
  8 13  2  0
  8 14  1  0
  9 11  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 14 15  2  0
 14 16  1  0
 15 17  1  0
 16 18  2  0
 17 19  2  0
 18 19  1  0
M  END
> <Name>
nordiazepam

> <ID>
nordiazepam

> <PRIMARY_SOM>
12

> <Citation>
Yang et al.,Biochem. Pharmacol.,55,889,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
norverapamil
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 32 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.059 10.3895 0 0
M  V30 2 C 12.8072 11.6896 0 0
M  V30 3 C 12.0554 12.9876 0 0
M  V30 4 C 10.5554 12.9855 0 0
M  V30 5 O 4.167 3.2804 0 0
M  V30 6 O 1.5711 1.7767 0 0
M  V30 7 O 12.8036 14.2877 0 0
M  V30 8 O 14.3072 11.6917 0 0
M  V30 9 C 1.5606 9.2767 0 0
M  V30 10 C 0.0627 7.7746 0 0
M  V30 11 C -0.6891 9.0726 0 0
M  V30 12 C -0.6855 6.4745 0 0
M  V30 13 C 2.867 4.0285 0 0
M  V30 14 C 1.569 3.2767 0 0
M  V30 15 C 0.2689 4.0249 0 0
M  V30 16 C 0.2668 5.5249 0 0
M  V30 17 C 1.5648 6.2767 0 0
M  V30 18 C 2.8649 5.5285 0 0
M  V30 19 C 1.5627 7.7767 0 0 CFG=2
M  V30 20 C 3.0627 7.7788 0 0
M  V30 21 C 3.8109 9.0789 0 0
M  V30 22 C 5.3109 9.081 0 0
M  V30 23 N 6.059 10.3811 0 0
M  V30 24 C 7.559 10.3832 0 0
M  V30 25 C 8.3072 11.6833 0 0
M  V30 26 C 9.8072 11.6854 0 0
M  V30 27 C 10.559 10.3874 0 0
M  V30 28 C 5.465 4.0322 0 0
M  V30 29 C 0.2731 1.0249 0 0
M  V30 30 C 12.0517 15.5856 0 0
M  V30 31 C 15.059 10.3937 0 0
M  V30 32 N 1.5585 10.7767 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 27
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 1 3 4
M  V30 6 1 3 7
M  V30 7 2 4 26
M  V30 8 1 5 13
M  V30 9 1 5 28
M  V30 10 1 6 14
M  V30 11 1 6 29
M  V30 12 1 7 30
M  V30 13 1 8 31
M  V30 14 1 19 9 CFG=1
M  V30 15 3 9 32
M  V30 16 1 10 11
M  V30 17 1 10 12
M  V30 18 1 10 19
M  V30 19 1 13 14
M  V30 20 2 13 18
M  V30 21 2 14 15
M  V30 22 1 15 16
M  V30 23 2 16 17
M  V30 24 1 17 18
M  V30 25 1 17 19
M  V30 26 1 19 20
M  V30 27 1 20 21
M  V30 28 1 21 22
M  V30 29 1 22 23
M  V30 30 1 23 24
M  V30 31 1 24 25
M  V30 32 1 25 26
M  V30 33 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 19) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
norverapamil

> <ID>
norverapamil

> <PRIMARY_SOM>
24

> <Citation>
Tracy et al.,Br. J. Clin. Pharmacol.,47,545,1999

> <DOI>
10.1046/j.136502125.1999.00923.x.

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
o-phenylphenol
  SciTegic08102311042D

 13 14  0  0  0  0            999 V2000
    5.5712    2.1495    0.0000 O   0  0
    4.2721   -0.1005    0.0000 C   0  0
    5.5712   -0.8505    0.0000 C   0  0
    4.2721    1.3995    0.0000 C   0  0
    2.9731   -0.8505    0.0000 C   0  0
    6.8702   -0.1005    0.0000 C   0  0
    5.5712   -2.3505    0.0000 C   0  0
    2.9731    2.1495    0.0000 C   0  0
    1.6740   -0.1005    0.0000 C   0  0
    8.1692   -0.8505    0.0000 C   0  0
    6.8702   -3.1005    0.0000 C   0  0
    1.6740    1.3995    0.0000 C   0  0
    8.1692   -2.3505    0.0000 C   0  0
  1  4  1  0
  2  3  1  0
  2  4  2  0
  2  5  1  0
  3  6  2  0
  3  7  1  0
  4  8  1  0
  5  9  2  0
  6 10  1  0
  7 11  2  0
  8 12  2  0
  9 12  1  0
 10 13  2  0
 11 13  1  0
M  END
> <Name>
o-phenylphenol

> <ID>
o-phenylphenol

> <PRIMARY_SOM>
9

> <Citation>
Ozawa et al.,Xenobiotica,30,1005,2000

> <DOI>
10.1080/00498250050200159

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ochratoxin_a
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.9216 10.0245 0 0
M  V30 2 C 3.6226 10.7745 0 0
M  V30 3 C 3.6226 12.2745 0 0
M  V30 4 C 2.3236 10.0245 0 0
M  V30 5 C 2.3236 13.0245 0 0
M  V30 6 C 4.9216 13.0245 0 0
M  V30 7 C 1.0245 10.7745 0 0
M  V30 8 C 1.0245 12.2745 0 0
M  V30 9 C 2.3236 14.5245 0 0
M  V30 10 C 4.9216 14.5245 0 0 CFG=1
M  V30 11 C -0.2745 10.0245 0 0
M  V30 12 O -0.2745 13.0245 0 0
M  V30 13 O 1.0245 15.2745 0 0
M  V30 14 O 3.6226 15.2745 0 0
M  V30 15 C 6.2207 15.2745 0 0
M  V30 16 N -0.2745 8.5245 0 0
M  V30 17 O -1.5735 10.7745 0 0
M  V30 18 C -1.5735 7.7745 0 0 CFG=1
M  V30 19 C -1.5735 6.2745 0 0
M  V30 20 C -2.8726 8.5245 0 0
M  V30 21 C -2.8726 5.5245 0 0
M  V30 22 O -4.1716 7.7745 0 0
M  V30 23 O -2.8726 10.0245 0 0
M  V30 24 C -2.8726 4.0245 0 0
M  V30 25 C -4.1716 6.2745 0 0
M  V30 26 C -4.1716 3.2745 0 0
M  V30 27 C -5.4706 5.5245 0 0
M  V30 28 C -5.4706 4.0245 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 8
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 9 14
M  V30 15 1 10 14
M  V30 16 1 10 15 CFG=1
M  V30 17 1 11 16
M  V30 18 2 11 17
M  V30 19 1 18 16 CFG=1
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 1 20 23
M  V30 25 2 21 24
M  V30 26 1 21 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 18) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
ochratoxin_a

> <ID>
ochratoxin_a

> <PRIMARY_SOM>
6

> <Citation>
Herbert Zepnik, Axel Phler, Ute Schauer and Wolfgang Dekant, Toxicological Sciences 59, 59-67 (2001)

> <DOI>
10.1093/toxsci/59.1.59

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
olanzapine
  SciTegic08102311042D

 22 25  0  0  0  0            999 V2000
    5.0358    7.7846    0.0000 C   0  0
    4.7020    9.2470    0.0000 C   0  0
    5.8015   10.2673    0.0000 C   0  0
    7.2349    9.8253    0.0000 C   0  0
    7.5687    8.3629    0.0000 C   0  0
    6.4692    7.3426    0.0000 C   0  0
    4.1007    6.6118    0.0000 N   0  0
    2.6007    6.6117    0.0000 C   0  0
    1.9499    5.2603    0.0000 N   0  0
    1.6654    7.7844    0.0000 C   0  0
    1.9991    9.2469    0.0000 C   0  0
    3.3505    9.8977    0.0000 N   0  0
    0.1714    7.6499    0.0000 C   0  0
   -0.4182    9.0292    0.0000 C   0  0
   -1.8806    9.3629    0.0000 C   0  0
    0.7114   10.0161    0.0000 S   0  0
    0.4541    5.1481    0.0000 C   0  0
   -0.1967    3.7966    0.0000 C   0  0
    0.6484    2.5573    0.0000 N   0  0
   -0.0024    1.2058    0.0000 C   0  0
    2.1442    2.6695    0.0000 C   0  0
    2.7949    4.0209    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  2 12  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
  9 17  1  0
  9 22  1  0
 10 11  2  0
 10 13  1  0
 11 12  1  0
 11 16  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
M  END
> <Name>
olanzapine

> <ID>
olanzapine

> <PRIMARY_SOM>
19

> <SECONDARY_SOM>
20

> <TERTIARY_SOM>
15

> <Citation>
Ring et al.,J. Pharmacol. Exp. Ther.,276,658,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
perhexiline
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -5.4706 -7.0245 0 0
M  V30 2 C -2.8726 -5.5245 0 0
M  V30 3 C -1.5735 -4.7745 0 0
M  V30 4 C -2.8726 -7.0245 0 0
M  V30 5 C -4.1716 -4.7745 0 0
M  V30 6 C -0.2745 -5.5245 0 0
M  V30 7 C -1.5735 -3.2745 0 0
M  V30 8 C -4.1716 -7.7745 0 0
M  V30 9 C -1.5735 -7.7745 0 0
M  V30 10 C -5.4707 -5.5245 0 0 CFG=1
M  V30 11 C 1.0245 -4.7745 0 0
M  V30 12 C -0.2745 -2.5245 0 0
M  V30 13 C -4.1716 -9.2745 0 0
M  V30 14 C -1.5735 -9.2745 0 0
M  V30 15 C 1.0245 -3.2745 0 0
M  V30 16 C -2.8726 -10.0245 0 0
M  V30 17 C -6.7697 -4.7745 0 0
M  V30 18 C -8.0687 -5.5245 0 0
M  V30 19 C -6.7697 -7.7745 0 0
M  V30 20 C -8.0687 -7.0245 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 10 5 CFG=3
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 1 10 17
M  V30 16 1 11 15
M  V30 17 1 12 15
M  V30 18 1 13 16
M  V30 19 1 14 16
M  V30 20 1 17 18
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
perhexiline

> <ID>
perhexiline

> <PRIMARY_SOM>
15 16

> <Citation>
Davies et al.,Drug Metab. Disp.,35,128,2007

> <DOI>
10.1124/dmd.106.012252

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
phenanthrene
  SciTegic08102311042D

 14 16  0  0  0  0            999 V2000
    1.2300    0.7100    0.0000 C   0  0
    0.0000    1.4200    0.0000 C   0  0
   -1.2300    0.7100    0.0000 C   0  0
   -1.2300   -0.7100    0.0000 C   0  0
    0.0000   -1.4200    0.0000 C   0  0
    1.2300   -0.7100    0.0000 C   0  0
    2.4600   -1.4200    0.0000 C   0  0
    3.6890   -0.7100    0.0000 C   0  0
    3.6890    0.7100    0.0000 C   0  0
    2.4600    1.4200    0.0000 C   0  0
    0.0000    2.8400    0.0000 C   0  0
   -1.2300    3.5500    0.0000 C   0  0
   -2.4600    2.8400    0.0000 C   0  0
   -2.4600    1.4200    0.0000 C   0  0
  1  2  1  0
  1  6  1  0
  1 10  2  0
  2  3  1  0
  2 11  2  0
  3  4  1  0
  3 14  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
M  END
> <Name>
phenanthrene

> <ID>
phenanthrene

> <PRIMARY_SOM>
4 5

> <SECONDARY_SOM>
7 8 13 14

> <TERTIARY_SOM>
9 10 11 12

> <Citation>
Shou et al., Canc. Lett. 1994, 83, 305-313

> <DOI>
10.1016/0304-3835(94)90334-4

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
pioglitazone
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.3805 4.2718 0 0
M  V30 2 C 16.3805 5.7718 0 0
M  V30 3 C 15.0815 6.5218 0 0
M  V30 4 C 15.0815 8.0218 0 0
M  V30 5 N 13.7824 8.7718 0 0
M  V30 6 C 12.4834 8.0218 0 0
M  V30 7 C 12.4834 6.5218 0 0
M  V30 8 C 13.7824 5.7718 0 0
M  V30 9 C 11.1844 8.7718 0 0
M  V30 10 C 9.8853 8.0218 0 0
M  V30 11 O 8.5863 8.7718 0 0
M  V30 12 C 7.2872 8.0218 0 0
M  V30 13 C 5.9882 8.7718 0 0
M  V30 14 C 4.6892 8.0218 0 0
M  V30 15 C 4.6892 6.5218 0 0
M  V30 16 C 5.9882 5.7718 0 0
M  V30 17 C 7.2872 6.5218 0 0
M  V30 18 C 3.3901 5.7718 0 0
M  V30 19 C 3.3901 4.2718 0 0 CFG=2
M  V30 20 C 2.1766 3.3901 0 0
M  V30 21 O 0.75 3.8537 0 0
M  V30 22 N 2.6401 1.9635 0 0
M  V30 23 C 4.1401 1.9635 0 0
M  V30 24 O 5.0218 0.75 0 0
M  V30 25 S 4.6036 3.3901 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 3 4
M  V30 4 2 3 8
M  V30 5 2 4 5
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 1 6 9
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 17
M  V30 15 2 13 14
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 15 18
M  V30 19 1 16 17
M  V30 20 1 19 18 CFG=1
M  V30 21 1 19 20
M  V30 22 1 19 25
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 22 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 19) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
pioglitazone

> <ID>
pioglitazone

> <PRIMARY_SOM>
2

> <Citation>
Jaakkola et al., Basic Clin. Pharmacol. Toxicol., 2006, 99, 44-51

> <DOI>
10.1111/j.1742-7843.2006.pto_437.x

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
pranidipine
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -2.8726 8.5245 0 0 CFG=2
M  V30 2 C -1.5736 7.7745 0 0
M  V30 3 C -2.8726 10.0245 0 0
M  V30 4 C -4.1716 7.7745 0 0
M  V30 5 C -1.5736 6.2745 0 0
M  V30 6 C -0.2745 8.5245 0 0
M  V30 7 C -4.1716 10.7745 0 0
M  V30 8 C -1.5736 10.7745 0 0
M  V30 9 C -5.4707 8.5245 0 0
M  V30 10 C -4.1716 6.2745 0 0
M  V30 11 C -0.2745 5.5245 0 0
M  V30 12 C 1.0245 7.7745 0 0
M  V30 13 N -5.4707 10.0245 0 0
M  V30 14 C -4.1716 12.2745 0 0
M  V30 15 O -1.5736 12.2745 0 0
M  V30 16 O -0.2745 10.0245 0 0
M  V30 17 C -6.7697 7.7745 0 0
M  V30 18 O -5.4707 5.5245 0 0
M  V30 19 O -2.8726 5.5245 0 0
M  V30 20 C 1.0245 6.2745 0 0
M  V30 21 N -0.2745 4.0245 0 0 CHG=1
M  V30 22 C -0.2745 13.0245 0 0
M  V30 23 C -5.4707 4.0245 0 0
M  V30 24 O -1.5736 3.2745 0 0 CHG=-1
M  V30 25 O 1.0245 3.2745 0 0
M  V30 26 C -0.2745 14.5245 0 0
M  V30 27 C 1.0245 15.2745 0 0
M  V30 28 C 1.0245 16.7745 0 0
M  V30 29 C 2.3235 17.5245 0 0
M  V30 30 C -0.2745 17.5245 0 0
M  V30 31 C 2.3235 19.0245 0 0
M  V30 32 C -0.2745 19.0245 0 0
M  V30 33 C 1.0245 19.7745 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 1 7 14
M  V30 14 1 8 15
M  V30 15 2 8 16
M  V30 16 1 9 13
M  V30 17 1 9 17
M  V30 18 1 10 18
M  V30 19 2 10 19
M  V30 20 2 11 20
M  V30 21 1 11 21
M  V30 22 1 12 20
M  V30 23 1 15 22
M  V30 24 1 18 23
M  V30 25 1 21 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 2 26 27
M  V30 29 1 27 28
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
pranidipine

> <ID>
pranidipine

> <PRIMARY_SOM>
13 1

> <Citation>
Kudo et al.,Drug Metab. Disp.,27,303,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
pregnenolone
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.104 2.1443 0 0
M  V30 2 O 10.7847 -5.3605 0 0
M  V30 3 C 9.8983 -2.3557 0 0 CFG=2
M  V30 4 C 9.8983 -0.8557 0 0 CFG=2
M  V30 5 C 8.5992 -0.1057 0 0 CFG=1
M  V30 6 C 7.3002 -0.8557 0 0 CFG=1
M  V30 7 C 6.0012 -0.1057 0 0 CFG=2
M  V30 8 C 8.5992 -3.1057 0 0
M  V30 9 C 11.3249 -2.8192 0 0 CFG=2
M  V30 10 C 7.3002 -2.3557 0 0
M  V30 11 C 11.3249 -0.3921 0 0
M  V30 12 C 12.2065 -1.6057 0 0
M  V30 13 C 8.5992 1.3943 0 0
M  V30 14 C 6.0012 1.3943 0 0
M  V30 15 C 10.0551 -3.8474 0 0
M  V30 16 C 4.7021 -0.8557 0 0
M  V30 17 C 7.3002 2.1443 0 0
M  V30 18 C 6.0012 -1.6057 0 0
M  V30 19 C 4.7021 2.1443 0 0
M  V30 20 C 3.4031 -0.1057 0 0
M  V30 21 C 11.7884 -4.2458 0 0
M  V30 22 C 3.4031 1.3943 0 0 CFG=2
M  V30 23 C 13.2556 -4.5576 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 22 1 CFG=3
M  V30 2 2 2 21
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 1 3 9
M  V30 6 1 3 15 CFG=3
M  V30 7 1 4 5
M  V30 8 1 4 11 CFG=3
M  V30 9 1 5 6
M  V30 10 1 5 13 CFG=1
M  V30 11 1 6 7
M  V30 12 1 6 10 CFG=3
M  V30 13 1 7 14
M  V30 14 1 7 16
M  V30 15 1 7 18 CFG=3
M  V30 16 1 8 10
M  V30 17 1 9 12
M  V30 18 1 9 21 CFG=3
M  V30 19 1 11 12
M  V30 20 1 13 17
M  V30 21 2 14 17
M  V30 22 1 14 19
M  V30 23 1 16 20
M  V30 24 1 19 22
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 3 4 5 6 7 9 22) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
pregnenolone

> <ID>
pregnenolone

> <PRIMARY_SOM>
12

> <Citation>
Niwa et al., xenobiotica, 1998, 28, 539-547

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
proguanil
  SciTegic08102311042D

 17 17  0  0  0  0            999 V2000
    1.0245   -0.2745    0.0000 Cl  0  0
    8.8188   -7.7745    0.0000 N   0  0
    6.2207   -3.2745    0.0000 N   0  0
    7.5197   -5.5245    0.0000 N   0  0
    6.2207   -7.7745    0.0000 N   0  0
    4.9216   -5.5245    0.0000 N   0  0
    8.8188   -9.2745    0.0000 C   0  0
   10.1178  -10.0245    0.0000 C   0  0
    7.5197  -10.0245    0.0000 C   0  0
    4.9216   -2.5245    0.0000 C   0  0
    7.5197   -7.0245    0.0000 C   0  0
    4.9216   -1.0245    0.0000 C   0  0
    3.6226   -3.2745    0.0000 C   0  0
    6.2207   -4.7745    0.0000 C   0  0
    3.6226   -0.2745    0.0000 C   0  0
    2.3236   -2.5245    0.0000 C   0  0
    2.3236   -1.0245    0.0000 C   0  0
  1 17  1  0
  2  7  1  0
  2 11  1  0
  3 10  1  0
  3 14  1  0
  4 11  1  0
  4 14  1  0
  5 11  2  0
  6 14  2  0
  7  8  1  0
  7  9  1  0
 10 12  2  0
 10 13  1  0
 12 15  1  0
 13 16  2  0
 15 17  2  0
 16 17  1  0
M  END
> <Name>
proguanil

> <ID>
proguanil

> <PRIMARY_SOM>
3 7

> <Citation>
Diaz et al.,Drug Metab. Disp.,36,380,2008

> <DOI>
10.1124/dmd.106.013920

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
propofol
  SciTegic08102311042D

 13 13  0  0  0  0            999 V2000
    5.5712   -3.6495    0.0000 C   0  0
    6.8702   -4.3995    0.0000 C   0  0
    6.8702   -5.8995    0.0000 C   0  0
    8.1692   -3.6495    0.0000 C   0  0
    5.5712   -2.1495    0.0000 C   0  0
    6.8702   -1.3995    0.0000 O   0  0
    4.2721   -1.3995    0.0000 C   0  0
    4.2721    0.1005    0.0000 C   0  0
    2.9731    0.8505    0.0000 C   0  0
    5.5712    0.8505    0.0000 C   0  0
    2.9731   -2.1495    0.0000 C   0  0
    2.9731   -3.6495    0.0000 C   0  0
    4.2721   -4.3995    0.0000 C   0  0
  1  2  1  0
  1  5  1  0
  1 13  2  0
  2  3  1  0
  2  4  1  0
  5  6  1  0
  5  7  2  0
  7  8  1  0
  7 11  1  0
  8  9  1  0
  8 10  1  0
 11 12  2  0
 12 13  1  0
M  END
> <Name>
propofol

> <ID>
propofol

> <PRIMARY_SOM>
12

> <Citation>
Court et al.,Anesthesiology,94,110,2001
J. Guitton, T. Buronfosse, M. Desage, J. P. Flinois, J. P. Perdrix, J. L. Brazier, P. Beaune, Br. J. Anaesth. 1998, 80, 788-795.

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
prostaglandin_H2
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O -2.4354 3.0847 0 0
M  V30 2 O -2.4354 3.0847 0 0
M  V30 3 O 1.5339 0.1926 0 0
M  V30 4 O 0.5197 -6.7315 0 0
M  V30 5 O 2.884 -5.6544 0 0
M  V30 6 C -3.2112 1.4588 0 0 CFG=2
M  V30 7 C -2.5274 2.1306 0 0 CFG=2
M  V30 8 C -4.1668 1.3838 0 0 CFG=2
M  V30 9 C -2.4354 3.0847 0 0 CFG=1
M  V30 10 C -3.919 2.8632 0 0
M  V30 11 C -2.5894 0.0938 0 0
M  V30 12 C -1.1737 1.4846 0 0
M  V30 13 C -3.4607 -1.1272 0 0
M  V30 14 C 0.0627 2.334 0 0
M  V30 15 C 1.4164 1.688 0 0 CFG=2
M  V30 16 C -2.8388 -2.4923 0 0
M  V30 17 C 2.6528 2.5374 0 0
M  V30 18 C -1.3458 -2.6363 0 0
M  V30 19 C 4.0066 1.8914 0 0
M  V30 20 C 5.2429 2.7408 0 0
M  V30 21 C -0.7239 -4.0014 0 0
M  V30 22 C 6.4639 1.8696 0 0
M  V30 23 C 0.7691 -4.1454 0 0
M  V30 24 C 6.3199 0.3765 0 0
M  V30 25 C 1.391 -5.5104 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=1
M  V30 3 1 9 2 CFG=1
M  V30 4 1 15 3 CFG=3
M  V30 5 1 4 25
M  V30 6 2 5 25
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 11 CFG=1
M  V30 10 1 7 9
M  V30 11 1 7 12 CFG=3
M  V30 12 1 8 10
M  V30 13 1 9 10
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 16
M  V30 17 1 14 15
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 21
M  V30 22 1 19 20
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 6 7 8 9 15) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
prostaglandin_H2

> <ID>
prostaglandin_H2

> <PRIMARY_SOM>
8 9

> <Citation>
Plastaras, J.P.; Guengerich, F.P.; Nebert, D.W.; Marnett, L.J. Xenobiotic Metabolizing Cytochromes P450 Convert Prostaglandin Endoperoxide to Hydroxyheptadecatrienoic Acid and Mutagen, Malondialdehyde
. J. Biol. Chem. 2000, 275, 1178411790.

> <DOI>
10.1074/jbc.275.16.11784

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ps_15
  SciTegic08102311042D

 24 24  0  0  0  0            999 V2000
    7.5197    0.4755    0.0000 Cl  0  0
    2.3236   -2.5245    0.0000 Cl  0  0
    2.3236    0.4755    0.0000 Cl  0  0
    7.5197   -2.5245    0.0000 O   0  0
   10.1178   -7.0245    0.0000 O   0  0
   12.7159  -13.0245    0.0000 N   0  0
   10.1178   -8.5245    0.0000 N   0  0
   11.4168  -10.7745    0.0000 N   0  0
   14.0149  -10.7745    0.0000 N   0  0
   12.7159   -8.5245    0.0000 N   0  0
    8.8188   -4.7745    0.0000 C   0  0
    7.5197   -4.0245    0.0000 C   0  0
    8.8188   -6.2745    0.0000 C   0  0
   14.0149  -13.7745    0.0000 C   0  0
    6.2207   -1.7745    0.0000 C   0  0
   14.0149  -15.2745    0.0000 C   0  0
   15.3140  -13.0245    0.0000 C   0  0
    6.2207   -0.2745    0.0000 C   0  0
    4.9216   -2.5245    0.0000 C   0  0
    3.6226   -1.7745    0.0000 C   0  0
    4.9216    0.4755    0.0000 C   0  0
    3.6226   -0.2745    0.0000 C   0  0
   12.7159  -11.5245    0.0000 C   0  0
   11.4168   -9.2745    0.0000 C   0  0
  1 18  1  0
  2 20  1  0
  3 22  1  0
  4 12  1  0
  4 15  1  0
  5  7  1  0
  5 13  1  0
  6 14  1  0
  6 23  2  0
  7 24  1  0
  8 23  1  0
  8 24  2  0
  9 23  1  0
 10 24  1  0
 11 12  1  0
 11 13  1  0
 14 16  1  0
 14 17  1  0
 15 18  2  0
 15 19  1  0
 18 21  1  0
 19 20  2  0
 20 22  1  0
 21 22  2  0
M  END
> <Name>
ps_15

> <ID>
ps_15

> <PRIMARY_SOM>
7 14

> <Citation>
Diaz et al.,Drug Metab. Disp.,36,380,2008

> <DOI>
10.1124/dmd.106.013920

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
quetiapine
  SciTegic08102311042D

 27 30  0  0  0  0            999 V2000
   17.2247    3.3075    0.0000 C   0  0
   18.6581    2.8654    0.0000 C   0  0
   18.9919    1.4030    0.0000 C   0  0
   17.8923    0.3827    0.0000 C   0  0
   16.4589    0.8248    0.0000 C   0  0
   16.1251    2.2872    0.0000 C   0  0
   15.5237   -0.3479    0.0000 S   0  0
   14.0237   -0.3479    0.0000 C   0  0
   13.0885    0.8248    0.0000 C   0  0
   13.4222    2.2872    0.0000 C   0  0
   12.2495    3.2224    0.0000 N   0  0
   14.7737    2.9380    0.0000 N   0  0
   13.4757   -1.7442    0.0000 C   0  0
   11.9924   -1.9678    0.0000 C   0  0
   11.0572   -0.7951    0.0000 C   0  0
   11.6052    0.6012    0.0000 C   0  0
   12.4730    4.7057    0.0000 C   0  0
   11.3003    5.6409    0.0000 C   0  0
    9.9040    5.0929    0.0000 N   0  0
    8.7312    6.0281    0.0000 C   0  0
    7.3349    5.4801    0.0000 C   0  0
    6.1622    6.4153    0.0000 O   0  0
    4.7659    5.8673    0.0000 C   0  0
    3.5931    6.8025    0.0000 C   0  0
    2.1968    6.2545    0.0000 O   0  0
    9.6804    3.6096    0.0000 C   0  0
   10.8532    2.6744    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  6 12  1  0
  7  8  1  0
  8  9  1  0
  8 13  2  0
  9 10  1  0
  9 16  2  0
 10 11  1  0
 10 12  2  0
 11 17  1  0
 11 27  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 26  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 26 27  1  0
M  END
> <Name>
quetiapine

> <ID>
quetiapine

> <PRIMARY_SOM>
7

> <Citation>
Shen W.,Ann. Clin. Pschia.,11,145,1999

> <DOI>
10.1023/A:1022312111429

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
reduced_diclofenac
  SciTegic08102311042D

 18 19  0  0  0  0            999 V2000
    5.5712    2.1495    0.0000 C   0  0
    5.5711    3.6495    0.0000 C   0  0
    4.2721    4.3995    0.0000 C   0  0
    2.9731    3.6495    0.0000 C   0  0
    2.9731    2.1495    0.0000 C   0  0
    4.2721    1.3995    0.0000 C   0  0
    6.8702    4.3995    0.0000 Cl  0  0
    4.2721   -0.1005    0.0000 Cl  0  0
    6.8702    1.3995    0.0000 N   0  0
    6.8702   -0.1005    0.0000 C   0  0
    8.1692   -0.8505    0.0000 C   0  0
    8.1692   -2.3505    0.0000 C   0  0
    6.8702   -3.1005    0.0000 C   0  0
    5.5712   -2.3505    0.0000 C   0  0
    5.5712   -0.8505    0.0000 C   0  0
    9.4683   -0.1005    0.0000 C   0  0
   10.7673   -0.8505    0.0000 C   0  0
   12.0663   -0.1005    0.0000 O   0  0
  1  2  1  0
  1  6  2  0
  1  9  1  0
  2  3  2  0
  2  7  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  8  1  0
  9 10  1  0
 10 11  1  0
 10 15  2  0
 11 12  2  0
 11 16  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 16 17  1  0
 17 18  1  0
M  END
> <Name>
reduced_diclofenac

> <ID>
reduced_diclofenac

> <PRIMARY_SOM>
13

> <Citation>
Mancy et al.,Biochemistry,38,14264,1999

> <DOI>
10.1021/bi991195u

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
rosiglitazone
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.3164 -12.7078 0 0
M  V30 2 C 12.8164 -12.7078 0 0
M  V30 3 C 10.8528 -11.2812 0 0
M  V30 4 S 13.2799 -11.2812 0 0
M  V30 5 C 12.0664 -10.3995 0 0 CFG=1
M  V30 6 C 4.2721 -1.3995 0 0
M  V30 7 N 4.2721 0.1005 0 0
M  V30 8 O 13.698 -13.9213 0 0
M  V30 9 N 5.5712 -2.1495 0 0
M  V30 10 O 9.4263 -10.8177 0 0
M  V30 11 C 12.0664 -8.8995 0 0
M  V30 12 C 10.7673 -8.1495 0 0
M  V30 13 C 8.1692 -6.6495 0 0
M  V30 14 C 10.7673 -6.6495 0 0
M  V30 15 C 9.4683 -8.8995 0 0
M  V30 16 C 8.1692 -8.1495 0 0
M  V30 17 C 9.4683 -5.8995 0 0
M  V30 18 O 6.8702 -5.8995 0 0
M  V30 19 C 6.8702 -4.3995 0 0
M  V30 20 C 5.5712 -3.6495 0 0
M  V30 21 C 2.9731 -2.1495 0 0
M  V30 22 C 2.9731 0.8505 0 0
M  V30 23 C 6.8702 -1.3995 0 0
M  V30 24 C 1.674 -1.3995 0 0
M  V30 25 C 1.674 0.1005 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 8
M  V30 5 1 3 5
M  V30 6 2 3 10
M  V30 7 1 4 5
M  V30 8 1 5 11 CFG=3
M  V30 9 2 6 7
M  V30 10 1 6 9
M  V30 11 1 6 21
M  V30 12 1 7 22
M  V30 13 1 9 20
M  V30 14 1 9 23
M  V30 15 1 11 12
M  V30 16 1 12 14
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 19 1 13 17
M  V30 20 1 13 18
M  V30 21 2 14 17
M  V30 22 1 15 16
M  V30 23 1 18 19
M  V30 24 1 19 20
M  V30 25 2 21 24
M  V30 26 2 22 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
rosiglitazone

> <ID>
rosiglitazone

> <PRIMARY_SOM>
23

> <Citation>
Baldwin et al.,Brit. J. Clin. Pharm.,48,424,1999

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
safrole
  SciTegic08102311042D

 12 13  0  0  0  0            999 V2000
    6.7253   -4.1485    0.0000 C   0  0
    6.7253   -5.6485    0.0000 C   0  0
    5.4263   -3.3985    0.0000 C   0  0
    8.0243   -6.3985    0.0000 C   0  0
    5.4263   -1.8985    0.0000 C   0  0
    4.1272   -4.1485    0.0000 C   0  0
    4.1272   -1.1485    0.0000 C   0  0
    2.8282   -3.3985    0.0000 C   0  0
    2.8282   -1.8985    0.0000 C   0  0
    3.8153    0.3187    0.0000 O   0  0
    1.7135   -0.8948    0.0000 O   0  0
    2.3236    0.4755    0.0000 C   0  0
  1  2  1  0
  1  3  1  0
  2  4  2  0
  3  5  2  0
  3  6  1  0
  5  7  1  0
  6  8  2  0
  7  9  2  0
  7 10  1  0
  8  9  1  0
  9 11  1  0
 10 12  1  0
 11 12  1  0
M  END
> <Name>
safrole

> <ID>
safrole

> <PRIMARY_SOM>
1

> <Citation>
Ueng et al.,Chem. Res. Toxicol.,17,1151,2004

> <DOI>
10.1021/tx030055p

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
sertindole
  SciTegic08102311042D

 31 35  0  0  0  0            999 V2000
   15.3521   -1.6858    0.0000 C   0  0
   15.3521   -0.1858    0.0000 C   0  0
   14.0531    0.5642    0.0000 C   0  0
   14.0531    2.0642    0.0000 Cl  0  0
   12.7541   -0.1858    0.0000 C   0  0
   12.7541   -1.6858    0.0000 C   0  0
   14.0531   -2.4358    0.0000 C   0  0
   11.6393   -2.6895    0.0000 C   0  0
   10.1721   -2.3776    0.0000 C   0  0
   12.2494   -4.0598    0.0000 C   0  0
   13.7412   -3.9030    0.0000 N   0  0
   14.7449   -5.0177    0.0000 C   0  0
   16.2121   -4.7058    0.0000 C   0  0
   17.2158   -5.8206    0.0000 C   0  0
   16.7523   -7.2471    0.0000 C   0  0
   17.7560   -8.3619    0.0000 F   0  0
   15.2851   -7.5590    0.0000 C   0  0
   14.2814   -6.4443    0.0000 C   0  0
    9.1684   -3.4923    0.0000 C   0  0
    7.7012   -3.1804    0.0000 C   0  0
    7.2377   -1.7539    0.0000 N   0  0
    5.7704   -1.4420    0.0000 C   0  0
    5.3069   -0.0154    0.0000 C   0  0
    3.8397    0.2965    0.0000 N   0  0
    8.2414   -0.6391    0.0000 C   0  0
    9.7086   -0.9510    0.0000 C   0  0
    2.7250   -0.7072    0.0000 C   0  0
    1.4259    0.0428    0.0000 C   0  0
    1.7378    1.5100    0.0000 N   0  0
    3.2296    1.6668    0.0000 C   0  0
    3.9796    2.9658    0.0000 O   0  0
  1  2  1  0
  1  7  2  0
  2  3  2  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  7 11  1  0
  8  9  1  0
  8 10  2  0
  9 19  1  0
  9 26  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 18  2  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 17 18  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 25  1  0
 22 23  1  0
 23 24  1  0
 24 27  1  0
 24 30  1  0
 25 26  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  2  0
M  END
> <Name>
sertindole

> <ID>
sertindole

> <PRIMARY_SOM>
22

> <Citation>
Shen,Ann. Clin. Psych.,11,145,1999

> <DOI>
10.1023/A:1022312111429

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
sibutramine
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.8014 0.174 0 0
M  V30 2 N 6.9976 -5.424 0 0
M  V30 3 C 6.9976 -2.8259 0 0
M  V30 4 C 7.7476 -1.5269 0 0
M  V30 5 C 8.2966 -3.5759 0 0
M  V30 6 C 6.2476 -4.125 0 0 CFG=2
M  V30 7 C 9.0466 -2.2769 0 0
M  V30 8 C 5.6986 -2.076 0 0
M  V30 9 C 4.7476 -4.125 0 0
M  V30 10 C 3.9976 -5.424 0 0
M  V30 11 C 5.6986 -0.576 0 0
M  V30 12 C 4.3995 -2.826 0 0
M  V30 13 C 6.2476 -6.7231 0 0
M  V30 14 C 8.4976 -5.424 0 0
M  V30 15 C 2.4976 -5.424 0 0
M  V30 16 C 4.7476 -6.7231 0 0
M  V30 17 C 4.3995 0.174 0 0
M  V30 18 C 3.1005 -2.076 0 0
M  V30 19 C 3.1005 -0.576 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 6
M  V30 3 1 2 13
M  V30 4 1 2 14
M  V30 5 1 3 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 8
M  V30 9 1 4 7
M  V30 10 1 5 7
M  V30 11 1 6 9 CFG=1
M  V30 12 2 8 11
M  V30 13 1 8 12
M  V30 14 1 9 10
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 1 11 17
M  V30 18 2 12 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
sibutramine

> <ID>
sibutramine

> <PRIMARY_SOM>
13 14

> <Citation>
Bae et al.,Drug Metab. Disp.,36,1679,2008

> <DOI>
10.1124/dmd.108.020727

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
simvastatin_hydroxy_acid
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 31 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.0394 7.5 0 0
M  V30 2 O 15.0394 6 0 0
M  V30 3 C 13.7404 8.25 0 0
M  V30 4 C 12.4413 7.5 0 0 CFG=1
M  V30 5 C 11.1423 8.25 0 0
M  V30 6 O 16.3385 8.25 0 0
M  V30 7 O 9.8433 6 0 0
M  V30 8 C 9.8433 7.5 0 0 CFG=1
M  V30 9 O 12.4414 6 0 0
M  V30 10 C 8.5442 8.25 0 0
M  V30 11 C 7.2452 7.5 0 0
M  V30 12 C 5.9462 8.25 0 0 CFG=1
M  V30 13 C 5.9462 9.75 0 0 CFG=2
M  V30 14 C 4.6471 7.5 0 0 CFG=2
M  V30 15 C 4.6471 10.5 0 0
M  V30 16 C 3.3481 8.25 0 0
M  V30 17 C 3.3481 9.75 0 0
M  V30 18 C 7.2452 10.5 0 0
M  V30 19 C 4.6471 6 0 0 CFG=2
M  V30 20 C 3.3481 5.25 0 0
M  V30 21 C 2.049 6 0 0 CFG=2
M  V30 22 C 2.049 7.5 0 0
M  V30 23 C 0.75 5.25 0 0
M  V30 24 O 5.9462 5.25 0 0
M  V30 25 C 5.9462 3.75 0 0
M  V30 26 C 7.2452 3 0 0
M  V30 27 C 7.2452 1.5 0 0
M  V30 28 C 8.7452 3 0 0
M  V30 29 C 7.9952 4.299 0 0
M  V30 30 C 8.5442 0.75 0 0
M  V30 31 O 4.6471 3 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 6
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 9 CFG=3
M  V30 7 1 5 8
M  V30 8 1 8 7 CFG=1
M  V30 9 1 8 10
M  V30 10 1 10 11
M  V30 11 1 12 11 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 13 18 CFG=3
M  V30 16 1 14 16 CFG=1
M  V30 17 1 14 19
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 16 22
M  V30 21 1 19 20
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 21
M  V30 24 1 21 22
M  V30 25 1 21 23 CFG=1
M  V30 26 1 24 25
M  V30 27 1 25 26
M  V30 28 2 25 31
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 4 8 12 13 14 19 21) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
simvastatin_hydroxy_acid

> <ID>
simvastatin_hydroxy_acid

> <PRIMARY_SOM>
22 15

> <SECONDARY_SOM>
21

> <TERTIARY_SOM>
23

> <Citation>
Prueksaritanont et al.,Brit. J. Clin. Pharm.,56,120,2003
Prueksaritanont et al.,Drug Metab. Disp.,25,1191,1997

> <DOI>
10.1046/j.1365-2125.2003.01833.x

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
styrene
  SciTegic08102311042D

  8  8  0  0  0  0            999 V2000
    2.2231    2.1495    0.0000 C   0  0
    2.2231    3.6495    0.0000 C   0  0
    3.5221    4.3995    0.0000 C   0  0
    3.5221    5.8995    0.0000 C   0  0
    0.9240    4.3995    0.0000 C   0  0
   -0.3750    3.6495    0.0000 C   0  0
   -0.3750    2.1495    0.0000 C   0  0
    0.9240    1.3995    0.0000 C   0  0
  1  2  1  0
  1  8  2  0
  2  3  1  0
  2  5  2  0
  3  4  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
M  END
> <Name>
styrene

> <ID>
styrene

> <PRIMARY_SOM>
3 4

> <Citation>
Nakajima et al.,Chem. Res. Toxicol.,7,891,1994

> <DOI>
10.1021/tx00042a026

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
tamarixetin
  SciTegic08102311042D

 23 25  0  0  0  0            999 V2000
   10.7673   -2.3505    0.0000 C   0  0
   10.7673   -0.8505    0.0000 C   0  0
    9.4683   -3.1005    0.0000 C   0  0
   12.0664   -3.1005    0.0000 C   0  0
    9.4683   -0.1005    0.0000 O   0  0
   12.0663   -0.1005    0.0000 C   0  0
    8.1692   -2.3505    0.0000 C   0  0
    9.4683   -4.6005    0.0000 O   0  0
   13.3654   -2.3504    0.0000 C   0  0
   12.0664   -4.6005    0.0000 O   0  0
    8.1692   -0.8505    0.0000 C   0  0
   13.3654   -0.8504    0.0000 C   0  0
    6.8702   -3.1005    0.0000 O   0  0
    6.8702   -0.1005    0.0000 C   0  0
   14.6644   -0.1004    0.0000 O   0  0
    6.8702    1.3995    0.0000 C   0  0
    5.5712   -0.8505    0.0000 C   0  0
    5.5712    2.1495    0.0000 C   0  0
    4.2721   -0.1005    0.0000 C   0  0
    4.2721    1.3995    0.0000 C   0  0
    5.5712    3.6495    0.0000 O   0  0
    2.9731    2.1495    0.0000 O   0  0
    1.6740    1.3995    0.0000 C   0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  6 12  2  0
  7 11  2  0
  7 13  1  0
  9 12  1  0
 11 14  1  0
 12 15  1  0
 14 16  2  0
 14 17  1  0
 16 18  1  0
 17 19  2  0
 18 20  2  0
 18 21  1  0
 19 20  1  0
 20 22  1  0
 22 23  1  0
M  END
> <Name>
tamarixetin

> <ID>
tamarixetin

> <PRIMARY_SOM>
23

> <Citation>
Breinholt et al.,Food and Chem. Tox.,40,609,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
tangeretin_T27
  SciTegic08102311042D

 26 28  0  0  0  0            999 V2000
    4.1716    4.7745    0.0000 O   0  0
    4.1716    3.2745    0.0000 C   0  0
    2.8726    5.5245    0.0000 C   0  0
    2.8726    7.0245    0.0000 C   0  0
    1.5736    4.7745    0.0000 C   0  0
    1.5736    7.7745    0.0000 C   0  0
    4.1716    7.7745    0.0000 O   0  0
    1.5736    3.2745    0.0000 O   0  0
    0.2745    5.5245    0.0000 C   0  0
    0.2745    7.0245    0.0000 C   0  0
    1.5736    9.2745    0.0000 C   0  0
    4.1716    9.2745    0.0000 C   0  0
    0.2745    2.5245    0.0000 C   0  0
   -1.0245    4.7745    0.0000 O   0  0
   -1.0245    7.7745    0.0000 O   0  0
    0.2745   10.0245    0.0000 O   0  0
    2.8726   10.0245    0.0000 C   0  0
    5.4707   10.0245    0.0000 C   0  0
   -2.3235    5.5245    0.0000 C   0  0
   -2.3236    7.0245    0.0000 C   0  0
    5.4707   11.5245    0.0000 C   0  0
    6.7697    9.2745    0.0000 C   0  0
    6.7697   12.2745    0.0000 C   0  0
    8.0688   10.0245    0.0000 C   0  0
    8.0688   11.5245    0.0000 C   0  0
    9.3678   12.2745    0.0000 O   0  0
  1  2  1  0
  1  3  1  0
  3  4  2  0
  3  5  1  0
  4  6  1  0
  4  7  1  0
  5  8  1  0
  5  9  2  0
  6 10  2  0
  6 11  1  0
  7 12  1  0
  8 13  1  0
  9 10  1  0
  9 14  1  0
 10 15  1  0
 11 16  2  0
 11 17  1  0
 12 17  2  0
 12 18  1  0
 14 19  1  0
 15 20  1  0
 18 21  2  0
 18 22  1  0
 21 23  1  0
 22 24  2  0
 23 25  2  0
 24 25  1  0
 25 26  1  0
M  END
> <Name>
tangeretin_T27

> <ID>
tangeretin_T27

> <PRIMARY_SOM>
23 24

> <Citation>
Brienholt et al.,Pharmacol. Toxicol.,93,14,2003

> <DOI>
10.1034/j.1600-0773.2003.930102.x

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
tegafur
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 2.3236 -0.4754 0 0
M  V30 2 O 8.89 0.1351 0 0
M  V30 3 O 7.5196 2.5249 0 0
M  V30 4 O 2.3234 2.5246 0 0
M  V30 5 N 6.2207 0.2748 0 0
M  V30 6 N 4.9215 2.5248 0 0
M  V30 7 C 7.5197 -0.4751 0 0 CFG=2
M  V30 8 C 7.6766 -1.9669 0 0
M  V30 9 C 9.1438 -2.2787 0 0
M  V30 10 C 9.8938 -0.9796 0 0
M  V30 11 C 6.2206 1.7748 0 0
M  V30 12 C 4.9217 -0.4752 0 0
M  V30 13 C 3.6226 0.2747 0 0
M  V30 14 C 3.6225 1.7747 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 7
M  V30 3 1 2 10
M  V30 4 2 3 11
M  V30 5 2 4 14
M  V30 6 1 7 5 CFG=1
M  V30 7 1 5 11
M  V30 8 1 5 12
M  V30 9 1 6 11
M  V30 10 1 6 14
M  V30 11 1 7 8
M  V30 12 1 8 9
M  V30 13 1 9 10
M  V30 14 2 12 13
M  V30 15 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
tegafur

> <ID>
tegafur

> <PRIMARY_SOM>
7

> <Citation>
Komatsu, T.; Yamazaki, H.; Shimada, N.; Nakajima, M.; Yokoi, T. Roles of Cytochromes P450 1A2 2A6, and 2C8 in 5-Fluorouracil Formation from Tegafur, an Anticancer Prodrug, in Human Liver Microsomes. D
rug Metab. Dispos. 2000, 28, 14571463.

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
temazepam
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -0.4036 4.952 0 0
M  V30 2 C -1.5032 3.9318 0 0
M  V30 3 C -2.9366 4.3739 0 0
M  V30 4 C -3.2704 5.8363 0 0
M  V30 5 C -2.1708 6.8566 0 0
M  V30 6 C -0.7374 6.4144 0 0
M  V30 7 Cl 0.3621 7.4347 0 0
M  V30 8 C -4.6218 6.4871 0 0
M  V30 9 N -3.8718 3.2012 0 0
M  V30 10 C -3.221 1.8497 0 0
M  V30 11 O -6.0226 1.8497 0 0
M  V30 12 C -5.3718 3.2012 0 0
M  V30 13 C -6.3071 4.3739 0 0 CFG=2
M  V30 14 O -7.7694 4.0401 0 0
M  V30 15 N -5.9733 5.8363 0 0
M  V30 16 C -4.6218 7.9871 0 0
M  V30 17 C -3.3228 8.7371 0 0
M  V30 18 C -5.9209 8.7371 0 0
M  V30 19 C -3.3228 10.2371 0 0
M  V30 20 C -5.9209 10.2371 0 0
M  V30 21 C -4.6218 10.9871 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 9
M  V30 6 2 4 5
M  V30 7 1 4 8
M  V30 8 1 5 6
M  V30 9 1 6 7
M  V30 10 2 8 15
M  V30 11 1 8 16
M  V30 12 1 9 10
M  V30 13 1 9 12
M  V30 14 2 11 12
M  V30 15 1 12 13
M  V30 16 1 13 14 CFG=3
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
temazepam

> <ID>
temazepam

> <PRIMARY_SOM>
10

> <Citation>
Yang et al.,Biochem. Pharmacol.,55,889,1998

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
tetranor
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C -1.2252 0.3757 0 0 CFG=2
M  V30 2 C -0.7252 1.7899 0 0 CFG=2
M  V30 3 C -2.7247 0.4142 0 0 CFG=1
M  V30 4 N -0.375 -0.8601 0 0
M  V30 5 C -1.9156 2.7024 0 0 CFG=1
M  V30 6 C 0.7129 2.2166 0 0
M  V30 7 C -1.4889 1.2644 0 0
M  V30 8 C -3.9152 1.3268 0 0
M  V30 9 S -1.0201 -2.2143 0 0
M  V30 10 C -3.4151 2.741 0 0
M  V30 11 C 1.0623 3.6753 0 0
M  V30 12 C 0.3341 -2.8594 0 0
M  V30 13 O -1.6652 -3.5685 0 0
M  V30 14 O -2.3743 -1.5692 0 0
M  V30 15 C 1.5699 -2.0092 0 0
M  V30 16 C 0.4526 -4.3547 0 0
M  V30 17 C 2.9241 -2.6543 0 0
M  V30 18 C 1.8068 -4.9998 0 0
M  V30 19 C 3.0425 -4.1496 0 0
M  V30 20 C 2.5003 4.1021 0 0
M  V30 21 O 3.5889 3.0701 0 0
M  V30 22 O 2.8498 5.5608 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7 CFG=1
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 7 CFG=3
M  V30 10 1 5 10
M  V30 11 1 6 11
M  V30 12 1 8 10
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 2 9 14
M  V30 16 1 11 20
M  V30 17 2 12 15
M  V30 18 1 12 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 2 3 5) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
tetranor

> <ID>
tetranor

> <PRIMARY_SOM>
10

> <Citation>
Yamaguchi et al.,Drug Metab. Disp.,25,75,1997

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
theophylline
  SciTegic08102311042D

 13 14  0  0  0  0            999 V2000
    6.9028   -2.9559    0.0000 C   0  0
    6.9028   -1.4559    0.0000 C   0  0
    8.2018   -0.7059    0.0000 O   0  0
    5.6037   -0.7059    0.0000 N   0  0
    5.6037    0.7941    0.0000 C   0  0
    4.3047   -1.4559    0.0000 C   0  0
    3.0056   -0.7059    0.0000 O   0  0
    4.3047   -2.9559    0.0000 N   0  0
    3.0056   -3.7059    0.0000 C   0  0
    5.6037   -3.7059    0.0000 C   0  0
    5.9156   -5.1731    0.0000 N   0  0
    7.4074   -5.3299    0.0000 C   0  0
    8.0175   -3.9596    0.0000 N   0  0
  1  2  1  0
  1 10  2  0
  1 13  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
M  END
> <Name>
theophylline

> <ID>
theophylline

> <PRIMARY_SOM>
12

> <Citation>
Zhang and Kaminsky,Biochem. Pharmacol.,50,205,1995

> <DOI>
10.1016/0006-2952(95)00120-O

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
ticlopidine
  SciTegic08102311042D

 17 19  0  0  0  0            999 V2000
    4.8212    6.6495    0.0000 C   0  0
    6.2477    6.1860    0.0000 C   0  0
    7.1294    7.3995    0.0000 C   0  0
    6.2477    8.6130    0.0000 S   0  0
    4.8212    8.1495    0.0000 C   0  0
    3.5221    8.8995    0.0000 C   0  0
    2.2231    8.1495    0.0000 C   0  0
    2.2231    6.6495    0.0000 N   0  0
    0.9240    5.8995    0.0000 C   0  0
    0.9240    4.3995    0.0000 C   0  0
    3.5221    5.8995    0.0000 C   0  0
   -0.3750    3.6495    0.0000 C   0  0
   -1.6740    4.3995    0.0000 Cl  0  0
   -0.3750    2.1495    0.0000 C   0  0
    0.9240    1.3995    0.0000 C   0  0
    2.2231    2.1495    0.0000 C   0  0
    2.2231    3.6495    0.0000 C   0  0
  1  2  1  0
  1  5  2  0
  1 11  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 10 12  1  0
 10 17  2  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
M  END
> <Name>
ticlopidine

> <ID>
ticlopidine

> <PRIMARY_SOM>
4

> <Citation>
Dansette et al.,Chem. Res. Toxicol.,22,369,2009

> <DOI>
10.1021/tx8004828

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
tirilazad
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 46 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 14.8385 -5.4393 0 0
M  V30 2 O 3.6869 1.2626 0 0
M  V30 3 N 12.8311 -7.6687 0 0
M  V30 4 N 13.7582 -10.5219 0 0
M  V30 5 N 13.218 -13.0632 0 0
M  V30 6 N 17.6197 -13.9988 0 0
M  V30 7 N 12.6779 -15.6045 0 0
M  V30 8 N 15.1488 -14.8017 0 0
M  V30 9 C 11.4812 -3.2373 0 0 CFG=1
M  V30 10 C 11.4812 -1.7373 0 0 CFG=2
M  V30 11 C 12.9078 -3.7009 0 0 CFG=2
M  V30 12 C 10.1822 -0.9873 0 0 CFG=1
M  V30 13 C 12.9078 -1.2738 0 0
M  V30 14 C 13.7895 -2.4873 0 0 CFG=1
M  V30 15 C 10.1822 -3.9873 0 0
M  V30 16 C 8.8831 -1.7373 0 0
M  V30 17 C 10.1822 0.5127 0 0
M  V30 18 C 11.638 -4.7291 0 0
M  V30 19 C 7.5841 -0.9873 0 0 CFG=1
M  V30 20 C 8.8831 -3.2373 0 0
M  V30 21 C 13.3713 -5.1274 0 0
M  V30 22 C 15.2895 -2.4873 0 0
M  V30 23 C 8.8831 1.2627 0 0
M  V30 24 C 7.5841 0.5127 0 0
M  V30 25 C 7.5841 -2.4873 0 0
M  V30 26 C 12.3676 -6.2422 0 0
M  V30 27 C 6.285 -1.7373 0 0
M  V30 28 C 6.285 1.2627 0 0
M  V30 29 C 4.986 -0.9873 0 0
M  V30 30 C 4.986 0.5127 0 0
M  V30 31 C 11.8275 -8.7835 0 0
M  V30 32 C 14.2984 -7.9806 0 0
M  V30 33 C 12.291 -10.21 0 0
M  V30 34 C 14.7619 -9.4072 0 0
M  V30 35 C 14.2217 -11.9485 0 0
M  V30 36 C 15.689 -12.2604 0 0
M  V30 37 C 16.1525 -13.6869 0 0
M  V30 38 C 13.6816 -14.4898 0 0
M  V30 39 C 18.7344 -12.9951 0 0
M  V30 40 C 18.2298 -15.3691 0 0
M  V30 41 C 12.9898 -17.0717 0 0
M  V30 42 C 11.1861 -15.4477 0 0
M  V30 43 C 20.0335 -13.7451 0 0
M  V30 44 C 19.7216 -15.2123 0 0
M  V30 45 C 11.6907 -17.8217 0 0
M  V30 46 C 10.576 -16.8181 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 2 2 30
M  V30 3 1 3 26
M  V30 4 1 3 31
M  V30 5 1 3 32
M  V30 6 1 4 33
M  V30 7 1 4 34
M  V30 8 1 4 35
M  V30 9 2 5 35
M  V30 10 1 5 38
M  V30 11 1 6 37
M  V30 12 1 6 39
M  V30 13 1 6 40
M  V30 14 1 7 38
M  V30 15 1 7 41
M  V30 16 1 7 42
M  V30 17 1 8 37
M  V30 18 2 8 38
M  V30 19 1 9 10
M  V30 20 1 9 11
M  V30 21 1 9 15
M  V30 22 1 9 18 CFG=3
M  V30 23 1 10 12
M  V30 24 1 10 13 CFG=3
M  V30 25 1 11 14
M  V30 26 1 11 21 CFG=3
M  V30 27 1 12 16
M  V30 28 1 12 17 CFG=1
M  V30 29 1 13 14
M  V30 30 1 14 22 CFG=1
M  V30 31 1 15 20
M  V30 32 1 16 19
M  V30 33 2 16 20
M  V30 34 1 17 23
M  V30 35 1 19 24
M  V30 36 1 19 25 CFG=3
M  V30 37 1 19 27
M  V30 38 1 21 26
M  V30 39 1 23 24
M  V30 40 2 24 28
M  V30 41 2 27 29
M  V30 42 1 28 30
M  V30 43 1 29 30
M  V30 44 1 31 33
M  V30 45 1 32 34
M  V30 46 1 35 36
M  V30 47 2 36 37
M  V30 48 1 39 43
M  V30 49 1 40 44
M  V30 50 1 41 45
M  V30 51 1 42 46
M  V30 52 1 43 44
M  V30 53 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 9 10 11 12 14 19) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
tirilazad

> <ID>
tirilazad

> <PRIMARY_SOM>
23

> <SECONDARY_SOM>
39 40 43 44

> <Citation>
Wienkers et al.,J. Pharm. Exp. Ther.,277,982,1996

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
tpa023
  SciTegic08102311042D

 29 32  0  0  0  0            999 V2000
   11.5476    6.3901    0.0000 C   0  0
   13.0148    6.7020    0.0000 C   0  0
   13.4783    8.1286    0.0000 C   0  0
   12.4746    9.2433    0.0000 C   0  0
   11.0074    8.9314    0.0000 C   0  0
   10.5439    7.5048    0.0000 C   0  0
   14.0185    5.5873    0.0000 F   0  0
   11.0840    4.9635    0.0000 C   0  0
   11.9657    3.7500    0.0000 N   0  0
   11.0840    2.5365    0.0000 N   0  0
    9.6574    3.0000    0.0000 C   0  0
    9.6574    4.5000    0.0000 N   0  0
    8.3584    2.2500    0.0000 C   0  0
    7.0594    3.0000    0.0000 C   0  0
    7.0594    4.5000    0.0000 C   0  0
    8.3584    5.2500    0.0000 N   0  0
    5.7603    2.2500    0.0000 C   0  0
    5.7603    5.2500    0.0000 O   0  0
    5.7603    0.7500    0.0000 C   0  0
    4.4613    3.0000    0.0000 C   0  0
    4.4613    1.5000    0.0000 C   0  0
    5.7603    6.7500    0.0000 C   0  0
    4.4613    7.5000    0.0000 C   0  0
    3.0910    6.8899    0.0000 N   0  0
    2.0873    8.0046    0.0000 C   0  0
    2.8373    9.3037    0.0000 N   0  0
    4.3045    8.9918    0.0000 N   0  0
    5.4192    9.9955    0.0000 C   0  0
    5.1073   11.4627    0.0000 C   0  0
  1  2  1  0
  1  6  2  0
  1  8  1  0
  2  3  2  0
  2  7  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  8  9  2  0
  8 12  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 12 16  1  0
 13 14  2  0
 14 15  1  0
 14 17  1  0
 15 16  2  0
 15 18  1  0
 17 19  1  0
 17 20  1  0
 17 21  1  0
 18 22  1  0
 22 23  1  0
 23 24  2  0
 23 27  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
M  END
> <Name>
tpa023

> <ID>
tpa023

> <PRIMARY_SOM>
19 20 21 28

> <Citation>
Ma et al.,Drug Metab. Disp.,35,1301,2007

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
urporphyrinogen
  SciTegic08102311042D

 60 64  0  0  0  0            999 V2000
   13.6810   -0.5980    0.0000 O   0  0
    6.5900   -4.6900    0.0000 O   0  0
    9.3220    6.1980    0.0000 O   0  0
    2.5720    2.0080    0.0000 O   0  0
   13.0040    0.9970    0.0000 O   0  0
    8.2380   -4.1590    0.0000 O   0  0
    7.7510    5.4690    0.0000 O   0  0
    3.2410    0.4100    0.0000 O   0  0
   12.5010    4.4120    0.0000 O   0  0
    9.0080   -5.6980    0.0000 O   0  0
    4.4170    5.0440    0.0000 O   0  0
    3.3540   -2.8180    0.0000 O   0  0
   13.5500    3.0340    0.0000 O   0  0
   10.4030   -4.6710    0.0000 O   0  0
    5.8120    6.0710    0.0000 O   0  0
    2.4880   -1.3180    0.0000 O   0  0
    9.6260    0.6830    0.0000 N   0  0
    8.1240   -0.6870    0.0000 N   0  0
    8.0910    2.0520    0.0000 N   0  0
    6.6210    0.6830    0.0000 N   0  0
   10.1940    1.4850    0.0000 C   0  0
    8.9260   -1.2880    0.0000 C   0  0
    7.2890    2.6870    0.0000 C   0  0
    6.0540   -0.0860    0.0000 C   0  0
   10.2270   -0.0520    0.0000 C   0  0
    7.3230   -1.3210    0.0000 C   0  0
    8.9260    2.7200    0.0000 C   0  0
    6.0540    1.4510    0.0000 C   0  0
    9.8940    2.4190    0.0000 C   0  0
    9.9280   -1.0200    0.0000 C   0  0
    6.3210    2.4190    0.0000 C   0  0
    6.3550   -1.0200    0.0000 C   0  0
   11.1630    1.2170    0.0000 C   0  0
    8.6250   -2.2550    0.0000 C   0  0
    7.5900    3.6550    0.0000 C   0  0
    5.0860    0.1820    0.0000 C   0  0
   11.1630    0.2160    0.0000 C   0  0
    7.6240   -2.2550    0.0000 C   0  0
    8.5920    3.6550    0.0000 C   0  0
    5.0860    1.1840    0.0000 C   0  0
   11.9590    1.8230    0.0000 C   0  0
    9.2180   -3.0610    0.0000 C   0  0
    6.9980    4.4600    0.0000 C   0  0
    4.2200   -0.3180    0.0000 C   0  0
   11.9620   -0.3860    0.0000 C   0  0
    6.9530   -2.9970    0.0000 C   0  0
    9.1670    4.4720    0.0000 C   0  0
    4.2900    1.7890    0.0000 C   0  0
   11.8320    2.8150    0.0000 C   0  0
    8.8170   -3.9770    0.0000 C   0  0
    6.0040    4.3490    0.0000 C   0  0
    4.2200   -1.3180    0.0000 C   0  0
   12.8820    0.0040    0.0000 C   0  0
    7.2600   -3.9490    0.0000 C   0  0
    8.7470    5.3800    0.0000 C   0  0
    3.3680    1.4020    0.0000 C   0  0
   12.6280    3.4200    0.0000 C   0  0
    9.4100   -4.7820    0.0000 C   0  0
    5.4110    5.1550    0.0000 C   0  0
    3.3540   -1.8180    0.0000 C   0  0
  1 53  1  0
  2 54  1  0
  3 55  1  0
  4 56  1  0
  5 53  2  0
  6 54  2  0
  7 55  2  0
  8 56  2  0
  9 57  1  0
 10 58  1  0
 11 59  1  0
 12 60  1  0
 13 57  2  0
 14 58  2  0
 15 59  2  0
 16 60  2  0
 17 21  1  0
 17 25  1  0
 18 22  1  0
 18 26  1  0
 19 23  1  0
 19 27  1  0
 20 24  1  0
 20 28  1  0
 21 29  1  0
 21 33  2  0
 22 30  1  0
 22 34  2  0
 23 31  1  0
 23 35  2  0
 24 32  1  0
 24 36  2  0
 25 30  1  0
 25 37  2  0
 26 32  1  0
 26 38  2  0
 27 29  1  0
 27 39  2  0
 28 31  1  0
 28 40  2  0
 33 37  1  0
 33 41  1  0
 34 38  1  0
 34 42  1  0
 35 39  1  0
 35 43  1  0
 36 40  1  0
 36 44  1  0
 37 45  1  0
 38 46  1  0
 39 47  1  0
 40 48  1  0
 41 49  1  0
 42 50  1  0
 43 51  1  0
 44 52  1  0
 45 53  1  0
 46 54  1  0
 47 55  1  0
 48 56  1  0
 49 57  1  0
 50 58  1  0
 51 59  1  0
 52 60  1  0
M  END
> <Name>
urporphyrinogen

> <ID>
urporphyrinogen

> <PRIMARY_SOM>
29 30 31 32

> <Citation>
Sinclair et al., Drug Metab. Dispos., 1998, 26, 1019-1025

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
vicriviroc
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N -9.4683 -2.8995 0 0
M  V30 2 C -8.1692 -3.6495 0 0 CFG=1
M  V30 3 C -8.1692 -5.1495 0 0
M  V30 4 O -9.4683 -5.8995 0 0
M  V30 5 C -9.4683 -7.3995 0 0
M  V30 6 C -6.8702 -2.8995 0 0
M  V30 7 C -5.5712 -3.6495 0 0
M  V30 8 C -4.2721 -2.8995 0 0
M  V30 9 C -4.2721 -1.3995 0 0
M  V30 10 C -5.5712 -0.6495 0 0
M  V30 11 C -6.8702 -1.3995 0 0
M  V30 12 C -2.9731 -0.6495 0 0
M  V30 13 F -1.674 -1.3995 0 0
M  V30 14 F -2.9731 0.8505 0 0
M  V30 15 F -1.674 0.1005 0 0
M  V30 16 C -9.4683 -1.3995 0 0 CFG=1
M  V30 17 C -8.1692 -0.6495 0 0
M  V30 18 C -10.7673 -0.6495 0 0
M  V30 19 N -12.0663 -1.3995 0 0
M  V30 20 C -13.3654 -0.6495 0 0
M  V30 21 C -13.8784 -2.0591 0 0
M  V30 22 C -12.0663 -2.8995 0 0
M  V30 23 C -10.7673 -3.6495 0 0
M  V30 24 C -12.4012 0.4995 0 0
M  V30 25 C -12.9142 1.9091 0 0
M  V30 26 N -14.3914 2.1696 0 0
M  V30 27 C -15.3556 1.0205 0 0
M  V30 28 C -14.8426 -0.389 0 0
M  V30 29 C -14.9045 3.5791 0 0
M  V30 30 C -16.3817 3.8396 0 0
M  V30 31 O -13.9403 4.7282 0 0
M  V30 32 C -16.8947 5.2491 0 0
M  V30 33 C -15.9305 6.3982 0 0
M  V30 34 N -18.3719 5.5096 0 0
M  V30 35 C -19.3361 4.3605 0 0
M  V30 36 N -18.8231 2.951 0 0
M  V30 37 C -17.3459 2.6905 0 0
M  V30 38 C -16.8328 1.281 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 1 23
M  V30 4 1 2 3 CFG=3
M  V30 5 1 2 6
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 6 7
M  V30 9 2 6 11
M  V30 10 2 7 8
M  V30 11 1 8 9
M  V30 12 2 9 10
M  V30 13 1 9 12
M  V30 14 1 10 11
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 18 1 16 17 CFG=3
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 19 22
M  V30 23 1 20 21
M  V30 24 1 20 24
M  V30 25 1 20 28
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 25 26
M  V30 29 1 26 27
M  V30 30 1 26 29
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 1 30 32
M  V30 35 2 30 37
M  V30 36 1 32 33
M  V30 37 2 32 34
M  V30 38 1 34 35
M  V30 39 2 35 36
M  V30 40 1 36 37
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 16) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
vicriviroc

> <ID>
vicriviroc

> <PRIMARY_SOM>
5

> <SECONDARY_SOM>
34 35 36

> <TERTIARY_SOM>
2 3 17

> <Citation>
Ghosal et al., Drug Metab. Disp.,35,2186,2007

> <DOI>
10.1124/dmd.107.017517

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
voreloxin
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2728 9.6515 0 0
M  V30 2 C 5.2728 11.1515 0 0
M  V30 3 C 3.9737 11.9015 0 0
M  V30 4 C 2.6747 11.1515 0 0
M  V30 5 C 2.6747 9.6515 0 0
M  V30 6 N 3.9737 8.9015 0 0
M  V30 7 N 6.5718 8.9015 0 0
M  V30 8 C 7.8708 9.6515 0 0
M  V30 9 C 7.8708 11.1515 0 0
M  V30 10 C 6.5718 11.9015 0 0
M  V30 11 O 6.5718 13.4015 0 0
M  V30 12 C 6.5718 7.4015 0 0
M  V30 13 N 7.7853 6.5199 0 0
M  V30 14 C 7.3218 5.0933 0 0
M  V30 15 C 5.8218 5.0933 0 0
M  V30 16 S 5.3583 6.5199 0 0
M  V30 17 C 9.1699 11.9015 0 0
M  V30 18 O 9.1699 13.4015 0 0
M  V30 19 O 10.4689 11.1515 0 0
M  V30 20 C -0.2484 7.0979 0 0 CFG=1
M  V30 21 C -0.9984 8.3969 0 0 CFG=1
M  V30 22 C 0.0053 9.5116 0 0
M  V30 23 N 1.3756 8.9015 0 0
M  V30 24 C 1.2189 7.4097 0 0
M  V30 25 N -0.8585 5.7276 0 0
M  V30 26 C -2.3503 5.5708 0 0
M  V30 27 O -2.4902 8.5537 0 0
M  V30 28 C -3.3718 7.3402 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 7
M  V30 4 2 2 3
M  V30 5 1 2 10
M  V30 6 1 3 4
M  V30 7 2 4 5
M  V30 8 1 5 6
M  V30 9 1 5 23
M  V30 10 1 7 8
M  V30 11 1 7 12
M  V30 12 2 8 9
M  V30 13 1 9 10
M  V30 14 1 9 17
M  V30 15 2 10 11
M  V30 16 2 12 13
M  V30 17 1 12 16
M  V30 18 1 13 14
M  V30 19 2 14 15
M  V30 20 1 15 16
M  V30 21 1 17 18
M  V30 22 2 17 19
M  V30 23 1 20 21
M  V30 24 1 20 24
M  V30 25 1 20 25 CFG=1
M  V30 26 1 21 22
M  V30 27 1 21 27 CFG=3
M  V30 28 1 22 23
M  V30 29 1 23 24
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 20 21) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
voreloxin

> <ID>
voreloxin

> <PRIMARY_SOM>
8 9 26 28

> <Citation>
Evanchik et al.,Drug Metab. Disp.,37,594,2009

> <DOI>
10.1124/dmd.108.023432

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
warfarin-r
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9586 -7.4901 0 0
M  V30 2 O 7.2539 -5.238 0 0
M  V30 3 O 2.0577 -5.2466 0 0
M  V30 4 O 7.2464 -0.738 0 0
M  V30 5 C 4.6533 -3.7423 0 0 CFG=2
M  V30 6 C 4.6558 -5.2423 0 0
M  V30 7 C 5.9511 -2.9901 0 0
M  V30 8 C 3.353 -2.9945 0 0
M  V30 9 C 3.358 -5.9944 0 0
M  V30 10 C 5.9561 -5.9901 0 0
M  V30 11 C 3.3605 -7.4944 0 0
M  V30 12 C 5.9486 -1.4901 0 0
M  V30 13 C 3.3506 -1.4945 0 0
M  V30 14 C 2.0552 -3.7466 0 0
M  V30 15 C 4.6608 -8.2423 0 0
M  V30 16 C 2.0627 -8.2466 0 0
M  V30 17 C 2.0503 -0.7466 0 0
M  V30 18 C 0.755 -2.9988 0 0
M  V30 19 C 4.6484 -0.7423 0 0
M  V30 20 C 4.6633 -9.7423 0 0
M  V30 21 C 0.7525 -1.4988 0 0
M  V30 22 C 2.0652 -9.7466 0 0
M  V30 23 C 3.3655 -10.4944 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 15
M  V30 3 1 2 10
M  V30 4 2 3 9
M  V30 5 2 4 12
M  V30 6 1 5 6
M  V30 7 1 5 7 CFG=1
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 8 14
M  V30 14 1 9 11
M  V30 15 2 11 15
M  V30 16 1 11 16
M  V30 17 1 12 19
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 15 20
M  V30 21 2 16 22
M  V30 22 2 17 21
M  V30 23 1 18 21
M  V30 24 2 20 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
warfarin-r

> <ID>
warfarin-r

> <PRIMARY_SOM>
7

> <SECONDARY_SOM>
23

> <Citation>
Rendic,Drug Metab. Rev.,34,83,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
warfarin-s
  SciTegic08102311042D

  0  0  0  0  0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9586 -7.4901 0 0
M  V30 2 O 7.2539 -5.238 0 0
M  V30 3 O 2.0577 -5.2466 0 0
M  V30 4 O 7.2464 -0.738 0 0
M  V30 5 C 4.6533 -3.7423 0 0 CFG=1
M  V30 6 C 4.6558 -5.2423 0 0
M  V30 7 C 5.9511 -2.9901 0 0
M  V30 8 C 3.353 -2.9945 0 0
M  V30 9 C 3.358 -5.9944 0 0
M  V30 10 C 5.9561 -5.9901 0 0
M  V30 11 C 3.3605 -7.4944 0 0
M  V30 12 C 5.9486 -1.4901 0 0
M  V30 13 C 3.3506 -1.4945 0 0
M  V30 14 C 2.0552 -3.7466 0 0
M  V30 15 C 4.6608 -8.2423 0 0
M  V30 16 C 2.0627 -8.2466 0 0
M  V30 17 C 2.0503 -0.7466 0 0
M  V30 18 C 0.755 -2.9988 0 0
M  V30 19 C 4.6484 -0.7423 0 0
M  V30 20 C 4.6633 -9.7423 0 0
M  V30 21 C 0.7525 -1.4988 0 0
M  V30 22 C 2.0652 -9.7466 0 0
M  V30 23 C 3.3655 -10.4944 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 15
M  V30 3 1 2 10
M  V30 4 2 3 9
M  V30 5 2 4 12
M  V30 6 1 5 6
M  V30 7 1 5 7 CFG=3
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 8 14
M  V30 14 1 9 11
M  V30 15 2 11 15
M  V30 16 1 11 16
M  V30 17 1 12 19
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 15 20
M  V30 21 2 16 22
M  V30 22 2 17 21
M  V30 23 1 18 21
M  V30 24 2 20 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5) 
M  V30 END COLLECTION
M  V30 END CTAB
M  END
> <Name>
warfarin-s

> <ID>
warfarin-s

> <PRIMARY_SOM>
21

> <SECONDARY_SOM>
7

> <Citation>
Rendic,Drug Metab. Rev.,34,83,2002

> <New_Or_Updated_From_Original_Merck_Dataset>
1

> <SBRS Components Version>
1.1 2023-06-16 dd43dcc

$$$$
